data_2kie_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kie _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.497 1.689 0 CA-C-O 120.955 0.314 . . . . 1.0 111.908 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.56 161.14 80.66 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.893 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.75 144.67 99.59 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.363 1.375 . . . . 1.0 111.652 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.17 -44.6 91.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.38 -28.37 73.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.248 -0.741 . . . . 1.0 111.248 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.75 149.06 47.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.975 0.417 . . . . 1.0 110.959 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.2 80.42 15.58 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.516 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.96 98.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.081 1.854 . . . . 1.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.8 mt -65.6 -41.36 92.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.026 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.49 145.51 26.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.979 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -135.42 130.28 34.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.445 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.7 158.66 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.88 0.371 . . . . 1.0 110.853 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.36 123.3 46.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.578 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.84 -163.75 11.06 Favored Glycine 0 N--CA 1.46 0.275 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt -139.09 125.53 20.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.408 . . . . 1.0 110.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -89.18 120.85 30.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.3 mtm -106.73 136.78 45.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.689 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.8 147.65 52.31 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.732 -0.469 . . . . 1.0 109.732 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.57 -65.27 0.38 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.743 -0.662 . . . . 1.0 112.496 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -32.23 83.32 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.791 2.327 . . . . 1.0 113.952 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -174.99 -176.3 0.95 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -125.18 171.15 10.56 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.146 0.498 . . . . 1.0 110.563 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -157.83 129.21 3.82 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.202 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.38 146.93 49.04 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.305 1.145 . . . . 1.0 111.502 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.6 p -154.95 -172.99 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.687 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.14 138.74 20.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.18 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.8 mt -106.54 124.69 49.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.054 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.4 m -130.64 122.44 27.41 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.115 0.483 . . . . 1.0 111.556 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.2 tp -93.5 131.41 38.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.28 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.46 148.55 37.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.043 0.449 . . . . 1.0 111.244 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.49 123.53 48.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.731 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -134.05 131.03 38.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.024 0.44 . . . . 1.0 110.82 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.7 m120 61.9 33.45 17.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.822 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.36 17.91 77.92 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.646 HE22 ' NE2' ' A' ' 123' ' ' GLN . 45.6 tp60 -125.71 158.06 35.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.548 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 96.2 m-85 -99.72 135.83 40.55 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.023 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -145.17 141.32 28.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.927 0.394 . . . . 1.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.21 124.77 49.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.611 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.427 HG22 HD13 ' A' ' 47' ' ' ILE . 81.8 mt -107.09 127.03 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.941 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.94 122.93 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -109.61 128.51 55.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.067 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 52' ' ' GLU . 9.1 mp -102.6 126.69 49.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -71.54 40.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.207 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 50' ' ' LEU . 38.9 tp10 -49.69 144.26 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.294 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.78 -39.91 95.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.219 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.05 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.967 0.413 . . . . 1.0 110.384 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.77 148.23 31.72 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.733 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -62.54 104.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.241 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 t -70.27 135.46 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.496 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -99.17 108.35 20.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.785 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -106.1 112.47 25.52 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.15 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 1.0 110.157 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.67 91.29 34.1 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.078 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.31 143.7 93.07 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.17 1.913 . . . . 1.0 112.431 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 63' ' ' ILE . 93.3 mt -88.17 122.22 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.826 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -174.68 -160.88 0.1 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.998 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 t -60.22 -41.93 94.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.212 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -64.8 -34.13 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.554 -0.293 . . . . 1.0 111.033 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -94.56 127.47 40.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.353 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.577 ' NH2' HE21 ' A' ' 92' ' ' GLN . 86.3 mtm180 -136.09 142.54 44.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.334 0.588 . . . . 1.0 110.857 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.71 100.86 7.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.207 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 m -101.95 122.98 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.965 0.412 . . . . 1.0 110.561 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -89.38 106.83 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.599 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.63 ' H ' ' NH1' ' A' ' 90' ' ' ARG . 36.1 tp10 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 121.113 0.482 . . . . 1.0 111.0 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.001 0.429 . . . . 1.0 110.253 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.46 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 94.2 mt -63.79 -43.27 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.8 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.295 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.2 t -103.73 62.23 0.76 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 1.0 110.335 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.4 m120 -80.71 -173.62 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.993 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 t 67.85 86.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.94 81.01 0.09 OUTLIER Glycine 0 CA--C 1.521 0.431 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.2 132.19 39.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.72 0.295 . . . . 1.0 111.785 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.432 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 62.7 mttp -112.17 127.66 56.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 89' ' ' ILE . 46.7 pt -129.17 158.08 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.63 ' NH1' ' H ' ' A' ' 72' ' ' GLU . 1.8 mpt_? -126.47 140.85 52.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.215 0.531 . . . . 1.0 110.003 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.1 133.85 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.913 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.577 HE21 ' NH2' ' A' ' 68' ' ' ARG . 12.9 pt20 -142.36 138.29 31.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.127 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.53 0.205 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -174.54 129.5 0.34 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.584 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -142.96 149.53 38.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -105.61 149.01 26.69 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.096 0.474 . . . . 1.0 111.231 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -142.34 149.72 39.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.118 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -144.51 152.24 40.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.875 0.369 . . . . 1.0 111.009 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.54 99.71 15.52 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.16 -12.74 32.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.626 1.551 . . . . 1.0 112.788 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.57 101.1 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -57.4 -54.17 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.985 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -52.08 -44.23 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.544 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -68.9 -38.38 79.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 1.0 110.537 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -35.87 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.988 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.38 -45.53 92.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.318 -0.553 . . . . 1.0 111.105 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -66.97 -44.21 81.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.905 -0.718 . . . . 1.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.18 -49.21 76.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.203 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.67 -40.35 84.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.273 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.564 ' HG ' ' N ' ' A' ' 115' ' ' ALA . 78.0 p -64.73 -47.43 78.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.395 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.564 ' N ' ' HG ' ' A' ' 114' ' ' SER . . . -65.73 -48.44 71.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.347 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.66 -44.08 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.37 -44.35 95.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.097 0.475 . . . . 1.0 110.213 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.38 84.96 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.99 72.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.671 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.27 -36.49 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 1.0 111.295 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.82 -45.05 95.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.797 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.11 93.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.444 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.646 ' NE2' HE22 ' A' ' 43' ' ' GLN . 87.3 mt-30 -70.55 -37.79 74.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.851 0.358 . . . . 1.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.574 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.496 1.628 0 CA-C-O 120.884 0.285 . . . . 1.0 111.944 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.85 159.02 84.4 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.059 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.63 144.52 99.55 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.295 1.33 . . . . 1.0 111.653 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.32 -45.71 85.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.253 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.77 -28.91 74.06 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.45 141.2 58.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.941 0.401 . . . . 1.0 111.068 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.78 79.62 0.43 Allowed Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.78 94.74 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.883 1.722 . . . . 1.0 112.814 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -43.12 95.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.894 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.69 148.29 42.15 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.317 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 t -141.56 130.45 23.08 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.57 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 55.3 t -137.59 158.1 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.979 0.418 . . . . 1.0 110.725 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.426 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 80.7 tt0 -107.39 122.76 47.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.445 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.11 -160.92 9.87 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 71.1 mtp -136.36 130.21 32.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.386 . . . . 1.0 110.418 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.56 123.11 36.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.6 mpp? -113.29 137.83 50.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.982 0.42 . . . . 1.0 110.526 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -140.62 149.13 41.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.007 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.71 -65.17 0.48 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.884 -0.598 . . . . 1.0 112.697 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.12 -32.53 94.79 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.774 2.316 . . . . 1.0 113.564 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.6 177.58 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.852 -0.339 . . . . 1.0 110.878 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.3 169.25 11.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.894 0.378 . . . . 1.0 110.788 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 18.0 pt-20 -159.68 143.15 10.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.639 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.99 141.91 85.8 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.34 1.36 . . . . 1.0 110.929 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 22' ' ' GLY . 22.0 p -147.78 -175.73 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.38 136.25 18.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.95 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 mt -100.08 124.49 45.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.998 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -127.99 126.86 42.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.13 0.491 . . . . 1.0 111.429 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.3 tp -96.37 126.17 41.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.886 -0.783 . . . . 1.0 108.886 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.43 152.13 48.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.072 0.463 . . . . 1.0 111.467 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.2 118.28 33.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.673 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -130.56 137.8 49.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.861 0.362 . . . . 1.0 110.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 59.04 33.59 23.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.444 -0.798 . . . . 1.0 111.387 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.98 22.44 77.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.437 ' OE1' ' N ' ' A' ' 44' ' ' TYR . 6.5 tp-100 -131.09 147.7 52.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.437 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 72.0 m-85 -88.52 133.84 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.67 140.73 30.21 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.07 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 tt -104.85 119.97 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.731 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.621 ' CG2' HE21 ' A' ' 58' ' ' GLN . 78.4 mt -101.79 127.76 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.052 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.5 mt -104.36 116.76 48.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -97.63 132.34 43.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.016 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mp -105.15 130.81 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.88 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -103.01 27.19 7.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.282 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 97.1 mt-10 -45.65 150.09 0.54 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -62.33 -40.31 95.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.3 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -54.55 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.38 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.49 158.11 43.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.88 112.54 17.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.071 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 t -95.25 133.41 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.921 0.391 . . . . 1.0 110.531 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.621 HE21 ' CG2' ' A' ' 47' ' ' ILE . 55.6 tp60 -99.64 107.37 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.422 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -105.93 112.52 25.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.983 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.84 111.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.876 0.369 . . . . 1.0 110.187 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.33 116.78 48.39 Favored Pre-proline 0 N--CA 1.467 0.384 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.127 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.59 147.54 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.644 1.563 . . . . 1.0 112.61 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.51 120.04 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.2 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -175.22 -162.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -64.15 -26.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.185 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -83.69 -10.74 57.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.678 0.275 . . . . 1.0 110.948 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.81 129.29 56.0 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -136.5 146.86 46.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.743 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.87 106.46 9.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.506 -0.77 . . . . 1.0 108.937 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m -109.14 126.46 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.052 0.453 . . . . 1.0 110.969 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 52.9 tp60 -82.8 115.29 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.635 179.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.951 0.405 . . . . 1.0 110.153 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.93 -42.39 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.39 -25.93 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.895 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.2 t -103.87 66.58 0.85 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.07 0.462 . . . . 1.0 110.568 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' A' ' 85' ' ' SER . 12.4 m120 -91.73 -171.48 2.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.166 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 85' ' ' SER . 6.9 p 65.06 98.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.987 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.3 77.53 0.13 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.492 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -95.7 134.21 38.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.802 0.334 . . . . 1.0 111.772 -178.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.621 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 99.5 mttt -107.94 123.82 49.21 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.0 149.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.498 ' C ' HE22 ' A' ' 92' ' ' GLN . 81.9 mtt85 -121.86 143.98 49.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.915 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.51 135.35 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.877 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.498 HE22 ' C ' ' A' ' 90' ' ' ARG . 15.1 mp0 -136.95 151.75 49.38 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.737 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.646 0.26 . . . . 1.0 110.739 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.75 124.84 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 1.0 110.756 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.11 132.06 44.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.295 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -91.55 151.9 20.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 1.0 111.076 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.18 153.69 43.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.202 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -138.82 143.87 39.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.953 0.406 . . . . 1.0 110.901 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 mm -127.17 91.08 47.46 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -16.99 41.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.698 1.598 . . . . 1.0 112.681 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.69 106.35 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.64 -54.69 35.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 1.0 112.182 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -52.42 -42.77 64.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.607 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -70.55 -37.54 74.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.573 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.9 t -59.19 -35.57 73.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.891 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.27 -44.38 95.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.451 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.12 -44.51 84.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.979 -0.689 . . . . 1.0 110.454 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -60.76 -49.8 76.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.149 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.46 -41.58 80.0 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.466 -0.493 . . . . 1.0 111.223 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.6 t -63.55 -45.55 90.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.595 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.43 -49.31 56.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.544 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.46 -45.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.026 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.02 -48.59 81.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.35 80.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.577 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.35 91.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.752 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.74 -45.91 80.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.948 0.404 . . . . 1.0 111.351 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.78 -43.14 89.7 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.472 0.653 . . . . 1.0 110.368 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.96 77.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.855 -1.066 . . . . 1.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -71.92 -39.87 69.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.393 . . . . 1.0 110.556 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.597 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.498 1.753 0 CA-C-O 120.971 0.321 . . . . 1.0 111.716 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.37 158.57 3.86 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.75 142.99 99.3 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.308 1.338 . . . . 1.0 111.688 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.18 -45.23 83.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.382 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.72 81.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.26 50.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.06 0.457 . . . . 1.0 111.144 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -98.19 107.86 43.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.7 103.89 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.435 1.423 . . . . 1.0 112.871 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.93 -43.22 79.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.186 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.79 151.52 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.076 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -140.92 135.0 30.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 1.0 110.547 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 p -142.45 152.12 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.018 0.437 . . . . 1.0 111.163 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -106.64 121.85 45.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -130.46 -155.87 8.45 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 21.4 mmt -137.04 128.65 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.939 0.4 . . . . 1.0 110.244 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -90.21 126.33 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.338 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.0 mtm -109.32 138.75 45.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 29' ' ' LEU . 99.3 mttt -135.64 149.68 49.4 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.898 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -67.07 0.29 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.569 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.28 -32.6 81.95 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.793 2.328 . . . . 1.0 113.852 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -173.94 -170.06 0.53 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.408 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -130.38 169.67 15.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.021 0.439 . . . . 1.0 110.313 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -156.29 144.39 14.31 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.396 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.98 146.14 96.45 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.294 1.329 . . . . 1.0 111.293 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 34' ' ' ALA . 19.7 t -158.02 170.15 22.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.314 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.645 ' N ' ' SG ' ' A' ' 33' ' ' CYS . . . -138.14 139.99 39.68 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.854 0.359 . . . . 1.0 110.239 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 mt -107.07 121.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.764 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -125.08 122.91 38.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.229 0.537 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.0 tp -94.67 122.64 37.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.31 146.25 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.145 0.498 . . . . 1.0 111.309 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -98.71 126.69 44.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.747 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -139.82 136.73 34.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.971 0.415 . . . . 1.0 110.727 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 59.15 33.75 22.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.568 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.24 24.88 76.33 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.748 -0.941 . . . . 1.0 110.748 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -135.44 159.44 41.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -100.22 133.16 45.03 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -141.42 142.93 33.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.044 0.45 . . . . 1.0 110.34 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -104.32 119.69 39.52 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.896 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.0 mt -98.15 128.87 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.55 131.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.497 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 73.2 mt-30 -123.23 124.65 43.5 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.99 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 10.4 mp -99.9 114.75 28.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -72.49 62.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -62.51 151.86 36.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.314 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.87 -41.66 98.12 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.57 -77.36 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -147.82 150.56 34.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -68.73 138.37 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.967 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.18 130.37 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 1.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -91.09 108.35 19.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.791 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.07 114.68 28.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.28 116.12 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.86 0.362 . . . . 1.0 110.46 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.1 91.6 32.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.19 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -57.42 142.77 95.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.213 1.942 . . . . 1.0 112.591 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.62 122.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -175.66 -163.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.201 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.9 p -63.84 -22.2 66.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -85.61 -11.34 54.17 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.602 0.239 . . . . 1.0 111.06 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -121.84 135.27 54.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -137.42 151.38 48.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.104 0.478 . . . . 1.0 110.711 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.7 p -138.76 111.65 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 128.28 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 1.0 111.196 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.641 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 49.5 tp60 -82.27 97.53 8.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.585 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.17 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.963 0.411 . . . . 1.0 110.204 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 83' ' ' SER . 32.6 mm -71.64 -24.13 23.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.18 -3.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.053 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 29.8 t -138.97 138.18 37.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 1.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.9 m120 -146.69 -171.32 3.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.105 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 61.77 85.1 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.31 78.28 0.27 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.571 -1.412 . . . . 1.0 109.571 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.535 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.85 137.62 35.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 111.866 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.641 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 99.7 mttt -112.41 127.03 55.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 pp -118.17 132.05 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -97.1 141.67 29.96 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.7 t -121.63 134.85 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.572 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -143.46 150.64 39.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.18 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.557 0 N-CA-C 110.644 -0.982 . . . . 1.0 110.644 179.545 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 120.684 0.278 . . . . 1.0 110.616 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.12 132.88 54.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 1.0 110.363 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -140.43 125.49 18.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.611 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -88.22 144.07 26.67 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.993 0.425 . . . . 1.0 111.192 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.83 152.05 49.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -139.59 144.64 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.821 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.8 mm -127.64 91.55 45.26 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.3 -16.99 39.85 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.822 1.681 . . . . 1.0 112.751 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -87.79 104.28 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.96 -54.99 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 1.0 112.32 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -52.1 -44.31 64.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.425 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.17 -36.17 77.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.533 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 4.2 t -61.75 -38.07 86.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.999 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.77 -46.09 89.64 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.223 -0.591 . . . . 1.0 111.301 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -43.55 82.0 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.964 -0.695 . . . . 1.0 110.764 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.8 -50.36 72.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.156 -0.929 . . . . 1.0 111.094 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.85 -41.0 83.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.329 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 t -62.27 -45.12 94.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.105 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.52 -47.13 67.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.382 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.0 t -63.35 -45.6 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.964 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.16 -45.85 92.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 1.0 110.255 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.6 86.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.425 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.76 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.455 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.488 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 95.1 mt-30 -68.32 -37.66 80.78 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.25 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.54 -43.15 90.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.085 0.469 . . . . 1.0 110.623 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.93 75.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.732 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.31 -38.9 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.734 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.403 ' OXT' ' OG ' ' A' ' 124' ' ' SER . 2.1 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.405 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.476 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 34.9 Cg_endo . . . . . 0 N--CA 1.497 1.723 0 CA-C-O 120.891 0.288 . . . . 1.0 112.154 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.35 145.55 57.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.859 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 142.31 71.06 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.734 1.623 . . . . 1.0 111.41 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -67.77 -42.79 86.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.681 -0.691 . . . . 1.0 111.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -38.37 47.03 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.94 146.17 46.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.902 0.382 . . . . 1.0 111.009 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.82 80.32 0.33 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.13 99.71 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.846 1.697 . . . . 1.0 112.832 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.23 -43.2 92.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.82 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.23 153.52 38.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.353 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -137.96 135.8 36.37 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.633 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.64 149.26 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.04 0.448 . . . . 1.0 111.262 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -104.31 121.68 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.39 -162.96 10.9 Favored Glycine 0 N--CA 1.462 0.386 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 88.9 mmm -128.65 131.99 48.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 1.0 110.315 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -94.9 124.06 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -108.47 137.22 46.79 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.545 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.93 150.07 44.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.019 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.71 -66.29 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.794 -0.639 . . . . 1.0 112.597 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.68 -33.0 93.8 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.779 2.319 . . . . 1.0 113.691 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 179.7 -174.57 0.25 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.007 -0.277 . . . . 1.0 110.769 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.33 169.47 11.76 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 1.0 110.739 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -158.1 144.31 12.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.619 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.8 145.12 97.4 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.392 1.394 . . . . 1.0 111.04 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.7 p -154.97 -179.11 7.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.382 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.67 142.53 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.427 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.28 122.53 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.257 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -122.67 116.7 24.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.381 0.61 . . . . 1.0 111.757 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.9 tp -83.55 130.37 35.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.21 -0.905 . . . . 1.0 109.218 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.24 151.49 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.007 0.432 . . . . 1.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -110.61 121.73 46.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.711 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -134.02 139.19 45.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.903 0.382 . . . . 1.0 110.911 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.11 33.65 22.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.548 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.28 25.22 75.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -135.17 153.83 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -91.18 131.95 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -141.23 141.61 34.0 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.985 0.422 . . . . 1.0 110.445 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.6 127.54 52.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.685 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.42 118.29 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.154 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.9 mt -100.98 122.87 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -108.22 130.54 55.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.079 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.68 111.19 23.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 52' ' ' GLU . 97.8 m-70 -57.49 -12.8 2.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' HIS . 3.5 tp10 42.39 -167.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.455 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -63.74 -41.75 97.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -138.73 -68.5 0.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.747 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -69.9 142.13 53.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.177 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 56' ' ' HIS . 20.9 p80 -89.06 112.29 23.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.41 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -84.19 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.616 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.476 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 83.0 mt-30 -102.13 132.16 48.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.127 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -127.25 109.61 11.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -93.57 122.3 44.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.728 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -133.3 126.76 19.53 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.01 157.84 46.5 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.799 1.666 . . . . 1.0 112.64 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -102.66 115.92 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.178 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' PHE . 50.8 p30 -172.94 -155.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.229 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 m -60.98 -41.6 96.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.348 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.71 -43.05 97.72 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.838 0.352 . . . . 1.0 110.433 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 11.6 t80 -94.03 125.65 38.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.649 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -133.68 142.11 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.87 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.3 t -121.27 111.47 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.962 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.0 m -112.76 126.67 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.959 0.409 . . . . 1.0 110.622 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -87.99 112.83 23.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.744 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.641 -179.858 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.955 0.407 . . . . 1.0 110.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.438 ' C ' ' N ' ' A' ' 83' ' ' SER . 94.6 mt -64.16 -43.29 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.661 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.29 -18.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.036 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 21.9 m -128.19 118.37 23.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.942 0.401 . . . . 1.0 110.284 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.0 m120 -138.32 -167.83 2.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.781 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 70.15 89.47 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.36 75.69 0.33 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 109.342 -1.503 . . . . 1.0 109.342 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.9 138.65 34.12 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.964 0.411 . . . . 1.0 112.006 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.54 124.95 53.15 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.0 150.94 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -121.44 147.08 46.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.88 136.45 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.594 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -128.82 150.3 50.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.097 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 110.681 -0.968 . . . . 1.0 110.681 -179.852 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.831 0.348 . . . . 1.0 110.655 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.73 127.88 33.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 1.0 110.111 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -127.26 143.11 51.31 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -120.17 140.0 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.958 0.408 . . . . 1.0 111.236 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.17 150.62 50.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.69 -0.686 . . . . 1.0 110.472 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.12 135.75 24.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.758 0.313 . . . . 1.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 54.4 mt -124.56 100.97 34.22 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.64 -10.41 23.5 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.607 1.538 . . . . 1.0 112.684 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.43 105.73 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.72 -52.81 63.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.015 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -53.86 -42.1 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.628 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -69.94 -34.88 74.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.512 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.6 t -66.72 -33.22 75.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.99 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.6 mt -62.74 -46.18 89.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.489 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.73 -43.06 80.87 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.602 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.93 -48.93 79.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.124 -0.943 . . . . 1.0 111.394 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.8 mt -65.41 -40.85 93.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.644 -0.423 . . . . 1.0 111.362 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.7 p -64.0 -44.24 93.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.228 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.07 -51.02 59.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.314 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.87 -42.25 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.751 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.7 tp -57.74 -45.07 86.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.065 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.377 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.87 70.57 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.044 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -68.01 -41.1 82.71 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.64 0.257 . . . . 1.0 111.102 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.24 -43.75 98.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.958 0.409 . . . . 1.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.73 96.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.236 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.3 -40.44 93.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.652 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.903 -1.046 . . . . 1.0 110.485 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.496 1.666 0 CA-C-O 121.07 0.363 . . . . 1.0 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 pp -56.47 161.44 4.19 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.121 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.46 143.56 99.66 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.974 1.116 . . . . 1.0 111.79 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.34 -42.9 91.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.02 -34.37 78.73 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.07 137.75 53.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.925 0.393 . . . . 1.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -97.66 108.46 45.68 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.28 103.14 1.7 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.502 1.468 . . . . 1.0 112.999 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.63 -43.47 89.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.152 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 155.68 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.209 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 t -146.67 135.67 22.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.594 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.94 160.82 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.165 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -102.48 122.51 44.47 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 34' ' ' ALA . . . -118.88 -174.95 16.14 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.792 -0.923 . . . . 1.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.3 mmt -134.9 99.25 4.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 1.0 110.092 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.7 tt0 -59.59 133.96 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 72.5 mtm -113.43 131.38 56.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.748 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.15 144.04 51.08 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.56 -64.88 0.49 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.84 -0.618 . . . . 1.0 112.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.22 -31.98 93.78 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.694 2.262 . . . . 1.0 113.633 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.46 -179.87 1.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.641 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.0 168.2 10.43 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.919 0.39 . . . . 1.0 110.522 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.5 128.7 6.27 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.516 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.44 142.36 78.22 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.944 1.096 . . . . 1.0 111.163 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.4 p -156.76 -178.28 7.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.394 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -150.95 138.19 19.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.308 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.2 mt -102.22 123.97 46.98 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.915 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -126.48 120.46 29.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.059 0.456 . . . . 1.0 111.356 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.67 131.23 40.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.248 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 150.93 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 1.0 111.239 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.06 120.82 41.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.682 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -128.07 132.31 49.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.217 0.532 . . . . 1.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.16 31.7 21.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.157 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.65 7.52 85.8 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.851 -0.69 . . . . 1.0 111.426 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.664 HE22 ' NE2' ' A' ' 123' ' ' GLN . 44.0 tp60 -112.5 136.79 51.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.101 -0.333 . . . . 1.0 110.101 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.497 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 75.0 m-85 -81.7 134.74 35.49 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.34 139.64 28.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.375 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.7 119.4 39.42 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.405 HG21 HD12 ' A' ' 47' ' ' ILE . 90.9 mt -99.12 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.6 mt -96.91 117.21 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -102.35 131.3 49.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.928 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mp -110.3 127.2 54.9 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -85.41 52.73 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.237 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -45.49 152.95 0.27 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.77 -40.02 93.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.362 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -62.49 -46.44 88.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.509 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -173.11 -163.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.701 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -108.11 126.24 52.52 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.31 137.17 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.055 0.455 . . . . 1.0 110.463 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -104.8 131.12 52.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.018 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -107.97 119.65 40.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.565 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.1 mt -92.11 119.74 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 1.0 110.332 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 61' ' ' ILE . 44.1 mt -135.45 94.2 15.63 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.269 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.5 142.52 80.76 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.046 1.831 . . . . 1.0 112.625 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.2 mt -82.12 124.83 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.354 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.684 HD22 ' HE2' ' A' ' 66' ' ' HIS . 6.0 p30 -172.96 -163.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.126 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.4 t -59.71 -41.29 90.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.564 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.684 ' HE2' HD22 ' A' ' 64' ' ' ASN . 3.5 p80 -69.84 -14.48 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.958 -0.297 . . . . 1.0 111.122 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.0 t80 -114.93 128.06 56.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.18 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -141.29 145.86 36.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.145 0.497 . . . . 1.0 110.889 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 t -121.32 118.61 29.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 1.0 108.991 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.71 128.84 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.068 0.461 . . . . 1.0 110.848 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.611 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 56.4 tp60 -86.47 103.24 14.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.518 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.331 179.779 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 20.0 p-10 . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 121.034 0.445 . . . . 1.0 110.329 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.42 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 26.3 mm -68.32 -24.53 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.39 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.03 72.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.818 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.5 t -100.46 62.57 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.09 0.472 . . . . 1.0 110.398 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 10.9 m120 -80.47 -171.69 3.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.164 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 85' ' ' SER . 19.2 p 57.83 94.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.73 77.09 0.21 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.429 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.62 136.56 36.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.765 0.317 . . . . 1.0 111.72 -177.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.611 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 64.9 mttp -108.02 120.03 41.14 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -118.63 131.01 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -106.61 144.73 32.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.894 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.63 133.13 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.641 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -124.23 136.06 53.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.741 -0.944 . . . . 1.0 110.741 179.793 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.803 0.335 . . . . 1.0 110.671 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.02 135.66 55.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 1.0 110.727 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -133.8 137.58 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.588 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -87.32 150.47 23.84 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.917 0.389 . . . . 1.0 111.035 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -143.39 149.33 37.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.298 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.14 145.84 39.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.918 0.389 . . . . 1.0 110.931 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.87 92.86 43.54 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.28 -15.44 38.88 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.757 1.638 . . . . 1.0 112.602 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.453 ' OD2' ' CG ' ' A' ' 108' ' ' HIS . 38.6 t0 -93.2 106.56 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.81 -52.92 63.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.026 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.93 -46.81 32.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.378 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.453 ' CG ' ' OD2' ' A' ' 105' ' ' ASP . 43.9 m170 -68.5 -39.34 81.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 1.0 110.38 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 t -59.08 -39.76 83.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.16 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.52 -44.84 93.09 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.418 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.16 -44.96 82.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.3 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.55 -49.38 76.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.339 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.8 -40.51 88.13 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.603 -0.439 . . . . 1.0 111.211 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -62.73 -44.7 95.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.822 0.344 . . . . 1.0 111.083 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.12 -48.28 62.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.361 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.09 -44.76 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.14 -45.03 96.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.016 0.436 . . . . 1.0 110.161 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.07 86.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.555 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.07 -49.09 75.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -71.11 -38.23 72.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 1.0 110.983 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.04 -44.5 96.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.223 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.41 96.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.221 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.664 ' NE2' HE22 ' A' ' 43' ' ' GLN . 88.2 mt-30 -65.38 -41.22 93.99 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.66 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.384 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.52 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 37.1 Cg_endo . . . . . 0 N--CA 1.497 1.703 0 CA-C-O 120.818 0.257 . . . . 1.0 111.981 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -53.96 158.06 3.77 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.907 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.76 143.29 99.65 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.156 1.238 . . . . 1.0 111.687 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.35 -45.08 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.79 78.72 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 142.27 57.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.06 0.457 . . . . 1.0 111.162 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.22 79.85 0.4 Allowed Pre-proline 0 N--CA 1.464 0.261 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.35 98.97 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.893 1.729 . . . . 1.0 112.918 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -43.55 93.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.754 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.94 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.341 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 t -136.33 138.77 42.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.763 0.316 . . . . 1.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.95 150.9 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.083 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -105.29 121.34 43.67 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.85 -172.66 13.2 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.426 ' O ' ' SD ' ' A' ' 25' ' ' MET . 86.2 mmm -120.44 127.31 52.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 1.0 110.091 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -90.11 119.71 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.3 mpp? -110.4 136.68 49.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.946 0.403 . . . . 1.0 110.34 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.34 150.43 42.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.025 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.69 -64.74 0.51 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.706 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.45 -34.15 93.32 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.658 2.239 . . . . 1.0 113.624 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.4 ' C ' ' CD1' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.06 175.21 0.66 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.812 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -117.17 169.06 9.75 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.099 0.476 . . . . 1.0 110.527 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -160.68 142.9 9.41 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.644 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.85 145.71 94.75 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.498 1.465 . . . . 1.0 111.241 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.2 p -155.21 -171.66 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.466 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.44 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.405 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.3 mt -113.37 130.09 56.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.019 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -130.51 128.17 40.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.167 0.508 . . . . 1.0 111.556 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.9 tp -95.17 124.55 39.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.009 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.64 149.95 45.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.112 0.482 . . . . 1.0 111.314 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -108.11 120.67 42.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.389 -0.823 . . . . 1.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -132.88 135.94 45.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.871 0.367 . . . . 1.0 110.87 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.5 m120 59.26 34.49 23.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 1.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.57 23.6 76.55 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.004 -0.838 . . . . 1.0 111.004 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -133.77 157.08 46.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.94 133.43 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -139.02 146.66 41.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.197 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -105.45 134.31 48.77 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 78.0 mt -114.09 124.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.2 mt -105.1 120.37 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -112.34 126.86 55.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.152 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.93 123.69 47.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -78.85 58.04 2.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.371 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -54.75 155.91 3.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.299 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.28 -41.44 98.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.2 -81.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -142.01 150.13 40.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.741 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -67.35 141.71 57.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.307 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.43 132.61 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.992 0.425 . . . . 1.0 110.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 84.0 mt-30 -95.01 126.62 40.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.914 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -120.52 117.28 27.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.478 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -93.35 108.22 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.865 0.364 . . . . 1.0 110.061 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mm -114.66 121.88 34.93 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.58 149.95 39.6 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.778 1.652 . . . . 1.0 112.615 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.3 115.36 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -169.57 -158.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.362 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -59.51 -41.67 90.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -65.73 -37.69 87.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' A' ' 64' ' ' ASN . 16.4 t80 -95.63 123.83 39.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.834 0.35 . . . . 1.0 110.06 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -140.13 144.05 36.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.099 0.476 . . . . 1.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.36 99.71 7.38 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -104.56 124.95 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.905 0.383 . . . . 1.0 110.811 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.608 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 48.4 tp60 -77.7 104.46 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.455 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.66 179.806 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 35.0 p-10 . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 120.882 0.372 . . . . 1.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.446 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 91.9 mt -67.84 -25.31 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.535 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.02 91.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.128 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 83' ' ' SER . 2.0 t -97.47 70.73 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.181 0.515 . . . . 1.0 110.321 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 9.7 m120 -98.7 -169.2 1.75 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.207 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 m 61.82 84.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.58 76.47 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 109.462 -1.455 . . . . 1.0 109.462 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.03 142.98 26.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.933 0.397 . . . . 1.0 111.803 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.608 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 55.8 mtpt -118.56 128.07 54.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 89' ' ' ILE . 47.5 pt -127.82 163.6 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.75 142.15 50.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.8 t -121.6 135.76 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.087 0.47 . . . . 1.0 110.564 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -119.92 163.47 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.225 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.683 0.278 . . . . 1.0 110.5 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.86 115.95 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.175 0.512 . . . . 1.0 110.6 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -129.03 137.91 51.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.237 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.64 151.05 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.739 0.304 . . . . 1.0 110.705 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -137.35 155.17 49.73 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.478 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -147.4 126.08 12.58 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.972 0.415 . . . . 1.0 111.389 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.93 99.52 14.12 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 -10.05 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.407 1.404 . . . . 1.0 112.472 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -96.49 107.34 19.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.83 -52.73 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.7 -0.682 . . . . 1.0 112.157 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.0 OUTLIER -52.44 -43.97 65.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.593 -0.443 . . . . 1.0 110.388 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -69.6 -34.19 73.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.377 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.922 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.08 -47.65 79.24 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.357 -0.537 . . . . 1.0 111.706 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.57 -44.74 77.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.862 -0.735 . . . . 1.0 110.171 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -61.36 -49.44 76.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.131 -0.94 . . . . 1.0 111.495 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.32 -41.65 84.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.169 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -63.06 -45.89 90.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.529 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.4 78.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.456 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.19 -44.49 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.894 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.74 -44.83 96.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 1.0 110.295 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.39 86.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -48.71 77.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -70.28 -36.89 74.67 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.77 -45.77 91.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.151 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.28 -40.08 96.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.306 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.79 -40.19 94.83 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.801 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.586 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 45.4 Cg_endo . . . . . 0 N--CA 1.498 1.793 0 CA-C-O 120.894 0.289 . . . . 1.0 112.151 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.18 150.73 87.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.805 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.51 141.06 90.51 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.627 1.551 . . . . 1.0 111.72 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.3 t -68.35 -43.29 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.293 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.18 -41.31 4.85 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.86 146.13 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.594 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -93.22 107.02 22.48 Favored Pre-proline 0 N--CA 1.466 0.347 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.94 99.87 1.35 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.614 1.543 . . . . 1.0 113.181 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.49 -43.41 85.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.282 0.563 . . . . 1.0 109.892 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.12 149.08 29.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.327 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 t -141.34 130.18 23.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.689 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -142.03 159.66 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-O 120.928 0.394 . . . . 1.0 110.955 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -108.32 122.43 46.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.511 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.442 ' C ' ' SD ' ' A' ' 23' ' ' MET . . . -130.59 -152.52 7.42 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 22' ' ' GLY . 2.8 mpt? -143.99 126.53 15.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 1.0 110.522 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 84.2 tt0 -87.42 121.43 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.601 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -105.79 138.85 41.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.62 150.22 49.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.67 -66.63 0.38 Allowed Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.583 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.56 -33.59 86.83 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.761 2.307 . . . . 1.0 113.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -174.0 -171.97 0.68 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 121.009 -0.276 . . . . 1.0 110.463 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -130.23 169.13 15.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.973 0.416 . . . . 1.0 110.454 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 134.66 8.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.83 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.16 141.59 69.18 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 CA-C-N 120.199 1.107 . . . . 1.0 111.244 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 15.5 p -150.31 -176.24 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.403 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.71 138.64 22.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.0 mt -105.66 123.86 48.61 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.969 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.7 m -129.6 113.91 15.4 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.117 0.484 . . . . 1.0 111.584 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.9 tp -81.43 127.39 32.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.03 149.19 47.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.138 0.494 . . . . 1.0 111.363 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -112.98 121.95 46.18 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.405 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -135.36 139.89 44.61 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.039 0.447 . . . . 1.0 110.76 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m120 58.97 33.86 23.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.324 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.83 23.93 75.67 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -131.3 152.61 50.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.0 130.41 40.13 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -142.41 142.1 32.33 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.026 0.441 . . . . 1.0 110.231 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.5 tp -104.38 124.78 49.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.0 mt -103.38 122.19 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.988 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.88 114.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.68 132.79 47.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.071 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 52' ' ' GLU . 10.0 mp -108.04 129.44 55.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.7 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -80.18 36.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.268 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' A' ' 50' ' ' LEU . 35.9 tp10 -49.77 142.46 8.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.199 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.68 -38.69 91.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -59.04 -53.85 53.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.34 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -174.46 149.87 1.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.58 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 t -67.11 133.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.214 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 97.0 mt-30 -106.79 128.63 54.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.143 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -122.18 117.39 26.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.56 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.66 111.86 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.161 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -115.97 114.53 41.45 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.793 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.27 151.07 37.89 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.667 1.578 . . . . 1.0 112.462 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.9 mt -97.52 118.81 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.429 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -170.22 -158.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.352 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -61.05 -42.62 98.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.109 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -65.41 -36.11 82.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.979 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 64' ' ' ASN . 17.3 t80 -95.12 123.78 38.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.41 122.35 15.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.234 0.54 . . . . 1.0 110.817 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 t -87.89 115.0 25.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.247 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 m -115.74 124.32 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.908 0.385 . . . . 1.0 110.583 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -84.48 135.44 34.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.902 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 21.9 p-10 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 121.032 0.444 . . . . 1.0 110.732 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' SER . 36.5 mm -63.99 -40.93 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.221 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.6 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . 44.0 t -142.91 140.19 31.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 1.0 110.151 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 83' ' ' SER . 17.0 m120 -146.15 -172.22 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.985 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER 76.97 89.68 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.19 77.49 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 135.15 35.92 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.01 0.433 . . . . 1.0 111.882 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.04 113.32 25.78 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.66 129.79 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.817 0.341 . . . . 1.0 110.429 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.86 142.18 33.57 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.105 -0.498 . . . . 1.0 109.982 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.06 133.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.706 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.22 141.61 31.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.299 0.095 . . . . 1.0 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -176.9 128.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.9 0.381 . . . . 1.0 110.581 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.88 145.08 35.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -104.06 147.32 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.93 0.395 . . . . 1.0 111.169 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.87 152.42 45.08 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.998 -0.547 . . . . 1.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -138.26 144.53 40.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.984 0.421 . . . . 1.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.7 mm -127.31 89.88 50.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.59 -16.44 46.93 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.721 1.614 . . . . 1.0 112.652 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -87.2 101.09 13.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.81 -55.07 39.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 1.0 112.087 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -51.84 -44.03 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.771 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -68.45 -39.67 81.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.919 0.39 . . . . 1.0 110.422 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -58.07 -36.84 73.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.107 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.416 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.27 -44.58 83.21 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.868 -0.733 . . . . 1.0 110.542 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -62.18 -50.33 72.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.707 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.67 -40.86 92.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.119 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 m -61.53 -43.82 98.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.098 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.8 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.157 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.95 -44.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.882 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.16 -45.96 92.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.061 0.457 . . . . 1.0 110.276 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.94 -37.39 84.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.311 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.12 -48.54 78.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.03 -38.72 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.923 0.392 . . . . 1.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.13 -44.86 90.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.754 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.08 75.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.951 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.18 -39.87 68.35 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.68 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.039 -0.981 . . . . 1.0 110.684 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo . . . . . 0 N--CA 1.497 1.707 0 CA-C-O 121.002 0.334 . . . . 1.0 111.822 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' A' ' 10' ' ' LEU . 4.1 mm? -53.94 146.4 28.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.93 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -55.11 144.16 70.9 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.076 1.184 . . . . 1.0 111.5 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.86 -45.15 97.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.551 -0.749 . . . . 1.0 111.015 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.47 -28.67 73.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.14 -0.784 . . . . 1.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 147.39 52.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 1.0 110.976 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -118.28 80.49 15.91 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.431 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.45 97.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.158 1.905 . . . . 1.0 112.689 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' LEU . 98.3 mt -65.47 -41.34 93.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.799 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.6 149.08 28.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.229 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 t -138.23 136.4 36.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.806 0.336 . . . . 1.0 110.619 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 p -144.82 151.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.331 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.1 137.52 36.03 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.604 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -150.65 -168.5 15.56 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.647 -0.981 . . . . 1.0 110.647 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -127.84 130.54 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 1.0 110.515 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -93.12 120.82 33.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.457 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 71.4 mtm -107.76 136.09 48.08 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.609 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.91 149.49 38.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.051 0.453 . . . . 1.0 109.965 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -37.11 -65.35 0.6 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.77 -0.65 . . . . 1.0 112.749 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.14 -32.78 95.04 Favored 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 122.728 2.285 . . . . 1.0 114.135 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.14 177.21 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 121.084 -0.246 . . . . 1.0 110.61 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.57 168.86 11.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.0 0.429 . . . . 1.0 110.287 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 16.7 pt-20 -161.46 143.91 9.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.41 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.46 144.93 95.51 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.338 1.359 . . . . 1.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 22' ' ' GLY . 4.2 p -154.05 -178.13 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.571 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.05 143.13 24.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.197 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.7 mt -106.25 120.93 43.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.873 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m -127.27 115.36 18.91 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.232 0.539 . . . . 1.0 111.458 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 17' ' ' LEU . 65.4 tp -87.76 128.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.062 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.88 144.26 41.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 1.0 111.425 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -98.77 121.26 40.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.544 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.95 134.18 42.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.914 0.388 . . . . 1.0 110.948 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 58.15 33.78 23.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.681 -0.69 . . . . 1.0 111.791 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.35 78.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.873 -0.891 . . . . 1.0 110.873 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 44.2 tt0 -131.36 161.28 32.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.419 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 94.5 m-85 -103.41 137.25 41.78 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -145.54 144.1 30.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.004 0.43 . . . . 1.0 110.352 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.2 tp -104.57 128.9 52.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.634 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.57 129.17 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.42 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.32 120.18 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -108.53 127.83 54.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.082 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 4.2 mm? -101.27 132.44 46.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.906 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -95.49 18.99 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.305 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 94.1 mt-10 -45.6 136.84 5.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.419 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.74 -38.5 90.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.195 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.13 -50.92 69.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.377 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -170.58 154.92 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.166 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -84.58 113.88 21.57 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.14 131.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.938 0.399 . . . . 1.0 110.344 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -121.13 117.41 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.585 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -106.53 134.94 48.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 60' ' ' ILE . 34.0 mm -93.82 109.54 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.902 0.382 . . . . 1.0 110.16 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.409 HG21 HD12 ' A' ' 61' ' ' ILE . 30.6 mm -112.41 104.59 56.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 147.82 36.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.596 1.53 . . . . 1.0 112.642 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 97.2 mt -91.81 119.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 63' ' ' ILE . 79.3 m-20 -163.85 -165.37 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.059 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.1 p -61.54 -37.25 83.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.34 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -71.57 -32.2 67.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.296 . . . . 1.0 111.186 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 16.4 t80 -92.24 123.24 35.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.931 0.396 . . . . 1.0 109.987 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -135.05 144.48 47.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.549 . . . . 1.0 110.82 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.5 t -117.96 112.36 20.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.049 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.94 125.83 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.852 0.358 . . . . 1.0 111.012 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' OE1' ' OD1' ' A' ' 80' ' ' ASP . 42.5 tt0 -84.44 102.1 12.52 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.719 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.512 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.514 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 70.5 m-20 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.876 0.37 . . . . 1.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.07 -42.57 95.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.59 -32.03 57.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.053 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ASP . 34.5 t -147.4 126.84 13.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.73 0.3 . . . . 1.0 110.706 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 80' ' ' ASP . 35.4 m120 -147.76 27.02 1.0 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.963 0.411 . . . . 1.0 111.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 t -80.45 100.89 8.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.396 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.96 80.37 0.12 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.952 -1.659 . . . . 1.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.86 129.5 38.76 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.134 0.42 . . . . 1.0 112.134 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.43 121.77 46.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 153.11 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.62 142.9 50.15 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.28 132.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.851 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -137.77 135.68 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.985 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.855 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.577 0.227 . . . . 1.0 110.879 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -174.32 112.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.479 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -129.33 134.19 47.79 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -91.89 157.58 16.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.857 0.361 . . . . 1.0 111.0 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.73 153.77 47.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.402 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -140.03 140.78 36.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.841 0.353 . . . . 1.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.1 mm -128.67 89.61 48.74 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.07 -16.63 36.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.918 1.745 . . . . 1.0 112.651 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -87.55 106.51 18.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.697 -0.482 . . . . 1.0 109.697 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.0 -54.58 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 1.0 112.032 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.19 -44.23 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.559 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -69.2 -37.14 77.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.736 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 113' ' ' LEU . 11.5 t -62.39 -31.91 72.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.157 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.78 -45.52 92.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.71 -42.99 85.5 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.039 -0.665 . . . . 1.0 110.622 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.65 -51.13 68.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.223 -0.899 . . . . 1.0 111.322 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.449 ' CD1' HD21 ' A' ' 84' ' ' ASN . 91.2 mt -66.76 -41.07 88.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.277 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.489 ' HG ' ' H ' ' A' ' 115' ' ' ALA . 77.9 p -63.19 -45.96 89.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.82 0.343 . . . . 1.0 111.345 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.489 ' H ' ' HG ' ' A' ' 114' ' ' SER . . . -69.2 -47.99 63.34 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.414 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.75 -43.9 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.636 0.255 . . . . 1.0 111.113 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.63 -45.74 91.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 1.0 110.215 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -37.81 87.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.229 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.04 72.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.736 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -70.95 -35.97 72.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.355 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.66 -44.68 96.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.85 97.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.286 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.69 -41.06 88.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.698 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.507 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 35.6 Cg_endo . . . . . 0 N--CA 1.495 1.597 0 CA-C-O 120.999 0.333 . . . . 1.0 111.974 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.55 150.92 53.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.12 143.29 99.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.326 1.351 . . . . 1.0 111.526 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 13' ' ' GLY . 13.4 m -68.63 -42.89 83.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -67.26 -28.12 73.64 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.399 -0.68 . . . . 1.0 111.399 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.89 58.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.906 0.384 . . . . 1.0 111.015 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -99.0 102.85 16.62 Favored Pre-proline 0 N--CA 1.465 0.275 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.42 100.58 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.605 1.536 . . . . 1.0 112.915 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.5 -43.72 84.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.333 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.43 149.91 31.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -141.82 131.71 24.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.526 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 66.4 t -139.17 158.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 121.124 0.488 . . . . 1.0 110.822 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 97.4 mt-10 -106.29 123.06 47.46 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.523 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.71 -160.5 9.59 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -139.0 127.34 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.867 0.365 . . . . 1.0 110.557 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -87.14 123.89 32.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.628 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.7 mtm -107.35 137.45 45.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.61 149.13 50.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -66.61 0.32 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.791 -0.641 . . . . 1.0 112.566 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.21 -33.62 90.06 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.804 2.336 . . . . 1.0 113.537 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.46 -174.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.526 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -126.1 168.64 13.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.067 0.461 . . . . 1.0 110.635 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -153.88 143.78 15.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.459 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.3 146.55 93.76 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.486 1.458 . . . . 1.0 111.117 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.5 p -155.14 -172.88 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.579 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.73 136.7 16.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.8 mt -101.53 122.75 44.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.823 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -128.19 123.26 33.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.237 0.541 . . . . 1.0 111.7 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.6 tp -94.77 122.09 37.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.02 151.08 51.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.084 0.469 . . . . 1.0 111.25 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -110.7 122.5 47.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.639 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -134.01 138.62 45.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.981 0.419 . . . . 1.0 110.843 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 58.96 33.8 23.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.41 77.2 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -131.15 155.73 46.51 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.83 135.2 36.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.327 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -145.5 139.57 26.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -105.27 120.75 42.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.84 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 47' ' ' ILE . 79.8 mt -104.46 127.25 58.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.318 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.1 mt -105.37 116.76 49.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -96.15 127.51 42.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.54 133.47 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.773 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -106.39 34.33 3.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.306 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.81 149.09 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.99 -38.04 89.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.391 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -59.19 -51.2 71.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.227 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -175.02 166.27 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.749 -0.659 . . . . 1.0 111.026 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -84.62 127.45 34.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.979 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.41 136.03 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.042 0.449 . . . . 1.0 110.439 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 9' ' ' PRO . 56.7 tt0 -100.01 109.38 21.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.184 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -102.34 113.49 26.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.957 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.63 123.09 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.899 0.38 . . . . 1.0 110.381 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -132.37 117.63 15.67 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.141 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.72 157.8 39.61 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.766 1.644 . . . . 1.0 112.645 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.69 123.57 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -173.71 -161.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.441 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 78.1 p -62.08 -39.08 91.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.192 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.441 ' N ' ' HG ' ' A' ' 65' ' ' SER . 93.8 m-70 -67.37 -38.23 84.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.591 -0.277 . . . . 1.0 111.179 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -84.01 125.42 32.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 1.0 110.212 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -134.09 144.59 48.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.297 0.57 . . . . 1.0 110.745 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -127.11 120.66 29.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.278 -0.874 . . . . 1.0 109.251 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 m -119.62 125.3 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.767 0.318 . . . . 1.0 110.596 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.461 ' NE2' ' OG ' ' A' ' 83' ' ' SER . 59.1 tt0 -90.25 118.29 29.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.7 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 . . . . . 0 N--CA 1.465 0.28 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.042 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.056 0.455 . . . . 1.0 110.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 81' ' ' ILE . 89.9 mt -63.75 -42.19 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.379 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.13 -24.46 26.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.941 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.566 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 30.0 t -113.34 124.75 53.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.247 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.9 m120 -150.81 -171.75 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.124 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' OG ' ' A' ' 85' ' ' SER . 4.7 p 66.37 97.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.51 79.04 0.09 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 135.33 36.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.865 0.365 . . . . 1.0 111.946 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.58 113.38 26.65 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.412 -0.959 . . . . 1.0 108.412 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.17 125.7 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 1.0 110.162 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 65.3 mtp180 -102.57 146.52 28.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.71 132.47 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.678 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -145.61 148.13 32.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.274 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.578 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 120.716 0.293 . . . . 1.0 110.302 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 90' ' ' ARG . 77.2 tt0 -65.85 127.96 34.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.164 0.507 . . . . 1.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -132.02 160.77 34.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.076 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.466 ' CZ ' ' NH2' ' A' ' 90' ' ' ARG . 85.5 mtt85 -123.58 144.08 49.81 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.953 0.406 . . . . 1.0 110.964 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -143.95 155.95 44.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.947 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -138.71 146.44 41.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 1.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.0 mm -127.39 90.46 48.66 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.37 -16.09 43.01 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.833 1.689 . . . . 1.0 112.65 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -87.57 100.9 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.15 -53.42 58.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.201 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -52.97 -42.21 65.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.668 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -71.56 -36.57 70.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.885 0.374 . . . . 1.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.48 -36.19 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.064 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.14 -44.41 95.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.478 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -66.72 -44.49 81.48 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.29 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -61.01 -49.37 77.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.204 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.01 -42.43 89.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.539 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.5 m -63.13 -43.8 97.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.419 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.03 -48.83 61.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.355 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.29 -43.44 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.56 -45.42 91.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.932 0.396 . . . . 1.0 110.257 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.86 85.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.338 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.38 -49.01 77.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.839 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -67.61 -37.69 82.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.776 0.322 . . . . 1.0 111.04 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -60.12 -44.34 94.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.053 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.28 94.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.395 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.8 -39.73 91.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.665 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.939 -1.029 . . . . 1.0 110.875 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.496 1.657 0 CA-C-O 120.87 0.279 . . . . 1.0 111.802 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.46 149.66 75.54 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.889 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.39 143.67 89.2 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.805 1.67 . . . . 1.0 111.621 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 m -78.7 -19.5 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.029 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.2 -33.51 84.6 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.32 170.59 15.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.03 0.443 . . . . 1.0 110.98 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.32 81.7 17.61 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.799 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.26 95.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.547 2.165 . . . . 1.0 112.7 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.21 -41.88 96.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.717 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.69 155.62 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.055 -0.975 . . . . 1.0 110.411 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -148.84 142.39 25.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.851 0.357 . . . . 1.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.96 161.05 23.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.304 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -94.99 122.51 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -125.34 167.19 17.78 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.2 mtp -117.6 103.01 9.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.864 0.364 . . . . 1.0 110.292 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' CE1' ' A' ' 101' ' ' PHE . 47.9 tp10 -60.22 121.37 11.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.109 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 102' ' ' GLU . 76.0 mtm -106.32 131.19 53.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.433 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.6 146.46 39.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.959 0.409 . . . . 1.0 109.998 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.22 -65.29 0.72 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.568 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.9 -33.38 95.88 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.627 2.218 . . . . 1.0 113.628 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.8 -169.53 0.17 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.659 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -132.65 168.91 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.951 0.405 . . . . 1.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 18.3 pt-20 -154.39 134.8 8.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.24 141.37 70.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 CA-C-N 120.264 1.13 . . . . 1.0 111.369 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 22' ' ' GLY . 28.5 p -149.17 -175.99 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.524 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.43 137.09 12.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.302 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 mt -98.32 122.76 41.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.501 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.8 m -118.87 119.29 33.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.14 0.495 . . . . 1.0 111.283 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.7 tp -98.03 130.8 44.83 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.35 154.0 41.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.089 0.471 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -111.0 122.61 48.34 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -133.21 133.21 42.44 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 1.0 110.556 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 60.86 34.77 19.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.417 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.0 25.35 75.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.029 -0.829 . . . . 1.0 111.029 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -134.82 144.38 47.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.18 -0.304 . . . . 1.0 110.18 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -88.39 136.51 32.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -143.73 144.54 31.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.051 0.453 . . . . 1.0 110.514 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.28 126.01 53.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.499 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.435 HG22 HD13 ' A' ' 47' ' ' ILE . 90.7 mt -111.71 131.64 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.151 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.5 mm -95.2 122.75 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.818 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.92 136.12 49.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.809 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -104.81 20.41 18.78 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.25 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.8 mt-10 -40.43 141.07 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.88 0.371 . . . . 1.0 110.668 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.92 -39.64 92.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.474 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.47 -51.88 67.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.365 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -173.98 147.08 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 56' ' ' HIS . 19.6 p80 -75.83 112.51 12.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 t -90.77 132.76 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -112.38 117.91 33.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.649 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -121.83 127.65 50.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -100.4 125.91 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.056 0.455 . . . . 1.0 110.487 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.67 93.2 35.46 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.438 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.78 145.05 85.26 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.147 1.898 . . . . 1.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 97.6 mt -85.88 117.66 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -176.73 -160.37 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.121 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.7 p -65.47 -23.25 66.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.283 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -83.76 -10.46 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.02 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -113.78 129.81 56.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.963 0.411 . . . . 1.0 110.079 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -129.67 155.73 45.39 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.582 0.706 . . . . 1.0 111.081 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 26.3 p -144.48 100.2 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.562 -1.199 . . . . 1.0 109.798 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -102.53 122.39 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.844 0.355 . . . . 1.0 110.617 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 83' ' ' SER . 56.3 tt0 -98.81 125.4 44.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.05 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 . . . . . 0 CA--C 1.517 -0.326 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.914 179.47 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.984 0.421 . . . . 1.0 110.219 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.74 -42.56 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.527 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.17 -31.73 53.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.04 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.561 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 40.8 m -105.53 120.75 42.41 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.095 -0.335 . . . . 1.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.3 m120 -150.16 -167.99 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.227 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.87 86.77 0.12 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.33 69.84 1.27 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.005 -1.638 . . . . 1.0 109.005 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.3 142.57 27.26 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.047 0.451 . . . . 1.0 111.896 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -128.3 131.18 48.69 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.96 162.72 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.323 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.736 ' NH2' HH22 ' A' ' 100' ' ' ARG . 68.0 mtt180 -128.58 140.48 51.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.96 134.7 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.99 0.424 . . . . 1.0 110.626 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.85 140.06 52.63 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.334 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 -179.821 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 98' ' ' GLU . 3.9 ptm180 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.318 0.104 . . . . 1.0 110.798 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 97' ' ' ARG . 47.8 tp10 -174.97 93.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 1.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -104.56 135.05 46.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.736 HH22 ' NH2' ' A' ' 90' ' ' ARG . 57.4 mtp85 -101.37 150.25 23.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.937 0.399 . . . . 1.0 110.812 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.549 ' CE1' ' OE1' ' A' ' 24' ' ' GLU . 70.1 m-85 -129.24 154.9 46.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.556 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 25' ' ' MET . 81.4 tt0 -149.04 121.73 8.63 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.988 0.423 . . . . 1.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.16 98.41 26.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.78 -10.67 25.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.68 1.587 . . . . 1.0 112.595 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -94.35 106.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.86 -54.98 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.002 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -50.07 -44.85 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.519 -0.473 . . . . 1.0 110.464 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -68.57 -40.19 80.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 1.0 110.642 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.16 -36.85 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.033 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -63.7 -44.66 93.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.46 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.26 -45.22 81.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.312 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -61.48 -49.1 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.4 -41.58 80.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.344 -0.542 . . . . 1.0 111.238 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.2 t -63.36 -44.97 93.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.686 0.279 . . . . 1.0 111.535 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.63 -50.32 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.465 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.8 -45.18 99.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.592 -0.276 . . . . 1.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -60.67 -46.01 91.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 110.318 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.09 76.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 1.0 110.533 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.44 99.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.818 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -66.38 -40.2 89.54 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.663 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -63.25 -44.22 95.79 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.624 0.726 . . . . 1.0 110.115 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.4 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.174 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' A' ' 63' ' ' ILE . 89.3 mt-30 -66.26 -40.58 90.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.742 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.599 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 29.8 Cg_endo . . . . . 0 N--CA 1.498 1.746 0 CA-C-O 120.853 0.272 . . . . 1.0 111.958 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.62 162.17 0.99 Allowed Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.826 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.83 152.41 64.04 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.488 1.459 . . . . 1.0 111.443 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -85.97 70.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.692 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.86 -26.93 0.39 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.57 140.67 53.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 111.035 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 15.5 mm100 -102.54 80.95 0.35 Allowed Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.69 88.42 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.681 1.587 . . . . 1.0 112.152 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.695 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.42 137.58 38.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.578 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.28 125.76 26.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 54.6 t -135.93 157.07 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.767 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 46.7 tp10 -105.79 122.96 47.16 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.98 -157.76 8.78 Favored Glycine 0 N--CA 1.463 0.491 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -140.51 123.59 16.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.886 0.374 . . . . 1.0 110.36 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -88.94 119.32 29.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.518 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.3 mpp? -107.58 136.04 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.509 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.68 149.08 52.6 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -65.82 0.41 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.635 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.83 -32.62 85.7 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.814 2.343 . . . . 1.0 113.705 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.43 -176.72 1.12 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.434 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -126.72 169.1 13.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 1.0 110.682 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -158.15 141.98 11.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.553 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.25 144.34 95.33 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.297 1.331 . . . . 1.0 110.985 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.3 p -152.01 174.21 13.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.321 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.09 131.78 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.955 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.1 mt -96.63 121.6 38.64 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.999 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.3 m -129.24 124.67 35.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.197 0.522 . . . . 1.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.24 125.86 35.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.432 -0.803 . . . . 1.0 108.851 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.86 155.45 42.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.127 0.489 . . . . 1.0 111.052 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.523 ' OE1' ' CZ ' ' A' ' 44' ' ' TYR . 20.6 tt0 -134.19 116.52 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.829 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.464 ' CZ ' ' OE1' ' A' ' 45' ' ' GLU . 34.2 ptt180 -137.25 144.21 42.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.233 0.539 . . . . 1.0 111.248 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 59.11 28.05 17.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.107 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.04 78.37 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -127.31 137.88 52.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CZ ' ' OE1' ' A' ' 39' ' ' GLN . 84.1 m-85 -87.92 135.72 33.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 40' ' ' ARG . 22.6 pt-20 -144.89 144.61 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 1.0 110.482 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.9 tp -103.76 121.16 42.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.292 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.2 mt -105.16 124.77 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.944 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.35 115.89 49.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -96.78 131.8 43.13 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.983 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mp -106.82 130.43 54.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.805 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -104.06 29.17 6.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.126 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE1' ' OE2' ' A' ' 54' ' ' GLU . 96.6 mt-10 -43.69 145.6 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.606 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.14 -36.07 82.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' OE2' ' OE1' ' A' ' 52' ' ' GLU . 3.3 pt-20 -62.03 -46.72 87.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -177.29 154.96 1.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.567 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -78.01 127.84 32.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.0 109.876 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.42 135.94 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.042 0.449 . . . . 1.0 110.474 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 83.4 mt-30 -108.6 126.37 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.158 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.82 119.02 36.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.716 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.5 mm -92.75 112.64 26.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.93 0.395 . . . . 1.0 110.369 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 61' ' ' ILE . 33.1 mm -117.64 89.44 32.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.221 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.67 141.44 95.47 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.228 1.952 . . . . 1.0 112.455 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -83.53 124.81 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.558 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.702 HD22 ' HE2' ' A' ' 66' ' ' HIS . 5.2 p30 176.04 -165.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.963 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -59.19 -38.04 78.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.706 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.702 ' HE2' HD22 ' A' ' 64' ' ' ASN . 3.3 p80 -74.54 -2.75 27.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.75 0.31 . . . . 1.0 111.401 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.436 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 42.0 t80 -116.25 132.21 56.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.155 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -130.71 148.29 52.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.861 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 t -143.2 104.32 4.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.052 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.21 128.14 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.885 0.374 . . . . 1.0 110.886 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 58.2 tp60 -78.9 96.15 5.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.821 -179.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.835 0.35 . . . . 1.0 110.289 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.86 -41.99 94.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.493 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.01 -22.52 5.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.905 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 11.0 t -111.42 122.84 48.9 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.054 0.454 . . . . 1.0 110.414 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 83' ' ' SER . 13.7 m120 -148.74 -166.79 2.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.07 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 t 56.82 88.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.73 72.52 0.7 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.447 -1.461 . . . . 1.0 109.447 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.482 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.32 134.94 36.28 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.799 0.333 . . . . 1.0 111.686 -178.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.623 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 63.8 mttp -111.87 131.63 55.23 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.15 157.96 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.712 ' NH2' HH22 ' A' ' 100' ' ' ARG . 96.9 mtt180 -131.19 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.2 132.25 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -146.91 154.71 41.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.358 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.667 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -63.42 136.08 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.409 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -136.13 159.14 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.131 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.712 HH22 ' NH2' ' A' ' 90' ' ' ARG . 66.6 mtp85 -122.23 145.11 48.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.061 0.458 . . . . 1.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -140.21 155.67 46.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.175 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -139.41 141.51 37.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.891 0.376 . . . . 1.0 111.06 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mm -124.03 89.45 51.69 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.62 -15.62 37.72 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.85 1.7 . . . . 1.0 112.762 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -88.65 105.12 17.46 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.43 -53.84 52.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.23 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -53.06 -42.45 65.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.571 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -70.27 -37.68 74.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.492 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.61 -34.44 74.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.423 . . . . 1.0 111.001 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.72 -44.74 95.44 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.309 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.87 -43.25 84.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.164 -0.615 . . . . 1.0 110.579 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -60.27 -49.2 78.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.293 -0.867 . . . . 1.0 111.211 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.9 -41.86 86.43 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.336 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 57.8 m -63.53 -44.17 95.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.822 0.344 . . . . 1.0 111.451 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.34 -48.8 54.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.609 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -65.45 -43.57 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.904 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.92 -45.11 93.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 110.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.92 -38.85 89.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.6 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.3 -49.34 76.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.765 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.48 -36.78 74.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.335 . . . . 1.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.76 -44.93 94.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.158 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.9 95.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.285 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -67.86 -41.23 83.22 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.63 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 33.1 Cg_endo . . . . . 0 N--CA 1.497 1.7 0 CA-C-O 120.872 0.28 . . . . 1.0 111.77 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.1 155.6 16.15 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.158 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.55 143.86 99.48 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.336 1.358 . . . . 1.0 111.628 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.6 -44.96 93.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.14 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.62 78.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 140.41 58.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 1.0 110.961 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -104.07 80.7 0.44 Allowed Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.242 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.75 99.95 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.98 1.787 . . . . 1.0 112.102 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -64.65 -43.85 92.3 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.392 0.615 . . . . 1.0 110.154 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.87 141.36 24.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.19 -0.914 . . . . 1.0 109.932 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -131.64 128.87 40.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.212 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.9 162.25 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.147 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -99.75 122.62 43.0 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -123.06 179.2 16.2 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 93.3 mmm -126.15 99.61 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' CD ' HH21 ' A' ' 99' ' ' ARG . 81.3 tt0 -62.29 132.54 52.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.098 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 73.9 mtm -120.8 140.25 51.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.782 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -141.56 148.68 39.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.32 -65.59 0.34 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.779 -0.646 . . . . 1.0 112.504 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.63 -31.85 92.62 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.65 2.233 . . . . 1.0 114.108 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.35 176.28 0.63 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.399 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -118.01 169.2 9.85 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 1.0 110.177 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.39 141.9 13.25 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.448 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 144.91 96.39 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.026 1.15 . . . . 1.0 111.359 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 22' ' ' GLY . 17.1 p -153.58 -179.84 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.438 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.93 128.64 24.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.081 0.467 . . . . 1.0 110.239 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 3.9 mm? -100.52 119.66 38.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.966 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.6 m -130.66 122.01 26.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.0 111.853 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.42 129.99 36.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.006 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.29 148.63 41.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.44 . . . . 1.0 111.457 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -109.02 121.24 44.72 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.66 136.65 46.6 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.057 0.456 . . . . 1.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 m120 59.73 33.66 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.908 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.37 77.82 Favored Glycine 0 N--CA 1.463 0.476 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -130.36 154.39 47.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.483 -0.359 . . . . 1.0 110.055 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -92.58 135.1 34.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -143.94 143.81 31.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 1.0 110.317 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -103.89 124.78 49.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.423 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 47' ' ' ILE . 72.1 mt -102.53 118.07 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.7 mt -103.44 120.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.643 -0.502 . . . . 1.0 109.643 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -115.08 129.58 56.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.762 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.4 mp -101.22 127.37 47.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -76.73 62.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.298 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.3 154.34 40.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.252 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -62.46 -40.83 97.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.193 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.33 -82.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.882 0.372 . . . . 1.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -142.29 152.14 42.7 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -70.71 123.07 21.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.22 133.89 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.12 0.486 . . . . 1.0 110.481 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 81.9 mt-30 -95.23 123.92 38.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.86 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -120.45 117.08 26.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.444 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 60' ' ' ILE . 41.6 mm -94.22 110.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.911 0.386 . . . . 1.0 110.626 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm -115.16 119.07 39.31 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.165 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.01 150.83 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.797 1.665 . . . . 1.0 112.669 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 63' ' ' ILE . 97.8 mt -104.46 118.35 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.319 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -172.22 -153.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.234 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.0 p -64.16 -40.24 95.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.191 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -66.6 -41.15 88.92 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 8.0 t80 -96.23 130.1 43.39 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.788 0.328 . . . . 1.0 110.18 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -139.42 142.54 37.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.541 . . . . 1.0 110.826 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -119.91 115.5 23.92 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.12 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.77 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.91 0.386 . . . . 1.0 110.644 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -81.05 107.18 13.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.416 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.458 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 83' ' ' SER . 89.0 m-20 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 1.0 110.139 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 83' ' ' SER . 97.9 mt -64.41 -42.74 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.757 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.86 -9.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.233 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.2 t -139.98 136.43 33.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 1.0 110.239 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 83' ' ' SER . 18.0 m120 -148.54 -173.07 4.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.827 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 85' ' ' SER . 3.0 p 75.7 99.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.44 77.7 0.13 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 139.78 30.67 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.246 0.461 . . . . 1.0 112.246 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -113.1 125.2 54.11 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.334 -0.987 . . . . 1.0 108.334 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pt -119.02 130.46 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.434 ' CZ ' HH11 ' A' ' 100' ' ' ARG . 20.2 mmt180 -96.26 142.59 28.22 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.9 t -124.93 135.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 1.0 110.197 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -131.47 139.36 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.012 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.548 0 N-CA-C 110.808 -0.917 . . . . 1.0 110.808 -179.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.65 0.262 . . . . 1.0 110.771 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -175.51 108.22 0.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.426 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.508 HH21 ' CD ' ' A' ' 24' ' ' GLU . 85.6 mtp180 -107.05 123.84 48.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.662 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.434 HH11 ' CZ ' ' A' ' 90' ' ' ARG . 94.9 mtt-85 -83.97 146.28 28.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.183 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.17 147.48 36.68 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.241 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.05 152.33 39.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.705 0.288 . . . . 1.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -126.84 102.49 25.07 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.89 -13.06 29.08 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.648 1.565 . . . . 1.0 112.953 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -91.81 105.4 17.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.14 -54.82 42.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.167 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.439 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.55 -38.93 81.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 1.0 110.348 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -36.43 70.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.798 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.0 mt -61.88 -46.28 90.11 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.152 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.85 -44.53 80.77 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.905 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.32 -48.87 76.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.91 -41.66 91.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.552 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.7 m -62.16 -43.46 98.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.831 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.29 -47.32 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.303 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.59 -42.49 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.953 0.406 . . . . 1.0 111.158 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.32 -42.68 91.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.167 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.76 90.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.05 87.9 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.623 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -69.9 -38.31 76.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.97 -46.04 92.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.055 0.455 . . . . 1.0 109.832 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.15 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.48 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.39 -39.07 88.83 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.605 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.451 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo . . . . . 0 N--CA 1.499 1.828 0 CA-C-O 120.904 0.294 . . . . 1.0 112.071 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.6 mt -71.08 150.03 94.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.859 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.76 142.03 61.92 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.914 1.742 . . . . 1.0 111.466 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.32 -32.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.734 -0.667 . . . . 1.0 111.349 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.05 -36.36 90.18 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.7 165.87 21.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 1.0 110.978 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.53 80.67 22.9 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.602 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.23 96.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.676 2.251 . . . . 1.0 112.773 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.3 mt -65.37 -41.43 93.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.83 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.06 146.59 27.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.251 -0.886 . . . . 1.0 110.36 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 t -134.31 131.06 37.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.807 0.337 . . . . 1.0 110.542 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.3 m -137.97 160.79 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.367 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -100.08 154.79 18.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.623 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -169.92 -169.61 33.35 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 23' ' ' MET . 2.5 mpt? -132.2 129.19 39.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 1.0 110.388 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -91.97 117.36 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.44 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.8 mtm -101.49 135.66 42.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.789 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.79 151.47 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.714 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -67.03 0.33 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.667 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.35 -33.77 88.48 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.882 2.388 . . . . 1.0 113.603 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' C ' ' CD1' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.36 -176.61 0.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -122.07 168.45 11.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.11 0.481 . . . . 1.0 110.695 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -155.28 142.41 13.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.737 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.03 143.39 94.97 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.355 1.37 . . . . 1.0 111.257 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 22' ' ' GLY . 12.4 p -153.57 -179.2 7.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.385 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.23 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.936 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.6 mt -101.58 123.77 46.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.5 m -127.43 124.29 38.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.227 0.537 . . . . 1.0 111.357 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.7 tp -91.59 128.93 37.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.016 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.45 148.68 43.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.159 0.504 . . . . 1.0 111.388 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -109.23 123.06 48.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.723 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -135.09 135.81 41.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.967 0.413 . . . . 1.0 111.194 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.13 34.59 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.658 -0.701 . . . . 1.0 111.523 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.4 21.75 76.11 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -129.89 156.76 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -98.54 132.46 43.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -140.79 147.08 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.44 . . . . 1.0 110.065 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -103.99 122.21 44.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.438 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.52 117.76 51.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -99.75 118.41 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -100.03 131.64 45.87 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 52' ' ' GLU . 8.6 mp -105.99 123.34 47.84 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -80.11 36.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.154 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 50' ' ' LEU . 35.0 tp10 -46.47 135.0 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.985 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.4 -35.88 81.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -66.79 -80.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.402 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -132.57 129.28 38.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.933 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -61.94 102.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.922 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.91 131.44 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -107.79 136.57 47.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.956 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 40.6 t0 -101.03 123.5 45.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.5 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.31 119.26 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 1.0 110.3 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.11 119.23 15.52 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.896 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.49 157.21 40.82 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.678 1.586 . . . . 1.0 112.598 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.46 119.67 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.537 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -171.89 -160.06 0.15 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.43 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 t -61.12 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.041 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -64.81 -36.15 83.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.875 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 64' ' ' ASN . 28.2 t80 -95.0 136.87 34.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.968 0.413 . . . . 1.0 110.439 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 92' ' ' GLN . 37.5 ptt180 -143.38 145.99 33.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.904 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 27.5 p -117.0 99.66 7.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.384 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -102.82 124.26 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.032 0.444 . . . . 1.0 110.985 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.2 tp-100 -83.14 100.84 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.381 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.792 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.88 0.372 . . . . 1.0 110.376 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 81' ' ' ILE . 94.4 mt -63.94 -42.47 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.675 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.33 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.029 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -106.9 78.26 1.23 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.099 0.476 . . . . 1.0 110.577 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.67 -170.4 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m 64.59 88.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.69 82.92 0.06 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.56 135.24 41.27 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.834 0.309 . . . . 1.0 111.834 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 65.7 mttp -111.53 128.71 56.1 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.6 pt -125.01 157.35 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.31 134.63 45.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.99 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.46 132.94 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.366 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 98' ' ' GLU . 86.2 mt-30 -135.4 152.79 51.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.024 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 1.0 110.765 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 48.5 tp10 -61.01 128.45 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 1.0 110.526 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 99.9 mtt180 -135.35 143.39 46.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.033 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -127.16 145.99 50.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.752 0.31 . . . . 1.0 111.181 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -144.25 153.72 42.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.357 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -143.51 147.35 34.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.972 0.415 . . . . 1.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.03 98.73 26.5 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 -11.29 28.6 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.706 1.604 . . . . 1.0 112.67 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 105.3 17.6 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.09 -53.98 52.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.911 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -50.75 -43.52 58.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.576 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -69.97 -40.21 75.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.879 0.371 . . . . 1.0 110.531 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -57.1 -34.87 68.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.083 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.519 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.48 -44.84 81.56 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.185 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -59.88 -48.67 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.158 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.11 -41.36 86.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.389 -0.525 . . . . 1.0 111.281 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.549 ' HG ' ' H ' ' A' ' 115' ' ' ALA . 78.0 p -65.59 -46.08 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.607 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.549 ' H ' ' HG ' ' A' ' 114' ' ' SER . . . -67.13 -50.05 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.318 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.15 -44.21 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.66 -45.21 95.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.421 . . . . 1.0 110.196 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.42 82.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.452 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.44 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.678 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.508 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 87.3 mt-30 -69.77 -38.6 76.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.407 . . . . 1.0 110.84 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -63.95 -44.46 92.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.039 0.447 . . . . 1.0 110.919 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.95 75.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.866 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.85 -40.51 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 1.0 110.571 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.595 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.496 1.661 0 CA-C-O 120.956 0.315 . . . . 1.0 112.025 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.76 144.44 85.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.956 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.64 148.51 53.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.797 1.665 . . . . 1.0 111.841 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.18 -43.15 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.563 . . . . 1.0 111.109 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.5 -36.64 47.79 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.76 151.12 47.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 1.0 110.825 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -118.15 83.57 20.12 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.326 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.56 125.04 16.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.262 1.975 . . . . 1.0 112.431 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.7 mt -101.1 -32.66 10.47 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.428 -0.805 . . . . 1.0 109.632 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.48 151.19 29.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.326 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -146.33 129.17 16.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.859 0.361 . . . . 1.0 110.556 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -141.43 163.15 20.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.259 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -101.37 122.43 43.72 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 33' ' ' CYS . . . -131.54 152.11 19.96 Favored Glycine 0 N--CA 1.464 0.555 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 mmm -99.19 100.66 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.999 0.428 . . . . 1.0 110.187 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.84 126.8 28.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.589 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.441 ' SD ' ' C ' ' A' ' 101' ' ' PHE . 1.6 mpp? -109.85 137.16 48.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.03 149.79 50.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.635 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.28 -66.23 0.3 Allowed Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.915 -0.584 . . . . 1.0 112.633 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.49 -33.28 88.15 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.796 2.331 . . . . 1.0 113.484 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -177.79 -172.51 0.35 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.672 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -122.67 168.87 11.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.047 0.451 . . . . 1.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -154.12 140.87 13.12 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.723 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.22 142.0 84.71 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.267 1.312 . . . . 1.0 111.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 22' ' ' GLY . 13.6 p -150.95 169.23 22.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.551 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.18 118.94 19.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 109.852 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -91.92 126.3 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.012 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.6 m -130.81 120.69 24.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.095 0.474 . . . . 1.0 111.344 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 tp -90.38 130.99 36.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.07 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.81 148.17 32.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.173 0.511 . . . . 1.0 111.362 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.72 127.01 48.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -138.0 138.15 38.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.887 0.375 . . . . 1.0 111.007 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.44 35.22 24.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.662 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.56 27.56 73.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.7 158.95 43.28 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -99.27 130.34 45.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.908 -0.405 . . . . 1.0 109.908 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.27 143.77 34.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.931 0.396 . . . . 1.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.4 125.21 50.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.275 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -103.31 124.6 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mt -99.25 128.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -118.4 119.62 35.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.691 0.282 . . . . 1.0 110.807 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.0 mp -100.58 131.18 46.63 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -94.29 60.53 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 1.0 110.413 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.24 157.6 10.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.183 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.15 -38.74 87.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.754 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 54' ' ' GLU . 56.6 mp0 -78.96 -104.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.226 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -106.52 152.49 23.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -73.3 145.77 45.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.233 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.76 130.7 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.983 0.42 . . . . 1.0 110.303 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -106.53 108.08 19.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.788 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -116.74 113.05 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.633 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.41 115.64 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.387 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.05 120.18 39.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.38 147.89 33.15 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.791 1.661 . . . . 1.0 112.498 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 ' CG2' HE22 ' A' ' 123' ' ' GLN . 96.4 mt -92.8 122.49 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.228 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.6 p30 -174.16 -159.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.353 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -41.25 90.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.2 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -66.06 -36.28 82.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.353 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . 15.1 t80 -101.54 123.63 45.88 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -133.81 141.08 47.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.326 0.584 . . . . 1.0 111.026 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.0 t -103.31 105.87 16.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.245 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -111.07 126.4 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.229 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.408 ' OE1' ' O ' ' A' ' 83' ' ' SER . 48.1 tt0 -97.49 131.1 44.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.492 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.374 -179.589 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' SER . 94.8 m-20 . . . . . 0 N--CA 1.463 0.225 0 CA-C-O 121.034 0.445 . . . . 1.0 110.396 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 41.0 mm -64.58 -42.26 94.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.68 -27.02 15.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.815 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 9.5 t -123.81 119.1 28.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.043 0.449 . . . . 1.0 110.314 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 83' ' ' SER . 23.4 m120 -146.73 -167.0 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 1.0 109.827 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.24 92.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.05 67.18 2.18 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 108.892 -1.683 . . . . 1.0 108.892 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 148.95 25.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.221 0.534 . . . . 1.0 111.596 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -129.85 135.83 48.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.335 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 89' ' ' ILE . 45.9 pt -120.33 162.89 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.306 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -123.99 137.52 54.59 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.8 t -116.92 133.84 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.922 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -140.77 152.77 45.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.115 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.551 0 N-CA-C 110.552 -1.019 . . . . 1.0 110.552 179.824 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.833 0.349 . . . . 1.0 110.946 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -63.46 140.3 58.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -141.03 154.19 45.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.153 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -125.52 154.18 42.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.979 0.419 . . . . 1.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.441 ' C ' ' SD ' ' A' ' 25' ' ' MET . 98.5 m-85 -138.33 158.7 43.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.769 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -144.72 123.45 12.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mm -110.45 96.62 28.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.15 -14.55 28.8 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.536 1.491 . . . . 1.0 112.674 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -94.32 113.66 25.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.974 0.416 . . . . 1.0 110.002 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.03 -55.09 39.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.231 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -52.06 -43.34 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.654 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -68.2 -38.55 82.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.914 0.388 . . . . 1.0 110.131 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.232 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.4 -45.39 91.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.644 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -66.3 -45.41 80.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.974 -0.69 . . . . 1.0 110.703 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.46 -49.61 76.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.284 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.44 -42.56 92.26 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.382 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -63.83 -45.14 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.735 0.303 . . . . 1.0 111.478 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.93 -50.83 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.441 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.68 -46.37 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.03 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.01 -48.02 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 1.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.99 78.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.548 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.24 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.553 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.51 -44.8 85.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -66.21 -43.43 86.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.504 0.668 . . . . 1.0 110.488 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.32 78.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.904 -1.044 . . . . 1.0 111.998 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.483 HE22 ' CG2' ' A' ' 63' ' ' ILE . 6.3 pt20 -72.2 -38.32 69.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.48 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.062 -0.971 . . . . 1.0 110.567 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo . . . . . 0 N--CA 1.497 1.712 0 CA-C-O 120.886 0.286 . . . . 1.0 111.969 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mp -66.79 149.15 98.53 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.99 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.05 143.9 91.63 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.67 1.58 . . . . 1.0 111.429 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.88 -43.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.178 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.4 51.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.39 137.78 44.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.059 0.457 . . . . 1.0 111.025 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -98.95 108.6 50.11 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.57 103.87 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.532 1.488 . . . . 1.0 112.789 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.88 -43.6 83.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.191 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.21 148.95 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.216 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -138.34 131.36 29.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.765 0.317 . . . . 1.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.21 160.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.158 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -100.1 122.67 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.502 ' O ' ' SG ' ' A' ' 33' ' ' CYS . . . -132.26 158.16 22.82 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 84.1 mmm -99.37 120.88 40.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.887 0.375 . . . . 1.0 110.203 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.85 118.24 24.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.693 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -102.65 137.21 41.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.07 152.86 52.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.266 -0.425 . . . . 1.0 109.982 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.38 -66.48 0.36 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.894 -0.593 . . . . 1.0 112.506 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.22 -32.92 73.34 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.747 2.298 . . . . 1.0 113.877 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.29 -170.3 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 121.105 -0.238 . . . . 1.0 110.385 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -124.71 169.28 12.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.962 0.41 . . . . 1.0 110.25 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 9.3 pt-20 -153.57 133.19 7.33 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.797 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.29 142.56 78.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 CA-C-N 120.245 1.123 . . . . 1.0 111.34 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 22' ' ' GLY . 8.9 p -152.1 -170.18 3.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.526 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.8 131.3 8.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.293 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -100.84 123.16 44.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.088 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.4 m -126.34 112.33 15.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.298 0.57 . . . . 1.0 111.723 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.47 127.75 32.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.378 -0.828 . . . . 1.0 109.086 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.06 148.28 36.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.441 . . . . 1.0 111.445 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -102.42 128.99 48.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.901 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -139.9 136.97 34.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.931 0.396 . . . . 1.0 110.872 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 m120 59.18 33.78 22.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.513 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.93 22.56 78.38 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.655 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 48.4 tp60 -132.58 157.13 45.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.655 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 81.0 m-85 -96.3 131.84 42.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -144.06 143.88 31.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 1.0 110.404 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.1 tp -104.2 124.96 50.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.257 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 47' ' ' ILE . 80.8 mt -100.12 124.81 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.118 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.9 mt -96.53 117.54 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -109.15 130.58 55.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.003 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.94 127.76 52.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 76.2 t60 -93.8 25.39 3.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.9 mt-10 -55.02 137.55 46.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.45 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -62.72 -39.7 94.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.26 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -53.47 -51.18 63.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.913 0.387 . . . . 1.0 110.18 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -166.72 148.21 6.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.767 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.03 86.8 6.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.869 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 t -80.81 133.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.539 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -128.29 119.28 24.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.744 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.37 129.64 55.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -96.41 114.66 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.775 0.321 . . . . 1.0 110.273 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.03 121.37 35.32 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.18 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 155.48 42.57 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.987 1.792 . . . . 1.0 112.628 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 63' ' ' ILE . 98.0 mt -98.13 112.79 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.373 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 78.6 m-20 -161.68 -160.67 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.6 t -60.35 -41.94 94.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -66.17 -36.75 83.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.021 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -93.03 124.09 36.76 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.823 0.344 . . . . 1.0 110.16 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.49 141.75 45.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.289 0.566 . . . . 1.0 110.769 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.507 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 26.6 p -113.46 99.7 7.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.222 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -109.45 128.46 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.448 . . . . 1.0 111.049 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.636 HE21 ' N ' ' A' ' 88' ' ' LYS . 34.1 tp60 -80.77 116.86 20.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' GLN . 17.7 pt-20 . . . . . 0 N--CA 1.469 0.492 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.645 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.181 0.515 . . . . 1.0 110.077 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 81' ' ' ILE . 93.6 mt -63.65 -42.61 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.693 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.82 -26.01 44.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.126 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.53 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 5.7 t -104.28 102.61 12.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 83' ' ' SER . 9.8 m120 -136.27 -168.94 2.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.994 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 m 62.13 82.58 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.17 77.35 0.26 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 132.64 37.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.798 0.332 . . . . 1.0 111.751 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.636 ' N ' HE21 ' A' ' 71' ' ' GLN . 98.8 mttt -110.22 129.49 55.71 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.5 pt -126.83 160.15 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -130.52 133.96 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.482 . . . . 1.0 109.849 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.2 t -114.54 134.55 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.418 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.43 154.96 41.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.327 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.828 0.347 . . . . 1.0 110.879 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -59.66 137.63 57.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.468 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.43 154.53 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.082 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -124.74 150.97 45.66 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.185 0.517 . . . . 1.0 111.394 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -143.83 156.86 44.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.43 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -148.56 118.67 7.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.048 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.62 99.8 12.55 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.83 -11.82 28.03 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.542 1.495 . . . . 1.0 112.887 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -91.42 106.19 18.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.98 -52.91 63.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.091 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -52.24 -43.83 64.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.406 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.47 -38.96 77.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.0 110.564 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -35.22 71.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.024 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -45.33 93.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.306 -0.558 . . . . 1.0 111.148 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.77 -43.22 84.6 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.787 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -61.1 -49.39 77.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.077 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.24 -42.02 89.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.472 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 m -63.12 -45.38 92.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 1.0 111.317 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.55 -49.03 67.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.33 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.46 -45.65 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.977 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -60.98 -45.1 96.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.034 0.445 . . . . 1.0 110.148 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.22 -37.76 86.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.459 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.18 -49.99 73.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.679 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.503 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 92.3 mt-30 -70.69 -38.07 73.68 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.227 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.72 -43.09 94.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.007 0.432 . . . . 1.0 110.517 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.6 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.33 -35.82 68.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 1.0 110.752 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.019 -0.991 . . . . 1.0 110.476 -179.905 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 N--CA 1.497 1.722 0 CA-C-O 121.012 0.338 . . . . 1.0 111.986 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.38 84.01 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.774 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.583 ' CD ' HE22 ' A' ' 58' ' ' GLN . 24.4 Cg_endo -59.51 140.48 94.22 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.857 1.705 . . . . 1.0 111.542 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.89 -43.79 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.215 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -37.34 -38.88 0.44 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.38 -0.688 . . . . 1.0 111.38 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.28 147.95 41.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.722 0.296 . . . . 1.0 110.538 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -98.2 102.43 14.01 Favored Pre-proline 0 C--O 1.223 -0.338 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -75.28 103.14 1.68 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.5 1.467 . . . . 1.0 113.522 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.1 mt -67.12 -41.84 85.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.178 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 155.31 40.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.259 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -143.49 130.64 20.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.42 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 47.9 t -141.31 159.08 22.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.698 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 83.0 tt0 -104.55 121.13 42.86 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -123.56 -169.51 13.22 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.837 -0.905 . . . . 1.0 110.837 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 89.3 mmm -136.94 101.47 4.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.87 0.367 . . . . 1.0 110.037 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.578 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.0 tt0 -61.05 128.8 38.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.609 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -106.01 136.38 45.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.312 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -135.64 151.91 50.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.72 -68.15 0.29 Allowed Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.74 -0.664 . . . . 1.0 112.605 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.93 -32.47 92.54 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.864 2.376 . . . . 1.0 113.553 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -179.85 -167.01 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.344 -0.243 . . . . 1.0 110.344 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -122.46 168.5 12.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.888 0.375 . . . . 1.0 110.201 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -146.21 138.73 13.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.653 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.34 139.63 73.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 CA-C-N 120.171 1.097 . . . . 1.0 111.418 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.578 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 17.2 p -153.65 177.68 10.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.56 138.72 23.63 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.905 0.383 . . . . 1.0 110.122 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 5.5 mp -102.62 120.57 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 1.0 109.999 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -127.31 113.17 15.92 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.28 0.562 . . . . 1.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 tp -86.48 127.51 34.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.434 -0.803 . . . . 1.0 108.975 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.94 156.56 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.16 0.505 . . . . 1.0 111.484 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -113.87 122.65 47.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.608 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -133.32 137.89 46.15 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.886 0.374 . . . . 1.0 110.919 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 59.13 34.17 23.18 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.606 -0.725 . . . . 1.0 111.513 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.77 25.34 75.22 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.771 -0.931 . . . . 1.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -134.09 153.33 51.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -93.53 134.9 35.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.02 143.79 31.35 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.963 0.411 . . . . 1.0 110.264 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.0 tp -103.46 116.56 32.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.356 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.8 mt -109.69 115.78 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 101' ' ' PHE . 60.2 mt -106.57 116.9 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -81.27 128.43 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.705 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 mp -110.4 130.26 55.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.615 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.623 ' ND1' ' N ' ' A' ' 51' ' ' HIS . 0.9 OUTLIER -94.53 54.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.218 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -46.61 150.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.55 -39.97 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.33 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -62.95 -46.13 89.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.133 0.492 . . . . 1.0 110.488 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -168.9 -158.98 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.796 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.01 115.11 28.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.893 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.76 138.13 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.169 0.509 . . . . 1.0 110.499 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.583 HE22 ' CD ' ' A' ' 11' ' ' PRO . 17.3 pt20 -97.56 141.42 30.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -102.06 115.18 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.738 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.8 mm -92.82 101.42 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.923 0.392 . . . . 1.0 110.092 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 61' ' ' ILE . 33.8 mm -117.63 90.21 34.96 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.143 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.14 146.48 88.04 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 1.0 112.407 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 96.6 mt -93.28 115.43 32.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 63' ' ' ILE . 80.7 m-20 -163.58 -166.75 1.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.177 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -33.24 74.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.223 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -76.2 -12.48 60.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.743 0.306 . . . . 1.0 111.17 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.407 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 32.9 t80 -114.06 130.05 56.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.052 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.68 145.08 44.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.4 t -121.55 106.04 11.01 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.399 -0.818 . . . . 1.0 109.2 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 m -107.36 125.37 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.729 0.3 . . . . 1.0 110.762 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.439 HE22 ' N ' ' A' ' 88' ' ' LYS . 9.3 tp-100 -99.1 115.88 30.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.339 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.7 179.778 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.925 0.393 . . . . 1.0 109.955 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.503 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 95.8 mt -64.04 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.67 -24.92 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.945 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 m -102.6 59.54 0.8 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.844 0.354 . . . . 1.0 110.429 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.7 m120 -82.65 -171.63 3.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.145 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m 66.69 87.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.04 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.12 79.04 0.11 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 139.8 30.84 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.921 0.391 . . . . 1.0 111.754 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.439 ' N ' HE22 ' A' ' 71' ' ' GLN . 22.3 pttp -126.83 134.14 50.6 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 89' ' ' ILE . 50.3 pt -126.18 161.24 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.231 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.95 138.14 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.697 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -117.46 133.96 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.448 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -136.91 134.65 37.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.046 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.673 0.273 . . . . 1.0 110.468 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -174.75 126.22 0.29 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.438 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -137.76 123.66 20.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -89.98 151.15 21.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.925 0.393 . . . . 1.0 111.24 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 48' ' ' ILE . 67.6 m-85 -136.53 148.62 47.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.26 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.95 144.32 45.36 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 1.0 110.753 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.2 mm -129.41 90.37 44.6 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.27 -17.82 44.76 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 1.0 112.762 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -88.88 108.67 19.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.69 -0.485 . . . . 1.0 109.69 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.91 -53.18 50.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.068 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -53.18 -40.9 64.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.664 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -73.0 -35.88 66.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 1.0 110.396 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.9 t -60.73 -34.24 74.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.901 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.8 -44.79 95.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.425 -0.51 . . . . 1.0 111.352 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.84 -43.67 83.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.969 -0.692 . . . . 1.0 110.189 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.22 -49.03 79.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.353 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -65.89 -41.62 91.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.269 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.3 t -63.31 -44.74 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.235 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.87 -50.32 64.94 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.359 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.21 -44.15 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.26 -45.75 92.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 1.0 110.225 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.14 86.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.549 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.7 79.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.809 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.29 -37.62 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 1.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -60.37 -44.51 95.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.029 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.59 94.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.49 -40.2 92.79 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.792 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.222 -0.386 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.386 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.498 1.74 0 CA-C-O 120.784 0.244 . . . . 1.0 111.989 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.7 mt -70.2 135.41 86.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.064 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.91 147.58 68.61 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.686 1.59 . . . . 1.0 111.68 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -70.02 -32.39 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.156 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.23 94.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.56 141.83 44.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 1.0 110.778 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.535 HE21 ' NE2' ' A' ' 39' ' ' GLN . 10.3 mt-30 -101.67 100.34 14.03 Favored Pre-proline 0 C--O 1.224 -0.283 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.38 103.15 1.69 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.523 1.482 . . . . 1.0 112.83 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.76 -43.34 89.18 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.131 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.87 151.65 37.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.237 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -141.42 128.08 20.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.452 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 53.3 t -141.59 160.7 21.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.926 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 55.7 mp0 -103.55 121.96 43.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -124.99 -173.37 13.69 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 25' ' ' MET . 90.7 mmm -131.26 107.31 8.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 1.0 110.125 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 99' ' ' ARG . 84.8 tt0 -76.19 126.48 31.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.644 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.532 ' N ' ' SD ' ' A' ' 25' ' ' MET . 0.9 OUTLIER -116.04 139.82 49.89 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.634 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.68 150.4 50.62 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 1.0 109.865 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.9 -65.6 0.47 Allowed Glycine 0 CA--C 1.533 1.188 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.665 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.52 -32.36 88.05 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 122.732 2.288 . . . . 1.0 113.786 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.78 -179.56 0.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 121.032 -0.267 . . . . 1.0 110.465 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -125.14 169.21 12.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.053 0.454 . . . . 1.0 110.787 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -157.92 143.43 12.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.426 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.64 144.23 93.82 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.264 1.309 . . . . 1.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.5 p -149.14 173.67 13.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.403 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.7 129.1 34.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.01 0.433 . . . . 1.0 110.182 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 3.8 mm? -97.4 118.21 33.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -129.84 113.82 15.15 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.166 0.507 . . . . 1.0 111.56 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.4 tp -85.98 129.8 34.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.464 -0.789 . . . . 1.0 109.047 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.12 156.96 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.999 0.428 . . . . 1.0 111.283 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.535 ' NE2' HE21 ' A' ' 15' ' ' GLN . 1.2 tm0? -119.47 119.62 34.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -127.31 137.19 52.76 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.977 0.418 . . . . 1.0 110.913 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 58.86 32.38 22.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.498 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.21 18.45 78.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.641 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 41.3 tp60 -125.51 140.44 52.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.113 -0.328 . . . . 1.0 110.113 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.641 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 69.9 m-85 -80.27 135.72 36.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.51 140.28 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.355 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.5 tp -104.34 126.13 51.18 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.311 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.8 mt -104.37 121.18 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.983 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.7 115.45 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -105.65 130.94 53.57 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.879 0.371 . . . . 1.0 110.931 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.16 128.41 53.89 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -90.13 62.5 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.331 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 55' ' ' GLN . 97.9 mt-10 -60.85 146.22 47.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.36 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.52 -39.55 93.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.086 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -63.23 -41.07 99.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' GLU . 15.8 pt20 -172.39 -156.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -127.34 127.97 45.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.975 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.79 130.69 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.171 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -102.58 116.26 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.987 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -102.05 113.26 26.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.521 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -94.61 111.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 1.0 110.524 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 61' ' ' ILE . 30.1 mm -113.68 120.29 39.67 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.089 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.6 148.1 36.75 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.792 1.661 . . . . 1.0 112.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.0 mt -92.58 122.97 44.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.444 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -172.22 -160.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.266 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.507 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 78.0 p -61.53 -40.01 93.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -68.51 -32.51 72.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.682 0.277 . . . . 1.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.8 t80 -95.4 126.14 40.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.044 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 65' ' ' SER . 84.4 mtt85 -137.75 145.91 43.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.2 0.524 . . . . 1.0 110.874 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.2 t -122.33 117.89 27.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.064 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 4.8 m -118.36 125.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.756 0.312 . . . . 1.0 110.462 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.1 tp-100 -83.68 123.78 30.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.441 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.96 -179.988 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 120.928 0.394 . . . . 1.0 110.039 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.523 ' C ' ' H ' ' A' ' 83' ' ' SER . 93.8 mt -64.23 -43.18 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.691 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.0 -11.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.156 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.533 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 30.7 t -133.18 135.15 44.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.009 0.433 . . . . 1.0 110.157 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.7 m120 -146.25 -176.76 5.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.911 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t 72.04 89.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.24 80.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.74 133.61 36.93 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.1 mttt -109.95 113.21 25.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.463 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 2.1 pp -117.51 128.81 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -103.39 146.16 28.9 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.46 133.7 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.897 0.379 . . . . 1.0 110.639 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -136.19 137.95 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.182 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.722 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.432 ' CG ' ' N ' ' A' ' 98' ' ' GLU . 35.8 ptt-85 . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.486 0.184 . . . . 1.0 110.753 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' ARG . 48.5 tp10 -175.04 121.45 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.874 0.368 . . . . 1.0 110.228 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.514 ' NE ' ' OE2' ' A' ' 24' ' ' GLU . 81.0 mtp180 -138.08 124.35 20.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -87.76 149.2 24.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.933 0.396 . . . . 1.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -141.08 148.28 39.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.286 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -144.31 134.44 24.19 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.369 . . . . 1.0 111.074 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.68 99.72 48.52 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 -13.05 31.08 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.504 1.469 . . . . 1.0 112.768 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -90.72 103.04 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -53.51 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 1.0 112.207 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -53.04 -43.77 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.549 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -69.56 -36.68 76.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.908 0.385 . . . . 1.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.4 t -60.13 -36.2 76.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.0 mt -62.53 -44.31 96.66 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.103 -0.639 . . . . 1.0 111.28 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.11 -45.98 75.57 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.749 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.99 -49.01 76.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.818 . . . . 1.0 111.567 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.77 -41.36 92.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.221 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.3 -45.89 75.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.306 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.09 -46.84 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.768 0.318 . . . . 1.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -43.46 98.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.474 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.63 88.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.94 -49.22 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.622 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -69.68 -38.41 77.01 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.189 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.997 0.427 . . . . 1.0 110.624 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.21 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.624 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -72.88 -40.24 65.76 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.844 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.665 179.897 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo . . . . . 0 N--CA 1.499 1.815 0 CA-C-O 120.984 0.327 . . . . 1.0 112.134 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -66.51 144.38 98.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.834 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.69 142.43 63.92 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.711 1.608 . . . . 1.0 111.464 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 p -72.16 -32.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.275 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.31 93.75 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.01 144.58 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 1.0 111.101 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.37 107.15 33.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.58 102.81 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.457 1.438 . . . . 1.0 112.757 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.03 -43.82 86.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.102 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 154.13 35.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.273 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -142.81 132.5 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 1.0 110.529 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.0 152.3 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.043 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -107.84 121.9 45.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.747 -0.66 . . . . 1.0 109.317 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.21 -158.76 9.67 Favored Glycine 0 N--CA 1.462 0.4 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -131.14 131.2 43.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.066 0.46 . . . . 1.0 110.658 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.566 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 25.9 tp10 -91.68 126.53 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.4 mtm -113.67 135.63 53.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.633 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -141.48 149.27 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.237 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -36.39 -64.91 0.56 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 115.745 -0.662 . . . . 1.0 112.762 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.18 -32.79 94.98 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.885 2.39 . . . . 1.0 113.973 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 178.97 177.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 121.163 -0.215 . . . . 1.0 110.645 179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -122.05 169.23 11.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.05 0.452 . . . . 1.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.32 144.24 9.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.38 146.77 81.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.091 1.068 . . . . 1.0 111.412 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 31.8 p -153.16 -178.22 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.526 -0.307 . . . . 1.0 110.4 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.04 145.18 24.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.643 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 44.6 mt -115.2 116.45 28.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -121.56 114.58 21.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.32 0.581 . . . . 1.0 111.559 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 tp -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.308 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.18 149.64 41.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.066 0.46 . . . . 1.0 111.393 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -104.07 128.38 51.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.665 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -140.62 137.06 33.35 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.749 -0.381 . . . . 1.0 110.895 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 58.79 33.02 22.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.695 -0.684 . . . . 1.0 111.591 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.95 77.09 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.61 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 46.5 tp60 -132.34 157.57 44.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.61 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 86.8 m-85 -99.16 134.43 42.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.043 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -146.22 141.9 27.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.845 0.355 . . . . 1.0 110.336 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.7 tp -104.86 125.05 50.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.631 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.3 mt -98.95 121.71 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.9 mt -107.21 124.76 63.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.477 ' NE2' ' HE2' ' A' ' 56' ' ' HIS . 74.0 mt-30 -114.88 122.76 47.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.963 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 52' ' ' GLU . 9.9 mp -105.15 128.37 53.35 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.23 45.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.21 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 50' ' ' LEU . 39.6 tp10 -41.77 146.52 0.25 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.403 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -61.6 -39.28 90.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.292 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -59.0 -47.6 84.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.965 0.412 . . . . 1.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -174.4 -162.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.477 ' HE2' ' NE2' ' A' ' 49' ' ' GLN . 54.5 t60 -97.19 81.47 3.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.061 0.458 . . . . 1.0 109.834 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.77 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.528 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -108.64 116.97 32.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.517 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -100.45 132.58 45.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.95 110.85 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.814 0.34 . . . . 1.0 110.139 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 61' ' ' ILE . 34.0 mm -115.09 108.73 47.75 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.238 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 151.23 38.21 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.639 1.559 . . . . 1.0 112.571 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.1 mt -95.08 124.33 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.616 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.691 HD22 ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -172.04 -150.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 1.0 109.847 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -72.37 -39.93 67.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 1.0 112.083 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.691 ' CG ' HD22 ' A' ' 64' ' ' ASN . 2.4 p80 -74.61 -16.85 60.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.788 0.328 . . . . 1.0 111.318 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 61.1 t80 -102.46 123.72 46.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.87 142.51 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.323 0.583 . . . . 1.0 110.853 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.33 106.67 10.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.212 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.59 129.63 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.053 0.454 . . . . 1.0 111.381 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.0 tp-100 -80.38 100.58 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.471 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.476 179.813 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.961 0.41 . . . . 1.0 110.271 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.88 -42.62 96.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.678 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.79 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.085 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 11.7 t -109.58 119.8 40.52 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 83' ' ' SER . 13.0 m120 -148.02 -175.19 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.078 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.75 88.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.64 71.78 0.79 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.47 139.29 30.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.952 0.406 . . . . 1.0 111.675 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 52.1 mtpt -116.73 129.33 56.05 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.31 160.14 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -130.23 143.03 50.54 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.913 0.387 . . . . 1.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.11 133.25 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.908 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.74 152.47 42.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.745 0.307 . . . . 1.0 110.652 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -57.25 135.22 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 1.0 110.778 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.71 136.52 40.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.488 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 77.4 mtp180 -106.71 139.5 41.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.225 0.536 . . . . 1.0 110.944 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 85.1 m-85 -133.92 152.1 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.198 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.99 127.03 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.907 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.79 89.47 7.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.21 -15.65 35.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.787 1.658 . . . . 1.0 112.777 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.32 106.64 18.63 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -60.81 -53.43 57.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.028 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -52.94 -43.74 66.54 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.628 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 59.1 m170 -68.57 -36.74 79.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.484 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -63.3 -34.59 78.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.787 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.37 -46.25 89.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.387 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.63 -42.98 81.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.66 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -61.82 -49.05 77.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.104 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.7 -41.57 95.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.474 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 115' ' ' ALA . 77.8 p -63.57 -44.5 93.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.903 0.382 . . . . 1.0 111.164 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.494 ' H ' ' HG ' ' A' ' 114' ' ' SER . . . -65.9 -48.04 72.8 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.251 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.67 -42.22 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.828 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.49 -44.66 89.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.997 0.427 . . . . 1.0 110.077 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.69 91.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.435 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.814 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -67.88 -39.83 83.62 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.021 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.76 -45.32 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.029 0.442 . . . . 1.0 110.1 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -67.99 -39.67 83.22 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.722 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.454 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 N--CA 1.496 1.667 0 CA-C-O 120.855 0.273 . . . . 1.0 111.925 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.39 166.37 11.34 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.94 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.56 148.39 92.45 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.642 1.561 . . . . 1.0 111.561 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.12 -45.05 95.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.15 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.4 -29.97 76.55 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.231 -0.747 . . . . 1.0 111.231 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.76 58.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 1.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -109.4 108.36 59.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 128.13 11.08 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.643 1.562 . . . . 1.0 112.765 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -100.86 -38.85 8.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.713 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.62 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.105 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -143.34 137.73 28.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.794 0.331 . . . . 1.0 110.512 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.6 146.92 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.981 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -108.76 122.16 46.57 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -140.32 -158.06 7.44 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 16.7 mmm -127.97 129.06 46.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.909 0.385 . . . . 1.0 110.432 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.63 118.77 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.24 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.1 mtm -97.8 136.22 38.45 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.508 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.24 151.84 51.5 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.19 -64.93 0.45 Allowed Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.954 -0.567 . . . . 1.0 112.704 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.35 -34.05 56.44 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.725 2.283 . . . . 1.0 113.746 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.75 -173.41 0.6 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.321 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -121.29 168.36 11.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.9 0.381 . . . . 1.0 110.465 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.13 141.35 13.47 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.742 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.97 145.44 74.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 CA-C-N 120.221 1.115 . . . . 1.0 111.52 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 22' ' ' GLY . 11.5 p -158.97 -176.24 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.608 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.76 134.48 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.182 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.8 mt -104.18 128.08 51.84 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.003 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -125.02 123.26 39.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.246 0.546 . . . . 1.0 111.522 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.1 tp -89.42 127.18 35.8 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.236 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.79 150.11 39.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.133 0.492 . . . . 1.0 111.434 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -106.0 123.88 48.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -134.47 131.27 37.88 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 1.0 110.742 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 m120 61.09 34.6 19.04 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.684 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.35 75.81 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -134.77 149.6 50.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -94.67 134.09 37.63 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.59 147.67 34.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.874 0.369 . . . . 1.0 110.432 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 46' ' ' LEU . 4.4 tt -108.4 120.54 42.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.068 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.8 mt -99.07 128.04 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -95.05 119.78 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -107.54 129.95 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.033 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 mp -109.5 136.34 49.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -95.45 20.18 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.113 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -48.28 138.32 9.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.271 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -63.19 -38.62 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.414 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.87 -52.17 65.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 1.0 110.31 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -172.32 155.14 3.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -82.92 102.64 11.82 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 1.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.57 134.2 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -122.16 108.22 13.06 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.658 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -101.51 125.67 48.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.647 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mm -92.39 105.96 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.09 108.29 48.47 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.044 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.27 145.11 34.06 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.658 1.572 . . . . 1.0 112.449 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.5 123.63 38.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -174.9 -162.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 -40.48 86.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.143 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -65.52 -39.81 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.02 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.77 122.56 35.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.206 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -140.31 111.42 7.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.235 0.541 . . . . 1.0 110.927 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.8 p -102.54 111.61 23.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.033 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -116.0 129.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.98 0.419 . . . . 1.0 110.76 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.654 HE22 ' ND2' ' A' ' 84' ' ' ASN . 50.9 tt0 -75.28 120.45 20.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.852 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.889 0.375 . . . . 1.0 110.081 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.445 HG22 HD12 ' A' ' 81' ' ' ILE . 34.8 mm -113.94 -37.08 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.449 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -47.35 82.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.889 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 t -140.12 139.77 35.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.874 0.369 . . . . 1.0 110.519 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.654 ' ND2' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -158.15 36.99 0.25 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.525 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -83.95 112.8 20.49 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 48.32 82.5 0.03 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.212 -1.555 . . . . 1.0 109.212 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.485 ' CB ' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -115.2 150.25 36.4 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.221 0.534 . . . . 1.0 111.573 -177.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 151.47 33.56 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.51 169.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.53 HH21 ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -139.21 126.1 20.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.027 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 130.69 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -152.63 153.33 33.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.11 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.612 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.865 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.815 0.341 . . . . 1.0 110.807 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' CD ' HH21 ' A' ' 90' ' ' ARG . 80.6 tt0 -60.46 131.44 50.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.0 110.649 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -137.64 135.41 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.572 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -129.61 149.94 51.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.031 0.444 . . . . 1.0 111.601 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -144.71 161.03 40.22 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.333 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -145.26 139.64 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.919 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.28 101.08 31.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.04 -12.04 21.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.605 1.537 . . . . 1.0 112.618 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.61 111.53 23.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.34 -51.25 70.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.611 0.597 . . . . 1.0 112.611 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -55.13 -38.95 68.89 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.424 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -77.45 -33.8 54.67 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.74 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -53.98 52.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.373 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.55 -39.47 94.48 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.908 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.14 -44.81 91.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.661 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.59 -52.84 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.868 -0.605 . . . . 1.0 111.318 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.586 ' CD1' ' NE2' ' A' ' 71' ' ' GLN . 30.4 mt -66.54 -40.75 89.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.2 t -62.5 -44.34 96.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.678 0.275 . . . . 1.0 111.42 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.81 -49.66 61.09 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.531 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.25 -43.63 91.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.117 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.33 -46.75 88.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.889 0.376 . . . . 1.0 110.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.2 -29.85 70.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.49 92.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.09 -43.16 99.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.819 0.342 . . . . 1.0 111.626 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.77 -43.56 98.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.521 0.677 . . . . 1.0 109.916 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.8 87.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.859 -1.064 . . . . 1.0 111.21 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -65.63 -43.55 89.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.676 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.043 -0.979 . . . . 1.0 110.608 179.915 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 N--CA 1.497 1.708 0 CA-C-O 120.824 0.26 . . . . 1.0 111.986 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -60.78 140.75 93.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.93 144.66 77.51 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.765 1.643 . . . . 1.0 111.587 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.06 -43.01 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.071 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.99 -37.67 45.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.161 -0.775 . . . . 1.0 111.161 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 143.98 56.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 1.0 110.962 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.38 79.9 0.42 Allowed Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 108.882 -0.784 . . . . 1.0 108.882 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.7 96.45 0.14 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.819 1.679 . . . . 1.0 113.157 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.69 -41.92 91.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.269 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.15 40.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.107 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -140.08 131.94 27.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.557 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.4 m -139.37 159.17 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.255 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -113.56 121.86 45.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.0 178.6 17.83 Favored Glycine 0 N--CA 1.463 0.47 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.8 mtp -118.18 102.89 9.35 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.798 0.332 . . . . 1.0 110.477 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.39 122.45 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.476 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 76.8 mtm -105.47 137.58 43.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.487 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.74 151.24 50.82 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.39 -67.2 0.26 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.846 -0.616 . . . . 1.0 112.709 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.12 -32.98 83.37 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.781 2.321 . . . . 1.0 113.401 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.8 -172.3 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.626 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -125.18 169.13 12.53 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.184 0.516 . . . . 1.0 110.521 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -152.85 144.38 16.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.05 142.19 91.58 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.365 1.376 . . . . 1.0 111.146 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.7 p -154.18 -174.64 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.525 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.68 15.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.338 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mp -110.69 122.09 46.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.949 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.2 m -123.53 115.42 21.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.254 0.549 . . . . 1.0 111.576 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.4 tp -81.29 129.41 34.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.266 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.48 152.04 40.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 1.0 111.477 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -109.6 122.94 48.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.676 ' NH1' HD22 ' A' ' 41' ' ' ASN . 66.4 ttp85 -134.63 137.16 43.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.097 0.475 . . . . 1.0 110.688 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.676 HD22 ' NH1' ' A' ' 40' ' ' ARG . 67.7 m-20 60.27 34.2 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.442 -0.799 . . . . 1.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.13 24.01 76.02 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -132.73 150.07 52.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.06 130.27 37.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -143.07 143.14 31.74 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.014 0.435 . . . . 1.0 110.353 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 tp -104.58 129.17 52.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.38 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 47' ' ' ILE . 76.3 mt -104.0 126.72 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.493 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 48' ' ' ILE . 38.8 mm -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -108.05 128.16 54.42 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 52' ' ' GLU . 10.0 mp -106.76 129.72 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.322 -0.622 . . . . 1.0 109.322 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' LYS . 64.2 t-80 -43.07 95.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.59 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' LEU . 6.1 pt-20 -37.04 96.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.11 0.481 . . . . 1.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' HIS . 69.1 mttm -61.53 -37.93 85.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.916 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.39 -17.77 0.28 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.199 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.48 164.47 30.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.744 0.307 . . . . 1.0 110.844 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 55.6 p-80 -69.69 116.99 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.98 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 30.7 m -119.85 130.84 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.895 0.378 . . . . 1.0 110.43 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -151.19 108.26 3.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.809 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.07 117.93 32.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.753 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.17 114.19 29.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.926 0.393 . . . . 1.0 110.313 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mm -110.6 116.86 51.92 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.122 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.6 151.71 41.99 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.784 1.656 . . . . 1.0 112.552 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.502 ' CG2' HE22 ' A' ' 123' ' ' GLN . 96.9 mt -93.71 122.09 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.475 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' PHE . 46.2 p30 -170.73 -163.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.383 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -59.0 -40.93 86.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -66.2 -36.15 82.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.995 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 64' ' ' ASN . 36.5 t80 -95.09 129.59 42.12 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.961 0.41 . . . . 1.0 110.327 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -136.35 146.83 46.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.242 0.544 . . . . 1.0 111.234 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.2 p -115.47 110.23 18.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.369 -0.832 . . . . 1.0 109.423 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.93 135.42 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.862 0.363 . . . . 1.0 110.797 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.566 HE21 ' CB ' ' A' ' 87' ' ' CYS . 57.6 tt0 -103.41 122.07 44.12 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.87 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.105 179.467 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 34.8 p-10 . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.93 0.395 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 97.4 mt -67.69 -24.21 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.965 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 36.9 t -115.86 127.32 54.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.095 0.474 . . . . 1.0 110.333 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 85' ' ' SER . 10.4 m120 -148.7 -176.94 5.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.236 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 79.49 91.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.19 79.91 0.07 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.224 -1.55 . . . . 1.0 109.224 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.566 ' CB ' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -115.98 148.18 40.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.777 0.322 . . . . 1.0 111.404 -177.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -106.84 139.65 40.92 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.532 ' C ' HH11 ' A' ' 90' ' ' ARG . 1.8 pp -128.02 161.33 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.532 HH11 ' C ' ' A' ' 89' ' ' ILE . 1.7 mpt_? -126.27 145.84 50.25 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.343 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.57 135.37 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.192 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.445 ' NE2' ' CD ' ' A' ' 98' ' ' GLU . 48.7 mm-40 -128.34 148.92 50.7 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.846 -0.616 . . . . 1.0 110.247 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.723 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 179.406 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' NH2' ' A' ' 99' ' ' ARG . 35.2 ptt-85 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.839 0.352 . . . . 1.0 110.664 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CD ' ' NE2' ' A' ' 92' ' ' GLN . 83.3 tt0 -65.94 127.25 31.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.508 ' NH2' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -130.02 137.51 50.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.408 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.411 ' NH1' ' CZ ' ' A' ' 90' ' ' ARG . 95.2 mtt-85 -99.91 152.62 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.829 0.347 . . . . 1.0 111.115 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.08 155.23 42.02 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.966 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -146.62 135.23 22.11 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.894 0.378 . . . . 1.0 111.166 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mm -107.2 103.06 46.64 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.93 -11.84 29.87 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.475 1.45 . . . . 1.0 112.827 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -97.96 121.71 40.2 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.75 -48.79 79.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.64 -0.709 . . . . 1.0 112.41 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -59.65 -40.17 86.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.453 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -71.17 -39.88 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.0 110.677 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -56.39 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.358 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.78 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.314 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -62.54 -45.55 92.43 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.772 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -61.21 -51.33 69.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.072 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.6 -42.29 91.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.26 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -64.71 -46.7 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 1.0 111.6 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.43 66.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.301 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.0 t -65.02 -44.88 95.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.8 tp -61.54 -46.76 88.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.097 0.475 . . . . 1.0 110.518 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.82 80.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.352 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.16 88.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.579 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -65.55 -44.97 85.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.863 0.363 . . . . 1.0 111.201 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -66.39 -43.13 86.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.402 0.62 . . . . 1.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.47 77.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.95 -1.023 . . . . 1.0 111.888 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.502 HE22 ' CG2' ' A' ' 63' ' ' ILE . 6.5 pt20 -72.05 -40.31 68.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.625 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.25 -21.07 67.42 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.656 2.237 . . . . 1.0 111.997 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.62 147.98 39.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.374 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.58 171.8 55.15 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.2 p -66.78 -19.2 65.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 1.0 110.766 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.6 mtp -128.56 149.12 50.75 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -42.09 149.71 0.42 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.522 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.51 159.63 42.68 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.084 1.856 . . . . 1.0 112.085 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.69 -31.37 69.5 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.658 2.239 . . . . 1.0 111.908 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.56 161.14 80.66 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.893 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.75 144.67 99.59 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.363 1.375 . . . . 1.0 111.652 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.17 -44.6 91.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.38 -28.37 73.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.248 -0.741 . . . . 1.0 111.248 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.75 149.06 47.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.975 0.417 . . . . 1.0 110.959 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.2 80.42 15.58 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.516 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.96 98.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.081 1.854 . . . . 1.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.8 mt -65.6 -41.36 92.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.026 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.49 145.51 26.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.979 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -135.42 130.28 34.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.445 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.7 158.66 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.88 0.371 . . . . 1.0 110.853 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.36 123.3 46.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.578 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.84 -163.75 11.06 Favored Glycine 0 N--CA 1.46 0.275 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt -139.09 125.53 20.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.408 . . . . 1.0 110.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -89.18 120.85 30.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.3 mtm -106.73 136.78 45.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.689 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.8 147.65 52.31 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.732 -0.469 . . . . 1.0 109.732 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.57 -65.27 0.38 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.743 -0.662 . . . . 1.0 112.496 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -32.23 83.32 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.791 2.327 . . . . 1.0 113.952 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -174.99 -176.3 0.95 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -125.18 171.15 10.56 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.146 0.498 . . . . 1.0 110.563 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -157.83 129.21 3.82 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.202 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.38 146.93 49.04 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.305 1.145 . . . . 1.0 111.502 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.6 p -154.95 -172.99 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.687 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.14 138.74 20.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.18 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.8 mt -106.54 124.69 49.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.054 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.4 m -130.64 122.44 27.41 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.115 0.483 . . . . 1.0 111.556 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.2 tp -93.5 131.41 38.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.28 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.46 148.55 37.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.043 0.449 . . . . 1.0 111.244 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.49 123.53 48.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.731 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -134.05 131.03 38.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.024 0.44 . . . . 1.0 110.82 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.7 m120 61.9 33.45 17.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.822 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.36 17.91 77.92 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.646 HE22 ' NE2' ' A' ' 123' ' ' GLN . 45.6 tp60 -125.71 158.06 35.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.548 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 96.2 m-85 -99.72 135.83 40.55 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.023 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -145.17 141.32 28.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.927 0.394 . . . . 1.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.21 124.77 49.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.611 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.427 HG22 HD13 ' A' ' 47' ' ' ILE . 81.8 mt -107.09 127.03 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.941 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.94 122.93 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -109.61 128.51 55.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.067 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 52' ' ' GLU . 9.1 mp -102.6 126.69 49.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -71.54 40.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.207 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 50' ' ' LEU . 38.9 tp10 -49.69 144.26 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.294 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.78 -39.91 95.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.219 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.05 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.967 0.413 . . . . 1.0 110.384 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.77 148.23 31.72 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.733 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -62.54 104.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.241 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 t -70.27 135.46 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.496 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -99.17 108.35 20.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.785 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -106.1 112.47 25.52 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.15 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 1.0 110.157 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.67 91.29 34.1 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.078 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.31 143.7 93.07 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.17 1.913 . . . . 1.0 112.431 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 63' ' ' ILE . 93.3 mt -88.17 122.22 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.826 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -174.68 -160.88 0.1 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.998 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 t -60.22 -41.93 94.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.212 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -64.8 -34.13 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.554 -0.293 . . . . 1.0 111.033 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -94.56 127.47 40.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.353 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.577 ' NH2' HE21 ' A' ' 92' ' ' GLN . 86.3 mtm180 -136.09 142.54 44.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.334 0.588 . . . . 1.0 110.857 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.71 100.86 7.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.207 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 m -101.95 122.98 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.965 0.412 . . . . 1.0 110.561 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -89.38 106.83 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.599 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.63 ' H ' ' NH1' ' A' ' 90' ' ' ARG . 36.1 tp10 36.87 60.75 0.94 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.113 0.482 . . . . 1.0 111.0 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' CB ' ' OG1' ' A' ' 76' ' ' THR . . . -175.39 166.29 3.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.132 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -65.92 -41.31 91.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.588 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -167.42 79.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.648 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 79' ' ' ILE . 14.9 m -114.63 57.34 0.71 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.201 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.4 mt -66.78 -35.42 80.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.309 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.06 -41.16 99.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.685 -0.234 . . . . 1.0 110.404 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 87.2 mt -119.03 131.21 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.002 0.43 . . . . 1.0 111.2 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 95.9 m-20 -144.35 -38.21 0.3 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.253 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.46 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 94.2 mt -63.79 -43.27 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.8 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.295 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.2 t -103.73 62.23 0.76 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 1.0 110.335 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.4 m120 -80.71 -173.62 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.993 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 t 67.85 86.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.94 81.01 0.09 OUTLIER Glycine 0 CA--C 1.521 0.431 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.2 132.19 39.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.72 0.295 . . . . 1.0 111.785 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.432 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 62.7 mttp -112.17 127.66 56.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 89' ' ' ILE . 46.7 pt -129.17 158.08 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.63 ' NH1' ' H ' ' A' ' 72' ' ' GLU . 1.8 mpt_? -126.47 140.85 52.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.215 0.531 . . . . 1.0 110.003 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.1 133.85 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.913 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.577 HE21 ' NH2' ' A' ' 68' ' ' ARG . 12.9 pt20 -142.36 138.29 31.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.127 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 177.61 -169.58 41.68 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.42 -41.79 98.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.695 0.283 . . . . 1.0 111.348 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -60.85 -36.74 79.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.793 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.504 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 44.9 pt -144.82 144.45 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 110.547 -0.168 . . . . 1.0 110.547 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -67.39 -54.37 21.08 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.476 -0.49 . . . . 1.0 110.637 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -174.54 129.5 0.34 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.584 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.504 ' HE ' ' CD1' ' A' ' 96' ' ' ILE . 75.5 mtm180 -142.96 149.53 38.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -105.61 149.01 26.69 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.096 0.474 . . . . 1.0 111.231 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -142.34 149.72 39.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.118 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -144.51 152.24 40.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.875 0.369 . . . . 1.0 111.009 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.54 99.71 15.52 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.16 -12.74 32.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.626 1.551 . . . . 1.0 112.788 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.57 101.1 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -57.4 -54.17 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.985 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -52.08 -44.23 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.544 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -68.9 -38.38 79.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 1.0 110.537 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -35.87 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.988 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.38 -45.53 92.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.318 -0.553 . . . . 1.0 111.105 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -66.97 -44.21 81.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.905 -0.718 . . . . 1.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.18 -49.21 76.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.203 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.67 -40.35 84.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.273 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.564 ' HG ' ' N ' ' A' ' 115' ' ' ALA . 78.0 p -64.73 -47.43 78.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.395 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.564 ' N ' ' HG ' ' A' ' 114' ' ' SER . . . -65.73 -48.44 71.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.347 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.66 -44.08 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.37 -44.35 95.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.097 0.475 . . . . 1.0 110.213 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.38 84.96 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.99 72.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.671 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.27 -36.49 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 1.0 111.295 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.82 -45.05 95.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.797 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.11 93.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.444 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.646 ' NE2' HE22 ' A' ' 43' ' ' GLN . 87.3 mt-30 -70.55 -37.79 74.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.851 0.358 . . . . 1.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.574 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.431 -1.467 . . . . 1.0 109.431 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.58 143.53 99.44 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.82 2.346 . . . . 1.0 112.072 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.22 143.53 37.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.303 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.71 -179.24 32.68 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.782 -0.927 . . . . 1.0 110.782 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.6 t -151.32 147.05 26.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.794 0.33 . . . . 1.0 110.542 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -155.22 147.8 24.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.318 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -42.31 105.44 0.41 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.667 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.34 159.76 17.39 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.016 1.811 . . . . 1.0 112.354 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.49 -31.78 80.39 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.649 2.233 . . . . 1.0 111.944 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.85 159.02 84.4 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.059 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.63 144.52 99.55 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.295 1.33 . . . . 1.0 111.653 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.32 -45.71 85.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.253 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.77 -28.91 74.06 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.45 141.2 58.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.941 0.401 . . . . 1.0 111.068 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.78 79.62 0.43 Allowed Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.78 94.74 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.883 1.722 . . . . 1.0 112.814 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -43.12 95.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.894 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.69 148.29 42.15 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.317 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 t -141.56 130.45 23.08 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.57 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 55.3 t -137.59 158.1 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.979 0.418 . . . . 1.0 110.725 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 80.7 tt0 -107.39 122.76 47.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.445 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.11 -160.92 9.87 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 71.1 mtp -136.36 130.21 32.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.386 . . . . 1.0 110.418 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.56 123.11 36.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.6 mpp? -113.29 137.83 50.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.982 0.42 . . . . 1.0 110.526 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -140.62 149.13 41.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.007 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.71 -65.17 0.48 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.884 -0.598 . . . . 1.0 112.697 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.12 -32.53 94.79 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.774 2.316 . . . . 1.0 113.564 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.6 177.58 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.852 -0.339 . . . . 1.0 110.878 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.3 169.25 11.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.894 0.378 . . . . 1.0 110.788 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 18.0 pt-20 -159.68 143.15 10.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.639 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.99 141.91 85.8 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.34 1.36 . . . . 1.0 110.929 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 22' ' ' GLY . 22.0 p -147.78 -175.73 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.38 136.25 18.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.95 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 mt -100.08 124.49 45.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.998 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -127.99 126.86 42.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.13 0.491 . . . . 1.0 111.429 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.3 tp -96.37 126.17 41.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.886 -0.783 . . . . 1.0 108.886 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.43 152.13 48.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.072 0.463 . . . . 1.0 111.467 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.2 118.28 33.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.673 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -130.56 137.8 49.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.861 0.362 . . . . 1.0 110.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 59.04 33.59 23.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.444 -0.798 . . . . 1.0 111.387 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.98 22.44 77.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.437 ' OE1' ' N ' ' A' ' 44' ' ' TYR . 6.5 tp-100 -131.09 147.7 52.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.437 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 72.0 m-85 -88.52 133.84 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.67 140.73 30.21 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.07 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 tt -104.85 119.97 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.731 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.621 ' CG2' HE21 ' A' ' 58' ' ' GLN . 78.4 mt -101.79 127.76 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.052 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.5 mt -104.36 116.76 48.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -97.63 132.34 43.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.016 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mp -105.15 130.81 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.88 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -103.01 27.19 7.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.282 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 97.1 mt-10 -45.65 150.09 0.54 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -62.33 -40.31 95.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.3 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -54.55 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.38 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.49 158.11 43.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.88 112.54 17.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.071 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 t -95.25 133.41 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.921 0.391 . . . . 1.0 110.531 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.621 HE21 ' CG2' ' A' ' 47' ' ' ILE . 55.6 tp60 -99.64 107.37 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.422 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -105.93 112.52 25.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.983 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.84 111.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.876 0.369 . . . . 1.0 110.187 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.33 116.78 48.39 Favored Pre-proline 0 N--CA 1.467 0.384 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.127 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.59 147.54 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.644 1.563 . . . . 1.0 112.61 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.51 120.04 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.2 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -175.22 -162.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -64.15 -26.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.185 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -83.69 -10.74 57.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.678 0.275 . . . . 1.0 110.948 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.81 129.29 56.0 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -136.5 146.86 46.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.743 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.428 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 4.7 t -127.87 106.46 9.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.506 -0.77 . . . . 1.0 108.937 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m -109.14 126.46 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.052 0.453 . . . . 1.0 110.969 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 52.9 tp60 -82.8 115.29 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 37.11 58.82 1.16 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.635 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -177.99 -173.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.863 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -108.66 -17.42 13.96 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.417 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -161.55 86.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.688 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 79' ' ' ILE . 4.9 m -141.92 43.67 1.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.462 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 69' ' ' CYS . 23.3 mt -66.42 -35.06 79.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.382 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.11 -40.86 98.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.672 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.438 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 86.5 mt -116.14 129.8 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.047 0.451 . . . . 1.0 111.086 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 89.9 m-20 -146.74 -36.28 0.24 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.153 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.93 -42.39 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.39 -25.93 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.895 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.2 t -103.87 66.58 0.85 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.07 0.462 . . . . 1.0 110.568 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' A' ' 85' ' ' SER . 12.4 m120 -91.73 -171.48 2.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.166 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 85' ' ' SER . 6.9 p 65.06 98.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.987 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.3 77.53 0.13 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.492 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -95.7 134.21 38.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.802 0.334 . . . . 1.0 111.772 -178.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.621 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 99.5 mttt -107.94 123.82 49.21 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.0 149.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.498 ' C ' HE22 ' A' ' 92' ' ' GLN . 81.9 mtt85 -121.86 143.98 49.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.915 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.51 135.35 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.877 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.498 HE22 ' C ' ' A' ' 90' ' ' ARG . 15.1 mp0 -136.95 151.75 49.38 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -165.22 160.78 34.18 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.34 -43.88 89.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.672 0.272 . . . . 1.0 111.483 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -86.63 -8.61 57.32 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 93' ' ' GLY . 19.9 pt -126.7 149.17 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.744 0.307 . . . . 1.0 110.544 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -87.45 162.46 17.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.646 0.26 . . . . 1.0 110.739 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.75 124.84 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 1.0 110.756 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.11 132.06 44.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.295 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -91.55 151.9 20.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 1.0 111.076 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.18 153.69 43.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.202 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -138.82 143.87 39.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.953 0.406 . . . . 1.0 110.901 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 mm -127.17 91.08 47.46 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -16.99 41.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.698 1.598 . . . . 1.0 112.681 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.69 106.35 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.64 -54.69 35.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 1.0 112.182 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -52.42 -42.77 64.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.607 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -70.55 -37.54 74.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.573 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.9 t -59.19 -35.57 73.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.891 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.27 -44.38 95.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.451 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.12 -44.51 84.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.979 -0.689 . . . . 1.0 110.454 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -60.76 -49.8 76.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.149 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.46 -41.58 80.0 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.466 -0.493 . . . . 1.0 111.223 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.6 t -63.55 -45.55 90.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.595 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.43 -49.31 56.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.544 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.46 -45.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.026 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.02 -48.59 81.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.35 80.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.577 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.35 91.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.752 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.74 -45.91 80.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.948 0.404 . . . . 1.0 111.351 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.78 -43.14 89.7 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.472 0.653 . . . . 1.0 110.368 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.96 77.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.855 -1.066 . . . . 1.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -71.92 -39.87 69.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.393 . . . . 1.0 110.556 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.597 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.43 -1.468 . . . . 1.0 109.43 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.6 146.92 96.48 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.953 2.435 . . . . 1.0 112.177 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 3.5 mm? -80.52 137.64 36.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.302 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.96 165.7 40.5 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.732 -0.947 . . . . 1.0 110.732 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -157.33 151.77 25.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.89 0.376 . . . . 1.0 110.729 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.402 ' HG2' ' H ' ' A' ' 7' ' ' GLU . 11.9 ttt 45.48 -136.82 0.6 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.428 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 6' ' ' MET . 1.0 OUTLIER -102.01 105.38 41.79 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.209 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -81.54 158.94 19.41 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.047 1.831 . . . . 1.0 112.026 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.42 -31.7 61.45 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.747 2.298 . . . . 1.0 111.716 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.37 158.57 3.86 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.75 142.99 99.3 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.308 1.338 . . . . 1.0 111.688 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.18 -45.23 83.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.382 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.72 81.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.26 50.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.06 0.457 . . . . 1.0 111.144 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -98.19 107.86 43.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.7 103.89 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.435 1.423 . . . . 1.0 112.871 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.93 -43.22 79.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.186 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.79 151.52 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.076 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -140.92 135.0 30.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 1.0 110.547 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 p -142.45 152.12 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.018 0.437 . . . . 1.0 111.163 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -106.64 121.85 45.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -130.46 -155.87 8.45 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 21.4 mmt -137.04 128.65 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.939 0.4 . . . . 1.0 110.244 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -90.21 126.33 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.338 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.0 mtm -109.32 138.75 45.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 29' ' ' LEU . 99.3 mttt -135.64 149.68 49.4 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.898 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -67.07 0.29 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.569 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.28 -32.6 81.95 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.793 2.328 . . . . 1.0 113.852 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -173.94 -170.06 0.53 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.408 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -130.38 169.67 15.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.021 0.439 . . . . 1.0 110.313 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -156.29 144.39 14.31 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.396 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.98 146.14 96.45 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.294 1.329 . . . . 1.0 111.293 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 34' ' ' ALA . 19.7 t -158.02 170.15 22.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.314 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.645 ' N ' ' SG ' ' A' ' 33' ' ' CYS . . . -138.14 139.99 39.68 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.854 0.359 . . . . 1.0 110.239 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 mt -107.07 121.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.764 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -125.08 122.91 38.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.229 0.537 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.0 tp -94.67 122.64 37.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.31 146.25 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.145 0.498 . . . . 1.0 111.309 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -98.71 126.69 44.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.747 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -139.82 136.73 34.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.971 0.415 . . . . 1.0 110.727 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 59.15 33.75 22.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.568 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.24 24.88 76.33 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.748 -0.941 . . . . 1.0 110.748 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -135.44 159.44 41.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -100.22 133.16 45.03 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -141.42 142.93 33.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.044 0.45 . . . . 1.0 110.34 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -104.32 119.69 39.52 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.896 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.0 mt -98.15 128.87 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.55 131.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 73.2 mt-30 -123.23 124.65 43.5 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.99 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 10.4 mp -99.9 114.75 28.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -72.49 62.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -62.51 151.86 36.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.314 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.87 -41.66 98.12 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.57 -77.36 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -147.82 150.56 34.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -68.73 138.37 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.967 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.18 130.37 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 1.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -91.09 108.35 19.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.791 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.07 114.68 28.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.28 116.12 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.86 0.362 . . . . 1.0 110.46 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.1 91.6 32.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.19 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -57.42 142.77 95.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.213 1.942 . . . . 1.0 112.591 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.62 122.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -175.66 -163.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.201 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.9 p -63.84 -22.2 66.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -85.61 -11.34 54.17 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.602 0.239 . . . . 1.0 111.06 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -121.84 135.27 54.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -137.42 151.38 48.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.104 0.478 . . . . 1.0 110.711 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.7 p -138.76 111.65 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 128.28 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 1.0 111.196 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.641 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 49.5 tp60 -82.27 97.53 8.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.585 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 57.85 -0.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.17 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . -95.07 149.34 21.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.958 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -71.97 -44.84 62.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.637 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -161.99 83.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.659 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 m -154.65 82.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.065 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.5 mt -64.43 -33.54 76.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.479 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -41.54 99.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.025 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.25 132.3 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.183 0.516 . . . . 1.0 111.059 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -168.45 -41.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.204 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 83' ' ' SER . 32.6 mm -71.64 -24.13 23.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.18 -3.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.053 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 29.8 t -138.97 138.18 37.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 1.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.9 m120 -146.69 -171.32 3.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.105 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 61.77 85.1 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.31 78.28 0.27 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.571 -1.412 . . . . 1.0 109.571 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.535 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.85 137.62 35.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 111.866 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.641 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 99.7 mttt -112.41 127.03 55.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 pp -118.17 132.05 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -97.1 141.67 29.96 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.7 t -121.63 134.85 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.572 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -143.46 150.64 39.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.18 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -172.9 156.21 24.38 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.644 -0.982 . . . . 1.0 110.644 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -66.19 -43.72 86.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.725 0.298 . . . . 1.0 111.596 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -84.84 -7.12 59.31 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 93' ' ' GLY . 19.2 pt -129.03 154.38 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 110.143 -0.318 . . . . 1.0 110.143 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -94.69 160.26 14.7 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.684 0.278 . . . . 1.0 110.616 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.12 132.88 54.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 1.0 110.363 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -140.43 125.49 18.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.611 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -88.22 144.07 26.67 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.993 0.425 . . . . 1.0 111.192 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.83 152.05 49.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -139.59 144.64 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.821 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.8 mm -127.64 91.55 45.26 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.3 -16.99 39.85 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.822 1.681 . . . . 1.0 112.751 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -87.79 104.28 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.96 -54.99 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 1.0 112.32 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -52.1 -44.31 64.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.425 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.17 -36.17 77.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.533 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 4.2 t -61.75 -38.07 86.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.999 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.77 -46.09 89.64 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.223 -0.591 . . . . 1.0 111.301 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -43.55 82.0 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.964 -0.695 . . . . 1.0 110.764 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.8 -50.36 72.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.156 -0.929 . . . . 1.0 111.094 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.85 -41.0 83.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.329 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 t -62.27 -45.12 94.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.105 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.52 -47.13 67.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.382 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.0 t -63.35 -45.6 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.964 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.16 -45.85 92.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 1.0 110.255 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.6 86.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.425 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.76 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.455 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.488 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 95.1 mt-30 -68.32 -37.66 80.78 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.25 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.54 -43.15 90.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.085 0.469 . . . . 1.0 110.623 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.93 75.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.732 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.31 -38.9 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.734 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.403 ' OXT' ' OG ' ' A' ' 124' ' ' SER . 2.1 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.405 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.624 -1.391 . . . . 1.0 109.624 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.73 145.75 95.01 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.792 2.328 . . . . 1.0 111.84 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.8 tp -107.23 125.79 51.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.306 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.41 178.62 49.97 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.9 p -67.96 -18.08 64.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 1.0 110.605 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 95.9 mtp -111.58 142.04 44.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.815 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -63.39 151.2 88.02 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.364 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.64 160.21 44.43 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.226 1.951 . . . . 1.0 111.973 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.476 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 34.9 Cg_endo -63.46 -31.49 71.88 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.822 2.348 . . . . 1.0 112.154 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.35 145.55 57.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.859 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 142.31 71.06 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.734 1.623 . . . . 1.0 111.41 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -67.77 -42.79 86.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.681 -0.691 . . . . 1.0 111.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -38.37 47.03 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.94 146.17 46.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.902 0.382 . . . . 1.0 111.009 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.82 80.32 0.33 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.13 99.71 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.846 1.697 . . . . 1.0 112.832 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.23 -43.2 92.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.82 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.23 153.52 38.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.353 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -137.96 135.8 36.37 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.633 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.64 149.26 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.04 0.448 . . . . 1.0 111.262 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -104.31 121.68 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.39 -162.96 10.9 Favored Glycine 0 N--CA 1.462 0.386 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 88.9 mmm -128.65 131.99 48.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 1.0 110.315 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -94.9 124.06 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -108.47 137.22 46.79 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.545 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.93 150.07 44.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.019 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.71 -66.29 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.794 -0.639 . . . . 1.0 112.597 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.68 -33.0 93.8 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.779 2.319 . . . . 1.0 113.691 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 179.7 -174.57 0.25 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.007 -0.277 . . . . 1.0 110.769 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.33 169.47 11.76 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 1.0 110.739 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -158.1 144.31 12.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.619 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.8 145.12 97.4 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.392 1.394 . . . . 1.0 111.04 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.7 p -154.97 -179.11 7.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.382 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.67 142.53 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.427 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.28 122.53 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.257 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -122.67 116.7 24.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.381 0.61 . . . . 1.0 111.757 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.9 tp -83.55 130.37 35.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.21 -0.905 . . . . 1.0 109.218 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.24 151.49 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.007 0.432 . . . . 1.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -110.61 121.73 46.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.711 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -134.02 139.19 45.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.903 0.382 . . . . 1.0 110.911 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.11 33.65 22.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.548 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.28 25.22 75.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -135.17 153.83 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -91.18 131.95 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -141.23 141.61 34.0 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.985 0.422 . . . . 1.0 110.445 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.6 127.54 52.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.685 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.42 118.29 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.154 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.9 mt -100.98 122.87 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -108.22 130.54 55.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.079 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.68 111.19 23.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 52' ' ' GLU . 97.8 m-70 -57.49 -12.8 2.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' HIS . 3.5 tp10 42.39 -167.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.455 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -63.74 -41.75 97.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -138.73 -68.5 0.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.747 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -69.9 142.13 53.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.177 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 56' ' ' HIS . 20.9 p80 -89.06 112.29 23.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.41 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -84.19 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.616 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.476 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 83.0 mt-30 -102.13 132.16 48.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.127 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -127.25 109.61 11.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -93.57 122.3 44.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.728 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -133.3 126.76 19.53 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.01 157.84 46.5 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.799 1.666 . . . . 1.0 112.64 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -102.66 115.92 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.178 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' PHE . 50.8 p30 -172.94 -155.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.229 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 m -60.98 -41.6 96.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.348 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.71 -43.05 97.72 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.838 0.352 . . . . 1.0 110.433 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 11.6 t80 -94.03 125.65 38.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.649 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -133.68 142.11 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.87 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.413 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 10.3 t -121.27 111.47 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.962 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.0 m -112.76 126.67 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.959 0.409 . . . . 1.0 110.622 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -87.99 112.83 23.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.744 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 40.04 55.36 2.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.641 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 178.19 -168.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.624 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -109.88 -10.92 14.73 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.431 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 76' ' ' THR . 97.4 mt-10 -140.57 -105.43 0.15 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.799 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER 36.1 35.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.504 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD2' ' O ' ' A' ' 69' ' ' CYS . 97.0 mt -63.23 -41.55 99.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.714 -0.676 . . . . 1.0 111.178 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 78' ' ' LEU . 10.7 mp -65.69 -38.92 90.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.652 0.263 . . . . 1.0 110.462 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 76' ' ' THR . 43.0 mm -102.43 124.33 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.17 0.509 . . . . 1.0 111.001 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 97.3 m-20 -144.25 -41.18 0.27 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.112 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.438 ' C ' ' N ' ' A' ' 83' ' ' SER . 94.6 mt -64.16 -43.29 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.661 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.29 -18.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.036 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 21.9 m -128.19 118.37 23.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.942 0.401 . . . . 1.0 110.284 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.0 m120 -138.32 -167.83 2.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.781 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 70.15 89.47 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.36 75.69 0.33 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 109.342 -1.503 . . . . 1.0 109.342 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.9 138.65 34.12 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.964 0.411 . . . . 1.0 112.006 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.54 124.95 53.15 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.0 150.94 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -121.44 147.08 46.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.88 136.45 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.594 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -128.82 150.3 50.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.097 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -158.66 161.28 31.7 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.681 -0.968 . . . . 1.0 110.681 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.18 -42.48 93.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.798 0.332 . . . . 1.0 111.404 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -86.29 -8.62 57.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.256 -0.429 . . . . 1.0 112.097 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 93' ' ' GLY . 16.1 pt -127.27 155.77 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 120.721 0.296 . . . . 1.0 110.493 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -96.42 -161.63 0.89 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.831 0.348 . . . . 1.0 110.655 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.73 127.88 33.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 1.0 110.111 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -127.26 143.11 51.31 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -120.17 140.0 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.958 0.408 . . . . 1.0 111.236 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.17 150.62 50.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.69 -0.686 . . . . 1.0 110.472 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.12 135.75 24.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.758 0.313 . . . . 1.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 54.4 mt -124.56 100.97 34.22 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.64 -10.41 23.5 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.607 1.538 . . . . 1.0 112.684 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.43 105.73 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.72 -52.81 63.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.015 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -53.86 -42.1 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.628 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -69.94 -34.88 74.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.512 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.6 t -66.72 -33.22 75.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.99 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.6 mt -62.74 -46.18 89.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.489 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.73 -43.06 80.87 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.602 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -60.93 -48.93 79.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.124 -0.943 . . . . 1.0 111.394 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.8 mt -65.41 -40.85 93.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.644 -0.423 . . . . 1.0 111.362 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.7 p -64.0 -44.24 93.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.228 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.07 -51.02 59.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.314 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.87 -42.25 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.751 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.7 tp -57.74 -45.07 86.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.065 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.377 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.87 70.57 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.044 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -68.01 -41.1 82.71 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.64 0.257 . . . . 1.0 111.102 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.24 -43.75 98.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.958 0.409 . . . . 1.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.73 96.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.236 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.3 -40.44 93.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.652 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.903 -1.046 . . . . 1.0 110.485 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.46 -1.456 . . . . 1.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.86 148.82 90.12 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.748 2.299 . . . . 1.0 112.072 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 83.4 mt -102.73 130.39 49.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.265 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.69 103.35 0.62 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -60.8 -41.18 95.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 1.0 110.809 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -147.28 154.24 40.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.362 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 17.8 mp0 -59.67 118.91 35.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.84 160.59 27.5 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.889 1.726 . . . . 1.0 112.32 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.12 -52.12 0.25 Allowed 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.52 2.146 . . . . 1.0 111.884 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 pp -56.47 161.44 4.19 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.121 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.46 143.56 99.66 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.974 1.116 . . . . 1.0 111.79 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.34 -42.9 91.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.02 -34.37 78.73 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.07 137.75 53.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.925 0.393 . . . . 1.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -97.66 108.46 45.68 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.28 103.14 1.7 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.502 1.468 . . . . 1.0 112.999 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.63 -43.47 89.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.152 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 155.68 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.209 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 t -146.67 135.67 22.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.594 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.94 160.82 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.165 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -102.48 122.51 44.47 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 34' ' ' ALA . . . -118.88 -174.95 16.14 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.792 -0.923 . . . . 1.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.3 mmt -134.9 99.25 4.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 1.0 110.092 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.7 tt0 -59.59 133.96 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 72.5 mtm -113.43 131.38 56.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.748 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.15 144.04 51.08 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.56 -64.88 0.49 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.84 -0.618 . . . . 1.0 112.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.22 -31.98 93.78 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.694 2.262 . . . . 1.0 113.633 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.46 -179.87 1.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.641 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.0 168.2 10.43 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.919 0.39 . . . . 1.0 110.522 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.5 128.7 6.27 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.516 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.44 142.36 78.22 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.944 1.096 . . . . 1.0 111.163 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.4 p -156.76 -178.28 7.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.394 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -150.95 138.19 19.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.308 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.2 mt -102.22 123.97 46.98 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.915 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -126.48 120.46 29.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.059 0.456 . . . . 1.0 111.356 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.67 131.23 40.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.248 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 150.93 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 1.0 111.239 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.06 120.82 41.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.682 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -128.07 132.31 49.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.217 0.532 . . . . 1.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.16 31.7 21.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.157 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.65 7.52 85.8 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.851 -0.69 . . . . 1.0 111.426 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.664 HE22 ' NE2' ' A' ' 123' ' ' GLN . 44.0 tp60 -112.5 136.79 51.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.101 -0.333 . . . . 1.0 110.101 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.497 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 75.0 m-85 -81.7 134.74 35.49 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.34 139.64 28.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.375 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.7 119.4 39.42 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.405 HG21 HD12 ' A' ' 47' ' ' ILE . 90.9 mt -99.12 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.6 mt -96.91 117.21 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -102.35 131.3 49.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.928 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mp -110.3 127.2 54.9 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -85.41 52.73 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.237 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -45.49 152.95 0.27 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.77 -40.02 93.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.362 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -62.49 -46.44 88.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.509 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -173.11 -163.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.701 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -108.11 126.24 52.52 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.31 137.17 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.055 0.455 . . . . 1.0 110.463 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -104.8 131.12 52.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.018 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -107.97 119.65 40.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.565 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.1 mt -92.11 119.74 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 1.0 110.332 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 61' ' ' ILE . 44.1 mt -135.45 94.2 15.63 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.269 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.5 142.52 80.76 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.046 1.831 . . . . 1.0 112.625 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.2 mt -82.12 124.83 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.354 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.684 HD22 ' HE2' ' A' ' 66' ' ' HIS . 6.0 p30 -172.96 -163.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.126 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.4 t -59.71 -41.29 90.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.564 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.684 ' HE2' HD22 ' A' ' 64' ' ' ASN . 3.5 p80 -69.84 -14.48 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.958 -0.297 . . . . 1.0 111.122 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.0 t80 -114.93 128.06 56.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.18 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -141.29 145.86 36.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.145 0.497 . . . . 1.0 110.889 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.417 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 2.9 t -121.32 118.61 29.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 1.0 108.991 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 30.3 m -118.71 128.84 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.068 0.461 . . . . 1.0 110.848 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.611 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 56.4 tp60 -86.47 103.24 14.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.518 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 57.78 -0.37 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.331 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . -110.35 174.11 6.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.966 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -98.82 -24.52 14.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.464 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -168.06 81.34 0.17 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.608 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.9 m -151.85 73.93 1.08 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.302 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' CD2' ' O ' ' A' ' 69' ' ' CYS . 39.6 mt -70.41 -28.89 65.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.426 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.77 -40.35 97.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.632 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 mm -110.23 128.84 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.999 0.428 . . . . 1.0 110.945 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 20.0 p-10 -156.22 -38.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.329 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.42 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 26.3 mm -68.32 -24.53 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.39 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.03 72.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.818 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.5 t -100.46 62.57 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.09 0.472 . . . . 1.0 110.398 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 10.9 m120 -80.47 -171.69 3.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.164 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 85' ' ' SER . 19.2 p 57.83 94.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.73 77.09 0.21 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.429 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.62 136.56 36.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.765 0.317 . . . . 1.0 111.72 -177.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.611 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 64.9 mttp -108.02 120.03 41.14 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -118.63 131.01 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -106.61 144.73 32.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.894 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.63 133.13 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.641 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -124.23 136.06 53.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -145.75 145.85 15.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.741 -0.944 . . . . 1.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.65 -45.88 70.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.821 0.343 . . . . 1.0 111.478 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -80.24 -13.47 59.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.174 -0.466 . . . . 1.0 112.237 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.0 pt -127.02 160.77 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 120.554 0.216 . . . . 1.0 110.657 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -87.74 151.33 22.99 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.671 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.02 135.66 55.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 1.0 110.727 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -133.8 137.58 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.588 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -87.32 150.47 23.84 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.917 0.389 . . . . 1.0 111.035 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -143.39 149.33 37.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.298 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.14 145.84 39.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.918 0.389 . . . . 1.0 110.931 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.87 92.86 43.54 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.28 -15.44 38.88 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.757 1.638 . . . . 1.0 112.602 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.453 ' OD2' ' CG ' ' A' ' 108' ' ' HIS . 38.6 t0 -93.2 106.56 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.81 -52.92 63.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.026 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.93 -46.81 32.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.378 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.453 ' CG ' ' OD2' ' A' ' 105' ' ' ASP . 43.9 m170 -68.5 -39.34 81.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 1.0 110.38 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 t -59.08 -39.76 83.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.16 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.52 -44.84 93.09 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.418 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.16 -44.96 82.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.3 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.55 -49.38 76.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.339 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.8 -40.51 88.13 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.603 -0.439 . . . . 1.0 111.211 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -62.73 -44.7 95.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.822 0.344 . . . . 1.0 111.083 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.12 -48.28 62.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.361 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.09 -44.76 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.14 -45.03 96.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.016 0.436 . . . . 1.0 110.161 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.07 86.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.555 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.07 -49.09 75.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -71.11 -38.23 72.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 1.0 110.983 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.04 -44.5 96.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.223 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.41 96.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.221 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.664 ' NE2' HE22 ' A' ' 43' ' ' GLN . 88.2 mt-30 -65.38 -41.22 93.99 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.66 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.384 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.485 -1.446 . . . . 1.0 109.485 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 34.1 Cg_endo -63.85 -21.72 69.1 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.769 2.312 . . . . 1.0 111.928 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.1 mt -106.72 128.81 54.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.847 0.356 . . . . 1.0 110.433 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.48 153.64 6.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t -66.67 140.98 57.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 1.0 110.541 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.9 ttm -138.78 142.65 38.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.158 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -139.03 95.14 9.6 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.126 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.03 159.05 15.59 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.148 1.898 . . . . 1.0 112.049 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.52 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 37.1 Cg_endo -64.63 -32.39 58.04 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.607 2.205 . . . . 1.0 111.981 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -53.96 158.06 3.77 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.907 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.76 143.29 99.65 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.156 1.238 . . . . 1.0 111.687 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.35 -45.08 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.79 78.72 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 142.27 57.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.06 0.457 . . . . 1.0 111.162 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.22 79.85 0.4 Allowed Pre-proline 0 N--CA 1.464 0.261 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.35 98.97 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.893 1.729 . . . . 1.0 112.918 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -43.55 93.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.754 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.94 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.341 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 t -136.33 138.77 42.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.763 0.316 . . . . 1.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.95 150.9 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.083 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -105.29 121.34 43.67 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.85 -172.66 13.2 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.426 ' O ' ' SD ' ' A' ' 25' ' ' MET . 86.2 mmm -120.44 127.31 52.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 1.0 110.091 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -90.11 119.71 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.3 mpp? -110.4 136.68 49.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.946 0.403 . . . . 1.0 110.34 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.34 150.43 42.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.025 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.69 -64.74 0.51 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.706 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.45 -34.15 93.32 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.658 2.239 . . . . 1.0 113.624 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.4 ' C ' ' CD1' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.06 175.21 0.66 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.812 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -117.17 169.06 9.75 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.099 0.476 . . . . 1.0 110.527 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -160.68 142.9 9.41 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.644 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.85 145.71 94.75 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.498 1.465 . . . . 1.0 111.241 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.2 p -155.21 -171.66 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.466 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.44 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.405 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.3 mt -113.37 130.09 56.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.019 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -130.51 128.17 40.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.167 0.508 . . . . 1.0 111.556 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.9 tp -95.17 124.55 39.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.009 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.64 149.95 45.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.112 0.482 . . . . 1.0 111.314 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -108.11 120.67 42.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.389 -0.823 . . . . 1.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -132.88 135.94 45.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.871 0.367 . . . . 1.0 110.87 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.5 m120 59.26 34.49 23.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 1.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.57 23.6 76.55 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.004 -0.838 . . . . 1.0 111.004 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -133.77 157.08 46.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.94 133.43 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -139.02 146.66 41.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.197 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -105.45 134.31 48.77 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 78.0 mt -114.09 124.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.2 mt -105.1 120.37 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -112.34 126.86 55.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.152 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.93 123.69 47.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -78.85 58.04 2.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.371 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -54.75 155.91 3.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.299 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.28 -41.44 98.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.2 -81.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -142.01 150.13 40.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.741 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -67.35 141.71 57.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.307 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.43 132.61 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.992 0.425 . . . . 1.0 110.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 84.0 mt-30 -95.01 126.62 40.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.914 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -120.52 117.28 27.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.478 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -93.35 108.22 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.865 0.364 . . . . 1.0 110.061 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mm -114.66 121.88 34.93 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.58 149.95 39.6 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.778 1.652 . . . . 1.0 112.615 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.3 115.36 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -169.57 -158.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.362 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -59.51 -41.67 90.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -65.73 -37.69 87.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' A' ' 64' ' ' ASN . 16.4 t80 -95.63 123.83 39.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.834 0.35 . . . . 1.0 110.06 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -140.13 144.05 36.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.099 0.476 . . . . 1.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.36 99.71 7.38 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -104.56 124.95 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.905 0.383 . . . . 1.0 110.811 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.608 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 48.4 tp60 -77.7 104.46 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.455 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 37.52 56.93 1.42 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.66 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' CB ' ' HG1' ' A' ' 76' ' ' THR . . . -176.82 177.31 1.35 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.592 . . . . 1.0 110.85 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -87.09 -11.11 51.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.46 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' LEU . 81.5 tt0 -146.41 -92.49 0.09 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.782 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 76' ' ' THR . 88.1 m 42.61 24.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.224 0.535 . . . . 1.0 110.793 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 75' ' ' GLU . 98.3 mt -65.52 -40.49 93.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.811 -0.631 . . . . 1.0 111.364 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.48 -40.38 95.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.966 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 76' ' ' THR . 84.0 mt -109.52 130.45 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.098 0.475 . . . . 1.0 111.244 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 35.0 p-10 -144.57 -33.8 0.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.424 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.446 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 91.9 mt -67.84 -25.31 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.535 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.02 91.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.128 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 83' ' ' SER . 2.0 t -97.47 70.73 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.181 0.515 . . . . 1.0 110.321 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 9.7 m120 -98.7 -169.2 1.75 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.207 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 m 61.82 84.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.58 76.47 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 109.462 -1.455 . . . . 1.0 109.462 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.03 142.98 26.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.933 0.397 . . . . 1.0 111.803 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.608 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 55.8 mtpt -118.56 128.07 54.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 89' ' ' ILE . 47.5 pt -127.82 163.6 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.75 142.15 50.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.8 t -121.6 135.76 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.087 0.47 . . . . 1.0 110.564 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -119.92 163.47 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.225 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 174.45 149.84 7.36 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.0 -39.69 90.5 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.277 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -80.26 -11.53 59.71 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 93' ' ' GLY . 12.0 pt -128.26 155.95 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.865 0.364 . . . . 1.0 110.698 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -96.3 175.26 6.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.683 0.278 . . . . 1.0 110.5 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.86 115.95 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.175 0.512 . . . . 1.0 110.6 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -129.03 137.91 51.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.237 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.64 151.05 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.739 0.304 . . . . 1.0 110.705 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -137.35 155.17 49.73 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.478 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -147.4 126.08 12.58 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.972 0.415 . . . . 1.0 111.389 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.93 99.52 14.12 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 -10.05 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.407 1.404 . . . . 1.0 112.472 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -96.49 107.34 19.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.83 -52.73 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.7 -0.682 . . . . 1.0 112.157 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.0 OUTLIER -52.44 -43.97 65.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.593 -0.443 . . . . 1.0 110.388 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -69.6 -34.19 73.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.377 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.922 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.08 -47.65 79.24 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.357 -0.537 . . . . 1.0 111.706 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.57 -44.74 77.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.862 -0.735 . . . . 1.0 110.171 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -61.36 -49.44 76.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.131 -0.94 . . . . 1.0 111.495 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.32 -41.65 84.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.169 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -63.06 -45.89 90.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.529 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.4 78.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.456 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.19 -44.49 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.894 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.74 -44.83 96.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 1.0 110.295 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.39 86.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -48.71 77.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -70.28 -36.89 74.67 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.77 -45.77 91.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.151 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.28 -40.08 96.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.306 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.79 -40.19 94.83 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.801 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.586 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 43.9 Cg_endo -67.21 152.64 79.26 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.723 2.282 . . . . 1.0 111.993 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 6' ' ' MET . 91.1 mt -74.44 145.97 43.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.445 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.24 -36.37 93.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.4 t -61.66 -43.74 98.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.343 . . . . 1.0 111.014 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.427 ' O ' ' O ' ' A' ' 3' ' ' LEU . 97.2 mmm -106.25 126.27 52.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.552 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -80.14 151.94 73.34 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.43 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.22 159.58 43.7 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.163 1.908 . . . . 1.0 111.996 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 45.4 Cg_endo -67.83 -33.28 27.43 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.642 2.228 . . . . 1.0 112.151 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.18 150.73 87.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.805 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.51 141.06 90.51 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.627 1.551 . . . . 1.0 111.72 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.3 t -68.35 -43.29 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.293 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.18 -41.31 4.85 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.86 146.13 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.594 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -93.22 107.02 22.48 Favored Pre-proline 0 N--CA 1.466 0.347 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.94 99.87 1.35 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.614 1.543 . . . . 1.0 113.181 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.49 -43.41 85.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.282 0.563 . . . . 1.0 109.892 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.12 149.08 29.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.327 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 t -141.34 130.18 23.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.689 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -142.03 159.66 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-O 120.928 0.394 . . . . 1.0 110.955 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -108.32 122.43 46.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.511 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' C ' ' SD ' ' A' ' 23' ' ' MET . . . -130.59 -152.52 7.42 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 22' ' ' GLY . 2.8 mpt? -143.99 126.53 15.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 1.0 110.522 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 84.2 tt0 -87.42 121.43 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.601 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -105.79 138.85 41.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.62 150.22 49.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.67 -66.63 0.38 Allowed Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.583 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.56 -33.59 86.83 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.761 2.307 . . . . 1.0 113.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -174.0 -171.97 0.68 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 121.009 -0.276 . . . . 1.0 110.463 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -130.23 169.13 15.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.973 0.416 . . . . 1.0 110.454 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 134.66 8.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.83 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.16 141.59 69.18 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 CA-C-N 120.199 1.107 . . . . 1.0 111.244 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 15.5 p -150.31 -176.24 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.403 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.71 138.64 22.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.0 mt -105.66 123.86 48.61 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.969 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.7 m -129.6 113.91 15.4 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.117 0.484 . . . . 1.0 111.584 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.9 tp -81.43 127.39 32.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.03 149.19 47.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.138 0.494 . . . . 1.0 111.363 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -112.98 121.95 46.18 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.405 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -135.36 139.89 44.61 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.039 0.447 . . . . 1.0 110.76 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m120 58.97 33.86 23.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.324 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.83 23.93 75.67 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -131.3 152.61 50.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.0 130.41 40.13 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -142.41 142.1 32.33 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.026 0.441 . . . . 1.0 110.231 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.5 tp -104.38 124.78 49.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.0 mt -103.38 122.19 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.988 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.88 114.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.68 132.79 47.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.071 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 52' ' ' GLU . 10.0 mp -108.04 129.44 55.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.7 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -80.18 36.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.268 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' A' ' 50' ' ' LEU . 35.9 tp10 -49.77 142.46 8.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.199 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.68 -38.69 91.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -59.04 -53.85 53.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.34 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -174.46 149.87 1.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.58 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 t -67.11 133.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.214 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 97.0 mt-30 -106.79 128.63 54.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.143 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -122.18 117.39 26.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.56 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.66 111.86 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.161 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -115.97 114.53 41.45 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.793 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.27 151.07 37.89 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.667 1.578 . . . . 1.0 112.462 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.9 mt -97.52 118.81 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.429 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -170.22 -158.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.352 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -61.05 -42.62 98.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.109 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -65.41 -36.11 82.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.979 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 64' ' ' ASN . 17.3 t80 -95.12 123.78 38.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.41 122.35 15.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.234 0.54 . . . . 1.0 110.817 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 t -87.89 115.0 25.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.247 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 m -115.74 124.32 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.908 0.385 . . . . 1.0 110.583 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.478 ' N ' ' OG1' ' A' ' 76' ' ' THR . 52.4 tt0 -84.48 135.44 34.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 55.25 -96.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.902 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.29 170.86 14.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.881 -0.599 . . . . 1.0 111.007 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.93 -8.55 59.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.764 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -85.82 -7.76 58.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.818 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.478 ' OG1' ' N ' ' A' ' 71' ' ' GLN . 1.8 p -89.39 46.44 1.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.152 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.2 -42.71 99.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.991 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -105.6 -9.21 17.51 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.589 -0.278 . . . . 1.0 111.193 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 79' ' ' ILE . 81.1 mt -101.49 130.75 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.997 0.427 . . . . 1.0 110.643 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 21.9 p-10 -152.29 -50.15 0.11 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.732 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' SER . 36.5 mm -63.99 -40.93 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.221 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.6 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . 44.0 t -142.91 140.19 31.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 1.0 110.151 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 83' ' ' SER . 17.0 m120 -146.15 -172.22 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.985 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER 76.97 89.68 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.19 77.49 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 135.15 35.92 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.01 0.433 . . . . 1.0 111.882 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.04 113.32 25.78 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.66 129.79 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.817 0.341 . . . . 1.0 110.429 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.86 142.18 33.57 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.105 -0.498 . . . . 1.0 109.982 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.06 133.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.706 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.22 141.61 31.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 175.65 -167.0 38.66 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.51 -40.89 96.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.643 0.258 . . . . 1.0 111.244 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -61.08 -37.95 84.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.672 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' GLY . 44.5 pt -143.26 148.5 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.676 0.274 . . . . 1.0 110.888 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -72.2 -48.2 44.83 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.992 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -176.9 128.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.9 0.381 . . . . 1.0 110.581 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.88 145.08 35.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -104.06 147.32 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.93 0.395 . . . . 1.0 111.169 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.87 152.42 45.08 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.998 -0.547 . . . . 1.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -138.26 144.53 40.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.984 0.421 . . . . 1.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.7 mm -127.31 89.88 50.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.59 -16.44 46.93 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.721 1.614 . . . . 1.0 112.652 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -87.2 101.09 13.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.81 -55.07 39.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 1.0 112.087 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -51.84 -44.03 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.771 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -68.45 -39.67 81.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.919 0.39 . . . . 1.0 110.422 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -58.07 -36.84 73.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.107 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.416 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.27 -44.58 83.21 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.868 -0.733 . . . . 1.0 110.542 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -62.18 -50.33 72.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.707 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.67 -40.86 92.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.119 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 m -61.53 -43.82 98.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.098 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.8 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.157 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.95 -44.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.882 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.16 -45.96 92.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.061 0.457 . . . . 1.0 110.276 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.94 -37.39 84.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.311 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.12 -48.54 78.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.03 -38.72 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.923 0.392 . . . . 1.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.13 -44.86 90.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.754 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.08 75.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.951 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.18 -39.87 68.35 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.68 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.039 -0.981 . . . . 1.0 110.684 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.91 146.6 91.67 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.801 2.334 . . . . 1.0 112.12 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.29 149.49 40.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.054 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.67 -43.63 98.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.173 -0.771 . . . . 1.0 111.173 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' MET . 10.9 p -77.3 160.96 28.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.698 0.285 . . . . 1.0 110.528 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' SER . 23.9 tpp -59.34 -126.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.277 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.416 ' H ' ' CG ' ' A' ' 6' ' ' MET . 40.2 mt-10 -140.45 98.53 7.26 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.0 159.62 23.99 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.004 1.802 . . . . 1.0 112.05 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.13 -30.2 88.55 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.673 2.249 . . . . 1.0 111.822 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 4.1 mm? -53.94 146.4 28.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.93 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -55.11 144.16 70.9 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.076 1.184 . . . . 1.0 111.5 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.86 -45.15 97.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.551 -0.749 . . . . 1.0 111.015 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.47 -28.67 73.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.14 -0.784 . . . . 1.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 147.39 52.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 1.0 110.976 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -118.28 80.49 15.91 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.431 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.45 97.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.158 1.905 . . . . 1.0 112.689 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' LEU . 98.3 mt -65.47 -41.34 93.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.799 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.6 149.08 28.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.229 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 t -138.23 136.4 36.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.806 0.336 . . . . 1.0 110.619 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 p -144.82 151.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.331 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.1 137.52 36.03 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.604 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -150.65 -168.5 15.56 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.647 -0.981 . . . . 1.0 110.647 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -127.84 130.54 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 1.0 110.515 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -93.12 120.82 33.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.457 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 71.4 mtm -107.76 136.09 48.08 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.609 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.91 149.49 38.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.051 0.453 . . . . 1.0 109.965 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -37.11 -65.35 0.6 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.77 -0.65 . . . . 1.0 112.749 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.14 -32.78 95.04 Favored 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 122.728 2.285 . . . . 1.0 114.135 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.14 177.21 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 121.084 -0.246 . . . . 1.0 110.61 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.57 168.86 11.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.0 0.429 . . . . 1.0 110.287 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 16.7 pt-20 -161.46 143.91 9.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.41 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.46 144.93 95.51 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.338 1.359 . . . . 1.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 22' ' ' GLY . 4.2 p -154.05 -178.13 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.571 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.05 143.13 24.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.197 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.7 mt -106.25 120.93 43.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.873 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m -127.27 115.36 18.91 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.232 0.539 . . . . 1.0 111.458 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 17' ' ' LEU . 65.4 tp -87.76 128.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.062 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.88 144.26 41.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 1.0 111.425 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -98.77 121.26 40.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.544 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.95 134.18 42.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.914 0.388 . . . . 1.0 110.948 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 58.15 33.78 23.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.681 -0.69 . . . . 1.0 111.791 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.35 78.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.873 -0.891 . . . . 1.0 110.873 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 44.2 tt0 -131.36 161.28 32.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 94.5 m-85 -103.41 137.25 41.78 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -145.54 144.1 30.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.004 0.43 . . . . 1.0 110.352 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.2 tp -104.57 128.9 52.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.634 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.57 129.17 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.42 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.32 120.18 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -108.53 127.83 54.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.082 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 50' ' ' LEU . 4.2 mm? -101.27 132.44 46.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.906 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -95.49 18.99 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.305 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 94.1 mt-10 -45.6 136.84 5.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.419 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.74 -38.5 90.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.195 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.13 -50.92 69.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.377 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -170.58 154.92 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.166 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -84.58 113.88 21.57 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.14 131.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.938 0.399 . . . . 1.0 110.344 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -121.13 117.41 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.585 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -106.53 134.94 48.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 60' ' ' ILE . 34.0 mm -93.82 109.54 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.902 0.382 . . . . 1.0 110.16 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.409 HG21 HD12 ' A' ' 61' ' ' ILE . 30.6 mm -112.41 104.59 56.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 147.82 36.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.596 1.53 . . . . 1.0 112.642 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 97.2 mt -91.81 119.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 63' ' ' ILE . 79.3 m-20 -163.85 -165.37 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.059 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.1 p -61.54 -37.25 83.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.34 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -71.57 -32.2 67.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.296 . . . . 1.0 111.186 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 16.4 t80 -92.24 123.24 35.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.931 0.396 . . . . 1.0 109.987 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -135.05 144.48 47.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.549 . . . . 1.0 110.82 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.5 t -117.96 112.36 20.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.049 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.94 125.83 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.852 0.358 . . . . 1.0 111.012 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' OE1' ' OD1' ' A' ' 80' ' ' ASP . 42.5 tt0 -84.44 102.1 12.52 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.719 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 38.64 47.82 1.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.512 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -174.04 -155.94 0.07 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.009 -0.542 . . . . 1.0 110.685 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -106.62 -6.19 18.14 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.032 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 77' ' ' LEU . 83.4 tt0 -157.43 -85.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.007 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 79' ' ' ILE . 89.5 m 54.25 5.89 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.482 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 75' ' ' GLU . 84.7 mt -62.0 -38.81 90.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.253 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 10.6 mp -63.27 -41.12 98.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.573 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' THR . 87.8 mt -109.12 127.26 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.053 0.454 . . . . 1.0 111.02 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.514 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 70.5 m-20 -160.39 -41.42 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.323 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.07 -42.57 95.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.59 -32.03 57.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.053 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ASP . 34.5 t -147.4 126.84 13.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.73 0.3 . . . . 1.0 110.706 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 80' ' ' ASP . 35.4 m120 -147.76 27.02 1.0 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.963 0.411 . . . . 1.0 111.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 t -80.45 100.89 8.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.396 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.96 80.37 0.12 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.952 -1.659 . . . . 1.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.86 129.5 38.76 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.134 0.42 . . . . 1.0 112.134 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.43 121.77 46.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 153.11 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.62 142.9 50.15 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.28 132.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.851 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -137.77 135.68 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.985 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 177.44 -174.67 47.14 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.48 -35.93 82.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.333 . . . . 1.0 110.984 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -59.11 -38.48 79.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.492 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 43.2 pt -141.7 151.73 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.37 0.129 . . . . 1.0 110.723 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -71.21 -56.98 4.95 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.879 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -174.32 112.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.479 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.492 ' HE ' ' CD1' ' A' ' 96' ' ' ILE . 76.7 mtm180 -129.33 134.19 47.79 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -91.89 157.58 16.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.857 0.361 . . . . 1.0 111.0 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.73 153.77 47.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.402 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -140.03 140.78 36.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.841 0.353 . . . . 1.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.1 mm -128.67 89.61 48.74 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.07 -16.63 36.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.918 1.745 . . . . 1.0 112.651 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -87.55 106.51 18.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.697 -0.482 . . . . 1.0 109.697 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.0 -54.58 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 1.0 112.032 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.19 -44.23 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.559 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -69.2 -37.14 77.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.736 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 113' ' ' LEU . 11.5 t -62.39 -31.91 72.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.157 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.78 -45.52 92.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.71 -42.99 85.5 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.039 -0.665 . . . . 1.0 110.622 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.65 -51.13 68.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.223 -0.899 . . . . 1.0 111.322 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.449 ' CD1' HD21 ' A' ' 84' ' ' ASN . 91.2 mt -66.76 -41.07 88.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.277 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.489 ' HG ' ' H ' ' A' ' 115' ' ' ALA . 77.9 p -63.19 -45.96 89.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.82 0.343 . . . . 1.0 111.345 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.489 ' H ' ' HG ' ' A' ' 114' ' ' SER . . . -69.2 -47.99 63.34 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.414 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.75 -43.9 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.636 0.255 . . . . 1.0 111.113 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.63 -45.74 91.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 1.0 110.215 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -37.81 87.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.229 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.04 72.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.736 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -70.95 -35.97 72.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.355 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.66 -44.68 96.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.85 97.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.286 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.69 -41.06 88.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.698 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.507 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.81 144.82 99.62 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.912 2.408 . . . . 1.0 112.194 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.36 -41.68 98.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.502 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.86 152.16 52.07 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.894 -0.882 . . . . 1.0 110.894 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.7 p -82.66 -6.12 59.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 1.0 110.534 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.0 tpp -84.31 129.61 34.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.647 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -47.01 152.34 1.0 Allowed Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.496 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 160.25 44.5 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.273 1.982 . . . . 1.0 111.967 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 35.6 Cg_endo -63.97 -31.51 66.47 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.578 2.185 . . . . 1.0 111.974 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.55 150.92 53.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.12 143.29 99.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.326 1.351 . . . . 1.0 111.526 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 13' ' ' GLY . 13.4 m -68.63 -42.89 83.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -67.26 -28.12 73.64 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.399 -0.68 . . . . 1.0 111.399 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.89 58.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.906 0.384 . . . . 1.0 111.015 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -99.0 102.85 16.62 Favored Pre-proline 0 N--CA 1.465 0.275 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.42 100.58 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.605 1.536 . . . . 1.0 112.915 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.5 -43.72 84.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.333 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.43 149.91 31.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -141.82 131.71 24.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.526 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 66.4 t -139.17 158.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 121.124 0.488 . . . . 1.0 110.822 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 97.4 mt-10 -106.29 123.06 47.46 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.523 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.71 -160.5 9.59 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -139.0 127.34 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.867 0.365 . . . . 1.0 110.557 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -87.14 123.89 32.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.628 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.7 mtm -107.35 137.45 45.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.61 149.13 50.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -66.61 0.32 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.791 -0.641 . . . . 1.0 112.566 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.21 -33.62 90.06 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.804 2.336 . . . . 1.0 113.537 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.46 -174.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.526 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -126.1 168.64 13.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.067 0.461 . . . . 1.0 110.635 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -153.88 143.78 15.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.459 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.3 146.55 93.76 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.486 1.458 . . . . 1.0 111.117 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.5 p -155.14 -172.88 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.579 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.73 136.7 16.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.8 mt -101.53 122.75 44.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.823 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -128.19 123.26 33.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.237 0.541 . . . . 1.0 111.7 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.6 tp -94.77 122.09 37.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.02 151.08 51.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.084 0.469 . . . . 1.0 111.25 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -110.7 122.5 47.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.639 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -134.01 138.62 45.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.981 0.419 . . . . 1.0 110.843 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 58.96 33.8 23.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.41 77.2 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -131.15 155.73 46.51 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.83 135.2 36.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.327 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -145.5 139.57 26.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -105.27 120.75 42.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.84 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 47' ' ' ILE . 79.8 mt -104.46 127.25 58.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.318 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.1 mt -105.37 116.76 49.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -96.15 127.51 42.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.54 133.47 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.773 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -106.39 34.33 3.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.306 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.81 149.09 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.99 -38.04 89.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.391 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -59.19 -51.2 71.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.227 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -175.02 166.27 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.749 -0.659 . . . . 1.0 111.026 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -84.62 127.45 34.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.979 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.41 136.03 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.042 0.449 . . . . 1.0 110.439 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 9' ' ' PRO . 56.7 tt0 -100.01 109.38 21.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.184 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -102.34 113.49 26.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.957 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.63 123.09 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.899 0.38 . . . . 1.0 110.381 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -132.37 117.63 15.67 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.141 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.72 157.8 39.61 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.766 1.644 . . . . 1.0 112.645 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.69 123.57 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -173.71 -161.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.441 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 78.1 p -62.08 -39.08 91.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.192 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.441 ' N ' ' HG ' ' A' ' 65' ' ' SER . 93.8 m-70 -67.37 -38.23 84.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.591 -0.277 . . . . 1.0 111.179 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -84.01 125.42 32.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 1.0 110.212 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -134.09 144.59 48.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.297 0.57 . . . . 1.0 110.745 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -127.11 120.66 29.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.278 -0.874 . . . . 1.0 109.251 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 m -119.62 125.3 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.767 0.318 . . . . 1.0 110.596 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.461 ' NE2' ' OG ' ' A' ' 83' ' ' SER . 59.1 tt0 -90.25 118.29 29.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.7 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 36.78 64.83 0.53 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 171.79 -171.86 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.387 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -97.98 -13.72 20.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.059 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -144.25 -100.16 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.4 m 39.6 63.13 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.534 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.21 -31.09 10.74 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.232 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.85 -40.47 83.67 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.221 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.2 mt -116.6 130.24 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.138 0.494 . . . . 1.0 110.976 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -134.83 -21.24 1.7 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.03 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 81' ' ' ILE . 89.9 mt -63.75 -42.19 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.379 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.13 -24.46 26.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.941 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.566 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 30.0 t -113.34 124.75 53.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.247 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.9 m120 -150.81 -171.75 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.124 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' OG ' ' A' ' 85' ' ' SER . 4.7 p 66.37 97.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.51 79.04 0.09 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 135.33 36.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.865 0.365 . . . . 1.0 111.946 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.58 113.38 26.65 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.412 -0.959 . . . . 1.0 108.412 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.17 125.7 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 1.0 110.162 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 65.3 mtp180 -102.57 146.52 28.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.71 132.47 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.678 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -145.61 148.13 32.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.274 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 120.92 -166.41 13.97 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 96' ' ' ILE . 99.0 m-20 43.97 -166.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.39 . . . . 1.0 110.757 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -68.25 21.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 1.0 112.051 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.539 ' H ' ' C ' ' A' ' 94' ' ' ASP . 43.9 pt -130.65 155.24 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.602 0.239 . . . . 1.0 110.395 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -96.8 -169.74 1.93 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.716 0.293 . . . . 1.0 110.302 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 90' ' ' ARG . 77.2 tt0 -65.85 127.96 34.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.164 0.507 . . . . 1.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -132.02 160.77 34.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.076 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.466 ' CZ ' ' NH2' ' A' ' 90' ' ' ARG . 85.5 mtt85 -123.58 144.08 49.81 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.953 0.406 . . . . 1.0 110.964 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -143.95 155.95 44.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.947 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -138.71 146.44 41.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 1.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.0 mm -127.39 90.46 48.66 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.37 -16.09 43.01 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.833 1.689 . . . . 1.0 112.65 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -87.57 100.9 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.15 -53.42 58.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.201 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -52.97 -42.21 65.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.668 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -71.56 -36.57 70.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.885 0.374 . . . . 1.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.48 -36.19 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.064 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.14 -44.41 95.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.478 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -66.72 -44.49 81.48 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.29 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -61.01 -49.37 77.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.204 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.01 -42.43 89.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.539 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.5 m -63.13 -43.8 97.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.419 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.03 -48.83 61.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.355 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.29 -43.44 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.56 -45.42 91.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.932 0.396 . . . . 1.0 110.257 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.86 85.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.338 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.38 -49.01 77.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.839 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -67.61 -37.69 82.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.776 0.322 . . . . 1.0 111.04 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -60.12 -44.34 94.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.053 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.28 94.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.395 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.8 -39.73 91.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.665 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.939 -1.029 . . . . 1.0 110.875 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -60.94 145.0 99.69 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.883 2.389 . . . . 1.0 112.099 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.9 mt -76.22 146.05 39.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.39 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.52 173.42 55.01 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.4 t -74.41 98.13 3.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 1.0 110.435 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.2 mtt -139.27 146.33 40.27 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.532 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.18 114.79 18.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.604 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.14 159.59 23.56 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.019 1.813 . . . . 1.0 112.316 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.28 -32.35 41.94 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.669 2.246 . . . . 1.0 111.802 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.46 149.66 75.54 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.889 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.39 143.67 89.2 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.805 1.67 . . . . 1.0 111.621 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 m -78.7 -19.5 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.029 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.2 -33.51 84.6 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.32 170.59 15.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.03 0.443 . . . . 1.0 110.98 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.32 81.7 17.61 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.799 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.26 95.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.547 2.165 . . . . 1.0 112.7 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.21 -41.88 96.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.717 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.69 155.62 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.055 -0.975 . . . . 1.0 110.411 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -148.84 142.39 25.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.851 0.357 . . . . 1.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.96 161.05 23.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.304 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -94.99 122.51 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -125.34 167.19 17.78 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.2 mtp -117.6 103.01 9.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.864 0.364 . . . . 1.0 110.292 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' CE1' ' A' ' 101' ' ' PHE . 47.9 tp10 -60.22 121.37 11.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.109 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 102' ' ' GLU . 76.0 mtm -106.32 131.19 53.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.433 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.6 146.46 39.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.959 0.409 . . . . 1.0 109.998 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.22 -65.29 0.72 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.568 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.9 -33.38 95.88 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.627 2.218 . . . . 1.0 113.628 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.8 -169.53 0.17 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.659 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -132.65 168.91 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.951 0.405 . . . . 1.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 18.3 pt-20 -154.39 134.8 8.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.24 141.37 70.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 CA-C-N 120.264 1.13 . . . . 1.0 111.369 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 22' ' ' GLY . 28.5 p -149.17 -175.99 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.524 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.43 137.09 12.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.302 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.7 mt -98.32 122.76 41.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.501 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.8 m -118.87 119.29 33.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.14 0.495 . . . . 1.0 111.283 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.7 tp -98.03 130.8 44.83 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.35 154.0 41.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.089 0.471 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -111.0 122.61 48.34 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -133.21 133.21 42.44 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 1.0 110.556 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 60.86 34.77 19.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.417 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.0 25.35 75.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.029 -0.829 . . . . 1.0 111.029 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -134.82 144.38 47.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.18 -0.304 . . . . 1.0 110.18 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -88.39 136.51 32.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -143.73 144.54 31.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.051 0.453 . . . . 1.0 110.514 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.28 126.01 53.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.499 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.435 HG22 HD13 ' A' ' 47' ' ' ILE . 90.7 mt -111.71 131.64 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.151 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.5 mm -95.2 122.75 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.818 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.92 136.12 49.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.809 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -104.81 20.41 18.78 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.25 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.8 mt-10 -40.43 141.07 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.88 0.371 . . . . 1.0 110.668 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.92 -39.64 92.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.474 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.47 -51.88 67.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.365 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -173.98 147.08 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.478 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 19.6 p80 -75.83 112.51 12.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 t -90.77 132.76 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -112.38 117.91 33.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.649 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -121.83 127.65 50.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -100.4 125.91 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.056 0.455 . . . . 1.0 110.487 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.67 93.2 35.46 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.438 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.78 145.05 85.26 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.147 1.898 . . . . 1.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 97.6 mt -85.88 117.66 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -176.73 -160.37 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.121 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.7 p -65.47 -23.25 66.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.283 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -83.76 -10.46 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.02 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -113.78 129.81 56.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.963 0.411 . . . . 1.0 110.079 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' NH2' ' OE1' ' A' ' 75' ' ' GLU . 77.0 mtp180 -129.67 155.73 45.39 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.582 0.706 . . . . 1.0 111.081 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 26.3 p -144.48 100.2 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.562 -1.199 . . . . 1.0 109.798 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -102.53 122.39 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.844 0.355 . . . . 1.0 110.617 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 83' ' ' SER . 56.3 tt0 -98.81 125.4 44.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.05 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 47.34 18.83 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.914 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 71' ' ' GLN . . . -158.79 -160.62 0.88 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.685 -0.689 . . . . 1.0 111.066 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.411 ' O ' ' NH2' ' A' ' 68' ' ' ARG . 97.6 mt-10 -129.52 -8.55 4.63 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.405 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.534 ' OE1' ' NH2' ' A' ' 68' ' ' ARG . 43.8 tp10 -147.96 83.43 1.51 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.13 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' ILE . 6.2 t -157.84 44.25 0.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.228 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' CD2' ' H ' ' A' ' 69' ' ' CYS . 53.5 mt -63.38 -43.02 98.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.177 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.37 -37.62 74.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.979 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 76' ' ' THR . 79.3 mt -99.81 127.71 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.093 0.473 . . . . 1.0 111.129 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 71.9 m-20 -155.48 -29.47 0.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.219 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.74 -42.56 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.527 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.17 -31.73 53.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.04 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.561 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 40.8 m -105.53 120.75 42.41 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.095 -0.335 . . . . 1.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.3 m120 -150.16 -167.99 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.227 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.87 86.77 0.12 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.33 69.84 1.27 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.005 -1.638 . . . . 1.0 109.005 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.3 142.57 27.26 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.047 0.451 . . . . 1.0 111.896 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -128.3 131.18 48.69 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.96 162.72 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.323 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.736 ' NH2' HH22 ' A' ' 100' ' ' ARG . 68.0 mtt180 -128.58 140.48 51.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.96 134.7 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.99 0.424 . . . . 1.0 110.626 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.85 140.06 52.63 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.334 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -169.61 -175.34 38.65 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.533 ' OD1' ' CE3' ' A' ' 95' ' ' TRP . 13.4 p-10 -74.43 -37.77 63.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.714 0.292 . . . . 1.0 111.191 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.533 ' CE3' ' OD1' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -65.71 -34.92 79.32 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.385 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 93' ' ' GLY . 25.5 pt -127.74 156.55 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.676 0.274 . . . . 1.0 110.634 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 98' ' ' GLU . 3.9 ptm180 -84.93 -53.28 5.41 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.798 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 97' ' ' ARG . 47.8 tp10 -174.97 93.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 1.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -104.56 135.05 46.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.736 HH22 ' NH2' ' A' ' 90' ' ' ARG . 57.4 mtp85 -101.37 150.25 23.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.937 0.399 . . . . 1.0 110.812 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.549 ' CE1' ' OE1' ' A' ' 24' ' ' GLU . 70.1 m-85 -129.24 154.9 46.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.556 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 25' ' ' MET . 81.4 tt0 -149.04 121.73 8.63 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.988 0.423 . . . . 1.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.16 98.41 26.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.78 -10.67 25.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.68 1.587 . . . . 1.0 112.595 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -94.35 106.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.86 -54.98 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.002 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -50.07 -44.85 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.519 -0.473 . . . . 1.0 110.464 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -68.57 -40.19 80.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 1.0 110.642 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.16 -36.85 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.033 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -63.7 -44.66 93.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.46 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.26 -45.22 81.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.312 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -61.48 -49.1 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.4 -41.58 80.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.344 -0.542 . . . . 1.0 111.238 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.2 t -63.36 -44.97 93.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.686 0.279 . . . . 1.0 111.535 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.63 -50.32 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.465 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.8 -45.18 99.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.592 -0.276 . . . . 1.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -60.67 -46.01 91.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 110.318 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.09 76.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 1.0 110.533 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.44 99.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.818 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -66.38 -40.2 89.54 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.663 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -63.25 -44.22 95.79 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.624 0.726 . . . . 1.0 110.115 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.4 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.174 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' A' ' 63' ' ' ILE . 89.3 mt-30 -66.26 -40.58 90.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.742 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.599 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.585 -1.406 . . . . 1.0 109.585 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.57 -18.04 48.53 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.646 2.23 . . . . 1.0 112.092 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.416 ' C ' ' CD2' ' A' ' 3' ' ' LEU . 5.6 tt -97.84 120.43 38.22 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.873 0.368 . . . . 1.0 110.104 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.0 -43.12 0.32 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -70.88 139.81 50.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.332 . . . . 1.0 110.632 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.64 -40.4 95.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.352 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -105.13 103.75 43.52 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.431 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -82.33 160.05 17.42 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.165 1.91 . . . . 1.0 112.255 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 29.8 Cg_endo -62.22 -30.2 81.37 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.667 2.245 . . . . 1.0 111.958 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.62 162.17 0.99 Allowed Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.826 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.83 152.41 64.04 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.488 1.459 . . . . 1.0 111.443 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -85.97 70.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.692 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.86 -26.93 0.39 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.57 140.67 53.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 111.035 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 15.5 mm100 -102.54 80.95 0.35 Allowed Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.69 88.42 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.681 1.587 . . . . 1.0 112.152 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.695 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.42 137.58 38.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.578 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.28 125.76 26.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 54.6 t -135.93 157.07 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.767 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 46.7 tp10 -105.79 122.96 47.16 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.98 -157.76 8.78 Favored Glycine 0 N--CA 1.463 0.491 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -140.51 123.59 16.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.886 0.374 . . . . 1.0 110.36 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -88.94 119.32 29.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.518 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.3 mpp? -107.58 136.04 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.509 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.68 149.08 52.6 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -65.82 0.41 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.635 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.83 -32.62 85.7 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.814 2.343 . . . . 1.0 113.705 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.43 -176.72 1.12 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.434 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -126.72 169.1 13.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 1.0 110.682 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -158.15 141.98 11.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.553 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.25 144.34 95.33 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.297 1.331 . . . . 1.0 110.985 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.3 p -152.01 174.21 13.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.321 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.09 131.78 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.955 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.1 mt -96.63 121.6 38.64 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.999 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.3 m -129.24 124.67 35.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.197 0.522 . . . . 1.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.24 125.86 35.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.432 -0.803 . . . . 1.0 108.851 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.86 155.45 42.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.127 0.489 . . . . 1.0 111.052 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' OE1' ' CZ ' ' A' ' 44' ' ' TYR . 20.6 tt0 -134.19 116.52 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.829 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.464 ' CZ ' ' OE1' ' A' ' 45' ' ' GLU . 34.2 ptt180 -137.25 144.21 42.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.233 0.539 . . . . 1.0 111.248 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 59.11 28.05 17.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.107 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.04 78.37 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -127.31 137.88 52.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CZ ' ' OE1' ' A' ' 39' ' ' GLN . 84.1 m-85 -87.92 135.72 33.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 40' ' ' ARG . 22.6 pt-20 -144.89 144.61 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 1.0 110.482 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.9 tp -103.76 121.16 42.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.292 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.2 mt -105.16 124.77 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.944 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.35 115.89 49.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -96.78 131.8 43.13 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.983 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mp -106.82 130.43 54.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.805 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -104.06 29.17 6.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.126 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE1' ' OE2' ' A' ' 54' ' ' GLU . 96.6 mt-10 -43.69 145.6 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.606 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.14 -36.07 82.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' OE2' ' OE1' ' A' ' 52' ' ' GLU . 3.3 pt-20 -62.03 -46.72 87.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -177.29 154.96 1.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.567 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -78.01 127.84 32.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.0 109.876 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.42 135.94 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.042 0.449 . . . . 1.0 110.474 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 83.4 mt-30 -108.6 126.37 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.158 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.82 119.02 36.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.716 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.5 mm -92.75 112.64 26.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.93 0.395 . . . . 1.0 110.369 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 61' ' ' ILE . 33.1 mm -117.64 89.44 32.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.221 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.67 141.44 95.47 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.228 1.952 . . . . 1.0 112.455 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -83.53 124.81 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.558 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.702 HD22 ' HE2' ' A' ' 66' ' ' HIS . 5.2 p30 176.04 -165.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.963 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -59.19 -38.04 78.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.706 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.702 ' HE2' HD22 ' A' ' 64' ' ' ASN . 3.3 p80 -74.54 -2.75 27.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.75 0.31 . . . . 1.0 111.401 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.436 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 42.0 t80 -116.25 132.21 56.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.155 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -130.71 148.29 52.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.861 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 t -143.2 104.32 4.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.052 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.21 128.14 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.885 0.374 . . . . 1.0 110.886 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 58.2 tp60 -78.9 96.15 5.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 36.92 57.65 1.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -159.01 164.92 35.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.982 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -68.05 -37.69 81.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.68 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -170.73 81.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.668 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -123.15 45.67 2.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.073 0.463 . . . . 1.0 110.523 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.466 ' H ' HD12 ' A' ' 77' ' ' LEU . 5.0 mp -67.62 -36.49 80.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.569 . . . . 1.0 111.439 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.37 -42.91 99.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.453 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 91.4 mt -110.78 129.46 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.093 0.473 . . . . 1.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 97.8 m-20 -142.11 -30.17 0.57 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.289 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.86 -41.99 94.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.493 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.01 -22.52 5.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.905 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 11.0 t -111.42 122.84 48.9 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.054 0.454 . . . . 1.0 110.414 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 83' ' ' SER . 13.7 m120 -148.74 -166.79 2.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.07 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 t 56.82 88.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.73 72.52 0.7 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.447 -1.461 . . . . 1.0 109.447 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.482 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.32 134.94 36.28 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.799 0.333 . . . . 1.0 111.686 -178.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.623 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 63.8 mttp -111.87 131.63 55.23 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.15 157.96 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.712 ' NH2' HH22 ' A' ' 100' ' ' ARG . 96.9 mtt180 -131.19 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.2 132.25 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -146.91 154.71 41.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.358 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -165.04 172.54 40.73 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -67.64 -44.5 77.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.866 0.365 . . . . 1.0 111.219 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -85.08 -11.76 54.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.121 -0.49 . . . . 1.0 112.073 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.4 pt -126.24 153.78 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.639 0.257 . . . . 1.0 110.655 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -92.03 162.6 14.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.667 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -63.42 136.08 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.409 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -136.13 159.14 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.131 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.712 HH22 ' NH2' ' A' ' 90' ' ' ARG . 66.6 mtp85 -122.23 145.11 48.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.061 0.458 . . . . 1.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -140.21 155.67 46.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.175 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -139.41 141.51 37.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.891 0.376 . . . . 1.0 111.06 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mm -124.03 89.45 51.69 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.62 -15.62 37.72 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.85 1.7 . . . . 1.0 112.762 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -88.65 105.12 17.46 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.43 -53.84 52.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.23 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -53.06 -42.45 65.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.571 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -70.27 -37.68 74.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.492 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.61 -34.44 74.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.423 . . . . 1.0 111.001 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.72 -44.74 95.44 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.309 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.87 -43.25 84.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.164 -0.615 . . . . 1.0 110.579 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -60.27 -49.2 78.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.293 -0.867 . . . . 1.0 111.211 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.9 -41.86 86.43 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.336 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 57.8 m -63.53 -44.17 95.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.822 0.344 . . . . 1.0 111.451 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.34 -48.8 54.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.609 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -65.45 -43.57 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.904 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.92 -45.11 93.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 110.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.92 -38.85 89.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.6 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.3 -49.34 76.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.765 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.48 -36.78 74.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.335 . . . . 1.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.76 -44.93 94.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.158 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.9 95.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.285 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -67.86 -41.23 83.22 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.63 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.15 145.24 96.4 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.951 2.434 . . . . 1.0 112.229 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.88 -41.4 97.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.48 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.43 6.1 18.07 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.3 t -66.83 133.46 50.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 1.0 110.881 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.29 -39.77 92.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.322 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -139.56 98.58 7.98 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.178 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.47 160.41 14.78 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.273 1.982 . . . . 1.0 112.32 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 33.1 Cg_endo -63.41 -31.07 72.75 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.647 2.231 . . . . 1.0 111.77 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.1 155.6 16.15 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.158 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.55 143.86 99.48 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.336 1.358 . . . . 1.0 111.628 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.6 -44.96 93.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.14 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.62 78.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 140.41 58.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 1.0 110.961 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -104.07 80.7 0.44 Allowed Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.242 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.75 99.95 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.98 1.787 . . . . 1.0 112.102 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -64.65 -43.85 92.3 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.392 0.615 . . . . 1.0 110.154 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.87 141.36 24.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.19 -0.914 . . . . 1.0 109.932 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -131.64 128.87 40.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.212 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.9 162.25 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.147 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -99.75 122.62 43.0 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -123.06 179.2 16.2 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 93.3 mmm -126.15 99.61 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' CD ' HH21 ' A' ' 99' ' ' ARG . 81.3 tt0 -62.29 132.54 52.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.098 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 73.9 mtm -120.8 140.25 51.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.782 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -141.56 148.68 39.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.32 -65.59 0.34 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.779 -0.646 . . . . 1.0 112.504 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.63 -31.85 92.62 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.65 2.233 . . . . 1.0 114.108 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.35 176.28 0.63 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.399 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -118.01 169.2 9.85 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 1.0 110.177 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.39 141.9 13.25 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.448 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 144.91 96.39 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.026 1.15 . . . . 1.0 111.359 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 22' ' ' GLY . 17.1 p -153.58 -179.84 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.438 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.93 128.64 24.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.081 0.467 . . . . 1.0 110.239 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 3.9 mm? -100.52 119.66 38.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.966 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.6 m -130.66 122.01 26.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.0 111.853 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.42 129.99 36.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.006 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.29 148.63 41.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.44 . . . . 1.0 111.457 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -109.02 121.24 44.72 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.66 136.65 46.6 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.057 0.456 . . . . 1.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 m120 59.73 33.66 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.908 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.37 77.82 Favored Glycine 0 N--CA 1.463 0.476 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -130.36 154.39 47.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.483 -0.359 . . . . 1.0 110.055 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -92.58 135.1 34.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -143.94 143.81 31.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 1.0 110.317 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -103.89 124.78 49.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.423 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 47' ' ' ILE . 72.1 mt -102.53 118.07 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.7 mt -103.44 120.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.643 -0.502 . . . . 1.0 109.643 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -115.08 129.58 56.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.762 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.4 mp -101.22 127.37 47.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -76.73 62.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.298 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.3 154.34 40.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.252 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -62.46 -40.83 97.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.193 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.33 -82.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.882 0.372 . . . . 1.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -142.29 152.14 42.7 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -70.71 123.07 21.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.22 133.89 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.12 0.486 . . . . 1.0 110.481 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 81.9 mt-30 -95.23 123.92 38.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.86 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -120.45 117.08 26.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.444 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 60' ' ' ILE . 41.6 mm -94.22 110.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.911 0.386 . . . . 1.0 110.626 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm -115.16 119.07 39.31 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.165 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.01 150.83 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.797 1.665 . . . . 1.0 112.669 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 63' ' ' ILE . 97.8 mt -104.46 118.35 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.319 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -172.22 -153.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.234 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.0 p -64.16 -40.24 95.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.191 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -66.6 -41.15 88.92 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 8.0 t80 -96.23 130.1 43.39 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.788 0.328 . . . . 1.0 110.18 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -139.42 142.54 37.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.541 . . . . 1.0 110.826 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -119.91 115.5 23.92 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.12 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.77 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.91 0.386 . . . . 1.0 110.644 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.675 ' C ' ' H ' ' A' ' 73' ' ' ALA . 49.5 tt0 -81.05 107.18 13.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.416 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 73' ' ' ALA . 94.1 mt-10 60.59 -16.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.458 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.675 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . 37.96 -158.09 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.527 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 56.34 3.31 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.143 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 73' ' ' ALA . 5.3 pt-20 179.25 -19.98 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.872 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.37 71.9 1.4 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.126 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 HD11 ' H ' ' A' ' 77' ' ' LEU . 4.5 mp -78.5 -74.67 0.26 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.955 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.98 -39.01 69.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.698 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 89.4 mt -78.99 137.57 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.181 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 83' ' ' SER . 89.0 m-20 -136.57 -29.29 0.96 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 1.0 110.139 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 83' ' ' SER . 97.9 mt -64.41 -42.74 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.757 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.86 -9.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.233 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.2 t -139.98 136.43 33.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 1.0 110.239 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 83' ' ' SER . 18.0 m120 -148.54 -173.07 4.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.827 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 85' ' ' SER . 3.0 p 75.7 99.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.44 77.7 0.13 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 139.78 30.67 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.246 0.461 . . . . 1.0 112.246 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -113.1 125.2 54.11 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.334 -0.987 . . . . 1.0 108.334 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pt -119.02 130.46 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.434 ' CZ ' HH11 ' A' ' 100' ' ' ARG . 20.2 mmt180 -96.26 142.59 28.22 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.9 t -124.93 135.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 1.0 110.197 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -131.47 139.36 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.012 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -165.92 170.3 40.6 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.808 -0.917 . . . . 1.0 110.808 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -69.6 -42.7 74.08 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 122.534 -0.392 . . . . 1.0 111.505 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -65.55 -32.07 73.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 1.0 111.795 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.486 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.3 pt -128.58 139.35 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 110.338 -0.245 . . . . 1.0 110.338 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.41 -57.58 7.98 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.771 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -175.51 108.22 0.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.426 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.508 HH21 ' CD ' ' A' ' 24' ' ' GLU . 85.6 mtp180 -107.05 123.84 48.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.662 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.434 HH11 ' CZ ' ' A' ' 90' ' ' ARG . 94.9 mtt-85 -83.97 146.28 28.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.183 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.17 147.48 36.68 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.241 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.05 152.33 39.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.705 0.288 . . . . 1.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -126.84 102.49 25.07 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.89 -13.06 29.08 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.648 1.565 . . . . 1.0 112.953 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -91.81 105.4 17.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.14 -54.82 42.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.167 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.439 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.55 -38.93 81.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 1.0 110.348 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -36.43 70.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.798 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.0 mt -61.88 -46.28 90.11 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.152 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.85 -44.53 80.77 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.905 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.32 -48.87 76.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.91 -41.66 91.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.552 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.7 m -62.16 -43.46 98.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.831 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.29 -47.32 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.303 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.59 -42.49 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.953 0.406 . . . . 1.0 111.158 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.32 -42.68 91.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.167 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.76 90.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.05 87.9 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.623 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -69.9 -38.31 76.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.97 -46.04 92.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.055 0.455 . . . . 1.0 109.832 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.15 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.48 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.39 -39.07 88.83 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.605 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.451 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.479 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.675 -1.37 . . . . 1.0 109.675 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 34.1 Cg_endo -63.9 -22.42 68.71 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.759 2.306 . . . . 1.0 111.988 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.92 -42.11 99.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.247 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.77 -124.73 36.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.7 m -71.62 159.72 33.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 1.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.2 mtm -63.18 -40.09 96.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.149 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -87.05 151.68 52.11 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.173 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.94 159.76 37.66 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.168 1.912 . . . . 1.0 112.109 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.8 -32.51 77.7 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.749 2.299 . . . . 1.0 112.071 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.6 mt -71.08 150.03 94.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.859 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.76 142.03 61.92 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.914 1.742 . . . . 1.0 111.466 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.32 -32.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.734 -0.667 . . . . 1.0 111.349 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.05 -36.36 90.18 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.7 165.87 21.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 1.0 110.978 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.53 80.67 22.9 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.602 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.23 96.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.676 2.251 . . . . 1.0 112.773 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.3 mt -65.37 -41.43 93.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.83 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.06 146.59 27.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.251 -0.886 . . . . 1.0 110.36 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 t -134.31 131.06 37.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.807 0.337 . . . . 1.0 110.542 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.3 m -137.97 160.79 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.367 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -100.08 154.79 18.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.623 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -169.92 -169.61 33.35 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 23' ' ' MET . 2.5 mpt? -132.2 129.19 39.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 1.0 110.388 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -91.97 117.36 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.44 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.8 mtm -101.49 135.66 42.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.789 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.79 151.47 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.714 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -67.03 0.33 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.667 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.35 -33.77 88.48 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.882 2.388 . . . . 1.0 113.603 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' C ' ' CD1' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.36 -176.61 0.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -122.07 168.45 11.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.11 0.481 . . . . 1.0 110.695 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -155.28 142.41 13.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.737 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.03 143.39 94.97 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.355 1.37 . . . . 1.0 111.257 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 22' ' ' GLY . 12.4 p -153.57 -179.2 7.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.385 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.23 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.936 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.6 mt -101.58 123.77 46.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.5 m -127.43 124.29 38.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.227 0.537 . . . . 1.0 111.357 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.7 tp -91.59 128.93 37.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.016 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.45 148.68 43.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.159 0.504 . . . . 1.0 111.388 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -109.23 123.06 48.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.723 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -135.09 135.81 41.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.967 0.413 . . . . 1.0 111.194 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.13 34.59 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.658 -0.701 . . . . 1.0 111.523 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.4 21.75 76.11 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -129.89 156.76 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -98.54 132.46 43.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -140.79 147.08 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.44 . . . . 1.0 110.065 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -103.99 122.21 44.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.438 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.52 117.76 51.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -99.75 118.41 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -100.03 131.64 45.87 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 52' ' ' GLU . 8.6 mp -105.99 123.34 47.84 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -80.11 36.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.154 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 50' ' ' LEU . 35.0 tp10 -46.47 135.0 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.985 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.4 -35.88 81.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -66.79 -80.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.402 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -132.57 129.28 38.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.933 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -61.94 102.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.922 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.91 131.44 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -107.79 136.57 47.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.956 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 40.6 t0 -101.03 123.5 45.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.5 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.31 119.26 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 1.0 110.3 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.11 119.23 15.52 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.896 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.49 157.21 40.82 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.678 1.586 . . . . 1.0 112.598 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.46 119.67 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.537 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -171.89 -160.06 0.15 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.43 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 t -61.12 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.041 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -64.81 -36.15 83.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.875 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 64' ' ' ASN . 28.2 t80 -95.0 136.87 34.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.968 0.413 . . . . 1.0 110.439 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 92' ' ' GLN . 37.5 ptt180 -143.38 145.99 33.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.904 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 27.5 p -117.0 99.66 7.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.384 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -102.82 124.26 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.032 0.444 . . . . 1.0 110.985 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.649 ' C ' ' H ' ' A' ' 73' ' ' ALA . 9.2 tp-100 -83.14 100.84 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.381 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 63.94 -26.29 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.792 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.649 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . -92.43 -158.79 0.61 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.88 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -133.65 7.18 3.8 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.532 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -170.92 36.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.613 ' CG2' ' H ' ' A' ' 71' ' ' GLN . 7.6 t -94.46 40.46 1.09 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.464 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.4 mt -63.54 -39.56 94.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.514 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 78' ' ' LEU . 3.8 mm? -63.39 -41.28 98.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.659 -0.246 . . . . 1.0 110.565 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' THR . 86.4 mt -116.73 127.55 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.24 0.543 . . . . 1.0 111.228 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 98.5 m-20 -142.52 -39.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.376 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 81' ' ' ILE . 94.4 mt -63.94 -42.47 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.675 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.33 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.029 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -106.9 78.26 1.23 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.099 0.476 . . . . 1.0 110.577 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.67 -170.4 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m 64.59 88.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.69 82.92 0.06 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.56 135.24 41.27 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.834 0.309 . . . . 1.0 111.834 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 65.7 mttp -111.53 128.71 56.1 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.6 pt -125.01 157.35 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.31 134.63 45.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.99 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.46 132.94 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.366 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 98' ' ' GLU . 86.2 mt-30 -135.4 152.79 51.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.024 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -168.08 167.61 40.26 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 95' ' ' TRP . 36.9 p-10 -68.03 -39.54 83.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.791 0.329 . . . . 1.0 111.266 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.528 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 3.2 p-90 -88.42 -9.89 51.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.759 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.457 ' O ' ' O ' ' A' ' 93' ' ' GLY . 14.3 pt -125.13 151.42 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.787 0.327 . . . . 1.0 110.657 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 -95.34 -171.89 2.51 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 1.0 110.765 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 48.5 tp10 -61.01 128.45 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 1.0 110.526 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 99.9 mtt180 -135.35 143.39 46.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.033 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -127.16 145.99 50.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.752 0.31 . . . . 1.0 111.181 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -144.25 153.72 42.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.357 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -143.51 147.35 34.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.972 0.415 . . . . 1.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.03 98.73 26.5 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 -11.29 28.6 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.706 1.604 . . . . 1.0 112.67 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 105.3 17.6 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.09 -53.98 52.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.911 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -50.75 -43.52 58.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.576 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -69.97 -40.21 75.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.879 0.371 . . . . 1.0 110.531 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -57.1 -34.87 68.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.083 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.519 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.48 -44.84 81.56 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.185 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -59.88 -48.67 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.158 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.11 -41.36 86.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.389 -0.525 . . . . 1.0 111.281 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.549 ' HG ' ' H ' ' A' ' 115' ' ' ALA . 78.0 p -65.59 -46.08 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.607 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.549 ' H ' ' HG ' ' A' ' 114' ' ' SER . . . -67.13 -50.05 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.318 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.15 -44.21 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.66 -45.21 95.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.421 . . . . 1.0 110.196 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.42 82.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.452 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.44 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.678 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.508 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 87.3 mt-30 -69.77 -38.6 76.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.407 . . . . 1.0 110.84 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -63.95 -44.46 92.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.039 0.447 . . . . 1.0 110.919 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.95 75.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.866 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.85 -40.51 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 1.0 110.571 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.595 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.23 150.64 87.24 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.743 2.295 . . . . 1.0 112.029 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.51 141.37 48.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.184 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' SER . . . -85.26 177.42 50.5 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 4' ' ' GLY . 66.6 m 51.54 102.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.776 0.322 . . . . 1.0 110.467 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.59 -39.96 95.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.367 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.37 96.99 41.8 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.307 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.35 159.49 17.34 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.232 1.955 . . . . 1.0 112.256 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.7 -32.23 68.61 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.652 2.235 . . . . 1.0 112.025 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.76 144.44 85.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.956 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.64 148.51 53.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.797 1.665 . . . . 1.0 111.841 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.18 -43.15 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.563 . . . . 1.0 111.109 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.5 -36.64 47.79 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.76 151.12 47.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 1.0 110.825 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -118.15 83.57 20.12 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.326 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.56 125.04 16.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.262 1.975 . . . . 1.0 112.431 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.7 mt -101.1 -32.66 10.47 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.428 -0.805 . . . . 1.0 109.632 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.48 151.19 29.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.326 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -146.33 129.17 16.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.859 0.361 . . . . 1.0 110.556 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -141.43 163.15 20.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.259 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -101.37 122.43 43.72 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 33' ' ' CYS . . . -131.54 152.11 19.96 Favored Glycine 0 N--CA 1.464 0.555 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 mmm -99.19 100.66 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.999 0.428 . . . . 1.0 110.187 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.84 126.8 28.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.589 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.441 ' SD ' ' C ' ' A' ' 101' ' ' PHE . 1.6 mpp? -109.85 137.16 48.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.03 149.79 50.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.635 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.28 -66.23 0.3 Allowed Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.915 -0.584 . . . . 1.0 112.633 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.49 -33.28 88.15 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.796 2.331 . . . . 1.0 113.484 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -177.79 -172.51 0.35 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.672 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -122.67 168.87 11.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.047 0.451 . . . . 1.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -154.12 140.87 13.12 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.723 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.22 142.0 84.71 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.267 1.312 . . . . 1.0 111.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 22' ' ' GLY . 13.6 p -150.95 169.23 22.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.551 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.18 118.94 19.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 109.852 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -91.92 126.3 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.012 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.6 m -130.81 120.69 24.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.095 0.474 . . . . 1.0 111.344 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 tp -90.38 130.99 36.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.07 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.81 148.17 32.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.173 0.511 . . . . 1.0 111.362 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.72 127.01 48.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -138.0 138.15 38.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.887 0.375 . . . . 1.0 111.007 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.44 35.22 24.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.662 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.56 27.56 73.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.7 158.95 43.28 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -99.27 130.34 45.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.908 -0.405 . . . . 1.0 109.908 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.27 143.77 34.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.931 0.396 . . . . 1.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.4 125.21 50.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.275 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -103.31 124.6 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mt -99.25 128.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -118.4 119.62 35.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.691 0.282 . . . . 1.0 110.807 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.0 mp -100.58 131.18 46.63 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -94.29 60.53 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 1.0 110.413 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.24 157.6 10.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.183 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.15 -38.74 87.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.754 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 54' ' ' GLU . 56.6 mp0 -78.96 -104.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.226 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -106.52 152.49 23.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -73.3 145.77 45.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.233 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.76 130.7 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.983 0.42 . . . . 1.0 110.303 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -106.53 108.08 19.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.788 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -116.74 113.05 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.633 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.41 115.64 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.387 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.05 120.18 39.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.38 147.89 33.15 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.791 1.661 . . . . 1.0 112.498 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 ' CG2' HE22 ' A' ' 123' ' ' GLN . 96.4 mt -92.8 122.49 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.228 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.6 p30 -174.16 -159.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.353 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -41.25 90.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.2 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -66.06 -36.28 82.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.353 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . 15.1 t80 -101.54 123.63 45.88 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -133.81 141.08 47.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.326 0.584 . . . . 1.0 111.026 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.0 t -103.31 105.87 16.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.245 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -111.07 126.4 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.229 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.43 ' O ' ' OG1' ' A' ' 76' ' ' THR . 48.1 tt0 -97.49 131.1 44.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.492 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 59.49 -100.99 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.374 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.58 170.66 16.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.005 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 80.8 mm-40 -83.4 -10.74 58.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.737 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -82.3 -12.75 57.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.842 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.441 ' O ' ' OG1' ' A' ' 76' ' ' THR . 1.1 p -87.81 42.88 1.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.125 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.419 ' CD2' ' O ' ' A' ' 74' ' ' GLU . 54.6 mt -61.79 -43.02 99.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.109 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -108.34 -9.36 15.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.595 0.236 . . . . 1.0 111.223 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.437 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 76.5 mt -102.4 130.42 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.911 0.386 . . . . 1.0 110.543 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 94.8 m-20 -144.9 -32.75 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.85 -0.613 . . . . 1.0 110.396 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 41.0 mm -64.58 -42.26 94.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.68 -27.02 15.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.815 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 9.5 t -123.81 119.1 28.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.043 0.449 . . . . 1.0 110.314 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 83' ' ' SER . 23.4 m120 -146.73 -167.0 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 1.0 109.827 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.24 92.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.05 67.18 2.18 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 108.892 -1.683 . . . . 1.0 108.892 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 148.95 25.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.221 0.534 . . . . 1.0 111.596 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -129.85 135.83 48.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.335 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 89' ' ' ILE . 45.9 pt -120.33 162.89 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.306 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -123.99 137.52 54.59 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.8 t -116.92 133.84 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.922 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -140.77 152.77 45.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.115 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.42 162.85 35.73 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.552 -1.019 . . . . 1.0 110.552 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -70.97 -47.88 56.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.719 0.295 . . . . 1.0 111.464 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -82.65 -9.68 59.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.898 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 93' ' ' GLY . 33.7 pt -126.74 151.18 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.701 0.286 . . . . 1.0 110.793 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -83.44 164.61 19.8 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.833 0.349 . . . . 1.0 110.946 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -63.46 140.3 58.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -141.03 154.19 45.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.153 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -125.52 154.18 42.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.979 0.419 . . . . 1.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.441 ' C ' ' SD ' ' A' ' 25' ' ' MET . 98.5 m-85 -138.33 158.7 43.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.769 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -144.72 123.45 12.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mm -110.45 96.62 28.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.15 -14.55 28.8 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.536 1.491 . . . . 1.0 112.674 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -94.32 113.66 25.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.974 0.416 . . . . 1.0 110.002 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.03 -55.09 39.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.231 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -52.06 -43.34 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.654 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -68.2 -38.55 82.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.914 0.388 . . . . 1.0 110.131 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.232 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.4 -45.39 91.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.644 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -66.3 -45.41 80.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.974 -0.69 . . . . 1.0 110.703 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.46 -49.61 76.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.284 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.44 -42.56 92.26 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.382 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -63.83 -45.14 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.735 0.303 . . . . 1.0 111.478 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.93 -50.83 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.441 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.68 -46.37 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.03 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.01 -48.02 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 1.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.99 78.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.548 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.24 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.553 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.51 -44.8 85.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -66.21 -43.43 86.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.504 0.668 . . . . 1.0 110.488 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.32 78.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.904 -1.044 . . . . 1.0 111.998 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.483 HE22 ' CG2' ' A' ' 63' ' ' ILE . 6.3 pt20 -72.2 -38.32 69.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.48 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.062 -0.971 . . . . 1.0 110.567 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.357 -1.497 . . . . 1.0 109.357 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.2 144.18 98.83 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.672 2.248 . . . . 1.0 112.102 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.93 145.76 44.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.265 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.562 ' C ' ' H ' ' A' ' 6' ' ' MET . . . -73.56 158.99 52.89 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 t 54.27 3.63 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.608 0.242 . . . . 1.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.562 ' H ' ' C ' ' A' ' 4' ' ' GLY . 10.2 tpp -100.43 -34.97 9.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.893 0.378 . . . . 1.0 110.245 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -44.69 151.93 0.57 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.508 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -38.65 156.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.147 1.898 . . . . 1.0 112.328 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.07 -23.38 73.6 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.532 2.155 . . . . 1.0 111.969 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mp -66.79 149.15 98.53 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.99 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.05 143.9 91.63 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.67 1.58 . . . . 1.0 111.429 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.88 -43.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.178 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.4 51.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.39 137.78 44.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.059 0.457 . . . . 1.0 111.025 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -98.95 108.6 50.11 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.57 103.87 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.532 1.488 . . . . 1.0 112.789 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.88 -43.6 83.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.191 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.21 148.95 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.216 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -138.34 131.36 29.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.765 0.317 . . . . 1.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.21 160.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.158 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -100.1 122.67 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.502 ' O ' ' SG ' ' A' ' 33' ' ' CYS . . . -132.26 158.16 22.82 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 84.1 mmm -99.37 120.88 40.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.887 0.375 . . . . 1.0 110.203 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.85 118.24 24.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.693 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -102.65 137.21 41.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.07 152.86 52.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.266 -0.425 . . . . 1.0 109.982 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.38 -66.48 0.36 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.894 -0.593 . . . . 1.0 112.506 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.22 -32.92 73.34 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.747 2.298 . . . . 1.0 113.877 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.29 -170.3 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 121.105 -0.238 . . . . 1.0 110.385 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -124.71 169.28 12.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.962 0.41 . . . . 1.0 110.25 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 9.3 pt-20 -153.57 133.19 7.33 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.797 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.29 142.56 78.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 CA-C-N 120.245 1.123 . . . . 1.0 111.34 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 22' ' ' GLY . 8.9 p -152.1 -170.18 3.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.526 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.8 131.3 8.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.293 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -100.84 123.16 44.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.088 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.4 m -126.34 112.33 15.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.298 0.57 . . . . 1.0 111.723 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.47 127.75 32.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.378 -0.828 . . . . 1.0 109.086 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.06 148.28 36.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.441 . . . . 1.0 111.445 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -102.42 128.99 48.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.901 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -139.9 136.97 34.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.931 0.396 . . . . 1.0 110.872 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 m120 59.18 33.78 22.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.513 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.93 22.56 78.38 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.655 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 48.4 tp60 -132.58 157.13 45.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.655 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 81.0 m-85 -96.3 131.84 42.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -144.06 143.88 31.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 1.0 110.404 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.1 tp -104.2 124.96 50.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.257 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 47' ' ' ILE . 80.8 mt -100.12 124.81 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.118 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.9 mt -96.53 117.54 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -109.15 130.58 55.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.003 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.94 127.76 52.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 76.2 t60 -93.8 25.39 3.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.9 mt-10 -55.02 137.55 46.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.45 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -62.72 -39.7 94.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.26 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -53.47 -51.18 63.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.913 0.387 . . . . 1.0 110.18 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -166.72 148.21 6.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.767 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.03 86.8 6.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.869 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 t -80.81 133.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.539 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -128.29 119.28 24.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.744 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.37 129.64 55.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -96.41 114.66 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.775 0.321 . . . . 1.0 110.273 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.03 121.37 35.32 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.18 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 155.48 42.57 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.987 1.792 . . . . 1.0 112.628 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 63' ' ' ILE . 98.0 mt -98.13 112.79 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.373 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 78.6 m-20 -161.68 -160.67 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.6 t -60.35 -41.94 94.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -66.17 -36.75 83.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.021 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -93.03 124.09 36.76 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.823 0.344 . . . . 1.0 110.16 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.49 141.75 45.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.289 0.566 . . . . 1.0 110.769 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.507 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 26.6 p -113.46 99.7 7.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.222 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -109.45 128.46 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.448 . . . . 1.0 111.049 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.636 HE21 ' N ' ' A' ' 88' ' ' LYS . 34.1 tp60 -80.77 116.86 20.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' GLN . 17.7 pt-20 32.77 38.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.645 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 71' ' ' GLN . . . -159.2 -156.67 0.54 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.732 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -129.31 17.15 6.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.375 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 77' ' ' LEU . 5.8 pt-20 -161.17 -111.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.624 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 76' ' ' THR . 89.5 m 38.86 28.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.629 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 75' ' ' GLU . 85.8 mt -65.63 -39.01 91.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 1.0 111.334 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.57 -40.59 97.36 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.648 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 76' ' ' THR . 35.1 mm -109.33 129.24 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.065 0.46 . . . . 1.0 111.025 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -137.69 -27.81 0.92 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.181 0.515 . . . . 1.0 110.077 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 81' ' ' ILE . 93.6 mt -63.65 -42.61 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.693 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.82 -26.01 44.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.126 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.53 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 5.7 t -104.28 102.61 12.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 83' ' ' SER . 9.8 m120 -136.27 -168.94 2.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.994 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 m 62.13 82.58 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.17 77.35 0.26 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 132.64 37.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.798 0.332 . . . . 1.0 111.751 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.636 ' N ' HE21 ' A' ' 71' ' ' GLN . 98.8 mttt -110.22 129.49 55.71 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.5 pt -126.83 160.15 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -130.52 133.96 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.482 . . . . 1.0 109.849 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.2 t -114.54 134.55 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.418 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.43 154.96 41.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.327 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.11 167.0 37.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.54 -43.17 94.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.607 0.241 . . . . 1.0 111.608 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -90.48 -6.54 54.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.181 0.437 . . . . 1.0 112.181 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 93' ' ' GLY . 19.3 pt -126.97 152.76 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.4 162.11 15.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.828 0.347 . . . . 1.0 110.879 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -59.66 137.63 57.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.468 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.43 154.53 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.082 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -124.74 150.97 45.66 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.185 0.517 . . . . 1.0 111.394 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -143.83 156.86 44.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.43 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -148.56 118.67 7.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.048 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.62 99.8 12.55 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.83 -11.82 28.03 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.542 1.495 . . . . 1.0 112.887 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -91.42 106.19 18.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.98 -52.91 63.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.091 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -52.24 -43.83 64.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.406 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.47 -38.96 77.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.0 110.564 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -35.22 71.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.024 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -45.33 93.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.306 -0.558 . . . . 1.0 111.148 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.77 -43.22 84.6 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.787 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -61.1 -49.39 77.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.077 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.24 -42.02 89.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.472 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 m -63.12 -45.38 92.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 1.0 111.317 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.55 -49.03 67.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.33 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.46 -45.65 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.977 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -60.98 -45.1 96.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.034 0.445 . . . . 1.0 110.148 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.22 -37.76 86.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.459 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.18 -49.99 73.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.679 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.503 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 92.3 mt-30 -70.69 -38.07 73.68 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.227 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.72 -43.09 94.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.007 0.432 . . . . 1.0 110.517 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.6 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.33 -35.82 68.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 1.0 110.752 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.019 -0.991 . . . . 1.0 110.476 -179.905 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 32.3 Cg_endo -63.44 -25.17 70.71 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.682 2.255 . . . . 1.0 112.152 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.7 mt 53.13 -171.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.08 24.36 76.61 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.9 m -66.19 143.59 57.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 1.0 110.533 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.9 mmm -82.78 148.08 28.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.116 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -41.01 103.93 0.32 Allowed Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.765 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -83.6 159.66 14.47 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.182 1.921 . . . . 1.0 112.241 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.99 -32.8 43.74 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.657 2.238 . . . . 1.0 111.986 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.38 84.01 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.774 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.583 ' CD ' HE22 ' A' ' 58' ' ' GLN . 24.4 Cg_endo -59.51 140.48 94.22 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.857 1.705 . . . . 1.0 111.542 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.89 -43.79 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.215 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -37.34 -38.88 0.44 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.38 -0.688 . . . . 1.0 111.38 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.28 147.95 41.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.722 0.296 . . . . 1.0 110.538 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -98.2 102.43 14.01 Favored Pre-proline 0 C--O 1.223 -0.338 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -75.28 103.14 1.68 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.5 1.467 . . . . 1.0 113.522 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.1 mt -67.12 -41.84 85.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.178 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 155.31 40.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.259 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -143.49 130.64 20.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.42 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 47.9 t -141.31 159.08 22.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.698 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 83.0 tt0 -104.55 121.13 42.86 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -123.56 -169.51 13.22 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.837 -0.905 . . . . 1.0 110.837 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 89.3 mmm -136.94 101.47 4.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.87 0.367 . . . . 1.0 110.037 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.578 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.0 tt0 -61.05 128.8 38.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.609 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -106.01 136.38 45.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.312 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -135.64 151.91 50.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.72 -68.15 0.29 Allowed Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.74 -0.664 . . . . 1.0 112.605 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.93 -32.47 92.54 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.864 2.376 . . . . 1.0 113.553 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -179.85 -167.01 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.344 -0.243 . . . . 1.0 110.344 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -122.46 168.5 12.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.888 0.375 . . . . 1.0 110.201 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -146.21 138.73 13.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.653 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.34 139.63 73.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 CA-C-N 120.171 1.097 . . . . 1.0 111.418 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.578 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 17.2 p -153.65 177.68 10.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.56 138.72 23.63 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.905 0.383 . . . . 1.0 110.122 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' A' ' 35' ' ' LEU . 5.5 mp -102.62 120.57 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 1.0 109.999 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -127.31 113.17 15.92 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.28 0.562 . . . . 1.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 tp -86.48 127.51 34.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.434 -0.803 . . . . 1.0 108.975 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.94 156.56 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.16 0.505 . . . . 1.0 111.484 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -113.87 122.65 47.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.608 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -133.32 137.89 46.15 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.886 0.374 . . . . 1.0 110.919 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 59.13 34.17 23.18 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.606 -0.725 . . . . 1.0 111.513 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.77 25.34 75.22 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.771 -0.931 . . . . 1.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -134.09 153.33 51.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -93.53 134.9 35.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.02 143.79 31.35 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.963 0.411 . . . . 1.0 110.264 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.0 tp -103.46 116.56 32.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.356 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.8 mt -109.69 115.78 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 101' ' ' PHE . 60.2 mt -106.57 116.9 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -81.27 128.43 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.705 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 mp -110.4 130.26 55.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.615 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.623 ' N ' ' ND1' ' A' ' 51' ' ' HIS . 0.9 OUTLIER -94.53 54.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.218 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -46.61 150.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.55 -39.97 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.33 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -62.95 -46.13 89.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.133 0.492 . . . . 1.0 110.488 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -168.9 -158.98 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.796 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.01 115.11 28.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.893 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.76 138.13 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.169 0.509 . . . . 1.0 110.499 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.583 HE22 ' CD ' ' A' ' 11' ' ' PRO . 17.3 pt20 -97.56 141.42 30.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -102.06 115.18 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.738 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.8 mm -92.82 101.42 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.923 0.392 . . . . 1.0 110.092 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 61' ' ' ILE . 33.8 mm -117.63 90.21 34.96 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.143 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.14 146.48 88.04 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 1.0 112.407 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 96.6 mt -93.28 115.43 32.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 63' ' ' ILE . 80.7 m-20 -163.58 -166.75 1.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.177 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -33.24 74.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.223 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.461 ' ND1' ' OD1' ' A' ' 94' ' ' ASP . 6.2 p80 -76.2 -12.48 60.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.743 0.306 . . . . 1.0 111.17 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.407 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 32.9 t80 -114.06 130.05 56.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.052 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.68 145.08 44.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.4 t -121.55 106.04 11.01 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.399 -0.818 . . . . 1.0 109.2 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 m -107.36 125.37 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.729 0.3 . . . . 1.0 110.762 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.439 HE22 ' N ' ' A' ' 88' ' ' LYS . 9.3 tp-100 -99.1 115.88 30.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.339 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 37.74 57.04 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.7 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' ' OG1' ' A' ' 76' ' ' THR . . . -176.14 162.99 2.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.082 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -68.74 -37.41 79.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.595 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -170.23 80.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.605 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 79' ' ' ILE . 14.6 m -118.02 59.65 0.79 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.172 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.9 -35.45 80.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.301 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.09 -42.05 99.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.335 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' THR . 89.6 mt -119.12 129.32 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.24 0.543 . . . . 1.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 99.9 m-20 -142.63 -33.95 0.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.531 -0.758 . . . . 1.0 109.955 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.503 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 95.8 mt -64.04 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.67 -24.92 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.945 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 m -102.6 59.54 0.8 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.844 0.354 . . . . 1.0 110.429 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.7 m120 -82.65 -171.63 3.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.145 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m 66.69 87.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.04 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.12 79.04 0.11 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 139.8 30.84 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.921 0.391 . . . . 1.0 111.754 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.439 ' N ' HE22 ' A' ' 71' ' ' GLN . 22.3 pttp -126.83 134.14 50.6 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 89' ' ' ILE . 50.3 pt -126.18 161.24 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.231 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.95 138.14 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.697 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -117.46 133.96 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.448 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -136.91 134.65 37.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.046 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 123.07 -158.23 17.67 Favored Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 96' ' ' ILE . 94.8 m-20 43.9 -165.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.633 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -70.04 20.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 1.0 112.101 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.51 ' H ' ' C ' ' A' ' 94' ' ' ASP . 21.0 pt -130.53 133.61 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.898 0.38 . . . . 1.0 110.628 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -73.38 -44.58 58.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.468 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -174.75 126.22 0.29 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.438 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -137.76 123.66 20.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -89.98 151.15 21.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.925 0.393 . . . . 1.0 111.24 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 48' ' ' ILE . 67.6 m-85 -136.53 148.62 47.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.26 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.95 144.32 45.36 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 1.0 110.753 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.2 mm -129.41 90.37 44.6 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.27 -17.82 44.76 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 1.0 112.762 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -88.88 108.67 19.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.69 -0.485 . . . . 1.0 109.69 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.91 -53.18 50.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.068 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -53.18 -40.9 64.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.664 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -73.0 -35.88 66.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 1.0 110.396 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.9 t -60.73 -34.24 74.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.901 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.8 -44.79 95.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.425 -0.51 . . . . 1.0 111.352 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.84 -43.67 83.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.969 -0.692 . . . . 1.0 110.189 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.22 -49.03 79.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.353 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -65.89 -41.62 91.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.269 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.3 t -63.31 -44.74 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.235 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.87 -50.32 64.94 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.359 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.21 -44.15 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.26 -45.75 92.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 1.0 110.225 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.14 86.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.549 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.7 79.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.809 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.29 -37.62 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 1.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -60.37 -44.51 95.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.029 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.59 94.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.49 -40.2 92.79 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.792 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.222 -0.386 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.386 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.97 -35.67 81.41 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.768 2.312 . . . . 1.0 112.144 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 77.5 mt -62.52 -41.71 99.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.28 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.97 173.76 53.48 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.741 -0.944 . . . . 1.0 110.741 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 t -152.54 151.34 30.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.901 0.382 . . . . 1.0 110.695 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.2 ttm 49.83 -129.9 2.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.501 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -138.73 95.57 9.81 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.059 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.45 159.08 19.66 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.04 1.827 . . . . 1.0 112.216 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.42 -32.61 60.06 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.56 2.174 . . . . 1.0 111.989 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.7 mt -70.2 135.41 86.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.064 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.91 147.58 68.61 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.686 1.59 . . . . 1.0 111.68 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -70.02 -32.39 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.156 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.23 94.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.56 141.83 44.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 1.0 110.778 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.535 HE21 ' NE2' ' A' ' 39' ' ' GLN . 10.3 mt-30 -101.67 100.34 14.03 Favored Pre-proline 0 C--O 1.224 -0.283 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.38 103.15 1.69 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.523 1.482 . . . . 1.0 112.83 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.76 -43.34 89.18 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.131 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.87 151.65 37.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.237 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -141.42 128.08 20.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.452 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 21' ' ' GLU . 53.3 t -141.59 160.7 21.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.926 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 55.7 mp0 -103.55 121.96 43.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -124.99 -173.37 13.69 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 25' ' ' MET . 90.7 mmm -131.26 107.31 8.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 1.0 110.125 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 99' ' ' ARG . 84.8 tt0 -76.19 126.48 31.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.644 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.532 ' N ' ' SD ' ' A' ' 25' ' ' MET . 0.9 OUTLIER -116.04 139.82 49.89 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.634 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.68 150.4 50.62 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 1.0 109.865 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.9 -65.6 0.47 Allowed Glycine 0 CA--C 1.533 1.188 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.665 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.52 -32.36 88.05 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 122.732 2.288 . . . . 1.0 113.786 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.78 -179.56 0.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 121.032 -0.267 . . . . 1.0 110.465 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -125.14 169.21 12.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.053 0.454 . . . . 1.0 110.787 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -157.92 143.43 12.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.426 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.64 144.23 93.82 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.264 1.309 . . . . 1.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.5 p -149.14 173.67 13.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.403 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.7 129.1 34.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.01 0.433 . . . . 1.0 110.182 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 3.8 mm? -97.4 118.21 33.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -129.84 113.82 15.15 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.166 0.507 . . . . 1.0 111.56 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.4 tp -85.98 129.8 34.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.464 -0.789 . . . . 1.0 109.047 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.12 156.96 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.999 0.428 . . . . 1.0 111.283 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.535 ' NE2' HE21 ' A' ' 15' ' ' GLN . 1.2 tm0? -119.47 119.62 34.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -127.31 137.19 52.76 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.977 0.418 . . . . 1.0 110.913 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 58.86 32.38 22.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.498 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.21 18.45 78.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.641 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 41.3 tp60 -125.51 140.44 52.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.113 -0.328 . . . . 1.0 110.113 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.641 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 69.9 m-85 -80.27 135.72 36.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.51 140.28 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.355 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.5 tp -104.34 126.13 51.18 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.311 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.8 mt -104.37 121.18 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.983 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.7 115.45 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -105.65 130.94 53.57 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.879 0.371 . . . . 1.0 110.931 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.16 128.41 53.89 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -90.13 62.5 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.331 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 55' ' ' GLN . 97.9 mt-10 -60.85 146.22 47.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.36 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.52 -39.55 93.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.086 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -63.23 -41.07 99.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' GLU . 15.8 pt20 -172.39 -156.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -127.34 127.97 45.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.975 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.79 130.69 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.171 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -102.58 116.26 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.987 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -102.05 113.26 26.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.521 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -94.61 111.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 1.0 110.524 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 61' ' ' ILE . 30.1 mm -113.68 120.29 39.67 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.089 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.6 148.1 36.75 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.792 1.661 . . . . 1.0 112.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.0 mt -92.58 122.97 44.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.444 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -172.22 -160.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.266 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.507 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 78.0 p -61.53 -40.01 93.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -68.51 -32.51 72.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.682 0.277 . . . . 1.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.8 t80 -95.4 126.14 40.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.044 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 65' ' ' SER . 84.4 mtt85 -137.75 145.91 43.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.2 0.524 . . . . 1.0 110.874 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.2 t -122.33 117.89 27.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.064 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 4.8 m -118.36 125.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.756 0.312 . . . . 1.0 110.462 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.1 tp-100 -83.68 123.78 30.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.441 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 49.32 -101.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.96 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.89 150.61 48.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.679 . . . . 1.0 110.982 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 80.5 mm-40 -74.55 -6.4 48.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.739 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -80.65 -9.17 59.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.971 0.415 . . . . 1.0 110.968 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 76' ' ' THR . 1.3 p -100.03 46.69 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.219 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.455 ' CD2' ' O ' ' A' ' 74' ' ' GLU . 49.1 mt -62.16 -44.4 96.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.11 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.17 -10.5 17.89 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.732 -0.213 . . . . 1.0 110.774 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 79' ' ' ILE . 81.8 mt -102.32 132.44 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.997 0.427 . . . . 1.0 110.8 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 98.5 m-20 -141.57 -38.7 0.4 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.039 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.523 ' C ' ' H ' ' A' ' 83' ' ' SER . 93.8 mt -64.23 -43.18 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.691 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.0 -11.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.156 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.533 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 30.7 t -133.18 135.15 44.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.009 0.433 . . . . 1.0 110.157 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.7 m120 -146.25 -176.76 5.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.911 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t 72.04 89.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.24 80.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.74 133.61 36.93 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.1 mttt -109.95 113.21 25.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.463 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 2.1 pp -117.51 128.81 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -103.39 146.16 28.9 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.46 133.7 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.897 0.379 . . . . 1.0 110.639 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -136.19 137.95 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.182 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 179.27 -175.28 47.03 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 65.1 t0 -64.7 -40.99 96.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.858 0.361 . . . . 1.0 111.384 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -60.83 -37.07 80.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.733 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' GLY . 38.1 pt -138.51 140.69 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.679 0.276 . . . . 1.0 110.607 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.432 ' CG ' ' N ' ' A' ' 98' ' ' GLU . 35.8 ptt-85 -71.7 -46.91 57.22 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.511 -0.476 . . . . 1.0 110.753 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' ARG . 48.5 tp10 -175.04 121.45 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.874 0.368 . . . . 1.0 110.228 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.514 ' NE ' ' OE2' ' A' ' 24' ' ' GLU . 81.0 mtp180 -138.08 124.35 20.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -87.76 149.2 24.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.933 0.396 . . . . 1.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -141.08 148.28 39.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.286 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -144.31 134.44 24.19 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.369 . . . . 1.0 111.074 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.68 99.72 48.52 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 -13.05 31.08 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.504 1.469 . . . . 1.0 112.768 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -90.72 103.04 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -53.51 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 1.0 112.207 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -53.04 -43.77 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.549 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -69.56 -36.68 76.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.908 0.385 . . . . 1.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.4 t -60.13 -36.2 76.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.0 mt -62.53 -44.31 96.66 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.103 -0.639 . . . . 1.0 111.28 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.11 -45.98 75.57 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.749 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.99 -49.01 76.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.818 . . . . 1.0 111.567 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.77 -41.36 92.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.221 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.3 -45.89 75.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.306 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.09 -46.84 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.768 0.318 . . . . 1.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -43.46 98.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.474 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.63 88.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.94 -49.22 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.622 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -69.68 -38.41 77.01 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.189 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.997 0.427 . . . . 1.0 110.624 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.21 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.624 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -72.88 -40.24 65.76 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.844 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.665 179.897 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.611 -1.396 . . . . 1.0 109.611 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.59 147.22 95.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.803 2.335 . . . . 1.0 112.125 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.65 -41.26 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.258 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.28 170.91 43.29 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.6 m -81.27 -6.44 58.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 1.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 50.0 ttp -82.94 130.81 35.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.815 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -51.96 151.45 6.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.414 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.99 160.12 43.55 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.15 1.9 . . . . 1.0 112.056 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.26 -31.7 73.8 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.745 2.297 . . . . 1.0 112.134 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -66.51 144.38 98.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.834 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.69 142.43 63.92 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.711 1.608 . . . . 1.0 111.464 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 p -72.16 -32.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.275 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.31 93.75 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.01 144.58 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 1.0 111.101 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.37 107.15 33.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.58 102.81 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.457 1.438 . . . . 1.0 112.757 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.03 -43.82 86.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.102 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 154.13 35.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.273 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -142.81 132.5 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 1.0 110.529 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.0 152.3 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.043 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -107.84 121.9 45.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.747 -0.66 . . . . 1.0 109.317 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.21 -158.76 9.67 Favored Glycine 0 N--CA 1.462 0.4 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -131.14 131.2 43.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.066 0.46 . . . . 1.0 110.658 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.566 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 25.9 tp10 -91.68 126.53 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.4 mtm -113.67 135.63 53.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.633 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -141.48 149.27 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.237 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -36.39 -64.91 0.56 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 115.745 -0.662 . . . . 1.0 112.762 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.18 -32.79 94.98 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.885 2.39 . . . . 1.0 113.973 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 178.97 177.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 121.163 -0.215 . . . . 1.0 110.645 179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -122.05 169.23 11.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.05 0.452 . . . . 1.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.32 144.24 9.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.38 146.77 81.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.091 1.068 . . . . 1.0 111.412 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 31.8 p -153.16 -178.22 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.526 -0.307 . . . . 1.0 110.4 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.04 145.18 24.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.643 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 44.6 mt -115.2 116.45 28.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -121.56 114.58 21.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.32 0.581 . . . . 1.0 111.559 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 tp -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.308 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.18 149.64 41.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.066 0.46 . . . . 1.0 111.393 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -104.07 128.38 51.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.665 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -140.62 137.06 33.35 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.749 -0.381 . . . . 1.0 110.895 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 58.79 33.02 22.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.695 -0.684 . . . . 1.0 111.591 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.95 77.09 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.61 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 46.5 tp60 -132.34 157.57 44.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.61 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 86.8 m-85 -99.16 134.43 42.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.043 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -146.22 141.9 27.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.845 0.355 . . . . 1.0 110.336 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.7 tp -104.86 125.05 50.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.631 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.3 mt -98.95 121.71 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.9 mt -107.21 124.76 63.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.477 ' NE2' ' HE2' ' A' ' 56' ' ' HIS . 74.0 mt-30 -114.88 122.76 47.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.963 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 52' ' ' GLU . 9.9 mp -105.15 128.37 53.35 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.23 45.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.21 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 50' ' ' LEU . 39.6 tp10 -41.77 146.52 0.25 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.403 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -61.6 -39.28 90.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.292 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -59.0 -47.6 84.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.965 0.412 . . . . 1.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -174.4 -162.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.477 ' HE2' ' NE2' ' A' ' 49' ' ' GLN . 54.5 t60 -97.19 81.47 3.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.061 0.458 . . . . 1.0 109.834 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.77 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.528 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -108.64 116.97 32.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.517 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -100.45 132.58 45.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.95 110.85 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.814 0.34 . . . . 1.0 110.139 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 61' ' ' ILE . 34.0 mm -115.09 108.73 47.75 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.238 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 151.23 38.21 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.639 1.559 . . . . 1.0 112.571 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.1 mt -95.08 124.33 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.616 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.691 HD22 ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -172.04 -150.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 1.0 109.847 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -72.37 -39.93 67.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 1.0 112.083 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.691 ' CG ' HD22 ' A' ' 64' ' ' ASN . 2.4 p80 -74.61 -16.85 60.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.788 0.328 . . . . 1.0 111.318 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 61.1 t80 -102.46 123.72 46.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.87 142.51 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.323 0.583 . . . . 1.0 110.853 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.33 106.67 10.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.212 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.59 129.63 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.053 0.454 . . . . 1.0 111.381 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.0 tp-100 -80.38 100.58 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.471 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 39.16 56.42 2.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.476 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.75 -170.32 2.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.874 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -101.96 -28.7 12.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.439 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -166.08 92.34 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.666 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 79' ' ' ILE . 6.5 t -138.47 42.18 2.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.125 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.6 -40.73 97.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.338 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 78' ' ' LEU . 3.7 mm? -65.05 -39.58 93.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.626 -0.261 . . . . 1.0 110.484 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.423 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 17.2 mm -102.76 121.64 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.047 0.451 . . . . 1.0 110.91 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 97.5 m-20 -143.86 -39.88 0.29 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.271 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.88 -42.62 96.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.678 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.79 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.085 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 11.7 t -109.58 119.8 40.52 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 83' ' ' SER . 13.0 m120 -148.02 -175.19 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.078 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.75 88.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.64 71.78 0.79 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.47 139.29 30.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.952 0.406 . . . . 1.0 111.675 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 52.1 mtpt -116.73 129.33 56.05 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.31 160.14 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -130.23 143.03 50.54 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.913 0.387 . . . . 1.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.11 133.25 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.908 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.74 152.47 42.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -166.23 166.42 38.78 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.68 -41.71 95.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.627 0.251 . . . . 1.0 111.198 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -90.55 -8.57 49.91 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.178 0.436 . . . . 1.0 112.178 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 93' ' ' GLY . 18.1 pt -126.72 152.06 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 110.141 -0.318 . . . . 1.0 110.141 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -94.58 166.95 11.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.745 0.307 . . . . 1.0 110.652 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -57.25 135.22 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 1.0 110.778 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.71 136.52 40.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.488 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 77.4 mtp180 -106.71 139.5 41.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.225 0.536 . . . . 1.0 110.944 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 85.1 m-85 -133.92 152.1 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.198 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.99 127.03 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.907 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.79 89.47 7.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.21 -15.65 35.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.787 1.658 . . . . 1.0 112.777 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.32 106.64 18.63 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -60.81 -53.43 57.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.028 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -52.94 -43.74 66.54 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.628 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 59.1 m170 -68.57 -36.74 79.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.484 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -63.3 -34.59 78.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.787 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.37 -46.25 89.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.387 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.63 -42.98 81.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.66 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -61.82 -49.05 77.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.104 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.7 -41.57 95.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.474 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 115' ' ' ALA . 77.8 p -63.57 -44.5 93.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.903 0.382 . . . . 1.0 111.164 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.494 ' H ' ' HG ' ' A' ' 114' ' ' SER . . . -65.9 -48.04 72.8 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.251 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.67 -42.22 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.828 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.49 -44.66 89.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.997 0.427 . . . . 1.0 110.077 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.69 91.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.435 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.814 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -67.88 -39.83 83.62 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.021 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.76 -45.32 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.029 0.442 . . . . 1.0 110.1 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -67.99 -39.67 83.22 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.722 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.454 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.564 -1.415 . . . . 1.0 109.564 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.88 -23.25 68.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.644 2.229 . . . . 1.0 112.029 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.07 -40.88 98.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.421 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.64 9.92 82.37 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.896 -0.881 . . . . 1.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 m -72.7 150.76 42.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 1.0 110.549 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.6 ttp -80.85 139.73 35.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.494 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -42.58 151.35 0.38 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.543 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 159.28 48.61 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.104 1.869 . . . . 1.0 112.011 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.39 -31.64 72.5 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.75 2.3 . . . . 1.0 111.925 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.39 166.37 11.34 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.94 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.56 148.39 92.45 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.642 1.561 . . . . 1.0 111.561 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.12 -45.05 95.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.15 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.4 -29.97 76.55 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.231 -0.747 . . . . 1.0 111.231 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.76 58.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 1.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -109.4 108.36 59.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 128.13 11.08 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.643 1.562 . . . . 1.0 112.765 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -100.86 -38.85 8.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.713 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.62 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.105 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -143.34 137.73 28.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.794 0.331 . . . . 1.0 110.512 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.6 146.92 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.981 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -108.76 122.16 46.57 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -140.32 -158.06 7.44 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 16.7 mmm -127.97 129.06 46.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.909 0.385 . . . . 1.0 110.432 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.63 118.77 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.24 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.1 mtm -97.8 136.22 38.45 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.508 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.24 151.84 51.5 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.19 -64.93 0.45 Allowed Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.954 -0.567 . . . . 1.0 112.704 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.35 -34.05 56.44 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.725 2.283 . . . . 1.0 113.746 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.75 -173.41 0.6 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.321 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -121.29 168.36 11.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.9 0.381 . . . . 1.0 110.465 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.13 141.35 13.47 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.742 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.97 145.44 74.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 CA-C-N 120.221 1.115 . . . . 1.0 111.52 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 22' ' ' GLY . 11.5 p -158.97 -176.24 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.608 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.76 134.48 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.182 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.8 mt -104.18 128.08 51.84 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.003 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -125.02 123.26 39.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.246 0.546 . . . . 1.0 111.522 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.1 tp -89.42 127.18 35.8 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.236 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.79 150.11 39.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.133 0.492 . . . . 1.0 111.434 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -106.0 123.88 48.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -134.47 131.27 37.88 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 1.0 110.742 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 m120 61.09 34.6 19.04 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.684 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.35 75.81 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -134.77 149.6 50.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -94.67 134.09 37.63 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.59 147.67 34.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.874 0.369 . . . . 1.0 110.432 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 46' ' ' LEU . 4.4 tt -108.4 120.54 42.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.068 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.8 mt -99.07 128.04 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -95.05 119.78 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -107.54 129.95 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.033 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 mp -109.5 136.34 49.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -95.45 20.18 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.113 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -48.28 138.32 9.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.271 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -63.19 -38.62 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.414 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.87 -52.17 65.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 1.0 110.31 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -172.32 155.14 3.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -82.92 102.64 11.82 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 1.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.57 134.2 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -122.16 108.22 13.06 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.658 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -101.51 125.67 48.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.647 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mm -92.39 105.96 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.09 108.29 48.47 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.044 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.27 145.11 34.06 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.658 1.572 . . . . 1.0 112.449 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.5 123.63 38.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -174.9 -162.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 -40.48 86.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.143 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -65.52 -39.81 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.02 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.77 122.56 35.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.206 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -140.31 111.42 7.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.235 0.541 . . . . 1.0 110.927 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.8 p -102.54 111.61 23.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.033 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -116.0 129.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.98 0.419 . . . . 1.0 110.76 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.654 HE22 ' ND2' ' A' ' 84' ' ' ASN . 50.9 tt0 -75.28 120.45 20.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 48.5 -86.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 71' ' ' GLN . . . -71.48 152.81 42.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.551 -0.75 . . . . 1.0 110.804 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.42 -33.96 76.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.566 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 77' ' ' LEU . 80.5 mm-40 -54.9 -70.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.069 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 79' ' ' ILE . 7.1 m 73.54 -26.6 0.19 Allowed 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.98 0.8 . . . . 1.0 110.546 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.547 ' H ' ' C ' ' A' ' 75' ' ' GLU . 51.4 mt -65.44 -41.5 93.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.85 -0.613 . . . . 1.0 111.316 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.83 -41.19 87.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.532 -0.303 . . . . 1.0 110.818 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' THR . 49.7 mm -120.12 130.73 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.011 0.434 . . . . 1.0 110.848 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -173.11 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.081 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.445 HG22 HD12 ' A' ' 81' ' ' ILE . 34.8 mm -113.94 -37.08 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.449 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -47.35 82.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.889 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 t -140.12 139.77 35.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.874 0.369 . . . . 1.0 110.519 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.654 ' ND2' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -158.15 36.99 0.25 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.525 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -83.95 112.8 20.49 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 48.32 82.5 0.03 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.212 -1.555 . . . . 1.0 109.212 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.485 ' CB ' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -115.2 150.25 36.4 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.221 0.534 . . . . 1.0 111.573 -177.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 151.47 33.56 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.51 169.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.53 HH21 ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -139.21 126.1 20.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.027 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 130.69 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -152.63 153.33 33.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.11 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.22 163.65 36.16 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -64.19 -42.45 96.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.772 0.32 . . . . 1.0 111.457 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -84.94 -7.71 59.05 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.869 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 93' ' ' GLY . 8.8 pt -125.24 161.6 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.766 0.317 . . . . 1.0 110.419 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -98.37 -179.82 4.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.815 0.341 . . . . 1.0 110.807 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' CD ' HH21 ' A' ' 90' ' ' ARG . 80.6 tt0 -60.46 131.44 50.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.0 110.649 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -137.64 135.41 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.572 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -129.61 149.94 51.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.031 0.444 . . . . 1.0 111.601 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -144.71 161.03 40.22 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.333 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -145.26 139.64 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.919 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.28 101.08 31.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.04 -12.04 21.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.605 1.537 . . . . 1.0 112.618 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.61 111.53 23.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.34 -51.25 70.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.611 0.597 . . . . 1.0 112.611 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -55.13 -38.95 68.89 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.424 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -77.45 -33.8 54.67 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.74 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -53.98 52.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.373 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.55 -39.47 94.48 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.908 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.14 -44.81 91.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.661 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.59 -52.84 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.868 -0.605 . . . . 1.0 111.318 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.586 ' CD1' ' NE2' ' A' ' 71' ' ' GLN . 30.4 mt -66.54 -40.75 89.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.2 t -62.5 -44.34 96.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.678 0.275 . . . . 1.0 111.42 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.81 -49.66 61.09 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.531 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.25 -43.63 91.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.117 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.33 -46.75 88.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.889 0.376 . . . . 1.0 110.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.2 -29.85 70.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.49 92.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.09 -43.16 99.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.819 0.342 . . . . 1.0 111.626 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.77 -43.56 98.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.521 0.677 . . . . 1.0 109.916 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.8 87.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.859 -1.064 . . . . 1.0 111.21 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -65.63 -43.55 89.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.676 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.043 -0.979 . . . . 1.0 110.608 179.915 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.461 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.65 -1.38 . . . . 1.0 109.65 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 50.0 Cg_exo -54.39 -36.62 87.98 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.751 2.3 . . . . 1.0 112.032 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.1 mt -95.43 129.67 42.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.397 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.42 -177.35 42.6 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.3 t -61.32 -41.85 97.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.073 0.463 . . . . 1.0 110.689 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.9 mtp -77.67 144.61 37.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.654 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -52.44 152.28 6.52 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.434 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.58 160.38 44.29 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.235 1.957 . . . . 1.0 111.967 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.11 -32.52 91.48 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.668 2.245 . . . . 1.0 111.986 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -60.78 140.75 93.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.93 144.66 77.51 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.765 1.643 . . . . 1.0 111.587 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.06 -43.01 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.071 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.99 -37.67 45.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.161 -0.775 . . . . 1.0 111.161 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 143.98 56.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 1.0 110.962 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.38 79.9 0.42 Allowed Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 108.882 -0.784 . . . . 1.0 108.882 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.7 96.45 0.14 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.819 1.679 . . . . 1.0 113.157 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.69 -41.92 91.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.269 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.15 40.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.107 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -140.08 131.94 27.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.557 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.4 m -139.37 159.17 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.255 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -113.56 121.86 45.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.0 178.6 17.83 Favored Glycine 0 N--CA 1.463 0.47 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.8 mtp -118.18 102.89 9.35 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.798 0.332 . . . . 1.0 110.477 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.39 122.45 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.476 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 76.8 mtm -105.47 137.58 43.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.487 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.74 151.24 50.82 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.39 -67.2 0.26 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.846 -0.616 . . . . 1.0 112.709 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.12 -32.98 83.37 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.781 2.321 . . . . 1.0 113.401 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.8 -172.3 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.626 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -125.18 169.13 12.53 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.184 0.516 . . . . 1.0 110.521 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -152.85 144.38 16.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.05 142.19 91.58 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.365 1.376 . . . . 1.0 111.146 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.7 p -154.18 -174.64 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.525 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.68 15.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.338 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mp -110.69 122.09 46.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.949 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.2 m -123.53 115.42 21.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.254 0.549 . . . . 1.0 111.576 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.4 tp -81.29 129.41 34.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.266 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.48 152.04 40.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 1.0 111.477 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -109.6 122.94 48.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.676 ' NH1' HD22 ' A' ' 41' ' ' ASN . 66.4 ttp85 -134.63 137.16 43.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.097 0.475 . . . . 1.0 110.688 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.676 HD22 ' NH1' ' A' ' 40' ' ' ARG . 67.7 m-20 60.27 34.2 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.442 -0.799 . . . . 1.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.13 24.01 76.02 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -132.73 150.07 52.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.06 130.27 37.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -143.07 143.14 31.74 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.014 0.435 . . . . 1.0 110.353 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 tp -104.58 129.17 52.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.38 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 47' ' ' ILE . 76.3 mt -104.0 126.72 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.493 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 48' ' ' ILE . 38.8 mm -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -108.05 128.16 54.42 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 52' ' ' GLU . 10.0 mp -106.76 129.72 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.322 -0.622 . . . . 1.0 109.322 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' LYS . 64.2 t-80 -43.07 95.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.59 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' LEU . 6.1 pt-20 -37.04 96.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.11 0.481 . . . . 1.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' HIS . 69.1 mttm -61.53 -37.93 85.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.916 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.39 -17.77 0.28 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.199 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.48 164.47 30.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.744 0.307 . . . . 1.0 110.844 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 55.6 p-80 -69.69 116.99 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.98 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 30.7 m -119.85 130.84 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.895 0.378 . . . . 1.0 110.43 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -151.19 108.26 3.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.809 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.07 117.93 32.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.753 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.17 114.19 29.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.926 0.393 . . . . 1.0 110.313 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mm -110.6 116.86 51.92 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.122 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.6 151.71 41.99 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.784 1.656 . . . . 1.0 112.552 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.502 ' CG2' HE22 ' A' ' 123' ' ' GLN . 96.9 mt -93.71 122.09 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.475 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' PHE . 46.2 p30 -170.73 -163.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.383 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -59.0 -40.93 86.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -66.2 -36.15 82.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.995 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 64' ' ' ASN . 36.5 t80 -95.09 129.59 42.12 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.961 0.41 . . . . 1.0 110.327 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -136.35 146.83 46.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.242 0.544 . . . . 1.0 111.234 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.2 p -115.47 110.23 18.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.369 -0.832 . . . . 1.0 109.423 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.93 135.42 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.862 0.363 . . . . 1.0 110.797 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.566 HE21 ' CB ' ' A' ' 87' ' ' CYS . 57.6 tt0 -103.41 122.07 44.12 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.87 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 42.78 18.23 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.105 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 71' ' ' GLN . . . -133.62 148.34 51.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.954 -0.567 . . . . 1.0 111.056 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.03 -39.22 79.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.478 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -160.5 78.68 0.64 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.51 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.1 m -140.75 70.07 1.35 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.452 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.434 HD11 ' H ' ' A' ' 77' ' ' LEU . 4.8 mp -71.28 -27.78 63.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.408 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.28 -40.49 96.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.563 -0.29 . . . . 1.0 110.303 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.3 mt -110.36 126.76 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.277 0.561 . . . . 1.0 110.856 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 34.8 p-10 -157.1 -41.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.579 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 97.4 mt -67.69 -24.21 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.965 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 36.9 t -115.86 127.32 54.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.095 0.474 . . . . 1.0 110.333 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 85' ' ' SER . 10.4 m120 -148.7 -176.94 5.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.236 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 79.49 91.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.19 79.91 0.07 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.224 -1.55 . . . . 1.0 109.224 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.566 ' CB ' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -115.98 148.18 40.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.777 0.322 . . . . 1.0 111.404 -177.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -106.84 139.65 40.92 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.532 ' C ' HH11 ' A' ' 90' ' ' ARG . 1.8 pp -128.02 161.33 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.532 HH11 ' C ' ' A' ' 89' ' ' ILE . 1.7 mpt_? -126.27 145.84 50.25 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.343 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.57 135.37 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.192 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.445 ' NE2' ' CD ' ' A' ' 98' ' ' GLU . 48.7 mm-40 -128.34 148.92 50.7 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.846 -0.616 . . . . 1.0 110.247 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.5 150.45 18.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -71.02 -46.61 61.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.714 0.292 . . . . 1.0 111.764 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -82.48 -8.23 59.62 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.9 0.333 . . . . 1.0 111.9 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 93' ' ' GLY . 35.0 pt -127.94 153.88 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.682 0.277 . . . . 1.0 110.731 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' NH2' ' A' ' 99' ' ' ARG . 35.2 ptt-85 -84.5 164.47 18.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.839 0.352 . . . . 1.0 110.664 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CD ' ' NE2' ' A' ' 92' ' ' GLN . 83.3 tt0 -65.94 127.25 31.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.508 ' NH2' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -130.02 137.51 50.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.408 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.411 ' NH1' ' CZ ' ' A' ' 90' ' ' ARG . 95.2 mtt-85 -99.91 152.62 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.829 0.347 . . . . 1.0 111.115 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.08 155.23 42.02 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.966 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -146.62 135.23 22.11 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.894 0.378 . . . . 1.0 111.166 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mm -107.2 103.06 46.64 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.93 -11.84 29.87 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.475 1.45 . . . . 1.0 112.827 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -97.96 121.71 40.2 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.75 -48.79 79.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.64 -0.709 . . . . 1.0 112.41 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -59.65 -40.17 86.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.453 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -71.17 -39.88 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.0 110.677 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -56.39 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.358 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.78 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.314 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -62.54 -45.55 92.43 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.772 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -61.21 -51.33 69.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.072 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.6 -42.29 91.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.26 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -64.71 -46.7 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 1.0 111.6 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.43 66.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.301 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.0 t -65.02 -44.88 95.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.8 tp -61.54 -46.76 88.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.097 0.475 . . . . 1.0 110.518 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.82 80.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.352 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.16 88.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.579 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -65.55 -44.97 85.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.863 0.363 . . . . 1.0 111.201 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -66.39 -43.13 86.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.402 0.62 . . . . 1.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.47 77.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.95 -1.023 . . . . 1.0 111.888 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.502 HE22 ' CG2' ' A' ' 63' ' ' ILE . 6.5 pt20 -72.05 -40.31 68.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.625 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.497 1.689 0 CA-C-O 120.955 0.314 . . . . 1.0 111.908 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.56 161.14 80.66 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.893 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.75 144.67 99.59 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.363 1.375 . . . . 1.0 111.652 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.17 -44.6 91.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.38 -28.37 73.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.248 -0.741 . . . . 1.0 111.248 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.75 149.06 47.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.975 0.417 . . . . 1.0 110.959 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -118.2 80.42 15.58 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.516 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.96 98.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.081 1.854 . . . . 1.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 37' ' ' LEU . 96.8 mt -65.6 -41.36 92.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.026 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.49 145.51 26.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.979 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -135.42 130.28 34.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.445 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.7 158.66 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.88 0.371 . . . . 1.0 110.853 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.36 123.3 46.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.578 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.84 -163.75 11.06 Favored Glycine 0 N--CA 1.46 0.275 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt -139.09 125.53 20.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.408 . . . . 1.0 110.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -89.18 120.85 30.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.3 mtm -106.73 136.78 45.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.689 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.8 147.65 52.31 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.732 -0.469 . . . . 1.0 109.732 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.57 -65.27 0.38 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.743 -0.662 . . . . 1.0 112.496 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -32.23 83.32 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.791 2.327 . . . . 1.0 113.952 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.44 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -174.99 -176.3 0.95 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -125.18 171.15 10.56 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.146 0.498 . . . . 1.0 110.563 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -157.83 129.21 3.82 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.202 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.38 146.93 49.04 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.305 1.145 . . . . 1.0 111.502 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.6 p -154.95 -172.99 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.687 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.14 138.74 20.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.18 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.4 HD13 ' CZ ' ' A' ' 112' ' ' PHE . 54.8 mt -106.54 124.69 49.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.054 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.4 m -130.64 122.44 27.41 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.115 0.483 . . . . 1.0 111.556 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.633 HD23 ' HB1' ' A' ' 115' ' ' ALA . 57.2 tp -93.5 131.41 38.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.28 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.46 148.55 37.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.043 0.449 . . . . 1.0 111.244 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.49 123.53 48.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.731 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -134.05 131.03 38.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.024 0.44 . . . . 1.0 110.82 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.7 m120 61.9 33.45 17.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.822 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.36 17.91 77.92 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.486 ' CD ' ' H ' ' A' ' 44' ' ' TYR . 6.4 tp-100 -125.71 158.06 35.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' H ' ' CD ' ' A' ' 43' ' ' GLN . 96.2 m-85 -99.72 135.83 40.55 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.023 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -145.17 141.32 28.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.927 0.394 . . . . 1.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.21 124.77 49.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.611 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -107.09 127.03 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.941 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.94 122.93 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.9 mt-30 -109.61 128.51 55.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.067 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 52' ' ' GLU . 9.1 mp -102.6 126.69 49.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -71.54 40.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.207 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 50' ' ' LEU . 38.9 tp10 -49.69 144.26 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.294 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.78 -39.91 95.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.219 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.05 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.967 0.413 . . . . 1.0 110.384 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.77 148.23 31.72 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.733 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -62.54 104.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.241 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 t -70.27 135.46 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.496 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -99.17 108.35 20.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.785 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -106.1 112.47 25.52 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.15 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 1.0 110.157 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.67 91.29 34.1 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.078 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.31 143.7 93.07 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.17 1.913 . . . . 1.0 112.431 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.3 mt -88.17 122.22 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.826 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -174.68 -160.88 0.1 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.998 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 t -60.22 -41.93 94.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.212 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -64.8 -34.13 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.554 -0.293 . . . . 1.0 111.033 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -94.56 127.47 40.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.353 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -136.09 142.54 44.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.334 0.588 . . . . 1.0 110.857 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.71 100.86 7.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.207 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 70' ' ' VAL . 10.4 m -101.95 122.98 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.965 0.412 . . . . 1.0 110.561 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' NE2' ' CG2' ' A' ' 89' ' ' ILE . 7.3 tp-100 -89.38 106.83 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.599 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.71 ' H ' ' NH1' ' A' ' 90' ' ' ARG . 36.1 tp10 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 121.113 0.482 . . . . 1.0 111.0 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.001 0.429 . . . . 1.0 110.253 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.46 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 94.2 mt -63.79 -43.27 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.8 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.295 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.2 t -103.73 62.23 0.76 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 1.0 110.335 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.4 m120 -80.71 -173.62 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.993 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.408 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 2.3 t 67.85 86.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.94 81.01 0.09 OUTLIER Glycine 0 CA--C 1.521 0.431 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.2 132.19 39.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.72 0.295 . . . . 1.0 111.785 -177.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.432 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 62.7 mttp -112.17 127.66 56.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.496 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 46.7 pt -129.17 158.08 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.71 ' NH1' ' H ' ' A' ' 72' ' ' GLU . 1.8 mpt_? -126.47 140.85 52.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.215 0.531 . . . . 1.0 110.003 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.1 133.85 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.913 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.36 138.29 31.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.127 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.53 0.205 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -174.54 129.5 0.34 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.584 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -142.96 149.53 38.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -105.61 149.01 26.69 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.096 0.474 . . . . 1.0 111.231 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -142.34 149.72 39.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.118 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -144.51 152.24 40.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.875 0.369 . . . . 1.0 111.009 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.54 99.71 15.52 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.16 -12.74 32.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.626 1.551 . . . . 1.0 112.788 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.57 101.1 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.6 tt0 -57.4 -54.17 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.985 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -52.08 -44.23 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.544 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -68.9 -38.38 79.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 1.0 110.537 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -35.87 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.988 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.38 -45.53 92.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.318 -0.553 . . . . 1.0 111.105 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -66.97 -44.21 81.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.905 -0.718 . . . . 1.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 42.4 t80 -62.18 -49.21 76.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.203 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 87' ' ' CYS . 96.7 mt -67.67 -40.35 84.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.273 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -64.73 -47.43 78.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.395 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.73 -48.44 71.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.347 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.66 -44.08 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.37 -44.35 95.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.097 0.475 . . . . 1.0 110.213 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.38 84.96 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.99 72.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.671 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.27 -36.49 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 1.0 111.295 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.82 -45.05 95.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.797 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.11 93.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.444 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -70.55 -37.79 74.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.851 0.358 . . . . 1.0 110.74 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.574 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.496 1.628 0 CA-C-O 120.884 0.285 . . . . 1.0 111.944 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.488 HD21 ' NE2' ' A' ' 49' ' ' GLN . 18.3 mt -68.85 159.02 84.4 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.059 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.63 144.52 99.55 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.295 1.33 . . . . 1.0 111.653 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 13' ' ' GLY . 7.8 p -67.32 -45.71 85.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.253 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' HG13 ' A' ' 12' ' ' VAL . . . -65.77 -28.91 74.06 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.45 141.2 58.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.941 0.401 . . . . 1.0 111.068 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.78 79.62 0.43 Allowed Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.78 94.74 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.883 1.722 . . . . 1.0 112.814 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -43.12 95.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.894 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.69 148.29 42.15 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.317 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 t -141.56 130.45 23.08 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.57 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 21' ' ' GLU . 55.3 t -137.59 158.1 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.979 0.418 . . . . 1.0 110.725 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.46 ' N ' HG12 ' A' ' 20' ' ' VAL . 80.7 tt0 -107.39 122.76 47.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.445 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.11 -160.92 9.87 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 71.1 mtp -136.36 130.21 32.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.386 . . . . 1.0 110.418 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.56 123.11 36.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.6 mpp? -113.29 137.83 50.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.982 0.42 . . . . 1.0 110.526 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -140.62 149.13 41.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.007 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.71 -65.17 0.48 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.884 -0.598 . . . . 1.0 112.697 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.12 -32.53 94.79 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.774 2.316 . . . . 1.0 113.564 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.6 177.58 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.852 -0.339 . . . . 1.0 110.878 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.3 169.25 11.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.894 0.378 . . . . 1.0 110.788 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 18.0 pt-20 -159.68 143.15 10.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.639 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.99 141.91 85.8 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.34 1.36 . . . . 1.0 110.929 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 22' ' ' GLY . 22.0 p -147.78 -175.73 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.38 136.25 18.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.95 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 103' ' ' ILE . 61.0 mt -100.08 124.49 45.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.998 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -127.99 126.86 42.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.13 0.491 . . . . 1.0 111.429 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.518 HD23 ' HB1' ' A' ' 115' ' ' ALA . 47.3 tp -96.37 126.17 41.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.886 -0.783 . . . . 1.0 108.886 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.43 152.13 48.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.072 0.463 . . . . 1.0 111.467 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.2 118.28 33.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.673 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -130.56 137.8 49.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.861 0.362 . . . . 1.0 110.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 59.04 33.59 23.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.444 -0.798 . . . . 1.0 111.387 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.98 22.44 77.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.437 ' OE1' ' N ' ' A' ' 44' ' ' TYR . 6.5 tp-100 -131.09 147.7 52.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.437 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 72.0 m-85 -88.52 133.84 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.67 140.73 30.21 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.07 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.2 tt -104.85 119.97 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.731 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.636 ' N ' HD23 ' A' ' 46' ' ' LEU . 78.4 mt -101.79 127.76 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.052 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.5 mt -104.36 116.76 48.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.488 ' NE2' HD21 ' A' ' 10' ' ' LEU . 35.0 mt-30 -97.63 132.34 43.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.6 mp -105.15 130.81 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.88 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -103.01 27.19 7.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.282 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 97.1 mt-10 -45.65 150.09 0.54 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -62.33 -40.31 95.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.3 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -54.55 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.38 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.49 158.11 43.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.88 112.54 17.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.071 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 t -95.25 133.41 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.921 0.391 . . . . 1.0 110.531 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -99.64 107.37 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.422 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -105.93 112.52 25.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.983 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.84 111.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.876 0.369 . . . . 1.0 110.187 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.33 116.78 48.39 Favored Pre-proline 0 N--CA 1.467 0.384 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.127 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.59 147.54 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.644 1.563 . . . . 1.0 112.61 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.51 120.04 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.2 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -175.22 -162.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -64.15 -26.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.185 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -83.69 -10.74 57.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.678 0.275 . . . . 1.0 110.948 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.81 129.29 56.0 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -136.5 146.86 46.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.743 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.87 106.46 9.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.506 -0.77 . . . . 1.0 108.937 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m -109.14 126.46 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.052 0.453 . . . . 1.0 110.969 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 7.6 tp-100 -82.8 115.29 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.635 179.897 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.951 0.405 . . . . 1.0 110.153 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.93 -42.39 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.39 -25.93 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.895 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -103.87 66.58 0.85 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.07 0.462 . . . . 1.0 110.568 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' A' ' 85' ' ' SER . 94.5 m-20 -91.73 -171.48 2.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.166 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 85' ' ' SER . 6.9 p 65.06 98.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.987 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.3 77.53 0.13 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 134.21 38.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.802 0.334 . . . . 1.0 111.772 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.48 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.5 mttt -107.94 123.82 49.21 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.46 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 2.4 pp -121.0 149.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -121.86 143.98 49.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.915 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.51 135.35 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.877 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 92' ' ' GLN . 1.6 mp0 -136.95 151.75 49.38 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.737 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.646 0.26 . . . . 1.0 110.739 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.75 124.84 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 1.0 110.756 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.11 132.06 44.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.295 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -91.55 151.9 20.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 1.0 111.076 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.18 153.69 43.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.202 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -138.82 143.87 39.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.953 0.406 . . . . 1.0 110.901 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.627 HD11 HD12 ' A' ' 35' ' ' LEU . 5.9 mm -127.17 91.08 47.46 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -16.99 41.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.698 1.598 . . . . 1.0 112.681 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.69 106.35 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.4 tt0 -62.64 -54.69 35.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 1.0 112.182 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -52.42 -42.77 64.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.607 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -70.55 -37.54 74.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.573 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.9 t -59.19 -35.57 73.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.891 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.27 -44.38 95.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.451 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.12 -44.51 84.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.979 -0.689 . . . . 1.0 110.454 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 51.1 t80 -60.76 -49.8 76.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.149 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.46 -41.58 80.0 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.466 -0.493 . . . . 1.0 111.223 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.6 t -63.55 -45.55 90.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.595 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.518 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.43 -49.31 56.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.544 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.46 -45.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.026 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.02 -48.59 81.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.35 80.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.577 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.35 91.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.752 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.74 -45.91 80.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.948 0.404 . . . . 1.0 111.351 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.78 -43.14 89.7 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.472 0.653 . . . . 1.0 110.368 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.96 77.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.855 -1.066 . . . . 1.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -71.92 -39.87 69.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.393 . . . . 1.0 110.556 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.597 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.498 1.753 0 CA-C-O 120.971 0.321 . . . . 1.0 111.716 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.37 158.57 3.86 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.75 142.99 99.3 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.308 1.338 . . . . 1.0 111.688 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.18 -45.23 83.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.382 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.72 81.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.26 50.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.06 0.457 . . . . 1.0 111.144 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -98.19 107.86 43.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.7 103.89 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.435 1.423 . . . . 1.0 112.871 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.93 -43.22 79.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.186 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.79 151.52 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.076 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -140.92 135.0 30.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 1.0 110.547 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 35' ' ' LEU . 2.6 p -142.45 152.12 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.018 0.437 . . . . 1.0 111.163 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -106.64 121.85 45.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -130.46 -155.87 8.45 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 21.4 mmt -137.04 128.65 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.939 0.4 . . . . 1.0 110.244 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -90.21 126.33 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.338 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.0 mtm -109.32 138.75 45.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 29' ' ' LEU . 99.3 mttt -135.64 149.68 49.4 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.898 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -67.07 0.29 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.569 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.28 -32.6 81.95 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.793 2.328 . . . . 1.0 113.852 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -173.94 -170.06 0.53 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.408 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -130.38 169.67 15.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.021 0.439 . . . . 1.0 110.313 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -156.29 144.39 14.31 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.396 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.98 146.14 96.45 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.294 1.329 . . . . 1.0 111.293 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 34' ' ' ALA . 19.7 t -158.02 170.15 22.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.314 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.645 ' N ' ' SG ' ' A' ' 33' ' ' CYS . . . -138.14 139.99 39.68 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.854 0.359 . . . . 1.0 110.239 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 103' ' ' ILE . 60.9 mt -107.07 121.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.764 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -125.08 122.91 38.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.229 0.537 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.594 HD23 ' HB1' ' A' ' 115' ' ' ALA . 62.0 tp -94.67 122.64 37.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.31 146.25 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.145 0.498 . . . . 1.0 111.309 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -98.71 126.69 44.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.747 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -139.82 136.73 34.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.971 0.415 . . . . 1.0 110.727 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 59.15 33.75 22.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.568 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.24 24.88 76.33 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.748 -0.941 . . . . 1.0 110.748 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -135.44 159.44 41.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -100.22 133.16 45.03 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -141.42 142.93 33.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.044 0.45 . . . . 1.0 110.34 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.8 tt -104.32 119.69 39.52 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.896 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.628 ' N ' HD23 ' A' ' 46' ' ' LEU . 72.0 mt -98.15 128.87 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.55 131.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.466 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 73.2 mt-30 -123.23 124.65 43.5 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.99 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.4 mp -99.9 114.75 28.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -72.49 62.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -62.51 151.86 36.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.314 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.87 -41.66 98.12 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.57 -77.36 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -147.82 150.56 34.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -68.73 138.37 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.967 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.18 130.37 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 1.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -91.09 108.35 19.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.791 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.07 114.68 28.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.28 116.12 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.86 0.362 . . . . 1.0 110.46 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.1 91.6 32.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.19 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -57.42 142.77 95.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.213 1.942 . . . . 1.0 112.591 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.62 122.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -175.66 -163.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.201 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.9 p -63.84 -22.2 66.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -85.61 -11.34 54.17 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.602 0.239 . . . . 1.0 111.06 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -121.84 135.27 54.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -137.42 151.38 48.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.104 0.478 . . . . 1.0 110.711 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.7 p -138.76 111.65 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 128.28 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 1.0 111.196 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 7.5 tp-100 -82.27 97.53 8.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.585 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.17 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.963 0.411 . . . . 1.0 110.204 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 83' ' ' SER . 32.6 mm -71.64 -24.13 23.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.18 -3.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.053 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 81' ' ' ILE . 29.8 t -138.97 138.18 37.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 1.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -146.69 -171.32 3.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.105 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 61.77 85.1 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.31 78.28 0.27 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.571 -1.412 . . . . 1.0 109.571 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.85 137.62 35.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 111.866 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.49 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.7 mttt -112.41 127.03 55.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.448 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 1.7 pp -118.17 132.05 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -97.1 141.67 29.96 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.7 t -121.63 134.85 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.572 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -143.46 150.64 39.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.18 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.557 0 N-CA-C 110.644 -0.982 . . . . 1.0 110.644 179.545 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 120.684 0.278 . . . . 1.0 110.616 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.12 132.88 54.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 1.0 110.363 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -140.43 125.49 18.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.611 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -88.22 144.07 26.67 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.993 0.425 . . . . 1.0 111.192 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.83 152.05 49.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -139.59 144.64 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.821 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 35' ' ' LEU . 5.8 mm -127.64 91.55 45.26 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.3 -16.99 39.85 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.822 1.681 . . . . 1.0 112.751 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -87.79 104.28 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.96 -54.99 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 1.0 112.32 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -52.1 -44.31 64.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.425 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -69.17 -36.17 77.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.533 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 113' ' ' LEU . 4.2 t -61.75 -38.07 86.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.999 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.77 -46.09 89.64 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.223 -0.591 . . . . 1.0 111.301 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -43.55 82.0 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.964 -0.695 . . . . 1.0 110.764 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.8 -50.36 72.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.156 -0.929 . . . . 1.0 111.094 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 109' ' ' CYS . 95.9 mt -67.85 -41.0 83.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.329 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 t -62.27 -45.12 94.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.105 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.594 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.52 -47.13 67.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.382 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.403 ' HA ' HD22 ' A' ' 37' ' ' LEU . 67.0 t -63.35 -45.6 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.964 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.16 -45.85 92.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 1.0 110.255 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.6 86.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.425 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.76 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.455 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.488 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 95.1 mt-30 -68.32 -37.66 80.78 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.25 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.54 -43.15 90.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.085 0.469 . . . . 1.0 110.623 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.93 75.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.732 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.31 -38.9 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.734 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.405 -179.773 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.497 1.723 0 CA-C-O 120.891 0.288 . . . . 1.0 112.154 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.35 145.55 57.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.859 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 142.31 71.06 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.734 1.623 . . . . 1.0 111.41 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -67.77 -42.79 86.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.681 -0.691 . . . . 1.0 111.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -38.37 47.03 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.94 146.17 46.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.902 0.382 . . . . 1.0 111.009 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -102.82 80.32 0.33 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.13 99.71 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.846 1.697 . . . . 1.0 112.832 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.23 -43.2 92.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.82 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.23 153.52 38.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.353 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -137.96 135.8 36.37 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.633 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.8 p -141.64 149.26 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.04 0.448 . . . . 1.0 111.262 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -104.31 121.68 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.39 -162.96 10.9 Favored Glycine 0 N--CA 1.462 0.386 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 88.9 mmm -128.65 131.99 48.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 1.0 110.315 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -94.9 124.06 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -108.47 137.22 46.79 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.545 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.93 150.07 44.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.019 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.71 -66.29 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.794 -0.639 . . . . 1.0 112.597 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.68 -33.0 93.8 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.779 2.319 . . . . 1.0 113.691 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.7 -174.57 0.25 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.007 -0.277 . . . . 1.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.33 169.47 11.76 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 1.0 110.739 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -158.1 144.31 12.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.619 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.8 145.12 97.4 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.392 1.394 . . . . 1.0 111.04 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.7 p -154.97 -179.11 7.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.382 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.67 142.53 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.427 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 20' ' ' VAL . 4.9 mp -112.28 122.53 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.257 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -122.67 116.7 24.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.381 0.61 . . . . 1.0 111.757 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.682 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.9 tp -83.55 130.37 35.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.21 -0.905 . . . . 1.0 109.218 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.24 151.49 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.007 0.432 . . . . 1.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -110.61 121.73 46.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.711 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -134.02 139.19 45.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.903 0.382 . . . . 1.0 110.911 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.11 33.65 22.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.548 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.28 25.22 75.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -135.17 153.83 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -91.18 131.95 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -141.23 141.61 34.0 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.985 0.422 . . . . 1.0 110.445 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.6 127.54 52.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.685 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.42 118.29 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.154 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.9 mt -100.98 122.87 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.467 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.8 mt-30 -108.22 130.54 55.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -107.68 111.19 23.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 52' ' ' GLU . 97.8 m-70 -57.49 -12.8 2.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' HIS . 3.5 tp10 42.39 -167.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.455 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -63.74 -41.75 97.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -138.73 -68.5 0.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.747 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -69.9 142.13 53.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.177 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.62 ' CD2' ' O ' ' A' ' 56' ' ' HIS . 55.4 p-80 -89.06 112.29 23.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.41 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -84.19 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.616 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.13 132.16 48.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.127 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -127.25 109.61 11.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -93.57 122.3 44.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.728 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -133.3 126.76 19.53 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.01 157.84 46.5 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.799 1.666 . . . . 1.0 112.64 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -102.66 115.92 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.178 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' PHE . 50.8 p30 -172.94 -155.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.229 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 m -60.98 -41.6 96.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.348 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -43.05 97.72 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.838 0.352 . . . . 1.0 110.433 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 64' ' ' ASN . 11.6 t80 -94.03 125.65 38.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.649 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -133.68 142.11 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.87 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.3 t -121.27 111.47 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.962 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.0 m -112.76 126.67 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.959 0.409 . . . . 1.0 110.622 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' A' ' 83' ' ' SER . 18.8 tt0 -87.99 112.83 23.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.744 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.641 -179.858 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.955 0.407 . . . . 1.0 110.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.438 ' C ' ' N ' ' A' ' 83' ' ' SER . 94.6 mt -64.16 -43.29 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.661 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.29 -18.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.036 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 21.9 m -128.19 118.37 23.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.942 0.401 . . . . 1.0 110.284 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.0 m120 -138.32 -167.83 2.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.781 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 70.15 89.47 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.36 75.69 0.33 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 109.342 -1.503 . . . . 1.0 109.342 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.9 138.65 34.12 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.964 0.411 . . . . 1.0 112.006 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.54 124.95 53.15 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.0 150.94 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -121.44 147.08 46.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.88 136.45 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.594 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -128.82 150.3 50.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.097 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 110.681 -0.968 . . . . 1.0 110.681 -179.852 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.831 0.348 . . . . 1.0 110.655 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.73 127.88 33.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 1.0 110.111 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -127.26 143.11 51.31 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -120.17 140.0 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.958 0.408 . . . . 1.0 111.236 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.17 150.62 50.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.69 -0.686 . . . . 1.0 110.472 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.12 135.75 24.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.758 0.313 . . . . 1.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 54.4 mt -124.56 100.97 34.22 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.64 -10.41 23.5 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.607 1.538 . . . . 1.0 112.684 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.43 105.73 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.72 -52.81 63.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.015 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -53.86 -42.1 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.628 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.504 ' HB3' HG23 ' A' ' 20' ' ' VAL . 5.0 m-70 -69.94 -34.88 74.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.512 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.6 t -66.72 -33.22 75.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.99 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.6 mt -62.74 -46.18 89.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.489 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.73 -43.06 80.87 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.602 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.459 ' CE1' HG21 ' A' ' 116' ' ' VAL . 46.9 t80 -60.93 -48.93 79.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.124 -0.943 . . . . 1.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 113' ' ' LEU . 96.8 mt -65.41 -40.85 93.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.644 -0.423 . . . . 1.0 111.362 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.7 p -64.0 -44.24 93.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.228 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.682 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.07 -51.02 59.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.314 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 112' ' ' PHE . 70.0 t -64.87 -42.25 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.7 tp -57.74 -45.07 86.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.065 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.377 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.87 70.57 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.044 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -68.01 -41.1 82.71 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.64 0.257 . . . . 1.0 111.102 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.24 -43.75 98.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.958 0.409 . . . . 1.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.73 96.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.236 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.3 -40.44 93.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.652 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.903 -1.046 . . . . 1.0 110.485 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.496 1.666 0 CA-C-O 121.07 0.363 . . . . 1.0 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 pp -56.47 161.44 4.19 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.121 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.46 143.56 99.66 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.974 1.116 . . . . 1.0 111.79 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.34 -42.9 91.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.02 -34.37 78.73 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.07 137.75 53.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.925 0.393 . . . . 1.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -97.66 108.46 45.68 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.28 103.14 1.7 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.502 1.468 . . . . 1.0 112.999 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.63 -43.47 89.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.152 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 155.68 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.209 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 t -146.67 135.67 22.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.594 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.94 160.82 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.165 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -102.48 122.51 44.47 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' H ' ' HA ' ' A' ' 34' ' ' ALA . . . -118.88 -174.95 16.14 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.792 -0.923 . . . . 1.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.3 mmt -134.9 99.25 4.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 1.0 110.092 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.7 tt0 -59.59 133.96 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 72.5 mtm -113.43 131.38 56.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.748 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.15 144.04 51.08 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.56 -64.88 0.49 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.84 -0.618 . . . . 1.0 112.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.22 -31.98 93.78 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.694 2.262 . . . . 1.0 113.633 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.46 -179.87 1.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.641 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.0 168.2 10.43 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.919 0.39 . . . . 1.0 110.522 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.5 128.7 6.27 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.516 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.44 142.36 78.22 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.944 1.096 . . . . 1.0 111.163 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.4 p -156.76 -178.28 7.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.394 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -150.95 138.19 19.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.308 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.2 mt -102.22 123.97 46.98 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.915 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -126.48 120.46 29.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.059 0.456 . . . . 1.0 111.356 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.515 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.5 tp -94.67 131.23 40.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.248 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 150.93 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 1.0 111.239 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.06 120.82 41.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.682 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -128.07 132.31 49.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.217 0.532 . . . . 1.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.16 31.7 21.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.157 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.65 7.52 85.8 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.851 -0.69 . . . . 1.0 111.426 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -112.5 136.79 51.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.101 -0.333 . . . . 1.0 110.101 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -81.7 134.74 35.49 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.077 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.34 139.64 28.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.375 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.4 tt -108.7 119.4 39.42 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.607 ' N ' HD23 ' A' ' 46' ' ' LEU . 90.9 mt -99.12 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.6 mt -96.91 117.21 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.8 mt-30 -102.35 131.3 49.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.928 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -110.3 127.2 54.9 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -85.41 52.73 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.237 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -45.49 152.95 0.27 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.77 -40.02 93.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.362 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -62.49 -46.44 88.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.509 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -173.11 -163.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.701 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -108.11 126.24 52.52 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.31 137.17 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.055 0.455 . . . . 1.0 110.463 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -104.8 131.12 52.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.018 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -107.97 119.65 40.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.565 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.1 mt -92.11 119.74 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 1.0 110.332 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mt -135.45 94.2 15.63 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.269 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.5 142.52 80.76 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.046 1.831 . . . . 1.0 112.625 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.2 mt -82.12 124.83 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.354 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 66' ' ' HIS . 6.0 p30 -172.96 -163.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.126 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.4 t -59.71 -41.29 90.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.564 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.632 ' CD2' ' ND2' ' A' ' 64' ' ' ASN . 3.5 p80 -69.84 -14.48 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.958 -0.297 . . . . 1.0 111.122 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.0 t80 -114.93 128.06 56.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.18 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -141.29 145.86 36.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.145 0.497 . . . . 1.0 110.889 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 t -121.32 118.61 29.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 1.0 108.991 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.71 128.84 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.068 0.461 . . . . 1.0 110.848 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.476 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 8.5 tp-100 -86.47 103.24 14.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.518 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.331 179.779 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 20.0 p-10 . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 121.034 0.445 . . . . 1.0 110.329 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.42 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 26.3 mm -68.32 -24.53 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.39 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.03 72.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.818 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.5 t -100.46 62.57 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.09 0.472 . . . . 1.0 110.398 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 10.9 m120 -80.47 -171.69 3.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.164 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 85' ' ' SER . 19.2 p 57.83 94.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.73 77.09 0.21 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 136.56 36.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.765 0.317 . . . . 1.0 111.72 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.476 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 64.9 mttp -108.02 120.03 41.14 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.449 ' CG2' HE22 ' A' ' 71' ' ' GLN . 2.2 pp -118.63 131.01 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -106.61 144.73 32.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.894 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.63 133.13 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.641 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -124.23 136.06 53.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.741 -0.944 . . . . 1.0 110.741 179.793 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.803 0.335 . . . . 1.0 110.671 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.02 135.66 55.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 1.0 110.727 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -133.8 137.58 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.588 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -87.32 150.47 23.84 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.917 0.389 . . . . 1.0 111.035 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -143.39 149.33 37.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.298 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.14 145.84 39.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.918 0.389 . . . . 1.0 110.931 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.87 92.86 43.54 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.28 -15.44 38.88 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.757 1.638 . . . . 1.0 112.602 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.453 ' OD2' ' CG ' ' A' ' 108' ' ' HIS . 38.6 t0 -93.2 106.56 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.81 -52.92 63.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.026 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.93 -46.81 32.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.378 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.453 ' CG ' ' OD2' ' A' ' 105' ' ' ASP . 43.9 m170 -68.5 -39.34 81.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 1.0 110.38 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 t -59.08 -39.76 83.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.16 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.52 -44.84 93.09 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.418 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.16 -44.96 82.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.3 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.55 -49.38 76.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.339 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.8 -40.51 88.13 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.603 -0.439 . . . . 1.0 111.211 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -62.73 -44.7 95.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.822 0.344 . . . . 1.0 111.083 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.515 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.12 -48.28 62.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.361 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.09 -44.76 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.14 -45.03 96.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.016 0.436 . . . . 1.0 110.161 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.07 86.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.555 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.07 -49.09 75.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -71.11 -38.23 72.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 1.0 110.983 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.04 -44.5 96.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.223 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.41 96.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.221 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.38 -41.22 93.99 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.66 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.384 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.497 1.703 0 CA-C-O 120.818 0.257 . . . . 1.0 111.981 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -53.96 158.06 3.77 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.907 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.76 143.29 99.65 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.156 1.238 . . . . 1.0 111.687 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.35 -45.08 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.79 78.72 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 142.27 57.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.06 0.457 . . . . 1.0 111.162 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -104.22 79.85 0.4 Allowed Pre-proline 0 N--CA 1.464 0.261 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.35 98.97 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.893 1.729 . . . . 1.0 112.918 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -43.55 93.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.754 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.94 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.341 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 t -136.33 138.77 42.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.763 0.316 . . . . 1.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG11 ' CG ' ' A' ' 112' ' ' PHE . 2.8 p -142.95 150.9 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.083 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -105.29 121.34 43.67 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.85 -172.66 13.2 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.426 ' O ' ' SD ' ' A' ' 25' ' ' MET . 86.2 mmm -120.44 127.31 52.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 1.0 110.091 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -90.11 119.71 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.3 mpp? -110.4 136.68 49.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.946 0.403 . . . . 1.0 110.34 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.34 150.43 42.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.025 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.69 -64.74 0.51 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.706 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.45 -34.15 93.32 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.658 2.239 . . . . 1.0 113.624 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.06 175.21 0.66 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.812 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -117.17 169.06 9.75 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.099 0.476 . . . . 1.0 110.527 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -160.68 142.9 9.41 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.644 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.85 145.71 94.75 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.498 1.465 . . . . 1.0 111.241 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.2 p -155.21 -171.66 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.466 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.44 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.405 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 20' ' ' VAL . 68.3 mt -113.37 130.09 56.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -130.51 128.17 40.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.167 0.508 . . . . 1.0 111.556 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.655 HD23 ' HB1' ' A' ' 115' ' ' ALA . 51.9 tp -95.17 124.55 39.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.009 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.64 149.95 45.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.112 0.482 . . . . 1.0 111.314 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -108.11 120.67 42.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.389 -0.823 . . . . 1.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -132.88 135.94 45.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.871 0.367 . . . . 1.0 110.87 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 59.26 34.49 23.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 1.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.57 23.6 76.55 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.004 -0.838 . . . . 1.0 111.004 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -133.77 157.08 46.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.94 133.43 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -139.02 146.66 41.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.197 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -105.45 134.31 48.77 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.706 ' N ' HD13 ' A' ' 46' ' ' LEU . 78.0 mt -114.09 124.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.2 mt -105.1 120.37 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -112.34 126.86 55.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.152 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.9 mp -103.93 123.69 47.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -78.85 58.04 2.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.371 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -54.75 155.91 3.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.299 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.28 -41.44 98.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.2 -81.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -142.01 150.13 40.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.741 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -67.35 141.71 57.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.307 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.43 132.61 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.992 0.425 . . . . 1.0 110.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -95.01 126.62 40.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.914 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -120.52 117.28 27.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.478 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -93.35 108.22 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.865 0.364 . . . . 1.0 110.061 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mm -114.66 121.88 34.93 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.58 149.95 39.6 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.778 1.652 . . . . 1.0 112.615 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.3 115.36 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -169.57 -158.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.362 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -59.51 -41.67 90.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -65.73 -37.69 87.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' A' ' 64' ' ' ASN . 16.4 t80 -95.63 123.83 39.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.834 0.35 . . . . 1.0 110.06 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -140.13 144.05 36.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.099 0.476 . . . . 1.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.36 99.71 7.38 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 70' ' ' VAL . 35.4 m -104.56 124.95 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.905 0.383 . . . . 1.0 110.811 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.459 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 6.9 tp-100 -77.7 104.46 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.455 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.66 179.806 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 35.0 p-10 . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 120.882 0.372 . . . . 1.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.446 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 91.9 mt -67.84 -25.31 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.535 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.02 91.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.128 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -97.47 70.73 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.181 0.515 . . . . 1.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 9.7 m120 -98.7 -169.2 1.75 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.207 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 m 61.82 84.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.58 76.47 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 109.462 -1.455 . . . . 1.0 109.462 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.03 142.98 26.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.933 0.397 . . . . 1.0 111.803 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.459 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 55.8 mtpt -118.56 128.07 54.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.5 pt -127.82 163.6 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.75 142.15 50.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.8 t -121.6 135.76 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.087 0.47 . . . . 1.0 110.564 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -119.92 163.47 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.225 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.866 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.683 0.278 . . . . 1.0 110.5 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.86 115.95 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.175 0.512 . . . . 1.0 110.6 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -129.03 137.91 51.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.237 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.64 151.05 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.739 0.304 . . . . 1.0 110.705 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -137.35 155.17 49.73 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.478 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -147.4 126.08 12.58 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.972 0.415 . . . . 1.0 111.389 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.425 HG12 HG21 ' A' ' 20' ' ' VAL . 3.0 mp -102.93 99.52 14.12 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 -10.05 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.407 1.404 . . . . 1.0 112.472 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -96.49 107.34 19.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.83 -52.73 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.7 -0.682 . . . . 1.0 112.157 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.0 OUTLIER -52.44 -43.97 65.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.593 -0.443 . . . . 1.0 110.388 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.46 ' HB3' HG23 ' A' ' 20' ' ' VAL . 60.7 m170 -69.6 -34.19 73.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.377 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.422 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.922 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.08 -47.65 79.24 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.357 -0.537 . . . . 1.0 111.706 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.57 -44.74 77.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.862 -0.735 . . . . 1.0 110.171 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.516 ' CG ' HG11 ' A' ' 20' ' ' VAL . 37.0 t80 -61.36 -49.44 76.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.131 -0.94 . . . . 1.0 111.495 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.422 HD11 ' SG ' ' A' ' 109' ' ' CYS . 91.7 mt -67.32 -41.65 84.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.169 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -63.06 -45.89 90.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.529 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.655 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.97 -46.4 78.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.456 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.431 ' HA ' HD22 ' A' ' 37' ' ' LEU . 76.5 t -64.19 -44.49 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.894 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.74 -44.83 96.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 1.0 110.295 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.39 86.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -48.71 77.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -70.28 -36.89 74.67 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.77 -45.77 91.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.151 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.28 -40.08 96.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.306 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.79 -40.19 94.83 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.801 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.586 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 45.4 Cg_endo . . . . . 0 N--CA 1.498 1.793 0 CA-C-O 120.894 0.289 . . . . 1.0 112.151 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -74.18 150.73 87.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.805 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.51 141.06 90.51 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.627 1.551 . . . . 1.0 111.72 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.3 t -68.35 -43.29 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.293 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.18 -41.31 4.85 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.86 146.13 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.594 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -93.22 107.02 22.48 Favored Pre-proline 0 N--CA 1.466 0.347 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.94 99.87 1.35 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.614 1.543 . . . . 1.0 113.181 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.49 -43.41 85.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.282 0.563 . . . . 1.0 109.892 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.12 149.08 29.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.327 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 t -141.34 130.18 23.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.689 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -142.03 159.66 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-O 120.928 0.394 . . . . 1.0 110.955 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -108.32 122.43 46.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.511 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.442 ' C ' ' SD ' ' A' ' 23' ' ' MET . . . -130.59 -152.52 7.42 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 22' ' ' GLY . 2.8 mpt? -143.99 126.53 15.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 1.0 110.522 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 84.2 tt0 -87.42 121.43 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.601 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -105.79 138.85 41.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.62 150.22 49.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.67 -66.63 0.38 Allowed Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.583 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.56 -33.59 86.83 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.761 2.307 . . . . 1.0 113.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -174.0 -171.97 0.68 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 121.009 -0.276 . . . . 1.0 110.463 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -130.23 169.13 15.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.973 0.416 . . . . 1.0 110.454 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 134.66 8.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.83 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.16 141.59 69.18 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 CA-C-N 120.199 1.107 . . . . 1.0 111.244 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 15.5 p -150.31 -176.24 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.403 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.71 138.64 22.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.451 HD12 HD11 ' A' ' 103' ' ' ILE . 71.0 mt -105.66 123.86 48.61 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.7 m -129.6 113.91 15.4 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.117 0.484 . . . . 1.0 111.584 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.505 HD23 ' HB1' ' A' ' 115' ' ' ALA . 49.9 tp -81.43 127.39 32.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.03 149.19 47.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.138 0.494 . . . . 1.0 111.363 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -112.98 121.95 46.18 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.405 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -135.36 139.89 44.61 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.039 0.447 . . . . 1.0 110.76 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 58.97 33.86 23.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.324 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.83 23.93 75.67 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -131.3 152.61 50.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.0 130.41 40.13 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -142.41 142.1 32.33 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.026 0.441 . . . . 1.0 110.231 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.5 tp -104.38 124.78 49.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.0 mt -103.38 122.19 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.988 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.88 114.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.471 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.9 mt-30 -101.68 132.79 47.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.071 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.0 mp -108.04 129.44 55.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.7 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -80.18 36.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.268 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -49.77 142.46 8.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.199 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.68 -38.69 91.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -59.04 -53.85 53.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.34 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -174.46 149.87 1.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.58 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 t -67.11 133.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.214 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 97.0 mt-30 -106.79 128.63 54.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.143 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -122.18 117.39 26.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.56 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.66 111.86 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.161 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -115.97 114.53 41.45 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.793 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.27 151.07 37.89 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.667 1.578 . . . . 1.0 112.462 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.9 mt -97.52 118.81 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.429 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -170.22 -158.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.352 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -61.05 -42.62 98.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.109 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -65.41 -36.11 82.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.979 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 64' ' ' ASN . 17.3 t80 -95.12 123.78 38.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.41 122.35 15.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.234 0.54 . . . . 1.0 110.817 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 t -87.89 115.0 25.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.247 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 70' ' ' VAL . 4.6 m -115.74 124.32 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.908 0.385 . . . . 1.0 110.583 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 87' ' ' CYS . 52.4 tt0 -84.48 135.44 34.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.902 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 21.9 p-10 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 121.032 0.444 . . . . 1.0 110.732 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' SER . 36.5 mm -63.99 -40.93 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.221 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.6 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . 44.0 t -142.91 140.19 31.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 1.0 110.151 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 85' ' ' SER . 91.1 m-20 -146.15 -172.22 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.985 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER 76.97 89.68 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.19 77.49 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.409 ' HB3' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.21 135.15 35.92 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.01 0.433 . . . . 1.0 111.882 -177.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.04 113.32 25.78 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.66 129.79 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.817 0.341 . . . . 1.0 110.429 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.86 142.18 33.57 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.105 -0.498 . . . . 1.0 109.982 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.06 133.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.706 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.22 141.61 31.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 98' ' ' GLU . 50.4 ptt85 . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.299 0.095 . . . . 1.0 110.992 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 97' ' ' ARG . 84.1 tt0 -176.9 128.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.9 0.381 . . . . 1.0 110.581 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.88 145.08 35.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -104.06 147.32 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.93 0.395 . . . . 1.0 111.169 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.87 152.42 45.08 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.998 -0.547 . . . . 1.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -138.26 144.53 40.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.984 0.421 . . . . 1.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.451 HD11 HD12 ' A' ' 35' ' ' LEU . 5.7 mm -127.31 89.88 50.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.59 -16.44 46.93 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.721 1.614 . . . . 1.0 112.652 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -87.2 101.09 13.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.81 -55.07 39.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 1.0 112.087 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -51.84 -44.03 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.771 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -68.45 -39.67 81.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.919 0.39 . . . . 1.0 110.422 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -58.07 -36.84 73.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.107 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.414 HD21 ' ND2' ' A' ' 84' ' ' ASN . 96.5 mt -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.416 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.27 -44.58 83.21 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.868 -0.733 . . . . 1.0 110.542 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -62.18 -50.33 72.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.707 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.67 -40.86 92.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.119 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 m -61.53 -43.82 98.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.098 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.44 -42.8 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.157 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.95 -44.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.882 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.16 -45.96 92.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.061 0.457 . . . . 1.0 110.276 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.94 -37.39 84.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.311 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.12 -48.54 78.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -70.03 -38.72 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.923 0.392 . . . . 1.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.13 -44.86 90.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.754 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.08 75.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.951 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.18 -39.87 68.35 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.68 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.039 -0.981 . . . . 1.0 110.684 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo . . . . . 0 N--CA 1.497 1.707 0 CA-C-O 121.002 0.334 . . . . 1.0 111.822 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 10' ' ' LEU . 4.1 mm? -53.94 146.4 28.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.93 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -55.11 144.16 70.9 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.076 1.184 . . . . 1.0 111.5 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.86 -45.15 97.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.551 -0.749 . . . . 1.0 111.015 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.47 -28.67 73.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.14 -0.784 . . . . 1.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 147.39 52.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 1.0 110.976 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -118.28 80.49 15.91 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.431 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.45 97.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.158 1.905 . . . . 1.0 112.689 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' LEU . 98.3 mt -65.47 -41.34 93.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.799 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.6 149.08 28.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.229 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 t -138.23 136.4 36.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.806 0.336 . . . . 1.0 110.619 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.5 p -144.82 151.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.331 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.1 137.52 36.03 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.604 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -150.65 -168.5 15.56 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.647 -0.981 . . . . 1.0 110.647 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -127.84 130.54 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 1.0 110.515 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.55 ' OE1' HD11 ' A' ' 50' ' ' LEU . 81.3 tt0 -93.12 120.82 33.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.457 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 71.4 mtm -107.76 136.09 48.08 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.609 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.91 149.49 38.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.051 0.453 . . . . 1.0 109.965 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -37.11 -65.35 0.6 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.77 -0.65 . . . . 1.0 112.749 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.14 -32.78 95.04 Favored 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 122.728 2.285 . . . . 1.0 114.135 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.53 ' C ' HD12 ' A' ' 29' ' ' LEU . 1.0 OUTLIER 179.14 177.21 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 121.084 -0.246 . . . . 1.0 110.61 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.57 168.86 11.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.0 0.429 . . . . 1.0 110.287 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 16.7 pt-20 -161.46 143.91 9.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.41 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.46 144.93 95.51 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.338 1.359 . . . . 1.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 22' ' ' GLY . 4.2 p -154.05 -178.13 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.571 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.05 143.13 24.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.197 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 103' ' ' ILE . 49.7 mt -106.25 120.93 43.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.873 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m -127.27 115.36 18.91 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.232 0.539 . . . . 1.0 111.458 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.59 HD23 ' HB1' ' A' ' 115' ' ' ALA . 65.4 tp -87.76 128.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.062 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.88 144.26 41.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 1.0 111.425 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -98.77 121.26 40.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.544 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.95 134.18 42.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.914 0.388 . . . . 1.0 110.948 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 58.15 33.78 23.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.681 -0.69 . . . . 1.0 111.791 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.35 78.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.873 -0.891 . . . . 1.0 110.873 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 44.2 tt0 -131.36 161.28 32.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.419 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 94.5 m-85 -103.41 137.25 41.78 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -145.54 144.1 30.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.004 0.43 . . . . 1.0 110.352 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.2 tp -104.57 128.9 52.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.634 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.57 129.17 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.42 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.32 120.18 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' C ' HD22 ' A' ' 50' ' ' LEU . 37.1 mt-30 -108.53 127.83 54.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.082 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.55 HD11 ' OE1' ' A' ' 24' ' ' GLU . 4.2 mm? -101.27 132.44 46.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.906 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -95.49 18.99 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.305 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 94.1 mt-10 -45.6 136.84 5.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.419 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.74 -38.5 90.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.195 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.13 -50.92 69.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.377 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -170.58 154.92 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.166 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -84.58 113.88 21.57 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.14 131.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.938 0.399 . . . . 1.0 110.344 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -121.13 117.41 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.585 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -106.53 134.94 48.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.0 mm -93.82 109.54 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.902 0.382 . . . . 1.0 110.16 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.6 mm -112.41 104.59 56.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 147.82 36.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.596 1.53 . . . . 1.0 112.642 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 97.2 mt -91.81 119.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.431 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 79.3 m-20 -163.85 -165.37 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.059 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.1 p -61.54 -37.25 83.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.34 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -71.57 -32.2 67.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.296 . . . . 1.0 111.186 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 16.4 t80 -92.24 123.24 35.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.931 0.396 . . . . 1.0 109.987 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -135.05 144.48 47.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.549 . . . . 1.0 110.82 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.5 t -117.96 112.36 20.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.049 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.94 125.83 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.852 0.358 . . . . 1.0 111.012 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' OE1' ' OD1' ' A' ' 80' ' ' ASP . 42.5 tt0 -84.44 102.1 12.52 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.719 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.512 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.514 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 70.5 m-20 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.876 0.37 . . . . 1.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.07 -42.57 95.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.59 -32.03 57.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.053 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ASP . 34.5 t -147.4 126.84 13.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.73 0.3 . . . . 1.0 110.706 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 80' ' ' ASP . 35.4 m120 -147.76 27.02 1.0 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.963 0.411 . . . . 1.0 111.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 t -80.45 100.89 8.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.396 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.96 80.37 0.12 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.952 -1.659 . . . . 1.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.86 129.5 38.76 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.134 0.42 . . . . 1.0 112.134 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.43 121.77 46.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 153.11 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.62 142.9 50.15 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.28 132.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.851 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -137.77 135.68 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.985 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.855 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.577 0.227 . . . . 1.0 110.879 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -174.32 112.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.479 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -129.33 134.19 47.79 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -91.89 157.58 16.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.857 0.361 . . . . 1.0 111.0 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.73 153.77 47.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.402 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -140.03 140.78 36.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.841 0.353 . . . . 1.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 35' ' ' LEU . 6.1 mm -128.67 89.61 48.74 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.07 -16.63 36.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.918 1.745 . . . . 1.0 112.651 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -87.55 106.51 18.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.697 -0.482 . . . . 1.0 109.697 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.0 -54.58 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 1.0 112.032 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.19 -44.23 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.559 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.433 ' HB3' HG23 ' A' ' 20' ' ' VAL . 7.1 m-70 -69.2 -37.14 77.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.736 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 113' ' ' LEU . 11.5 t -62.39 -31.91 72.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.157 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.78 -45.52 92.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.71 -42.99 85.5 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.039 -0.665 . . . . 1.0 110.622 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 116' ' ' VAL . 47.0 t80 -62.65 -51.13 68.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.223 -0.899 . . . . 1.0 111.322 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.462 ' CD1' HD22 ' A' ' 84' ' ' ASN . 91.2 mt -66.76 -41.07 88.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.277 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.9 p -63.19 -45.96 89.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.82 0.343 . . . . 1.0 111.345 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.2 -47.99 63.34 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.414 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 112' ' ' PHE . 55.9 t -64.75 -43.9 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.636 0.255 . . . . 1.0 111.113 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.63 -45.74 91.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 1.0 110.215 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -37.81 87.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.229 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.04 72.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.736 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -70.95 -35.97 72.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.355 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.66 -44.68 96.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.85 97.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.286 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.69 -41.06 88.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.698 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.507 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 35.6 Cg_endo . . . . . 0 N--CA 1.495 1.597 0 CA-C-O 120.999 0.333 . . . . 1.0 111.974 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.55 150.92 53.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.12 143.29 99.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.326 1.351 . . . . 1.0 111.526 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 13' ' ' GLY . 13.4 m -68.63 -42.89 83.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -67.26 -28.12 73.64 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.399 -0.68 . . . . 1.0 111.399 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.89 58.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.906 0.384 . . . . 1.0 111.015 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -99.0 102.85 16.62 Favored Pre-proline 0 N--CA 1.465 0.275 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.42 100.58 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.605 1.536 . . . . 1.0 112.915 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.5 -43.72 84.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.333 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.43 149.91 31.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -141.82 131.71 24.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.526 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 21' ' ' GLU . 66.4 t -139.17 158.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 121.124 0.488 . . . . 1.0 110.822 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' N ' HG12 ' A' ' 20' ' ' VAL . 97.4 mt-10 -106.29 123.06 47.46 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.523 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.71 -160.5 9.59 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -139.0 127.34 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.867 0.365 . . . . 1.0 110.557 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -87.14 123.89 32.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.628 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.7 mtm -107.35 137.45 45.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.61 149.13 50.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -66.61 0.32 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.791 -0.641 . . . . 1.0 112.566 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.21 -33.62 90.06 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.804 2.336 . . . . 1.0 113.537 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -174.46 -174.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.526 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -126.1 168.64 13.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.067 0.461 . . . . 1.0 110.635 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -153.88 143.78 15.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.459 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.3 146.55 93.76 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.486 1.458 . . . . 1.0 111.117 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.5 p -155.14 -172.88 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.579 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.73 136.7 16.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 103' ' ' ILE . 21.8 mt -101.53 122.75 44.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.823 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -128.19 123.26 33.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.237 0.541 . . . . 1.0 111.7 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.607 HD23 ' HB1' ' A' ' 115' ' ' ALA . 46.6 tp -94.77 122.09 37.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.02 151.08 51.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.084 0.469 . . . . 1.0 111.25 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -110.7 122.5 47.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.639 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -134.01 138.62 45.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.981 0.419 . . . . 1.0 110.843 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 58.96 33.8 23.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.41 77.2 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -131.15 155.73 46.51 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.83 135.2 36.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.327 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -145.5 139.57 26.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 47' ' ' ILE . 5.2 tt -105.27 120.75 42.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.84 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.597 ' N ' HD23 ' A' ' 46' ' ' LEU . 79.8 mt -104.46 127.25 58.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.318 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.41 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 65.1 mt -105.37 116.76 49.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -96.15 127.51 42.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.54 133.47 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.773 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -106.39 34.33 3.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.306 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.81 149.09 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.99 -38.04 89.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.391 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -59.19 -51.2 71.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.227 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -175.02 166.27 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.749 -0.659 . . . . 1.0 111.026 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -84.62 127.45 34.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.979 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.41 136.03 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.042 0.449 . . . . 1.0 110.439 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 9' ' ' PRO . 56.7 tt0 -100.01 109.38 21.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.184 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -102.34 113.49 26.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.957 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.63 123.09 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.899 0.38 . . . . 1.0 110.381 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -132.37 117.63 15.67 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.141 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.72 157.8 39.61 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.766 1.644 . . . . 1.0 112.645 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.69 123.57 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -173.71 -161.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -62.08 -39.08 91.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.192 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -67.37 -38.23 84.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.591 -0.277 . . . . 1.0 111.179 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -84.01 125.42 32.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 1.0 110.212 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -134.09 144.59 48.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.297 0.57 . . . . 1.0 110.745 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -127.11 120.66 29.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.278 -0.874 . . . . 1.0 109.251 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 70' ' ' VAL . 6.9 m -119.62 125.3 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.767 0.318 . . . . 1.0 110.596 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -90.25 118.29 29.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.7 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 . . . . . 0 N--CA 1.465 0.28 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.042 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.056 0.455 . . . . 1.0 110.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.75 -42.19 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.379 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.13 -24.46 26.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.941 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 30.0 t -113.34 124.75 53.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.247 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 83' ' ' SER . 90.5 m-20 -150.81 -171.75 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.124 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' OG ' ' A' ' 85' ' ' SER . 4.7 p 66.37 97.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.51 79.04 0.09 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 135.33 36.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.865 0.365 . . . . 1.0 111.946 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.58 113.38 26.65 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.412 -0.959 . . . . 1.0 108.412 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.44 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.3 pp -116.17 125.7 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 1.0 110.162 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 65.3 mtp180 -102.57 146.52 28.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.71 132.47 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.678 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -145.61 148.13 32.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.274 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.578 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 120.716 0.293 . . . . 1.0 110.302 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 90' ' ' ARG . 77.2 tt0 -65.85 127.96 34.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.164 0.507 . . . . 1.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -132.02 160.77 34.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.076 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.466 ' CZ ' ' NH2' ' A' ' 90' ' ' ARG . 85.5 mtt85 -123.58 144.08 49.81 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.953 0.406 . . . . 1.0 110.964 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 91.0 m-85 -143.95 155.95 44.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.947 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -138.71 146.44 41.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 1.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 35' ' ' LEU . 6.0 mm -127.39 90.46 48.66 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.37 -16.09 43.01 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.833 1.689 . . . . 1.0 112.65 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -87.57 100.9 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.15 -53.42 58.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.201 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -52.97 -42.21 65.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.668 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -71.56 -36.57 70.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.885 0.374 . . . . 1.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.48 -36.19 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.064 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.14 -44.41 95.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.478 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -66.72 -44.49 81.48 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.29 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -61.01 -49.37 77.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.204 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.01 -42.43 89.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.539 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.5 m -63.13 -43.8 97.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.419 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.607 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.03 -48.83 61.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.355 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.29 -43.44 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.56 -45.42 91.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.932 0.396 . . . . 1.0 110.257 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.86 85.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.338 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.38 -49.01 77.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.839 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -67.61 -37.69 82.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.776 0.322 . . . . 1.0 111.04 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -60.12 -44.34 94.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.053 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.28 94.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.395 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.8 -39.73 91.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.665 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.939 -1.029 . . . . 1.0 110.875 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HG2' HE21 ' A' ' 49' ' ' GLN . 36.5 Cg_endo . . . . . 0 N--CA 1.496 1.657 0 CA-C-O 120.87 0.279 . . . . 1.0 111.802 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -78.46 149.66 75.54 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.889 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.39 143.67 89.2 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.805 1.67 . . . . 1.0 111.621 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 m -78.7 -19.5 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.029 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.2 -33.51 84.6 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.32 170.59 15.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.03 0.443 . . . . 1.0 110.98 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -118.32 81.7 17.61 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.799 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.26 95.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.547 2.165 . . . . 1.0 112.7 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.21 -41.88 96.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.717 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.69 155.62 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.055 -0.975 . . . . 1.0 110.411 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -148.84 142.39 25.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.851 0.357 . . . . 1.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.96 161.05 23.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.304 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -94.99 122.51 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -125.34 167.19 17.78 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.2 mtp -117.6 103.01 9.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.864 0.364 . . . . 1.0 110.292 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' CE1' ' A' ' 101' ' ' PHE . 47.9 tp10 -60.22 121.37 11.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.109 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 102' ' ' GLU . 76.0 mtm -106.32 131.19 53.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.433 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.6 146.46 39.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.959 0.409 . . . . 1.0 109.998 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.22 -65.29 0.72 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.568 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.9 -33.38 95.88 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.627 2.218 . . . . 1.0 113.628 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -178.8 -169.53 0.17 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.659 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -132.65 168.91 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.951 0.405 . . . . 1.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 18.3 pt-20 -154.39 134.8 8.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.24 141.37 70.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 CA-C-N 120.264 1.13 . . . . 1.0 111.369 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 22' ' ' GLY . 28.5 p -149.17 -175.99 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.524 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.43 137.09 12.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.302 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 112' ' ' PHE . 47.7 mt -98.32 122.76 41.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.501 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.8 m -118.87 119.29 33.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.14 0.495 . . . . 1.0 111.283 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.429 HD23 ' HB1' ' A' ' 115' ' ' ALA . 54.7 tp -98.03 130.8 44.83 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.35 154.0 41.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.089 0.471 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -111.0 122.61 48.34 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -133.21 133.21 42.44 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 1.0 110.556 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 60.86 34.77 19.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.417 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.0 25.35 75.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.029 -0.829 . . . . 1.0 111.029 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -134.82 144.38 47.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.18 -0.304 . . . . 1.0 110.18 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.417 ' HB2' HE21 ' A' ' 123' ' ' GLN . 34.5 m-85 -88.39 136.51 32.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -143.73 144.54 31.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.051 0.453 . . . . 1.0 110.514 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.28 126.01 53.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.499 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.7 mt -111.71 131.64 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.151 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.5 mm -95.2 122.75 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' C ' HD12 ' A' ' 50' ' ' LEU . 13.2 mm100 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.818 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -109.92 136.12 49.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.809 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -104.81 20.41 18.78 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.25 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.8 mt-10 -40.43 141.07 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.88 0.371 . . . . 1.0 110.668 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.92 -39.64 92.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.474 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.47 -51.88 67.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.365 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -173.98 147.08 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.478 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 19.6 p80 -75.83 112.51 12.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 t -90.77 132.76 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -112.38 117.91 33.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.649 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -121.83 127.65 50.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -100.4 125.91 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.056 0.455 . . . . 1.0 110.487 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.67 93.2 35.46 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.438 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.78 145.05 85.26 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.147 1.898 . . . . 1.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 97.6 mt -85.88 117.66 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 53.2 p30 -176.73 -160.37 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.121 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.7 p -65.47 -23.25 66.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.283 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -83.76 -10.46 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.02 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 27.2 t80 -113.78 129.81 56.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.963 0.411 . . . . 1.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -129.67 155.73 45.39 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.582 0.706 . . . . 1.0 111.081 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 26.3 p -144.48 100.2 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.562 -1.199 . . . . 1.0 109.798 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 70' ' ' VAL . 33.2 m -102.53 122.39 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.844 0.355 . . . . 1.0 110.617 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 83' ' ' SER . 56.3 tt0 -98.81 125.4 44.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.05 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 . . . . . 0 CA--C 1.517 -0.326 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.914 179.47 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.984 0.421 . . . . 1.0 110.219 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.74 -42.56 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.527 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.17 -31.73 53.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.04 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.439 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 40.8 m -105.53 120.75 42.41 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.095 -0.335 . . . . 1.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 83' ' ' SER . 90.5 m-20 -150.16 -167.99 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.227 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.87 86.77 0.12 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.33 69.84 1.27 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.005 -1.638 . . . . 1.0 109.005 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.3 142.57 27.26 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.047 0.451 . . . . 1.0 111.896 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -128.3 131.18 48.69 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.96 162.72 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.323 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.764 ' NH2' HH22 ' A' ' 100' ' ' ARG . 68.0 mtt180 -128.58 140.48 51.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.96 134.7 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.99 0.424 . . . . 1.0 110.626 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.85 140.06 52.63 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.334 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 -179.821 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 98' ' ' GLU . 3.9 ptm180 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.318 0.104 . . . . 1.0 110.798 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 97' ' ' ARG . 47.8 tp10 -174.97 93.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 1.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -104.56 135.05 46.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.764 HH22 ' NH2' ' A' ' 90' ' ' ARG . 57.4 mtp85 -101.37 150.25 23.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.937 0.399 . . . . 1.0 110.812 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.549 ' CE1' ' OE1' ' A' ' 24' ' ' GLU . 70.1 m-85 -129.24 154.9 46.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.556 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 25' ' ' MET . 81.4 tt0 -149.04 121.73 8.63 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.988 0.423 . . . . 1.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.16 98.41 26.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.78 -10.67 25.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.68 1.587 . . . . 1.0 112.595 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -94.35 106.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.86 -54.98 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.002 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -50.07 -44.85 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.519 -0.473 . . . . 1.0 110.464 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -68.57 -40.19 80.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 1.0 110.642 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.16 -36.85 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.033 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -63.7 -44.66 93.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.46 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.26 -45.22 81.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.312 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 53.3 t80 -61.48 -49.1 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.405 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.4 -41.58 80.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.344 -0.542 . . . . 1.0 111.238 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.2 t -63.36 -44.97 93.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.686 0.279 . . . . 1.0 111.535 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.63 -50.32 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.465 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.8 -45.18 99.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.592 -0.276 . . . . 1.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -60.67 -46.01 91.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 110.318 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.09 76.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 1.0 110.533 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.44 99.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.818 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -66.38 -40.2 89.54 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.663 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -63.25 -44.22 95.79 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.624 0.726 . . . . 1.0 110.115 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.4 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.174 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' A' ' 63' ' ' ILE . 89.3 mt-30 -66.26 -40.58 90.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.742 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.599 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 N--CA 1.498 1.746 0 CA-C-O 120.853 0.272 . . . . 1.0 111.958 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.62 162.17 0.99 Allowed Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.826 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.83 152.41 64.04 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.488 1.459 . . . . 1.0 111.443 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -85.97 70.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.692 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.86 -26.93 0.39 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.57 140.67 53.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 111.035 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 15.5 mm100 -102.54 80.95 0.35 Allowed Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.69 88.42 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.681 1.587 . . . . 1.0 112.152 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.695 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.42 137.58 38.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.578 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.28 125.76 26.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 21' ' ' GLU . 54.6 t -135.93 157.07 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.767 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.523 ' OE1' ' HB2' ' A' ' 34' ' ' ALA . 46.7 tp10 -105.79 122.96 47.16 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.98 -157.76 8.78 Favored Glycine 0 N--CA 1.463 0.491 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -140.51 123.59 16.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.886 0.374 . . . . 1.0 110.36 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -88.94 119.32 29.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.518 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.3 mpp? -107.58 136.04 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.509 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.68 149.08 52.6 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -65.82 0.41 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.635 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.83 -32.62 85.7 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.814 2.343 . . . . 1.0 113.705 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -174.43 -176.72 1.12 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.434 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -126.72 169.1 13.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 1.0 110.682 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -158.15 141.98 11.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.553 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.25 144.34 95.33 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.297 1.331 . . . . 1.0 110.985 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.3 p -152.01 174.21 13.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.321 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -140.09 131.78 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.955 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 103' ' ' ILE . 31.1 mt -96.63 121.6 38.64 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.999 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.3 m -129.24 124.67 35.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.197 0.522 . . . . 1.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.572 HD23 ' HB1' ' A' ' 115' ' ' ALA . 37.4 tp -90.24 125.86 35.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.432 -0.803 . . . . 1.0 108.851 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.86 155.45 42.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.127 0.489 . . . . 1.0 111.052 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.523 ' OE1' ' CZ ' ' A' ' 44' ' ' TYR . 20.6 tt0 -134.19 116.52 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.829 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.464 ' CZ ' ' OE1' ' A' ' 45' ' ' GLU . 34.2 ptt180 -137.25 144.21 42.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.233 0.539 . . . . 1.0 111.248 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 59.11 28.05 17.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.107 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.04 78.37 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -127.31 137.88 52.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CZ ' ' OE1' ' A' ' 39' ' ' GLN . 84.1 m-85 -87.92 135.72 33.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 40' ' ' ARG . 22.6 pt-20 -144.89 144.61 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 1.0 110.482 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.9 tp -103.76 121.16 42.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.292 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.2 mt -105.16 124.77 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.944 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.35 115.89 49.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.43 ' C ' HD12 ' A' ' 50' ' ' LEU . 80.4 mt-30 -96.78 131.8 43.13 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.983 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 49' ' ' GLN . 9.1 mp -106.82 130.43 54.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.805 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -104.06 29.17 6.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.126 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE1' ' OE2' ' A' ' 54' ' ' GLU . 96.6 mt-10 -43.69 145.6 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.606 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.14 -36.07 82.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' OE2' ' OE1' ' A' ' 52' ' ' GLU . 3.3 pt-20 -62.03 -46.72 87.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -177.29 154.96 1.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.567 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -78.01 127.84 32.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.0 109.876 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.42 135.94 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.042 0.449 . . . . 1.0 110.474 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -108.6 126.37 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.158 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.82 119.02 36.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.716 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.5 mm -92.75 112.64 26.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.93 0.395 . . . . 1.0 110.369 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mm -117.64 89.44 32.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.221 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.67 141.44 95.47 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.228 1.952 . . . . 1.0 112.455 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -83.53 124.81 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.558 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.627 ' ND2' ' CD2' ' A' ' 66' ' ' HIS . 5.2 p30 176.04 -165.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.963 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -59.19 -38.04 78.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.706 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CD2' ' ND2' ' A' ' 64' ' ' ASN . 3.3 p80 -74.54 -2.75 27.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.75 0.31 . . . . 1.0 111.401 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 42.0 t80 -116.25 132.21 56.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.155 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -130.71 148.29 52.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.861 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 t -143.2 104.32 4.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.052 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.21 128.14 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.885 0.374 . . . . 1.0 110.886 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 8.2 tp-100 -78.9 96.15 5.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.821 -179.826 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.835 0.35 . . . . 1.0 110.289 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.86 -41.99 94.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.493 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.01 -22.52 5.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.905 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t -111.42 122.84 48.9 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.054 0.454 . . . . 1.0 110.414 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -148.74 -166.79 2.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.07 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 t 56.82 88.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.73 72.52 0.7 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.447 -1.461 . . . . 1.0 109.447 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 134.94 36.28 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.799 0.333 . . . . 1.0 111.686 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.488 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 63.8 mttp -111.87 131.63 55.23 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 35' ' ' LEU . 34.2 pt -125.15 157.96 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.74 ' NH2' HH22 ' A' ' 100' ' ' ARG . 96.9 mtt180 -131.19 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.2 132.25 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -146.91 154.71 41.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.358 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.667 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -63.42 136.08 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.409 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -136.13 159.14 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.131 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.74 HH22 ' NH2' ' A' ' 90' ' ' ARG . 66.6 mtp85 -122.23 145.11 48.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.061 0.458 . . . . 1.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -140.21 155.67 46.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.175 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -139.41 141.51 37.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.891 0.376 . . . . 1.0 111.06 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.506 HD11 HD12 ' A' ' 35' ' ' LEU . 5.1 mm -124.03 89.45 51.69 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.62 -15.62 37.72 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.85 1.7 . . . . 1.0 112.762 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -88.65 105.12 17.46 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.4 tt0 -60.43 -53.84 52.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.23 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -53.06 -42.45 65.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.571 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -70.27 -37.68 74.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.492 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.61 -34.44 74.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.423 . . . . 1.0 111.001 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.72 -44.74 95.44 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.309 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.87 -43.25 84.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.164 -0.615 . . . . 1.0 110.579 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.476 ' CE2' HD13 ' A' ' 89' ' ' ILE . 59.1 t80 -60.27 -49.2 78.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.293 -0.867 . . . . 1.0 111.211 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.9 -41.86 86.43 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.336 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 57.8 m -63.53 -44.17 95.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.822 0.344 . . . . 1.0 111.451 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -70.34 -48.8 54.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.609 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' CE1' ' A' ' 112' ' ' PHE . 62.3 t -65.45 -43.57 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.904 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.92 -45.11 93.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 110.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.92 -38.85 89.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.6 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.3 -49.34 76.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.765 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.48 -36.78 74.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.335 . . . . 1.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.76 -44.93 94.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.158 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.9 95.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.285 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -67.86 -41.23 83.22 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.63 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 N--CA 1.497 1.7 0 CA-C-O 120.872 0.28 . . . . 1.0 111.77 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.1 155.6 16.15 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.158 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.55 143.86 99.48 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.336 1.358 . . . . 1.0 111.628 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.6 -44.96 93.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.14 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.62 78.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 140.41 58.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 1.0 110.961 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -104.07 80.7 0.44 Allowed Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.242 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.75 99.95 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.98 1.787 . . . . 1.0 112.102 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -64.65 -43.85 92.3 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.392 0.615 . . . . 1.0 110.154 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.87 141.36 24.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.19 -0.914 . . . . 1.0 109.932 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -131.64 128.87 40.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.212 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.9 162.25 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.147 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -99.75 122.62 43.0 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -123.06 179.2 16.2 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 93.3 mmm -126.15 99.61 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' A' ' 99' ' ' ARG . 81.3 tt0 -62.29 132.54 52.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.098 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 73.9 mtm -120.8 140.25 51.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.782 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -141.56 148.68 39.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.32 -65.59 0.34 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.779 -0.646 . . . . 1.0 112.504 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.63 -31.85 92.62 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.65 2.233 . . . . 1.0 114.108 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 29' ' ' LEU . 1.0 OUTLIER 179.35 176.28 0.63 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.399 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -118.01 169.2 9.85 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 1.0 110.177 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.39 141.9 13.25 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.448 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 144.91 96.39 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.026 1.15 . . . . 1.0 111.359 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 22' ' ' GLY . 17.1 p -153.58 -179.84 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.438 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' C ' HD22 ' A' ' 35' ' ' LEU . . . -138.93 128.64 24.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.081 0.467 . . . . 1.0 110.239 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 35' ' ' LEU . 3.9 mm? -100.52 119.66 38.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.966 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.6 m -130.66 122.01 26.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.0 111.853 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.661 HD23 ' HB1' ' A' ' 115' ' ' ALA . 57.5 tp -90.42 129.99 36.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.006 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.29 148.63 41.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.44 . . . . 1.0 111.457 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -109.02 121.24 44.72 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.66 136.65 46.6 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.057 0.456 . . . . 1.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 59.73 33.66 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.908 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.37 77.82 Favored Glycine 0 N--CA 1.463 0.476 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -130.36 154.39 47.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.483 -0.359 . . . . 1.0 110.055 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -92.58 135.1 34.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -143.94 143.81 31.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 1.0 110.317 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -103.89 124.78 49.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.423 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.53 118.07 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.7 mt -103.44 120.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.643 -0.502 . . . . 1.0 109.643 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' HD12 ' A' ' 50' ' ' LEU . 79.1 mt-30 -115.08 129.58 56.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.762 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.4 mp -101.22 127.37 47.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -76.73 62.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.298 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.3 154.34 40.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.252 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -62.46 -40.83 97.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.193 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.33 -82.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.882 0.372 . . . . 1.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -142.29 152.14 42.7 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -70.71 123.07 21.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.22 133.89 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.12 0.486 . . . . 1.0 110.481 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -95.23 123.92 38.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -120.45 117.08 26.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.444 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.22 110.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.911 0.386 . . . . 1.0 110.626 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm -115.16 119.07 39.31 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.165 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.01 150.83 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.797 1.665 . . . . 1.0 112.669 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.442 HG23 HE21 ' A' ' 120' ' ' GLN . 97.8 mt -104.46 118.35 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.319 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -172.22 -153.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.234 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.0 p -64.16 -40.24 95.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.191 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -66.6 -41.15 88.92 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 8.0 t80 -96.23 130.1 43.39 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.788 0.328 . . . . 1.0 110.18 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -139.42 142.54 37.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.541 . . . . 1.0 110.826 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -119.91 115.5 23.92 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.12 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.77 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.91 0.386 . . . . 1.0 110.644 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.427 ' OE1' HD13 ' A' ' 113' ' ' LEU . 19.7 tt0 -81.05 107.18 13.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.416 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.458 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 83' ' ' SER . 89.0 m-20 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 1.0 110.139 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.41 -42.74 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.757 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.86 -9.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.233 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 80' ' ' ASP . 3.2 t -139.98 136.43 33.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 1.0 110.239 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' A' ' 85' ' ' SER . 91.5 m-20 -148.54 -173.07 4.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.827 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 85' ' ' SER . 3.0 p 75.7 99.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.44 77.7 0.13 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.499 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.41 139.78 30.67 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.246 0.461 . . . . 1.0 112.246 -177.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -113.1 125.2 54.11 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.334 -0.987 . . . . 1.0 108.334 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pt -119.02 130.46 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.444 ' CZ ' HH11 ' A' ' 100' ' ' ARG . 20.2 mmt180 -96.26 142.59 28.22 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.9 t -124.93 135.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 1.0 110.197 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -131.47 139.36 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.012 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.548 0 N-CA-C 110.808 -0.917 . . . . 1.0 110.808 -179.947 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.65 0.262 . . . . 1.0 110.771 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -175.51 108.22 0.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.426 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' A' ' 24' ' ' GLU . 85.6 mtp180 -107.05 123.84 48.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.662 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.444 HH11 ' CZ ' ' A' ' 90' ' ' ARG . 94.9 mtt-85 -83.97 146.28 28.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.183 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.17 147.48 36.68 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.241 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.05 152.33 39.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.705 0.288 . . . . 1.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -126.84 102.49 25.07 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.89 -13.06 29.08 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.648 1.565 . . . . 1.0 112.953 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -91.81 105.4 17.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.14 -54.82 42.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.167 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.687 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.439 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.55 -38.93 81.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 1.0 110.348 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.494 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -57.09 -36.43 70.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.798 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.0 mt -61.88 -46.28 90.11 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.152 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.85 -44.53 80.77 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.905 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.32 -48.87 76.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.499 HD11 ' SG ' ' A' ' 87' ' ' CYS . 95.9 mt -65.91 -41.66 91.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.552 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.7 m -62.16 -43.46 98.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.831 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.29 -47.32 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HA ' HD22 ' A' ' 37' ' ' LEU . 76.6 t -66.59 -42.49 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.953 0.406 . . . . 1.0 111.158 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.32 -42.68 91.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.167 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.76 90.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.05 87.9 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.623 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 63' ' ' ILE . 60.2 mm-40 -69.9 -38.31 76.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.97 -46.04 92.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.055 0.455 . . . . 1.0 109.832 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.15 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.48 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.39 -39.07 88.83 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.605 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.451 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo . . . . . 0 N--CA 1.499 1.828 0 CA-C-O 120.904 0.294 . . . . 1.0 112.071 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.6 mt -71.08 150.03 94.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.859 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.76 142.03 61.92 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.914 1.742 . . . . 1.0 111.466 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.32 -32.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.734 -0.667 . . . . 1.0 111.349 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.05 -36.36 90.18 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB1' ' HB1' ' A' ' 38' ' ' ALA . . . -80.7 165.87 21.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 1.0 110.978 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -119.53 80.67 22.9 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.602 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.23 96.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.676 2.251 . . . . 1.0 112.773 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.3 mt -65.37 -41.43 93.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.83 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.06 146.59 27.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.251 -0.886 . . . . 1.0 110.36 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 t -134.31 131.06 37.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.807 0.337 . . . . 1.0 110.542 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 35' ' ' LEU . 28.3 m -137.97 160.79 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.367 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -100.08 154.79 18.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.623 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -169.92 -169.61 33.35 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 23' ' ' MET . 2.5 mpt? -132.2 129.19 39.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 1.0 110.388 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -91.97 117.36 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.44 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.8 mtm -101.49 135.66 42.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.789 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.79 151.47 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.714 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -67.03 0.33 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.667 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.35 -33.77 88.48 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.882 2.388 . . . . 1.0 113.603 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.519 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.36 -176.61 0.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -122.07 168.45 11.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.11 0.481 . . . . 1.0 110.695 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -155.28 142.41 13.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.737 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.03 143.39 94.97 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.355 1.37 . . . . 1.0 111.257 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 22' ' ' GLY . 12.4 p -153.57 -179.2 7.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.385 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.23 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.936 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.52 HD13 HD11 ' A' ' 89' ' ' ILE . 26.6 mt -101.58 123.77 46.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.5 m -127.43 124.29 38.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.227 0.537 . . . . 1.0 111.357 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.618 HD23 ' HB1' ' A' ' 115' ' ' ALA . 54.7 tp -91.59 128.93 37.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.016 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.45 148.68 43.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.159 0.504 . . . . 1.0 111.388 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -109.23 123.06 48.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.723 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -135.09 135.81 41.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.967 0.413 . . . . 1.0 111.194 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 60.13 34.59 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.658 -0.701 . . . . 1.0 111.523 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.4 21.75 76.11 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -129.89 156.76 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -98.54 132.46 43.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -140.79 147.08 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.44 . . . . 1.0 110.065 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -103.99 122.21 44.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.438 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.52 117.76 51.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -99.75 118.41 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' HD12 ' A' ' 50' ' ' LEU . 77.0 mt-30 -100.03 131.64 45.87 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.442 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.6 mp -105.99 123.34 47.84 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -80.11 36.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.154 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' LEU . 35.0 tp10 -46.47 135.0 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.985 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.4 -35.88 81.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -66.79 -80.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.402 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -132.57 129.28 38.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.933 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -61.94 102.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.922 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.91 131.44 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -107.79 136.57 47.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.956 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 40.6 t0 -101.03 123.5 45.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.5 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.31 119.26 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 1.0 110.3 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.459 HD11 ' NH1' ' A' ' 99' ' ' ARG . 6.8 mt -133.11 119.23 15.52 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.896 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.49 157.21 40.82 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.678 1.586 . . . . 1.0 112.598 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.46 119.67 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.537 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -171.89 -160.06 0.15 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.43 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 t -61.12 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.041 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -64.81 -36.15 83.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.875 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 64' ' ' ASN . 28.2 t80 -95.0 136.87 34.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.968 0.413 . . . . 1.0 110.439 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 92' ' ' GLN . 37.5 ptt180 -143.38 145.99 33.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.904 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 27.5 p -117.0 99.66 7.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.384 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' VAL . 31.8 m -102.82 124.26 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.032 0.444 . . . . 1.0 110.985 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.2 tp-100 -83.14 100.84 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.381 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.792 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.88 0.372 . . . . 1.0 110.376 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.94 -42.47 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.675 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.33 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.029 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -106.9 78.26 1.23 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.099 0.476 . . . . 1.0 110.577 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.421 ' ND2' HD21 ' A' ' 110' ' ' LEU . 92.4 m-20 -104.67 -170.4 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.378 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.404 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.4 m 64.59 88.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.69 82.92 0.06 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.56 135.24 41.27 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.834 0.309 . . . . 1.0 111.834 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 65.7 mttp -111.53 128.71 56.1 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.52 HD11 HD13 ' A' ' 35' ' ' LEU . 33.6 pt -125.01 157.35 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.31 134.63 45.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.99 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.46 132.94 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.366 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 98' ' ' GLU . 86.2 mt-30 -135.4 152.79 51.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.024 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 1.0 110.765 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 48.5 tp10 -61.01 128.45 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 1.0 110.526 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.459 ' NH1' HD11 ' A' ' 61' ' ' ILE . 99.9 mtt180 -135.35 143.39 46.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.033 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -127.16 145.99 50.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.752 0.31 . . . . 1.0 111.181 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -144.25 153.72 42.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.357 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -143.51 147.35 34.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.972 0.415 . . . . 1.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.452 HD11 HD12 ' A' ' 35' ' ' LEU . 5.1 mp -128.03 98.73 26.5 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 -11.29 28.6 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.706 1.604 . . . . 1.0 112.67 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 105.3 17.6 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.2 tt0 -59.09 -53.98 52.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -50.75 -43.52 58.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.576 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -69.97 -40.21 75.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.879 0.371 . . . . 1.0 110.531 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -57.1 -34.87 68.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.083 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.421 HD21 ' ND2' ' A' ' 84' ' ' ASN . 96.0 mt -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.519 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.48 -44.84 81.56 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.185 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CE2' HD13 ' A' ' 89' ' ' ILE . 57.0 t80 -59.88 -48.67 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.158 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.11 -41.36 86.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.389 -0.525 . . . . 1.0 111.281 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -65.59 -46.08 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.607 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.618 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.13 -50.05 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.318 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.4 HG21 ' CE1' ' A' ' 112' ' ' PHE . 61.5 t -64.15 -44.21 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.66 -45.21 95.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.421 . . . . 1.0 110.196 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.42 82.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.452 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.44 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.678 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.462 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 87.3 mt-30 -69.77 -38.6 76.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.407 . . . . 1.0 110.84 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -63.95 -44.46 92.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.039 0.447 . . . . 1.0 110.919 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.95 75.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.866 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.85 -40.51 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 1.0 110.571 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.595 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.496 1.661 0 CA-C-O 120.956 0.315 . . . . 1.0 112.025 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.76 144.44 85.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.956 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.64 148.51 53.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.797 1.665 . . . . 1.0 111.841 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.18 -43.15 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.563 . . . . 1.0 111.109 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.5 -36.64 47.79 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.76 151.12 47.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 1.0 110.825 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -118.15 83.57 20.12 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.326 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.56 125.04 16.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.262 1.975 . . . . 1.0 112.431 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.7 mt -101.1 -32.66 10.47 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.428 -0.805 . . . . 1.0 109.632 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.48 151.19 29.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.326 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -146.33 129.17 16.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.859 0.361 . . . . 1.0 110.556 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -141.43 163.15 20.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.259 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -101.37 122.43 43.72 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -131.54 152.11 19.96 Favored Glycine 0 N--CA 1.464 0.555 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 mmm -99.19 100.66 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.999 0.428 . . . . 1.0 110.187 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.84 126.8 28.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.589 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.441 ' SD ' ' C ' ' A' ' 101' ' ' PHE . 1.6 mpp? -109.85 137.16 48.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.03 149.79 50.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.635 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.28 -66.23 0.3 Allowed Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.915 -0.584 . . . . 1.0 112.633 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.49 -33.28 88.15 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.796 2.331 . . . . 1.0 113.484 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -177.79 -172.51 0.35 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.672 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -122.67 168.87 11.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.047 0.451 . . . . 1.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -154.12 140.87 13.12 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.723 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.22 142.0 84.71 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.267 1.312 . . . . 1.0 111.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' GLY . 13.6 p -150.95 169.23 22.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.551 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.18 118.94 19.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 109.852 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 101' ' ' PHE . 13.2 mt -91.92 126.3 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.012 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.6 m -130.81 120.69 24.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.095 0.474 . . . . 1.0 111.344 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.523 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.6 tp -90.38 130.99 36.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.07 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.81 148.17 32.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.173 0.511 . . . . 1.0 111.362 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.72 127.01 48.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -138.0 138.15 38.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.887 0.375 . . . . 1.0 111.007 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.44 35.22 24.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.662 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.56 27.56 73.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.7 158.95 43.28 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -99.27 130.34 45.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.908 -0.405 . . . . 1.0 109.908 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.27 143.77 34.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.931 0.396 . . . . 1.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.4 125.21 50.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.275 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -103.31 124.6 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mt -99.25 128.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' C ' HD12 ' A' ' 50' ' ' LEU . 14.2 mm100 -118.4 119.62 35.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.691 0.282 . . . . 1.0 110.807 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.0 mp -100.58 131.18 46.63 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.572 ' HD1' ' CD2' ' A' ' 56' ' ' HIS . 95.4 m-70 -94.29 60.53 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 1.0 110.413 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.24 157.6 10.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.183 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.15 -38.74 87.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.754 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 54' ' ' GLU . 56.6 mp0 -78.96 -104.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.226 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -106.52 152.49 23.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.572 ' CD2' ' HD1' ' A' ' 51' ' ' HIS . 60.7 m80 -73.3 145.77 45.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.233 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.76 130.7 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.983 0.42 . . . . 1.0 110.303 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -106.53 108.08 19.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.788 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -116.74 113.05 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.633 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.41 115.64 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.387 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.05 120.18 39.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.38 147.89 33.15 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.791 1.661 . . . . 1.0 112.498 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.58 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 96.4 mt -92.8 122.49 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.228 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.6 p30 -174.16 -159.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.353 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -41.25 90.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.2 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -66.06 -36.28 82.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.353 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . 15.1 t80 -101.54 123.63 45.88 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -133.81 141.08 47.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.326 0.584 . . . . 1.0 111.026 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.0 t -103.31 105.87 16.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.245 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 70' ' ' VAL . 5.9 m -111.07 126.4 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.229 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 83' ' ' SER . 20.8 tt0 -97.49 131.1 44.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.492 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.374 -179.589 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.659 ' HB3' HD12 ' A' ' 113' ' ' LEU . 94.8 m-20 . . . . . 0 N--CA 1.463 0.225 0 CA-C-O 121.034 0.445 . . . . 1.0 110.396 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 41.0 mm -64.58 -42.26 94.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.68 -27.02 15.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.815 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.552 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 9.5 t -123.81 119.1 28.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.043 0.449 . . . . 1.0 110.314 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 83' ' ' SER . 23.4 m120 -146.73 -167.0 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 1.0 109.827 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.24 92.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.05 67.18 2.18 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 108.892 -1.683 . . . . 1.0 108.892 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 148.95 25.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.221 0.534 . . . . 1.0 111.596 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HE2' HH21 ' A' ' 90' ' ' ARG . 25.2 pttm -129.85 135.83 48.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.335 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.33 162.89 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.306 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.418 HH21 ' HE2' ' A' ' 88' ' ' LYS . 3.4 mpt_? -123.99 137.52 54.59 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.8 t -116.92 133.84 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.922 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -140.77 152.77 45.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.115 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.551 0 N-CA-C 110.552 -1.019 . . . . 1.0 110.552 179.824 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.833 0.349 . . . . 1.0 110.946 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -63.46 140.3 58.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -141.03 154.19 45.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.153 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -125.52 154.18 42.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.979 0.419 . . . . 1.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.441 ' C ' ' SD ' ' A' ' 25' ' ' MET . 98.5 m-85 -138.33 158.7 43.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.769 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -144.72 123.45 12.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mm -110.45 96.62 28.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.15 -14.55 28.8 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.536 1.491 . . . . 1.0 112.674 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -94.32 113.66 25.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.974 0.416 . . . . 1.0 110.002 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.03 -55.09 39.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.231 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -52.06 -43.34 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.654 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -68.2 -38.55 82.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.914 0.388 . . . . 1.0 110.131 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.232 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.4 -45.39 91.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.644 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -66.3 -45.41 80.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.974 -0.69 . . . . 1.0 110.703 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.46 -49.61 76.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.284 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 80' ' ' ASP . 3.4 mm? -65.44 -42.56 92.26 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.382 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -63.83 -45.14 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.735 0.303 . . . . 1.0 111.478 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.523 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -64.93 -50.83 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.441 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.68 -46.37 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.03 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.01 -48.02 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 1.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.99 78.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.548 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.24 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.553 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -65.51 -44.8 85.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -66.21 -43.43 86.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.504 0.668 . . . . 1.0 110.488 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.32 78.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.904 -1.044 . . . . 1.0 111.998 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.58 ' NE2' ' O ' ' A' ' 63' ' ' ILE . 17.2 pt20 -72.2 -38.32 69.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.48 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.062 -0.971 . . . . 1.0 110.567 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo . . . . . 0 N--CA 1.497 1.712 0 CA-C-O 120.886 0.286 . . . . 1.0 111.969 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 10' ' ' LEU . 3.9 mp -66.79 149.15 98.53 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.99 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.05 143.9 91.63 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.67 1.58 . . . . 1.0 111.429 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.88 -43.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.178 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.4 51.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.39 137.78 44.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.059 0.457 . . . . 1.0 111.025 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -98.95 108.6 50.11 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.57 103.87 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.532 1.488 . . . . 1.0 112.789 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.88 -43.6 83.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.191 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.21 148.95 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.216 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -138.34 131.36 29.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.765 0.317 . . . . 1.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.21 160.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.158 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 34' ' ' ALA . 41.8 tp10 -100.1 122.67 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 33' ' ' CYS . . . -132.26 158.16 22.82 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 84.1 mmm -99.37 120.88 40.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.887 0.375 . . . . 1.0 110.203 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.85 118.24 24.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.693 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -102.65 137.21 41.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.07 152.86 52.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.266 -0.425 . . . . 1.0 109.982 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.38 -66.48 0.36 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.894 -0.593 . . . . 1.0 112.506 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.22 -32.92 73.34 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.747 2.298 . . . . 1.0 113.877 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.29 -170.3 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 121.105 -0.238 . . . . 1.0 110.385 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -124.71 169.28 12.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.962 0.41 . . . . 1.0 110.25 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 9.3 pt-20 -153.57 133.19 7.33 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.797 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.29 142.56 78.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 CA-C-N 120.245 1.123 . . . . 1.0 111.34 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 22' ' ' GLY . 8.9 p -152.1 -170.18 3.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.526 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.472 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -156.8 131.3 8.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.293 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -100.84 123.16 44.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.088 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.4 m -126.34 112.33 15.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.298 0.57 . . . . 1.0 111.723 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.679 HD23 ' HB1' ' A' ' 115' ' ' ALA . 55.4 tp -80.47 127.75 32.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.378 -0.828 . . . . 1.0 109.086 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.06 148.28 36.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.441 . . . . 1.0 111.445 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -102.42 128.99 48.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.901 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -139.9 136.97 34.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.931 0.396 . . . . 1.0 110.872 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 59.18 33.78 22.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.513 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.93 22.56 78.38 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.443 ' CD ' ' H ' ' A' ' 44' ' ' TYR . 7.3 tp-100 -132.58 157.13 45.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.443 ' H ' ' CD ' ' A' ' 43' ' ' GLN . 81.0 m-85 -96.3 131.84 42.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -144.06 143.88 31.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 1.0 110.404 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.1 tp -104.2 124.96 50.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.257 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.8 mt -100.12 124.81 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.118 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.9 mt -96.53 117.54 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' C ' HD12 ' A' ' 50' ' ' LEU . 36.4 mt-30 -109.15 130.58 55.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.7 mp -104.94 127.76 52.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 51.0 t-80 -93.8 25.39 3.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.9 mt-10 -55.02 137.55 46.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.45 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -62.72 -39.7 94.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.26 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -53.47 -51.18 63.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.913 0.387 . . . . 1.0 110.18 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -166.72 148.21 6.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.767 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.03 86.8 6.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.869 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 t -80.81 133.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.539 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -128.29 119.28 24.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.744 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.37 129.64 55.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -96.41 114.66 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.775 0.321 . . . . 1.0 110.273 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.03 121.37 35.32 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.18 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 155.48 42.57 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.987 1.792 . . . . 1.0 112.628 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' CG ' ' A' ' 64' ' ' ASN . 98.0 mt -98.13 112.79 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.373 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 78.6 m-20 -161.68 -160.67 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.6 t -60.35 -41.94 94.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -66.17 -36.75 83.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.021 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 19.2 t80 -93.03 124.09 36.76 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.823 0.344 . . . . 1.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.49 141.75 45.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.289 0.566 . . . . 1.0 110.769 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.507 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 26.6 p -113.46 99.7 7.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.222 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -109.45 128.46 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.448 . . . . 1.0 111.049 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 72' ' ' GLU . 5.3 tp-100 -80.77 116.86 20.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' GLN . 17.7 pt-20 . . . . . 0 N--CA 1.469 0.492 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.645 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.181 0.515 . . . . 1.0 110.077 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.65 -42.61 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.693 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.82 -26.01 44.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.126 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.53 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 5.7 t -104.28 102.61 12.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 83' ' ' SER . 9.8 m120 -136.27 -168.94 2.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.994 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.403 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 2.3 m 62.13 82.58 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.17 77.35 0.26 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 132.64 37.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.798 0.332 . . . . 1.0 111.751 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.22 129.49 55.71 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.404 HD13 ' HE2' ' A' ' 112' ' ' PHE . 48.5 pt -126.83 160.15 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -130.52 133.96 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.482 . . . . 1.0 109.849 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.2 t -114.54 134.55 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.418 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.43 154.96 41.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.327 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.828 0.347 . . . . 1.0 110.879 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -59.66 137.63 57.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.468 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.43 154.53 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.082 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -124.74 150.97 45.66 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.185 0.517 . . . . 1.0 111.394 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -143.83 156.86 44.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.43 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -148.56 118.67 7.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.048 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.62 99.8 12.55 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.83 -11.82 28.03 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.542 1.495 . . . . 1.0 112.887 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -91.42 106.19 18.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 85' ' ' SER . 80.3 tt0 -59.98 -52.91 63.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.091 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -52.24 -43.83 64.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.406 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.47 -38.96 77.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.0 110.564 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -35.22 71.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.024 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -45.33 93.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.306 -0.558 . . . . 1.0 111.148 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.77 -43.22 84.6 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.787 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.404 ' HE2' HD13 ' A' ' 89' ' ' ILE . 51.8 t80 -61.1 -49.39 77.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.077 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 113' ' ' LEU . 95.8 mt -66.24 -42.02 89.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.472 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 m -63.12 -45.38 92.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 1.0 111.317 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.679 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -66.55 -49.03 67.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.33 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.46 -45.65 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.977 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -60.98 -45.1 96.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.034 0.445 . . . . 1.0 110.148 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.22 -37.76 86.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.459 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.18 -49.99 73.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.679 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.503 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 92.3 mt-30 -70.69 -38.07 73.68 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.227 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.72 -43.09 94.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.007 0.432 . . . . 1.0 110.517 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.6 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.33 -35.82 68.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 1.0 110.752 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.019 -0.991 . . . . 1.0 110.476 -179.905 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 N--CA 1.497 1.722 0 CA-C-O 121.012 0.338 . . . . 1.0 111.986 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.38 84.01 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.774 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.51 140.48 94.22 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.857 1.705 . . . . 1.0 111.542 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.89 -43.79 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.215 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -37.34 -38.88 0.44 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.38 -0.688 . . . . 1.0 111.38 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.28 147.95 41.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.722 0.296 . . . . 1.0 110.538 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -98.2 102.43 14.01 Favored Pre-proline 0 C--O 1.223 -0.338 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -75.28 103.14 1.68 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.5 1.467 . . . . 1.0 113.522 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.1 mt -67.12 -41.84 85.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.178 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 155.31 40.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.259 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -143.49 130.64 20.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.42 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 21' ' ' GLU . 47.9 t -141.31 159.08 22.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.698 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 20' ' ' VAL . 83.0 tt0 -104.55 121.13 42.86 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -123.56 -169.51 13.22 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.837 -0.905 . . . . 1.0 110.837 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 89.3 mmm -136.94 101.47 4.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.87 0.367 . . . . 1.0 110.037 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.578 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.0 tt0 -61.05 128.8 38.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.609 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -106.01 136.38 45.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.312 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -135.64 151.91 50.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.72 -68.15 0.29 Allowed Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.74 -0.664 . . . . 1.0 112.605 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.93 -32.47 92.54 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.864 2.376 . . . . 1.0 113.553 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -179.85 -167.01 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.344 -0.243 . . . . 1.0 110.344 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -122.46 168.5 12.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.888 0.375 . . . . 1.0 110.201 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -146.21 138.73 13.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.653 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.34 139.63 73.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 CA-C-N 120.171 1.097 . . . . 1.0 111.418 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.578 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 17.2 p -153.65 177.68 10.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -147.56 138.72 23.63 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.905 0.383 . . . . 1.0 110.122 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.704 ' N ' HD12 ' A' ' 35' ' ' LEU . 5.5 mp -102.62 120.57 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 1.0 109.999 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -127.31 113.17 15.92 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.28 0.562 . . . . 1.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.647 HD23 ' HB1' ' A' ' 115' ' ' ALA . 45.5 tp -86.48 127.51 34.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.434 -0.803 . . . . 1.0 108.975 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.94 156.56 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.16 0.505 . . . . 1.0 111.484 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -113.87 122.65 47.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.608 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -133.32 137.89 46.15 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.886 0.374 . . . . 1.0 110.919 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 59.13 34.17 23.18 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.606 -0.725 . . . . 1.0 111.513 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.77 25.34 75.22 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.771 -0.931 . . . . 1.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -134.09 153.33 51.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -93.53 134.9 35.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.02 143.79 31.35 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.963 0.411 . . . . 1.0 110.264 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.0 tp -103.46 116.56 32.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.356 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.8 mt -109.69 115.78 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 101' ' ' PHE . 60.2 mt -106.57 116.9 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' C ' HD12 ' A' ' 50' ' ' LEU . 11.7 mm100 -81.27 128.43 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.705 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.4 mp -110.4 130.26 55.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.615 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.623 ' N ' ' ND1' ' A' ' 51' ' ' HIS . 0.9 OUTLIER -94.53 54.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.218 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -46.61 150.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.55 -39.97 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.33 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -62.95 -46.13 89.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.133 0.492 . . . . 1.0 110.488 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -168.9 -158.98 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.796 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.01 115.11 28.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.893 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.76 138.13 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.169 0.509 . . . . 1.0 110.499 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.45 ' OE1' HD11 ' A' ' 60' ' ' ILE . 17.4 pt20 -97.56 141.42 30.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -102.06 115.18 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.738 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.45 HD11 ' OE1' ' A' ' 58' ' ' GLN . 51.8 mm -92.82 101.42 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.923 0.392 . . . . 1.0 110.092 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.8 mm -117.63 90.21 34.96 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.143 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.14 146.48 88.04 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 1.0 112.407 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 96.6 mt -93.28 115.43 32.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.46 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 80.7 m-20 -163.58 -166.75 1.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.177 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -33.24 74.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.223 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -76.2 -12.48 60.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.743 0.306 . . . . 1.0 111.17 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.46 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 32.9 t80 -114.06 130.05 56.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.052 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.68 145.08 44.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.4 t -121.55 106.04 11.01 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.399 -0.818 . . . . 1.0 109.2 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 70' ' ' VAL . 5.8 m -107.36 125.37 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.729 0.3 . . . . 1.0 110.762 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.468 HE22 ' N ' ' A' ' 88' ' ' LYS . 9.3 tp-100 -99.1 115.88 30.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.339 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.7 179.778 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.925 0.393 . . . . 1.0 109.955 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.503 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 95.8 mt -64.04 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.67 -24.92 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.945 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 m -102.6 59.54 0.8 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.844 0.354 . . . . 1.0 110.429 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.7 m120 -82.65 -171.63 3.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.145 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 m 66.69 87.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.04 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.12 79.04 0.11 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 139.8 30.84 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.921 0.391 . . . . 1.0 111.754 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' N ' HE22 ' A' ' 71' ' ' GLN . 22.3 pttp -126.83 134.14 50.6 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.3 pt -126.18 161.24 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.231 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.95 138.14 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.697 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -117.46 133.96 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.448 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -136.91 134.65 37.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.046 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.673 0.273 . . . . 1.0 110.468 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -174.75 126.22 0.29 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.438 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -137.76 123.66 20.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -89.98 151.15 21.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.925 0.393 . . . . 1.0 111.24 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 48' ' ' ILE . 67.6 m-85 -136.53 148.62 47.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.26 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.95 144.32 45.36 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 1.0 110.753 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 35' ' ' LEU . 6.2 mm -129.41 90.37 44.6 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.27 -17.82 44.76 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 1.0 112.762 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -88.88 108.67 19.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.69 -0.485 . . . . 1.0 109.69 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.8 tt0 -64.91 -53.18 50.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.068 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -53.18 -40.9 64.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.664 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -73.0 -35.88 66.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 1.0 110.396 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.9 t -60.73 -34.24 74.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.901 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.8 -44.79 95.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.425 -0.51 . . . . 1.0 111.352 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.84 -43.67 83.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.969 -0.692 . . . . 1.0 110.189 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.428 ' CZ ' HD23 ' A' ' 35' ' ' LEU . 42.3 t80 -60.22 -49.03 79.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.353 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -65.89 -41.62 91.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.269 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.3 t -63.31 -44.74 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.235 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.87 -50.32 64.94 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.359 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.21 -44.15 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.26 -45.75 92.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 1.0 110.225 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.14 86.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.549 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.7 79.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.809 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.29 -37.62 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 1.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -60.37 -44.51 95.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.029 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.59 94.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.49 -40.2 92.79 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.792 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.222 -0.386 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.386 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.498 1.74 0 CA-C-O 120.784 0.244 . . . . 1.0 111.989 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.7 mt -70.2 135.41 86.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.064 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.681 ' HD3' HE22 ' A' ' 58' ' ' GLN . 50.7 Cg_endo -68.91 147.58 68.61 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.686 1.59 . . . . 1.0 111.68 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -70.02 -32.39 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.156 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.23 94.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.56 141.83 44.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 1.0 110.778 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -101.67 100.34 14.03 Favored Pre-proline 0 C--O 1.224 -0.283 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.38 103.15 1.69 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.523 1.482 . . . . 1.0 112.83 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.76 -43.34 89.18 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.131 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.87 151.65 37.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.237 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -141.42 128.08 20.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.452 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 21' ' ' GLU . 53.3 t -141.59 160.7 21.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.926 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 55.7 mp0 -103.55 121.96 43.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -124.99 -173.37 13.69 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 25' ' ' MET . 90.7 mmm -131.26 107.31 8.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 1.0 110.125 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 99' ' ' ARG . 84.8 tt0 -76.19 126.48 31.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.644 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.532 ' N ' ' SD ' ' A' ' 25' ' ' MET . 0.9 OUTLIER -116.04 139.82 49.89 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.634 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.68 150.4 50.62 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 1.0 109.865 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.9 -65.6 0.47 Allowed Glycine 0 CA--C 1.533 1.188 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.665 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.52 -32.36 88.05 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 122.732 2.288 . . . . 1.0 113.786 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -176.78 -179.56 0.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 121.032 -0.267 . . . . 1.0 110.465 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -125.14 169.21 12.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.053 0.454 . . . . 1.0 110.787 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -157.92 143.43 12.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.426 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.64 144.23 93.82 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.264 1.309 . . . . 1.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.5 p -149.14 173.67 13.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.403 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' C ' HD22 ' A' ' 35' ' ' LEU . . . -134.7 129.1 34.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.01 0.433 . . . . 1.0 110.182 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 35' ' ' LEU . 3.8 mm? -97.4 118.21 33.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -129.84 113.82 15.15 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.166 0.507 . . . . 1.0 111.56 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD23 ' HB1' ' A' ' 115' ' ' ALA . 47.4 tp -85.98 129.8 34.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.464 -0.789 . . . . 1.0 109.047 178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.12 156.96 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.999 0.428 . . . . 1.0 111.283 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -119.47 119.62 34.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.576 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -127.31 137.19 52.76 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.977 0.418 . . . . 1.0 110.913 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 58.86 32.38 22.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.498 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.21 18.45 78.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 44' ' ' TYR . 7.6 tp-100 -125.51 140.44 52.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.113 -0.328 . . . . 1.0 110.113 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.451 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 69.9 m-85 -80.27 135.72 36.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.51 140.28 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.355 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.5 tp -104.34 126.13 51.18 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.311 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.8 mt -104.37 121.18 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.983 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.7 115.45 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.6 mt-30 -105.65 130.94 53.57 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.879 0.371 . . . . 1.0 110.931 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.605 HD21 ' NH2' ' A' ' 99' ' ' ARG . 10.9 mp -106.16 128.41 53.89 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.407 ' HD1' ' CE1' ' A' ' 56' ' ' HIS . 99.6 m-70 -90.13 62.5 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.331 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 55' ' ' GLN . 97.9 mt-10 -60.85 146.22 47.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.36 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.52 -39.55 93.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.086 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -63.23 -41.07 99.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' GLU . 15.8 pt20 -172.39 -156.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.407 ' CE1' ' HD1' ' A' ' 51' ' ' HIS . 97.9 m-70 -127.34 127.97 45.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.975 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.79 130.69 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.171 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.681 HE22 ' HD3' ' A' ' 11' ' ' PRO . 20.5 tt0 -102.58 116.26 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.987 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -102.05 113.26 26.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.521 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -94.61 111.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 1.0 110.524 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mm -113.68 120.29 39.67 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.089 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.6 148.1 36.75 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.792 1.661 . . . . 1.0 112.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.0 mt -92.58 122.97 44.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.444 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -172.22 -160.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.266 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.507 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 78.0 p -61.53 -40.01 93.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -68.51 -32.51 72.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.682 0.277 . . . . 1.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.8 t80 -95.4 126.14 40.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.044 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 65' ' ' SER . 84.4 mtt85 -137.75 145.91 43.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.2 0.524 . . . . 1.0 110.874 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.2 t -122.33 117.89 27.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.064 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 70' ' ' VAL . 4.8 m -118.36 125.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.756 0.312 . . . . 1.0 110.462 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.1 tp-100 -83.68 123.78 30.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.441 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.96 -179.988 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 120.928 0.394 . . . . 1.0 110.039 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 83' ' ' SER . 93.8 mt -64.23 -43.18 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.691 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.0 -11.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.156 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' ILE . 30.7 t -133.18 135.15 44.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.009 0.433 . . . . 1.0 110.157 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -146.25 -176.76 5.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.911 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t 72.04 89.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.24 80.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -93.74 133.61 36.93 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -177.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.1 mttt -109.95 113.21 25.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.463 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 2.1 pp -117.51 128.81 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -103.39 146.16 28.9 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.46 133.7 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.897 0.379 . . . . 1.0 110.639 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -136.19 137.95 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.182 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.722 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.432 ' CG ' ' N ' ' A' ' 98' ' ' GLU . 35.8 ptt-85 . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.486 0.184 . . . . 1.0 110.753 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' ARG . 48.5 tp10 -175.04 121.45 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.874 0.368 . . . . 1.0 110.228 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.605 ' NH2' HD21 ' A' ' 50' ' ' LEU . 81.0 mtp180 -138.08 124.35 20.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -87.76 149.2 24.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.933 0.396 . . . . 1.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -141.08 148.28 39.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.286 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -144.31 134.44 24.19 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.369 . . . . 1.0 111.074 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.68 99.72 48.52 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 -13.05 31.08 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.504 1.469 . . . . 1.0 112.768 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -90.72 103.04 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -53.51 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 1.0 112.207 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -53.04 -43.77 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.549 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -69.56 -36.68 76.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.908 0.385 . . . . 1.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 113' ' ' LEU . 1.4 t -60.13 -36.2 76.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.855 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.0 mt -62.53 -44.31 96.66 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.103 -0.639 . . . . 1.0 111.28 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.11 -45.98 75.57 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.749 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.99 -49.01 76.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.818 . . . . 1.0 111.567 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 87' ' ' CYS . 96.7 mt -65.77 -41.36 92.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.221 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.3 -45.89 75.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.306 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.09 -46.84 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.768 0.318 . . . . 1.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -43.46 98.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.474 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.63 88.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.94 -49.22 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.622 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -69.68 -38.41 77.01 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.189 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.997 0.427 . . . . 1.0 110.624 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.21 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.624 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -72.88 -40.24 65.76 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.844 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.665 179.897 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo . . . . . 0 N--CA 1.499 1.815 0 CA-C-O 120.984 0.327 . . . . 1.0 112.134 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -66.51 144.38 98.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.834 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.69 142.43 63.92 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.711 1.608 . . . . 1.0 111.464 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 p -72.16 -32.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.275 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.31 93.75 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.01 144.58 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 1.0 111.101 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.37 107.15 33.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.58 102.81 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.457 1.438 . . . . 1.0 112.757 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.03 -43.82 86.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.102 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 154.13 35.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.273 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -142.81 132.5 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 1.0 110.529 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.4 p -142.0 152.3 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.043 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -107.84 121.9 45.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.747 -0.66 . . . . 1.0 109.317 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.21 -158.76 9.67 Favored Glycine 0 N--CA 1.462 0.4 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -131.14 131.2 43.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.066 0.46 . . . . 1.0 110.658 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.566 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 25.9 tp10 -91.68 126.53 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.4 mtm -113.67 135.63 53.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.633 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -141.48 149.27 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.237 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -36.39 -64.91 0.56 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 115.745 -0.662 . . . . 1.0 112.762 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.18 -32.79 94.98 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.885 2.39 . . . . 1.0 113.973 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 178.97 177.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 121.163 -0.215 . . . . 1.0 110.645 179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -122.05 169.23 11.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.05 0.452 . . . . 1.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.32 144.24 9.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.38 146.77 81.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.091 1.068 . . . . 1.0 111.412 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 31.8 p -153.16 -178.22 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.526 -0.307 . . . . 1.0 110.4 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.04 145.18 24.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.643 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.546 ' CD1' HD11 ' A' ' 89' ' ' ILE . 44.6 mt -115.2 116.45 28.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.277 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -121.56 114.58 21.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.32 0.581 . . . . 1.0 111.559 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.733 HD23 ' HB1' ' A' ' 115' ' ' ALA . 52.5 tp -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.308 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.18 149.64 41.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.066 0.46 . . . . 1.0 111.393 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -104.07 128.38 51.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.665 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -140.62 137.06 33.35 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.749 -0.381 . . . . 1.0 110.895 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 58.79 33.02 22.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.695 -0.684 . . . . 1.0 111.591 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.95 77.09 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 44' ' ' TYR . 6.8 tp-100 -132.34 157.57 44.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.485 ' H ' ' CD ' ' A' ' 43' ' ' GLN . 86.8 m-85 -99.16 134.43 42.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.043 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -146.22 141.9 27.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.845 0.355 . . . . 1.0 110.336 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.7 tp -104.86 125.05 50.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.631 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.3 mt -98.95 121.71 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.9 mt -107.21 124.76 63.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' C ' HD12 ' A' ' 50' ' ' LEU . 37.3 mt-30 -114.88 122.76 47.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.963 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 49' ' ' GLN . 9.9 mp -105.15 128.37 53.35 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.23 45.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.21 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 50' ' ' LEU . 39.6 tp10 -41.77 146.52 0.25 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.403 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -61.6 -39.28 90.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.292 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -59.0 -47.6 84.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.965 0.412 . . . . 1.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -174.4 -162.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -97.19 81.47 3.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.061 0.458 . . . . 1.0 109.834 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.77 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.528 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -108.64 116.97 32.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.517 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -100.45 132.58 45.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.95 110.85 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.814 0.34 . . . . 1.0 110.139 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -115.09 108.73 47.75 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.238 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HG2' ' HE1' ' A' ' 66' ' ' HIS . 72.7 Cg_endo -75.24 151.23 38.21 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.639 1.559 . . . . 1.0 112.571 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.428 HG23 HE21 ' A' ' 120' ' ' GLN . 98.1 mt -95.08 124.33 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.477 ' ND2' ' ND1' ' A' ' 66' ' ' HIS . 14.9 p-10 -172.04 -150.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 1.0 109.847 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -72.37 -39.93 67.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 1.0 112.083 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.685 ' CD2' ' C ' ' A' ' 66' ' ' HIS . 2.4 p-80 -74.61 -16.85 60.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.788 0.328 . . . . 1.0 111.318 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.488 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 61.1 t80 -102.46 123.72 46.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.87 142.51 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.323 0.583 . . . . 1.0 110.853 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 89' ' ' ILE . 4.8 t -125.33 106.67 10.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.212 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.59 129.63 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.053 0.454 . . . . 1.0 111.381 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.0 tp-100 -80.38 100.58 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.471 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.476 179.813 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.961 0.41 . . . . 1.0 110.271 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.88 -42.62 96.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.678 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.79 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.085 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.7 t -109.58 119.8 40.52 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -148.02 -175.19 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.078 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.75 88.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.64 71.78 0.79 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.47 139.29 30.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.952 0.406 . . . . 1.0 111.675 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 52.1 mtpt -116.73 129.33 56.05 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.591 HD12 ' SG ' ' A' ' 69' ' ' CYS . 39.7 pt -125.31 160.14 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -130.23 143.03 50.54 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.913 0.387 . . . . 1.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.11 133.25 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.908 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.74 152.47 42.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.745 0.307 . . . . 1.0 110.652 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -57.25 135.22 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 1.0 110.778 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.71 136.52 40.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.488 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 77.4 mtp180 -106.71 139.5 41.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.225 0.536 . . . . 1.0 110.944 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 85.1 m-85 -133.92 152.1 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.198 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.99 127.03 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.907 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.79 89.47 7.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.21 -15.65 35.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.787 1.658 . . . . 1.0 112.777 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.32 106.64 18.63 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -60.81 -53.43 57.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.028 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -52.94 -43.74 66.54 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.628 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.425 ' HB3' HG23 ' A' ' 20' ' ' VAL . 59.1 m170 -68.57 -36.74 79.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.484 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -63.3 -34.59 78.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.787 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.37 -46.25 89.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.387 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.63 -42.98 81.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.66 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' HD13 ' A' ' 89' ' ' ILE . 46.2 t80 -61.82 -49.05 77.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.104 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.7 -41.57 95.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.474 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -44.5 93.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.903 0.382 . . . . 1.0 111.164 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.733 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.9 -48.04 72.8 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.251 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 112' ' ' PHE . 73.0 t -65.67 -42.22 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.828 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.49 -44.66 89.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.997 0.427 . . . . 1.0 110.077 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.69 91.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.435 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.814 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.428 HE21 HG23 ' A' ' 63' ' ' ILE . 59.2 mm-40 -67.88 -39.83 83.62 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.021 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.76 -45.32 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.029 0.442 . . . . 1.0 110.1 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -67.99 -39.67 83.22 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.722 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.454 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 N--CA 1.496 1.667 0 CA-C-O 120.855 0.273 . . . . 1.0 111.925 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.39 166.37 11.34 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.94 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.56 148.39 92.45 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.642 1.561 . . . . 1.0 111.561 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.12 -45.05 95.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.15 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.4 -29.97 76.55 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.231 -0.747 . . . . 1.0 111.231 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.76 58.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 1.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -109.4 108.36 59.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 128.13 11.08 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.643 1.562 . . . . 1.0 112.765 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -100.86 -38.85 8.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.713 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.62 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.105 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -143.34 137.73 28.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.794 0.331 . . . . 1.0 110.512 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.7 p -140.6 146.92 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.981 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -108.76 122.16 46.57 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -140.32 -158.06 7.44 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 16.7 mmm -127.97 129.06 46.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.909 0.385 . . . . 1.0 110.432 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.63 118.77 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.24 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.1 mtm -97.8 136.22 38.45 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.508 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.24 151.84 51.5 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.19 -64.93 0.45 Allowed Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.954 -0.567 . . . . 1.0 112.704 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.35 -34.05 56.44 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.725 2.283 . . . . 1.0 113.746 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -175.75 -173.41 0.6 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.321 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -121.29 168.36 11.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.9 0.381 . . . . 1.0 110.465 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.13 141.35 13.47 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.742 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.97 145.44 74.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 CA-C-N 120.221 1.115 . . . . 1.0 111.52 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 22' ' ' GLY . 11.5 p -158.97 -176.24 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.608 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.76 134.48 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.182 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 20' ' ' VAL . 51.8 mt -104.18 128.08 51.84 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.003 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -125.02 123.26 39.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.246 0.546 . . . . 1.0 111.522 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.567 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.1 tp -89.42 127.18 35.8 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.236 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.79 150.11 39.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.133 0.492 . . . . 1.0 111.434 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -106.0 123.88 48.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -134.47 131.27 37.88 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 1.0 110.742 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 61.09 34.6 19.04 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.684 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.35 75.81 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -134.77 149.6 50.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -94.67 134.09 37.63 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.59 147.67 34.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.874 0.369 . . . . 1.0 110.432 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.4 tt -108.4 120.54 42.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.068 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.654 ' N ' HD23 ' A' ' 46' ' ' LEU . 85.8 mt -99.07 128.04 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -95.05 119.78 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.5 mt-30 -107.54 129.95 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.033 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.4 mp -109.5 136.34 49.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -95.45 20.18 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.113 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -48.28 138.32 9.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.271 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -63.19 -38.62 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.414 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.87 -52.17 65.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 1.0 110.31 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -172.32 155.14 3.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -82.92 102.64 11.82 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 1.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.57 134.2 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -122.16 108.22 13.06 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.658 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -101.51 125.67 48.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.647 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mm -92.39 105.96 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.09 108.29 48.47 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.044 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.27 145.11 34.06 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.658 1.572 . . . . 1.0 112.449 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.5 123.63 38.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -174.9 -162.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 -40.48 86.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.143 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -65.52 -39.81 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.02 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.77 122.56 35.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.206 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -140.31 111.42 7.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.235 0.541 . . . . 1.0 110.927 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.8 p -102.54 111.61 23.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.033 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -116.0 129.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.98 0.419 . . . . 1.0 110.76 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.436 ' OE1' ' CD1' ' A' ' 113' ' ' LEU . 16.9 tt0 -75.28 120.45 20.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.852 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.889 0.375 . . . . 1.0 110.081 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.8 mm -113.94 -37.08 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.449 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -47.35 82.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.889 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 t -140.12 139.77 35.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.874 0.369 . . . . 1.0 110.519 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.412 ' OD1' ' SG ' ' A' ' 87' ' ' CYS . 0.5 OUTLIER -158.15 36.99 0.25 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.525 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -83.95 112.8 20.49 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 48.32 82.5 0.03 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.212 -1.555 . . . . 1.0 109.212 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.412 ' SG ' ' OD1' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -115.2 150.25 36.4 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.221 0.534 . . . . 1.0 111.573 -177.503 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 151.47 33.56 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.51 169.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -139.21 126.1 20.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.027 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 130.69 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -152.63 153.33 33.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.11 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.612 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.865 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.815 0.341 . . . . 1.0 110.807 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 90' ' ' ARG . 80.6 tt0 -60.46 131.44 50.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.0 110.649 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -137.64 135.41 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.572 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -129.61 149.94 51.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.031 0.444 . . . . 1.0 111.601 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -144.71 161.03 40.22 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.333 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -145.26 139.64 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.919 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 20' ' ' VAL . 4.3 mp -125.28 101.08 31.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.04 -12.04 21.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.605 1.537 . . . . 1.0 112.618 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.61 111.53 23.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.34 -51.25 70.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.611 0.597 . . . . 1.0 112.611 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -55.13 -38.95 68.89 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.424 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.564 ' HB3' HG23 ' A' ' 20' ' ' VAL . 5.0 m-70 -77.45 -33.8 54.67 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.74 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -53.98 52.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.373 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.55 -39.47 94.48 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.908 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.14 -44.81 91.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.661 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.59 -52.84 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.868 -0.605 . . . . 1.0 111.318 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.436 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 30.4 mt -66.54 -40.75 89.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.2 t -62.5 -44.34 96.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.678 0.275 . . . . 1.0 111.42 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.81 -49.66 61.09 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.531 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.25 -43.63 91.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.117 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.33 -46.75 88.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.889 0.376 . . . . 1.0 110.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.2 -29.85 70.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.49 92.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.09 -43.16 99.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.819 0.342 . . . . 1.0 111.626 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.77 -43.56 98.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.521 0.677 . . . . 1.0 109.916 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.8 87.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.859 -1.064 . . . . 1.0 111.21 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -65.63 -43.55 89.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.676 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.043 -0.979 . . . . 1.0 110.608 179.915 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 N--CA 1.497 1.708 0 CA-C-O 120.824 0.26 . . . . 1.0 111.986 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -60.78 140.75 93.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD3' HE22 ' A' ' 58' ' ' GLN . 39.7 Cg_endo -65.93 144.66 77.51 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.765 1.643 . . . . 1.0 111.587 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.06 -43.01 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.071 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.99 -37.67 45.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.161 -0.775 . . . . 1.0 111.161 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 143.98 56.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 1.0 110.962 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.38 79.9 0.42 Allowed Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 108.882 -0.784 . . . . 1.0 108.882 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.7 96.45 0.14 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.819 1.679 . . . . 1.0 113.157 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.69 -41.92 91.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.269 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.15 40.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.107 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -140.08 131.94 27.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.557 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.4 m -139.37 159.17 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.255 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -113.56 121.86 45.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.0 178.6 17.83 Favored Glycine 0 N--CA 1.463 0.47 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.8 mtp -118.18 102.89 9.35 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.798 0.332 . . . . 1.0 110.477 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.39 122.45 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.476 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 76.8 mtm -105.47 137.58 43.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.487 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.74 151.24 50.82 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.39 -67.2 0.26 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.846 -0.616 . . . . 1.0 112.709 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.12 -32.98 83.37 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.781 2.321 . . . . 1.0 113.401 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.8 -172.3 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.626 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -125.18 169.13 12.53 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.184 0.516 . . . . 1.0 110.521 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -152.85 144.38 16.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.05 142.19 91.58 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.365 1.376 . . . . 1.0 111.146 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.7 p -154.18 -174.64 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.525 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.68 15.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.338 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 20' ' ' VAL . 5.0 mp -110.69 122.09 46.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.949 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.2 m -123.53 115.42 21.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.254 0.549 . . . . 1.0 111.576 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.525 HD23 ' HB1' ' A' ' 115' ' ' ALA . 46.4 tp -81.29 129.41 34.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.266 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.48 152.04 40.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 1.0 111.477 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -109.6 122.94 48.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -134.63 137.16 43.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.097 0.475 . . . . 1.0 110.688 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.3 m120 60.27 34.2 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.442 -0.799 . . . . 1.0 111.38 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.13 24.01 76.02 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -132.73 150.07 52.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.446 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 59.7 m-85 -92.06 130.27 37.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -143.07 143.14 31.74 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.014 0.435 . . . . 1.0 110.353 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 tp -104.58 129.17 52.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.38 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.0 126.72 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.493 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' HD12 ' A' ' 50' ' ' LEU . 77.7 mt-30 -108.05 128.16 54.42 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.87 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 52' ' ' GLU . 10.0 mp -106.76 129.72 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.322 -0.622 . . . . 1.0 109.322 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' LYS . 64.2 t-80 -43.07 95.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.59 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' LEU . 6.1 pt-20 -37.04 96.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.11 0.481 . . . . 1.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' HIS . 69.1 mttm -61.53 -37.93 85.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.916 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.39 -17.77 0.28 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.199 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.48 164.47 30.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.744 0.307 . . . . 1.0 110.844 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 55.6 p-80 -69.69 116.99 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.98 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 30.7 m -119.85 130.84 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.895 0.378 . . . . 1.0 110.43 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.667 HE22 ' HD3' ' A' ' 11' ' ' PRO . 20.1 tt0 -151.19 108.26 3.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.809 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.07 117.93 32.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.753 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.17 114.19 29.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.926 0.393 . . . . 1.0 110.313 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mm -110.6 116.86 51.92 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.122 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.6 151.71 41.99 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.784 1.656 . . . . 1.0 112.552 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.71 122.09 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.475 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' PHE . 46.2 p30 -170.73 -163.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.383 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -59.0 -40.93 86.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -66.2 -36.15 82.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.995 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 64' ' ' ASN . 36.5 t80 -95.09 129.59 42.12 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.961 0.41 . . . . 1.0 110.327 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -136.35 146.83 46.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.242 0.544 . . . . 1.0 111.234 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.2 p -115.47 110.23 18.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.369 -0.832 . . . . 1.0 109.423 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.93 135.42 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.862 0.363 . . . . 1.0 110.797 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 80' ' ' ASP . 11.6 tt0 -103.41 122.07 44.12 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.87 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.105 179.467 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.569 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 34.8 p-10 . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.93 0.395 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 97.4 mt -67.69 -24.21 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.965 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 t -115.86 127.32 54.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.095 0.474 . . . . 1.0 110.333 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 85' ' ' SER . 84.8 m-20 -148.7 -176.94 5.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.236 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 79.49 91.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.19 79.91 0.07 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.224 -1.55 . . . . 1.0 109.224 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.98 148.18 40.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.777 0.322 . . . . 1.0 111.404 -177.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -106.84 139.65 40.92 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.551 ' C ' HH11 ' A' ' 90' ' ' ARG . 1.8 pp -128.02 161.33 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.551 HH11 ' C ' ' A' ' 89' ' ' ILE . 1.7 mpt_? -126.27 145.84 50.25 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.343 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.57 135.37 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.192 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -128.34 148.92 50.7 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.846 -0.616 . . . . 1.0 110.247 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.723 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 179.406 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' NH2' ' A' ' 99' ' ' ARG . 35.2 ptt-85 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.839 0.352 . . . . 1.0 110.664 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.94 127.25 31.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.865 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.508 ' NH2' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -130.02 137.51 50.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.408 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.411 ' NH1' ' CZ ' ' A' ' 90' ' ' ARG . 95.2 mtt-85 -99.91 152.62 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.829 0.347 . . . . 1.0 111.115 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.08 155.23 42.02 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.966 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -146.62 135.23 22.11 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.894 0.378 . . . . 1.0 111.166 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mm -107.2 103.06 46.64 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.93 -11.84 29.87 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.475 1.45 . . . . 1.0 112.827 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -97.96 121.71 40.2 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.75 -48.79 79.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.64 -0.709 . . . . 1.0 112.41 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -59.65 -40.17 86.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.453 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -71.17 -39.88 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.0 110.677 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -56.39 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.358 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.78 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.314 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -62.54 -45.55 92.43 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.772 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -61.21 -51.33 69.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.072 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 89' ' ' ILE . 94.9 mt -65.6 -42.29 91.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.26 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -64.71 -46.7 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 1.0 111.6 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -64.92 -50.43 66.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.301 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.0 t -65.02 -44.88 95.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.8 tp -61.54 -46.76 88.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.097 0.475 . . . . 1.0 110.518 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.82 80.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.352 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 44' ' ' TYR . . . -62.2 -38.16 88.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.579 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -65.55 -44.97 85.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.863 0.363 . . . . 1.0 111.201 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -66.39 -43.13 86.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.402 0.62 . . . . 1.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.47 77.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.95 -1.023 . . . . 1.0 111.888 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -72.05 -40.31 68.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.518 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.625 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.25 -21.07 67.42 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.656 2.237 . . . . 1.0 111.997 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.62 147.98 39.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.374 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.58 171.8 55.15 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.2 p -66.78 -19.2 65.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 1.0 110.766 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.6 mtp -128.56 149.12 50.75 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -42.09 149.71 0.42 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.522 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.51 159.63 42.68 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.084 1.856 . . . . 1.0 112.085 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.69 -31.37 69.5 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.658 2.239 . . . . 1.0 111.908 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.56 161.14 80.66 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.893 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.75 144.67 99.59 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.363 1.375 . . . . 1.0 111.652 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.17 -44.6 91.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.38 -28.37 73.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.248 -0.741 . . . . 1.0 111.248 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.75 149.06 47.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.975 0.417 . . . . 1.0 110.959 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -118.2 80.42 15.58 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.516 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.96 98.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.081 1.854 . . . . 1.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 37' ' ' LEU . 96.8 mt -65.6 -41.36 92.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.026 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.49 145.51 26.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.979 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -135.42 130.28 34.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.445 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.7 158.66 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.88 0.371 . . . . 1.0 110.853 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.36 123.3 46.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.578 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.84 -163.75 11.06 Favored Glycine 0 N--CA 1.46 0.275 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt -139.09 125.53 20.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.408 . . . . 1.0 110.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -89.18 120.85 30.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.3 mtm -106.73 136.78 45.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.689 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.8 147.65 52.31 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.732 -0.469 . . . . 1.0 109.732 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.57 -65.27 0.38 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.743 -0.662 . . . . 1.0 112.496 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -32.23 83.32 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.791 2.327 . . . . 1.0 113.952 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -174.99 -176.3 0.95 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -125.18 171.15 10.56 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.146 0.498 . . . . 1.0 110.563 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -157.83 129.21 3.82 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.202 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.38 146.93 49.04 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.305 1.145 . . . . 1.0 111.502 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.6 p -154.95 -172.99 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.687 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.14 138.74 20.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.18 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.4 HD13 ' CZ ' ' A' ' 112' ' ' PHE . 54.8 mt -106.54 124.69 49.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.054 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.4 m -130.64 122.44 27.41 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.115 0.483 . . . . 1.0 111.556 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.633 HD23 ' HB1' ' A' ' 115' ' ' ALA . 57.2 tp -93.5 131.41 38.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.28 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.46 148.55 37.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.043 0.449 . . . . 1.0 111.244 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.49 123.53 48.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.731 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -134.05 131.03 38.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.024 0.44 . . . . 1.0 110.82 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.7 m120 61.9 33.45 17.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.822 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.36 17.91 77.92 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.486 ' CD ' ' H ' ' A' ' 44' ' ' TYR . 6.4 tp-100 -125.71 158.06 35.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' H ' ' CD ' ' A' ' 43' ' ' GLN . 96.2 m-85 -99.72 135.83 40.55 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.023 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -145.17 141.32 28.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.927 0.394 . . . . 1.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.21 124.77 49.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.611 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -107.09 127.03 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.941 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.94 122.93 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.9 mt-30 -109.61 128.51 55.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.067 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 52' ' ' GLU . 9.1 mp -102.6 126.69 49.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -71.54 40.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.207 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 50' ' ' LEU . 38.9 tp10 -49.69 144.26 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.294 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.78 -39.91 95.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.219 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.05 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.967 0.413 . . . . 1.0 110.384 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.77 148.23 31.72 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.733 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -62.54 104.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.241 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 t -70.27 135.46 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.496 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -99.17 108.35 20.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.785 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -106.1 112.47 25.52 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.15 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 1.0 110.157 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.67 91.29 34.1 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.078 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.31 143.7 93.07 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.17 1.913 . . . . 1.0 112.431 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.3 mt -88.17 122.22 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.826 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -174.68 -160.88 0.1 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.998 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 t -60.22 -41.93 94.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.212 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -64.8 -34.13 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.554 -0.293 . . . . 1.0 111.033 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -94.56 127.47 40.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.353 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -136.09 142.54 44.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.334 0.588 . . . . 1.0 110.857 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.71 100.86 7.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.207 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 70' ' ' VAL . 10.4 m -101.95 122.98 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.965 0.412 . . . . 1.0 110.561 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' NE2' ' CG2' ' A' ' 89' ' ' ILE . 7.3 tp-100 -89.38 106.83 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.599 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.71 ' H ' ' NH1' ' A' ' 90' ' ' ARG . 36.1 tp10 36.87 60.75 0.94 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.113 0.482 . . . . 1.0 111.0 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' CB ' ' OG1' ' A' ' 76' ' ' THR . . . -175.39 166.29 3.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.132 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -65.92 -41.31 91.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.588 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -167.42 79.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.648 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 79' ' ' ILE . 14.9 m -114.63 57.34 0.71 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.201 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.4 mt -66.78 -35.42 80.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.309 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.06 -41.16 99.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.685 -0.234 . . . . 1.0 110.404 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 76' ' ' THR . 87.2 mt -119.03 131.21 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.002 0.43 . . . . 1.0 111.2 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 95.9 m-20 -144.35 -38.21 0.3 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.253 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.46 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 94.2 mt -63.79 -43.27 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.8 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.295 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.2 t -103.73 62.23 0.76 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 1.0 110.335 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.4 m120 -80.71 -173.62 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.993 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.408 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 2.3 t 67.85 86.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.94 81.01 0.09 OUTLIER Glycine 0 CA--C 1.521 0.431 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.2 132.19 39.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.72 0.295 . . . . 1.0 111.785 -177.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.432 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 62.7 mttp -112.17 127.66 56.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.496 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 46.7 pt -129.17 158.08 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.71 ' NH1' ' H ' ' A' ' 72' ' ' GLU . 1.8 mpt_? -126.47 140.85 52.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.215 0.531 . . . . 1.0 110.003 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.1 133.85 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.913 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.36 138.29 31.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.127 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 177.61 -169.58 41.68 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.42 -41.79 98.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.695 0.283 . . . . 1.0 111.348 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -60.85 -36.74 79.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.793 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.541 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 44.9 pt -144.82 144.45 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 110.547 -0.168 . . . . 1.0 110.547 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -67.39 -54.37 21.08 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.476 -0.49 . . . . 1.0 110.637 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -174.54 129.5 0.34 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.584 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.541 ' HE ' ' CD1' ' A' ' 96' ' ' ILE . 75.5 mtm180 -142.96 149.53 38.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -105.61 149.01 26.69 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.096 0.474 . . . . 1.0 111.231 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -142.34 149.72 39.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.118 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -144.51 152.24 40.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.875 0.369 . . . . 1.0 111.009 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.54 99.71 15.52 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.16 -12.74 32.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.626 1.551 . . . . 1.0 112.788 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.57 101.1 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.6 tt0 -57.4 -54.17 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.985 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -52.08 -44.23 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.544 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -68.9 -38.38 79.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 1.0 110.537 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -35.87 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.988 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.38 -45.53 92.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.318 -0.553 . . . . 1.0 111.105 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -66.97 -44.21 81.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.905 -0.718 . . . . 1.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 42.4 t80 -62.18 -49.21 76.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.203 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 87' ' ' CYS . 96.7 mt -67.67 -40.35 84.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.273 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -64.73 -47.43 78.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.395 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.73 -48.44 71.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.347 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.66 -44.08 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.37 -44.35 95.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.097 0.475 . . . . 1.0 110.213 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.38 84.96 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.99 72.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.671 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.27 -36.49 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 1.0 111.295 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.82 -45.05 95.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.797 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.11 93.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.444 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -70.55 -37.79 74.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.851 0.358 . . . . 1.0 110.74 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.574 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.431 -1.467 . . . . 1.0 109.431 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.58 143.53 99.44 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.82 2.346 . . . . 1.0 112.072 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.22 143.53 37.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.303 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.71 -179.24 32.68 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.782 -0.927 . . . . 1.0 110.782 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.6 t -151.32 147.05 26.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.794 0.33 . . . . 1.0 110.542 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -155.22 147.8 24.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.318 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -42.31 105.44 0.41 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.667 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.34 159.76 17.39 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.016 1.811 . . . . 1.0 112.354 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.49 -31.78 80.39 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.649 2.233 . . . . 1.0 111.944 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.488 HD21 ' NE2' ' A' ' 49' ' ' GLN . 18.3 mt -68.85 159.02 84.4 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.059 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.63 144.52 99.55 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.295 1.33 . . . . 1.0 111.653 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 13' ' ' GLY . 7.8 p -67.32 -45.71 85.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.253 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' HG13 ' A' ' 12' ' ' VAL . . . -65.77 -28.91 74.06 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.45 141.2 58.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.941 0.401 . . . . 1.0 111.068 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.78 79.62 0.43 Allowed Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.78 94.74 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.883 1.722 . . . . 1.0 112.814 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -43.12 95.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.894 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.69 148.29 42.15 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.317 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 t -141.56 130.45 23.08 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.57 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 21' ' ' GLU . 55.3 t -137.59 158.1 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.979 0.418 . . . . 1.0 110.725 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' N ' HG12 ' A' ' 20' ' ' VAL . 80.7 tt0 -107.39 122.76 47.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.445 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.11 -160.92 9.87 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 71.1 mtp -136.36 130.21 32.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.386 . . . . 1.0 110.418 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.56 123.11 36.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.6 mpp? -113.29 137.83 50.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.982 0.42 . . . . 1.0 110.526 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -140.62 149.13 41.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.007 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.71 -65.17 0.48 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.884 -0.598 . . . . 1.0 112.697 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.12 -32.53 94.79 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.774 2.316 . . . . 1.0 113.564 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.6 177.58 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.852 -0.339 . . . . 1.0 110.878 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.3 169.25 11.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.894 0.378 . . . . 1.0 110.788 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 18.0 pt-20 -159.68 143.15 10.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.639 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.99 141.91 85.8 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.34 1.36 . . . . 1.0 110.929 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 22' ' ' GLY . 22.0 p -147.78 -175.73 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.38 136.25 18.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.95 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 103' ' ' ILE . 61.0 mt -100.08 124.49 45.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.998 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -127.99 126.86 42.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.13 0.491 . . . . 1.0 111.429 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.518 HD23 ' HB1' ' A' ' 115' ' ' ALA . 47.3 tp -96.37 126.17 41.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.886 -0.783 . . . . 1.0 108.886 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.43 152.13 48.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.072 0.463 . . . . 1.0 111.467 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.2 118.28 33.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.673 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -130.56 137.8 49.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.861 0.362 . . . . 1.0 110.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 59.04 33.59 23.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.444 -0.798 . . . . 1.0 111.387 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.98 22.44 77.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.437 ' OE1' ' N ' ' A' ' 44' ' ' TYR . 6.5 tp-100 -131.09 147.7 52.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.437 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 72.0 m-85 -88.52 133.84 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.67 140.73 30.21 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.07 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.2 tt -104.85 119.97 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.731 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.636 ' N ' HD23 ' A' ' 46' ' ' LEU . 78.4 mt -101.79 127.76 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.052 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.5 mt -104.36 116.76 48.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' NE2' HD21 ' A' ' 10' ' ' LEU . 35.0 mt-30 -97.63 132.34 43.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.6 mp -105.15 130.81 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.88 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -103.01 27.19 7.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.282 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 97.1 mt-10 -45.65 150.09 0.54 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -62.33 -40.31 95.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.3 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -54.55 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.38 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.49 158.11 43.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.88 112.54 17.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.071 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 t -95.25 133.41 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.921 0.391 . . . . 1.0 110.531 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -99.64 107.37 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.422 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -105.93 112.52 25.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.983 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.84 111.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.876 0.369 . . . . 1.0 110.187 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.33 116.78 48.39 Favored Pre-proline 0 N--CA 1.467 0.384 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.127 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.59 147.54 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.644 1.563 . . . . 1.0 112.61 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.51 120.04 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.2 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -175.22 -162.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -64.15 -26.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.185 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -83.69 -10.74 57.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.678 0.275 . . . . 1.0 110.948 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.81 129.29 56.0 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -136.5 146.86 46.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.743 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.428 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 4.7 t -127.87 106.46 9.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.506 -0.77 . . . . 1.0 108.937 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m -109.14 126.46 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.052 0.453 . . . . 1.0 110.969 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 7.6 tp-100 -82.8 115.29 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 37.11 58.82 1.16 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.635 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -177.99 -173.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.863 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -108.66 -17.42 13.96 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.417 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -161.55 86.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.688 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 79' ' ' ILE . 4.9 m -141.92 43.67 1.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.462 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 69' ' ' CYS . 23.3 mt -66.42 -35.06 79.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.382 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.11 -40.86 98.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.672 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.532 ' O ' HG22 ' A' ' 76' ' ' THR . 86.5 mt -116.14 129.8 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.047 0.451 . . . . 1.0 111.086 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 89.9 m-20 -146.74 -36.28 0.24 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.153 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.93 -42.39 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.39 -25.93 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.895 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -103.87 66.58 0.85 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.07 0.462 . . . . 1.0 110.568 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' A' ' 85' ' ' SER . 94.5 m-20 -91.73 -171.48 2.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.166 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 85' ' ' SER . 6.9 p 65.06 98.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.987 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.3 77.53 0.13 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 134.21 38.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.802 0.334 . . . . 1.0 111.772 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.48 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.5 mttt -107.94 123.82 49.21 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.46 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 2.4 pp -121.0 149.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.449 HH12 ' N ' ' A' ' 73' ' ' ALA . 81.9 mtt85 -121.86 143.98 49.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.915 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.51 135.35 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.877 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 92' ' ' GLN . 1.6 mp0 -136.95 151.75 49.38 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -165.22 160.78 34.18 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.34 -43.88 89.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.672 0.272 . . . . 1.0 111.483 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.487 ' CE2' HG23 ' A' ' 96' ' ' ILE . 1.3 p-90 -86.63 -8.61 57.32 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.487 HG23 ' CE2' ' A' ' 95' ' ' TRP . 19.9 pt -126.7 149.17 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.744 0.307 . . . . 1.0 110.544 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -87.45 162.46 17.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.646 0.26 . . . . 1.0 110.739 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.75 124.84 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 1.0 110.756 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.11 132.06 44.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.295 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -91.55 151.9 20.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 1.0 111.076 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.18 153.69 43.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.202 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -138.82 143.87 39.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.953 0.406 . . . . 1.0 110.901 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.627 HD11 HD12 ' A' ' 35' ' ' LEU . 5.9 mm -127.17 91.08 47.46 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -16.99 41.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.698 1.598 . . . . 1.0 112.681 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.69 106.35 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.4 tt0 -62.64 -54.69 35.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 1.0 112.182 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -52.42 -42.77 64.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.607 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -70.55 -37.54 74.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.573 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.9 t -59.19 -35.57 73.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.891 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.27 -44.38 95.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.451 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.12 -44.51 84.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.979 -0.689 . . . . 1.0 110.454 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 51.1 t80 -60.76 -49.8 76.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.149 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.46 -41.58 80.0 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.466 -0.493 . . . . 1.0 111.223 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.6 t -63.55 -45.55 90.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.595 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.518 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.43 -49.31 56.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.544 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.46 -45.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.026 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.02 -48.59 81.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.35 80.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.577 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.35 91.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.752 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.74 -45.91 80.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.948 0.404 . . . . 1.0 111.351 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.78 -43.14 89.7 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.472 0.653 . . . . 1.0 110.368 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.96 77.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.855 -1.066 . . . . 1.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -71.92 -39.87 69.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.393 . . . . 1.0 110.556 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.597 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.43 -1.468 . . . . 1.0 109.43 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.6 146.92 96.48 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.953 2.435 . . . . 1.0 112.177 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.5 mm? -80.52 137.64 36.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.302 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.96 165.7 40.5 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.732 -0.947 . . . . 1.0 110.732 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -157.33 151.77 25.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.89 0.376 . . . . 1.0 110.729 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.9 ttt 45.48 -136.82 0.6 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.428 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.01 105.38 41.79 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.209 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -81.54 158.94 19.41 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.047 1.831 . . . . 1.0 112.026 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.42 -31.7 61.45 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.747 2.298 . . . . 1.0 111.716 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.37 158.57 3.86 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.75 142.99 99.3 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.308 1.338 . . . . 1.0 111.688 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.18 -45.23 83.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.382 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.72 81.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.26 50.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.06 0.457 . . . . 1.0 111.144 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -98.19 107.86 43.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.7 103.89 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.435 1.423 . . . . 1.0 112.871 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.93 -43.22 79.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.186 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.79 151.52 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.076 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -140.92 135.0 30.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 1.0 110.547 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 35' ' ' LEU . 2.6 p -142.45 152.12 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.018 0.437 . . . . 1.0 111.163 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -106.64 121.85 45.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -130.46 -155.87 8.45 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 21.4 mmt -137.04 128.65 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.939 0.4 . . . . 1.0 110.244 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -90.21 126.33 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.338 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.0 mtm -109.32 138.75 45.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 29' ' ' LEU . 99.3 mttt -135.64 149.68 49.4 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.898 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -67.07 0.29 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.569 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.28 -32.6 81.95 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.793 2.328 . . . . 1.0 113.852 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -173.94 -170.06 0.53 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.408 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -130.38 169.67 15.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.021 0.439 . . . . 1.0 110.313 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -156.29 144.39 14.31 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.396 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.98 146.14 96.45 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.294 1.329 . . . . 1.0 111.293 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 34' ' ' ALA . 19.7 t -158.02 170.15 22.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.314 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.645 ' N ' ' SG ' ' A' ' 33' ' ' CYS . . . -138.14 139.99 39.68 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.854 0.359 . . . . 1.0 110.239 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 103' ' ' ILE . 60.9 mt -107.07 121.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.764 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -125.08 122.91 38.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.229 0.537 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.594 HD23 ' HB1' ' A' ' 115' ' ' ALA . 62.0 tp -94.67 122.64 37.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.31 146.25 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.145 0.498 . . . . 1.0 111.309 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -98.71 126.69 44.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.747 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -139.82 136.73 34.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.971 0.415 . . . . 1.0 110.727 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 59.15 33.75 22.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.568 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.24 24.88 76.33 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.748 -0.941 . . . . 1.0 110.748 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -135.44 159.44 41.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -100.22 133.16 45.03 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -141.42 142.93 33.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.044 0.45 . . . . 1.0 110.34 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.8 tt -104.32 119.69 39.52 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.896 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.628 ' N ' HD23 ' A' ' 46' ' ' LEU . 72.0 mt -98.15 128.87 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.55 131.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.466 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 73.2 mt-30 -123.23 124.65 43.5 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.99 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.4 mp -99.9 114.75 28.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -72.49 62.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -62.51 151.86 36.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.314 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.87 -41.66 98.12 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.57 -77.36 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -147.82 150.56 34.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -68.73 138.37 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.967 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.18 130.37 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 1.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -91.09 108.35 19.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.791 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.07 114.68 28.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.28 116.12 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.86 0.362 . . . . 1.0 110.46 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.1 91.6 32.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.19 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -57.42 142.77 95.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.213 1.942 . . . . 1.0 112.591 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.62 122.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -175.66 -163.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.201 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.9 p -63.84 -22.2 66.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -85.61 -11.34 54.17 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.602 0.239 . . . . 1.0 111.06 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -121.84 135.27 54.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -137.42 151.38 48.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.104 0.478 . . . . 1.0 110.711 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.7 p -138.76 111.65 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 128.28 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 1.0 111.196 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 73' ' ' ALA . 7.5 tp-100 -82.27 97.53 8.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.585 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 57.85 -0.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.17 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . -95.07 149.34 21.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.958 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -71.97 -44.84 62.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.637 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -161.99 83.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.659 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 79' ' ' ILE . 7.4 m -154.65 82.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.065 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.5 mt -64.43 -33.54 76.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.479 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -62.84 -41.54 99.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.025 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.483 ' H ' HG22 ' A' ' 76' ' ' THR . 50.6 mm -90.25 132.3 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.183 0.516 . . . . 1.0 111.059 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -168.45 -41.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.204 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 83' ' ' SER . 32.6 mm -71.64 -24.13 23.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.18 -3.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.053 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 81' ' ' ILE . 29.8 t -138.97 138.18 37.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 1.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -146.69 -171.32 3.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.105 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 61.77 85.1 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.31 78.28 0.27 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.571 -1.412 . . . . 1.0 109.571 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.85 137.62 35.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 111.866 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.49 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.7 mttt -112.41 127.03 55.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.448 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 1.7 pp -118.17 132.05 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -97.1 141.67 29.96 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.7 t -121.63 134.85 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.572 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -143.46 150.64 39.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.18 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -172.9 156.21 24.38 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.644 -0.982 . . . . 1.0 110.644 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -66.19 -43.72 86.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.725 0.298 . . . . 1.0 111.596 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.495 ' CE2' HG23 ' A' ' 96' ' ' ILE . 2.3 p-90 -84.84 -7.12 59.31 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 95' ' ' TRP . 19.2 pt -129.03 154.38 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 110.143 -0.318 . . . . 1.0 110.143 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -94.69 160.26 14.7 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.684 0.278 . . . . 1.0 110.616 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.12 132.88 54.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 1.0 110.363 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -140.43 125.49 18.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.611 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -88.22 144.07 26.67 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.993 0.425 . . . . 1.0 111.192 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.83 152.05 49.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -139.59 144.64 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.821 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 35' ' ' LEU . 5.8 mm -127.64 91.55 45.26 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.3 -16.99 39.85 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.822 1.681 . . . . 1.0 112.751 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -87.79 104.28 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.96 -54.99 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 1.0 112.32 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -52.1 -44.31 64.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.425 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -69.17 -36.17 77.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.533 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 113' ' ' LEU . 4.2 t -61.75 -38.07 86.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.999 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.77 -46.09 89.64 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.223 -0.591 . . . . 1.0 111.301 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -43.55 82.0 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.964 -0.695 . . . . 1.0 110.764 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.8 -50.36 72.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.156 -0.929 . . . . 1.0 111.094 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 109' ' ' CYS . 95.9 mt -67.85 -41.0 83.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.329 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 t -62.27 -45.12 94.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.105 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.594 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.52 -47.13 67.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.382 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.403 ' HA ' HD22 ' A' ' 37' ' ' LEU . 67.0 t -63.35 -45.6 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.964 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.16 -45.85 92.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 1.0 110.255 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.6 86.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.425 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.76 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.455 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.488 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 95.1 mt-30 -68.32 -37.66 80.78 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.25 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.54 -43.15 90.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.085 0.469 . . . . 1.0 110.623 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.93 75.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.732 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.31 -38.9 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.734 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.405 -179.773 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.624 -1.391 . . . . 1.0 109.624 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.73 145.75 95.01 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.792 2.328 . . . . 1.0 111.84 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.8 tp -107.23 125.79 51.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.306 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.41 178.62 49.97 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.9 p -67.96 -18.08 64.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 1.0 110.605 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 95.9 mtp -111.58 142.04 44.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.815 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -63.39 151.2 88.02 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.364 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.64 160.21 44.43 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.226 1.951 . . . . 1.0 111.973 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.46 -31.49 71.88 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.822 2.348 . . . . 1.0 112.154 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.35 145.55 57.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.859 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 142.31 71.06 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.734 1.623 . . . . 1.0 111.41 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -67.77 -42.79 86.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.681 -0.691 . . . . 1.0 111.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -38.37 47.03 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.94 146.17 46.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.902 0.382 . . . . 1.0 111.009 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -102.82 80.32 0.33 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.13 99.71 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.846 1.697 . . . . 1.0 112.832 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.23 -43.2 92.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.82 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.23 153.52 38.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.353 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -137.96 135.8 36.37 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.633 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.8 p -141.64 149.26 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.04 0.448 . . . . 1.0 111.262 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -104.31 121.68 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.39 -162.96 10.9 Favored Glycine 0 N--CA 1.462 0.386 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 88.9 mmm -128.65 131.99 48.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 1.0 110.315 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -94.9 124.06 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -108.47 137.22 46.79 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.545 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.93 150.07 44.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.019 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.71 -66.29 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.794 -0.639 . . . . 1.0 112.597 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.68 -33.0 93.8 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.779 2.319 . . . . 1.0 113.691 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.7 -174.57 0.25 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.007 -0.277 . . . . 1.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.33 169.47 11.76 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 1.0 110.739 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -158.1 144.31 12.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.619 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.8 145.12 97.4 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.392 1.394 . . . . 1.0 111.04 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.7 p -154.97 -179.11 7.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.382 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.67 142.53 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.427 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 20' ' ' VAL . 4.9 mp -112.28 122.53 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.257 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -122.67 116.7 24.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.381 0.61 . . . . 1.0 111.757 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.682 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.9 tp -83.55 130.37 35.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.21 -0.905 . . . . 1.0 109.218 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.24 151.49 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.007 0.432 . . . . 1.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -110.61 121.73 46.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.711 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -134.02 139.19 45.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.903 0.382 . . . . 1.0 110.911 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.11 33.65 22.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.548 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.28 25.22 75.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -135.17 153.83 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -91.18 131.95 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -141.23 141.61 34.0 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.985 0.422 . . . . 1.0 110.445 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.6 127.54 52.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.685 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.42 118.29 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.154 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.9 mt -100.98 122.87 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.8 mt-30 -108.22 130.54 55.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -107.68 111.19 23.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 52' ' ' GLU . 97.8 m-70 -57.49 -12.8 2.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' HIS . 3.5 tp10 42.39 -167.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.455 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -63.74 -41.75 97.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -138.73 -68.5 0.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.747 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -69.9 142.13 53.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.177 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.62 ' CD2' ' O ' ' A' ' 56' ' ' HIS . 55.4 p-80 -89.06 112.29 23.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.41 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -84.19 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.616 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.13 132.16 48.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.127 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -127.25 109.61 11.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -93.57 122.3 44.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.728 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -133.3 126.76 19.53 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.01 157.84 46.5 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.799 1.666 . . . . 1.0 112.64 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -102.66 115.92 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.178 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' PHE . 50.8 p30 -172.94 -155.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.229 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 m -60.98 -41.6 96.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.348 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.71 -43.05 97.72 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.838 0.352 . . . . 1.0 110.433 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 11.6 t80 -94.03 125.65 38.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.649 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -133.68 142.11 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.87 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.413 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 10.3 t -121.27 111.47 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.962 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.0 m -112.76 126.67 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.959 0.409 . . . . 1.0 110.622 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' A' ' 83' ' ' SER . 18.8 tt0 -87.99 112.83 23.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.744 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 71.5 tt0 40.04 55.36 2.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.641 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 72' ' ' GLU . . . 178.19 -168.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.624 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -109.88 -10.92 14.73 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.431 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 76' ' ' THR . 97.4 mt-10 -140.57 -105.43 0.15 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.799 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER 36.1 35.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.504 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD2' ' O ' ' A' ' 69' ' ' CYS . 97.0 mt -63.23 -41.55 99.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.714 -0.676 . . . . 1.0 111.178 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 78' ' ' LEU . 10.7 mp -65.69 -38.92 90.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.652 0.263 . . . . 1.0 110.462 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 76' ' ' THR . 43.0 mm -102.43 124.33 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.17 0.509 . . . . 1.0 111.001 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 97.3 m-20 -144.25 -41.18 0.27 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.112 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.438 ' C ' ' N ' ' A' ' 83' ' ' SER . 94.6 mt -64.16 -43.29 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.661 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.29 -18.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.036 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 21.9 m -128.19 118.37 23.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.942 0.401 . . . . 1.0 110.284 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.0 m120 -138.32 -167.83 2.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.781 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 70.15 89.47 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.36 75.69 0.33 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 109.342 -1.503 . . . . 1.0 109.342 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.9 138.65 34.12 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.964 0.411 . . . . 1.0 112.006 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.54 124.95 53.15 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.0 150.94 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -121.44 147.08 46.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.88 136.45 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.594 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -128.82 150.3 50.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.097 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -158.66 161.28 31.7 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.681 -0.968 . . . . 1.0 110.681 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.18 -42.48 93.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.798 0.332 . . . . 1.0 111.404 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' A' ' 96' ' ' ILE . 2.6 p-90 -86.29 -8.62 57.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.256 -0.429 . . . . 1.0 112.097 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.508 HG23 ' CE2' ' A' ' 95' ' ' TRP . 16.1 pt -127.27 155.77 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 120.721 0.296 . . . . 1.0 110.493 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -96.42 -161.63 0.89 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.831 0.348 . . . . 1.0 110.655 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.73 127.88 33.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 1.0 110.111 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -127.26 143.11 51.31 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -120.17 140.0 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.958 0.408 . . . . 1.0 111.236 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.17 150.62 50.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.69 -0.686 . . . . 1.0 110.472 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.12 135.75 24.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.758 0.313 . . . . 1.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 54.4 mt -124.56 100.97 34.22 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.64 -10.41 23.5 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.607 1.538 . . . . 1.0 112.684 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.43 105.73 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.72 -52.81 63.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.015 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -53.86 -42.1 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.628 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.504 ' HB3' HG23 ' A' ' 20' ' ' VAL . 5.0 m-70 -69.94 -34.88 74.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.512 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.6 t -66.72 -33.22 75.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.99 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.6 mt -62.74 -46.18 89.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.489 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.73 -43.06 80.87 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.602 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.459 ' CE1' HG21 ' A' ' 116' ' ' VAL . 46.9 t80 -60.93 -48.93 79.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.124 -0.943 . . . . 1.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 113' ' ' LEU . 96.8 mt -65.41 -40.85 93.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.644 -0.423 . . . . 1.0 111.362 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.7 p -64.0 -44.24 93.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.228 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.682 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.07 -51.02 59.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.314 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 112' ' ' PHE . 70.0 t -64.87 -42.25 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.7 tp -57.74 -45.07 86.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.065 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.377 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.87 70.57 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.044 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -68.01 -41.1 82.71 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.64 0.257 . . . . 1.0 111.102 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.24 -43.75 98.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.958 0.409 . . . . 1.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.73 96.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.236 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.3 -40.44 93.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.652 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.903 -1.046 . . . . 1.0 110.485 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.46 -1.456 . . . . 1.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.86 148.82 90.12 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.748 2.299 . . . . 1.0 112.072 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 83.4 mt -102.73 130.39 49.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.265 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.69 103.35 0.62 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -60.8 -41.18 95.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 1.0 110.809 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -147.28 154.24 40.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.362 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 17.8 mp0 -59.67 118.91 35.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.84 160.59 27.5 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.889 1.726 . . . . 1.0 112.32 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.12 -52.12 0.25 Allowed 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.52 2.146 . . . . 1.0 111.884 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 pp -56.47 161.44 4.19 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.121 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.46 143.56 99.66 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.974 1.116 . . . . 1.0 111.79 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.34 -42.9 91.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.02 -34.37 78.73 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.07 137.75 53.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.925 0.393 . . . . 1.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -97.66 108.46 45.68 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.28 103.14 1.7 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.502 1.468 . . . . 1.0 112.999 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.63 -43.47 89.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.152 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 155.68 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.209 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 t -146.67 135.67 22.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.594 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.94 160.82 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.165 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -102.48 122.51 44.47 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' H ' ' HA ' ' A' ' 34' ' ' ALA . . . -118.88 -174.95 16.14 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.792 -0.923 . . . . 1.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.3 mmt -134.9 99.25 4.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 1.0 110.092 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.7 tt0 -59.59 133.96 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 72.5 mtm -113.43 131.38 56.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.748 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.15 144.04 51.08 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.56 -64.88 0.49 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.84 -0.618 . . . . 1.0 112.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.22 -31.98 93.78 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.694 2.262 . . . . 1.0 113.633 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.46 -179.87 1.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.641 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.0 168.2 10.43 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.919 0.39 . . . . 1.0 110.522 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.5 128.7 6.27 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.516 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.44 142.36 78.22 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.944 1.096 . . . . 1.0 111.163 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.4 p -156.76 -178.28 7.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.394 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -150.95 138.19 19.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.308 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.2 mt -102.22 123.97 46.98 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.915 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -126.48 120.46 29.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.059 0.456 . . . . 1.0 111.356 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.515 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.5 tp -94.67 131.23 40.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.248 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 150.93 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 1.0 111.239 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.06 120.82 41.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.682 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -128.07 132.31 49.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.217 0.532 . . . . 1.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.16 31.7 21.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.157 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.65 7.52 85.8 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.851 -0.69 . . . . 1.0 111.426 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -112.5 136.79 51.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.101 -0.333 . . . . 1.0 110.101 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -81.7 134.74 35.49 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.077 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.34 139.64 28.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.375 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.4 tt -108.7 119.4 39.42 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.607 ' N ' HD23 ' A' ' 46' ' ' LEU . 90.9 mt -99.12 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.6 mt -96.91 117.21 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.8 mt-30 -102.35 131.3 49.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.928 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -110.3 127.2 54.9 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -85.41 52.73 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.237 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -45.49 152.95 0.27 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.77 -40.02 93.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.362 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -62.49 -46.44 88.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.509 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -173.11 -163.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.701 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -108.11 126.24 52.52 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.31 137.17 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.055 0.455 . . . . 1.0 110.463 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -104.8 131.12 52.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.018 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -107.97 119.65 40.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.565 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.1 mt -92.11 119.74 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 1.0 110.332 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mt -135.45 94.2 15.63 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.269 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.5 142.52 80.76 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.046 1.831 . . . . 1.0 112.625 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.2 mt -82.12 124.83 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.354 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 66' ' ' HIS . 6.0 p30 -172.96 -163.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.126 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.4 t -59.71 -41.29 90.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.564 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.632 ' CD2' ' ND2' ' A' ' 64' ' ' ASN . 3.5 p80 -69.84 -14.48 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.958 -0.297 . . . . 1.0 111.122 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.0 t80 -114.93 128.06 56.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.18 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -141.29 145.86 36.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.145 0.497 . . . . 1.0 110.889 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.417 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 2.9 t -121.32 118.61 29.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 1.0 108.991 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 30.3 m -118.71 128.84 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.068 0.461 . . . . 1.0 110.848 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.546 ' C ' ' H ' ' A' ' 73' ' ' ALA . 8.5 tp-100 -86.47 103.24 14.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.518 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 57.78 -0.37 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.331 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . -110.35 174.11 6.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.966 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -98.82 -24.52 14.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.464 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -168.06 81.34 0.17 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.608 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.9 m -151.85 73.93 1.08 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.302 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' CD2' ' O ' ' A' ' 69' ' ' CYS . 39.6 mt -70.41 -28.89 65.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.426 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 78' ' ' LEU . 10.9 mp -62.77 -40.35 97.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.632 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 mm -110.23 128.84 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.999 0.428 . . . . 1.0 110.945 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 20.0 p-10 -156.22 -38.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.329 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.42 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 26.3 mm -68.32 -24.53 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.39 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.03 72.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.818 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.5 t -100.46 62.57 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.09 0.472 . . . . 1.0 110.398 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 10.9 m120 -80.47 -171.69 3.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.164 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 85' ' ' SER . 19.2 p 57.83 94.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.73 77.09 0.21 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 136.56 36.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.765 0.317 . . . . 1.0 111.72 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.476 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 64.9 mttp -108.02 120.03 41.14 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.449 ' CG2' HE22 ' A' ' 71' ' ' GLN . 2.2 pp -118.63 131.01 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -106.61 144.73 32.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.894 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.63 133.13 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.641 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -124.23 136.06 53.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -145.75 145.85 15.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.741 -0.944 . . . . 1.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.65 -45.88 70.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.821 0.343 . . . . 1.0 111.478 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.519 ' CE2' HG23 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -80.24 -13.47 59.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.174 -0.466 . . . . 1.0 112.237 -178.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 95' ' ' TRP . 42.0 pt -127.02 160.77 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 120.554 0.216 . . . . 1.0 110.657 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -87.74 151.33 22.99 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.671 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.02 135.66 55.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 1.0 110.727 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -133.8 137.58 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.588 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -87.32 150.47 23.84 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.917 0.389 . . . . 1.0 111.035 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -143.39 149.33 37.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.298 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.14 145.84 39.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.918 0.389 . . . . 1.0 110.931 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.87 92.86 43.54 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.28 -15.44 38.88 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.757 1.638 . . . . 1.0 112.602 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.453 ' OD2' ' CG ' ' A' ' 108' ' ' HIS . 38.6 t0 -93.2 106.56 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.81 -52.92 63.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.026 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.93 -46.81 32.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.378 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.453 ' CG ' ' OD2' ' A' ' 105' ' ' ASP . 43.9 m170 -68.5 -39.34 81.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 1.0 110.38 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 t -59.08 -39.76 83.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.16 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.52 -44.84 93.09 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.418 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.16 -44.96 82.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.3 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.55 -49.38 76.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.339 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.8 -40.51 88.13 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.603 -0.439 . . . . 1.0 111.211 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -62.73 -44.7 95.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.822 0.344 . . . . 1.0 111.083 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.515 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.12 -48.28 62.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.361 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.09 -44.76 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.14 -45.03 96.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.016 0.436 . . . . 1.0 110.161 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.07 86.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.555 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.07 -49.09 75.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -71.11 -38.23 72.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 1.0 110.983 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.04 -44.5 96.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.223 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.41 96.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.221 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.38 -41.22 93.99 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.66 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.384 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.485 -1.446 . . . . 1.0 109.485 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 34.1 Cg_endo -63.85 -21.72 69.1 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.769 2.312 . . . . 1.0 111.928 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.1 mt -106.72 128.81 54.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.847 0.356 . . . . 1.0 110.433 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.48 153.64 6.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t -66.67 140.98 57.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 1.0 110.541 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.9 ttm -138.78 142.65 38.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.158 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -139.03 95.14 9.6 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.126 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.03 159.05 15.59 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.148 1.898 . . . . 1.0 112.049 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.63 -32.39 58.04 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.607 2.205 . . . . 1.0 111.981 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -53.96 158.06 3.77 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.907 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.76 143.29 99.65 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.156 1.238 . . . . 1.0 111.687 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.35 -45.08 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.79 78.72 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 142.27 57.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.06 0.457 . . . . 1.0 111.162 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -104.22 79.85 0.4 Allowed Pre-proline 0 N--CA 1.464 0.261 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.35 98.97 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.893 1.729 . . . . 1.0 112.918 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -43.55 93.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.754 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.94 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.341 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 t -136.33 138.77 42.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.763 0.316 . . . . 1.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG11 ' CG ' ' A' ' 112' ' ' PHE . 2.8 p -142.95 150.9 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.083 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -105.29 121.34 43.67 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.85 -172.66 13.2 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.426 ' O ' ' SD ' ' A' ' 25' ' ' MET . 86.2 mmm -120.44 127.31 52.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 1.0 110.091 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -90.11 119.71 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.3 mpp? -110.4 136.68 49.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.946 0.403 . . . . 1.0 110.34 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.34 150.43 42.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.025 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.69 -64.74 0.51 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.706 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.45 -34.15 93.32 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.658 2.239 . . . . 1.0 113.624 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.06 175.21 0.66 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.812 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -117.17 169.06 9.75 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.099 0.476 . . . . 1.0 110.527 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -160.68 142.9 9.41 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.644 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.85 145.71 94.75 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.498 1.465 . . . . 1.0 111.241 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.2 p -155.21 -171.66 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.466 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.44 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.405 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 20' ' ' VAL . 68.3 mt -113.37 130.09 56.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -130.51 128.17 40.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.167 0.508 . . . . 1.0 111.556 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.655 HD23 ' HB1' ' A' ' 115' ' ' ALA . 51.9 tp -95.17 124.55 39.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.009 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.64 149.95 45.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.112 0.482 . . . . 1.0 111.314 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -108.11 120.67 42.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.389 -0.823 . . . . 1.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -132.88 135.94 45.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.871 0.367 . . . . 1.0 110.87 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 59.26 34.49 23.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 1.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.57 23.6 76.55 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.004 -0.838 . . . . 1.0 111.004 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -133.77 157.08 46.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.94 133.43 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -139.02 146.66 41.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.197 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -105.45 134.31 48.77 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.706 ' N ' HD13 ' A' ' 46' ' ' LEU . 78.0 mt -114.09 124.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.2 mt -105.1 120.37 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -112.34 126.86 55.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.152 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.9 mp -103.93 123.69 47.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -78.85 58.04 2.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.371 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -54.75 155.91 3.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.299 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.28 -41.44 98.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.2 -81.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -142.01 150.13 40.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.741 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -67.35 141.71 57.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.307 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.43 132.61 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.992 0.425 . . . . 1.0 110.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -95.01 126.62 40.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.914 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -120.52 117.28 27.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.478 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -93.35 108.22 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.865 0.364 . . . . 1.0 110.061 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG23 ' HE1' ' A' ' 95' ' ' TRP . 31.6 mm -114.66 121.88 34.93 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.627 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.58 149.95 39.6 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.778 1.652 . . . . 1.0 112.615 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.3 115.36 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -169.57 -158.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.362 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -59.51 -41.67 90.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -65.73 -37.69 87.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' A' ' 64' ' ' ASN . 16.4 t80 -95.63 123.83 39.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.834 0.35 . . . . 1.0 110.06 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -140.13 144.05 36.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.099 0.476 . . . . 1.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.36 99.71 7.38 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 70' ' ' VAL . 35.4 m -104.56 124.95 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.905 0.383 . . . . 1.0 110.811 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.459 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 6.9 tp-100 -77.7 104.46 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.455 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 37.52 56.93 1.42 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.66 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -176.82 177.31 1.35 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.592 . . . . 1.0 110.85 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -87.09 -11.11 51.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.46 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' LEU . 81.5 tt0 -146.41 -92.49 0.09 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.782 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.701 ' O ' HG22 ' A' ' 76' ' ' THR . 88.1 m 42.61 24.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.224 0.535 . . . . 1.0 110.793 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 75' ' ' GLU . 98.3 mt -65.52 -40.49 93.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.811 -0.631 . . . . 1.0 111.364 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.48 -40.38 95.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.966 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.659 ' O ' HG22 ' A' ' 76' ' ' THR . 84.0 mt -109.52 130.45 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.098 0.475 . . . . 1.0 111.244 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 35.0 p-10 -144.57 -33.8 0.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.424 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.446 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 91.9 mt -67.84 -25.31 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.535 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.02 91.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.128 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -97.47 70.73 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.181 0.515 . . . . 1.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 9.7 m120 -98.7 -169.2 1.75 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.207 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 m 61.82 84.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.58 76.47 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 109.462 -1.455 . . . . 1.0 109.462 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.03 142.98 26.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.933 0.397 . . . . 1.0 111.803 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.459 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 55.8 mtpt -118.56 128.07 54.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.5 pt -127.82 163.6 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.75 142.15 50.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.8 t -121.6 135.76 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.087 0.47 . . . . 1.0 110.564 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -119.92 163.47 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.225 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 174.45 149.84 7.36 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.0 -39.69 90.5 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.277 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.406 ' HE1' HG23 ' A' ' 61' ' ' ILE . 3.8 p90 -80.26 -11.53 59.71 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 93' ' ' GLY . 12.0 pt -128.26 155.95 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.865 0.364 . . . . 1.0 110.698 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -96.3 175.26 6.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.683 0.278 . . . . 1.0 110.5 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.86 115.95 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.175 0.512 . . . . 1.0 110.6 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -129.03 137.91 51.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.237 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.64 151.05 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.739 0.304 . . . . 1.0 110.705 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -137.35 155.17 49.73 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.478 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -147.4 126.08 12.58 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.972 0.415 . . . . 1.0 111.389 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.425 HG12 HG21 ' A' ' 20' ' ' VAL . 3.0 mp -102.93 99.52 14.12 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 -10.05 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.407 1.404 . . . . 1.0 112.472 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -96.49 107.34 19.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.83 -52.73 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.7 -0.682 . . . . 1.0 112.157 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.0 OUTLIER -52.44 -43.97 65.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.593 -0.443 . . . . 1.0 110.388 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.46 ' HB3' HG23 ' A' ' 20' ' ' VAL . 60.7 m170 -69.6 -34.19 73.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.377 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.422 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.922 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.08 -47.65 79.24 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.357 -0.537 . . . . 1.0 111.706 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.57 -44.74 77.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.862 -0.735 . . . . 1.0 110.171 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.516 ' CG ' HG11 ' A' ' 20' ' ' VAL . 37.0 t80 -61.36 -49.44 76.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.131 -0.94 . . . . 1.0 111.495 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.422 HD11 ' SG ' ' A' ' 109' ' ' CYS . 91.7 mt -67.32 -41.65 84.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.169 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -63.06 -45.89 90.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.529 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.655 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.97 -46.4 78.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.456 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.431 ' HA ' HD22 ' A' ' 37' ' ' LEU . 76.5 t -64.19 -44.49 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.894 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.74 -44.83 96.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 1.0 110.295 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.39 86.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -48.71 77.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -70.28 -36.89 74.67 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.77 -45.77 91.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.151 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.28 -40.08 96.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.306 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.79 -40.19 94.83 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.801 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.586 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 43.9 Cg_endo -67.21 152.64 79.26 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.723 2.282 . . . . 1.0 111.993 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 6' ' ' MET . 91.1 mt -74.44 145.97 43.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.445 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.24 -36.37 93.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.4 t -61.66 -43.74 98.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.343 . . . . 1.0 111.014 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.427 ' O ' ' O ' ' A' ' 3' ' ' LEU . 97.2 mmm -106.25 126.27 52.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.552 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -80.14 151.94 73.34 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.43 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.22 159.58 43.7 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.163 1.908 . . . . 1.0 111.996 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 45.4 Cg_endo -67.83 -33.28 27.43 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.642 2.228 . . . . 1.0 112.151 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -74.18 150.73 87.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.805 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.51 141.06 90.51 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.627 1.551 . . . . 1.0 111.72 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.3 t -68.35 -43.29 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.293 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.18 -41.31 4.85 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.86 146.13 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.594 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -93.22 107.02 22.48 Favored Pre-proline 0 N--CA 1.466 0.347 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.94 99.87 1.35 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.614 1.543 . . . . 1.0 113.181 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.49 -43.41 85.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.282 0.563 . . . . 1.0 109.892 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.12 149.08 29.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.327 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 t -141.34 130.18 23.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.689 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -142.03 159.66 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-O 120.928 0.394 . . . . 1.0 110.955 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -108.32 122.43 46.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.511 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' C ' ' SD ' ' A' ' 23' ' ' MET . . . -130.59 -152.52 7.42 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 22' ' ' GLY . 2.8 mpt? -143.99 126.53 15.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 1.0 110.522 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 84.2 tt0 -87.42 121.43 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.601 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -105.79 138.85 41.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.62 150.22 49.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.67 -66.63 0.38 Allowed Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.583 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.56 -33.59 86.83 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.761 2.307 . . . . 1.0 113.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -174.0 -171.97 0.68 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 121.009 -0.276 . . . . 1.0 110.463 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -130.23 169.13 15.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.973 0.416 . . . . 1.0 110.454 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 134.66 8.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.83 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.16 141.59 69.18 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 CA-C-N 120.199 1.107 . . . . 1.0 111.244 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 15.5 p -150.31 -176.24 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.403 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.71 138.64 22.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.451 HD12 HD11 ' A' ' 103' ' ' ILE . 71.0 mt -105.66 123.86 48.61 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.7 m -129.6 113.91 15.4 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.117 0.484 . . . . 1.0 111.584 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.505 HD23 ' HB1' ' A' ' 115' ' ' ALA . 49.9 tp -81.43 127.39 32.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.03 149.19 47.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.138 0.494 . . . . 1.0 111.363 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -112.98 121.95 46.18 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.405 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -135.36 139.89 44.61 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.039 0.447 . . . . 1.0 110.76 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 58.97 33.86 23.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.324 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.83 23.93 75.67 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -131.3 152.61 50.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.0 130.41 40.13 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -142.41 142.1 32.33 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.026 0.441 . . . . 1.0 110.231 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.5 tp -104.38 124.78 49.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.0 mt -103.38 122.19 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.988 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.88 114.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.471 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.9 mt-30 -101.68 132.79 47.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.071 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.0 mp -108.04 129.44 55.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.7 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -80.18 36.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.268 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -49.77 142.46 8.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.199 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.68 -38.69 91.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -59.04 -53.85 53.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.34 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -174.46 149.87 1.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.58 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 t -67.11 133.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.214 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 97.0 mt-30 -106.79 128.63 54.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.143 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -122.18 117.39 26.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.56 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.66 111.86 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.161 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -115.97 114.53 41.45 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.793 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.27 151.07 37.89 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.667 1.578 . . . . 1.0 112.462 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.9 mt -97.52 118.81 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.429 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -170.22 -158.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.352 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -61.05 -42.62 98.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.109 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -65.41 -36.11 82.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.979 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 64' ' ' ASN . 17.3 t80 -95.12 123.78 38.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.41 122.35 15.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.234 0.54 . . . . 1.0 110.817 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 t -87.89 115.0 25.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.247 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 70' ' ' VAL . 4.6 m -115.74 124.32 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.908 0.385 . . . . 1.0 110.583 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' HG21 ' A' ' 76' ' ' THR . 52.4 tt0 -84.48 135.44 34.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 55.25 -96.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.902 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.29 170.86 14.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.881 -0.599 . . . . 1.0 111.007 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' O ' HD21 ' A' ' 77' ' ' LEU . 97.5 mt-10 -83.93 -8.55 59.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.764 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -85.82 -7.76 58.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.818 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.495 HG21 ' O ' ' A' ' 71' ' ' GLN . 1.8 p -89.39 46.44 1.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.152 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD21 ' O ' ' A' ' 74' ' ' GLU . 37.4 mt -62.2 -42.71 99.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.991 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -105.6 -9.21 17.51 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.589 -0.278 . . . . 1.0 111.193 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.1 mt -101.49 130.75 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.997 0.427 . . . . 1.0 110.643 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 21.9 p-10 -152.29 -50.15 0.11 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.732 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' SER . 36.5 mm -63.99 -40.93 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.221 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.6 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . 44.0 t -142.91 140.19 31.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 1.0 110.151 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 85' ' ' SER . 91.1 m-20 -146.15 -172.22 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.985 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER 76.97 89.68 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.19 77.49 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.409 ' HB3' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.21 135.15 35.92 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.01 0.433 . . . . 1.0 111.882 -177.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.04 113.32 25.78 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.66 129.79 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.817 0.341 . . . . 1.0 110.429 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.86 142.18 33.57 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.105 -0.498 . . . . 1.0 109.982 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.06 133.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.706 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.22 141.61 31.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 175.65 -167.0 38.66 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.51 -40.89 96.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.643 0.258 . . . . 1.0 111.244 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -61.08 -37.95 84.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.672 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' GLY . 44.5 pt -143.26 148.5 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.676 0.274 . . . . 1.0 110.888 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 98' ' ' GLU . 50.4 ptt85 -72.2 -48.2 44.83 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.992 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 97' ' ' ARG . 84.1 tt0 -176.9 128.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.9 0.381 . . . . 1.0 110.581 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.88 145.08 35.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -104.06 147.32 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.93 0.395 . . . . 1.0 111.169 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.87 152.42 45.08 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.998 -0.547 . . . . 1.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -138.26 144.53 40.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.984 0.421 . . . . 1.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.451 HD11 HD12 ' A' ' 35' ' ' LEU . 5.7 mm -127.31 89.88 50.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.59 -16.44 46.93 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.721 1.614 . . . . 1.0 112.652 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -87.2 101.09 13.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.81 -55.07 39.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 1.0 112.087 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -51.84 -44.03 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.771 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -68.45 -39.67 81.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.919 0.39 . . . . 1.0 110.422 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -58.07 -36.84 73.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.107 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.414 HD21 ' ND2' ' A' ' 84' ' ' ASN . 96.5 mt -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.416 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.27 -44.58 83.21 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.868 -0.733 . . . . 1.0 110.542 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -62.18 -50.33 72.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.707 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.67 -40.86 92.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.119 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 m -61.53 -43.82 98.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.098 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.44 -42.8 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.157 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.95 -44.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.882 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.16 -45.96 92.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.061 0.457 . . . . 1.0 110.276 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.94 -37.39 84.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.311 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.12 -48.54 78.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -70.03 -38.72 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.923 0.392 . . . . 1.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.13 -44.86 90.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.754 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.08 75.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.951 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.18 -39.87 68.35 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.68 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.039 -0.981 . . . . 1.0 110.684 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.91 146.6 91.67 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.801 2.334 . . . . 1.0 112.12 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.29 149.49 40.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.054 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.67 -43.63 98.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.173 -0.771 . . . . 1.0 111.173 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' MET . 10.9 p -77.3 160.96 28.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.698 0.285 . . . . 1.0 110.528 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' SER . 23.9 tpp -59.34 -126.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.277 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -140.45 98.53 7.26 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.0 159.62 23.99 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.004 1.802 . . . . 1.0 112.05 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.13 -30.2 88.55 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.673 2.249 . . . . 1.0 111.822 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 10' ' ' LEU . 4.1 mm? -53.94 146.4 28.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.93 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -55.11 144.16 70.9 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.076 1.184 . . . . 1.0 111.5 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.86 -45.15 97.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.551 -0.749 . . . . 1.0 111.015 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.47 -28.67 73.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.14 -0.784 . . . . 1.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 147.39 52.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 1.0 110.976 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -118.28 80.49 15.91 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.431 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.45 97.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.158 1.905 . . . . 1.0 112.689 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' LEU . 98.3 mt -65.47 -41.34 93.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.799 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.6 149.08 28.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.229 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 t -138.23 136.4 36.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.806 0.336 . . . . 1.0 110.619 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.5 p -144.82 151.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.331 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.1 137.52 36.03 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.604 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -150.65 -168.5 15.56 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.647 -0.981 . . . . 1.0 110.647 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -127.84 130.54 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 1.0 110.515 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.55 ' OE1' HD11 ' A' ' 50' ' ' LEU . 81.3 tt0 -93.12 120.82 33.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.457 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 71.4 mtm -107.76 136.09 48.08 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.609 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.91 149.49 38.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.051 0.453 . . . . 1.0 109.965 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -37.11 -65.35 0.6 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.77 -0.65 . . . . 1.0 112.749 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.14 -32.78 95.04 Favored 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 122.728 2.285 . . . . 1.0 114.135 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.53 ' C ' HD12 ' A' ' 29' ' ' LEU . 1.0 OUTLIER 179.14 177.21 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 121.084 -0.246 . . . . 1.0 110.61 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.57 168.86 11.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.0 0.429 . . . . 1.0 110.287 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 16.7 pt-20 -161.46 143.91 9.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.41 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.46 144.93 95.51 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.338 1.359 . . . . 1.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 22' ' ' GLY . 4.2 p -154.05 -178.13 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.571 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.05 143.13 24.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.197 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 103' ' ' ILE . 49.7 mt -106.25 120.93 43.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.873 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m -127.27 115.36 18.91 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.232 0.539 . . . . 1.0 111.458 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.59 HD23 ' HB1' ' A' ' 115' ' ' ALA . 65.4 tp -87.76 128.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.062 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.88 144.26 41.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 1.0 111.425 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -98.77 121.26 40.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.544 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.95 134.18 42.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.914 0.388 . . . . 1.0 110.948 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 58.15 33.78 23.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.681 -0.69 . . . . 1.0 111.791 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.35 78.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.873 -0.891 . . . . 1.0 110.873 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 44.2 tt0 -131.36 161.28 32.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 94.5 m-85 -103.41 137.25 41.78 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -145.54 144.1 30.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.004 0.43 . . . . 1.0 110.352 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.2 tp -104.57 128.9 52.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.634 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.57 129.17 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.42 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.32 120.18 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' C ' HD22 ' A' ' 50' ' ' LEU . 37.1 mt-30 -108.53 127.83 54.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.082 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.55 HD11 ' OE1' ' A' ' 24' ' ' GLU . 4.2 mm? -101.27 132.44 46.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.906 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -95.49 18.99 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.305 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 94.1 mt-10 -45.6 136.84 5.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.419 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.74 -38.5 90.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.195 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.13 -50.92 69.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.377 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -170.58 154.92 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.166 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -84.58 113.88 21.57 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.14 131.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.938 0.399 . . . . 1.0 110.344 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -121.13 117.41 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.585 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -106.53 134.94 48.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.0 mm -93.82 109.54 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.902 0.382 . . . . 1.0 110.16 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.6 mm -112.41 104.59 56.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 147.82 36.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.596 1.53 . . . . 1.0 112.642 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 97.2 mt -91.81 119.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.431 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 79.3 m-20 -163.85 -165.37 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.059 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.1 p -61.54 -37.25 83.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.34 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -71.57 -32.2 67.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.296 . . . . 1.0 111.186 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 16.4 t80 -92.24 123.24 35.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.931 0.396 . . . . 1.0 109.987 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -135.05 144.48 47.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.549 . . . . 1.0 110.82 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.635 ' O ' HD21 ' A' ' 77' ' ' LEU . 7.5 t -117.96 112.36 20.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.049 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.94 125.83 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.852 0.358 . . . . 1.0 111.012 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' OE1' ' OD1' ' A' ' 80' ' ' ASP . 42.5 tt0 -84.44 102.1 12.52 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.719 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 38.64 47.82 1.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.512 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -174.04 -155.94 0.07 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.009 -0.542 . . . . 1.0 110.685 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -106.62 -6.19 18.14 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.032 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 77' ' ' LEU . 83.4 tt0 -157.43 -85.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.007 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.595 ' O ' HG22 ' A' ' 76' ' ' THR . 89.5 m 54.25 5.89 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.482 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.635 HD21 ' O ' ' A' ' 69' ' ' CYS . 84.7 mt -62.0 -38.81 90.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.253 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 78' ' ' LEU . 10.6 mp -63.27 -41.12 98.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.573 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' THR . 87.8 mt -109.12 127.26 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.053 0.454 . . . . 1.0 111.02 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.514 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 70.5 m-20 -160.39 -41.42 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.323 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.07 -42.57 95.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.59 -32.03 57.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.053 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ASP . 34.5 t -147.4 126.84 13.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.73 0.3 . . . . 1.0 110.706 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 80' ' ' ASP . 35.4 m120 -147.76 27.02 1.0 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.963 0.411 . . . . 1.0 111.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 t -80.45 100.89 8.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.396 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.96 80.37 0.12 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.952 -1.659 . . . . 1.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.86 129.5 38.76 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.134 0.42 . . . . 1.0 112.134 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.43 121.77 46.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 153.11 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.62 142.9 50.15 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.28 132.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.851 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -137.77 135.68 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.985 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 177.44 -174.67 47.14 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.48 -35.93 82.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.333 . . . . 1.0 110.984 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -59.11 -38.48 79.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.534 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 43.2 pt -141.7 151.73 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.37 0.129 . . . . 1.0 110.723 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -71.21 -56.98 4.95 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.879 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -174.32 112.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.479 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.534 ' HE ' ' CD1' ' A' ' 96' ' ' ILE . 76.7 mtm180 -129.33 134.19 47.79 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -91.89 157.58 16.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.857 0.361 . . . . 1.0 111.0 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.73 153.77 47.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.402 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -140.03 140.78 36.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.841 0.353 . . . . 1.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 35' ' ' LEU . 6.1 mm -128.67 89.61 48.74 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.07 -16.63 36.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.918 1.745 . . . . 1.0 112.651 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -87.55 106.51 18.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.697 -0.482 . . . . 1.0 109.697 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.0 -54.58 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 1.0 112.032 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.19 -44.23 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.559 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.433 ' HB3' HG23 ' A' ' 20' ' ' VAL . 7.1 m-70 -69.2 -37.14 77.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.736 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 113' ' ' LEU . 11.5 t -62.39 -31.91 72.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.157 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.78 -45.52 92.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.71 -42.99 85.5 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.039 -0.665 . . . . 1.0 110.622 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 116' ' ' VAL . 47.0 t80 -62.65 -51.13 68.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.223 -0.899 . . . . 1.0 111.322 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.462 ' CD1' HD22 ' A' ' 84' ' ' ASN . 91.2 mt -66.76 -41.07 88.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.277 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.9 p -63.19 -45.96 89.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.82 0.343 . . . . 1.0 111.345 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.2 -47.99 63.34 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.414 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 112' ' ' PHE . 55.9 t -64.75 -43.9 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.636 0.255 . . . . 1.0 111.113 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.63 -45.74 91.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 1.0 110.215 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -37.81 87.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.229 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.04 72.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.736 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -70.95 -35.97 72.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.355 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.66 -44.68 96.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.85 97.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.286 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.69 -41.06 88.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.698 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.507 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.81 144.82 99.62 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.912 2.408 . . . . 1.0 112.194 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.36 -41.68 98.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.502 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.86 152.16 52.07 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.894 -0.882 . . . . 1.0 110.894 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.7 p -82.66 -6.12 59.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 1.0 110.534 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.0 tpp -84.31 129.61 34.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.647 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -47.01 152.34 1.0 Allowed Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.496 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 160.25 44.5 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.273 1.982 . . . . 1.0 111.967 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 35.6 Cg_endo -63.97 -31.51 66.47 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.578 2.185 . . . . 1.0 111.974 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.55 150.92 53.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.12 143.29 99.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.326 1.351 . . . . 1.0 111.526 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 13' ' ' GLY . 13.4 m -68.63 -42.89 83.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -67.26 -28.12 73.64 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.399 -0.68 . . . . 1.0 111.399 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.89 58.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.906 0.384 . . . . 1.0 111.015 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -99.0 102.85 16.62 Favored Pre-proline 0 N--CA 1.465 0.275 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.42 100.58 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.605 1.536 . . . . 1.0 112.915 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.5 -43.72 84.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.333 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.43 149.91 31.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -141.82 131.71 24.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.526 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 21' ' ' GLU . 66.4 t -139.17 158.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 121.124 0.488 . . . . 1.0 110.822 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' N ' HG12 ' A' ' 20' ' ' VAL . 97.4 mt-10 -106.29 123.06 47.46 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.523 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.71 -160.5 9.59 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -139.0 127.34 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.867 0.365 . . . . 1.0 110.557 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -87.14 123.89 32.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.628 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.7 mtm -107.35 137.45 45.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.61 149.13 50.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -66.61 0.32 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.791 -0.641 . . . . 1.0 112.566 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.21 -33.62 90.06 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.804 2.336 . . . . 1.0 113.537 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -174.46 -174.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.526 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -126.1 168.64 13.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.067 0.461 . . . . 1.0 110.635 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -153.88 143.78 15.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.459 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.3 146.55 93.76 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.486 1.458 . . . . 1.0 111.117 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.5 p -155.14 -172.88 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.579 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.73 136.7 16.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 103' ' ' ILE . 21.8 mt -101.53 122.75 44.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.823 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -128.19 123.26 33.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.237 0.541 . . . . 1.0 111.7 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.607 HD23 ' HB1' ' A' ' 115' ' ' ALA . 46.6 tp -94.77 122.09 37.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.02 151.08 51.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.084 0.469 . . . . 1.0 111.25 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -110.7 122.5 47.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.639 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -134.01 138.62 45.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.981 0.419 . . . . 1.0 110.843 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 58.96 33.8 23.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.41 77.2 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -131.15 155.73 46.51 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.83 135.2 36.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.327 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -145.5 139.57 26.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 47' ' ' ILE . 5.2 tt -105.27 120.75 42.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.84 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.597 ' N ' HD23 ' A' ' 46' ' ' LEU . 79.8 mt -104.46 127.25 58.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.318 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.41 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 65.1 mt -105.37 116.76 49.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -96.15 127.51 42.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.54 133.47 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.773 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -106.39 34.33 3.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.306 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.81 149.09 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.99 -38.04 89.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.391 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -59.19 -51.2 71.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.227 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -175.02 166.27 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.749 -0.659 . . . . 1.0 111.026 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -84.62 127.45 34.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.979 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.41 136.03 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.042 0.449 . . . . 1.0 110.439 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 9' ' ' PRO . 56.7 tt0 -100.01 109.38 21.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.184 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -102.34 113.49 26.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.957 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.63 123.09 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.899 0.38 . . . . 1.0 110.381 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -132.37 117.63 15.67 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.141 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.72 157.8 39.61 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.766 1.644 . . . . 1.0 112.645 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.69 123.57 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -173.71 -161.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -62.08 -39.08 91.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.192 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -67.37 -38.23 84.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.591 -0.277 . . . . 1.0 111.179 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -84.01 125.42 32.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 1.0 110.212 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -134.09 144.59 48.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.297 0.57 . . . . 1.0 110.745 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -127.11 120.66 29.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.278 -0.874 . . . . 1.0 109.251 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 70' ' ' VAL . 6.9 m -119.62 125.3 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.767 0.318 . . . . 1.0 110.596 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -90.25 118.29 29.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.7 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 38.0 tp10 36.78 64.83 0.53 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.042 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 72' ' ' GLU . . . 171.79 -171.86 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.387 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -97.98 -13.72 20.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.059 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -144.25 -100.16 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 79' ' ' ILE . 45.4 m 39.6 63.13 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.534 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 77' ' ' LEU . 1.3 mp -102.21 -31.09 10.74 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.232 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.85 -40.47 83.67 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.221 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 76' ' ' THR . 91.2 mt -116.6 130.24 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.138 0.494 . . . . 1.0 110.976 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -134.83 -21.24 1.7 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.03 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.75 -42.19 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.379 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.13 -24.46 26.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.941 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 30.0 t -113.34 124.75 53.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.247 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 83' ' ' SER . 90.5 m-20 -150.81 -171.75 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.124 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' OG ' ' A' ' 85' ' ' SER . 4.7 p 66.37 97.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.51 79.04 0.09 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 135.33 36.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.865 0.365 . . . . 1.0 111.946 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.58 113.38 26.65 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.412 -0.959 . . . . 1.0 108.412 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.44 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.3 pp -116.17 125.7 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 1.0 110.162 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 65.3 mtp180 -102.57 146.52 28.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.71 132.47 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.678 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -145.61 148.13 32.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.274 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 120.92 -166.41 13.97 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 96' ' ' ILE . 99.0 m-20 43.97 -166.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.39 . . . . 1.0 110.757 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -68.25 21.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 1.0 112.051 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 94' ' ' ASP . 43.9 pt -130.65 155.24 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.602 0.239 . . . . 1.0 110.395 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -96.8 -169.74 1.93 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.716 0.293 . . . . 1.0 110.302 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 90' ' ' ARG . 77.2 tt0 -65.85 127.96 34.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.164 0.507 . . . . 1.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -132.02 160.77 34.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.076 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.466 ' CZ ' ' NH2' ' A' ' 90' ' ' ARG . 85.5 mtt85 -123.58 144.08 49.81 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.953 0.406 . . . . 1.0 110.964 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 91.0 m-85 -143.95 155.95 44.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.947 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -138.71 146.44 41.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 1.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 35' ' ' LEU . 6.0 mm -127.39 90.46 48.66 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.37 -16.09 43.01 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.833 1.689 . . . . 1.0 112.65 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -87.57 100.9 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.15 -53.42 58.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.201 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -52.97 -42.21 65.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.668 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -71.56 -36.57 70.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.885 0.374 . . . . 1.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.48 -36.19 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.064 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.14 -44.41 95.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.478 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -66.72 -44.49 81.48 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.29 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -61.01 -49.37 77.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.204 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.01 -42.43 89.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.539 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.5 m -63.13 -43.8 97.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.419 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.607 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.03 -48.83 61.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.355 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.29 -43.44 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.56 -45.42 91.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.932 0.396 . . . . 1.0 110.257 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.86 85.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.338 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.38 -49.01 77.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.839 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -67.61 -37.69 82.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.776 0.322 . . . . 1.0 111.04 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -60.12 -44.34 94.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.053 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.28 94.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.395 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.8 -39.73 91.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.665 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.939 -1.029 . . . . 1.0 110.875 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -60.94 145.0 99.69 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.883 2.389 . . . . 1.0 112.099 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.9 mt -76.22 146.05 39.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.39 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.52 173.42 55.01 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.4 t -74.41 98.13 3.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 1.0 110.435 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.2 mtt -139.27 146.33 40.27 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.532 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.18 114.79 18.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.604 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.14 159.59 23.56 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.019 1.813 . . . . 1.0 112.316 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HG2' HE21 ' A' ' 49' ' ' GLN . 36.5 Cg_endo -66.28 -32.35 41.94 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.669 2.246 . . . . 1.0 111.802 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -78.46 149.66 75.54 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.889 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.39 143.67 89.2 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.805 1.67 . . . . 1.0 111.621 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 m -78.7 -19.5 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.029 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.2 -33.51 84.6 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.32 170.59 15.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.03 0.443 . . . . 1.0 110.98 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -118.32 81.7 17.61 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.799 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.26 95.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.547 2.165 . . . . 1.0 112.7 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.21 -41.88 96.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.717 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.69 155.62 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.055 -0.975 . . . . 1.0 110.411 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -148.84 142.39 25.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.851 0.357 . . . . 1.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.96 161.05 23.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.304 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -94.99 122.51 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -125.34 167.19 17.78 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.2 mtp -117.6 103.01 9.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.864 0.364 . . . . 1.0 110.292 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' CE1' ' A' ' 101' ' ' PHE . 47.9 tp10 -60.22 121.37 11.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.109 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 102' ' ' GLU . 76.0 mtm -106.32 131.19 53.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.433 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.6 146.46 39.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.959 0.409 . . . . 1.0 109.998 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.22 -65.29 0.72 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.568 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.9 -33.38 95.88 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.627 2.218 . . . . 1.0 113.628 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -178.8 -169.53 0.17 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.659 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -132.65 168.91 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.951 0.405 . . . . 1.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 18.3 pt-20 -154.39 134.8 8.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.24 141.37 70.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 CA-C-N 120.264 1.13 . . . . 1.0 111.369 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 22' ' ' GLY . 28.5 p -149.17 -175.99 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.524 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.43 137.09 12.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.302 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 112' ' ' PHE . 47.7 mt -98.32 122.76 41.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.501 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.8 m -118.87 119.29 33.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.14 0.495 . . . . 1.0 111.283 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.429 HD23 ' HB1' ' A' ' 115' ' ' ALA . 54.7 tp -98.03 130.8 44.83 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.35 154.0 41.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.089 0.471 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -111.0 122.61 48.34 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -133.21 133.21 42.44 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 1.0 110.556 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 60.86 34.77 19.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.417 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.0 25.35 75.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.029 -0.829 . . . . 1.0 111.029 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -134.82 144.38 47.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.18 -0.304 . . . . 1.0 110.18 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.417 ' HB2' HE21 ' A' ' 123' ' ' GLN . 34.5 m-85 -88.39 136.51 32.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -143.73 144.54 31.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.051 0.453 . . . . 1.0 110.514 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.28 126.01 53.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.499 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.7 mt -111.71 131.64 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.151 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.5 mm -95.2 122.75 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' C ' HD12 ' A' ' 50' ' ' LEU . 13.2 mm100 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.818 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -109.92 136.12 49.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.809 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -104.81 20.41 18.78 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.25 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.8 mt-10 -40.43 141.07 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.88 0.371 . . . . 1.0 110.668 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.92 -39.64 92.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.474 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.47 -51.88 67.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.365 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -173.98 147.08 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.478 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 19.6 p80 -75.83 112.51 12.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 t -90.77 132.76 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -112.38 117.91 33.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.649 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -121.83 127.65 50.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -100.4 125.91 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.056 0.455 . . . . 1.0 110.487 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.559 HG23 ' HE1' ' A' ' 95' ' ' TRP . 60.0 mt -129.67 93.2 35.46 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.438 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.78 145.05 85.26 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.147 1.898 . . . . 1.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 97.6 mt -85.88 117.66 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 53.2 p30 -176.73 -160.37 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.121 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.7 p -65.47 -23.25 66.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.283 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -83.76 -10.46 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.02 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 27.2 t80 -113.78 129.81 56.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.963 0.411 . . . . 1.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' NH2' ' OE1' ' A' ' 75' ' ' GLU . 77.0 mtp180 -129.67 155.73 45.39 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.582 0.706 . . . . 1.0 111.081 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.547 ' H ' HD22 ' A' ' 77' ' ' LEU . 26.3 p -144.48 100.2 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.562 -1.199 . . . . 1.0 109.798 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 70' ' ' VAL . 33.2 m -102.53 122.39 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.844 0.355 . . . . 1.0 110.617 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 83' ' ' SER . 56.3 tt0 -98.81 125.4 44.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.05 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 47.34 18.83 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.914 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 71' ' ' GLN . . . -158.79 -160.62 0.88 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.685 -0.689 . . . . 1.0 111.066 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' O ' HG11 ' A' ' 70' ' ' VAL . 97.6 mt-10 -129.52 -8.55 4.63 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.405 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.534 ' OE1' ' NH2' ' A' ' 68' ' ' ARG . 43.8 tp10 -147.96 83.43 1.51 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.13 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' ILE . 6.2 t -157.84 44.25 0.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.228 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.547 HD22 ' H ' ' A' ' 69' ' ' CYS . 53.5 mt -63.38 -43.02 98.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.177 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.37 -37.62 74.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.979 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 76' ' ' THR . 79.3 mt -99.81 127.71 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.093 0.473 . . . . 1.0 111.129 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 71.9 m-20 -155.48 -29.47 0.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.219 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.74 -42.56 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.527 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.17 -31.73 53.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.04 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.439 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 40.8 m -105.53 120.75 42.41 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.095 -0.335 . . . . 1.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 83' ' ' SER . 90.5 m-20 -150.16 -167.99 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.227 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.87 86.77 0.12 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.33 69.84 1.27 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.005 -1.638 . . . . 1.0 109.005 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.3 142.57 27.26 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.047 0.451 . . . . 1.0 111.896 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -128.3 131.18 48.69 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.96 162.72 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.323 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.764 ' NH2' HH22 ' A' ' 100' ' ' ARG . 68.0 mtt180 -128.58 140.48 51.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.96 134.7 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.99 0.424 . . . . 1.0 110.626 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.85 140.06 52.63 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.334 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -169.61 -175.34 38.65 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.533 ' OD1' ' CE3' ' A' ' 95' ' ' TRP . 13.4 p-10 -74.43 -37.77 63.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.714 0.292 . . . . 1.0 111.191 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.559 ' HE1' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -65.71 -34.92 79.32 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.385 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 93' ' ' GLY . 25.5 pt -127.74 156.55 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.676 0.274 . . . . 1.0 110.634 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 98' ' ' GLU . 3.9 ptm180 -84.93 -53.28 5.41 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.798 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 97' ' ' ARG . 47.8 tp10 -174.97 93.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 1.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -104.56 135.05 46.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.764 HH22 ' NH2' ' A' ' 90' ' ' ARG . 57.4 mtp85 -101.37 150.25 23.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.937 0.399 . . . . 1.0 110.812 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.549 ' CE1' ' OE1' ' A' ' 24' ' ' GLU . 70.1 m-85 -129.24 154.9 46.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.556 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 25' ' ' MET . 81.4 tt0 -149.04 121.73 8.63 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.988 0.423 . . . . 1.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.16 98.41 26.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.78 -10.67 25.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.68 1.587 . . . . 1.0 112.595 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -94.35 106.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.86 -54.98 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.002 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -50.07 -44.85 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.519 -0.473 . . . . 1.0 110.464 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -68.57 -40.19 80.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 1.0 110.642 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.16 -36.85 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.033 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -63.7 -44.66 93.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.46 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.26 -45.22 81.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.312 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 53.3 t80 -61.48 -49.1 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.405 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.4 -41.58 80.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.344 -0.542 . . . . 1.0 111.238 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.2 t -63.36 -44.97 93.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.686 0.279 . . . . 1.0 111.535 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.63 -50.32 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.465 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.8 -45.18 99.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.592 -0.276 . . . . 1.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -60.67 -46.01 91.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 110.318 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.09 76.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 1.0 110.533 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.44 99.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.818 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -66.38 -40.2 89.54 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.663 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -63.25 -44.22 95.79 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.624 0.726 . . . . 1.0 110.115 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.4 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.174 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' A' ' 63' ' ' ILE . 89.3 mt-30 -66.26 -40.58 90.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.742 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.599 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.585 -1.406 . . . . 1.0 109.585 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.57 -18.04 48.53 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.646 2.23 . . . . 1.0 112.092 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 4' ' ' GLY . 5.6 tt -97.84 120.43 38.22 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.873 0.368 . . . . 1.0 110.104 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.624 ' N ' HD23 ' A' ' 3' ' ' LEU . . . 164.0 -43.12 0.32 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -70.88 139.81 50.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.332 . . . . 1.0 110.632 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.64 -40.4 95.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.352 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -105.13 103.75 43.52 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.431 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -82.33 160.05 17.42 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.165 1.91 . . . . 1.0 112.255 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.22 -30.2 81.37 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.667 2.245 . . . . 1.0 111.958 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.62 162.17 0.99 Allowed Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.826 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.83 152.41 64.04 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.488 1.459 . . . . 1.0 111.443 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -85.97 70.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.692 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.86 -26.93 0.39 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.57 140.67 53.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 111.035 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 15.5 mm100 -102.54 80.95 0.35 Allowed Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.69 88.42 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.681 1.587 . . . . 1.0 112.152 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.695 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.42 137.58 38.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.578 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.28 125.76 26.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 21' ' ' GLU . 54.6 t -135.93 157.07 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.767 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.523 ' OE1' ' HB2' ' A' ' 34' ' ' ALA . 46.7 tp10 -105.79 122.96 47.16 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.98 -157.76 8.78 Favored Glycine 0 N--CA 1.463 0.491 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -140.51 123.59 16.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.886 0.374 . . . . 1.0 110.36 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -88.94 119.32 29.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.518 ' N ' ' SD ' ' A' ' 25' ' ' MET . 1.3 mpp? -107.58 136.04 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.509 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.68 149.08 52.6 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -65.82 0.41 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.635 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.83 -32.62 85.7 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.814 2.343 . . . . 1.0 113.705 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -174.43 -176.72 1.12 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.434 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -126.72 169.1 13.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 1.0 110.682 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -158.15 141.98 11.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.553 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.25 144.34 95.33 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.297 1.331 . . . . 1.0 110.985 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.3 p -152.01 174.21 13.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.321 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -140.09 131.78 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.955 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 103' ' ' ILE . 31.1 mt -96.63 121.6 38.64 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.999 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.3 m -129.24 124.67 35.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.197 0.522 . . . . 1.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD23 ' HB1' ' A' ' 115' ' ' ALA . 37.4 tp -90.24 125.86 35.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.432 -0.803 . . . . 1.0 108.851 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.86 155.45 42.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.127 0.489 . . . . 1.0 111.052 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' OE1' ' CZ ' ' A' ' 44' ' ' TYR . 20.6 tt0 -134.19 116.52 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.829 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.464 ' CZ ' ' OE1' ' A' ' 45' ' ' GLU . 34.2 ptt180 -137.25 144.21 42.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.233 0.539 . . . . 1.0 111.248 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 59.11 28.05 17.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.107 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.04 78.37 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -127.31 137.88 52.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CZ ' ' OE1' ' A' ' 39' ' ' GLN . 84.1 m-85 -87.92 135.72 33.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 40' ' ' ARG . 22.6 pt-20 -144.89 144.61 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 1.0 110.482 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.9 tp -103.76 121.16 42.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.292 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.2 mt -105.16 124.77 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.944 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.35 115.89 49.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' C ' HD12 ' A' ' 50' ' ' LEU . 80.4 mt-30 -96.78 131.8 43.13 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.983 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 49' ' ' GLN . 9.1 mp -106.82 130.43 54.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.805 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -104.06 29.17 6.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.126 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE1' ' OE2' ' A' ' 54' ' ' GLU . 96.6 mt-10 -43.69 145.6 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.606 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.14 -36.07 82.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' OE2' ' OE1' ' A' ' 52' ' ' GLU . 3.3 pt-20 -62.03 -46.72 87.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -177.29 154.96 1.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.567 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -78.01 127.84 32.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.0 109.876 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.42 135.94 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.042 0.449 . . . . 1.0 110.474 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -108.6 126.37 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.158 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.82 119.02 36.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.716 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.5 mm -92.75 112.64 26.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.93 0.395 . . . . 1.0 110.369 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mm -117.64 89.44 32.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.221 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.67 141.44 95.47 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.228 1.952 . . . . 1.0 112.455 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -83.53 124.81 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.558 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.627 ' ND2' ' CD2' ' A' ' 66' ' ' HIS . 5.2 p30 176.04 -165.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.963 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -59.19 -38.04 78.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.706 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CD2' ' ND2' ' A' ' 64' ' ' ASN . 3.3 p80 -74.54 -2.75 27.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.75 0.31 . . . . 1.0 111.401 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 42.0 t80 -116.25 132.21 56.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.155 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -130.71 148.29 52.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.861 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 t -143.2 104.32 4.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.052 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.21 128.14 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.885 0.374 . . . . 1.0 110.886 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 8.2 tp-100 -78.9 96.15 5.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 36.92 57.65 1.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -159.01 164.92 35.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.982 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -68.05 -37.69 81.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.68 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -170.73 81.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.668 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 79' ' ' ILE . 4.6 m -123.15 45.67 2.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.073 0.463 . . . . 1.0 110.523 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.541 ' H ' HD12 ' A' ' 77' ' ' LEU . 5.0 mp -67.62 -36.49 80.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.569 . . . . 1.0 111.439 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.37 -42.91 99.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.453 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 76' ' ' THR . 91.4 mt -110.78 129.46 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.093 0.473 . . . . 1.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 97.8 m-20 -142.11 -30.17 0.57 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.289 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.86 -41.99 94.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.493 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.01 -22.52 5.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.905 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t -111.42 122.84 48.9 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.054 0.454 . . . . 1.0 110.414 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -148.74 -166.79 2.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.07 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 t 56.82 88.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.73 72.52 0.7 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.447 -1.461 . . . . 1.0 109.447 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 134.94 36.28 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.799 0.333 . . . . 1.0 111.686 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.488 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 63.8 mttp -111.87 131.63 55.23 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 35' ' ' LEU . 34.2 pt -125.15 157.96 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.74 ' NH2' HH22 ' A' ' 100' ' ' ARG . 96.9 mtt180 -131.19 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.2 132.25 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -146.91 154.71 41.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.358 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -165.04 172.54 40.73 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -67.64 -44.5 77.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.866 0.365 . . . . 1.0 111.219 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CE2' HG23 ' A' ' 96' ' ' ILE . 1.0 OUTLIER -85.08 -11.76 54.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.121 -0.49 . . . . 1.0 112.073 -178.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.562 HG23 ' CE2' ' A' ' 95' ' ' TRP . 42.4 pt -126.24 153.78 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.639 0.257 . . . . 1.0 110.655 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -92.03 162.6 14.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.667 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -63.42 136.08 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.409 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -136.13 159.14 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.131 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.74 HH22 ' NH2' ' A' ' 90' ' ' ARG . 66.6 mtp85 -122.23 145.11 48.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.061 0.458 . . . . 1.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -140.21 155.67 46.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.175 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -139.41 141.51 37.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.891 0.376 . . . . 1.0 111.06 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.506 HD11 HD12 ' A' ' 35' ' ' LEU . 5.1 mm -124.03 89.45 51.69 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.62 -15.62 37.72 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.85 1.7 . . . . 1.0 112.762 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -88.65 105.12 17.46 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.4 tt0 -60.43 -53.84 52.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.23 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -53.06 -42.45 65.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.571 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -70.27 -37.68 74.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.492 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.61 -34.44 74.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.423 . . . . 1.0 111.001 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.72 -44.74 95.44 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.309 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.87 -43.25 84.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.164 -0.615 . . . . 1.0 110.579 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.476 ' CE2' HD13 ' A' ' 89' ' ' ILE . 59.1 t80 -60.27 -49.2 78.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.293 -0.867 . . . . 1.0 111.211 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.9 -41.86 86.43 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.336 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 57.8 m -63.53 -44.17 95.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.822 0.344 . . . . 1.0 111.451 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -70.34 -48.8 54.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.609 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' CE1' ' A' ' 112' ' ' PHE . 62.3 t -65.45 -43.57 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.904 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.92 -45.11 93.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 110.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.92 -38.85 89.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.6 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.3 -49.34 76.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.765 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.48 -36.78 74.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.335 . . . . 1.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.76 -44.93 94.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.158 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.9 95.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.285 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -67.86 -41.23 83.22 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.63 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.15 145.24 96.4 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.951 2.434 . . . . 1.0 112.229 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.88 -41.4 97.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.48 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.43 6.1 18.07 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.3 t -66.83 133.46 50.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 1.0 110.881 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.29 -39.77 92.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.322 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -139.56 98.58 7.98 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.178 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.47 160.41 14.78 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.273 1.982 . . . . 1.0 112.32 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.41 -31.07 72.75 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.647 2.231 . . . . 1.0 111.77 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.1 155.6 16.15 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.158 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.55 143.86 99.48 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.336 1.358 . . . . 1.0 111.628 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.6 -44.96 93.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.14 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.62 78.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 140.41 58.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 1.0 110.961 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -104.07 80.7 0.44 Allowed Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.242 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.75 99.95 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.98 1.787 . . . . 1.0 112.102 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -64.65 -43.85 92.3 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.392 0.615 . . . . 1.0 110.154 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.87 141.36 24.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.19 -0.914 . . . . 1.0 109.932 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -131.64 128.87 40.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.212 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.9 162.25 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.147 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -99.75 122.62 43.0 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -123.06 179.2 16.2 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 93.3 mmm -126.15 99.61 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' A' ' 99' ' ' ARG . 81.3 tt0 -62.29 132.54 52.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.098 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 73.9 mtm -120.8 140.25 51.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.782 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -141.56 148.68 39.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.32 -65.59 0.34 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.779 -0.646 . . . . 1.0 112.504 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.63 -31.85 92.62 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.65 2.233 . . . . 1.0 114.108 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 29' ' ' LEU . 1.0 OUTLIER 179.35 176.28 0.63 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.399 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -118.01 169.2 9.85 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 1.0 110.177 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.39 141.9 13.25 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.448 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 144.91 96.39 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.026 1.15 . . . . 1.0 111.359 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 22' ' ' GLY . 17.1 p -153.58 -179.84 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.438 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' C ' HD22 ' A' ' 35' ' ' LEU . . . -138.93 128.64 24.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.081 0.467 . . . . 1.0 110.239 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 35' ' ' LEU . 3.9 mm? -100.52 119.66 38.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.966 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.6 m -130.66 122.01 26.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.0 111.853 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.661 HD23 ' HB1' ' A' ' 115' ' ' ALA . 57.5 tp -90.42 129.99 36.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.006 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.29 148.63 41.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.44 . . . . 1.0 111.457 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -109.02 121.24 44.72 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.66 136.65 46.6 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.057 0.456 . . . . 1.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 59.73 33.66 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.908 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.37 77.82 Favored Glycine 0 N--CA 1.463 0.476 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -130.36 154.39 47.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.483 -0.359 . . . . 1.0 110.055 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -92.58 135.1 34.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -143.94 143.81 31.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 1.0 110.317 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -103.89 124.78 49.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.423 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.53 118.07 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.7 mt -103.44 120.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.643 -0.502 . . . . 1.0 109.643 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' HD12 ' A' ' 50' ' ' LEU . 79.1 mt-30 -115.08 129.58 56.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.762 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.4 mp -101.22 127.37 47.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -76.73 62.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.298 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.3 154.34 40.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.252 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -62.46 -40.83 97.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.193 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.33 -82.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.882 0.372 . . . . 1.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -142.29 152.14 42.7 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -70.71 123.07 21.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.22 133.89 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.12 0.486 . . . . 1.0 110.481 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -95.23 123.92 38.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -120.45 117.08 26.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.444 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.22 110.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.911 0.386 . . . . 1.0 110.626 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.438 HG23 ' HE1' ' A' ' 95' ' ' TRP . 34.7 mm -115.16 119.07 39.31 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.165 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.01 150.83 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.797 1.665 . . . . 1.0 112.669 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.442 HG23 HE21 ' A' ' 120' ' ' GLN . 97.8 mt -104.46 118.35 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.319 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -172.22 -153.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.234 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.0 p -64.16 -40.24 95.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.191 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -66.6 -41.15 88.92 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 8.0 t80 -96.23 130.1 43.39 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.788 0.328 . . . . 1.0 110.18 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -139.42 142.54 37.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.541 . . . . 1.0 110.826 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -119.91 115.5 23.92 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.12 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.77 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.91 0.386 . . . . 1.0 110.644 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.658 ' C ' ' H ' ' A' ' 73' ' ' ALA . 19.7 tt0 -81.05 107.18 13.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.416 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 73' ' ' ALA . 94.1 mt-10 60.59 -16.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.458 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . 37.96 -158.09 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.527 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 56.34 3.31 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.143 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 73' ' ' ALA . 5.3 pt-20 179.25 -19.98 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.872 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.37 71.9 1.4 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.126 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.505 ' H ' HD12 ' A' ' 77' ' ' LEU . 4.5 mp -78.5 -74.67 0.26 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.955 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 78' ' ' LEU . 11.1 mp -71.98 -39.01 69.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.698 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 89.4 mt -78.99 137.57 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.181 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 83' ' ' SER . 89.0 m-20 -136.57 -29.29 0.96 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 1.0 110.139 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.41 -42.74 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.757 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.86 -9.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.233 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 80' ' ' ASP . 3.2 t -139.98 136.43 33.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 1.0 110.239 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' A' ' 85' ' ' SER . 91.5 m-20 -148.54 -173.07 4.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.827 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 85' ' ' SER . 3.0 p 75.7 99.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.44 77.7 0.13 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.499 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.41 139.78 30.67 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.246 0.461 . . . . 1.0 112.246 -177.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -113.1 125.2 54.11 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.334 -0.987 . . . . 1.0 108.334 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pt -119.02 130.46 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.444 ' CZ ' HH11 ' A' ' 100' ' ' ARG . 20.2 mmt180 -96.26 142.59 28.22 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.9 t -124.93 135.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 1.0 110.197 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -131.47 139.36 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.012 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -165.92 170.3 40.6 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.808 -0.917 . . . . 1.0 110.808 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -69.6 -42.7 74.08 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 122.534 -0.392 . . . . 1.0 111.505 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.438 ' HE1' HG23 ' A' ' 61' ' ' ILE . 1.8 p90 -65.55 -32.07 73.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 1.0 111.795 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.486 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.3 pt -128.58 139.35 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 110.338 -0.245 . . . . 1.0 110.338 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.41 -57.58 7.98 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.771 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -175.51 108.22 0.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.426 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' A' ' 24' ' ' GLU . 85.6 mtp180 -107.05 123.84 48.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.662 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.444 HH11 ' CZ ' ' A' ' 90' ' ' ARG . 94.9 mtt-85 -83.97 146.28 28.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.183 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.17 147.48 36.68 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.241 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.05 152.33 39.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.705 0.288 . . . . 1.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -126.84 102.49 25.07 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.89 -13.06 29.08 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.648 1.565 . . . . 1.0 112.953 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -91.81 105.4 17.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.14 -54.82 42.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.167 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.687 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.439 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.55 -38.93 81.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 1.0 110.348 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.494 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -57.09 -36.43 70.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.798 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.0 mt -61.88 -46.28 90.11 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.152 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.85 -44.53 80.77 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.905 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.32 -48.87 76.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.499 HD11 ' SG ' ' A' ' 87' ' ' CYS . 95.9 mt -65.91 -41.66 91.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.552 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.7 m -62.16 -43.46 98.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.831 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.29 -47.32 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HA ' HD22 ' A' ' 37' ' ' LEU . 76.6 t -66.59 -42.49 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.953 0.406 . . . . 1.0 111.158 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.32 -42.68 91.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.167 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.76 90.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.05 87.9 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.623 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 63' ' ' ILE . 60.2 mm-40 -69.9 -38.31 76.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.97 -46.04 92.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.055 0.455 . . . . 1.0 109.832 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.15 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.48 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.39 -39.07 88.83 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.605 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.451 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.479 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.675 -1.37 . . . . 1.0 109.675 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 34.1 Cg_endo -63.9 -22.42 68.71 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.759 2.306 . . . . 1.0 111.988 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.92 -42.11 99.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.247 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.77 -124.73 36.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.7 m -71.62 159.72 33.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 1.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.2 mtm -63.18 -40.09 96.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.149 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -87.05 151.68 52.11 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.173 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.94 159.76 37.66 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.168 1.912 . . . . 1.0 112.109 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.8 -32.51 77.7 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.749 2.299 . . . . 1.0 112.071 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.6 mt -71.08 150.03 94.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.859 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.76 142.03 61.92 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.914 1.742 . . . . 1.0 111.466 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.32 -32.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.734 -0.667 . . . . 1.0 111.349 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.05 -36.36 90.18 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB1' ' HB1' ' A' ' 38' ' ' ALA . . . -80.7 165.87 21.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 1.0 110.978 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -119.53 80.67 22.9 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.602 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.23 96.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.676 2.251 . . . . 1.0 112.773 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.3 mt -65.37 -41.43 93.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.83 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.06 146.59 27.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.251 -0.886 . . . . 1.0 110.36 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 t -134.31 131.06 37.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.807 0.337 . . . . 1.0 110.542 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 35' ' ' LEU . 28.3 m -137.97 160.79 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.367 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -100.08 154.79 18.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.623 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -169.92 -169.61 33.35 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 23' ' ' MET . 2.5 mpt? -132.2 129.19 39.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 1.0 110.388 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -91.97 117.36 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.44 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.8 mtm -101.49 135.66 42.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.789 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.79 151.47 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.714 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -67.03 0.33 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.667 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.35 -33.77 88.48 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.882 2.388 . . . . 1.0 113.603 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.519 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.36 -176.61 0.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -122.07 168.45 11.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.11 0.481 . . . . 1.0 110.695 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -155.28 142.41 13.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.737 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.03 143.39 94.97 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.355 1.37 . . . . 1.0 111.257 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 22' ' ' GLY . 12.4 p -153.57 -179.2 7.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.385 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.23 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.936 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.52 HD13 HD11 ' A' ' 89' ' ' ILE . 26.6 mt -101.58 123.77 46.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.5 m -127.43 124.29 38.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.227 0.537 . . . . 1.0 111.357 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.618 HD23 ' HB1' ' A' ' 115' ' ' ALA . 54.7 tp -91.59 128.93 37.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.016 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.45 148.68 43.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.159 0.504 . . . . 1.0 111.388 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -109.23 123.06 48.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.723 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -135.09 135.81 41.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.967 0.413 . . . . 1.0 111.194 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 60.13 34.59 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.658 -0.701 . . . . 1.0 111.523 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.4 21.75 76.11 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -129.89 156.76 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -98.54 132.46 43.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -140.79 147.08 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.44 . . . . 1.0 110.065 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -103.99 122.21 44.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.438 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.52 117.76 51.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -99.75 118.41 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' HD12 ' A' ' 50' ' ' LEU . 77.0 mt-30 -100.03 131.64 45.87 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.442 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.6 mp -105.99 123.34 47.84 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -80.11 36.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.154 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' LEU . 35.0 tp10 -46.47 135.0 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.985 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.4 -35.88 81.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -66.79 -80.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.402 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -132.57 129.28 38.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.933 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -61.94 102.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.922 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.91 131.44 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -107.79 136.57 47.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.956 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 40.6 t0 -101.03 123.5 45.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.5 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.31 119.26 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 1.0 110.3 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.459 HD11 ' NH1' ' A' ' 99' ' ' ARG . 6.8 mt -133.11 119.23 15.52 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.896 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.49 157.21 40.82 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.678 1.586 . . . . 1.0 112.598 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.46 119.67 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.537 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -171.89 -160.06 0.15 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.43 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 t -61.12 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.041 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -64.81 -36.15 83.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.875 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 64' ' ' ASN . 28.2 t80 -95.0 136.87 34.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.968 0.413 . . . . 1.0 110.439 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 92' ' ' GLN . 37.5 ptt180 -143.38 145.99 33.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.904 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 27.5 p -117.0 99.66 7.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.384 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' VAL . 31.8 m -102.82 124.26 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.032 0.444 . . . . 1.0 110.985 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.648 ' H ' ' CG2' ' A' ' 76' ' ' THR . 9.2 tp-100 -83.14 100.84 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.381 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 63.94 -26.29 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.792 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . -92.43 -158.79 0.61 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.88 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -133.65 7.18 3.8 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.532 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -170.92 36.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.648 ' CG2' ' H ' ' A' ' 71' ' ' GLN . 7.6 t -94.46 40.46 1.09 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.464 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.4 mt -63.54 -39.56 94.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.514 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 78' ' ' LEU . 3.8 mm? -63.39 -41.28 98.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.659 -0.246 . . . . 1.0 110.565 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' THR . 86.4 mt -116.73 127.55 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.24 0.543 . . . . 1.0 111.228 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 98.5 m-20 -142.52 -39.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.376 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.94 -42.47 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.675 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.33 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.029 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -106.9 78.26 1.23 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.099 0.476 . . . . 1.0 110.577 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.421 ' ND2' HD21 ' A' ' 110' ' ' LEU . 92.4 m-20 -104.67 -170.4 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.378 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.404 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.4 m 64.59 88.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.69 82.92 0.06 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.56 135.24 41.27 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.834 0.309 . . . . 1.0 111.834 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 65.7 mttp -111.53 128.71 56.1 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.52 HD11 HD13 ' A' ' 35' ' ' LEU . 33.6 pt -125.01 157.35 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.31 134.63 45.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.99 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.46 132.94 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.366 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 98' ' ' GLU . 86.2 mt-30 -135.4 152.79 51.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.024 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -168.08 167.61 40.26 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 95' ' ' TRP . 36.9 p-10 -68.03 -39.54 83.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.791 0.329 . . . . 1.0 111.266 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.528 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 3.2 p-90 -88.42 -9.89 51.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.759 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.497 HG23 ' CE2' ' A' ' 95' ' ' TRP . 14.3 pt -125.13 151.42 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.787 0.327 . . . . 1.0 110.657 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 -95.34 -171.89 2.51 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 1.0 110.765 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 48.5 tp10 -61.01 128.45 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 1.0 110.526 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.459 ' NH1' HD11 ' A' ' 61' ' ' ILE . 99.9 mtt180 -135.35 143.39 46.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.033 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -127.16 145.99 50.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.752 0.31 . . . . 1.0 111.181 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -144.25 153.72 42.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.357 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -143.51 147.35 34.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.972 0.415 . . . . 1.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.452 HD11 HD12 ' A' ' 35' ' ' LEU . 5.1 mp -128.03 98.73 26.5 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 -11.29 28.6 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.706 1.604 . . . . 1.0 112.67 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 105.3 17.6 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.2 tt0 -59.09 -53.98 52.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -50.75 -43.52 58.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.576 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -69.97 -40.21 75.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.879 0.371 . . . . 1.0 110.531 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -57.1 -34.87 68.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.083 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.421 HD21 ' ND2' ' A' ' 84' ' ' ASN . 96.0 mt -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.519 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.48 -44.84 81.56 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.185 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CE2' HD13 ' A' ' 89' ' ' ILE . 57.0 t80 -59.88 -48.67 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.158 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.11 -41.36 86.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.389 -0.525 . . . . 1.0 111.281 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -65.59 -46.08 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.607 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.618 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.13 -50.05 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.318 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.4 HG21 ' CE1' ' A' ' 112' ' ' PHE . 61.5 t -64.15 -44.21 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.66 -45.21 95.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.421 . . . . 1.0 110.196 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.42 82.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.452 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.44 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.678 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.462 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 87.3 mt-30 -69.77 -38.6 76.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.407 . . . . 1.0 110.84 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -63.95 -44.46 92.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.039 0.447 . . . . 1.0 110.919 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.95 75.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.866 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.85 -40.51 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 1.0 110.571 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.595 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.23 150.64 87.24 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.743 2.295 . . . . 1.0 112.029 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.51 141.37 48.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.184 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' SER . . . -85.26 177.42 50.5 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 4' ' ' GLY . 66.6 m 51.54 102.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.776 0.322 . . . . 1.0 110.467 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.59 -39.96 95.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.367 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.37 96.99 41.8 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.307 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.35 159.49 17.34 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.232 1.955 . . . . 1.0 112.256 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.7 -32.23 68.61 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.652 2.235 . . . . 1.0 112.025 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.76 144.44 85.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.956 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.64 148.51 53.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.797 1.665 . . . . 1.0 111.841 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.18 -43.15 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.563 . . . . 1.0 111.109 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.5 -36.64 47.79 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.76 151.12 47.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 1.0 110.825 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -118.15 83.57 20.12 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.326 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.56 125.04 16.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.262 1.975 . . . . 1.0 112.431 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.7 mt -101.1 -32.66 10.47 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.428 -0.805 . . . . 1.0 109.632 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.48 151.19 29.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.326 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -146.33 129.17 16.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.859 0.361 . . . . 1.0 110.556 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -141.43 163.15 20.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.259 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -101.37 122.43 43.72 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -131.54 152.11 19.96 Favored Glycine 0 N--CA 1.464 0.555 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 mmm -99.19 100.66 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.999 0.428 . . . . 1.0 110.187 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.84 126.8 28.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.589 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.441 ' SD ' ' C ' ' A' ' 101' ' ' PHE . 1.6 mpp? -109.85 137.16 48.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.03 149.79 50.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.635 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.28 -66.23 0.3 Allowed Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.915 -0.584 . . . . 1.0 112.633 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.49 -33.28 88.15 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.796 2.331 . . . . 1.0 113.484 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -177.79 -172.51 0.35 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.672 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -122.67 168.87 11.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.047 0.451 . . . . 1.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -154.12 140.87 13.12 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.723 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.22 142.0 84.71 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.267 1.312 . . . . 1.0 111.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' GLY . 13.6 p -150.95 169.23 22.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.551 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.18 118.94 19.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 109.852 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 101' ' ' PHE . 13.2 mt -91.92 126.3 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.012 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.6 m -130.81 120.69 24.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.095 0.474 . . . . 1.0 111.344 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.523 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.6 tp -90.38 130.99 36.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.07 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.81 148.17 32.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.173 0.511 . . . . 1.0 111.362 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.72 127.01 48.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -138.0 138.15 38.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.887 0.375 . . . . 1.0 111.007 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.44 35.22 24.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.662 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.56 27.56 73.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.7 158.95 43.28 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -99.27 130.34 45.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.908 -0.405 . . . . 1.0 109.908 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.27 143.77 34.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.931 0.396 . . . . 1.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.4 125.21 50.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.275 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -103.31 124.6 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mt -99.25 128.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' C ' HD12 ' A' ' 50' ' ' LEU . 14.2 mm100 -118.4 119.62 35.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.691 0.282 . . . . 1.0 110.807 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.0 mp -100.58 131.18 46.63 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.572 ' HD1' ' CD2' ' A' ' 56' ' ' HIS . 95.4 m-70 -94.29 60.53 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 1.0 110.413 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.24 157.6 10.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.183 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.15 -38.74 87.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.754 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 54' ' ' GLU . 56.6 mp0 -78.96 -104.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.226 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -106.52 152.49 23.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.572 ' CD2' ' HD1' ' A' ' 51' ' ' HIS . 60.7 m80 -73.3 145.77 45.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.233 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.76 130.7 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.983 0.42 . . . . 1.0 110.303 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -106.53 108.08 19.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.788 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -116.74 113.05 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.633 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.41 115.64 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.387 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.05 120.18 39.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.38 147.89 33.15 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.791 1.661 . . . . 1.0 112.498 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.58 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 96.4 mt -92.8 122.49 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.228 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.6 p30 -174.16 -159.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.353 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -41.25 90.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.2 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -66.06 -36.28 82.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.353 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . 15.1 t80 -101.54 123.63 45.88 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -133.81 141.08 47.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.326 0.584 . . . . 1.0 111.026 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.0 t -103.31 105.87 16.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.245 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.54 HG12 HD23 ' A' ' 77' ' ' LEU . 5.9 m -111.07 126.4 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.229 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 83' ' ' SER . 20.8 tt0 -97.49 131.1 44.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.492 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 59.49 -100.99 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.374 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.58 170.66 16.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.005 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' O ' HD21 ' A' ' 77' ' ' LEU . 80.8 mm-40 -83.4 -10.74 58.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.737 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -82.3 -12.75 57.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.842 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.441 ' O ' ' OG1' ' A' ' 76' ' ' THR . 1.1 p -87.81 42.88 1.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.125 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 70' ' ' VAL . 54.6 mt -61.79 -43.02 99.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.109 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -108.34 -9.36 15.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.595 0.236 . . . . 1.0 111.223 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.437 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 76.5 mt -102.4 130.42 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.911 0.386 . . . . 1.0 110.543 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.659 ' HB3' HD12 ' A' ' 113' ' ' LEU . 94.8 m-20 -144.9 -32.75 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.85 -0.613 . . . . 1.0 110.396 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 41.0 mm -64.58 -42.26 94.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.68 -27.02 15.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.815 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.552 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 9.5 t -123.81 119.1 28.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.043 0.449 . . . . 1.0 110.314 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 83' ' ' SER . 23.4 m120 -146.73 -167.0 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 1.0 109.827 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.24 92.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.05 67.18 2.18 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 108.892 -1.683 . . . . 1.0 108.892 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 148.95 25.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.221 0.534 . . . . 1.0 111.596 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HE2' HH21 ' A' ' 90' ' ' ARG . 25.2 pttm -129.85 135.83 48.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.335 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.33 162.89 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.306 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.418 HH21 ' HE2' ' A' ' 88' ' ' LYS . 3.4 mpt_? -123.99 137.52 54.59 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.8 t -116.92 133.84 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.922 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -140.77 152.77 45.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.115 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.42 162.85 35.73 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.552 -1.019 . . . . 1.0 110.552 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -70.97 -47.88 56.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.719 0.295 . . . . 1.0 111.464 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.514 ' CD1' HG23 ' A' ' 96' ' ' ILE . 1.0 OUTLIER -82.65 -9.68 59.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.898 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.514 HG23 ' CD1' ' A' ' 95' ' ' TRP . 33.7 pt -126.74 151.18 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.701 0.286 . . . . 1.0 110.793 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -83.44 164.61 19.8 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.833 0.349 . . . . 1.0 110.946 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -63.46 140.3 58.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -141.03 154.19 45.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.153 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -125.52 154.18 42.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.979 0.419 . . . . 1.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.441 ' C ' ' SD ' ' A' ' 25' ' ' MET . 98.5 m-85 -138.33 158.7 43.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.769 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -144.72 123.45 12.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mm -110.45 96.62 28.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.15 -14.55 28.8 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.536 1.491 . . . . 1.0 112.674 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -94.32 113.66 25.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.974 0.416 . . . . 1.0 110.002 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.03 -55.09 39.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.231 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -52.06 -43.34 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.654 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -68.2 -38.55 82.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.914 0.388 . . . . 1.0 110.131 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.232 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.4 -45.39 91.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.644 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -66.3 -45.41 80.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.974 -0.69 . . . . 1.0 110.703 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.46 -49.61 76.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.284 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 80' ' ' ASP . 3.4 mm? -65.44 -42.56 92.26 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.382 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -63.83 -45.14 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.735 0.303 . . . . 1.0 111.478 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.523 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -64.93 -50.83 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.441 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.68 -46.37 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.03 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.01 -48.02 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 1.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.99 78.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.548 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.24 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.553 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -65.51 -44.8 85.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -66.21 -43.43 86.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.504 0.668 . . . . 1.0 110.488 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.32 78.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.904 -1.044 . . . . 1.0 111.998 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.58 ' NE2' ' O ' ' A' ' 63' ' ' ILE . 17.2 pt20 -72.2 -38.32 69.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.48 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.062 -0.971 . . . . 1.0 110.567 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.357 -1.497 . . . . 1.0 109.357 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.2 144.18 98.83 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.672 2.248 . . . . 1.0 112.102 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.93 145.76 44.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.265 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 6' ' ' MET . . . -73.56 158.99 52.89 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 t 54.27 3.63 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.608 0.242 . . . . 1.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.533 ' H ' ' C ' ' A' ' 4' ' ' GLY . 10.2 tpp -100.43 -34.97 9.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.893 0.378 . . . . 1.0 110.245 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -44.69 151.93 0.57 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.508 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -38.65 156.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.147 1.898 . . . . 1.0 112.328 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.07 -23.38 73.6 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.532 2.155 . . . . 1.0 111.969 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 10' ' ' LEU . 3.9 mp -66.79 149.15 98.53 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.99 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.05 143.9 91.63 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.67 1.58 . . . . 1.0 111.429 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.88 -43.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.178 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.4 51.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.39 137.78 44.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.059 0.457 . . . . 1.0 111.025 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -98.95 108.6 50.11 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.57 103.87 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.532 1.488 . . . . 1.0 112.789 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.88 -43.6 83.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.191 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.21 148.95 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.216 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -138.34 131.36 29.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.765 0.317 . . . . 1.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.21 160.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.158 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 34' ' ' ALA . 41.8 tp10 -100.1 122.67 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 33' ' ' CYS . . . -132.26 158.16 22.82 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 84.1 mmm -99.37 120.88 40.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.887 0.375 . . . . 1.0 110.203 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.85 118.24 24.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.693 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -102.65 137.21 41.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.07 152.86 52.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.266 -0.425 . . . . 1.0 109.982 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.38 -66.48 0.36 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.894 -0.593 . . . . 1.0 112.506 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.22 -32.92 73.34 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.747 2.298 . . . . 1.0 113.877 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.29 -170.3 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 121.105 -0.238 . . . . 1.0 110.385 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -124.71 169.28 12.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.962 0.41 . . . . 1.0 110.25 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 9.3 pt-20 -153.57 133.19 7.33 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.797 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.29 142.56 78.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 CA-C-N 120.245 1.123 . . . . 1.0 111.34 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 22' ' ' GLY . 8.9 p -152.1 -170.18 3.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.526 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.472 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -156.8 131.3 8.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.293 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -100.84 123.16 44.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.088 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.4 m -126.34 112.33 15.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.298 0.57 . . . . 1.0 111.723 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.679 HD23 ' HB1' ' A' ' 115' ' ' ALA . 55.4 tp -80.47 127.75 32.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.378 -0.828 . . . . 1.0 109.086 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.06 148.28 36.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.441 . . . . 1.0 111.445 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -102.42 128.99 48.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.901 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -139.9 136.97 34.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.931 0.396 . . . . 1.0 110.872 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 59.18 33.78 22.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.513 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.93 22.56 78.38 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.443 ' CD ' ' H ' ' A' ' 44' ' ' TYR . 7.3 tp-100 -132.58 157.13 45.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.443 ' H ' ' CD ' ' A' ' 43' ' ' GLN . 81.0 m-85 -96.3 131.84 42.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -144.06 143.88 31.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 1.0 110.404 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.1 tp -104.2 124.96 50.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.257 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.8 mt -100.12 124.81 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.118 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.9 mt -96.53 117.54 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' C ' HD12 ' A' ' 50' ' ' LEU . 36.4 mt-30 -109.15 130.58 55.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.7 mp -104.94 127.76 52.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 51.0 t-80 -93.8 25.39 3.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.9 mt-10 -55.02 137.55 46.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.45 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -62.72 -39.7 94.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.26 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -53.47 -51.18 63.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.913 0.387 . . . . 1.0 110.18 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -166.72 148.21 6.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.767 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.03 86.8 6.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.869 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 t -80.81 133.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.539 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -128.29 119.28 24.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.744 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.37 129.64 55.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -96.41 114.66 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.775 0.321 . . . . 1.0 110.273 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.03 121.37 35.32 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.18 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 155.48 42.57 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.987 1.792 . . . . 1.0 112.628 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' CG ' ' A' ' 64' ' ' ASN . 98.0 mt -98.13 112.79 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.373 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 78.6 m-20 -161.68 -160.67 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.6 t -60.35 -41.94 94.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -66.17 -36.75 83.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.021 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 19.2 t80 -93.03 124.09 36.76 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.823 0.344 . . . . 1.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.49 141.75 45.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.289 0.566 . . . . 1.0 110.769 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.507 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 26.6 p -113.46 99.7 7.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.222 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -109.45 128.46 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.448 . . . . 1.0 111.049 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 72' ' ' GLU . 5.3 tp-100 -80.77 116.86 20.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' GLN . 17.7 pt-20 32.77 38.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.645 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 71' ' ' GLN . . . -159.2 -156.67 0.54 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.732 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -129.31 17.15 6.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.375 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 77' ' ' LEU . 5.8 pt-20 -161.17 -111.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.624 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.73 HG22 ' O ' ' A' ' 79' ' ' ILE . 89.5 m 38.86 28.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.629 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 75' ' ' GLU . 85.8 mt -65.63 -39.01 91.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 1.0 111.334 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.57 -40.59 97.36 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.648 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 76' ' ' THR . 35.1 mm -109.33 129.24 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.065 0.46 . . . . 1.0 111.025 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -137.69 -27.81 0.92 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.181 0.515 . . . . 1.0 110.077 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.65 -42.61 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.693 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.82 -26.01 44.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.126 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.53 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 5.7 t -104.28 102.61 12.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 83' ' ' SER . 9.8 m120 -136.27 -168.94 2.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.994 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.403 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 2.3 m 62.13 82.58 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.17 77.35 0.26 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 132.64 37.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.798 0.332 . . . . 1.0 111.751 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.22 129.49 55.71 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.404 HD13 ' HE2' ' A' ' 112' ' ' PHE . 48.5 pt -126.83 160.15 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -130.52 133.96 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.482 . . . . 1.0 109.849 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.2 t -114.54 134.55 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.418 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.43 154.96 41.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.327 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.11 167.0 37.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.54 -43.17 94.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.607 0.241 . . . . 1.0 111.608 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.513 ' CE2' HG23 ' A' ' 96' ' ' ILE . 1.5 p-90 -90.48 -6.54 54.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.181 0.437 . . . . 1.0 112.181 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.513 HG23 ' CE2' ' A' ' 95' ' ' TRP . 19.3 pt -126.97 152.76 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.4 162.11 15.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.828 0.347 . . . . 1.0 110.879 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -59.66 137.63 57.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.468 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.43 154.53 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.082 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -124.74 150.97 45.66 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.185 0.517 . . . . 1.0 111.394 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -143.83 156.86 44.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.43 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -148.56 118.67 7.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.048 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.62 99.8 12.55 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.83 -11.82 28.03 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.542 1.495 . . . . 1.0 112.887 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -91.42 106.19 18.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 85' ' ' SER . 80.3 tt0 -59.98 -52.91 63.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.091 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -52.24 -43.83 64.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.406 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.47 -38.96 77.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.0 110.564 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -35.22 71.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.024 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -45.33 93.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.306 -0.558 . . . . 1.0 111.148 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.77 -43.22 84.6 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.787 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.404 ' HE2' HD13 ' A' ' 89' ' ' ILE . 51.8 t80 -61.1 -49.39 77.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.077 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 113' ' ' LEU . 95.8 mt -66.24 -42.02 89.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.472 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 m -63.12 -45.38 92.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 1.0 111.317 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.679 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -66.55 -49.03 67.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.33 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.46 -45.65 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.977 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -60.98 -45.1 96.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.034 0.445 . . . . 1.0 110.148 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.22 -37.76 86.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.459 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.18 -49.99 73.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.679 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.503 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 92.3 mt-30 -70.69 -38.07 73.68 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.227 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.72 -43.09 94.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.007 0.432 . . . . 1.0 110.517 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.6 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.33 -35.82 68.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 1.0 110.752 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.019 -0.991 . . . . 1.0 110.476 -179.905 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 32.3 Cg_endo -63.44 -25.17 70.71 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.682 2.255 . . . . 1.0 112.152 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.7 mt 53.13 -171.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.08 24.36 76.61 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.9 m -66.19 143.59 57.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 1.0 110.533 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.9 mmm -82.78 148.08 28.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.116 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -41.01 103.93 0.32 Allowed Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.765 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -83.6 159.66 14.47 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.182 1.921 . . . . 1.0 112.241 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.99 -32.8 43.74 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.657 2.238 . . . . 1.0 111.986 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.38 84.01 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.774 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.51 140.48 94.22 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.857 1.705 . . . . 1.0 111.542 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.89 -43.79 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.215 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -37.34 -38.88 0.44 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.38 -0.688 . . . . 1.0 111.38 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.28 147.95 41.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.722 0.296 . . . . 1.0 110.538 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -98.2 102.43 14.01 Favored Pre-proline 0 C--O 1.223 -0.338 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -75.28 103.14 1.68 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.5 1.467 . . . . 1.0 113.522 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.1 mt -67.12 -41.84 85.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.178 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 155.31 40.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.259 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -143.49 130.64 20.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.42 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 21' ' ' GLU . 47.9 t -141.31 159.08 22.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.698 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 20' ' ' VAL . 83.0 tt0 -104.55 121.13 42.86 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -123.56 -169.51 13.22 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.837 -0.905 . . . . 1.0 110.837 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 89.3 mmm -136.94 101.47 4.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.87 0.367 . . . . 1.0 110.037 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.578 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.0 tt0 -61.05 128.8 38.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.609 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -106.01 136.38 45.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.312 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -135.64 151.91 50.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.72 -68.15 0.29 Allowed Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.74 -0.664 . . . . 1.0 112.605 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.93 -32.47 92.54 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.864 2.376 . . . . 1.0 113.553 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -179.85 -167.01 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.344 -0.243 . . . . 1.0 110.344 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -122.46 168.5 12.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.888 0.375 . . . . 1.0 110.201 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -146.21 138.73 13.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.653 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.34 139.63 73.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 CA-C-N 120.171 1.097 . . . . 1.0 111.418 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.578 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 17.2 p -153.65 177.68 10.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -147.56 138.72 23.63 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.905 0.383 . . . . 1.0 110.122 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.704 ' N ' HD12 ' A' ' 35' ' ' LEU . 5.5 mp -102.62 120.57 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 1.0 109.999 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -127.31 113.17 15.92 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.28 0.562 . . . . 1.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.647 HD23 ' HB1' ' A' ' 115' ' ' ALA . 45.5 tp -86.48 127.51 34.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.434 -0.803 . . . . 1.0 108.975 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.94 156.56 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.16 0.505 . . . . 1.0 111.484 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -113.87 122.65 47.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.608 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -133.32 137.89 46.15 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.886 0.374 . . . . 1.0 110.919 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 59.13 34.17 23.18 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.606 -0.725 . . . . 1.0 111.513 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.77 25.34 75.22 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.771 -0.931 . . . . 1.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -134.09 153.33 51.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -93.53 134.9 35.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.02 143.79 31.35 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.963 0.411 . . . . 1.0 110.264 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.0 tp -103.46 116.56 32.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.356 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.8 mt -109.69 115.78 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 101' ' ' PHE . 60.2 mt -106.57 116.9 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' C ' HD12 ' A' ' 50' ' ' LEU . 11.7 mm100 -81.27 128.43 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.705 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.4 mp -110.4 130.26 55.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.615 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.623 ' N ' ' ND1' ' A' ' 51' ' ' HIS . 0.9 OUTLIER -94.53 54.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.218 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -46.61 150.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.55 -39.97 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.33 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -62.95 -46.13 89.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.133 0.492 . . . . 1.0 110.488 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -168.9 -158.98 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.796 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.01 115.11 28.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.893 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.76 138.13 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.169 0.509 . . . . 1.0 110.499 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.45 ' OE1' HD11 ' A' ' 60' ' ' ILE . 17.4 pt20 -97.56 141.42 30.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -102.06 115.18 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.738 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.45 HD11 ' OE1' ' A' ' 58' ' ' GLN . 51.8 mm -92.82 101.42 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.923 0.392 . . . . 1.0 110.092 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.8 mm -117.63 90.21 34.96 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.143 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.14 146.48 88.04 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 1.0 112.407 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 96.6 mt -93.28 115.43 32.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.46 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 80.7 m-20 -163.58 -166.75 1.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.177 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -33.24 74.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.223 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.461 ' ND1' ' OD1' ' A' ' 94' ' ' ASP . 6.2 p80 -76.2 -12.48 60.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.743 0.306 . . . . 1.0 111.17 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.46 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 32.9 t80 -114.06 130.05 56.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.052 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.68 145.08 44.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.4 t -121.55 106.04 11.01 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.399 -0.818 . . . . 1.0 109.2 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 70' ' ' VAL . 5.8 m -107.36 125.37 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.729 0.3 . . . . 1.0 110.762 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.468 HE22 ' N ' ' A' ' 88' ' ' LYS . 9.3 tp-100 -99.1 115.88 30.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.339 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 37.74 57.04 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.7 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' ' OG1' ' A' ' 76' ' ' THR . . . -176.14 162.99 2.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.082 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -68.74 -37.41 79.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.595 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -170.23 80.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.605 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 79' ' ' ILE . 14.6 m -118.02 59.65 0.79 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.172 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.9 -35.45 80.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.301 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.09 -42.05 99.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.335 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 76' ' ' THR . 89.6 mt -119.12 129.32 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.24 0.543 . . . . 1.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 99.9 m-20 -142.63 -33.95 0.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.531 -0.758 . . . . 1.0 109.955 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.503 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 95.8 mt -64.04 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.67 -24.92 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.945 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 m -102.6 59.54 0.8 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.844 0.354 . . . . 1.0 110.429 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.7 m120 -82.65 -171.63 3.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.145 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 m 66.69 87.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.04 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.12 79.04 0.11 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 139.8 30.84 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.921 0.391 . . . . 1.0 111.754 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' N ' HE22 ' A' ' 71' ' ' GLN . 22.3 pttp -126.83 134.14 50.6 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.3 pt -126.18 161.24 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.231 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.95 138.14 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.697 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -117.46 133.96 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.448 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -136.91 134.65 37.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.046 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 123.07 -158.23 17.67 Favored Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 96' ' ' ILE . 94.8 m-20 43.9 -165.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.633 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -70.04 20.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 1.0 112.101 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 94' ' ' ASP . 21.0 pt -130.53 133.61 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.898 0.38 . . . . 1.0 110.628 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -73.38 -44.58 58.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.468 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -174.75 126.22 0.29 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.438 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -137.76 123.66 20.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -89.98 151.15 21.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.925 0.393 . . . . 1.0 111.24 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 48' ' ' ILE . 67.6 m-85 -136.53 148.62 47.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.26 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.95 144.32 45.36 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 1.0 110.753 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 35' ' ' LEU . 6.2 mm -129.41 90.37 44.6 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.27 -17.82 44.76 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 1.0 112.762 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -88.88 108.67 19.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.69 -0.485 . . . . 1.0 109.69 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.8 tt0 -64.91 -53.18 50.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.068 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -53.18 -40.9 64.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.664 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -73.0 -35.88 66.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 1.0 110.396 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.9 t -60.73 -34.24 74.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.901 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.8 -44.79 95.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.425 -0.51 . . . . 1.0 111.352 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.84 -43.67 83.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.969 -0.692 . . . . 1.0 110.189 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.428 ' CZ ' HD23 ' A' ' 35' ' ' LEU . 42.3 t80 -60.22 -49.03 79.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.353 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -65.89 -41.62 91.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.269 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.3 t -63.31 -44.74 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.235 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.87 -50.32 64.94 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.359 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.21 -44.15 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.26 -45.75 92.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 1.0 110.225 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.14 86.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.549 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.7 79.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.809 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.29 -37.62 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 1.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -60.37 -44.51 95.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.029 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.59 94.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.49 -40.2 92.79 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.792 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.222 -0.386 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.386 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.97 -35.67 81.41 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.768 2.312 . . . . 1.0 112.144 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 77.5 mt -62.52 -41.71 99.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.28 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.97 173.76 53.48 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.741 -0.944 . . . . 1.0 110.741 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 t -152.54 151.34 30.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.901 0.382 . . . . 1.0 110.695 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.2 ttm 49.83 -129.9 2.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.501 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -138.73 95.57 9.81 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.059 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.45 159.08 19.66 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.04 1.827 . . . . 1.0 112.216 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.42 -32.61 60.06 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.56 2.174 . . . . 1.0 111.989 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.7 mt -70.2 135.41 86.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.064 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.681 ' HD3' HE22 ' A' ' 58' ' ' GLN . 50.7 Cg_endo -68.91 147.58 68.61 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.686 1.59 . . . . 1.0 111.68 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -70.02 -32.39 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.156 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.23 94.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.56 141.83 44.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 1.0 110.778 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -101.67 100.34 14.03 Favored Pre-proline 0 C--O 1.224 -0.283 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.38 103.15 1.69 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.523 1.482 . . . . 1.0 112.83 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.76 -43.34 89.18 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.131 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.87 151.65 37.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.237 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -141.42 128.08 20.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.452 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 21' ' ' GLU . 53.3 t -141.59 160.7 21.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.926 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 55.7 mp0 -103.55 121.96 43.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -124.99 -173.37 13.69 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 25' ' ' MET . 90.7 mmm -131.26 107.31 8.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 1.0 110.125 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 99' ' ' ARG . 84.8 tt0 -76.19 126.48 31.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.644 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.532 ' N ' ' SD ' ' A' ' 25' ' ' MET . 0.9 OUTLIER -116.04 139.82 49.89 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.634 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.68 150.4 50.62 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 1.0 109.865 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.9 -65.6 0.47 Allowed Glycine 0 CA--C 1.533 1.188 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.665 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.52 -32.36 88.05 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 122.732 2.288 . . . . 1.0 113.786 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -176.78 -179.56 0.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 121.032 -0.267 . . . . 1.0 110.465 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -125.14 169.21 12.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.053 0.454 . . . . 1.0 110.787 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -157.92 143.43 12.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.426 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.64 144.23 93.82 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.264 1.309 . . . . 1.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.5 p -149.14 173.67 13.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.403 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' C ' HD22 ' A' ' 35' ' ' LEU . . . -134.7 129.1 34.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.01 0.433 . . . . 1.0 110.182 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 35' ' ' LEU . 3.8 mm? -97.4 118.21 33.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -129.84 113.82 15.15 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.166 0.507 . . . . 1.0 111.56 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD23 ' HB1' ' A' ' 115' ' ' ALA . 47.4 tp -85.98 129.8 34.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.464 -0.789 . . . . 1.0 109.047 178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.12 156.96 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.999 0.428 . . . . 1.0 111.283 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -119.47 119.62 34.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.576 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -127.31 137.19 52.76 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.977 0.418 . . . . 1.0 110.913 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 58.86 32.38 22.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.498 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.21 18.45 78.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 44' ' ' TYR . 7.6 tp-100 -125.51 140.44 52.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.113 -0.328 . . . . 1.0 110.113 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.451 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 69.9 m-85 -80.27 135.72 36.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.51 140.28 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.355 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.5 tp -104.34 126.13 51.18 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.311 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.8 mt -104.37 121.18 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.983 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.7 115.45 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.6 mt-30 -105.65 130.94 53.57 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.879 0.371 . . . . 1.0 110.931 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.605 HD21 ' NH2' ' A' ' 99' ' ' ARG . 10.9 mp -106.16 128.41 53.89 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.407 ' HD1' ' CE1' ' A' ' 56' ' ' HIS . 99.6 m-70 -90.13 62.5 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.331 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 55' ' ' GLN . 97.9 mt-10 -60.85 146.22 47.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.36 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.52 -39.55 93.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.086 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -63.23 -41.07 99.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' GLU . 15.8 pt20 -172.39 -156.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.407 ' CE1' ' HD1' ' A' ' 51' ' ' HIS . 97.9 m-70 -127.34 127.97 45.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.975 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.79 130.69 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.171 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.681 HE22 ' HD3' ' A' ' 11' ' ' PRO . 20.5 tt0 -102.58 116.26 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.987 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -102.05 113.26 26.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.521 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -94.61 111.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 1.0 110.524 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mm -113.68 120.29 39.67 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.089 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.6 148.1 36.75 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.792 1.661 . . . . 1.0 112.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.0 mt -92.58 122.97 44.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.444 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -172.22 -160.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.266 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.507 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 78.0 p -61.53 -40.01 93.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -68.51 -32.51 72.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.682 0.277 . . . . 1.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.8 t80 -95.4 126.14 40.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.044 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 65' ' ' SER . 84.4 mtt85 -137.75 145.91 43.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.2 0.524 . . . . 1.0 110.874 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.2 t -122.33 117.89 27.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.064 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 70' ' ' VAL . 4.8 m -118.36 125.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.756 0.312 . . . . 1.0 110.462 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.1 tp-100 -83.68 123.78 30.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.441 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 49.32 -101.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.96 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.89 150.61 48.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.679 . . . . 1.0 110.982 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' O ' HD21 ' A' ' 77' ' ' LEU . 80.5 mm-40 -74.55 -6.4 48.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.739 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -80.65 -9.17 59.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.971 0.415 . . . . 1.0 110.968 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 76' ' ' THR . 1.3 p -100.03 46.69 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.219 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.516 HD21 ' O ' ' A' ' 74' ' ' GLU . 49.1 mt -62.16 -44.4 96.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.11 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.17 -10.5 17.89 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.732 -0.213 . . . . 1.0 110.774 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.41 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 81.8 mt -102.32 132.44 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.997 0.427 . . . . 1.0 110.8 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 98.5 m-20 -141.57 -38.7 0.4 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.039 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 83' ' ' SER . 93.8 mt -64.23 -43.18 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.691 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.0 -11.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.156 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' ILE . 30.7 t -133.18 135.15 44.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.009 0.433 . . . . 1.0 110.157 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -146.25 -176.76 5.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.911 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t 72.04 89.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.24 80.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -93.74 133.61 36.93 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -177.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.1 mttt -109.95 113.21 25.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.463 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 2.1 pp -117.51 128.81 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -103.39 146.16 28.9 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.46 133.7 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.897 0.379 . . . . 1.0 110.639 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -136.19 137.95 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.182 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 179.27 -175.28 47.03 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 65.1 t0 -64.7 -40.99 96.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.858 0.361 . . . . 1.0 111.384 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -60.83 -37.07 80.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.733 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' GLY . 38.1 pt -138.51 140.69 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.679 0.276 . . . . 1.0 110.607 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.432 ' CG ' ' N ' ' A' ' 98' ' ' GLU . 35.8 ptt-85 -71.7 -46.91 57.22 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.511 -0.476 . . . . 1.0 110.753 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' ARG . 48.5 tp10 -175.04 121.45 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.874 0.368 . . . . 1.0 110.228 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.605 ' NH2' HD21 ' A' ' 50' ' ' LEU . 81.0 mtp180 -138.08 124.35 20.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -87.76 149.2 24.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.933 0.396 . . . . 1.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -141.08 148.28 39.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.286 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -144.31 134.44 24.19 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.369 . . . . 1.0 111.074 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.68 99.72 48.52 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 -13.05 31.08 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.504 1.469 . . . . 1.0 112.768 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -90.72 103.04 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -53.51 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 1.0 112.207 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -53.04 -43.77 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.549 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -69.56 -36.68 76.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.908 0.385 . . . . 1.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 113' ' ' LEU . 1.4 t -60.13 -36.2 76.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.855 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.0 mt -62.53 -44.31 96.66 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.103 -0.639 . . . . 1.0 111.28 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.11 -45.98 75.57 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.749 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.99 -49.01 76.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.818 . . . . 1.0 111.567 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 87' ' ' CYS . 96.7 mt -65.77 -41.36 92.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.221 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.3 -45.89 75.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.306 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.09 -46.84 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.768 0.318 . . . . 1.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -43.46 98.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.474 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.63 88.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.94 -49.22 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.622 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -69.68 -38.41 77.01 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.189 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.997 0.427 . . . . 1.0 110.624 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.21 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.624 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -72.88 -40.24 65.76 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.844 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.665 179.897 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.611 -1.396 . . . . 1.0 109.611 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.59 147.22 95.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.803 2.335 . . . . 1.0 112.125 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.65 -41.26 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.258 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.28 170.91 43.29 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.6 m -81.27 -6.44 58.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 1.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 50.0 ttp -82.94 130.81 35.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.815 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -51.96 151.45 6.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.414 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.99 160.12 43.55 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.15 1.9 . . . . 1.0 112.056 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.26 -31.7 73.8 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.745 2.297 . . . . 1.0 112.134 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -66.51 144.38 98.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.834 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.69 142.43 63.92 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.711 1.608 . . . . 1.0 111.464 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 p -72.16 -32.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.275 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.31 93.75 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.01 144.58 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 1.0 111.101 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.37 107.15 33.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.58 102.81 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.457 1.438 . . . . 1.0 112.757 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.03 -43.82 86.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.102 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 154.13 35.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.273 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -142.81 132.5 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 1.0 110.529 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.4 p -142.0 152.3 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.043 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -107.84 121.9 45.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.747 -0.66 . . . . 1.0 109.317 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.21 -158.76 9.67 Favored Glycine 0 N--CA 1.462 0.4 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -131.14 131.2 43.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.066 0.46 . . . . 1.0 110.658 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.566 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 25.9 tp10 -91.68 126.53 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.4 mtm -113.67 135.63 53.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.633 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -141.48 149.27 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.237 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -36.39 -64.91 0.56 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 115.745 -0.662 . . . . 1.0 112.762 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.18 -32.79 94.98 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.885 2.39 . . . . 1.0 113.973 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 178.97 177.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 121.163 -0.215 . . . . 1.0 110.645 179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -122.05 169.23 11.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.05 0.452 . . . . 1.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.32 144.24 9.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.38 146.77 81.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.091 1.068 . . . . 1.0 111.412 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 31.8 p -153.16 -178.22 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.526 -0.307 . . . . 1.0 110.4 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.04 145.18 24.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.643 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.546 ' CD1' HD11 ' A' ' 89' ' ' ILE . 44.6 mt -115.2 116.45 28.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.277 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -121.56 114.58 21.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.32 0.581 . . . . 1.0 111.559 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.733 HD23 ' HB1' ' A' ' 115' ' ' ALA . 52.5 tp -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.308 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.18 149.64 41.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.066 0.46 . . . . 1.0 111.393 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -104.07 128.38 51.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.665 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -140.62 137.06 33.35 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.749 -0.381 . . . . 1.0 110.895 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 58.79 33.02 22.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.695 -0.684 . . . . 1.0 111.591 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.95 77.09 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 44' ' ' TYR . 6.8 tp-100 -132.34 157.57 44.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.485 ' H ' ' CD ' ' A' ' 43' ' ' GLN . 86.8 m-85 -99.16 134.43 42.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.043 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -146.22 141.9 27.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.845 0.355 . . . . 1.0 110.336 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.7 tp -104.86 125.05 50.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.631 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.3 mt -98.95 121.71 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.9 mt -107.21 124.76 63.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' C ' HD12 ' A' ' 50' ' ' LEU . 37.3 mt-30 -114.88 122.76 47.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.963 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 49' ' ' GLN . 9.9 mp -105.15 128.37 53.35 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.23 45.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.21 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 50' ' ' LEU . 39.6 tp10 -41.77 146.52 0.25 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.403 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -61.6 -39.28 90.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.292 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -59.0 -47.6 84.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.965 0.412 . . . . 1.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -174.4 -162.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -97.19 81.47 3.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.061 0.458 . . . . 1.0 109.834 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.77 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.528 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -108.64 116.97 32.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.517 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -100.45 132.58 45.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.95 110.85 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.814 0.34 . . . . 1.0 110.139 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -115.09 108.73 47.75 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.238 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HG2' ' HE1' ' A' ' 66' ' ' HIS . 72.7 Cg_endo -75.24 151.23 38.21 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.639 1.559 . . . . 1.0 112.571 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.428 HG23 HE21 ' A' ' 120' ' ' GLN . 98.1 mt -95.08 124.33 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.477 ' ND2' ' ND1' ' A' ' 66' ' ' HIS . 14.9 p-10 -172.04 -150.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 1.0 109.847 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -72.37 -39.93 67.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 1.0 112.083 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.685 ' CD2' ' C ' ' A' ' 66' ' ' HIS . 2.4 p-80 -74.61 -16.85 60.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.788 0.328 . . . . 1.0 111.318 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.488 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 61.1 t80 -102.46 123.72 46.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.87 142.51 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.323 0.583 . . . . 1.0 110.853 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 89' ' ' ILE . 4.8 t -125.33 106.67 10.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.212 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.59 129.63 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.053 0.454 . . . . 1.0 111.381 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.0 tp-100 -80.38 100.58 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.471 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 39.16 56.42 2.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.476 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.75 -170.32 2.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.874 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -101.96 -28.7 12.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.439 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -166.08 92.34 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.666 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 79' ' ' ILE . 6.5 t -138.47 42.18 2.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.125 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.6 -40.73 97.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.338 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 78' ' ' LEU . 3.7 mm? -65.05 -39.58 93.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.626 -0.261 . . . . 1.0 110.484 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.423 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 17.2 mm -102.76 121.64 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.047 0.451 . . . . 1.0 110.91 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 97.5 m-20 -143.86 -39.88 0.29 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.271 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.88 -42.62 96.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.678 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.79 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.085 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.7 t -109.58 119.8 40.52 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -148.02 -175.19 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.078 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.75 88.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.64 71.78 0.79 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.47 139.29 30.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.952 0.406 . . . . 1.0 111.675 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 52.1 mtpt -116.73 129.33 56.05 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.591 HD12 ' SG ' ' A' ' 69' ' ' CYS . 39.7 pt -125.31 160.14 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -130.23 143.03 50.54 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.913 0.387 . . . . 1.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.11 133.25 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.908 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.74 152.47 42.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -166.23 166.42 38.78 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.68 -41.71 95.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.627 0.251 . . . . 1.0 111.198 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.547 ' CE2' HG23 ' A' ' 96' ' ' ILE . 2.0 p-90 -90.55 -8.57 49.91 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.178 0.436 . . . . 1.0 112.178 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.547 HG23 ' CE2' ' A' ' 95' ' ' TRP . 18.1 pt -126.72 152.06 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 110.141 -0.318 . . . . 1.0 110.141 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -94.58 166.95 11.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.745 0.307 . . . . 1.0 110.652 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -57.25 135.22 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 1.0 110.778 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.71 136.52 40.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.488 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 77.4 mtp180 -106.71 139.5 41.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.225 0.536 . . . . 1.0 110.944 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 85.1 m-85 -133.92 152.1 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.198 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.99 127.03 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.907 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.79 89.47 7.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.21 -15.65 35.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.787 1.658 . . . . 1.0 112.777 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.32 106.64 18.63 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -60.81 -53.43 57.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.028 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -52.94 -43.74 66.54 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.628 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.425 ' HB3' HG23 ' A' ' 20' ' ' VAL . 59.1 m170 -68.57 -36.74 79.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.484 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -63.3 -34.59 78.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.787 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.37 -46.25 89.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.387 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.63 -42.98 81.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.66 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' HD13 ' A' ' 89' ' ' ILE . 46.2 t80 -61.82 -49.05 77.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.104 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.7 -41.57 95.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.474 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -44.5 93.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.903 0.382 . . . . 1.0 111.164 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.733 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.9 -48.04 72.8 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.251 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 112' ' ' PHE . 73.0 t -65.67 -42.22 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.828 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.49 -44.66 89.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.997 0.427 . . . . 1.0 110.077 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.69 91.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.435 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.814 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.428 HE21 HG23 ' A' ' 63' ' ' ILE . 59.2 mm-40 -67.88 -39.83 83.62 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.021 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.76 -45.32 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.029 0.442 . . . . 1.0 110.1 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -67.99 -39.67 83.22 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.722 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.454 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.564 -1.415 . . . . 1.0 109.564 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.88 -23.25 68.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.644 2.229 . . . . 1.0 112.029 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.07 -40.88 98.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.421 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.64 9.92 82.37 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.896 -0.881 . . . . 1.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 m -72.7 150.76 42.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 1.0 110.549 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.6 ttp -80.85 139.73 35.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.494 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -42.58 151.35 0.38 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.543 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 159.28 48.61 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.104 1.869 . . . . 1.0 112.011 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.39 -31.64 72.5 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.75 2.3 . . . . 1.0 111.925 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.39 166.37 11.34 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.94 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.56 148.39 92.45 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.642 1.561 . . . . 1.0 111.561 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.12 -45.05 95.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.15 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.4 -29.97 76.55 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.231 -0.747 . . . . 1.0 111.231 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.76 58.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 1.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -109.4 108.36 59.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 128.13 11.08 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.643 1.562 . . . . 1.0 112.765 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -100.86 -38.85 8.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.713 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.62 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.105 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -143.34 137.73 28.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.794 0.331 . . . . 1.0 110.512 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.7 p -140.6 146.92 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.981 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -108.76 122.16 46.57 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -140.32 -158.06 7.44 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 16.7 mmm -127.97 129.06 46.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.909 0.385 . . . . 1.0 110.432 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.63 118.77 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.24 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.1 mtm -97.8 136.22 38.45 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.508 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.24 151.84 51.5 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.19 -64.93 0.45 Allowed Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.954 -0.567 . . . . 1.0 112.704 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.35 -34.05 56.44 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.725 2.283 . . . . 1.0 113.746 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -175.75 -173.41 0.6 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.321 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -121.29 168.36 11.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.9 0.381 . . . . 1.0 110.465 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.13 141.35 13.47 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.742 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.97 145.44 74.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 CA-C-N 120.221 1.115 . . . . 1.0 111.52 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 22' ' ' GLY . 11.5 p -158.97 -176.24 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.608 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.76 134.48 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.182 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 20' ' ' VAL . 51.8 mt -104.18 128.08 51.84 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.003 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -125.02 123.26 39.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.246 0.546 . . . . 1.0 111.522 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.567 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.1 tp -89.42 127.18 35.8 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.236 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.79 150.11 39.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.133 0.492 . . . . 1.0 111.434 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -106.0 123.88 48.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -134.47 131.27 37.88 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 1.0 110.742 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 61.09 34.6 19.04 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.684 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.35 75.81 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -134.77 149.6 50.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -94.67 134.09 37.63 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.59 147.67 34.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.874 0.369 . . . . 1.0 110.432 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.4 tt -108.4 120.54 42.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.068 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.654 ' N ' HD23 ' A' ' 46' ' ' LEU . 85.8 mt -99.07 128.04 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -95.05 119.78 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' C ' HD12 ' A' ' 50' ' ' LEU . 35.5 mt-30 -107.54 129.95 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.033 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.4 mp -109.5 136.34 49.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -95.45 20.18 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.113 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -48.28 138.32 9.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.271 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -63.19 -38.62 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.414 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.87 -52.17 65.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 1.0 110.31 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -172.32 155.14 3.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -82.92 102.64 11.82 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 1.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.57 134.2 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -122.16 108.22 13.06 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.658 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -101.51 125.67 48.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.647 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mm -92.39 105.96 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.09 108.29 48.47 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.044 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.27 145.11 34.06 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.658 1.572 . . . . 1.0 112.449 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.5 123.63 38.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -174.9 -162.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 -40.48 86.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.143 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.424 ' HB3' ' HE1' ' A' ' 95' ' ' TRP . 96.5 m-70 -65.52 -39.81 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.02 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.77 122.56 35.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.206 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -140.31 111.42 7.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.235 0.541 . . . . 1.0 110.927 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.8 p -102.54 111.61 23.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.033 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -116.0 129.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.98 0.419 . . . . 1.0 110.76 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 73' ' ' ALA . 16.9 tt0 -75.28 120.45 20.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 48.5 -86.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 71' ' ' GLN . . . -71.48 152.81 42.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.551 -0.75 . . . . 1.0 110.804 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.42 -33.96 76.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.566 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 77' ' ' LEU . 80.5 mm-40 -54.9 -70.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.069 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 79' ' ' ILE . 7.1 m 73.54 -26.6 0.19 Allowed 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.98 0.8 . . . . 1.0 110.546 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 75' ' ' GLU . 51.4 mt -65.44 -41.5 93.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.85 -0.613 . . . . 1.0 111.316 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.83 -41.19 87.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.532 -0.303 . . . . 1.0 110.818 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' THR . 49.7 mm -120.12 130.73 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.011 0.434 . . . . 1.0 110.848 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -173.11 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.081 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.8 mm -113.94 -37.08 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.449 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -47.35 82.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.889 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 t -140.12 139.77 35.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.874 0.369 . . . . 1.0 110.519 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.412 ' OD1' ' SG ' ' A' ' 87' ' ' CYS . 0.5 OUTLIER -158.15 36.99 0.25 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.525 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -83.95 112.8 20.49 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 48.32 82.5 0.03 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.212 -1.555 . . . . 1.0 109.212 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.412 ' SG ' ' OD1' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -115.2 150.25 36.4 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.221 0.534 . . . . 1.0 111.573 -177.503 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 151.47 33.56 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.51 169.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -139.21 126.1 20.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.027 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 130.69 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -152.63 153.33 33.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.11 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.22 163.65 36.16 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -64.19 -42.45 96.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.772 0.32 . . . . 1.0 111.457 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CD2' HG23 ' A' ' 96' ' ' ILE . 18.0 p-90 -84.94 -7.71 59.05 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.869 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.556 HG23 ' CD2' ' A' ' 95' ' ' TRP . 8.8 pt -125.24 161.6 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.766 0.317 . . . . 1.0 110.419 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -98.37 -179.82 4.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.815 0.341 . . . . 1.0 110.807 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 90' ' ' ARG . 80.6 tt0 -60.46 131.44 50.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.0 110.649 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -137.64 135.41 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.572 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -129.61 149.94 51.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.031 0.444 . . . . 1.0 111.601 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -144.71 161.03 40.22 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.333 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -145.26 139.64 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.919 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 20' ' ' VAL . 4.3 mp -125.28 101.08 31.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.04 -12.04 21.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.605 1.537 . . . . 1.0 112.618 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.61 111.53 23.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.34 -51.25 70.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.611 0.597 . . . . 1.0 112.611 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -55.13 -38.95 68.89 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.424 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.564 ' HB3' HG23 ' A' ' 20' ' ' VAL . 5.0 m-70 -77.45 -33.8 54.67 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.74 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -53.98 52.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.373 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.55 -39.47 94.48 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.908 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.14 -44.81 91.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.661 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.59 -52.84 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.868 -0.605 . . . . 1.0 111.318 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.436 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 30.4 mt -66.54 -40.75 89.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.2 t -62.5 -44.34 96.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.678 0.275 . . . . 1.0 111.42 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.81 -49.66 61.09 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.531 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.25 -43.63 91.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.117 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.33 -46.75 88.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.889 0.376 . . . . 1.0 110.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.2 -29.85 70.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.49 92.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.09 -43.16 99.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.819 0.342 . . . . 1.0 111.626 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.77 -43.56 98.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.521 0.677 . . . . 1.0 109.916 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.8 87.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.859 -1.064 . . . . 1.0 111.21 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -65.63 -43.55 89.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.676 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.043 -0.979 . . . . 1.0 110.608 179.915 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.461 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.65 -1.38 . . . . 1.0 109.65 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 50.0 Cg_exo -54.39 -36.62 87.98 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.751 2.3 . . . . 1.0 112.032 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.1 mt -95.43 129.67 42.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.397 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.42 -177.35 42.6 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.3 t -61.32 -41.85 97.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.073 0.463 . . . . 1.0 110.689 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.9 mtp -77.67 144.61 37.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.654 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -52.44 152.28 6.52 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.434 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.58 160.38 44.29 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.235 1.957 . . . . 1.0 111.967 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.11 -32.52 91.48 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.668 2.245 . . . . 1.0 111.986 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -60.78 140.75 93.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD3' HE22 ' A' ' 58' ' ' GLN . 39.7 Cg_endo -65.93 144.66 77.51 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.765 1.643 . . . . 1.0 111.587 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.06 -43.01 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.071 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.99 -37.67 45.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.161 -0.775 . . . . 1.0 111.161 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 143.98 56.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 1.0 110.962 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.38 79.9 0.42 Allowed Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 108.882 -0.784 . . . . 1.0 108.882 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.7 96.45 0.14 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.819 1.679 . . . . 1.0 113.157 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.69 -41.92 91.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.269 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.15 40.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.107 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -140.08 131.94 27.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.557 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.4 m -139.37 159.17 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.255 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -113.56 121.86 45.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.0 178.6 17.83 Favored Glycine 0 N--CA 1.463 0.47 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.8 mtp -118.18 102.89 9.35 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.798 0.332 . . . . 1.0 110.477 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.39 122.45 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.476 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 76.8 mtm -105.47 137.58 43.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.487 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.74 151.24 50.82 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.39 -67.2 0.26 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.846 -0.616 . . . . 1.0 112.709 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.12 -32.98 83.37 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.781 2.321 . . . . 1.0 113.401 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.8 -172.3 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.626 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -125.18 169.13 12.53 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.184 0.516 . . . . 1.0 110.521 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -152.85 144.38 16.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.05 142.19 91.58 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.365 1.376 . . . . 1.0 111.146 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.7 p -154.18 -174.64 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.525 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.68 15.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.338 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 20' ' ' VAL . 5.0 mp -110.69 122.09 46.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.949 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.2 m -123.53 115.42 21.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.254 0.549 . . . . 1.0 111.576 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.525 HD23 ' HB1' ' A' ' 115' ' ' ALA . 46.4 tp -81.29 129.41 34.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.266 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.48 152.04 40.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 1.0 111.477 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -109.6 122.94 48.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -134.63 137.16 43.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.097 0.475 . . . . 1.0 110.688 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.3 m120 60.27 34.2 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.442 -0.799 . . . . 1.0 111.38 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.13 24.01 76.02 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -132.73 150.07 52.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.446 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 59.7 m-85 -92.06 130.27 37.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -143.07 143.14 31.74 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.014 0.435 . . . . 1.0 110.353 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 tp -104.58 129.17 52.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.38 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.0 126.72 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.493 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' HD12 ' A' ' 50' ' ' LEU . 77.7 mt-30 -108.05 128.16 54.42 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.87 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 52' ' ' GLU . 10.0 mp -106.76 129.72 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.322 -0.622 . . . . 1.0 109.322 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' LYS . 64.2 t-80 -43.07 95.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.59 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' LEU . 6.1 pt-20 -37.04 96.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.11 0.481 . . . . 1.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' HIS . 69.1 mttm -61.53 -37.93 85.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.916 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.39 -17.77 0.28 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.199 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.48 164.47 30.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.744 0.307 . . . . 1.0 110.844 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 55.6 p-80 -69.69 116.99 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.98 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 30.7 m -119.85 130.84 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.895 0.378 . . . . 1.0 110.43 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.667 HE22 ' HD3' ' A' ' 11' ' ' PRO . 20.1 tt0 -151.19 108.26 3.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.809 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.07 117.93 32.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.753 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.17 114.19 29.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.926 0.393 . . . . 1.0 110.313 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mm -110.6 116.86 51.92 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.122 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.6 151.71 41.99 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.784 1.656 . . . . 1.0 112.552 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.71 122.09 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.475 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' PHE . 46.2 p30 -170.73 -163.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.383 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -59.0 -40.93 86.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -66.2 -36.15 82.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.995 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 64' ' ' ASN . 36.5 t80 -95.09 129.59 42.12 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.961 0.41 . . . . 1.0 110.327 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -136.35 146.83 46.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.242 0.544 . . . . 1.0 111.234 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.2 p -115.47 110.23 18.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.369 -0.832 . . . . 1.0 109.423 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.93 135.42 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.862 0.363 . . . . 1.0 110.797 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 80' ' ' ASP . 11.6 tt0 -103.41 122.07 44.12 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.87 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 42.78 18.23 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.105 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 71' ' ' GLN . . . -133.62 148.34 51.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.954 -0.567 . . . . 1.0 111.056 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.03 -39.22 79.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.478 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -160.5 78.68 0.64 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.51 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.1 m -140.75 70.07 1.35 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.452 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' H ' HD12 ' A' ' 77' ' ' LEU . 4.8 mp -71.28 -27.78 63.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.408 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 78' ' ' LEU . 11.0 mp -62.28 -40.49 96.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.563 -0.29 . . . . 1.0 110.303 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.3 mt -110.36 126.76 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.277 0.561 . . . . 1.0 110.856 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.569 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 34.8 p-10 -157.1 -41.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.579 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 97.4 mt -67.69 -24.21 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.965 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 t -115.86 127.32 54.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.095 0.474 . . . . 1.0 110.333 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 85' ' ' SER . 84.8 m-20 -148.7 -176.94 5.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.236 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 79.49 91.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.19 79.91 0.07 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.224 -1.55 . . . . 1.0 109.224 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.98 148.18 40.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.777 0.322 . . . . 1.0 111.404 -177.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -106.84 139.65 40.92 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.551 ' C ' HH11 ' A' ' 90' ' ' ARG . 1.8 pp -128.02 161.33 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.551 HH11 ' C ' ' A' ' 89' ' ' ILE . 1.7 mpt_? -126.27 145.84 50.25 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.343 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.57 135.37 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.192 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -128.34 148.92 50.7 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.846 -0.616 . . . . 1.0 110.247 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.5 150.45 18.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -71.02 -46.61 61.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.714 0.292 . . . . 1.0 111.764 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.518 ' CD1' HG23 ' A' ' 96' ' ' ILE . 1.2 p-90 -82.48 -8.23 59.62 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.9 0.333 . . . . 1.0 111.9 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.518 HG23 ' CD1' ' A' ' 95' ' ' TRP . 35.0 pt -127.94 153.88 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.682 0.277 . . . . 1.0 110.731 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' NH2' ' A' ' 99' ' ' ARG . 35.2 ptt-85 -84.5 164.47 18.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.839 0.352 . . . . 1.0 110.664 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.94 127.25 31.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.865 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.508 ' NH2' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -130.02 137.51 50.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.408 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.411 ' NH1' ' CZ ' ' A' ' 90' ' ' ARG . 95.2 mtt-85 -99.91 152.62 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.829 0.347 . . . . 1.0 111.115 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.08 155.23 42.02 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.966 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -146.62 135.23 22.11 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.894 0.378 . . . . 1.0 111.166 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mm -107.2 103.06 46.64 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.93 -11.84 29.87 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.475 1.45 . . . . 1.0 112.827 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -97.96 121.71 40.2 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.75 -48.79 79.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.64 -0.709 . . . . 1.0 112.41 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -59.65 -40.17 86.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.453 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -71.17 -39.88 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.0 110.677 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -56.39 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.358 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.78 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.314 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -62.54 -45.55 92.43 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.772 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -61.21 -51.33 69.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.072 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 89' ' ' ILE . 94.9 mt -65.6 -42.29 91.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.26 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -64.71 -46.7 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 1.0 111.6 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -64.92 -50.43 66.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.301 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.0 t -65.02 -44.88 95.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.8 tp -61.54 -46.76 88.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.097 0.475 . . . . 1.0 110.518 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.82 80.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.352 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 44' ' ' TYR . . . -62.2 -38.16 88.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.579 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -65.55 -44.97 85.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.863 0.363 . . . . 1.0 111.201 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -66.39 -43.13 86.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.402 0.62 . . . . 1.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.47 77.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.95 -1.023 . . . . 1.0 111.888 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -72.05 -40.31 68.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.518 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.625 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.497 1.689 0 CA-C-O 120.955 0.314 . . . . 1.0 111.908 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.56 161.14 80.66 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.893 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.75 144.67 99.59 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.363 1.375 . . . . 1.0 111.652 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.17 -44.6 91.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.38 -28.37 73.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.248 -0.741 . . . . 1.0 111.248 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.75 149.06 47.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.975 0.417 . . . . 1.0 110.959 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.2 80.42 15.58 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.516 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.96 98.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.081 1.854 . . . . 1.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 37' ' ' LEU . 96.8 mt -65.6 -41.36 92.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.026 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.49 145.51 26.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.979 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -135.42 130.28 34.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.445 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.7 158.66 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.88 0.371 . . . . 1.0 110.853 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.36 123.3 46.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.578 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.84 -163.75 11.06 Favored Glycine 0 N--CA 1.46 0.275 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt -139.09 125.53 20.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.408 . . . . 1.0 110.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -89.18 120.85 30.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.3 mtm -106.73 136.78 45.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.689 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.8 147.65 52.31 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.732 -0.469 . . . . 1.0 109.732 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.57 -65.27 0.38 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.743 -0.662 . . . . 1.0 112.496 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -32.23 83.32 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.791 2.327 . . . . 1.0 113.952 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.44 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -174.99 -176.3 0.95 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -125.18 171.15 10.56 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.146 0.498 . . . . 1.0 110.563 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -157.83 129.21 3.82 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.202 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.38 146.93 49.04 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.305 1.145 . . . . 1.0 111.502 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.6 p -154.95 -172.99 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.687 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.14 138.74 20.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.18 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.4 HD13 ' CZ ' ' A' ' 112' ' ' PHE . 54.8 mt -106.54 124.69 49.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.054 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.4 m -130.64 122.44 27.41 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.115 0.483 . . . . 1.0 111.556 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.633 HD23 ' HB1' ' A' ' 115' ' ' ALA . 57.2 tp -93.5 131.41 38.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.28 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.46 148.55 37.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.043 0.449 . . . . 1.0 111.244 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.49 123.53 48.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.731 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -134.05 131.03 38.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.024 0.44 . . . . 1.0 110.82 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.7 m120 61.9 33.45 17.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.822 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.36 17.91 77.92 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.676 HE22 ' NE2' ' A' ' 123' ' ' GLN . 45.6 tp60 -125.71 158.06 35.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.595 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 96.2 m-85 -99.72 135.83 40.55 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.023 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -145.17 141.32 28.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.927 0.394 . . . . 1.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.21 124.77 49.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.611 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -107.09 127.03 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.941 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.94 122.93 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.3 mt-30 -109.61 128.51 55.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.067 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 52' ' ' GLU . 9.1 mp -102.6 126.69 49.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -71.54 40.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.207 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 50' ' ' LEU . 38.9 tp10 -49.69 144.26 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.294 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.78 -39.91 95.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.219 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.05 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.967 0.413 . . . . 1.0 110.384 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.77 148.23 31.72 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.733 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -62.54 104.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.241 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 t -70.27 135.46 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.496 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -99.17 108.35 20.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.785 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -106.1 112.47 25.52 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.15 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 1.0 110.157 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.67 91.29 34.1 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.078 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.31 143.7 93.07 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.17 1.913 . . . . 1.0 112.431 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.3 mt -88.17 122.22 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.826 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -174.68 -160.88 0.1 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.998 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 t -60.22 -41.93 94.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.212 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -64.8 -34.13 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.554 -0.293 . . . . 1.0 111.033 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -94.56 127.47 40.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.353 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.593 ' NH2' HE21 ' A' ' 92' ' ' GLN . 86.3 mtm180 -136.09 142.54 44.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.334 0.588 . . . . 1.0 110.857 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.71 100.86 7.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.207 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 70' ' ' VAL . 10.4 m -101.95 122.98 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.965 0.412 . . . . 1.0 110.561 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -89.38 106.83 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.599 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.71 ' H ' ' NH1' ' A' ' 90' ' ' ARG . 36.1 tp10 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 121.113 0.482 . . . . 1.0 111.0 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.001 0.429 . . . . 1.0 110.253 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.46 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 94.2 mt -63.79 -43.27 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.8 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.295 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.2 t -103.73 62.23 0.76 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 1.0 110.335 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.4 m120 -80.71 -173.62 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.993 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.408 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 2.3 t 67.85 86.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.94 81.01 0.09 OUTLIER Glycine 0 CA--C 1.521 0.431 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.2 132.19 39.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.72 0.295 . . . . 1.0 111.785 -177.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.432 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 62.7 mttp -112.17 127.66 56.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.7 pt -129.17 158.08 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.71 ' NH1' ' H ' ' A' ' 72' ' ' GLU . 1.8 mpt_? -126.47 140.85 52.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.215 0.531 . . . . 1.0 110.003 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.1 133.85 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.913 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.593 HE21 ' NH2' ' A' ' 68' ' ' ARG . 12.9 pt20 -142.36 138.29 31.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.127 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.53 0.205 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -174.54 129.5 0.34 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.584 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -142.96 149.53 38.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -105.61 149.01 26.69 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.096 0.474 . . . . 1.0 111.231 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -142.34 149.72 39.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.118 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -144.51 152.24 40.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.875 0.369 . . . . 1.0 111.009 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.54 99.71 15.52 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.16 -12.74 32.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.626 1.551 . . . . 1.0 112.788 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.57 101.1 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.6 tt0 -57.4 -54.17 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.985 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -52.08 -44.23 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.544 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -68.9 -38.38 79.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 1.0 110.537 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -35.87 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.988 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.38 -45.53 92.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.318 -0.553 . . . . 1.0 111.105 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -66.97 -44.21 81.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.905 -0.718 . . . . 1.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 42.4 t80 -62.18 -49.21 76.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.203 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 87' ' ' CYS . 96.7 mt -67.67 -40.35 84.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.273 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -64.73 -47.43 78.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.395 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.73 -48.44 71.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.347 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.66 -44.08 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.37 -44.35 95.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.097 0.475 . . . . 1.0 110.213 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.38 84.96 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.99 72.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.671 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.27 -36.49 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 1.0 111.295 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.82 -45.05 95.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.797 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.11 93.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.444 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.676 ' NE2' HE22 ' A' ' 43' ' ' GLN . 87.3 mt-30 -70.55 -37.79 74.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.851 0.358 . . . . 1.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.574 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.496 1.628 0 CA-C-O 120.884 0.285 . . . . 1.0 111.944 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.85 159.02 84.4 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.059 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.63 144.52 99.55 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.295 1.33 . . . . 1.0 111.653 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 13' ' ' GLY . 7.8 p -67.32 -45.71 85.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.253 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' HG13 ' A' ' 12' ' ' VAL . . . -65.77 -28.91 74.06 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.45 141.2 58.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.941 0.401 . . . . 1.0 111.068 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.78 79.62 0.43 Allowed Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.78 94.74 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.883 1.722 . . . . 1.0 112.814 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -43.12 95.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.894 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.69 148.29 42.15 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.317 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 t -141.56 130.45 23.08 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.57 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 21' ' ' GLU . 55.3 t -137.59 158.1 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.979 0.418 . . . . 1.0 110.725 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.46 ' N ' HG12 ' A' ' 20' ' ' VAL . 80.7 tt0 -107.39 122.76 47.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.445 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.11 -160.92 9.87 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 71.1 mtp -136.36 130.21 32.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.386 . . . . 1.0 110.418 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.56 123.11 36.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 25' ' ' MET . 1.6 mpp? -113.29 137.83 50.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.982 0.42 . . . . 1.0 110.526 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -140.62 149.13 41.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.007 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.71 -65.17 0.48 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.884 -0.598 . . . . 1.0 112.697 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.12 -32.53 94.79 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.774 2.316 . . . . 1.0 113.564 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.6 177.58 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.852 -0.339 . . . . 1.0 110.878 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.3 169.25 11.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.894 0.378 . . . . 1.0 110.788 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 18.0 pt-20 -159.68 143.15 10.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.639 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.99 141.91 85.8 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.34 1.36 . . . . 1.0 110.929 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 22' ' ' GLY . 22.0 p -147.78 -175.73 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.38 136.25 18.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.95 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 103' ' ' ILE . 61.0 mt -100.08 124.49 45.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.998 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -127.99 126.86 42.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.13 0.491 . . . . 1.0 111.429 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.518 HD23 ' HB1' ' A' ' 115' ' ' ALA . 47.3 tp -96.37 126.17 41.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.886 -0.783 . . . . 1.0 108.886 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.43 152.13 48.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.072 0.463 . . . . 1.0 111.467 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.2 118.28 33.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.673 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -130.56 137.8 49.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.861 0.362 . . . . 1.0 110.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 59.04 33.59 23.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.444 -0.798 . . . . 1.0 111.387 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.98 22.44 77.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.437 ' OE1' ' N ' ' A' ' 44' ' ' TYR . 6.5 tp-100 -131.09 147.7 52.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.437 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 72.0 m-85 -88.52 133.84 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.67 140.73 30.21 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.07 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.2 tt -104.85 119.97 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.731 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.653 ' CG2' HE21 ' A' ' 58' ' ' GLN . 78.4 mt -101.79 127.76 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.052 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.5 mt -104.36 116.76 48.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.425 ' C ' HD12 ' A' ' 50' ' ' LEU . 80.9 mt-30 -97.63 132.34 43.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.6 mp -105.15 130.81 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.88 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -103.01 27.19 7.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.282 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 97.1 mt-10 -45.65 150.09 0.54 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -62.33 -40.31 95.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.3 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -54.55 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.38 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.49 158.11 43.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.88 112.54 17.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.071 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 t -95.25 133.41 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.921 0.391 . . . . 1.0 110.531 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.653 HE21 ' CG2' ' A' ' 47' ' ' ILE . 55.6 tp60 -99.64 107.37 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.422 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -105.93 112.52 25.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.983 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.84 111.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.876 0.369 . . . . 1.0 110.187 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.33 116.78 48.39 Favored Pre-proline 0 N--CA 1.467 0.384 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.127 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.59 147.54 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.644 1.563 . . . . 1.0 112.61 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.51 120.04 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.2 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -175.22 -162.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -64.15 -26.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.185 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -83.69 -10.74 57.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.678 0.275 . . . . 1.0 110.948 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.81 129.29 56.0 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -136.5 146.86 46.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.743 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.87 106.46 9.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.506 -0.77 . . . . 1.0 108.937 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m -109.14 126.46 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.052 0.453 . . . . 1.0 110.969 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.632 HE21 ' N ' ' A' ' 88' ' ' LYS . 52.9 tp60 -82.8 115.29 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.635 179.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.951 0.405 . . . . 1.0 110.153 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.93 -42.39 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.39 -25.93 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.895 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -103.87 66.58 0.85 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.07 0.462 . . . . 1.0 110.568 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' A' ' 85' ' ' SER . 12.4 m120 -91.73 -171.48 2.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.166 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 85' ' ' SER . 6.9 p 65.06 98.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.987 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.3 77.53 0.13 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.492 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -95.7 134.21 38.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.802 0.334 . . . . 1.0 111.772 -178.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.632 ' N ' HE21 ' A' ' 71' ' ' GLN . 99.5 mttt -107.94 123.82 49.21 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.0 149.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.512 ' C ' HE22 ' A' ' 92' ' ' GLN . 81.9 mtt85 -121.86 143.98 49.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.915 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.51 135.35 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.877 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.512 HE22 ' C ' ' A' ' 90' ' ' ARG . 15.1 mp0 -136.95 151.75 49.38 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.737 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.646 0.26 . . . . 1.0 110.739 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.75 124.84 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 1.0 110.756 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.11 132.06 44.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.295 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -91.55 151.9 20.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 1.0 111.076 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.18 153.69 43.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.202 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -138.82 143.87 39.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.953 0.406 . . . . 1.0 110.901 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.627 HD11 HD12 ' A' ' 35' ' ' LEU . 5.9 mm -127.17 91.08 47.46 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -16.99 41.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.698 1.598 . . . . 1.0 112.681 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.69 106.35 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.4 tt0 -62.64 -54.69 35.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 1.0 112.182 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -52.42 -42.77 64.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.607 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -70.55 -37.54 74.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.573 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.9 t -59.19 -35.57 73.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.891 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.27 -44.38 95.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.451 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.12 -44.51 84.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.979 -0.689 . . . . 1.0 110.454 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 51.1 t80 -60.76 -49.8 76.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.149 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.46 -41.58 80.0 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.466 -0.493 . . . . 1.0 111.223 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.6 t -63.55 -45.55 90.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.595 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.518 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.43 -49.31 56.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.544 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.46 -45.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.026 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.02 -48.59 81.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.35 80.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.577 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.35 91.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.752 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.74 -45.91 80.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.948 0.404 . . . . 1.0 111.351 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.78 -43.14 89.7 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.472 0.653 . . . . 1.0 110.368 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.96 77.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.855 -1.066 . . . . 1.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -71.92 -39.87 69.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.393 . . . . 1.0 110.556 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.597 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.498 1.753 0 CA-C-O 120.971 0.321 . . . . 1.0 111.716 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.37 158.57 3.86 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.75 142.99 99.3 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.308 1.338 . . . . 1.0 111.688 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.18 -45.23 83.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.382 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.72 81.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.26 50.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.06 0.457 . . . . 1.0 111.144 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -98.19 107.86 43.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.7 103.89 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.435 1.423 . . . . 1.0 112.871 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.93 -43.22 79.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.186 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.79 151.52 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.076 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -140.92 135.0 30.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 1.0 110.547 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 35' ' ' LEU . 2.6 p -142.45 152.12 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.018 0.437 . . . . 1.0 111.163 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -106.64 121.85 45.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -130.46 -155.87 8.45 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 21.4 mmt -137.04 128.65 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.939 0.4 . . . . 1.0 110.244 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -90.21 126.33 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.338 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.0 mtm -109.32 138.75 45.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 29' ' ' LEU . 99.3 mttt -135.64 149.68 49.4 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.898 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -67.07 0.29 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.569 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.28 -32.6 81.95 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.793 2.328 . . . . 1.0 113.852 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.444 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -173.94 -170.06 0.53 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.408 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -130.38 169.67 15.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.021 0.439 . . . . 1.0 110.313 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -156.29 144.39 14.31 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.396 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.98 146.14 96.45 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.294 1.329 . . . . 1.0 111.293 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 34' ' ' ALA . 19.7 t -158.02 170.15 22.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.314 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.645 ' N ' ' SG ' ' A' ' 33' ' ' CYS . . . -138.14 139.99 39.68 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.854 0.359 . . . . 1.0 110.239 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 103' ' ' ILE . 60.9 mt -107.07 121.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.764 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -125.08 122.91 38.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.229 0.537 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.594 HD23 ' HB1' ' A' ' 115' ' ' ALA . 62.0 tp -94.67 122.64 37.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.31 146.25 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.145 0.498 . . . . 1.0 111.309 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -98.71 126.69 44.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.747 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -139.82 136.73 34.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.971 0.415 . . . . 1.0 110.727 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 59.15 33.75 22.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.568 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.24 24.88 76.33 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.748 -0.941 . . . . 1.0 110.748 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -135.44 159.44 41.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -100.22 133.16 45.03 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -141.42 142.93 33.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.044 0.45 . . . . 1.0 110.34 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.8 tt -104.32 119.69 39.52 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.896 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.628 ' N ' HD23 ' A' ' 46' ' ' LEU . 72.0 mt -98.15 128.87 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.55 131.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.466 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 73.2 mt-30 -123.23 124.65 43.5 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.99 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 50' ' ' LEU . 10.4 mp -99.9 114.75 28.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -72.49 62.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -62.51 151.86 36.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.314 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.87 -41.66 98.12 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.57 -77.36 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -147.82 150.56 34.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -68.73 138.37 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.967 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.18 130.37 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 1.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -91.09 108.35 19.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.791 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.07 114.68 28.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.28 116.12 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.86 0.362 . . . . 1.0 110.46 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.1 91.6 32.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.19 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -57.42 142.77 95.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.213 1.942 . . . . 1.0 112.591 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.62 122.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -175.66 -163.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.201 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.9 p -63.84 -22.2 66.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -85.61 -11.34 54.17 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.602 0.239 . . . . 1.0 111.06 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -121.84 135.27 54.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -137.42 151.38 48.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.104 0.478 . . . . 1.0 110.711 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.7 p -138.76 111.65 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 128.28 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 1.0 111.196 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.641 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 49.5 tp60 -82.27 97.53 8.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.585 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.17 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.963 0.411 . . . . 1.0 110.204 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 83' ' ' SER . 32.6 mm -71.64 -24.13 23.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.18 -3.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.053 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 29.8 t -138.97 138.18 37.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 1.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.9 m120 -146.69 -171.32 3.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.105 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 61.77 85.1 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.31 78.28 0.27 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.571 -1.412 . . . . 1.0 109.571 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.535 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.85 137.62 35.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 111.866 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.641 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 99.7 mttt -112.41 127.03 55.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 pp -118.17 132.05 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -97.1 141.67 29.96 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.7 t -121.63 134.85 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.572 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -143.46 150.64 39.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.18 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.557 0 N-CA-C 110.644 -0.982 . . . . 1.0 110.644 179.545 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 120.684 0.278 . . . . 1.0 110.616 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.12 132.88 54.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 1.0 110.363 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -140.43 125.49 18.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.611 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -88.22 144.07 26.67 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.993 0.425 . . . . 1.0 111.192 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.83 152.05 49.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -139.59 144.64 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.821 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 35' ' ' LEU . 5.8 mm -127.64 91.55 45.26 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.3 -16.99 39.85 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.822 1.681 . . . . 1.0 112.751 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -87.79 104.28 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.96 -54.99 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 1.0 112.32 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -52.1 -44.31 64.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.425 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.17 -36.17 77.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.533 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 113' ' ' LEU . 4.2 t -61.75 -38.07 86.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.999 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.77 -46.09 89.64 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.223 -0.591 . . . . 1.0 111.301 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -43.55 82.0 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.964 -0.695 . . . . 1.0 110.764 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.8 -50.36 72.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.156 -0.929 . . . . 1.0 111.094 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 109' ' ' CYS . 95.9 mt -67.85 -41.0 83.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.329 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 t -62.27 -45.12 94.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.105 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.594 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.52 -47.13 67.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.382 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.403 ' HA ' HD22 ' A' ' 37' ' ' LEU . 67.0 t -63.35 -45.6 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.964 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.16 -45.85 92.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 1.0 110.255 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.6 86.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.425 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.76 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.455 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.488 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 95.1 mt-30 -68.32 -37.66 80.78 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.25 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.54 -43.15 90.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.085 0.469 . . . . 1.0 110.623 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.93 75.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.732 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.31 -38.9 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.734 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.405 -179.773 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.476 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 34.9 Cg_endo . . . . . 0 N--CA 1.497 1.723 0 CA-C-O 120.891 0.288 . . . . 1.0 112.154 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.35 145.55 57.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.859 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 142.31 71.06 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.734 1.623 . . . . 1.0 111.41 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -67.77 -42.79 86.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.681 -0.691 . . . . 1.0 111.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -38.37 47.03 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.94 146.17 46.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.902 0.382 . . . . 1.0 111.009 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.82 80.32 0.33 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.13 99.71 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.846 1.697 . . . . 1.0 112.832 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.23 -43.2 92.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.82 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.23 153.52 38.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.353 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -137.96 135.8 36.37 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.633 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.8 p -141.64 149.26 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.04 0.448 . . . . 1.0 111.262 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -104.31 121.68 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.39 -162.96 10.9 Favored Glycine 0 N--CA 1.462 0.386 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 88.9 mmm -128.65 131.99 48.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 1.0 110.315 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -94.9 124.06 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -108.47 137.22 46.79 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.545 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.93 150.07 44.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.019 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.71 -66.29 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.794 -0.639 . . . . 1.0 112.597 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.68 -33.0 93.8 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.779 2.319 . . . . 1.0 113.691 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.7 -174.57 0.25 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.007 -0.277 . . . . 1.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.33 169.47 11.76 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 1.0 110.739 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -158.1 144.31 12.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.619 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.8 145.12 97.4 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.392 1.394 . . . . 1.0 111.04 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.7 p -154.97 -179.11 7.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.382 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.67 142.53 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.427 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 20' ' ' VAL . 4.9 mp -112.28 122.53 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.257 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -122.67 116.7 24.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.381 0.61 . . . . 1.0 111.757 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.682 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.9 tp -83.55 130.37 35.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.21 -0.905 . . . . 1.0 109.218 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.24 151.49 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.007 0.432 . . . . 1.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -110.61 121.73 46.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.711 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -134.02 139.19 45.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.903 0.382 . . . . 1.0 110.911 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.11 33.65 22.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.548 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.28 25.22 75.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -135.17 153.83 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -91.18 131.95 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -141.23 141.61 34.0 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.985 0.422 . . . . 1.0 110.445 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.6 127.54 52.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.685 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.42 118.29 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.154 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.9 mt -100.98 122.87 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.467 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.8 mt-30 -108.22 130.54 55.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -107.68 111.19 23.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 52' ' ' GLU . 97.8 m-70 -57.49 -12.8 2.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' HIS . 3.5 tp10 42.39 -167.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.455 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -63.74 -41.75 97.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -138.73 -68.5 0.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.747 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -69.9 142.13 53.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.177 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 20.9 p80 -89.06 112.29 23.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.41 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -84.19 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.616 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.476 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 83.0 mt-30 -102.13 132.16 48.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.127 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -127.25 109.61 11.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -93.57 122.3 44.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.728 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -133.3 126.76 19.53 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.01 157.84 46.5 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.799 1.666 . . . . 1.0 112.64 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -102.66 115.92 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.178 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' PHE . 50.8 p30 -172.94 -155.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.229 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 m -60.98 -41.6 96.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.348 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.71 -43.05 97.72 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.838 0.352 . . . . 1.0 110.433 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 11.6 t80 -94.03 125.65 38.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.649 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -133.68 142.11 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.87 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.3 t -121.27 111.47 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.962 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.0 m -112.76 126.67 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.959 0.409 . . . . 1.0 110.622 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 87' ' ' CYS . 50.1 tt0 -87.99 112.83 23.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.744 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.641 -179.858 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.955 0.407 . . . . 1.0 110.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.438 ' C ' ' N ' ' A' ' 83' ' ' SER . 94.6 mt -64.16 -43.29 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.661 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.29 -18.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.036 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 21.9 m -128.19 118.37 23.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.942 0.401 . . . . 1.0 110.284 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.0 m120 -138.32 -167.83 2.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.781 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 70.15 89.47 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.36 75.69 0.33 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 109.342 -1.503 . . . . 1.0 109.342 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.419 ' HB3' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.9 138.65 34.12 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.964 0.411 . . . . 1.0 112.006 -177.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.54 124.95 53.15 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.0 150.94 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -121.44 147.08 46.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.88 136.45 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.594 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -128.82 150.3 50.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.097 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 110.681 -0.968 . . . . 1.0 110.681 -179.852 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.831 0.348 . . . . 1.0 110.655 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.73 127.88 33.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 1.0 110.111 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -127.26 143.11 51.31 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -120.17 140.0 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.958 0.408 . . . . 1.0 111.236 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.17 150.62 50.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.69 -0.686 . . . . 1.0 110.472 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.12 135.75 24.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.758 0.313 . . . . 1.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 54.4 mt -124.56 100.97 34.22 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.64 -10.41 23.5 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.607 1.538 . . . . 1.0 112.684 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.43 105.73 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.72 -52.81 63.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.015 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -53.86 -42.1 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.628 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.504 ' HB3' HG23 ' A' ' 20' ' ' VAL . 64.5 m170 -69.94 -34.88 74.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.512 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.6 t -66.72 -33.22 75.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.99 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.6 mt -62.74 -46.18 89.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.489 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.73 -43.06 80.87 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.602 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.459 ' CE1' HG21 ' A' ' 116' ' ' VAL . 46.9 t80 -60.93 -48.93 79.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.124 -0.943 . . . . 1.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 113' ' ' LEU . 96.8 mt -65.41 -40.85 93.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.644 -0.423 . . . . 1.0 111.362 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.7 p -64.0 -44.24 93.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.228 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.682 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.07 -51.02 59.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.314 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 112' ' ' PHE . 70.0 t -64.87 -42.25 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.7 tp -57.74 -45.07 86.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.065 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.377 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.87 70.57 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.044 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -68.01 -41.1 82.71 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.64 0.257 . . . . 1.0 111.102 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.24 -43.75 98.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.958 0.409 . . . . 1.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.73 96.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.236 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.3 -40.44 93.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.652 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.903 -1.046 . . . . 1.0 110.485 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' CG ' HE22 ' A' ' 49' ' ' GLN . 57.1 Cg_endo . . . . . 0 N--CA 1.496 1.666 0 CA-C-O 121.07 0.363 . . . . 1.0 111.884 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 pp -56.47 161.44 4.19 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.121 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.46 143.56 99.66 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.974 1.116 . . . . 1.0 111.79 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.34 -42.9 91.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.02 -34.37 78.73 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.07 137.75 53.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.925 0.393 . . . . 1.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -97.66 108.46 45.68 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.28 103.14 1.7 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.502 1.468 . . . . 1.0 112.999 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.63 -43.47 89.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.152 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 155.68 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.209 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 t -146.67 135.67 22.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.594 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.94 160.82 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.165 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -102.48 122.51 44.47 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' H ' ' HA ' ' A' ' 34' ' ' ALA . . . -118.88 -174.95 16.14 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.792 -0.923 . . . . 1.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.3 mmt -134.9 99.25 4.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 1.0 110.092 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.7 tt0 -59.59 133.96 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 72.5 mtm -113.43 131.38 56.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.748 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.15 144.04 51.08 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.56 -64.88 0.49 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.84 -0.618 . . . . 1.0 112.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.22 -31.98 93.78 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.694 2.262 . . . . 1.0 113.633 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.46 -179.87 1.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.641 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.0 168.2 10.43 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.919 0.39 . . . . 1.0 110.522 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.5 128.7 6.27 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.516 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.44 142.36 78.22 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.944 1.096 . . . . 1.0 111.163 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.4 p -156.76 -178.28 7.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.394 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -150.95 138.19 19.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.308 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.2 mt -102.22 123.97 46.98 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.915 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -126.48 120.46 29.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.059 0.456 . . . . 1.0 111.356 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.515 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.5 tp -94.67 131.23 40.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.248 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 150.93 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 1.0 111.239 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.06 120.82 41.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.682 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -128.07 132.31 49.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.217 0.532 . . . . 1.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.16 31.7 21.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.157 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.65 7.52 85.8 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.851 -0.69 . . . . 1.0 111.426 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.704 HE22 ' NE2' ' A' ' 123' ' ' GLN . 44.0 tp60 -112.5 136.79 51.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.101 -0.333 . . . . 1.0 110.101 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 75.0 m-85 -81.7 134.74 35.49 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.34 139.64 28.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.375 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.4 tt -108.7 119.4 39.42 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.607 ' N ' HD23 ' A' ' 46' ' ' LEU . 90.9 mt -99.12 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.6 mt -96.91 117.21 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.9 mt-30 -102.35 131.3 49.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.928 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -110.3 127.2 54.9 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -85.41 52.73 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.237 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -45.49 152.95 0.27 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.77 -40.02 93.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.362 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -62.49 -46.44 88.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.509 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -173.11 -163.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.701 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -108.11 126.24 52.52 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.31 137.17 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.055 0.455 . . . . 1.0 110.463 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -104.8 131.12 52.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.018 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -107.97 119.65 40.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.565 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.1 mt -92.11 119.74 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 1.0 110.332 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mt -135.45 94.2 15.63 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.269 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.5 142.52 80.76 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.046 1.831 . . . . 1.0 112.625 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.2 mt -82.12 124.83 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.354 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 66' ' ' HIS . 6.0 p30 -172.96 -163.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.126 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.4 t -59.71 -41.29 90.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.564 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.632 ' CD2' ' ND2' ' A' ' 64' ' ' ASN . 3.5 p80 -69.84 -14.48 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.958 -0.297 . . . . 1.0 111.122 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.0 t80 -114.93 128.06 56.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.18 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -141.29 145.86 36.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.145 0.497 . . . . 1.0 110.889 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 t -121.32 118.61 29.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 1.0 108.991 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.71 128.84 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.068 0.461 . . . . 1.0 110.848 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.611 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 56.4 tp60 -86.47 103.24 14.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.518 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.331 179.779 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 20.0 p-10 . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 121.034 0.445 . . . . 1.0 110.329 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.42 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 26.3 mm -68.32 -24.53 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.39 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.03 72.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.818 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.5 t -100.46 62.57 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.09 0.472 . . . . 1.0 110.398 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 10.9 m120 -80.47 -171.69 3.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.164 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 85' ' ' SER . 19.2 p 57.83 94.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.73 77.09 0.21 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.429 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.62 136.56 36.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.765 0.317 . . . . 1.0 111.72 -177.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.611 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 64.9 mttp -108.02 120.03 41.14 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -118.63 131.01 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -106.61 144.73 32.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.894 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.63 133.13 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.641 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -124.23 136.06 53.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.741 -0.944 . . . . 1.0 110.741 179.793 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.803 0.335 . . . . 1.0 110.671 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.02 135.66 55.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 1.0 110.727 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -133.8 137.58 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.588 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -87.32 150.47 23.84 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.917 0.389 . . . . 1.0 111.035 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -143.39 149.33 37.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.298 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.14 145.84 39.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.918 0.389 . . . . 1.0 110.931 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.87 92.86 43.54 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.28 -15.44 38.88 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.757 1.638 . . . . 1.0 112.602 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.453 ' OD2' ' CG ' ' A' ' 108' ' ' HIS . 38.6 t0 -93.2 106.56 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.81 -52.92 63.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.026 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.93 -46.81 32.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.378 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.453 ' CG ' ' OD2' ' A' ' 105' ' ' ASP . 43.9 m170 -68.5 -39.34 81.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 1.0 110.38 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 t -59.08 -39.76 83.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.16 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.52 -44.84 93.09 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.418 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.16 -44.96 82.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.3 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.55 -49.38 76.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.339 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.8 -40.51 88.13 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.603 -0.439 . . . . 1.0 111.211 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -62.73 -44.7 95.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.822 0.344 . . . . 1.0 111.083 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.515 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.12 -48.28 62.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.361 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.09 -44.76 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.14 -45.03 96.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.016 0.436 . . . . 1.0 110.161 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.07 86.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.555 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.07 -49.09 75.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -71.11 -38.23 72.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 1.0 110.983 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.04 -44.5 96.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.223 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.41 96.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.221 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.704 ' NE2' HE22 ' A' ' 43' ' ' GLN . 88.2 mt-30 -65.38 -41.22 93.99 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.66 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.384 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.52 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 37.1 Cg_endo . . . . . 0 N--CA 1.497 1.703 0 CA-C-O 120.818 0.257 . . . . 1.0 111.981 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -53.96 158.06 3.77 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.907 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.76 143.29 99.65 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.156 1.238 . . . . 1.0 111.687 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.35 -45.08 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.79 78.72 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 142.27 57.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.06 0.457 . . . . 1.0 111.162 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.22 79.85 0.4 Allowed Pre-proline 0 N--CA 1.464 0.261 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.35 98.97 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.893 1.729 . . . . 1.0 112.918 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -43.55 93.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.754 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.94 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.341 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 t -136.33 138.77 42.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.763 0.316 . . . . 1.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG11 ' CG ' ' A' ' 112' ' ' PHE . 2.8 p -142.95 150.9 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.083 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -105.29 121.34 43.67 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.85 -172.66 13.2 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.426 ' O ' ' SD ' ' A' ' 25' ' ' MET . 86.2 mmm -120.44 127.31 52.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 1.0 110.091 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -90.11 119.71 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 25' ' ' MET . 1.3 mpp? -110.4 136.68 49.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.946 0.403 . . . . 1.0 110.34 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.34 150.43 42.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.025 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.69 -64.74 0.51 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.706 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.45 -34.15 93.32 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.658 2.239 . . . . 1.0 113.624 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.06 175.21 0.66 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.812 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -117.17 169.06 9.75 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.099 0.476 . . . . 1.0 110.527 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -160.68 142.9 9.41 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.644 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.85 145.71 94.75 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.498 1.465 . . . . 1.0 111.241 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.2 p -155.21 -171.66 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.466 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.44 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.405 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 20' ' ' VAL . 68.3 mt -113.37 130.09 56.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -130.51 128.17 40.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.167 0.508 . . . . 1.0 111.556 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.655 HD23 ' HB1' ' A' ' 115' ' ' ALA . 51.9 tp -95.17 124.55 39.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.009 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.64 149.95 45.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.112 0.482 . . . . 1.0 111.314 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -108.11 120.67 42.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.389 -0.823 . . . . 1.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -132.88 135.94 45.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.871 0.367 . . . . 1.0 110.87 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.5 m120 59.26 34.49 23.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 1.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.57 23.6 76.55 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.004 -0.838 . . . . 1.0 111.004 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -133.77 157.08 46.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.94 133.43 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -139.02 146.66 41.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.197 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -105.45 134.31 48.77 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.706 ' N ' HD13 ' A' ' 46' ' ' LEU . 78.0 mt -114.09 124.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.2 mt -105.1 120.37 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -112.34 126.86 55.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.152 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 50' ' ' LEU . 10.9 mp -103.93 123.69 47.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -78.85 58.04 2.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.371 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -54.75 155.91 3.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.299 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.28 -41.44 98.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.2 -81.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -142.01 150.13 40.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.741 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -67.35 141.71 57.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.307 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.43 132.61 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.992 0.425 . . . . 1.0 110.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 84.0 mt-30 -95.01 126.62 40.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.914 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -120.52 117.28 27.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.478 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -93.35 108.22 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.865 0.364 . . . . 1.0 110.061 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mm -114.66 121.88 34.93 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.58 149.95 39.6 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.778 1.652 . . . . 1.0 112.615 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.3 115.36 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -169.57 -158.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.362 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -59.51 -41.67 90.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -65.73 -37.69 87.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' A' ' 64' ' ' ASN . 16.4 t80 -95.63 123.83 39.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.834 0.35 . . . . 1.0 110.06 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -140.13 144.05 36.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.099 0.476 . . . . 1.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.36 99.71 7.38 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 70' ' ' VAL . 35.4 m -104.56 124.95 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.905 0.383 . . . . 1.0 110.811 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.608 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 48.4 tp60 -77.7 104.46 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.455 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.66 179.806 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 35.0 p-10 . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 120.882 0.372 . . . . 1.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.446 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 91.9 mt -67.84 -25.31 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.535 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.02 91.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.128 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -97.47 70.73 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.181 0.515 . . . . 1.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 9.7 m120 -98.7 -169.2 1.75 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.207 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 m 61.82 84.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.58 76.47 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 109.462 -1.455 . . . . 1.0 109.462 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.03 142.98 26.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.933 0.397 . . . . 1.0 111.803 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.608 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 55.8 mtpt -118.56 128.07 54.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.5 pt -127.82 163.6 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.75 142.15 50.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.8 t -121.6 135.76 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.087 0.47 . . . . 1.0 110.564 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -119.92 163.47 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.225 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.866 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.683 0.278 . . . . 1.0 110.5 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.86 115.95 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.175 0.512 . . . . 1.0 110.6 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -129.03 137.91 51.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.237 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.64 151.05 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.739 0.304 . . . . 1.0 110.705 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -137.35 155.17 49.73 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.478 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -147.4 126.08 12.58 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.972 0.415 . . . . 1.0 111.389 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.425 HG12 HG21 ' A' ' 20' ' ' VAL . 3.0 mp -102.93 99.52 14.12 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 -10.05 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.407 1.404 . . . . 1.0 112.472 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -96.49 107.34 19.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.83 -52.73 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.7 -0.682 . . . . 1.0 112.157 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.0 OUTLIER -52.44 -43.97 65.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.593 -0.443 . . . . 1.0 110.388 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.46 ' HB3' HG23 ' A' ' 20' ' ' VAL . 60.7 m170 -69.6 -34.19 73.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.377 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.422 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.922 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.08 -47.65 79.24 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.357 -0.537 . . . . 1.0 111.706 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.57 -44.74 77.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.862 -0.735 . . . . 1.0 110.171 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.516 ' CG ' HG11 ' A' ' 20' ' ' VAL . 37.0 t80 -61.36 -49.44 76.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.131 -0.94 . . . . 1.0 111.495 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.422 HD11 ' SG ' ' A' ' 109' ' ' CYS . 91.7 mt -67.32 -41.65 84.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.169 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -63.06 -45.89 90.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.529 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.655 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.97 -46.4 78.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.456 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.431 ' HA ' HD22 ' A' ' 37' ' ' LEU . 76.5 t -64.19 -44.49 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.894 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.74 -44.83 96.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 1.0 110.295 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.39 86.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -48.71 77.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -70.28 -36.89 74.67 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.77 -45.77 91.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.151 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.28 -40.08 96.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.306 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.79 -40.19 94.83 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.801 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.586 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 45.4 Cg_endo . . . . . 0 N--CA 1.498 1.793 0 CA-C-O 120.894 0.289 . . . . 1.0 112.151 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -74.18 150.73 87.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.805 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.51 141.06 90.51 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.627 1.551 . . . . 1.0 111.72 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.3 t -68.35 -43.29 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.293 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.18 -41.31 4.85 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.86 146.13 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.594 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -93.22 107.02 22.48 Favored Pre-proline 0 N--CA 1.466 0.347 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.94 99.87 1.35 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.614 1.543 . . . . 1.0 113.181 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.49 -43.41 85.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.282 0.563 . . . . 1.0 109.892 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.12 149.08 29.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.327 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 t -141.34 130.18 23.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.689 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -142.03 159.66 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-O 120.928 0.394 . . . . 1.0 110.955 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -108.32 122.43 46.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.511 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.442 ' C ' ' SD ' ' A' ' 23' ' ' MET . . . -130.59 -152.52 7.42 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 22' ' ' GLY . 2.8 mpt? -143.99 126.53 15.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 1.0 110.522 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 84.2 tt0 -87.42 121.43 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.601 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -105.79 138.85 41.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.62 150.22 49.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.67 -66.63 0.38 Allowed Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.583 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.56 -33.59 86.83 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.761 2.307 . . . . 1.0 113.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -174.0 -171.97 0.68 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 121.009 -0.276 . . . . 1.0 110.463 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -130.23 169.13 15.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.973 0.416 . . . . 1.0 110.454 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 134.66 8.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.83 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.16 141.59 69.18 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 CA-C-N 120.199 1.107 . . . . 1.0 111.244 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 15.5 p -150.31 -176.24 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.403 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.71 138.64 22.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.451 HD12 HD11 ' A' ' 103' ' ' ILE . 71.0 mt -105.66 123.86 48.61 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.7 m -129.6 113.91 15.4 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.117 0.484 . . . . 1.0 111.584 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.505 HD23 ' HB1' ' A' ' 115' ' ' ALA . 49.9 tp -81.43 127.39 32.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.03 149.19 47.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.138 0.494 . . . . 1.0 111.363 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -112.98 121.95 46.18 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.405 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -135.36 139.89 44.61 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.039 0.447 . . . . 1.0 110.76 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m120 58.97 33.86 23.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.324 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.83 23.93 75.67 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -131.3 152.61 50.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.0 130.41 40.13 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -142.41 142.1 32.33 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.026 0.441 . . . . 1.0 110.231 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.5 tp -104.38 124.78 49.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.0 mt -103.38 122.19 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.988 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.88 114.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.471 ' C ' HD12 ' A' ' 50' ' ' LEU . 79.2 mt-30 -101.68 132.79 47.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.071 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.0 mp -108.04 129.44 55.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.7 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -80.18 36.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.268 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -49.77 142.46 8.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.199 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.68 -38.69 91.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -59.04 -53.85 53.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.34 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -174.46 149.87 1.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.58 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 t -67.11 133.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.214 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 97.0 mt-30 -106.79 128.63 54.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.143 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -122.18 117.39 26.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.56 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.66 111.86 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.161 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -115.97 114.53 41.45 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.793 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.27 151.07 37.89 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.667 1.578 . . . . 1.0 112.462 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.9 mt -97.52 118.81 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.429 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -170.22 -158.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.352 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -61.05 -42.62 98.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.109 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -65.41 -36.11 82.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.979 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 64' ' ' ASN . 17.3 t80 -95.12 123.78 38.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.41 122.35 15.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.234 0.54 . . . . 1.0 110.817 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 t -87.89 115.0 25.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.247 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 70' ' ' VAL . 4.6 m -115.74 124.32 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.908 0.385 . . . . 1.0 110.583 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 87' ' ' CYS . 52.4 tt0 -84.48 135.44 34.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.902 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 21.9 p-10 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 121.032 0.444 . . . . 1.0 110.732 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' SER . 36.5 mm -63.99 -40.93 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.221 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.6 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . 44.0 t -142.91 140.19 31.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 1.0 110.151 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 83' ' ' SER . 17.0 m120 -146.15 -172.22 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.985 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER 76.97 89.68 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.19 77.49 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.409 ' HB3' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.21 135.15 35.92 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.01 0.433 . . . . 1.0 111.882 -177.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.04 113.32 25.78 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.66 129.79 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.817 0.341 . . . . 1.0 110.429 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.86 142.18 33.57 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.105 -0.498 . . . . 1.0 109.982 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.06 133.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.706 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.22 141.61 31.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 98' ' ' GLU . 50.4 ptt85 . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.299 0.095 . . . . 1.0 110.992 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 97' ' ' ARG . 84.1 tt0 -176.9 128.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.9 0.381 . . . . 1.0 110.581 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.88 145.08 35.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -104.06 147.32 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.93 0.395 . . . . 1.0 111.169 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.87 152.42 45.08 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.998 -0.547 . . . . 1.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -138.26 144.53 40.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.984 0.421 . . . . 1.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.451 HD11 HD12 ' A' ' 35' ' ' LEU . 5.7 mm -127.31 89.88 50.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.59 -16.44 46.93 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.721 1.614 . . . . 1.0 112.652 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -87.2 101.09 13.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.81 -55.07 39.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 1.0 112.087 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -51.84 -44.03 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.771 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -68.45 -39.67 81.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.919 0.39 . . . . 1.0 110.422 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -58.07 -36.84 73.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.107 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.416 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.27 -44.58 83.21 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.868 -0.733 . . . . 1.0 110.542 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -62.18 -50.33 72.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.707 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.67 -40.86 92.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.119 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 m -61.53 -43.82 98.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.098 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.44 -42.8 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.157 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.95 -44.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.882 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.16 -45.96 92.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.061 0.457 . . . . 1.0 110.276 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.94 -37.39 84.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.311 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.12 -48.54 78.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.03 -38.72 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.923 0.392 . . . . 1.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.13 -44.86 90.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.754 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.08 75.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.951 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.18 -39.87 68.35 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.68 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.039 -0.981 . . . . 1.0 110.684 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo . . . . . 0 N--CA 1.497 1.707 0 CA-C-O 121.002 0.334 . . . . 1.0 111.822 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 10' ' ' LEU . 4.1 mm? -53.94 146.4 28.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.93 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -55.11 144.16 70.9 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.076 1.184 . . . . 1.0 111.5 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.86 -45.15 97.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.551 -0.749 . . . . 1.0 111.015 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.47 -28.67 73.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.14 -0.784 . . . . 1.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 147.39 52.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 1.0 110.976 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -118.28 80.49 15.91 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.431 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.45 97.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.158 1.905 . . . . 1.0 112.689 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' LEU . 98.3 mt -65.47 -41.34 93.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.799 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.6 149.08 28.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.229 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 t -138.23 136.4 36.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.806 0.336 . . . . 1.0 110.619 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.5 p -144.82 151.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.331 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.1 137.52 36.03 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.604 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -150.65 -168.5 15.56 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.647 -0.981 . . . . 1.0 110.647 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -127.84 130.54 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 1.0 110.515 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.55 ' OE1' HD11 ' A' ' 50' ' ' LEU . 81.3 tt0 -93.12 120.82 33.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.457 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 71.4 mtm -107.76 136.09 48.08 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.609 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.91 149.49 38.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.051 0.453 . . . . 1.0 109.965 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -37.11 -65.35 0.6 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.77 -0.65 . . . . 1.0 112.749 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.14 -32.78 95.04 Favored 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 122.728 2.285 . . . . 1.0 114.135 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 179.14 177.21 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 121.084 -0.246 . . . . 1.0 110.61 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.57 168.86 11.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.0 0.429 . . . . 1.0 110.287 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 16.7 pt-20 -161.46 143.91 9.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.41 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.46 144.93 95.51 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.338 1.359 . . . . 1.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 22' ' ' GLY . 4.2 p -154.05 -178.13 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.571 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.05 143.13 24.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.197 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 103' ' ' ILE . 49.7 mt -106.25 120.93 43.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.873 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m -127.27 115.36 18.91 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.232 0.539 . . . . 1.0 111.458 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.59 HD23 ' HB1' ' A' ' 115' ' ' ALA . 65.4 tp -87.76 128.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.062 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.88 144.26 41.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 1.0 111.425 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -98.77 121.26 40.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.544 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.95 134.18 42.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.914 0.388 . . . . 1.0 110.948 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 58.15 33.78 23.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.681 -0.69 . . . . 1.0 111.791 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.35 78.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.873 -0.891 . . . . 1.0 110.873 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 44.2 tt0 -131.36 161.28 32.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.419 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 94.5 m-85 -103.41 137.25 41.78 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -145.54 144.1 30.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.004 0.43 . . . . 1.0 110.352 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.2 tp -104.57 128.9 52.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.634 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.57 129.17 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.42 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.32 120.18 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' C ' HD22 ' A' ' 50' ' ' LEU . 74.9 mt-30 -108.53 127.83 54.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.082 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.55 HD11 ' OE1' ' A' ' 24' ' ' GLU . 4.2 mm? -101.27 132.44 46.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.906 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -95.49 18.99 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.305 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 94.1 mt-10 -45.6 136.84 5.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.419 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.74 -38.5 90.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.195 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.13 -50.92 69.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.377 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -170.58 154.92 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.166 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -84.58 113.88 21.57 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.14 131.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.938 0.399 . . . . 1.0 110.344 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.433 HE22 ' HA ' ' A' ' 10' ' ' LEU . 52.0 tt0 -121.13 117.41 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.585 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -106.53 134.94 48.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.0 mm -93.82 109.54 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.902 0.382 . . . . 1.0 110.16 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.6 mm -112.41 104.59 56.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 147.82 36.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.596 1.53 . . . . 1.0 112.642 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 97.2 mt -91.81 119.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.431 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 79.3 m-20 -163.85 -165.37 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.059 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.1 p -61.54 -37.25 83.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.34 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -71.57 -32.2 67.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.296 . . . . 1.0 111.186 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 16.4 t80 -92.24 123.24 35.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.931 0.396 . . . . 1.0 109.987 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -135.05 144.48 47.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.549 . . . . 1.0 110.82 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.5 t -117.96 112.36 20.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.049 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.94 125.83 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.852 0.358 . . . . 1.0 111.012 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' OE1' ' OD1' ' A' ' 80' ' ' ASP . 42.5 tt0 -84.44 102.1 12.52 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.719 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.512 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.514 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 70.5 m-20 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.876 0.37 . . . . 1.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.07 -42.57 95.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.59 -32.03 57.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.053 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ASP . 34.5 t -147.4 126.84 13.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.73 0.3 . . . . 1.0 110.706 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 80' ' ' ASP . 35.4 m120 -147.76 27.02 1.0 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.963 0.411 . . . . 1.0 111.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 t -80.45 100.89 8.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.396 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.96 80.37 0.12 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.952 -1.659 . . . . 1.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.86 129.5 38.76 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.134 0.42 . . . . 1.0 112.134 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.43 121.77 46.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 153.11 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.62 142.9 50.15 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.28 132.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.851 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -137.77 135.68 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.985 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.855 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.577 0.227 . . . . 1.0 110.879 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -174.32 112.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.479 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -129.33 134.19 47.79 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -91.89 157.58 16.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.857 0.361 . . . . 1.0 111.0 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.73 153.77 47.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.402 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -140.03 140.78 36.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.841 0.353 . . . . 1.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 35' ' ' LEU . 6.1 mm -128.67 89.61 48.74 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.07 -16.63 36.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.918 1.745 . . . . 1.0 112.651 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -87.55 106.51 18.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.697 -0.482 . . . . 1.0 109.697 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.0 -54.58 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 1.0 112.032 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.19 -44.23 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.559 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.433 ' HB3' HG23 ' A' ' 20' ' ' VAL . 57.9 m170 -69.2 -37.14 77.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.736 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 113' ' ' LEU . 11.5 t -62.39 -31.91 72.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.157 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.78 -45.52 92.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.71 -42.99 85.5 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.039 -0.665 . . . . 1.0 110.622 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 116' ' ' VAL . 47.0 t80 -62.65 -51.13 68.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.223 -0.899 . . . . 1.0 111.322 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.462 ' CD1' HD22 ' A' ' 84' ' ' ASN . 91.2 mt -66.76 -41.07 88.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.277 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.9 p -63.19 -45.96 89.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.82 0.343 . . . . 1.0 111.345 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.2 -47.99 63.34 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.414 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 112' ' ' PHE . 55.9 t -64.75 -43.9 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.636 0.255 . . . . 1.0 111.113 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.63 -45.74 91.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 1.0 110.215 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -37.81 87.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.229 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.04 72.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.736 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -70.95 -35.97 72.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.355 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.66 -44.68 96.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.85 97.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.286 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.69 -41.06 88.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.698 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.507 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 35.6 Cg_endo . . . . . 0 N--CA 1.495 1.597 0 CA-C-O 120.999 0.333 . . . . 1.0 111.974 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.55 150.92 53.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.12 143.29 99.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.326 1.351 . . . . 1.0 111.526 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 13' ' ' GLY . 13.4 m -68.63 -42.89 83.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -67.26 -28.12 73.64 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.399 -0.68 . . . . 1.0 111.399 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.89 58.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.906 0.384 . . . . 1.0 111.015 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -99.0 102.85 16.62 Favored Pre-proline 0 N--CA 1.465 0.275 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.42 100.58 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.605 1.536 . . . . 1.0 112.915 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.5 -43.72 84.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.333 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.43 149.91 31.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -141.82 131.71 24.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.526 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 21' ' ' GLU . 66.4 t -139.17 158.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 121.124 0.488 . . . . 1.0 110.822 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' N ' HG12 ' A' ' 20' ' ' VAL . 97.4 mt-10 -106.29 123.06 47.46 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.523 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.71 -160.5 9.59 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -139.0 127.34 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.867 0.365 . . . . 1.0 110.557 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -87.14 123.89 32.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.628 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.7 mtm -107.35 137.45 45.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.61 149.13 50.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -66.61 0.32 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.791 -0.641 . . . . 1.0 112.566 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.21 -33.62 90.06 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.804 2.336 . . . . 1.0 113.537 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -174.46 -174.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.526 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -126.1 168.64 13.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.067 0.461 . . . . 1.0 110.635 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -153.88 143.78 15.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.459 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.3 146.55 93.76 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.486 1.458 . . . . 1.0 111.117 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.5 p -155.14 -172.88 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.579 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.73 136.7 16.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 103' ' ' ILE . 21.8 mt -101.53 122.75 44.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.823 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -128.19 123.26 33.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.237 0.541 . . . . 1.0 111.7 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.607 HD23 ' HB1' ' A' ' 115' ' ' ALA . 46.6 tp -94.77 122.09 37.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.02 151.08 51.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.084 0.469 . . . . 1.0 111.25 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -110.7 122.5 47.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.639 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -134.01 138.62 45.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.981 0.419 . . . . 1.0 110.843 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 58.96 33.8 23.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.41 77.2 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -131.15 155.73 46.51 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.83 135.2 36.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.327 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -145.5 139.57 26.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 47' ' ' ILE . 5.2 tt -105.27 120.75 42.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.84 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.597 ' N ' HD23 ' A' ' 46' ' ' LEU . 79.8 mt -104.46 127.25 58.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.318 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.41 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 65.1 mt -105.37 116.76 49.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -96.15 127.51 42.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.54 133.47 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.773 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -106.39 34.33 3.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.306 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.81 149.09 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.99 -38.04 89.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.391 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -59.19 -51.2 71.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.227 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -175.02 166.27 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.749 -0.659 . . . . 1.0 111.026 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -84.62 127.45 34.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.979 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.41 136.03 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.042 0.449 . . . . 1.0 110.439 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 9' ' ' PRO . 56.7 tt0 -100.01 109.38 21.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.184 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -102.34 113.49 26.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.957 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.63 123.09 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.899 0.38 . . . . 1.0 110.381 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -132.37 117.63 15.67 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.141 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.72 157.8 39.61 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.766 1.644 . . . . 1.0 112.645 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.69 123.57 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -173.71 -161.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -62.08 -39.08 91.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.192 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -67.37 -38.23 84.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.591 -0.277 . . . . 1.0 111.179 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -84.01 125.42 32.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 1.0 110.212 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -134.09 144.59 48.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.297 0.57 . . . . 1.0 110.745 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -127.11 120.66 29.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.278 -0.874 . . . . 1.0 109.251 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 70' ' ' VAL . 6.9 m -119.62 125.3 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.767 0.318 . . . . 1.0 110.596 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.461 ' NE2' ' OG ' ' A' ' 83' ' ' SER . 59.1 tt0 -90.25 118.29 29.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.7 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 . . . . . 0 N--CA 1.465 0.28 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.042 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.056 0.455 . . . . 1.0 110.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.75 -42.19 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.379 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.13 -24.46 26.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.941 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.566 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 30.0 t -113.34 124.75 53.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.247 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.9 m120 -150.81 -171.75 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.124 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' OG ' ' A' ' 85' ' ' SER . 4.7 p 66.37 97.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.51 79.04 0.09 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 135.33 36.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.865 0.365 . . . . 1.0 111.946 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.58 113.38 26.65 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.412 -0.959 . . . . 1.0 108.412 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.44 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.3 pp -116.17 125.7 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 1.0 110.162 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 65.3 mtp180 -102.57 146.52 28.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.71 132.47 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.678 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -145.61 148.13 32.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.274 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.578 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 120.716 0.293 . . . . 1.0 110.302 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 90' ' ' ARG . 77.2 tt0 -65.85 127.96 34.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.164 0.507 . . . . 1.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -132.02 160.77 34.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.076 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.466 ' CZ ' ' NH2' ' A' ' 90' ' ' ARG . 85.5 mtt85 -123.58 144.08 49.81 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.953 0.406 . . . . 1.0 110.964 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 91.0 m-85 -143.95 155.95 44.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.947 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -138.71 146.44 41.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 1.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 35' ' ' LEU . 6.0 mm -127.39 90.46 48.66 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.37 -16.09 43.01 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.833 1.689 . . . . 1.0 112.65 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -87.57 100.9 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.15 -53.42 58.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.201 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -52.97 -42.21 65.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.668 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -71.56 -36.57 70.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.885 0.374 . . . . 1.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.48 -36.19 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.064 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.14 -44.41 95.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.478 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -66.72 -44.49 81.48 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.29 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -61.01 -49.37 77.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.204 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.01 -42.43 89.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.539 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.5 m -63.13 -43.8 97.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.419 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.607 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.03 -48.83 61.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.355 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.29 -43.44 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.56 -45.42 91.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.932 0.396 . . . . 1.0 110.257 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.86 85.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.338 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.38 -49.01 77.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.839 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -67.61 -37.69 82.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.776 0.322 . . . . 1.0 111.04 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -60.12 -44.34 94.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.053 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.28 94.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.395 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.8 -39.73 91.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.665 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.939 -1.029 . . . . 1.0 110.875 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HG2' HE21 ' A' ' 49' ' ' GLN . 36.5 Cg_endo . . . . . 0 N--CA 1.496 1.657 0 CA-C-O 120.87 0.279 . . . . 1.0 111.802 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -78.46 149.66 75.54 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.889 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.39 143.67 89.2 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.805 1.67 . . . . 1.0 111.621 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 m -78.7 -19.5 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.029 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.2 -33.51 84.6 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.32 170.59 15.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.03 0.443 . . . . 1.0 110.98 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.32 81.7 17.61 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.799 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.26 95.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.547 2.165 . . . . 1.0 112.7 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.21 -41.88 96.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.717 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.69 155.62 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.055 -0.975 . . . . 1.0 110.411 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -148.84 142.39 25.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.851 0.357 . . . . 1.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.96 161.05 23.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.304 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -94.99 122.51 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -125.34 167.19 17.78 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.2 mtp -117.6 103.01 9.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.864 0.364 . . . . 1.0 110.292 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' CE1' ' A' ' 101' ' ' PHE . 47.9 tp10 -60.22 121.37 11.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.109 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 102' ' ' GLU . 76.0 mtm -106.32 131.19 53.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.433 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.6 146.46 39.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.959 0.409 . . . . 1.0 109.998 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.22 -65.29 0.72 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.568 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.9 -33.38 95.88 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.627 2.218 . . . . 1.0 113.628 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.527 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -178.8 -169.53 0.17 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.659 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -132.65 168.91 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.951 0.405 . . . . 1.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 18.3 pt-20 -154.39 134.8 8.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.24 141.37 70.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 CA-C-N 120.264 1.13 . . . . 1.0 111.369 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 22' ' ' GLY . 28.5 p -149.17 -175.99 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.524 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.43 137.09 12.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.302 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 112' ' ' PHE . 47.7 mt -98.32 122.76 41.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.501 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.8 m -118.87 119.29 33.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.14 0.495 . . . . 1.0 111.283 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.429 HD23 ' HB1' ' A' ' 115' ' ' ALA . 54.7 tp -98.03 130.8 44.83 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.35 154.0 41.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.089 0.471 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -111.0 122.61 48.34 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -133.21 133.21 42.44 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 1.0 110.556 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 60.86 34.77 19.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.417 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.0 25.35 75.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.029 -0.829 . . . . 1.0 111.029 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -134.82 144.38 47.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.18 -0.304 . . . . 1.0 110.18 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.417 ' HB2' HE21 ' A' ' 123' ' ' GLN . 34.5 m-85 -88.39 136.51 32.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -143.73 144.54 31.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.051 0.453 . . . . 1.0 110.514 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.28 126.01 53.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.499 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.7 mt -111.71 131.64 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.151 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.5 mm -95.2 122.75 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' C ' HD12 ' A' ' 50' ' ' LEU . 13.2 mm100 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.818 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -109.92 136.12 49.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.809 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -104.81 20.41 18.78 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.25 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.8 mt-10 -40.43 141.07 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.88 0.371 . . . . 1.0 110.668 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.92 -39.64 92.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.474 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.47 -51.88 67.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.365 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -173.98 147.08 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.478 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 19.6 p80 -75.83 112.51 12.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 t -90.77 132.76 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -112.38 117.91 33.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.649 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -121.83 127.65 50.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -100.4 125.91 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.056 0.455 . . . . 1.0 110.487 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.67 93.2 35.46 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.438 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.78 145.05 85.26 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.147 1.898 . . . . 1.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 97.6 mt -85.88 117.66 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 53.2 p30 -176.73 -160.37 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.121 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.7 p -65.47 -23.25 66.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.283 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -83.76 -10.46 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.02 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 27.2 t80 -113.78 129.81 56.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.963 0.411 . . . . 1.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -129.67 155.73 45.39 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.582 0.706 . . . . 1.0 111.081 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 69' ' ' CYS . 26.3 p -144.48 100.2 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.562 -1.199 . . . . 1.0 109.798 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 70' ' ' VAL . 33.2 m -102.53 122.39 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.844 0.355 . . . . 1.0 110.617 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 83' ' ' SER . 56.3 tt0 -98.81 125.4 44.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.05 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 . . . . . 0 CA--C 1.517 -0.326 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.914 179.47 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.984 0.421 . . . . 1.0 110.219 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.74 -42.56 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.527 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.17 -31.73 53.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.04 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.561 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 40.8 m -105.53 120.75 42.41 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.095 -0.335 . . . . 1.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.3 m120 -150.16 -167.99 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.227 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.87 86.77 0.12 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.33 69.84 1.27 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.005 -1.638 . . . . 1.0 109.005 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.3 142.57 27.26 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.047 0.451 . . . . 1.0 111.896 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -128.3 131.18 48.69 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.96 162.72 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.323 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.764 ' NH2' HH22 ' A' ' 100' ' ' ARG . 68.0 mtt180 -128.58 140.48 51.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.96 134.7 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.99 0.424 . . . . 1.0 110.626 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.85 140.06 52.63 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.334 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 -179.821 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 98' ' ' GLU . 3.9 ptm180 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.318 0.104 . . . . 1.0 110.798 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 97' ' ' ARG . 47.8 tp10 -174.97 93.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 1.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -104.56 135.05 46.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.764 HH22 ' NH2' ' A' ' 90' ' ' ARG . 57.4 mtp85 -101.37 150.25 23.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.937 0.399 . . . . 1.0 110.812 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.549 ' CE1' ' OE1' ' A' ' 24' ' ' GLU . 70.1 m-85 -129.24 154.9 46.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.556 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 25' ' ' MET . 81.4 tt0 -149.04 121.73 8.63 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.988 0.423 . . . . 1.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.16 98.41 26.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.78 -10.67 25.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.68 1.587 . . . . 1.0 112.595 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -94.35 106.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.86 -54.98 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.002 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -50.07 -44.85 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.519 -0.473 . . . . 1.0 110.464 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -68.57 -40.19 80.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 1.0 110.642 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.16 -36.85 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.033 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -63.7 -44.66 93.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.46 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.26 -45.22 81.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.312 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 53.3 t80 -61.48 -49.1 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.405 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.4 -41.58 80.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.344 -0.542 . . . . 1.0 111.238 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.2 t -63.36 -44.97 93.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.686 0.279 . . . . 1.0 111.535 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.63 -50.32 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.465 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.8 -45.18 99.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.592 -0.276 . . . . 1.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -60.67 -46.01 91.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 110.318 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.09 76.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 1.0 110.533 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.44 99.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.818 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -66.38 -40.2 89.54 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.663 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -63.25 -44.22 95.79 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.624 0.726 . . . . 1.0 110.115 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.4 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.174 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' A' ' 63' ' ' ILE . 89.3 mt-30 -66.26 -40.58 90.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.742 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.599 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.521 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 29.8 Cg_endo . . . . . 0 N--CA 1.498 1.746 0 CA-C-O 120.853 0.272 . . . . 1.0 111.958 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.62 162.17 0.99 Allowed Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.826 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.83 152.41 64.04 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.488 1.459 . . . . 1.0 111.443 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -85.97 70.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.692 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.86 -26.93 0.39 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.57 140.67 53.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 111.035 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 15.5 mm100 -102.54 80.95 0.35 Allowed Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.69 88.42 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.681 1.587 . . . . 1.0 112.152 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.695 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.42 137.58 38.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.578 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.28 125.76 26.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 21' ' ' GLU . 54.6 t -135.93 157.07 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.767 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.523 ' OE1' ' HB2' ' A' ' 34' ' ' ALA . 46.7 tp10 -105.79 122.96 47.16 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.98 -157.76 8.78 Favored Glycine 0 N--CA 1.463 0.491 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -140.51 123.59 16.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.886 0.374 . . . . 1.0 110.36 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -88.94 119.32 29.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 25' ' ' MET . 1.3 mpp? -107.58 136.04 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.509 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.68 149.08 52.6 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -65.82 0.41 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.635 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.83 -32.62 85.7 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.814 2.343 . . . . 1.0 113.705 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -174.43 -176.72 1.12 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.434 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -126.72 169.1 13.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 1.0 110.682 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -158.15 141.98 11.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.553 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.25 144.34 95.33 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.297 1.331 . . . . 1.0 110.985 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.3 p -152.01 174.21 13.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.321 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -140.09 131.78 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.955 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 103' ' ' ILE . 31.1 mt -96.63 121.6 38.64 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.999 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.3 m -129.24 124.67 35.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.197 0.522 . . . . 1.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.572 HD23 ' HB1' ' A' ' 115' ' ' ALA . 37.4 tp -90.24 125.86 35.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.432 -0.803 . . . . 1.0 108.851 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.86 155.45 42.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.127 0.489 . . . . 1.0 111.052 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.523 ' OE1' ' CZ ' ' A' ' 44' ' ' TYR . 20.6 tt0 -134.19 116.52 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.829 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.464 ' CZ ' ' OE1' ' A' ' 45' ' ' GLU . 34.2 ptt180 -137.25 144.21 42.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.233 0.539 . . . . 1.0 111.248 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 59.11 28.05 17.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.107 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.04 78.37 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -127.31 137.88 52.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CZ ' ' OE1' ' A' ' 39' ' ' GLN . 84.1 m-85 -87.92 135.72 33.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 40' ' ' ARG . 22.6 pt-20 -144.89 144.61 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 1.0 110.482 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.9 tp -103.76 121.16 42.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.292 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.2 mt -105.16 124.77 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.944 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.35 115.89 49.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.43 ' C ' HD12 ' A' ' 50' ' ' LEU . 80.4 mt-30 -96.78 131.8 43.13 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.983 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 49' ' ' GLN . 9.1 mp -106.82 130.43 54.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.805 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -104.06 29.17 6.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.126 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE1' ' OE2' ' A' ' 54' ' ' GLU . 96.6 mt-10 -43.69 145.6 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.606 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.14 -36.07 82.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' OE2' ' OE1' ' A' ' 52' ' ' GLU . 3.3 pt-20 -62.03 -46.72 87.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -177.29 154.96 1.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.567 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -78.01 127.84 32.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.0 109.876 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.42 135.94 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.042 0.449 . . . . 1.0 110.474 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 83.4 mt-30 -108.6 126.37 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.158 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.82 119.02 36.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.716 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.5 mm -92.75 112.64 26.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.93 0.395 . . . . 1.0 110.369 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mm -117.64 89.44 32.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.221 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.67 141.44 95.47 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.228 1.952 . . . . 1.0 112.455 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -83.53 124.81 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.558 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.627 ' ND2' ' CD2' ' A' ' 66' ' ' HIS . 5.2 p30 176.04 -165.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.963 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -59.19 -38.04 78.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.706 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CD2' ' ND2' ' A' ' 64' ' ' ASN . 3.3 p80 -74.54 -2.75 27.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.75 0.31 . . . . 1.0 111.401 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 42.0 t80 -116.25 132.21 56.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.155 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -130.71 148.29 52.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.861 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 t -143.2 104.32 4.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.052 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.21 128.14 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.885 0.374 . . . . 1.0 110.886 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 58.2 tp60 -78.9 96.15 5.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.821 -179.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.835 0.35 . . . . 1.0 110.289 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.86 -41.99 94.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.493 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.01 -22.52 5.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.905 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 11.0 t -111.42 122.84 48.9 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.054 0.454 . . . . 1.0 110.414 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 83' ' ' SER . 13.7 m120 -148.74 -166.79 2.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.07 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 t 56.82 88.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.73 72.52 0.7 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.447 -1.461 . . . . 1.0 109.447 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.482 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.32 134.94 36.28 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.799 0.333 . . . . 1.0 111.686 -178.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.623 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 63.8 mttp -111.87 131.63 55.23 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 35' ' ' LEU . 34.2 pt -125.15 157.96 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.74 ' NH2' HH22 ' A' ' 100' ' ' ARG . 96.9 mtt180 -131.19 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.2 132.25 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -146.91 154.71 41.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.358 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.667 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -63.42 136.08 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.409 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -136.13 159.14 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.131 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.74 HH22 ' NH2' ' A' ' 90' ' ' ARG . 66.6 mtp85 -122.23 145.11 48.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.061 0.458 . . . . 1.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -140.21 155.67 46.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.175 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -139.41 141.51 37.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.891 0.376 . . . . 1.0 111.06 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.506 HD11 HD12 ' A' ' 35' ' ' LEU . 5.1 mm -124.03 89.45 51.69 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.62 -15.62 37.72 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.85 1.7 . . . . 1.0 112.762 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -88.65 105.12 17.46 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.4 tt0 -60.43 -53.84 52.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.23 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -53.06 -42.45 65.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.571 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -70.27 -37.68 74.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.492 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.61 -34.44 74.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.423 . . . . 1.0 111.001 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.72 -44.74 95.44 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.309 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.87 -43.25 84.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.164 -0.615 . . . . 1.0 110.579 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.476 ' CE2' HD13 ' A' ' 89' ' ' ILE . 59.1 t80 -60.27 -49.2 78.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.293 -0.867 . . . . 1.0 111.211 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.9 -41.86 86.43 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.336 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 57.8 m -63.53 -44.17 95.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.822 0.344 . . . . 1.0 111.451 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -70.34 -48.8 54.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.609 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' CE1' ' A' ' 112' ' ' PHE . 62.3 t -65.45 -43.57 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.904 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.92 -45.11 93.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 110.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.92 -38.85 89.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.6 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.3 -49.34 76.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.765 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.48 -36.78 74.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.335 . . . . 1.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.76 -44.93 94.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.158 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.9 95.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.285 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -67.86 -41.23 83.22 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.63 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 33.1 Cg_endo . . . . . 0 N--CA 1.497 1.7 0 CA-C-O 120.872 0.28 . . . . 1.0 111.77 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.1 155.6 16.15 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.158 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.55 143.86 99.48 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.336 1.358 . . . . 1.0 111.628 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.6 -44.96 93.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.14 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.62 78.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 140.41 58.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 1.0 110.961 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -104.07 80.7 0.44 Allowed Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.242 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.75 99.95 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.98 1.787 . . . . 1.0 112.102 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -64.65 -43.85 92.3 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.392 0.615 . . . . 1.0 110.154 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.87 141.36 24.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.19 -0.914 . . . . 1.0 109.932 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -131.64 128.87 40.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.212 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.9 162.25 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.147 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -99.75 122.62 43.0 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -123.06 179.2 16.2 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 93.3 mmm -126.15 99.61 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' A' ' 99' ' ' ARG . 81.3 tt0 -62.29 132.54 52.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.098 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 73.9 mtm -120.8 140.25 51.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.782 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -141.56 148.68 39.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.32 -65.59 0.34 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.779 -0.646 . . . . 1.0 112.504 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.63 -31.85 92.62 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.65 2.233 . . . . 1.0 114.108 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 179.35 176.28 0.63 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.399 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -118.01 169.2 9.85 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 1.0 110.177 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.39 141.9 13.25 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.448 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 144.91 96.39 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.026 1.15 . . . . 1.0 111.359 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 22' ' ' GLY . 17.1 p -153.58 -179.84 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.438 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' C ' HD22 ' A' ' 35' ' ' LEU . . . -138.93 128.64 24.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.081 0.467 . . . . 1.0 110.239 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 35' ' ' LEU . 3.9 mm? -100.52 119.66 38.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.966 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.6 m -130.66 122.01 26.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.0 111.853 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.661 HD23 ' HB1' ' A' ' 115' ' ' ALA . 57.5 tp -90.42 129.99 36.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.006 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.29 148.63 41.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.44 . . . . 1.0 111.457 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -109.02 121.24 44.72 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.66 136.65 46.6 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.057 0.456 . . . . 1.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 m120 59.73 33.66 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.908 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.37 77.82 Favored Glycine 0 N--CA 1.463 0.476 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -130.36 154.39 47.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.483 -0.359 . . . . 1.0 110.055 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -92.58 135.1 34.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -143.94 143.81 31.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 1.0 110.317 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -103.89 124.78 49.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.423 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.53 118.07 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.7 mt -103.44 120.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.643 -0.502 . . . . 1.0 109.643 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' HD12 ' A' ' 50' ' ' LEU . 79.1 mt-30 -115.08 129.58 56.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.762 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.4 mp -101.22 127.37 47.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -76.73 62.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.298 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.3 154.34 40.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.252 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -62.46 -40.83 97.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.193 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.33 -82.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.882 0.372 . . . . 1.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -142.29 152.14 42.7 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -70.71 123.07 21.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.22 133.89 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.12 0.486 . . . . 1.0 110.481 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 81.9 mt-30 -95.23 123.92 38.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.86 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -120.45 117.08 26.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.444 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.22 110.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.911 0.386 . . . . 1.0 110.626 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm -115.16 119.07 39.31 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.165 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.01 150.83 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.797 1.665 . . . . 1.0 112.669 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.442 HG23 HE21 ' A' ' 120' ' ' GLN . 97.8 mt -104.46 118.35 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.319 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -172.22 -153.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.234 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.0 p -64.16 -40.24 95.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.191 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -66.6 -41.15 88.92 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 8.0 t80 -96.23 130.1 43.39 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.788 0.328 . . . . 1.0 110.18 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -139.42 142.54 37.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.541 . . . . 1.0 110.826 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -119.91 115.5 23.92 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.12 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.77 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.91 0.386 . . . . 1.0 110.644 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.586 ' NE2' HD13 ' A' ' 113' ' ' LEU . 49.5 tt0 -81.05 107.18 13.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.416 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.458 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 83' ' ' SER . 89.0 m-20 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 1.0 110.139 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.41 -42.74 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.757 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.86 -9.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.233 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.2 t -139.98 136.43 33.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 1.0 110.239 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 83' ' ' SER . 18.0 m120 -148.54 -173.07 4.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.827 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 85' ' ' SER . 3.0 p 75.7 99.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.44 77.7 0.13 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.499 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.41 139.78 30.67 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.246 0.461 . . . . 1.0 112.246 -177.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -113.1 125.2 54.11 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.334 -0.987 . . . . 1.0 108.334 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pt -119.02 130.46 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.444 ' CZ ' HH11 ' A' ' 100' ' ' ARG . 20.2 mmt180 -96.26 142.59 28.22 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.9 t -124.93 135.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 1.0 110.197 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -131.47 139.36 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.012 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.548 0 N-CA-C 110.808 -0.917 . . . . 1.0 110.808 -179.947 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.65 0.262 . . . . 1.0 110.771 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -175.51 108.22 0.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.426 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' A' ' 24' ' ' GLU . 85.6 mtp180 -107.05 123.84 48.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.662 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.444 HH11 ' CZ ' ' A' ' 90' ' ' ARG . 94.9 mtt-85 -83.97 146.28 28.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.183 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.17 147.48 36.68 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.241 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.05 152.33 39.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.705 0.288 . . . . 1.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -126.84 102.49 25.07 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.89 -13.06 29.08 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.648 1.565 . . . . 1.0 112.953 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -91.81 105.4 17.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.14 -54.82 42.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.167 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.687 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.439 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.55 -38.93 81.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 1.0 110.348 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.494 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -57.09 -36.43 70.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.798 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.0 mt -61.88 -46.28 90.11 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.152 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.85 -44.53 80.77 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.905 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.32 -48.87 76.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.586 HD13 ' NE2' ' A' ' 71' ' ' GLN . 95.9 mt -65.91 -41.66 91.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.552 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.7 m -62.16 -43.46 98.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.831 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.29 -47.32 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HA ' HD22 ' A' ' 37' ' ' LEU . 76.6 t -66.59 -42.49 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.953 0.406 . . . . 1.0 111.158 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.32 -42.68 91.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.167 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.76 90.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.05 87.9 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.623 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 63' ' ' ILE . 60.2 mm-40 -69.9 -38.31 76.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.97 -46.04 92.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.055 0.455 . . . . 1.0 109.832 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.15 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.48 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.39 -39.07 88.83 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.605 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.451 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo . . . . . 0 N--CA 1.499 1.828 0 CA-C-O 120.904 0.294 . . . . 1.0 112.071 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.6 mt -71.08 150.03 94.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.859 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.76 142.03 61.92 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.914 1.742 . . . . 1.0 111.466 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.32 -32.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.734 -0.667 . . . . 1.0 111.349 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.05 -36.36 90.18 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB1' ' HB1' ' A' ' 38' ' ' ALA . . . -80.7 165.87 21.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 1.0 110.978 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.53 80.67 22.9 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.602 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.23 96.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.676 2.251 . . . . 1.0 112.773 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.3 mt -65.37 -41.43 93.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.83 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.06 146.59 27.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.251 -0.886 . . . . 1.0 110.36 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 t -134.31 131.06 37.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.807 0.337 . . . . 1.0 110.542 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 35' ' ' LEU . 28.3 m -137.97 160.79 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.367 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -100.08 154.79 18.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.623 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -169.92 -169.61 33.35 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 23' ' ' MET . 2.5 mpt? -132.2 129.19 39.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 1.0 110.388 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -91.97 117.36 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.44 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.8 mtm -101.49 135.66 42.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.789 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.79 151.47 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.714 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -67.03 0.33 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.667 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.35 -33.77 88.48 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.882 2.388 . . . . 1.0 113.603 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.36 -176.61 0.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -122.07 168.45 11.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.11 0.481 . . . . 1.0 110.695 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -155.28 142.41 13.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.737 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.03 143.39 94.97 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.355 1.37 . . . . 1.0 111.257 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 22' ' ' GLY . 12.4 p -153.57 -179.2 7.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.385 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.23 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.936 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.52 HD13 HD11 ' A' ' 89' ' ' ILE . 26.6 mt -101.58 123.77 46.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.5 m -127.43 124.29 38.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.227 0.537 . . . . 1.0 111.357 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.618 HD23 ' HB1' ' A' ' 115' ' ' ALA . 54.7 tp -91.59 128.93 37.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.016 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.45 148.68 43.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.159 0.504 . . . . 1.0 111.388 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -109.23 123.06 48.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.723 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -135.09 135.81 41.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.967 0.413 . . . . 1.0 111.194 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.13 34.59 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.658 -0.701 . . . . 1.0 111.523 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.4 21.75 76.11 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -129.89 156.76 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -98.54 132.46 43.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -140.79 147.08 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.44 . . . . 1.0 110.065 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -103.99 122.21 44.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.438 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.52 117.76 51.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -99.75 118.41 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' HD12 ' A' ' 50' ' ' LEU . 77.0 mt-30 -100.03 131.64 45.87 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.442 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.6 mp -105.99 123.34 47.84 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -80.11 36.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.154 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' LEU . 35.0 tp10 -46.47 135.0 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.985 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.4 -35.88 81.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -66.79 -80.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.402 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -132.57 129.28 38.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.933 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -61.94 102.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.922 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.91 131.44 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -107.79 136.57 47.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.956 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 40.6 t0 -101.03 123.5 45.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.5 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.31 119.26 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 1.0 110.3 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.459 HD11 ' NH1' ' A' ' 99' ' ' ARG . 6.8 mt -133.11 119.23 15.52 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.896 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.49 157.21 40.82 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.678 1.586 . . . . 1.0 112.598 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.46 119.67 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.537 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -171.89 -160.06 0.15 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.43 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 t -61.12 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.041 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -64.81 -36.15 83.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.875 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 64' ' ' ASN . 28.2 t80 -95.0 136.87 34.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.968 0.413 . . . . 1.0 110.439 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 92' ' ' GLN . 37.5 ptt180 -143.38 145.99 33.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.904 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 69' ' ' CYS . 27.5 p -117.0 99.66 7.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.384 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 70' ' ' VAL . 31.8 m -102.82 124.26 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.032 0.444 . . . . 1.0 110.985 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.2 tp-100 -83.14 100.84 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.381 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.792 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.88 0.372 . . . . 1.0 110.376 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.94 -42.47 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.675 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.33 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.029 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -106.9 78.26 1.23 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.099 0.476 . . . . 1.0 110.577 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.67 -170.4 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.404 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.4 m 64.59 88.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.69 82.92 0.06 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.56 135.24 41.27 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.834 0.309 . . . . 1.0 111.834 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 65.7 mttp -111.53 128.71 56.1 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.52 HD11 HD13 ' A' ' 35' ' ' LEU . 33.6 pt -125.01 157.35 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.31 134.63 45.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.99 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.46 132.94 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.366 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 98' ' ' GLU . 86.2 mt-30 -135.4 152.79 51.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.024 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 1.0 110.765 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 48.5 tp10 -61.01 128.45 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 1.0 110.526 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.459 ' NH1' HD11 ' A' ' 61' ' ' ILE . 99.9 mtt180 -135.35 143.39 46.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.033 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -127.16 145.99 50.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.752 0.31 . . . . 1.0 111.181 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -144.25 153.72 42.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.357 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -143.51 147.35 34.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.972 0.415 . . . . 1.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.452 HD11 HD12 ' A' ' 35' ' ' LEU . 5.1 mp -128.03 98.73 26.5 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 -11.29 28.6 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.706 1.604 . . . . 1.0 112.67 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 105.3 17.6 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.2 tt0 -59.09 -53.98 52.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -50.75 -43.52 58.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.576 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -69.97 -40.21 75.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.879 0.371 . . . . 1.0 110.531 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -57.1 -34.87 68.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.083 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.519 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.48 -44.84 81.56 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.185 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CE2' HD13 ' A' ' 89' ' ' ILE . 57.0 t80 -59.88 -48.67 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.158 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.11 -41.36 86.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.389 -0.525 . . . . 1.0 111.281 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -65.59 -46.08 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.607 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.618 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.13 -50.05 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.318 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.4 HG21 ' CE1' ' A' ' 112' ' ' PHE . 61.5 t -64.15 -44.21 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.66 -45.21 95.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.421 . . . . 1.0 110.196 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.42 82.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.452 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.44 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.678 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.462 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 87.3 mt-30 -69.77 -38.6 76.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.407 . . . . 1.0 110.84 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -63.95 -44.46 92.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.039 0.447 . . . . 1.0 110.919 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.95 75.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.866 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.85 -40.51 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 1.0 110.571 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.595 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.496 1.661 0 CA-C-O 120.956 0.315 . . . . 1.0 112.025 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.76 144.44 85.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.956 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.64 148.51 53.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.797 1.665 . . . . 1.0 111.841 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.18 -43.15 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.563 . . . . 1.0 111.109 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.5 -36.64 47.79 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.76 151.12 47.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 1.0 110.825 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -118.15 83.57 20.12 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.326 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.56 125.04 16.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.262 1.975 . . . . 1.0 112.431 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.7 mt -101.1 -32.66 10.47 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.428 -0.805 . . . . 1.0 109.632 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.48 151.19 29.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.326 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -146.33 129.17 16.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.859 0.361 . . . . 1.0 110.556 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -141.43 163.15 20.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.259 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -101.37 122.43 43.72 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -131.54 152.11 19.96 Favored Glycine 0 N--CA 1.464 0.555 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 mmm -99.19 100.66 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.999 0.428 . . . . 1.0 110.187 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.84 126.8 28.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.589 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.441 ' SD ' ' C ' ' A' ' 101' ' ' PHE . 1.6 mpp? -109.85 137.16 48.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.03 149.79 50.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.635 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.28 -66.23 0.3 Allowed Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.915 -0.584 . . . . 1.0 112.633 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.49 -33.28 88.15 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.796 2.331 . . . . 1.0 113.484 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -177.79 -172.51 0.35 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.672 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -122.67 168.87 11.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.047 0.451 . . . . 1.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -154.12 140.87 13.12 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.723 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.22 142.0 84.71 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.267 1.312 . . . . 1.0 111.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' GLY . 13.6 p -150.95 169.23 22.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.551 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.18 118.94 19.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 109.852 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 101' ' ' PHE . 13.2 mt -91.92 126.3 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.012 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.6 m -130.81 120.69 24.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.095 0.474 . . . . 1.0 111.344 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.523 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.6 tp -90.38 130.99 36.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.07 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.81 148.17 32.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.173 0.511 . . . . 1.0 111.362 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.72 127.01 48.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -138.0 138.15 38.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.887 0.375 . . . . 1.0 111.007 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.44 35.22 24.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.662 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.56 27.56 73.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.7 158.95 43.28 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -99.27 130.34 45.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.908 -0.405 . . . . 1.0 109.908 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.27 143.77 34.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.931 0.396 . . . . 1.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.4 125.21 50.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.275 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -103.31 124.6 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mt -99.25 128.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' C ' HD12 ' A' ' 50' ' ' LEU . 14.2 mm100 -118.4 119.62 35.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.691 0.282 . . . . 1.0 110.807 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -100.58 131.18 46.63 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.572 ' HD1' ' CD2' ' A' ' 56' ' ' HIS . 95.4 m-70 -94.29 60.53 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 1.0 110.413 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.24 157.6 10.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.183 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.15 -38.74 87.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.754 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 54' ' ' GLU . 56.6 mp0 -78.96 -104.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.226 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -106.52 152.49 23.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.572 ' CD2' ' HD1' ' A' ' 51' ' ' HIS . 60.7 m80 -73.3 145.77 45.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.233 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.76 130.7 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.983 0.42 . . . . 1.0 110.303 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -106.53 108.08 19.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.788 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -116.74 113.05 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.633 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.41 115.64 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.387 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.05 120.18 39.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.38 147.89 33.15 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.791 1.661 . . . . 1.0 112.498 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.513 ' CG2' HE22 ' A' ' 123' ' ' GLN . 96.4 mt -92.8 122.49 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.228 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.6 p30 -174.16 -159.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.353 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -41.25 90.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.2 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -66.06 -36.28 82.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.353 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . 15.1 t80 -101.54 123.63 45.88 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -133.81 141.08 47.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.326 0.584 . . . . 1.0 111.026 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.0 t -103.31 105.87 16.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.245 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 70' ' ' VAL . 5.9 m -111.07 126.4 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.229 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.408 ' OE1' ' O ' ' A' ' 83' ' ' SER . 48.1 tt0 -97.49 131.1 44.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.492 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.374 -179.589 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.659 ' HB3' HD12 ' A' ' 113' ' ' LEU . 94.8 m-20 . . . . . 0 N--CA 1.463 0.225 0 CA-C-O 121.034 0.445 . . . . 1.0 110.396 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 41.0 mm -64.58 -42.26 94.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.68 -27.02 15.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.815 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 9.5 t -123.81 119.1 28.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.043 0.449 . . . . 1.0 110.314 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 83' ' ' SER . 23.4 m120 -146.73 -167.0 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 1.0 109.827 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.24 92.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.05 67.18 2.18 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 108.892 -1.683 . . . . 1.0 108.892 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 148.95 25.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.221 0.534 . . . . 1.0 111.596 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HE2' HH21 ' A' ' 90' ' ' ARG . 25.2 pttm -129.85 135.83 48.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.335 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.33 162.89 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.306 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.418 HH21 ' HE2' ' A' ' 88' ' ' LYS . 3.4 mpt_? -123.99 137.52 54.59 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.8 t -116.92 133.84 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.922 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -140.77 152.77 45.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.115 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.551 0 N-CA-C 110.552 -1.019 . . . . 1.0 110.552 179.824 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.833 0.349 . . . . 1.0 110.946 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -63.46 140.3 58.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -141.03 154.19 45.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.153 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -125.52 154.18 42.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.979 0.419 . . . . 1.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.441 ' C ' ' SD ' ' A' ' 25' ' ' MET . 98.5 m-85 -138.33 158.7 43.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.769 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -144.72 123.45 12.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mm -110.45 96.62 28.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.15 -14.55 28.8 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.536 1.491 . . . . 1.0 112.674 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -94.32 113.66 25.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.974 0.416 . . . . 1.0 110.002 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.03 -55.09 39.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.231 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -52.06 -43.34 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.654 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -68.2 -38.55 82.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.914 0.388 . . . . 1.0 110.131 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.232 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.4 -45.39 91.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.644 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -66.3 -45.41 80.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.974 -0.69 . . . . 1.0 110.703 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.46 -49.61 76.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.284 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 80' ' ' ASP . 3.4 mm? -65.44 -42.56 92.26 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.382 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -63.83 -45.14 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.735 0.303 . . . . 1.0 111.478 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.523 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -64.93 -50.83 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.441 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.68 -46.37 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.03 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.01 -48.02 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 1.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.99 78.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.548 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.424 ' C ' HE21 ' A' ' 123' ' ' GLN . . . -60.98 -40.24 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.553 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.51 -44.8 85.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -66.21 -43.43 86.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.504 0.668 . . . . 1.0 110.488 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.32 78.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.904 -1.044 . . . . 1.0 111.998 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.513 HE22 ' CG2' ' A' ' 63' ' ' ILE . 6.3 pt20 -72.2 -38.32 69.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.48 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.062 -0.971 . . . . 1.0 110.567 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo . . . . . 0 N--CA 1.497 1.712 0 CA-C-O 120.886 0.286 . . . . 1.0 111.969 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 10' ' ' LEU . 3.9 mp -66.79 149.15 98.53 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.99 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.05 143.9 91.63 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.67 1.58 . . . . 1.0 111.429 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.88 -43.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.178 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.4 51.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.39 137.78 44.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.059 0.457 . . . . 1.0 111.025 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -98.95 108.6 50.11 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.57 103.87 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.532 1.488 . . . . 1.0 112.789 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.88 -43.6 83.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.191 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.21 148.95 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.216 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -138.34 131.36 29.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.765 0.317 . . . . 1.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.21 160.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.158 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 34' ' ' ALA . 41.8 tp10 -100.1 122.67 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 33' ' ' CYS . . . -132.26 158.16 22.82 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 84.1 mmm -99.37 120.88 40.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.887 0.375 . . . . 1.0 110.203 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.85 118.24 24.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.693 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -102.65 137.21 41.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.07 152.86 52.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.266 -0.425 . . . . 1.0 109.982 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.38 -66.48 0.36 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.894 -0.593 . . . . 1.0 112.506 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.22 -32.92 73.34 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.747 2.298 . . . . 1.0 113.877 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.29 -170.3 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 121.105 -0.238 . . . . 1.0 110.385 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -124.71 169.28 12.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.962 0.41 . . . . 1.0 110.25 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 9.3 pt-20 -153.57 133.19 7.33 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.797 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.29 142.56 78.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 CA-C-N 120.245 1.123 . . . . 1.0 111.34 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 22' ' ' GLY . 8.9 p -152.1 -170.18 3.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.526 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.472 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -156.8 131.3 8.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.293 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -100.84 123.16 44.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.088 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.4 m -126.34 112.33 15.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.298 0.57 . . . . 1.0 111.723 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.679 HD23 ' HB1' ' A' ' 115' ' ' ALA . 55.4 tp -80.47 127.75 32.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.378 -0.828 . . . . 1.0 109.086 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.06 148.28 36.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.441 . . . . 1.0 111.445 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -102.42 128.99 48.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.901 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -139.9 136.97 34.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.931 0.396 . . . . 1.0 110.872 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 m120 59.18 33.78 22.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.513 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.93 22.56 78.38 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.677 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 48.4 tp60 -132.58 157.13 45.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.677 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 81.0 m-85 -96.3 131.84 42.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -144.06 143.88 31.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 1.0 110.404 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.1 tp -104.2 124.96 50.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.257 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 ' NE2' ' A' ' 58' ' ' GLN . 80.8 mt -100.12 124.81 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.118 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.9 mt -96.53 117.54 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.3 mt-30 -109.15 130.58 55.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.7 mp -104.94 127.76 52.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 76.2 t60 -93.8 25.39 3.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.9 mt-10 -55.02 137.55 46.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.45 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -62.72 -39.7 94.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.26 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -53.47 -51.18 63.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.913 0.387 . . . . 1.0 110.18 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -166.72 148.21 6.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.767 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.03 86.8 6.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.869 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 t -80.81 133.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.539 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.432 ' NE2' HG21 ' A' ' 47' ' ' ILE . 50.6 tt0 -128.29 119.28 24.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.744 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.37 129.64 55.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -96.41 114.66 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.775 0.321 . . . . 1.0 110.273 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.03 121.37 35.32 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.18 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 155.48 42.57 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.987 1.792 . . . . 1.0 112.628 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' CG ' ' A' ' 64' ' ' ASN . 98.0 mt -98.13 112.79 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.373 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 78.6 m-20 -161.68 -160.67 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.6 t -60.35 -41.94 94.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -66.17 -36.75 83.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.021 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 19.2 t80 -93.03 124.09 36.76 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.823 0.344 . . . . 1.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.49 141.75 45.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.289 0.566 . . . . 1.0 110.769 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 69' ' ' CYS . 26.6 p -113.46 99.7 7.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.222 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -109.45 128.46 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.448 . . . . 1.0 111.049 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.661 HE21 ' N ' ' A' ' 88' ' ' LYS . 34.1 tp60 -80.77 116.86 20.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' GLN . 17.7 pt-20 . . . . . 0 N--CA 1.469 0.492 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.645 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.181 0.515 . . . . 1.0 110.077 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.65 -42.61 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.693 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.82 -26.01 44.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.126 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.53 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 5.7 t -104.28 102.61 12.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 83' ' ' SER . 9.8 m120 -136.27 -168.94 2.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.994 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.403 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 2.3 m 62.13 82.58 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.17 77.35 0.26 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 132.64 37.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.798 0.332 . . . . 1.0 111.751 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.661 ' N ' HE21 ' A' ' 71' ' ' GLN . 98.8 mttt -110.22 129.49 55.71 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.404 HD13 ' HE2' ' A' ' 112' ' ' PHE . 48.5 pt -126.83 160.15 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -130.52 133.96 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.482 . . . . 1.0 109.849 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.2 t -114.54 134.55 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.418 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.43 154.96 41.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.327 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.828 0.347 . . . . 1.0 110.879 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -59.66 137.63 57.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.468 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.43 154.53 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.082 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -124.74 150.97 45.66 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.185 0.517 . . . . 1.0 111.394 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -143.83 156.86 44.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.43 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -148.56 118.67 7.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.048 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.62 99.8 12.55 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.83 -11.82 28.03 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.542 1.495 . . . . 1.0 112.887 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -91.42 106.19 18.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 85' ' ' SER . 80.3 tt0 -59.98 -52.91 63.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.091 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -52.24 -43.83 64.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.406 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.47 -38.96 77.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.0 110.564 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -35.22 71.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.024 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -45.33 93.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.306 -0.558 . . . . 1.0 111.148 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.77 -43.22 84.6 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.787 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.404 ' HE2' HD13 ' A' ' 89' ' ' ILE . 51.8 t80 -61.1 -49.39 77.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.077 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 113' ' ' LEU . 95.8 mt -66.24 -42.02 89.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.472 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 m -63.12 -45.38 92.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 1.0 111.317 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.679 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -66.55 -49.03 67.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.33 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.46 -45.65 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.977 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -60.98 -45.1 96.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.034 0.445 . . . . 1.0 110.148 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.22 -37.76 86.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.459 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.18 -49.99 73.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.679 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.503 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 92.3 mt-30 -70.69 -38.07 73.68 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.227 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.72 -43.09 94.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.007 0.432 . . . . 1.0 110.517 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.6 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.33 -35.82 68.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 1.0 110.752 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.019 -0.991 . . . . 1.0 110.476 -179.905 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 N--CA 1.497 1.722 0 CA-C-O 121.012 0.338 . . . . 1.0 111.986 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.38 84.01 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.774 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.603 ' CD ' HE22 ' A' ' 58' ' ' GLN . 24.4 Cg_endo -59.51 140.48 94.22 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.857 1.705 . . . . 1.0 111.542 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.89 -43.79 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.215 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -37.34 -38.88 0.44 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.38 -0.688 . . . . 1.0 111.38 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.28 147.95 41.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.722 0.296 . . . . 1.0 110.538 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -98.2 102.43 14.01 Favored Pre-proline 0 C--O 1.223 -0.338 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -75.28 103.14 1.68 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.5 1.467 . . . . 1.0 113.522 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.1 mt -67.12 -41.84 85.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.178 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 155.31 40.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.259 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -143.49 130.64 20.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.42 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 21' ' ' GLU . 47.9 t -141.31 159.08 22.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.698 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 20' ' ' VAL . 83.0 tt0 -104.55 121.13 42.86 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -123.56 -169.51 13.22 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.837 -0.905 . . . . 1.0 110.837 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 89.3 mmm -136.94 101.47 4.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.87 0.367 . . . . 1.0 110.037 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.578 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.0 tt0 -61.05 128.8 38.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.609 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -106.01 136.38 45.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.312 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -135.64 151.91 50.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.72 -68.15 0.29 Allowed Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.74 -0.664 . . . . 1.0 112.605 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.93 -32.47 92.54 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.864 2.376 . . . . 1.0 113.553 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.546 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -179.85 -167.01 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.344 -0.243 . . . . 1.0 110.344 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -122.46 168.5 12.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.888 0.375 . . . . 1.0 110.201 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -146.21 138.73 13.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.653 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.34 139.63 73.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 CA-C-N 120.171 1.097 . . . . 1.0 111.418 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.578 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 17.2 p -153.65 177.68 10.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -147.56 138.72 23.63 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.905 0.383 . . . . 1.0 110.122 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 35' ' ' LEU . 5.5 mp -102.62 120.57 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 1.0 109.999 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -127.31 113.17 15.92 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.28 0.562 . . . . 1.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.647 HD23 ' HB1' ' A' ' 115' ' ' ALA . 45.5 tp -86.48 127.51 34.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.434 -0.803 . . . . 1.0 108.975 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.94 156.56 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.16 0.505 . . . . 1.0 111.484 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -113.87 122.65 47.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.608 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -133.32 137.89 46.15 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.886 0.374 . . . . 1.0 110.919 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 59.13 34.17 23.18 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.606 -0.725 . . . . 1.0 111.513 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.77 25.34 75.22 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.771 -0.931 . . . . 1.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -134.09 153.33 51.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -93.53 134.9 35.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.02 143.79 31.35 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.963 0.411 . . . . 1.0 110.264 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.0 tp -103.46 116.56 32.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.356 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.8 mt -109.69 115.78 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 101' ' ' PHE . 60.2 mt -106.57 116.9 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' C ' HD12 ' A' ' 50' ' ' LEU . 11.7 mm100 -81.27 128.43 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.705 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.4 mp -110.4 130.26 55.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.615 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.623 ' ND1' ' N ' ' A' ' 51' ' ' HIS . 0.9 OUTLIER -94.53 54.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.218 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -46.61 150.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.55 -39.97 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.33 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -62.95 -46.13 89.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.133 0.492 . . . . 1.0 110.488 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -168.9 -158.98 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.796 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.01 115.11 28.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.893 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.76 138.13 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.169 0.509 . . . . 1.0 110.499 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.681 HE21 HD11 ' A' ' 60' ' ' ILE . 17.3 pt20 -97.56 141.42 30.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -102.06 115.18 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.738 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.681 HD11 HE21 ' A' ' 58' ' ' GLN . 51.8 mm -92.82 101.42 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.923 0.392 . . . . 1.0 110.092 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.8 mm -117.63 90.21 34.96 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.143 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.14 146.48 88.04 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 1.0 112.407 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 96.6 mt -93.28 115.43 32.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.46 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 80.7 m-20 -163.58 -166.75 1.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.177 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -33.24 74.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.223 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -76.2 -12.48 60.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.743 0.306 . . . . 1.0 111.17 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.46 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 32.9 t80 -114.06 130.05 56.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.052 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.68 145.08 44.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.4 t -121.55 106.04 11.01 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.399 -0.818 . . . . 1.0 109.2 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 70' ' ' VAL . 5.8 m -107.36 125.37 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.729 0.3 . . . . 1.0 110.762 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.468 HE22 ' N ' ' A' ' 88' ' ' LYS . 9.3 tp-100 -99.1 115.88 30.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.339 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.7 179.778 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.925 0.393 . . . . 1.0 109.955 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.503 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 95.8 mt -64.04 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.67 -24.92 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.945 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 m -102.6 59.54 0.8 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.844 0.354 . . . . 1.0 110.429 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.7 m120 -82.65 -171.63 3.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.145 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 m 66.69 87.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.04 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.12 79.04 0.11 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 139.8 30.84 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.921 0.391 . . . . 1.0 111.754 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' N ' HE22 ' A' ' 71' ' ' GLN . 22.3 pttp -126.83 134.14 50.6 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.3 pt -126.18 161.24 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.231 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.95 138.14 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.697 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -117.46 133.96 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.448 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -136.91 134.65 37.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.046 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.673 0.273 . . . . 1.0 110.468 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -174.75 126.22 0.29 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.438 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -137.76 123.66 20.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -89.98 151.15 21.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.925 0.393 . . . . 1.0 111.24 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 48' ' ' ILE . 67.6 m-85 -136.53 148.62 47.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.26 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.95 144.32 45.36 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 1.0 110.753 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 35' ' ' LEU . 6.2 mm -129.41 90.37 44.6 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.27 -17.82 44.76 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 1.0 112.762 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -88.88 108.67 19.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.69 -0.485 . . . . 1.0 109.69 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.8 tt0 -64.91 -53.18 50.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.068 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -53.18 -40.9 64.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.664 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -73.0 -35.88 66.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 1.0 110.396 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.9 t -60.73 -34.24 74.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.901 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.8 -44.79 95.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.425 -0.51 . . . . 1.0 111.352 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.84 -43.67 83.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.969 -0.692 . . . . 1.0 110.189 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.428 ' CZ ' HD23 ' A' ' 35' ' ' LEU . 42.3 t80 -60.22 -49.03 79.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.353 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -65.89 -41.62 91.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.269 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.3 t -63.31 -44.74 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.235 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.87 -50.32 64.94 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.359 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.21 -44.15 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.26 -45.75 92.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 1.0 110.225 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.14 86.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.549 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.7 79.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.809 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.29 -37.62 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 1.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -60.37 -44.51 95.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.029 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.59 94.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.49 -40.2 92.79 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.792 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.222 -0.386 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.386 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.498 1.74 0 CA-C-O 120.784 0.244 . . . . 1.0 111.989 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.439 ' HA ' HE22 ' A' ' 58' ' ' GLN . 15.7 mt -70.2 135.41 86.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.064 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.431 ' HD3' HE22 ' A' ' 58' ' ' GLN . 50.7 Cg_endo -68.91 147.58 68.61 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.686 1.59 . . . . 1.0 111.68 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -70.02 -32.39 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.156 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.23 94.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.56 141.83 44.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 1.0 110.778 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.555 HE21 ' NE2' ' A' ' 39' ' ' GLN . 10.3 mt-30 -101.67 100.34 14.03 Favored Pre-proline 0 C--O 1.224 -0.283 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.38 103.15 1.69 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.523 1.482 . . . . 1.0 112.83 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.76 -43.34 89.18 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.131 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.87 151.65 37.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.237 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -141.42 128.08 20.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.452 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 21' ' ' GLU . 53.3 t -141.59 160.7 21.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.926 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 55.7 mp0 -103.55 121.96 43.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -124.99 -173.37 13.69 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 25' ' ' MET . 90.7 mmm -131.26 107.31 8.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 1.0 110.125 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 99' ' ' ARG . 84.8 tt0 -76.19 126.48 31.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.644 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 25' ' ' MET . 0.9 OUTLIER -116.04 139.82 49.89 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.634 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.68 150.4 50.62 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 1.0 109.865 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.9 -65.6 0.47 Allowed Glycine 0 CA--C 1.533 1.188 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.665 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.52 -32.36 88.05 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 122.732 2.288 . . . . 1.0 113.786 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.482 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -176.78 -179.56 0.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 121.032 -0.267 . . . . 1.0 110.465 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -125.14 169.21 12.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.053 0.454 . . . . 1.0 110.787 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -157.92 143.43 12.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.426 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.64 144.23 93.82 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.264 1.309 . . . . 1.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.5 p -149.14 173.67 13.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.403 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' C ' HD22 ' A' ' 35' ' ' LEU . . . -134.7 129.1 34.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.01 0.433 . . . . 1.0 110.182 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' N ' HD22 ' A' ' 35' ' ' LEU . 3.8 mm? -97.4 118.21 33.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -129.84 113.82 15.15 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.166 0.507 . . . . 1.0 111.56 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD23 ' HB1' ' A' ' 115' ' ' ALA . 47.4 tp -85.98 129.8 34.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.464 -0.789 . . . . 1.0 109.047 178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.12 156.96 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.999 0.428 . . . . 1.0 111.283 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.555 ' NE2' HE21 ' A' ' 15' ' ' GLN . 1.2 tm0? -119.47 119.62 34.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -127.31 137.19 52.76 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.977 0.418 . . . . 1.0 110.913 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 58.86 32.38 22.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.498 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.21 18.45 78.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.655 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 41.3 tp60 -125.51 140.44 52.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.113 -0.328 . . . . 1.0 110.113 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.655 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 69.9 m-85 -80.27 135.72 36.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.51 140.28 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.355 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.5 tp -104.34 126.13 51.18 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.311 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.8 mt -104.37 121.18 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.983 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.7 115.45 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' C ' HD12 ' A' ' 50' ' ' LEU . 80.1 mt-30 -105.65 130.94 53.57 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.879 0.371 . . . . 1.0 110.931 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.605 HD21 ' NH2' ' A' ' 99' ' ' ARG . 10.9 mp -106.16 128.41 53.89 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.407 ' HD1' ' CE1' ' A' ' 56' ' ' HIS . 99.6 m-70 -90.13 62.5 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.331 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 55' ' ' GLN . 97.9 mt-10 -60.85 146.22 47.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.36 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.52 -39.55 93.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.086 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -63.23 -41.07 99.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' GLU . 15.8 pt20 -172.39 -156.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.407 ' CE1' ' HD1' ' A' ' 51' ' ' HIS . 97.9 m-70 -127.34 127.97 45.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.975 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.79 130.69 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.171 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.439 HE22 ' HA ' ' A' ' 10' ' ' LEU . 50.7 tt0 -102.58 116.26 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.987 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -102.05 113.26 26.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.521 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -94.61 111.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 1.0 110.524 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mm -113.68 120.29 39.67 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.089 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.6 148.1 36.75 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.792 1.661 . . . . 1.0 112.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.0 mt -92.58 122.97 44.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.444 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -172.22 -160.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.266 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.507 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 78.0 p -61.53 -40.01 93.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -68.51 -32.51 72.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.682 0.277 . . . . 1.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.8 t80 -95.4 126.14 40.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.044 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 65' ' ' SER . 84.4 mtt85 -137.75 145.91 43.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.2 0.524 . . . . 1.0 110.874 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.2 t -122.33 117.89 27.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.064 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 70' ' ' VAL . 4.8 m -118.36 125.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.756 0.312 . . . . 1.0 110.462 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.1 tp-100 -83.68 123.78 30.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.441 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.96 -179.988 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 120.928 0.394 . . . . 1.0 110.039 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 83' ' ' SER . 93.8 mt -64.23 -43.18 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.691 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.0 -11.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.156 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.533 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 30.7 t -133.18 135.15 44.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.009 0.433 . . . . 1.0 110.157 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.7 m120 -146.25 -176.76 5.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.911 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t 72.04 89.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.24 80.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -93.74 133.61 36.93 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -177.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.1 mttt -109.95 113.21 25.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.463 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 2.1 pp -117.51 128.81 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -103.39 146.16 28.9 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.46 133.7 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.897 0.379 . . . . 1.0 110.639 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -136.19 137.95 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.182 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.722 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.432 ' CG ' ' N ' ' A' ' 98' ' ' GLU . 35.8 ptt-85 . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.486 0.184 . . . . 1.0 110.753 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' ARG . 48.5 tp10 -175.04 121.45 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.874 0.368 . . . . 1.0 110.228 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.605 ' NH2' HD21 ' A' ' 50' ' ' LEU . 81.0 mtp180 -138.08 124.35 20.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -87.76 149.2 24.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.933 0.396 . . . . 1.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -141.08 148.28 39.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.286 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -144.31 134.44 24.19 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.369 . . . . 1.0 111.074 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.68 99.72 48.52 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 -13.05 31.08 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.504 1.469 . . . . 1.0 112.768 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -90.72 103.04 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -53.51 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 1.0 112.207 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -53.04 -43.77 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.549 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -69.56 -36.68 76.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.908 0.385 . . . . 1.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 113' ' ' LEU . 1.4 t -60.13 -36.2 76.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.855 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.0 mt -62.53 -44.31 96.66 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.103 -0.639 . . . . 1.0 111.28 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.11 -45.98 75.57 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.749 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.99 -49.01 76.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.818 . . . . 1.0 111.567 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 87' ' ' CYS . 96.7 mt -65.77 -41.36 92.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.221 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.3 -45.89 75.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.306 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.09 -46.84 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.768 0.318 . . . . 1.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -43.46 98.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.474 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.63 88.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.94 -49.22 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.622 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -69.68 -38.41 77.01 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.189 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.997 0.427 . . . . 1.0 110.624 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.21 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.624 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -72.88 -40.24 65.76 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.844 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.665 179.897 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo . . . . . 0 N--CA 1.499 1.815 0 CA-C-O 120.984 0.327 . . . . 1.0 112.134 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.424 ' HA ' HE22 ' A' ' 58' ' ' GLN . 16.5 mt -66.51 144.38 98.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.834 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HD3' HE22 ' A' ' 58' ' ' GLN . 41.7 Cg_endo -66.69 142.43 63.92 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.711 1.608 . . . . 1.0 111.464 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 p -72.16 -32.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.275 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.31 93.75 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.01 144.58 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 1.0 111.101 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.37 107.15 33.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.58 102.81 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.457 1.438 . . . . 1.0 112.757 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.03 -43.82 86.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.102 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 154.13 35.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.273 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -142.81 132.5 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 1.0 110.529 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.4 p -142.0 152.3 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.043 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -107.84 121.9 45.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.747 -0.66 . . . . 1.0 109.317 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.21 -158.76 9.67 Favored Glycine 0 N--CA 1.462 0.4 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -131.14 131.2 43.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.066 0.46 . . . . 1.0 110.658 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.566 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 25.9 tp10 -91.68 126.53 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.4 mtm -113.67 135.63 53.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.633 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -141.48 149.27 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.237 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -36.39 -64.91 0.56 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 115.745 -0.662 . . . . 1.0 112.762 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.18 -32.79 94.98 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.885 2.39 . . . . 1.0 113.973 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.531 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 178.97 177.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 121.163 -0.215 . . . . 1.0 110.645 179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -122.05 169.23 11.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.05 0.452 . . . . 1.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.32 144.24 9.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.38 146.77 81.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.091 1.068 . . . . 1.0 111.412 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 31.8 p -153.16 -178.22 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.526 -0.307 . . . . 1.0 110.4 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.04 145.18 24.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.643 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.546 ' CD1' HD11 ' A' ' 89' ' ' ILE . 44.6 mt -115.2 116.45 28.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.277 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -121.56 114.58 21.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.32 0.581 . . . . 1.0 111.559 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.733 HD23 ' HB1' ' A' ' 115' ' ' ALA . 52.5 tp -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.308 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.18 149.64 41.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.066 0.46 . . . . 1.0 111.393 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -104.07 128.38 51.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.665 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -140.62 137.06 33.35 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.749 -0.381 . . . . 1.0 110.895 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 58.79 33.02 22.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.695 -0.684 . . . . 1.0 111.591 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.95 77.09 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.666 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 46.5 tp60 -132.34 157.57 44.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.666 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 86.8 m-85 -99.16 134.43 42.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.043 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -146.22 141.9 27.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.845 0.355 . . . . 1.0 110.336 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.7 tp -104.86 125.05 50.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.631 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.3 mt -98.95 121.71 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.9 mt -107.21 124.76 63.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' C ' HD12 ' A' ' 50' ' ' LEU . 74.0 mt-30 -114.88 122.76 47.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.963 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 49' ' ' GLN . 9.9 mp -105.15 128.37 53.35 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.23 45.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.21 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 50' ' ' LEU . 39.6 tp10 -41.77 146.52 0.25 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.403 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -61.6 -39.28 90.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.292 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -59.0 -47.6 84.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.965 0.412 . . . . 1.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -174.4 -162.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.422 ' NE2' ' NE2' ' A' ' 49' ' ' GLN . 54.5 t60 -97.19 81.47 3.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.061 0.458 . . . . 1.0 109.834 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.77 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.528 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.424 HE22 ' HA ' ' A' ' 10' ' ' LEU . 52.4 tt0 -108.64 116.97 32.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -100.45 132.58 45.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.95 110.85 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.814 0.34 . . . . 1.0 110.139 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -115.09 108.73 47.75 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.238 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 151.23 38.21 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.639 1.559 . . . . 1.0 112.571 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.428 HG23 HE21 ' A' ' 120' ' ' GLN . 98.1 mt -95.08 124.33 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.731 HD21 ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -172.04 -150.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 1.0 109.847 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -72.37 -39.93 67.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 1.0 112.083 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.731 ' CG ' HD21 ' A' ' 64' ' ' ASN . 2.4 p80 -74.61 -16.85 60.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.788 0.328 . . . . 1.0 111.318 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.429 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 61.1 t80 -102.46 123.72 46.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.87 142.51 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.323 0.583 . . . . 1.0 110.853 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 89' ' ' ILE . 4.8 t -125.33 106.67 10.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.212 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.59 129.63 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.053 0.454 . . . . 1.0 111.381 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.0 tp-100 -80.38 100.58 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.471 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.476 179.813 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.961 0.41 . . . . 1.0 110.271 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.88 -42.62 96.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.678 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.79 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.085 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 11.7 t -109.58 119.8 40.52 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 83' ' ' SER . 13.0 m120 -148.02 -175.19 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.078 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.75 88.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.64 71.78 0.79 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.47 139.29 30.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.952 0.406 . . . . 1.0 111.675 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 52.1 mtpt -116.73 129.33 56.05 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.591 HD12 ' SG ' ' A' ' 69' ' ' CYS . 39.7 pt -125.31 160.14 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -130.23 143.03 50.54 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.913 0.387 . . . . 1.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.11 133.25 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.908 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.74 152.47 42.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.745 0.307 . . . . 1.0 110.652 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -57.25 135.22 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 1.0 110.778 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.71 136.52 40.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.488 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 77.4 mtp180 -106.71 139.5 41.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.225 0.536 . . . . 1.0 110.944 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 85.1 m-85 -133.92 152.1 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.198 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.99 127.03 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.907 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.79 89.47 7.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.21 -15.65 35.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.787 1.658 . . . . 1.0 112.777 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.32 106.64 18.63 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -60.81 -53.43 57.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.028 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -52.94 -43.74 66.54 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.628 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.425 ' HB3' HG23 ' A' ' 20' ' ' VAL . 59.1 m170 -68.57 -36.74 79.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.484 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -63.3 -34.59 78.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.787 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.37 -46.25 89.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.387 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.63 -42.98 81.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.66 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' HD13 ' A' ' 89' ' ' ILE . 46.2 t80 -61.82 -49.05 77.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.104 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.7 -41.57 95.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.474 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -44.5 93.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.903 0.382 . . . . 1.0 111.164 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.733 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.9 -48.04 72.8 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.251 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 112' ' ' PHE . 73.0 t -65.67 -42.22 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.828 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.49 -44.66 89.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.997 0.427 . . . . 1.0 110.077 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.69 91.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.435 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.814 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.428 HE21 HG23 ' A' ' 63' ' ' ILE . 59.2 mm-40 -67.88 -39.83 83.62 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.021 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.76 -45.32 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.029 0.442 . . . . 1.0 110.1 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -67.99 -39.67 83.22 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.722 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.454 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 N--CA 1.496 1.667 0 CA-C-O 120.855 0.273 . . . . 1.0 111.925 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.404 ' HA ' HE22 ' A' ' 58' ' ' GLN . 8.4 mp -64.39 166.37 11.34 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.94 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.56 148.39 92.45 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.642 1.561 . . . . 1.0 111.561 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.12 -45.05 95.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.15 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.4 -29.97 76.55 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.231 -0.747 . . . . 1.0 111.231 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.76 58.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 1.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -109.4 108.36 59.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 128.13 11.08 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.643 1.562 . . . . 1.0 112.765 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -100.86 -38.85 8.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.713 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.62 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.105 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -143.34 137.73 28.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.794 0.331 . . . . 1.0 110.512 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.7 p -140.6 146.92 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.981 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -108.76 122.16 46.57 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -140.32 -158.06 7.44 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 16.7 mmm -127.97 129.06 46.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.909 0.385 . . . . 1.0 110.432 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.63 118.77 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.24 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.1 mtm -97.8 136.22 38.45 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.508 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.24 151.84 51.5 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.19 -64.93 0.45 Allowed Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.954 -0.567 . . . . 1.0 112.704 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.35 -34.05 56.44 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.725 2.283 . . . . 1.0 113.746 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -175.75 -173.41 0.6 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.321 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -121.29 168.36 11.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.9 0.381 . . . . 1.0 110.465 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.13 141.35 13.47 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.742 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.97 145.44 74.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 CA-C-N 120.221 1.115 . . . . 1.0 111.52 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 22' ' ' GLY . 11.5 p -158.97 -176.24 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.608 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.76 134.48 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.182 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 20' ' ' VAL . 51.8 mt -104.18 128.08 51.84 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.003 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -125.02 123.26 39.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.246 0.546 . . . . 1.0 111.522 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.567 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.1 tp -89.42 127.18 35.8 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.236 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.79 150.11 39.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.133 0.492 . . . . 1.0 111.434 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -106.0 123.88 48.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -134.47 131.27 37.88 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 1.0 110.742 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 m120 61.09 34.6 19.04 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.684 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.35 75.81 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -134.77 149.6 50.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -94.67 134.09 37.63 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.59 147.67 34.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.874 0.369 . . . . 1.0 110.432 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.4 tt -108.4 120.54 42.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.068 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.654 ' N ' HD23 ' A' ' 46' ' ' LEU . 85.8 mt -99.07 128.04 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -95.05 119.78 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' C ' HD12 ' A' ' 50' ' ' LEU . 75.9 mt-30 -107.54 129.95 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.033 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.4 mp -109.5 136.34 49.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -95.45 20.18 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.113 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -48.28 138.32 9.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.271 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -63.19 -38.62 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.414 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.87 -52.17 65.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 1.0 110.31 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -172.32 155.14 3.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -82.92 102.64 11.82 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 1.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.57 134.2 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.404 HE22 ' HA ' ' A' ' 10' ' ' LEU . 57.3 tt0 -122.16 108.22 13.06 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.658 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -101.51 125.67 48.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.647 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mm -92.39 105.96 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.09 108.29 48.47 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.044 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.27 145.11 34.06 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.658 1.572 . . . . 1.0 112.449 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.5 123.63 38.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -174.9 -162.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 -40.48 86.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.143 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -65.52 -39.81 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.02 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.77 122.56 35.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.206 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -140.31 111.42 7.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.235 0.541 . . . . 1.0 110.927 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.8 p -102.54 111.61 23.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.033 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -116.0 129.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.98 0.419 . . . . 1.0 110.76 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.684 HE22 ' ND2' ' A' ' 84' ' ' ASN . 50.9 tt0 -75.28 120.45 20.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.852 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.889 0.375 . . . . 1.0 110.081 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.8 mm -113.94 -37.08 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.449 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -47.35 82.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.889 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 t -140.12 139.77 35.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.874 0.369 . . . . 1.0 110.519 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.684 ' ND2' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -158.15 36.99 0.25 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.525 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -83.95 112.8 20.49 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 48.32 82.5 0.03 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.212 -1.555 . . . . 1.0 109.212 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.51 ' CB ' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -115.2 150.25 36.4 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.221 0.534 . . . . 1.0 111.573 -177.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 151.47 33.56 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.51 169.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -139.21 126.1 20.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.027 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 130.69 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -152.63 153.33 33.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.11 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.612 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.865 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.815 0.341 . . . . 1.0 110.807 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 90' ' ' ARG . 80.6 tt0 -60.46 131.44 50.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.0 110.649 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -137.64 135.41 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.572 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -129.61 149.94 51.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.031 0.444 . . . . 1.0 111.601 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -144.71 161.03 40.22 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.333 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -145.26 139.64 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.919 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 20' ' ' VAL . 4.3 mp -125.28 101.08 31.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.04 -12.04 21.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.605 1.537 . . . . 1.0 112.618 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.61 111.53 23.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.34 -51.25 70.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.611 0.597 . . . . 1.0 112.611 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -55.13 -38.95 68.89 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.424 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.564 ' HB3' HG23 ' A' ' 20' ' ' VAL . 66.7 m170 -77.45 -33.8 54.67 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.74 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -53.98 52.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.373 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.55 -39.47 94.48 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.908 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.14 -44.81 91.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.661 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.59 -52.84 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.868 -0.605 . . . . 1.0 111.318 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.586 ' CD1' ' NE2' ' A' ' 71' ' ' GLN . 30.4 mt -66.54 -40.75 89.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.2 t -62.5 -44.34 96.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.678 0.275 . . . . 1.0 111.42 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.81 -49.66 61.09 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.531 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.25 -43.63 91.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.117 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.33 -46.75 88.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.889 0.376 . . . . 1.0 110.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.2 -29.85 70.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.49 92.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.09 -43.16 99.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.819 0.342 . . . . 1.0 111.626 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.77 -43.56 98.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.521 0.677 . . . . 1.0 109.916 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.8 87.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.859 -1.064 . . . . 1.0 111.21 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -65.63 -43.55 89.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.676 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.043 -0.979 . . . . 1.0 110.608 179.915 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 N--CA 1.497 1.708 0 CA-C-O 120.824 0.26 . . . . 1.0 111.986 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HA ' HE22 ' A' ' 58' ' ' GLN . 16.0 mt -60.78 140.75 93.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.001 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD3' HE22 ' A' ' 58' ' ' GLN . 39.7 Cg_endo -65.93 144.66 77.51 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.765 1.643 . . . . 1.0 111.587 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.06 -43.01 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.071 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.99 -37.67 45.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.161 -0.775 . . . . 1.0 111.161 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 143.98 56.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 1.0 110.962 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.38 79.9 0.42 Allowed Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 108.882 -0.784 . . . . 1.0 108.882 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.7 96.45 0.14 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.819 1.679 . . . . 1.0 113.157 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.69 -41.92 91.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.269 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.15 40.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.107 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -140.08 131.94 27.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.557 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.4 m -139.37 159.17 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.255 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -113.56 121.86 45.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.0 178.6 17.83 Favored Glycine 0 N--CA 1.463 0.47 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.8 mtp -118.18 102.89 9.35 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.798 0.332 . . . . 1.0 110.477 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.39 122.45 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.476 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 76.8 mtm -105.47 137.58 43.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.487 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.74 151.24 50.82 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.39 -67.2 0.26 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.846 -0.616 . . . . 1.0 112.709 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.12 -32.98 83.37 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.781 2.321 . . . . 1.0 113.401 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.8 -172.3 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.626 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -125.18 169.13 12.53 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.184 0.516 . . . . 1.0 110.521 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -152.85 144.38 16.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.05 142.19 91.58 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.365 1.376 . . . . 1.0 111.146 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.7 p -154.18 -174.64 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.525 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.68 15.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.338 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 20' ' ' VAL . 5.0 mp -110.69 122.09 46.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.949 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.2 m -123.53 115.42 21.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.254 0.549 . . . . 1.0 111.576 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.525 HD23 ' HB1' ' A' ' 115' ' ' ALA . 46.4 tp -81.29 129.41 34.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.266 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.48 152.04 40.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 1.0 111.477 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -109.6 122.94 48.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.71 ' NH1' HD21 ' A' ' 41' ' ' ASN . 66.4 ttp85 -134.63 137.16 43.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.097 0.475 . . . . 1.0 110.688 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.71 HD21 ' NH1' ' A' ' 40' ' ' ARG . 67.7 m-20 60.27 34.2 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.442 -0.799 . . . . 1.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.13 24.01 76.02 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -132.73 150.07 52.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.446 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 59.7 m-85 -92.06 130.27 37.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -143.07 143.14 31.74 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.014 0.435 . . . . 1.0 110.353 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 tp -104.58 129.17 52.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.38 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.0 126.72 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.493 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' HD12 ' A' ' 50' ' ' LEU . 77.7 mt-30 -108.05 128.16 54.42 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.87 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 52' ' ' GLU . 10.0 mp -106.76 129.72 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.322 -0.622 . . . . 1.0 109.322 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' LYS . 64.2 t-80 -43.07 95.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.59 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' LEU . 6.1 pt-20 -37.04 96.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.11 0.481 . . . . 1.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' HIS . 69.1 mttm -61.53 -37.93 85.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.916 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.39 -17.77 0.28 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.199 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.48 164.47 30.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.744 0.307 . . . . 1.0 110.844 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 55.6 p-80 -69.69 116.99 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.98 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 30.7 m -119.85 130.84 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.895 0.378 . . . . 1.0 110.43 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.446 HE22 ' HD3' ' A' ' 11' ' ' PRO . 50.5 tt0 -151.19 108.26 3.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.809 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.07 117.93 32.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.753 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.17 114.19 29.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.926 0.393 . . . . 1.0 110.313 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mm -110.6 116.86 51.92 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.122 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.6 151.71 41.99 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.784 1.656 . . . . 1.0 112.552 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.53 ' CG2' HE22 ' A' ' 123' ' ' GLN . 96.9 mt -93.71 122.09 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.475 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' PHE . 46.2 p30 -170.73 -163.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.383 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -59.0 -40.93 86.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -66.2 -36.15 82.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.995 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 64' ' ' ASN . 36.5 t80 -95.09 129.59 42.12 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.961 0.41 . . . . 1.0 110.327 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -136.35 146.83 46.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.242 0.544 . . . . 1.0 111.234 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 69' ' ' CYS . 28.2 p -115.47 110.23 18.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.369 -0.832 . . . . 1.0 109.423 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.93 135.42 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.862 0.363 . . . . 1.0 110.797 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.604 HE21 ' CB ' ' A' ' 87' ' ' CYS . 57.6 tt0 -103.41 122.07 44.12 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.87 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.105 179.467 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 34.8 p-10 . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.93 0.395 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 97.4 mt -67.69 -24.21 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.965 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 36.9 t -115.86 127.32 54.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.095 0.474 . . . . 1.0 110.333 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 85' ' ' SER . 10.4 m120 -148.7 -176.94 5.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.236 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 79.49 91.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.19 79.91 0.07 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.224 -1.55 . . . . 1.0 109.224 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.604 ' CB ' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -115.98 148.18 40.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.777 0.322 . . . . 1.0 111.404 -177.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -106.84 139.65 40.92 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.551 ' C ' HH11 ' A' ' 90' ' ' ARG . 1.8 pp -128.02 161.33 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.551 HH11 ' C ' ' A' ' 89' ' ' ILE . 1.7 mpt_? -126.27 145.84 50.25 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.343 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.57 135.37 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.192 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.445 ' NE2' ' CD ' ' A' ' 98' ' ' GLU . 48.7 mm-40 -128.34 148.92 50.7 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.846 -0.616 . . . . 1.0 110.247 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.723 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 179.406 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' NH2' ' A' ' 99' ' ' ARG . 35.2 ptt-85 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.839 0.352 . . . . 1.0 110.664 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CD ' ' NE2' ' A' ' 92' ' ' GLN . 83.3 tt0 -65.94 127.25 31.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.508 ' NH2' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -130.02 137.51 50.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.408 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.411 ' NH1' ' CZ ' ' A' ' 90' ' ' ARG . 95.2 mtt-85 -99.91 152.62 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.829 0.347 . . . . 1.0 111.115 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.08 155.23 42.02 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.966 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -146.62 135.23 22.11 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.894 0.378 . . . . 1.0 111.166 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mm -107.2 103.06 46.64 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.93 -11.84 29.87 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.475 1.45 . . . . 1.0 112.827 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -97.96 121.71 40.2 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.75 -48.79 79.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.64 -0.709 . . . . 1.0 112.41 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -59.65 -40.17 86.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.453 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -71.17 -39.88 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.0 110.677 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -56.39 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.358 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.78 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.314 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -62.54 -45.55 92.43 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.772 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -61.21 -51.33 69.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.072 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 89' ' ' ILE . 94.9 mt -65.6 -42.29 91.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.26 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -64.71 -46.7 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 1.0 111.6 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -64.92 -50.43 66.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.301 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.0 t -65.02 -44.88 95.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.8 tp -61.54 -46.76 88.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.097 0.475 . . . . 1.0 110.518 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.82 80.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.352 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 44' ' ' TYR . . . -62.2 -38.16 88.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.579 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -65.55 -44.97 85.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.863 0.363 . . . . 1.0 111.201 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -66.39 -43.13 86.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.402 0.62 . . . . 1.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.47 77.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.95 -1.023 . . . . 1.0 111.888 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.53 HE22 ' CG2' ' A' ' 63' ' ' ILE . 6.5 pt20 -72.05 -40.31 68.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.625 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.25 -21.07 67.42 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.656 2.237 . . . . 1.0 111.997 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.62 147.98 39.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.374 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.58 171.8 55.15 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.2 p -66.78 -19.2 65.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 1.0 110.766 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.6 mtp -128.56 149.12 50.75 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -42.09 149.71 0.42 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.522 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.51 159.63 42.68 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.084 1.856 . . . . 1.0 112.085 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.69 -31.37 69.5 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.658 2.239 . . . . 1.0 111.908 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.56 161.14 80.66 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.893 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.75 144.67 99.59 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.363 1.375 . . . . 1.0 111.652 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.17 -44.6 91.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.38 -28.37 73.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.248 -0.741 . . . . 1.0 111.248 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.75 149.06 47.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.975 0.417 . . . . 1.0 110.959 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.2 80.42 15.58 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.516 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.96 98.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.081 1.854 . . . . 1.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 37' ' ' LEU . 96.8 mt -65.6 -41.36 92.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.026 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.49 145.51 26.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.979 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -135.42 130.28 34.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.445 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.7 158.66 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.88 0.371 . . . . 1.0 110.853 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.36 123.3 46.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.578 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.84 -163.75 11.06 Favored Glycine 0 N--CA 1.46 0.275 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt -139.09 125.53 20.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.408 . . . . 1.0 110.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -89.18 120.85 30.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.416 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.3 mtm -106.73 136.78 45.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.689 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.8 147.65 52.31 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.732 -0.469 . . . . 1.0 109.732 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.57 -65.27 0.38 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.743 -0.662 . . . . 1.0 112.496 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.11 -32.23 83.32 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.791 2.327 . . . . 1.0 113.952 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.44 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -174.99 -176.3 0.95 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -125.18 171.15 10.56 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.146 0.498 . . . . 1.0 110.563 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -157.83 129.21 3.82 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.202 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.38 146.93 49.04 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.305 1.145 . . . . 1.0 111.502 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.6 p -154.95 -172.99 4.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.687 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.14 138.74 20.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.18 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.4 HD13 ' CZ ' ' A' ' 112' ' ' PHE . 54.8 mt -106.54 124.69 49.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.054 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.4 m -130.64 122.44 27.41 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.115 0.483 . . . . 1.0 111.556 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.633 HD23 ' HB1' ' A' ' 115' ' ' ALA . 57.2 tp -93.5 131.41 38.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.28 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.46 148.55 37.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.043 0.449 . . . . 1.0 111.244 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.49 123.53 48.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.731 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -134.05 131.03 38.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.024 0.44 . . . . 1.0 110.82 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.7 m120 61.9 33.45 17.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.822 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.36 17.91 77.92 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.676 HE22 ' NE2' ' A' ' 123' ' ' GLN . 45.6 tp60 -125.71 158.06 35.77 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.595 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 96.2 m-85 -99.72 135.83 40.55 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.023 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -145.17 141.32 28.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.927 0.394 . . . . 1.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.21 124.77 49.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.611 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -107.09 127.03 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.941 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.94 122.93 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.3 mt-30 -109.61 128.51 55.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.067 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 52' ' ' GLU . 9.1 mp -102.6 126.69 49.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -71.54 40.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.207 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 50' ' ' LEU . 38.9 tp10 -49.69 144.26 6.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.294 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.78 -39.91 95.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.219 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.05 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.967 0.413 . . . . 1.0 110.384 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.77 148.23 31.72 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.733 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -62.54 104.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.241 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 t -70.27 135.46 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.496 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -99.17 108.35 20.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.785 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -106.1 112.47 25.52 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.15 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 1.0 110.157 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.67 91.29 34.1 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.078 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.31 143.7 93.07 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.17 1.913 . . . . 1.0 112.431 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.3 mt -88.17 122.22 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.826 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -174.68 -160.88 0.1 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.998 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 t -60.22 -41.93 94.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.212 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -64.8 -34.13 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.554 -0.293 . . . . 1.0 111.033 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -94.56 127.47 40.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.353 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.593 ' NH2' HE21 ' A' ' 92' ' ' GLN . 86.3 mtm180 -136.09 142.54 44.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.334 0.588 . . . . 1.0 110.857 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.71 100.86 7.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.207 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 70' ' ' VAL . 10.4 m -101.95 122.98 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.965 0.412 . . . . 1.0 110.561 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -89.38 106.83 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.599 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.71 ' H ' ' NH1' ' A' ' 90' ' ' ARG . 36.1 tp10 36.87 60.75 0.94 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.113 0.482 . . . . 1.0 111.0 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' CB ' ' OG1' ' A' ' 76' ' ' THR . . . -175.39 166.29 3.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.132 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -65.92 -41.31 91.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.588 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -167.42 79.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.648 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 79' ' ' ILE . 14.9 m -114.63 57.34 0.71 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.201 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.4 mt -66.78 -35.42 80.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.309 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.06 -41.16 99.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.685 -0.234 . . . . 1.0 110.404 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 76' ' ' THR . 87.2 mt -119.03 131.21 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.002 0.43 . . . . 1.0 111.2 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 95.9 m-20 -144.35 -38.21 0.3 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.253 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.46 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 94.2 mt -63.79 -43.27 97.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.8 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.295 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.2 t -103.73 62.23 0.76 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 1.0 110.335 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.4 m120 -80.71 -173.62 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.993 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.408 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 2.3 t 67.85 86.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.94 81.01 0.09 OUTLIER Glycine 0 CA--C 1.521 0.431 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.2 132.19 39.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.72 0.295 . . . . 1.0 111.785 -177.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.432 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 62.7 mttp -112.17 127.66 56.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.7 pt -129.17 158.08 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.71 ' NH1' ' H ' ' A' ' 72' ' ' GLU . 1.8 mpt_? -126.47 140.85 52.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.215 0.531 . . . . 1.0 110.003 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.1 133.85 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.913 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.593 HE21 ' NH2' ' A' ' 68' ' ' ARG . 12.9 pt20 -142.36 138.29 31.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.127 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 177.61 -169.58 41.68 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.42 -41.79 98.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.695 0.283 . . . . 1.0 111.348 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -60.85 -36.74 79.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.793 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.541 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 44.9 pt -144.82 144.45 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 110.547 -0.168 . . . . 1.0 110.547 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -67.39 -54.37 21.08 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.476 -0.49 . . . . 1.0 110.637 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -174.54 129.5 0.34 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.584 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.541 ' HE ' ' CD1' ' A' ' 96' ' ' ILE . 75.5 mtm180 -142.96 149.53 38.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -105.61 149.01 26.69 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.096 0.474 . . . . 1.0 111.231 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -142.34 149.72 39.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.118 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -144.51 152.24 40.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.875 0.369 . . . . 1.0 111.009 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.54 99.71 15.52 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.16 -12.74 32.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.626 1.551 . . . . 1.0 112.788 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.57 101.1 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.6 tt0 -57.4 -54.17 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.985 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -52.08 -44.23 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.544 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -68.9 -38.38 79.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 1.0 110.537 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -35.87 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.988 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.38 -45.53 92.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.318 -0.553 . . . . 1.0 111.105 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -66.97 -44.21 81.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.905 -0.718 . . . . 1.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 42.4 t80 -62.18 -49.21 76.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.203 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 87' ' ' CYS . 96.7 mt -67.67 -40.35 84.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.273 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -64.73 -47.43 78.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.395 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.73 -48.44 71.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.347 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.66 -44.08 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.37 -44.35 95.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.097 0.475 . . . . 1.0 110.213 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.15 -37.38 84.96 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.99 72.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.671 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -70.27 -36.49 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 1.0 111.295 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.82 -45.05 95.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.087 -0.506 . . . . 1.0 109.797 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.11 93.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.444 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.676 ' NE2' HE22 ' A' ' 43' ' ' GLN . 87.3 mt-30 -70.55 -37.79 74.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.851 0.358 . . . . 1.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.574 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.431 -1.467 . . . . 1.0 109.431 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.58 143.53 99.44 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.82 2.346 . . . . 1.0 112.072 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.22 143.53 37.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.303 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.71 -179.24 32.68 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.782 -0.927 . . . . 1.0 110.782 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.6 t -151.32 147.05 26.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.794 0.33 . . . . 1.0 110.542 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -155.22 147.8 24.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.318 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -42.31 105.44 0.41 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.667 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.34 159.76 17.39 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.016 1.811 . . . . 1.0 112.354 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.49 -31.78 80.39 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.649 2.233 . . . . 1.0 111.944 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.85 159.02 84.4 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.059 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.63 144.52 99.55 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.295 1.33 . . . . 1.0 111.653 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 13' ' ' GLY . 7.8 p -67.32 -45.71 85.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.253 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.542 ' N ' HG13 ' A' ' 12' ' ' VAL . . . -65.77 -28.91 74.06 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.45 141.2 58.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.941 0.401 . . . . 1.0 111.068 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.78 79.62 0.43 Allowed Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.78 94.74 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.883 1.722 . . . . 1.0 112.814 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -43.12 95.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.894 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.69 148.29 42.15 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.212 -0.904 . . . . 1.0 110.317 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 t -141.56 130.45 23.08 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.57 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 21' ' ' GLU . 55.3 t -137.59 158.1 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.979 0.418 . . . . 1.0 110.725 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' N ' HG12 ' A' ' 20' ' ' VAL . 80.7 tt0 -107.39 122.76 47.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.681 -0.69 . . . . 1.0 109.445 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.11 -160.92 9.87 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 71.1 mtp -136.36 130.21 32.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.386 . . . . 1.0 110.418 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.56 123.11 36.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.404 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 25' ' ' MET . 1.6 mpp? -113.29 137.83 50.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.982 0.42 . . . . 1.0 110.526 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -140.62 149.13 41.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.007 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.71 -65.17 0.48 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.884 -0.598 . . . . 1.0 112.697 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.12 -32.53 94.79 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.774 2.316 . . . . 1.0 113.564 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.6 177.58 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.852 -0.339 . . . . 1.0 110.878 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.3 169.25 11.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.894 0.378 . . . . 1.0 110.788 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 18.0 pt-20 -159.68 143.15 10.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.639 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.99 141.91 85.8 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.34 1.36 . . . . 1.0 110.929 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 22' ' ' GLY . 22.0 p -147.78 -175.73 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.38 136.25 18.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.95 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 103' ' ' ILE . 61.0 mt -100.08 124.49 45.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.998 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -127.99 126.86 42.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.13 0.491 . . . . 1.0 111.429 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.518 HD23 ' HB1' ' A' ' 115' ' ' ALA . 47.3 tp -96.37 126.17 41.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.886 -0.783 . . . . 1.0 108.886 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.43 152.13 48.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.072 0.463 . . . . 1.0 111.467 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.2 118.28 33.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.673 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -130.56 137.8 49.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.861 0.362 . . . . 1.0 110.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 59.04 33.59 23.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.444 -0.798 . . . . 1.0 111.387 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.98 22.44 77.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.437 ' OE1' ' N ' ' A' ' 44' ' ' TYR . 6.5 tp-100 -131.09 147.7 52.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.437 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 72.0 m-85 -88.52 133.84 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.921 -0.399 . . . . 1.0 109.921 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.67 140.73 30.21 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.07 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.2 tt -104.85 119.97 40.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.731 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.653 ' CG2' HE21 ' A' ' 58' ' ' GLN . 78.4 mt -101.79 127.76 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.052 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.5 mt -104.36 116.76 48.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.425 ' C ' HD12 ' A' ' 50' ' ' LEU . 80.9 mt-30 -97.63 132.34 43.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.6 mp -105.15 130.81 53.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.88 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -103.01 27.19 7.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.282 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 97.1 mt-10 -45.65 150.09 0.54 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -62.33 -40.31 95.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.3 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -54.55 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.38 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.49 158.11 43.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.88 112.54 17.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.071 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 t -95.25 133.41 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.921 0.391 . . . . 1.0 110.531 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.653 HE21 ' CG2' ' A' ' 47' ' ' ILE . 55.6 tp60 -99.64 107.37 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.422 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -105.93 112.52 25.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.983 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.84 111.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.876 0.369 . . . . 1.0 110.187 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.33 116.78 48.39 Favored Pre-proline 0 N--CA 1.467 0.384 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.127 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.59 147.54 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.644 1.563 . . . . 1.0 112.61 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.51 120.04 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.2 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -175.22 -162.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.201 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -64.15 -26.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.185 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -83.69 -10.74 57.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.678 0.275 . . . . 1.0 110.948 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.81 129.29 56.0 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -136.5 146.86 46.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.743 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.428 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 4.7 t -127.87 106.46 9.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.506 -0.77 . . . . 1.0 108.937 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.4 m -109.14 126.46 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.052 0.453 . . . . 1.0 110.969 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.632 HE21 ' N ' ' A' ' 88' ' ' LYS . 52.9 tp60 -82.8 115.29 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 37.11 58.82 1.16 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.635 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -177.99 -173.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.863 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -108.66 -17.42 13.96 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.417 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -161.55 86.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.688 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 79' ' ' ILE . 4.9 m -141.92 43.67 1.69 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.462 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 69' ' ' CYS . 23.3 mt -66.42 -35.06 79.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.382 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.11 -40.86 98.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.672 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.532 ' O ' HG22 ' A' ' 76' ' ' THR . 86.5 mt -116.14 129.8 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.047 0.451 . . . . 1.0 111.086 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 89.9 m-20 -146.74 -36.28 0.24 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.153 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.93 -42.39 91.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.39 -25.93 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.895 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -103.87 66.58 0.85 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.07 0.462 . . . . 1.0 110.568 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' A' ' 85' ' ' SER . 12.4 m120 -91.73 -171.48 2.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.166 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 85' ' ' SER . 6.9 p 65.06 98.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.987 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.3 77.53 0.13 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.492 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -95.7 134.21 38.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.802 0.334 . . . . 1.0 111.772 -178.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.632 ' N ' HE21 ' A' ' 71' ' ' GLN . 99.5 mttt -107.94 123.82 49.21 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.0 149.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.911 -0.403 . . . . 1.0 109.911 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.512 ' C ' HE22 ' A' ' 92' ' ' GLN . 81.9 mtt85 -121.86 143.98 49.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.915 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.51 135.35 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.877 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.512 HE22 ' C ' ' A' ' 90' ' ' ARG . 15.1 mp0 -136.95 151.75 49.38 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -165.22 160.78 34.18 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.34 -43.88 89.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.672 0.272 . . . . 1.0 111.483 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.487 ' CE2' HG23 ' A' ' 96' ' ' ILE . 1.3 p-90 -86.63 -8.61 57.32 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.487 HG23 ' CE2' ' A' ' 95' ' ' TRP . 19.9 pt -126.7 149.17 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.744 0.307 . . . . 1.0 110.544 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -87.45 162.46 17.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.646 0.26 . . . . 1.0 110.739 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.75 124.84 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 1.0 110.756 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.11 132.06 44.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.295 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -91.55 151.9 20.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 1.0 111.076 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.18 153.69 43.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.202 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -138.82 143.87 39.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.953 0.406 . . . . 1.0 110.901 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.627 HD11 HD12 ' A' ' 35' ' ' LEU . 5.9 mm -127.17 91.08 47.46 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -16.99 41.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.698 1.598 . . . . 1.0 112.681 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.69 106.35 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.4 tt0 -62.64 -54.69 35.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 1.0 112.182 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -52.42 -42.77 64.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.607 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -70.55 -37.54 74.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.573 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 8.9 t -59.19 -35.57 73.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.891 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.27 -44.38 95.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.451 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.12 -44.51 84.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.979 -0.689 . . . . 1.0 110.454 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 51.1 t80 -60.76 -49.8 76.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.149 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.46 -41.58 80.0 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.466 -0.493 . . . . 1.0 111.223 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.6 t -63.55 -45.55 90.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.595 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.518 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.43 -49.31 56.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.544 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.46 -45.05 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.026 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.02 -48.59 81.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.35 80.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.577 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.35 91.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.752 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.74 -45.91 80.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.948 0.404 . . . . 1.0 111.351 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.78 -43.14 89.7 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.472 0.653 . . . . 1.0 110.368 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.96 77.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.855 -1.066 . . . . 1.0 111.848 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -71.92 -39.87 69.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.393 . . . . 1.0 110.556 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.597 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.43 -1.468 . . . . 1.0 109.43 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.6 146.92 96.48 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.953 2.435 . . . . 1.0 112.177 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 3' ' ' LEU . 3.5 mm? -80.52 137.64 36.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.302 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.96 165.7 40.5 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.732 -0.947 . . . . 1.0 110.732 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -157.33 151.77 25.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.89 0.376 . . . . 1.0 110.729 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.9 ttt 45.48 -136.82 0.6 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.428 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.01 105.38 41.79 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.209 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -81.54 158.94 19.41 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.047 1.831 . . . . 1.0 112.026 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.42 -31.7 61.45 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.747 2.298 . . . . 1.0 111.716 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.37 158.57 3.86 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.75 142.99 99.3 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.308 1.338 . . . . 1.0 111.688 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.18 -45.23 83.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.382 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.72 81.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.26 50.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.06 0.457 . . . . 1.0 111.144 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -98.19 107.86 43.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.7 103.89 1.79 Allowed 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.435 1.423 . . . . 1.0 112.871 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.93 -43.22 79.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.186 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.79 151.52 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.076 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -140.92 135.0 30.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 1.0 110.547 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 35' ' ' LEU . 2.6 p -142.45 152.12 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.018 0.437 . . . . 1.0 111.163 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -106.64 121.85 45.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.964 -0.754 . . . . 1.0 108.964 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -130.46 -155.87 8.45 Favored Glycine 0 N--CA 1.463 0.488 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.477 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 21.4 mmt -137.04 128.65 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.939 0.4 . . . . 1.0 110.244 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -90.21 126.33 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.338 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.0 mtm -109.32 138.75 45.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.532 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 29' ' ' LEU . 99.3 mttt -135.64 149.68 49.4 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.898 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -67.07 0.29 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.569 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.28 -32.6 81.95 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.793 2.328 . . . . 1.0 113.852 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.444 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -173.94 -170.06 0.53 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.408 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -130.38 169.67 15.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.021 0.439 . . . . 1.0 110.313 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -156.29 144.39 14.31 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.396 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.98 146.14 96.45 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.294 1.329 . . . . 1.0 111.293 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.645 ' SG ' ' N ' ' A' ' 34' ' ' ALA . 19.7 t -158.02 170.15 22.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.314 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.645 ' N ' ' SG ' ' A' ' 33' ' ' CYS . . . -138.14 139.99 39.68 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.854 0.359 . . . . 1.0 110.239 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 103' ' ' ILE . 60.9 mt -107.07 121.02 43.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.764 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -125.08 122.91 38.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.229 0.537 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.594 HD23 ' HB1' ' A' ' 115' ' ' ALA . 62.0 tp -94.67 122.64 37.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.31 146.25 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.145 0.498 . . . . 1.0 111.309 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -98.71 126.69 44.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.747 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -139.82 136.73 34.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.971 0.415 . . . . 1.0 110.727 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 59.15 33.75 22.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.568 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.24 24.88 76.33 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.748 -0.941 . . . . 1.0 110.748 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -135.44 159.44 41.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -100.22 133.16 45.03 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -141.42 142.93 33.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.044 0.45 . . . . 1.0 110.34 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.8 tt -104.32 119.69 39.52 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.896 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.628 ' N ' HD23 ' A' ' 46' ' ' LEU . 72.0 mt -98.15 128.87 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.55 131.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.466 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 73.2 mt-30 -123.23 124.65 43.5 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.99 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 50' ' ' LEU . 10.4 mp -99.9 114.75 28.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -72.49 62.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.399 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -62.51 151.86 36.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.314 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.87 -41.66 98.12 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.57 -77.36 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -147.82 150.56 34.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -68.73 138.37 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.967 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.18 130.37 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.914 0.388 . . . . 1.0 110.597 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -91.09 108.35 19.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.791 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.07 114.68 28.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.28 116.12 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.86 0.362 . . . . 1.0 110.46 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.1 91.6 32.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.19 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -57.42 142.77 95.22 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.213 1.942 . . . . 1.0 112.591 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.62 122.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -175.66 -163.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.201 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.9 p -63.84 -22.2 66.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -85.61 -11.34 54.17 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.602 0.239 . . . . 1.0 111.06 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -121.84 135.27 54.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.065 -0.346 . . . . 1.0 110.065 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -137.42 151.38 48.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.104 0.478 . . . . 1.0 110.711 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 28.7 p -138.76 111.65 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 128.28 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 1.0 111.196 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.641 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 49.5 tp60 -82.27 97.53 8.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.585 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 57.85 -0.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.17 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . -95.07 149.34 21.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.958 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -71.97 -44.84 62.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.637 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -161.99 83.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.659 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 79' ' ' ILE . 7.4 m -154.65 82.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.065 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.5 mt -64.43 -33.54 76.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.479 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -62.84 -41.54 99.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.025 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.483 ' H ' HG22 ' A' ' 76' ' ' THR . 50.6 mm -90.25 132.3 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.183 0.516 . . . . 1.0 111.059 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -168.45 -41.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.204 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 83' ' ' SER . 32.6 mm -71.64 -24.13 23.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.643 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.18 -3.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.053 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 29.8 t -138.97 138.18 37.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.903 0.382 . . . . 1.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.9 m120 -146.69 -171.32 3.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.105 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 61.77 85.1 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.31 78.28 0.27 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.571 -1.412 . . . . 1.0 109.571 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.535 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.85 137.62 35.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 111.866 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.641 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 99.7 mttt -112.41 127.03 55.91 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 pp -118.17 132.05 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -97.1 141.67 29.96 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.896 -0.409 . . . . 1.0 109.896 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.7 t -121.63 134.85 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.572 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -143.46 150.64 39.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.18 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -172.9 156.21 24.38 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.644 -0.982 . . . . 1.0 110.644 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -66.19 -43.72 86.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.725 0.298 . . . . 1.0 111.596 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.495 ' CE2' HG23 ' A' ' 96' ' ' ILE . 2.3 p-90 -84.84 -7.12 59.31 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 95' ' ' TRP . 19.2 pt -129.03 154.38 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 110.143 -0.318 . . . . 1.0 110.143 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -94.69 160.26 14.7 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.684 0.278 . . . . 1.0 110.616 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.12 132.88 54.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 1.0 110.363 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -140.43 125.49 18.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.611 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -88.22 144.07 26.67 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.993 0.425 . . . . 1.0 111.192 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.83 152.05 49.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -139.59 144.64 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.821 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 35' ' ' LEU . 5.8 mm -127.64 91.55 45.26 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.3 -16.99 39.85 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.822 1.681 . . . . 1.0 112.751 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -87.79 104.28 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.96 -54.99 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 1.0 112.32 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -52.1 -44.31 64.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.425 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.17 -36.17 77.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.533 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 113' ' ' LEU . 4.2 t -61.75 -38.07 86.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.999 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.77 -46.09 89.64 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.223 -0.591 . . . . 1.0 111.301 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -43.55 82.0 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.964 -0.695 . . . . 1.0 110.764 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.8 -50.36 72.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.156 -0.929 . . . . 1.0 111.094 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 109' ' ' CYS . 95.9 mt -67.85 -41.0 83.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.329 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 t -62.27 -45.12 94.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.105 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.594 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.52 -47.13 67.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.382 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.403 ' HA ' HD22 ' A' ' 37' ' ' LEU . 67.0 t -63.35 -45.6 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.964 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.16 -45.85 92.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.1 0.476 . . . . 1.0 110.255 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.6 86.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.425 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.76 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.455 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.488 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 95.1 mt-30 -68.32 -37.66 80.78 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.25 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.54 -43.15 90.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.085 0.469 . . . . 1.0 110.623 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.93 75.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.732 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -72.31 -38.9 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.734 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.405 -179.773 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.624 -1.391 . . . . 1.0 109.624 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.73 145.75 95.01 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.792 2.328 . . . . 1.0 111.84 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.8 tp -107.23 125.79 51.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.306 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.41 178.62 49.97 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.9 p -67.96 -18.08 64.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 1.0 110.605 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 95.9 mtp -111.58 142.04 44.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.815 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -63.39 151.2 88.02 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.364 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.64 160.21 44.43 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.226 1.951 . . . . 1.0 111.973 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.476 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 34.9 Cg_endo -63.46 -31.49 71.88 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.822 2.348 . . . . 1.0 112.154 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.35 145.55 57.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.859 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 142.31 71.06 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.734 1.623 . . . . 1.0 111.41 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -67.77 -42.79 86.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.681 -0.691 . . . . 1.0 111.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -38.37 47.03 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.94 146.17 46.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.902 0.382 . . . . 1.0 111.009 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.82 80.32 0.33 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.13 99.71 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.846 1.697 . . . . 1.0 112.832 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.23 -43.2 92.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.82 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.23 153.52 38.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.353 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -137.96 135.8 36.37 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.633 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.8 p -141.64 149.26 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.04 0.448 . . . . 1.0 111.262 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -104.31 121.68 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -130.39 -162.96 10.9 Favored Glycine 0 N--CA 1.462 0.386 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 88.9 mmm -128.65 131.99 48.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 1.0 110.315 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -94.9 124.06 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -108.47 137.22 46.79 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.545 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.93 150.07 44.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.019 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.71 -66.29 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.794 -0.639 . . . . 1.0 112.597 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.68 -33.0 93.8 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.779 2.319 . . . . 1.0 113.691 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.7 -174.57 0.25 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.007 -0.277 . . . . 1.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -124.33 169.47 11.76 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.068 0.461 . . . . 1.0 110.739 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -158.1 144.31 12.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.619 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.8 145.12 97.4 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.392 1.394 . . . . 1.0 111.04 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.7 p -154.97 -179.11 7.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.382 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.67 142.53 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.427 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 20' ' ' VAL . 4.9 mp -112.28 122.53 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.257 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -122.67 116.7 24.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.381 0.61 . . . . 1.0 111.757 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.682 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.9 tp -83.55 130.37 35.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.21 -0.905 . . . . 1.0 109.218 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.24 151.49 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.007 0.432 . . . . 1.0 111.239 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -110.61 121.73 46.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.711 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -134.02 139.19 45.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.903 0.382 . . . . 1.0 110.911 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 59.11 33.65 22.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.548 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.28 25.22 75.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -135.17 153.83 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -91.18 131.95 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -141.23 141.61 34.0 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.985 0.422 . . . . 1.0 110.445 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.6 127.54 52.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.685 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.42 118.29 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.154 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.9 mt -100.98 122.87 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.8 mt-30 -108.22 130.54 55.15 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.079 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -107.68 111.19 23.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 52' ' ' GLU . 97.8 m-70 -57.49 -12.8 2.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 51' ' ' HIS . 3.5 tp10 42.39 -167.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.455 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -63.74 -41.75 97.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -138.73 -68.5 0.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.747 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -69.9 142.13 53.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.177 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 20.9 p80 -89.06 112.29 23.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.41 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -84.19 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.616 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.476 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 83.0 mt-30 -102.13 132.16 48.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.127 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -127.25 109.61 11.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.1 mt -93.57 122.3 44.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.728 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.0 mt -133.3 126.76 19.53 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.106 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.01 157.84 46.5 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.799 1.666 . . . . 1.0 112.64 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.5 mt -102.66 115.92 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.178 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' PHE . 50.8 p30 -172.94 -155.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.229 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 m -60.98 -41.6 96.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.348 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.71 -43.05 97.72 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.838 0.352 . . . . 1.0 110.433 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 11.6 t80 -94.03 125.65 38.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.649 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -133.68 142.11 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.87 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.413 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 10.3 t -121.27 111.47 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.962 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.0 m -112.76 126.67 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.959 0.409 . . . . 1.0 110.622 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 87' ' ' CYS . 50.1 tt0 -87.99 112.83 23.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.744 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 71.5 tt0 40.04 55.36 2.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.641 . . . . 1.0 110.641 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 72' ' ' GLU . . . 178.19 -168.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.624 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -109.88 -10.92 14.73 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.431 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 76' ' ' THR . 97.4 mt-10 -140.57 -105.43 0.15 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.799 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER 36.1 35.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.504 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD2' ' O ' ' A' ' 69' ' ' CYS . 97.0 mt -63.23 -41.55 99.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.714 -0.676 . . . . 1.0 111.178 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 78' ' ' LEU . 10.7 mp -65.69 -38.92 90.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.652 0.263 . . . . 1.0 110.462 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 76' ' ' THR . 43.0 mm -102.43 124.33 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.17 0.509 . . . . 1.0 111.001 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 97.3 m-20 -144.25 -41.18 0.27 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.112 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.438 ' C ' ' N ' ' A' ' 83' ' ' SER . 94.6 mt -64.16 -43.29 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.661 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.29 -18.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.036 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 21.9 m -128.19 118.37 23.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.942 0.401 . . . . 1.0 110.284 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.0 m120 -138.32 -167.83 2.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.781 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 70.15 89.47 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.616 -0.512 . . . . 1.0 109.616 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.36 75.69 0.33 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 109.342 -1.503 . . . . 1.0 109.342 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.419 ' HB3' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.9 138.65 34.12 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.964 0.411 . . . . 1.0 112.006 -177.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.54 124.95 53.15 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.0 150.94 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -121.44 147.08 46.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.88 136.45 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.594 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -128.82 150.3 50.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.097 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -158.66 161.28 31.7 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.681 -0.968 . . . . 1.0 110.681 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.18 -42.48 93.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.798 0.332 . . . . 1.0 111.404 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' A' ' 96' ' ' ILE . 2.6 p-90 -86.29 -8.62 57.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.256 -0.429 . . . . 1.0 112.097 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.508 HG23 ' CE2' ' A' ' 95' ' ' TRP . 16.1 pt -127.27 155.77 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-O 120.721 0.296 . . . . 1.0 110.493 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -96.42 -161.63 0.89 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.831 0.348 . . . . 1.0 110.655 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.73 127.88 33.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 1.0 110.111 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -127.26 143.11 51.31 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -120.17 140.0 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.958 0.408 . . . . 1.0 111.236 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.17 150.62 50.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.69 -0.686 . . . . 1.0 110.472 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -145.12 135.75 24.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.758 0.313 . . . . 1.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 54.4 mt -124.56 100.97 34.22 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.64 -10.41 23.5 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.607 1.538 . . . . 1.0 112.684 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.43 105.73 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.72 -52.81 63.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 1.0 112.015 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -53.86 -42.1 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.628 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.504 ' HB3' HG23 ' A' ' 20' ' ' VAL . 64.5 m170 -69.94 -34.88 74.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.512 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.6 t -66.72 -33.22 75.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.99 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.6 mt -62.74 -46.18 89.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.489 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.73 -43.06 80.87 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.602 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.459 ' CE1' HG21 ' A' ' 116' ' ' VAL . 46.9 t80 -60.93 -48.93 79.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.124 -0.943 . . . . 1.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 113' ' ' LEU . 96.8 mt -65.41 -40.85 93.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.644 -0.423 . . . . 1.0 111.362 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.7 p -64.0 -44.24 93.23 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.228 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.682 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.07 -51.02 59.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.314 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 112' ' ' PHE . 70.0 t -64.87 -42.25 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.7 tp -57.74 -45.07 86.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.065 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.377 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.87 70.57 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.044 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -68.01 -41.1 82.71 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.64 0.257 . . . . 1.0 111.102 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.24 -43.75 98.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.958 0.409 . . . . 1.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.73 96.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.236 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.3 -40.44 93.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.652 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.903 -1.046 . . . . 1.0 110.485 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.46 -1.456 . . . . 1.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.86 148.82 90.12 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.748 2.299 . . . . 1.0 112.072 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 83.4 mt -102.73 130.39 49.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.265 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.69 103.35 0.62 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 m -60.8 -41.18 95.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 1.0 110.809 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -147.28 154.24 40.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.362 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 17.8 mp0 -59.67 118.91 35.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.84 160.59 27.5 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.889 1.726 . . . . 1.0 112.32 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' CG ' HE22 ' A' ' 49' ' ' GLN . 57.1 Cg_endo -71.12 -52.12 0.25 Allowed 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.52 2.146 . . . . 1.0 111.884 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 pp -56.47 161.44 4.19 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.121 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.46 143.56 99.66 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.974 1.116 . . . . 1.0 111.79 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.34 -42.9 91.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.02 -34.37 78.73 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.07 137.75 53.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.925 0.393 . . . . 1.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -97.66 108.46 45.68 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.28 103.14 1.7 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.502 1.468 . . . . 1.0 112.999 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.63 -43.47 89.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.152 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 155.68 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 1.0 110.209 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 t -146.67 135.67 22.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.594 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.94 160.82 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.165 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -102.48 122.51 44.47 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' H ' ' HA ' ' A' ' 34' ' ' ALA . . . -118.88 -174.95 16.14 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.792 -0.923 . . . . 1.0 110.792 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.3 mmt -134.9 99.25 4.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 1.0 110.092 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.7 tt0 -59.59 133.96 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 72.5 mtm -113.43 131.38 56.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.748 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -131.15 144.04 51.08 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.56 -64.88 0.49 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.84 -0.618 . . . . 1.0 112.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.22 -31.98 93.78 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.694 2.262 . . . . 1.0 113.633 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.46 -179.87 1.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.641 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.0 168.2 10.43 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.919 0.39 . . . . 1.0 110.522 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.5 128.7 6.27 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.516 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.44 142.36 78.22 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.944 1.096 . . . . 1.0 111.163 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' GLY . 19.4 p -156.76 -178.28 7.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.394 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -150.95 138.19 19.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.308 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.2 mt -102.22 123.97 46.98 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.0 109.915 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.8 m -126.48 120.46 29.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.059 0.456 . . . . 1.0 111.356 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.515 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.5 tp -94.67 131.23 40.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.248 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 150.93 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 1.0 111.239 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.06 120.82 41.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.682 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -128.07 132.31 49.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.217 0.532 . . . . 1.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.16 31.7 21.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.157 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.65 7.52 85.8 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.851 -0.69 . . . . 1.0 111.426 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.704 HE22 ' NE2' ' A' ' 123' ' ' GLN . 44.0 tp60 -112.5 136.79 51.6 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.101 -0.333 . . . . 1.0 110.101 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 75.0 m-85 -81.7 134.74 35.49 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.34 139.64 28.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.375 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.4 tt -108.7 119.4 39.42 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.607 ' N ' HD23 ' A' ' 46' ' ' LEU . 90.9 mt -99.12 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.6 mt -96.91 117.21 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.9 mt-30 -102.35 131.3 49.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.928 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -110.3 127.2 54.9 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -85.41 52.73 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.237 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -45.49 152.95 0.27 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -61.77 -40.02 93.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.362 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -62.49 -46.44 88.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.509 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -173.11 -163.04 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.701 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -108.11 126.24 52.52 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.31 137.17 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.055 0.455 . . . . 1.0 110.463 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -104.8 131.12 52.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.018 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -107.97 119.65 40.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.565 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.1 mt -92.11 119.74 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 1.0 110.332 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mt -135.45 94.2 15.63 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.269 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.5 142.52 80.76 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.046 1.831 . . . . 1.0 112.625 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.2 mt -82.12 124.83 39.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.354 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 66' ' ' HIS . 6.0 p30 -172.96 -163.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.126 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.4 t -59.71 -41.29 90.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.564 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.632 ' CD2' ' ND2' ' A' ' 64' ' ' ASN . 3.5 p80 -69.84 -14.48 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.958 -0.297 . . . . 1.0 111.122 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.0 t80 -114.93 128.06 56.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.18 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -141.29 145.86 36.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.145 0.497 . . . . 1.0 110.889 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.417 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 2.9 t -121.32 118.61 29.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 1.0 108.991 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 30.3 m -118.71 128.84 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.068 0.461 . . . . 1.0 110.848 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.611 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 56.4 tp60 -86.47 103.24 14.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.518 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 57.78 -0.37 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.331 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . -110.35 174.11 6.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.966 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -98.82 -24.52 14.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.464 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -168.06 81.34 0.17 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.608 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.9 m -151.85 73.93 1.08 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.302 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' CD2' ' O ' ' A' ' 69' ' ' CYS . 39.6 mt -70.41 -28.89 65.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.426 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 78' ' ' LEU . 10.9 mp -62.77 -40.35 97.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.632 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 mm -110.23 128.84 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.999 0.428 . . . . 1.0 110.945 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 20.0 p-10 -156.22 -38.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.329 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.42 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 26.3 mm -68.32 -24.53 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.39 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.03 72.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.818 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.5 t -100.46 62.57 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.09 0.472 . . . . 1.0 110.398 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 10.9 m120 -80.47 -171.69 3.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.164 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 85' ' ' SER . 19.2 p 57.83 94.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.73 77.09 0.21 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.429 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -96.62 136.56 36.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.765 0.317 . . . . 1.0 111.72 -177.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.611 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 64.9 mttp -108.02 120.03 41.14 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -118.63 131.01 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -106.61 144.73 32.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.894 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.63 133.13 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.641 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -124.23 136.06 53.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -145.75 145.85 15.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.741 -0.944 . . . . 1.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.65 -45.88 70.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.821 0.343 . . . . 1.0 111.478 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.519 ' CE2' HG23 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -80.24 -13.47 59.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.174 -0.466 . . . . 1.0 112.237 -178.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 95' ' ' TRP . 42.0 pt -127.02 160.77 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 120.554 0.216 . . . . 1.0 110.657 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -87.74 151.33 22.99 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.671 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.02 135.66 55.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 1.0 110.727 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -133.8 137.58 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.588 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -87.32 150.47 23.84 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.917 0.389 . . . . 1.0 111.035 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -143.39 149.33 37.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.298 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.14 145.84 39.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.918 0.389 . . . . 1.0 110.931 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.87 92.86 43.54 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.28 -15.44 38.88 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.757 1.638 . . . . 1.0 112.602 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.453 ' OD2' ' CG ' ' A' ' 108' ' ' HIS . 38.6 t0 -93.2 106.56 18.51 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -59.81 -52.92 63.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.026 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.93 -46.81 32.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.378 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.453 ' CG ' ' OD2' ' A' ' 105' ' ' ASP . 43.9 m170 -68.5 -39.34 81.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 1.0 110.38 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.5 t -59.08 -39.76 83.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.16 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.52 -44.84 93.09 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.418 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.16 -44.96 82.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.3 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.55 -49.38 76.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.339 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.8 -40.51 88.13 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.603 -0.439 . . . . 1.0 111.211 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -62.73 -44.7 95.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.822 0.344 . . . . 1.0 111.083 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.515 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.12 -48.28 62.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.361 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.09 -44.76 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.14 -45.03 96.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.016 0.436 . . . . 1.0 110.161 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.07 86.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.555 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.07 -49.09 75.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -71.11 -38.23 72.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 1.0 110.983 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.04 -44.5 96.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.223 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.41 96.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.221 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.704 ' NE2' HE22 ' A' ' 43' ' ' GLN . 88.2 mt-30 -65.38 -41.22 93.99 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.66 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.384 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.485 -1.446 . . . . 1.0 109.485 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 34.1 Cg_endo -63.85 -21.72 69.1 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.769 2.312 . . . . 1.0 111.928 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.1 mt -106.72 128.81 54.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.847 0.356 . . . . 1.0 110.433 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.48 153.64 6.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t -66.67 140.98 57.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 1.0 110.541 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.9 ttm -138.78 142.65 38.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.158 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -139.03 95.14 9.6 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.126 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.03 159.05 15.59 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.148 1.898 . . . . 1.0 112.049 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.52 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 37.1 Cg_endo -64.63 -32.39 58.04 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.607 2.205 . . . . 1.0 111.981 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -53.96 158.06 3.77 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.907 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.76 143.29 99.65 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.156 1.238 . . . . 1.0 111.687 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.35 -45.08 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.036 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.81 -30.79 78.72 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.07 142.27 57.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.06 0.457 . . . . 1.0 111.162 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.22 79.85 0.4 Allowed Pre-proline 0 N--CA 1.464 0.261 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.35 98.97 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.893 1.729 . . . . 1.0 112.918 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -43.55 93.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.754 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.94 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.341 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 t -136.33 138.77 42.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.763 0.316 . . . . 1.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG11 ' CG ' ' A' ' 112' ' ' PHE . 2.8 p -142.95 150.9 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.083 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -105.29 121.34 43.67 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.85 -172.66 13.2 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.426 ' O ' ' SD ' ' A' ' 25' ' ' MET . 86.2 mmm -120.44 127.31 52.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 1.0 110.091 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -90.11 119.71 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 25' ' ' MET . 1.3 mpp? -110.4 136.68 49.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.946 0.403 . . . . 1.0 110.34 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.34 150.43 42.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.025 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.69 -64.74 0.51 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.706 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.45 -34.15 93.32 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.658 2.239 . . . . 1.0 113.624 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 179.06 175.21 0.66 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.812 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -117.17 169.06 9.75 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.099 0.476 . . . . 1.0 110.527 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -160.68 142.9 9.41 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.644 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.85 145.71 94.75 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.498 1.465 . . . . 1.0 111.241 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.2 p -155.21 -171.66 3.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.466 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.44 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.405 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 20' ' ' VAL . 68.3 mt -113.37 130.09 56.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -130.51 128.17 40.63 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.167 0.508 . . . . 1.0 111.556 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.655 HD23 ' HB1' ' A' ' 115' ' ' ALA . 51.9 tp -95.17 124.55 39.27 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.009 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.64 149.95 45.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.112 0.482 . . . . 1.0 111.314 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -108.11 120.67 42.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.389 -0.823 . . . . 1.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -132.88 135.94 45.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.871 0.367 . . . . 1.0 110.87 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.5 m120 59.26 34.49 23.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 1.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.57 23.6 76.55 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.004 -0.838 . . . . 1.0 111.004 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -133.77 157.08 46.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.94 133.43 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -139.02 146.66 41.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.197 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -105.45 134.31 48.77 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.706 ' N ' HD13 ' A' ' 46' ' ' LEU . 78.0 mt -114.09 124.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.2 mt -105.1 120.37 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -112.34 126.86 55.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.152 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 50' ' ' LEU . 10.9 mp -103.93 123.69 47.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -78.85 58.04 2.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.371 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -54.75 155.91 3.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.299 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.28 -41.44 98.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.2 -81.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -142.01 150.13 40.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.741 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -67.35 141.71 57.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.307 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.43 132.61 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.992 0.425 . . . . 1.0 110.682 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 84.0 mt-30 -95.01 126.62 40.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.914 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -120.52 117.28 27.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.478 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -93.35 108.22 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.865 0.364 . . . . 1.0 110.061 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG23 ' HE1' ' A' ' 95' ' ' TRP . 31.6 mm -114.66 121.88 34.93 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.627 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.58 149.95 39.6 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.778 1.652 . . . . 1.0 112.615 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.3 115.36 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -169.57 -158.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.362 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.4 m -59.51 -41.67 90.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.182 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -65.73 -37.69 87.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' A' ' 64' ' ' ASN . 16.4 t80 -95.63 123.83 39.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.834 0.35 . . . . 1.0 110.06 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -140.13 144.05 36.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.099 0.476 . . . . 1.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.36 99.71 7.38 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 70' ' ' VAL . 35.4 m -104.56 124.95 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.905 0.383 . . . . 1.0 110.811 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.608 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 48.4 tp60 -77.7 104.46 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.455 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 37.52 56.93 1.42 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.66 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -176.82 177.31 1.35 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.592 . . . . 1.0 110.85 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -87.09 -11.11 51.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.46 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' LEU . 81.5 tt0 -146.41 -92.49 0.09 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.782 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.701 ' O ' HG22 ' A' ' 76' ' ' THR . 88.1 m 42.61 24.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.224 0.535 . . . . 1.0 110.793 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 75' ' ' GLU . 98.3 mt -65.52 -40.49 93.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.811 -0.631 . . . . 1.0 111.364 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.48 -40.38 95.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.966 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.659 ' O ' HG22 ' A' ' 76' ' ' THR . 84.0 mt -109.52 130.45 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.098 0.475 . . . . 1.0 111.244 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 35.0 p-10 -144.57 -33.8 0.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.424 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.446 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 91.9 mt -67.84 -25.31 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.535 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.02 91.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.128 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -97.47 70.73 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.181 0.515 . . . . 1.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 81' ' ' ILE . 9.7 m120 -98.7 -169.2 1.75 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.207 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 m 61.82 84.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.58 76.47 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 109.462 -1.455 . . . . 1.0 109.462 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.03 142.98 26.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.933 0.397 . . . . 1.0 111.803 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.608 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 55.8 mtpt -118.56 128.07 54.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.5 pt -127.82 163.6 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.75 142.15 50.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.8 t -121.6 135.76 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.087 0.47 . . . . 1.0 110.564 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -119.92 163.47 17.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.225 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 174.45 149.84 7.36 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.0 -39.69 90.5 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.277 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.406 ' HE1' HG23 ' A' ' 61' ' ' ILE . 3.8 p90 -80.26 -11.53 59.71 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 93' ' ' GLY . 12.0 pt -128.26 155.95 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.865 0.364 . . . . 1.0 110.698 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -96.3 175.26 6.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.683 0.278 . . . . 1.0 110.5 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.86 115.95 3.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.175 0.512 . . . . 1.0 110.6 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -129.03 137.91 51.59 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.237 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.64 151.05 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.739 0.304 . . . . 1.0 110.705 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -137.35 155.17 49.73 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.478 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -147.4 126.08 12.58 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.972 0.415 . . . . 1.0 111.389 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.425 HG12 HG21 ' A' ' 20' ' ' VAL . 3.0 mp -102.93 99.52 14.12 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 -10.05 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.407 1.404 . . . . 1.0 112.472 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -96.49 107.34 19.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.83 -52.73 64.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.7 -0.682 . . . . 1.0 112.157 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.0 OUTLIER -52.44 -43.97 65.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.593 -0.443 . . . . 1.0 110.388 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.46 ' HB3' HG23 ' A' ' 20' ' ' VAL . 60.7 m170 -69.6 -34.19 73.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.377 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.422 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -64.32 -37.06 86.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.922 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.08 -47.65 79.24 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.357 -0.537 . . . . 1.0 111.706 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.57 -44.74 77.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.862 -0.735 . . . . 1.0 110.171 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.516 ' CG ' HG11 ' A' ' 20' ' ' VAL . 37.0 t80 -61.36 -49.44 76.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.131 -0.94 . . . . 1.0 111.495 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.422 HD11 ' SG ' ' A' ' 109' ' ' CYS . 91.7 mt -67.32 -41.65 84.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.169 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -63.06 -45.89 90.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.529 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.655 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.97 -46.4 78.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.456 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.431 ' HA ' HD22 ' A' ' 37' ' ' LEU . 76.5 t -64.19 -44.49 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.894 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.6 tp -60.74 -44.83 96.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 1.0 110.295 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.39 86.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.648 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -48.71 77.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -70.28 -36.89 74.67 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.77 -45.77 91.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.151 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.28 -40.08 96.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.306 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.79 -40.19 94.83 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.801 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.586 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 43.9 Cg_endo -67.21 152.64 79.26 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.723 2.282 . . . . 1.0 111.993 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 6' ' ' MET . 91.1 mt -74.44 145.97 43.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.445 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.24 -36.37 93.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.4 t -61.66 -43.74 98.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.343 . . . . 1.0 111.014 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.427 ' O ' ' O ' ' A' ' 3' ' ' LEU . 97.2 mmm -106.25 126.27 52.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.552 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -80.14 151.94 73.34 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.43 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.22 159.58 43.7 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.163 1.908 . . . . 1.0 111.996 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 45.4 Cg_endo -67.83 -33.28 27.43 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.642 2.228 . . . . 1.0 112.151 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -74.18 150.73 87.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.805 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.51 141.06 90.51 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.627 1.551 . . . . 1.0 111.72 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.3 t -68.35 -43.29 84.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.293 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.18 -41.31 4.85 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.86 146.13 44.35 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.594 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -93.22 107.02 22.48 Favored Pre-proline 0 N--CA 1.466 0.347 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.94 99.87 1.35 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.614 1.543 . . . . 1.0 113.181 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.49 -43.41 85.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.282 0.563 . . . . 1.0 109.892 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.12 149.08 29.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.369 -0.832 . . . . 1.0 110.327 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 t -141.34 130.18 23.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.689 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -142.03 159.66 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-O 120.928 0.394 . . . . 1.0 110.955 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -108.32 122.43 46.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.511 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' C ' ' SD ' ' A' ' 23' ' ' MET . . . -130.59 -152.52 7.42 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 22' ' ' GLY . 2.8 mpt? -143.99 126.53 15.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 1.0 110.522 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 84.2 tt0 -87.42 121.43 29.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.601 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.9 mtm -105.79 138.85 41.29 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.62 150.22 49.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.67 -66.63 0.38 Allowed Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.583 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.56 -33.59 86.83 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.761 2.307 . . . . 1.0 113.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -174.0 -171.97 0.68 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 121.009 -0.276 . . . . 1.0 110.463 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -130.23 169.13 15.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.973 0.416 . . . . 1.0 110.454 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 134.66 8.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.83 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.16 141.59 69.18 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 CA-C-N 120.199 1.107 . . . . 1.0 111.244 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 15.5 p -150.31 -176.24 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.403 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.71 138.64 22.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.451 HD12 HD11 ' A' ' 103' ' ' ILE . 71.0 mt -105.66 123.86 48.61 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.7 m -129.6 113.91 15.4 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.117 0.484 . . . . 1.0 111.584 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.505 HD23 ' HB1' ' A' ' 115' ' ' ALA . 49.9 tp -81.43 127.39 32.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.03 149.19 47.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.138 0.494 . . . . 1.0 111.363 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -112.98 121.95 46.18 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.405 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -135.36 139.89 44.61 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.039 0.447 . . . . 1.0 110.76 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m120 58.97 33.86 23.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.324 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.83 23.93 75.67 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -131.3 152.61 50.39 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.0 130.41 40.13 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -142.41 142.1 32.33 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.026 0.441 . . . . 1.0 110.231 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.5 tp -104.38 124.78 49.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.247 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.0 mt -103.38 122.19 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.988 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.88 114.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.471 ' C ' HD12 ' A' ' 50' ' ' LEU . 79.2 mt-30 -101.68 132.79 47.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.071 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.0 mp -108.04 129.44 55.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.7 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -80.18 36.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.268 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -49.77 142.46 8.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.199 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.68 -38.69 91.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -59.04 -53.85 53.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.34 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -174.46 149.87 1.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -60.58 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 t -67.11 133.45 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.214 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 97.0 mt-30 -106.79 128.63 54.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.143 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -122.18 117.39 26.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.56 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.66 111.86 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.161 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -115.97 114.53 41.45 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.793 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.27 151.07 37.89 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.667 1.578 . . . . 1.0 112.462 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.9 mt -97.52 118.81 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.429 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -170.22 -158.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.352 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -61.05 -42.62 98.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.109 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -65.41 -36.11 82.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.979 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 64' ' ' ASN . 17.3 t80 -95.12 123.78 38.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.41 122.35 15.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.234 0.54 . . . . 1.0 110.817 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 t -87.89 115.0 25.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.247 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 70' ' ' VAL . 4.6 m -115.74 124.32 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.908 0.385 . . . . 1.0 110.583 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' HG21 ' A' ' 76' ' ' THR . 52.4 tt0 -84.48 135.44 34.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 55.25 -96.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.902 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.29 170.86 14.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.881 -0.599 . . . . 1.0 111.007 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' O ' HD21 ' A' ' 77' ' ' LEU . 97.5 mt-10 -83.93 -8.55 59.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.764 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -85.82 -7.76 58.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.818 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.495 HG21 ' O ' ' A' ' 71' ' ' GLN . 1.8 p -89.39 46.44 1.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.152 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD21 ' O ' ' A' ' 74' ' ' GLU . 37.4 mt -62.2 -42.71 99.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.991 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -105.6 -9.21 17.51 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.589 -0.278 . . . . 1.0 111.193 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.1 mt -101.49 130.75 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.997 0.427 . . . . 1.0 110.643 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 21.9 p-10 -152.29 -50.15 0.11 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.732 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' SER . 36.5 mm -63.99 -40.93 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.221 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.6 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . 44.0 t -142.91 140.19 31.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.984 0.421 . . . . 1.0 110.151 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 83' ' ' SER . 17.0 m120 -146.15 -172.22 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.985 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER 76.97 89.68 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 -179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.19 77.49 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.407 -1.477 . . . . 1.0 109.407 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.409 ' HB3' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.21 135.15 35.92 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.01 0.433 . . . . 1.0 111.882 -177.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.04 113.32 25.78 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.66 129.79 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.817 0.341 . . . . 1.0 110.429 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -101.86 142.18 33.57 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.105 -0.498 . . . . 1.0 109.982 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.06 133.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.706 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -143.22 141.61 31.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.161 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 175.65 -167.0 38.66 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.51 -40.89 96.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.643 0.258 . . . . 1.0 111.244 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -61.08 -37.95 84.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.672 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' GLY . 44.5 pt -143.26 148.5 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.676 0.274 . . . . 1.0 110.888 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 98' ' ' GLU . 50.4 ptt85 -72.2 -48.2 44.83 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.992 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 97' ' ' ARG . 84.1 tt0 -176.9 128.39 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.9 0.381 . . . . 1.0 110.581 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.88 145.08 35.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -104.06 147.32 27.54 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.93 0.395 . . . . 1.0 111.169 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.87 152.42 45.08 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.998 -0.547 . . . . 1.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -138.26 144.53 40.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.984 0.421 . . . . 1.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.451 HD11 HD12 ' A' ' 35' ' ' LEU . 5.7 mm -127.31 89.88 50.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.59 -16.44 46.93 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.721 1.614 . . . . 1.0 112.652 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -87.2 101.09 13.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.81 -55.07 39.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 1.0 112.087 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -51.84 -44.03 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.771 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -68.45 -39.67 81.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.919 0.39 . . . . 1.0 110.422 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -58.07 -36.84 73.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.107 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.416 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.27 -44.58 83.21 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.868 -0.733 . . . . 1.0 110.542 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -62.18 -50.33 72.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.707 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.67 -40.86 92.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.119 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 m -61.53 -43.82 98.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.098 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.44 -42.8 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.157 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.95 -44.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.578 -0.283 . . . . 1.0 110.882 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.16 -45.96 92.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.061 0.457 . . . . 1.0 110.276 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.94 -37.39 84.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.311 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.12 -48.54 78.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.03 -38.72 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.923 0.392 . . . . 1.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.13 -44.86 90.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.754 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.08 75.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.951 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -72.18 -39.87 68.35 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.68 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.039 -0.981 . . . . 1.0 110.684 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.91 146.6 91.67 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.801 2.334 . . . . 1.0 112.12 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.29 149.49 40.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.054 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.67 -43.63 98.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.173 -0.771 . . . . 1.0 111.173 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' MET . 10.9 p -77.3 160.96 28.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.698 0.285 . . . . 1.0 110.528 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' SER . 23.9 tpp -59.34 -126.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.277 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -140.45 98.53 7.26 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.0 159.62 23.99 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.004 1.802 . . . . 1.0 112.05 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.13 -30.2 88.55 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.673 2.249 . . . . 1.0 111.822 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 10' ' ' LEU . 4.1 mm? -53.94 146.4 28.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.93 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -55.11 144.16 70.9 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.076 1.184 . . . . 1.0 111.5 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.86 -45.15 97.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.551 -0.749 . . . . 1.0 111.015 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.47 -28.67 73.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.14 -0.784 . . . . 1.0 111.14 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 147.39 52.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 1.0 110.976 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -118.28 80.49 15.91 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.431 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.45 97.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.158 1.905 . . . . 1.0 112.689 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' LEU . 98.3 mt -65.47 -41.34 93.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.477 -0.783 . . . . 1.0 109.799 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.6 149.08 28.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.229 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 t -138.23 136.4 36.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.806 0.336 . . . . 1.0 110.619 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.5 p -144.82 151.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.331 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.1 137.52 36.03 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.604 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -150.65 -168.5 15.56 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.647 -0.981 . . . . 1.0 110.647 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -127.84 130.54 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 1.0 110.515 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.55 ' OE1' HD11 ' A' ' 50' ' ' LEU . 81.3 tt0 -93.12 120.82 33.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.457 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 71.4 mtm -107.76 136.09 48.08 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.609 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.91 149.49 38.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.051 0.453 . . . . 1.0 109.965 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -37.11 -65.35 0.6 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.77 -0.65 . . . . 1.0 112.749 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.14 -32.78 95.04 Favored 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 122.728 2.285 . . . . 1.0 114.135 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 179.14 177.21 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 121.084 -0.246 . . . . 1.0 110.61 179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.57 168.86 11.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.0 0.429 . . . . 1.0 110.287 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' OE1' ' OE2' ' A' ' 52' ' ' GLU . 16.7 pt-20 -161.46 143.91 9.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.41 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.46 144.93 95.51 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.338 1.359 . . . . 1.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 22' ' ' GLY . 4.2 p -154.05 -178.13 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.571 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.05 143.13 24.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.197 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 103' ' ' ILE . 49.7 mt -106.25 120.93 43.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.873 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m -127.27 115.36 18.91 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.232 0.539 . . . . 1.0 111.458 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.59 HD23 ' HB1' ' A' ' 115' ' ' ALA . 65.4 tp -87.76 128.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.062 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.88 144.26 41.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 1.0 111.425 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -98.77 121.26 40.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.544 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.95 134.18 42.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.914 0.388 . . . . 1.0 110.948 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 58.15 33.78 23.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.681 -0.69 . . . . 1.0 111.791 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.35 78.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.873 -0.891 . . . . 1.0 110.873 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 44.2 tt0 -131.36 161.28 32.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' N ' ' CG ' ' A' ' 43' ' ' GLN . 94.5 m-85 -103.41 137.25 41.78 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -145.54 144.1 30.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.004 0.43 . . . . 1.0 110.352 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.2 tp -104.57 128.9 52.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.634 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.57 129.17 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.42 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.32 120.18 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' C ' HD22 ' A' ' 50' ' ' LEU . 74.9 mt-30 -108.53 127.83 54.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.082 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.55 HD11 ' OE1' ' A' ' 24' ' ' GLU . 4.2 mm? -101.27 132.44 46.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.906 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -95.49 18.99 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.305 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 31' ' ' GLU . 94.1 mt-10 -45.6 136.84 5.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.419 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.74 -38.5 90.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.195 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.13 -50.92 69.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.377 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -170.58 154.92 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 1.0 111.166 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -84.58 113.88 21.57 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.14 131.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.938 0.399 . . . . 1.0 110.344 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.433 HE22 ' HA ' ' A' ' 10' ' ' LEU . 52.0 tt0 -121.13 117.41 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.585 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -106.53 134.94 48.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.0 mm -93.82 109.54 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.902 0.382 . . . . 1.0 110.16 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.6 mm -112.41 104.59 56.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.067 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 147.82 36.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.596 1.53 . . . . 1.0 112.642 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 97.2 mt -91.81 119.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.431 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 79.3 m-20 -163.85 -165.37 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.059 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.1 p -61.54 -37.25 83.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.34 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -71.57 -32.2 67.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.296 . . . . 1.0 111.186 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 16.4 t80 -92.24 123.24 35.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.931 0.396 . . . . 1.0 109.987 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -135.05 144.48 47.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.549 . . . . 1.0 110.82 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.635 ' O ' HD21 ' A' ' 77' ' ' LEU . 7.5 t -117.96 112.36 20.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.049 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.94 125.83 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.852 0.358 . . . . 1.0 111.012 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' OE1' ' OD1' ' A' ' 80' ' ' ASP . 42.5 tt0 -84.44 102.1 12.52 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.719 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 38.64 47.82 1.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.512 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -174.04 -155.94 0.07 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.009 -0.542 . . . . 1.0 110.685 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -106.62 -6.19 18.14 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.032 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 77' ' ' LEU . 83.4 tt0 -157.43 -85.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.007 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.595 ' O ' HG22 ' A' ' 76' ' ' THR . 89.5 m 54.25 5.89 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.482 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.635 HD21 ' O ' ' A' ' 69' ' ' CYS . 84.7 mt -62.0 -38.81 90.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.253 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 78' ' ' LEU . 10.6 mp -63.27 -41.12 98.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.573 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 76' ' ' THR . 87.8 mt -109.12 127.26 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.053 0.454 . . . . 1.0 111.02 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.514 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 70.5 m-20 -160.39 -41.42 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.323 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.07 -42.57 95.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.59 -32.03 57.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.053 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' ASP . 34.5 t -147.4 126.84 13.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.73 0.3 . . . . 1.0 110.706 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 80' ' ' ASP . 35.4 m120 -147.76 27.02 1.0 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.963 0.411 . . . . 1.0 111.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 t -80.45 100.89 8.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.396 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.96 80.37 0.12 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.952 -1.659 . . . . 1.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.86 129.5 38.76 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.134 0.42 . . . . 1.0 112.134 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.43 121.77 46.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 153.11 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.62 142.9 50.15 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.28 132.69 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.851 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -137.77 135.68 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.985 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 177.44 -174.67 47.14 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.48 -35.93 82.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.333 . . . . 1.0 110.984 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -59.11 -38.48 79.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.534 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 43.2 pt -141.7 151.73 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.37 0.129 . . . . 1.0 110.723 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -71.21 -56.98 4.95 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.879 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -174.32 112.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.479 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.534 ' HE ' ' CD1' ' A' ' 96' ' ' ILE . 76.7 mtm180 -129.33 134.19 47.79 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -91.89 157.58 16.77 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.857 0.361 . . . . 1.0 111.0 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -139.73 153.77 47.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.402 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -140.03 140.78 36.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.841 0.353 . . . . 1.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 35' ' ' LEU . 6.1 mm -128.67 89.61 48.74 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.163 -0.68 . . . . 1.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.07 -16.63 36.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.918 1.745 . . . . 1.0 112.651 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -87.55 106.51 18.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.697 -0.482 . . . . 1.0 109.697 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.0 -54.58 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 1.0 112.032 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.19 -44.23 64.6 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.559 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.433 ' HB3' HG23 ' A' ' 20' ' ' VAL . 57.9 m170 -69.2 -37.14 77.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.736 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 113' ' ' LEU . 11.5 t -62.39 -31.91 72.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.157 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.78 -45.52 92.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.71 -42.99 85.5 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.039 -0.665 . . . . 1.0 110.622 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 116' ' ' VAL . 47.0 t80 -62.65 -51.13 68.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.223 -0.899 . . . . 1.0 111.322 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.462 ' CD1' HD22 ' A' ' 84' ' ' ASN . 91.2 mt -66.76 -41.07 88.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.277 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.9 p -63.19 -45.96 89.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.82 0.343 . . . . 1.0 111.345 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.2 -47.99 63.34 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.414 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 112' ' ' PHE . 55.9 t -64.75 -43.9 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.636 0.255 . . . . 1.0 111.113 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.63 -45.74 91.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 1.0 110.215 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -37.81 87.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.229 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.04 72.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.736 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -70.95 -35.97 72.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.355 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.66 -44.68 96.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.85 97.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.286 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.69 -41.06 88.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.698 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.507 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.81 144.82 99.62 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.912 2.408 . . . . 1.0 112.194 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.36 -41.68 98.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.502 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.86 152.16 52.07 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.894 -0.882 . . . . 1.0 110.894 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.7 p -82.66 -6.12 59.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 1.0 110.534 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.0 tpp -84.31 129.61 34.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.647 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -47.01 152.34 1.0 Allowed Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.496 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 160.25 44.5 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.273 1.982 . . . . 1.0 111.967 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' OE1' ' A' ' 58' ' ' GLN . 35.6 Cg_endo -63.97 -31.51 66.47 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.578 2.185 . . . . 1.0 111.974 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.55 150.92 53.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.12 143.29 99.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.326 1.351 . . . . 1.0 111.526 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 13' ' ' GLY . 13.4 m -68.63 -42.89 83.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -67.26 -28.12 73.64 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.399 -0.68 . . . . 1.0 111.399 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.89 58.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.906 0.384 . . . . 1.0 111.015 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -99.0 102.85 16.62 Favored Pre-proline 0 N--CA 1.465 0.275 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.42 100.58 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.605 1.536 . . . . 1.0 112.915 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.5 -43.72 84.57 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.333 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.43 149.91 31.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -141.82 131.71 24.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.526 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 21' ' ' GLU . 66.4 t -139.17 158.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 121.124 0.488 . . . . 1.0 110.822 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' N ' HG12 ' A' ' 20' ' ' VAL . 97.4 mt-10 -106.29 123.06 47.46 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.523 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.71 -160.5 9.59 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.8 mtt -139.0 127.34 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.867 0.365 . . . . 1.0 110.557 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -87.14 123.89 32.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.628 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.7 mtm -107.35 137.45 45.38 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.61 149.13 50.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.84 -66.61 0.32 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.791 -0.641 . . . . 1.0 112.566 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.21 -33.62 90.06 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.804 2.336 . . . . 1.0 113.537 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -174.46 -174.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.526 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -126.1 168.64 13.73 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.067 0.461 . . . . 1.0 110.635 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -153.88 143.78 15.39 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.459 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.3 146.55 93.76 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.486 1.458 . . . . 1.0 111.117 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 22' ' ' GLY . 15.5 p -155.14 -172.88 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.579 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.73 136.7 16.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.946 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 103' ' ' ILE . 21.8 mt -101.53 122.75 44.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.823 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -128.19 123.26 33.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.237 0.541 . . . . 1.0 111.7 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.607 HD23 ' HB1' ' A' ' 115' ' ' ALA . 46.6 tp -94.77 122.09 37.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.02 151.08 51.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.084 0.469 . . . . 1.0 111.25 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -110.7 122.5 47.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.639 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -134.01 138.62 45.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.981 0.419 . . . . 1.0 110.843 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 58.96 33.8 23.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.41 77.2 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -131.15 155.73 46.51 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -94.83 135.2 36.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.327 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -145.5 139.57 26.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.343 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 47' ' ' ILE . 5.2 tt -105.27 120.75 42.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.84 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.597 ' N ' HD23 ' A' ' 46' ' ' LEU . 79.8 mt -104.46 127.25 58.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.318 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.41 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 65.1 mt -105.37 116.76 49.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -96.15 127.51 42.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.54 133.47 46.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.734 -0.666 . . . . 1.0 109.773 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -106.39 34.33 3.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.306 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -45.81 149.09 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.99 -38.04 89.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.391 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -59.19 -51.2 71.03 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.227 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -175.02 166.27 3.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.749 -0.659 . . . . 1.0 111.026 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -84.62 127.45 34.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.138 -0.483 . . . . 1.0 109.979 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.41 136.03 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.042 0.449 . . . . 1.0 110.439 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 9' ' ' PRO . 56.7 tt0 -100.01 109.38 21.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.184 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -102.34 113.49 26.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.957 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.63 123.09 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.899 0.38 . . . . 1.0 110.381 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -132.37 117.63 15.67 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.141 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.72 157.8 39.61 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.766 1.644 . . . . 1.0 112.645 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.69 123.57 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -173.71 -161.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.1 p -62.08 -39.08 91.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.192 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -67.37 -38.23 84.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.591 -0.277 . . . . 1.0 111.179 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -84.01 125.42 32.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 1.0 110.212 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -134.09 144.59 48.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.297 0.57 . . . . 1.0 110.745 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -127.11 120.66 29.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.278 -0.874 . . . . 1.0 109.251 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 70' ' ' VAL . 6.9 m -119.62 125.3 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.767 0.318 . . . . 1.0 110.596 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.461 ' NE2' ' OG ' ' A' ' 83' ' ' SER . 59.1 tt0 -90.25 118.29 29.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.7 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 38.0 tp10 36.78 64.83 0.53 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.042 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 72' ' ' GLU . . . 171.79 -171.86 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.387 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -97.98 -13.72 20.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.059 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -144.25 -100.16 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 79' ' ' ILE . 45.4 m 39.6 63.13 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.534 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 77' ' ' LEU . 1.3 mp -102.21 -31.09 10.74 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.232 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.85 -40.47 83.67 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.221 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 76' ' ' THR . 91.2 mt -116.6 130.24 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.138 0.494 . . . . 1.0 110.976 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -134.83 -21.24 1.7 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.03 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.75 -42.19 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.379 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.13 -24.46 26.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.941 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.566 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 30.0 t -113.34 124.75 53.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.247 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.9 m120 -150.81 -171.75 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.124 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' OG ' ' A' ' 85' ' ' SER . 4.7 p 66.37 97.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.51 79.04 0.09 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 135.33 36.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.865 0.365 . . . . 1.0 111.946 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -107.58 113.38 26.65 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.412 -0.959 . . . . 1.0 108.412 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.44 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.3 pp -116.17 125.7 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.781 0.324 . . . . 1.0 110.162 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 65.3 mtp180 -102.57 146.52 28.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.651 -0.499 . . . . 1.0 109.651 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.71 132.47 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.678 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -145.61 148.13 32.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.274 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 120.92 -166.41 13.97 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 96' ' ' ILE . 99.0 m-20 43.97 -166.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.39 . . . . 1.0 110.757 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -68.25 21.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 1.0 112.051 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 94' ' ' ASP . 43.9 pt -130.65 155.24 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.602 0.239 . . . . 1.0 110.395 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -96.8 -169.74 1.93 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.716 0.293 . . . . 1.0 110.302 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 90' ' ' ARG . 77.2 tt0 -65.85 127.96 34.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.164 0.507 . . . . 1.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -132.02 160.77 34.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.076 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.466 ' CZ ' ' NH2' ' A' ' 90' ' ' ARG . 85.5 mtt85 -123.58 144.08 49.81 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.953 0.406 . . . . 1.0 110.964 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 91.0 m-85 -143.95 155.95 44.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.947 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -138.71 146.44 41.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 1.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 35' ' ' LEU . 6.0 mm -127.39 90.46 48.66 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.37 -16.09 43.01 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.833 1.689 . . . . 1.0 112.65 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -87.57 100.9 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.15 -53.42 58.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.201 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -52.97 -42.21 65.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.668 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -71.56 -36.57 70.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.885 0.374 . . . . 1.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.48 -36.19 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.064 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.14 -44.41 95.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.478 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -66.72 -44.49 81.48 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.29 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -61.01 -49.37 77.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.204 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.01 -42.43 89.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.539 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.5 m -63.13 -43.8 97.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.419 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.607 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.03 -48.83 61.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.355 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.29 -43.44 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.56 -45.42 91.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.932 0.396 . . . . 1.0 110.257 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.86 85.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.338 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.38 -49.01 77.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.839 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -67.61 -37.69 82.88 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.776 0.322 . . . . 1.0 111.04 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -60.12 -44.34 94.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.053 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.28 94.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 1.0 111.395 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.8 -39.73 91.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.665 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.939 -1.029 . . . . 1.0 110.875 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -60.94 145.0 99.69 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.883 2.389 . . . . 1.0 112.099 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.9 mt -76.22 146.05 39.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.39 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.52 173.42 55.01 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.4 t -74.41 98.13 3.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 1.0 110.435 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.2 mtt -139.27 146.33 40.27 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.532 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.18 114.79 18.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.604 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.14 159.59 23.56 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.019 1.813 . . . . 1.0 112.316 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HG2' HE21 ' A' ' 49' ' ' GLN . 36.5 Cg_endo -66.28 -32.35 41.94 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.669 2.246 . . . . 1.0 111.802 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -78.46 149.66 75.54 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.889 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.39 143.67 89.2 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.805 1.67 . . . . 1.0 111.621 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 m -78.7 -19.5 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.029 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.2 -33.51 84.6 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.32 170.59 15.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.03 0.443 . . . . 1.0 110.98 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.32 81.7 17.61 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.799 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.26 95.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.547 2.165 . . . . 1.0 112.7 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.21 -41.88 96.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.717 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.69 155.62 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.055 -0.975 . . . . 1.0 110.411 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -148.84 142.39 25.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.851 0.357 . . . . 1.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.96 161.05 23.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.304 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -94.99 122.51 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -125.34 167.19 17.78 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.2 mtp -117.6 103.01 9.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.864 0.364 . . . . 1.0 110.292 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' CE1' ' A' ' 101' ' ' PHE . 47.9 tp10 -60.22 121.37 11.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.109 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 102' ' ' GLU . 76.0 mtm -106.32 131.19 53.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.433 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -139.6 146.46 39.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.959 0.409 . . . . 1.0 109.998 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.22 -65.29 0.72 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.568 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.9 -33.38 95.88 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.627 2.218 . . . . 1.0 113.628 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.527 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -178.8 -169.53 0.17 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.659 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -132.65 168.91 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.951 0.405 . . . . 1.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 18.3 pt-20 -154.39 134.8 8.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.24 141.37 70.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 CA-C-N 120.264 1.13 . . . . 1.0 111.369 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 22' ' ' GLY . 28.5 p -149.17 -175.99 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.524 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.43 137.09 12.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.302 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 112' ' ' PHE . 47.7 mt -98.32 122.76 41.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.501 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.8 m -118.87 119.29 33.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.14 0.495 . . . . 1.0 111.283 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.429 HD23 ' HB1' ' A' ' 115' ' ' ALA . 54.7 tp -98.03 130.8 44.83 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.35 154.0 41.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.089 0.471 . . . . 1.0 111.31 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -111.0 122.61 48.34 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -133.21 133.21 42.44 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 1.0 110.556 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 60.86 34.77 19.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.417 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.0 25.35 75.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.029 -0.829 . . . . 1.0 111.029 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -134.82 144.38 47.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.18 -0.304 . . . . 1.0 110.18 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.417 ' HB2' HE21 ' A' ' 123' ' ' GLN . 34.5 m-85 -88.39 136.51 32.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -143.73 144.54 31.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.051 0.453 . . . . 1.0 110.514 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.28 126.01 53.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.499 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.7 mt -111.71 131.64 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.151 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.5 mm -95.2 122.75 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.511 -0.551 . . . . 1.0 109.511 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' C ' HD12 ' A' ' 50' ' ' LEU . 13.2 mm100 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.818 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.1 mp -109.92 136.12 49.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.971 -0.558 . . . . 1.0 109.809 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -104.81 20.41 18.78 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.25 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.8 mt-10 -40.43 141.07 0.56 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.88 0.371 . . . . 1.0 110.668 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.92 -39.64 92.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.474 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.47 -51.88 67.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.365 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -173.98 147.08 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.478 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 19.6 p80 -75.83 112.51 12.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 t -90.77 132.76 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -112.38 117.91 33.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.649 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -121.83 127.65 50.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.929 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.1 mt -100.4 125.91 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.056 0.455 . . . . 1.0 110.487 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.559 HG23 ' HE1' ' A' ' 95' ' ' TRP . 60.0 mt -129.67 93.2 35.46 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.438 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.78 145.05 85.26 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.147 1.898 . . . . 1.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 97.6 mt -85.88 117.66 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.316 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 53.2 p30 -176.73 -160.37 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.121 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.7 p -65.47 -23.25 66.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.283 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -83.76 -10.46 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.02 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 27.2 t80 -113.78 129.81 56.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.963 0.411 . . . . 1.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' NH2' ' OE1' ' A' ' 75' ' ' GLU . 77.0 mtp180 -129.67 155.73 45.39 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.582 0.706 . . . . 1.0 111.081 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.547 ' H ' HD22 ' A' ' 77' ' ' LEU . 26.3 p -144.48 100.2 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.562 -1.199 . . . . 1.0 109.798 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 70' ' ' VAL . 33.2 m -102.53 122.39 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.844 0.355 . . . . 1.0 110.617 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 83' ' ' SER . 56.3 tt0 -98.81 125.4 44.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.05 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 47.34 18.83 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.914 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 71' ' ' GLN . . . -158.79 -160.62 0.88 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.685 -0.689 . . . . 1.0 111.066 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' O ' HG11 ' A' ' 70' ' ' VAL . 97.6 mt-10 -129.52 -8.55 4.63 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.405 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.534 ' OE1' ' NH2' ' A' ' 68' ' ' ARG . 43.8 tp10 -147.96 83.43 1.51 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.13 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' ILE . 6.2 t -157.84 44.25 0.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.228 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.547 HD22 ' H ' ' A' ' 69' ' ' CYS . 53.5 mt -63.38 -43.02 98.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.177 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.37 -37.62 74.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.979 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 76' ' ' THR . 79.3 mt -99.81 127.71 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.093 0.473 . . . . 1.0 111.129 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 71.9 m-20 -155.48 -29.47 0.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.219 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.74 -42.56 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.527 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.17 -31.73 53.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.04 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.561 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 40.8 m -105.53 120.75 42.41 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.095 -0.335 . . . . 1.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 83' ' ' SER . 10.3 m120 -150.16 -167.99 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.227 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.87 86.77 0.12 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.33 69.84 1.27 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.005 -1.638 . . . . 1.0 109.005 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.3 142.57 27.26 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.047 0.451 . . . . 1.0 111.896 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -128.3 131.18 48.69 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.96 162.72 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.323 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.764 ' NH2' HH22 ' A' ' 100' ' ' ARG . 68.0 mtt180 -128.58 140.48 51.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.96 134.7 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.99 0.424 . . . . 1.0 110.626 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -126.85 140.06 52.63 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.334 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -169.61 -175.34 38.65 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.533 ' OD1' ' CE3' ' A' ' 95' ' ' TRP . 13.4 p-10 -74.43 -37.77 63.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.714 0.292 . . . . 1.0 111.191 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.559 ' HE1' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -65.71 -34.92 79.32 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.385 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 93' ' ' GLY . 25.5 pt -127.74 156.55 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.676 0.274 . . . . 1.0 110.634 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 98' ' ' GLU . 3.9 ptm180 -84.93 -53.28 5.41 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.798 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 97' ' ' ARG . 47.8 tp10 -174.97 93.55 0.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 1.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -104.56 135.05 46.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.764 HH22 ' NH2' ' A' ' 90' ' ' ARG . 57.4 mtp85 -101.37 150.25 23.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.937 0.399 . . . . 1.0 110.812 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.549 ' CE1' ' OE1' ' A' ' 24' ' ' GLU . 70.1 m-85 -129.24 154.9 46.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.556 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 25' ' ' MET . 81.4 tt0 -149.04 121.73 8.63 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.988 0.423 . . . . 1.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.16 98.41 26.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.78 -10.67 25.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.68 1.587 . . . . 1.0 112.595 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -94.35 106.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.86 -54.98 41.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.002 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -50.07 -44.85 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.519 -0.473 . . . . 1.0 110.464 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -68.57 -40.19 80.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 1.0 110.642 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.16 -36.85 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.033 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -63.7 -44.66 93.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.46 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.26 -45.22 81.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.312 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 53.3 t80 -61.48 -49.1 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.405 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.4 -41.58 80.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.344 -0.542 . . . . 1.0 111.238 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.2 t -63.36 -44.97 93.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.686 0.279 . . . . 1.0 111.535 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -69.63 -50.32 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.465 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.8 -45.18 99.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.592 -0.276 . . . . 1.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -60.67 -46.01 91.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.007 0.432 . . . . 1.0 110.318 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -35.09 76.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 1.0 110.533 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.44 99.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.818 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -66.38 -40.2 89.54 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.663 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -63.25 -44.22 95.79 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.624 0.726 . . . . 1.0 110.115 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.4 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.174 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' A' ' 63' ' ' ILE . 89.3 mt-30 -66.26 -40.58 90.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.742 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.599 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.585 -1.406 . . . . 1.0 109.585 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.57 -18.04 48.53 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.646 2.23 . . . . 1.0 112.092 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 4' ' ' GLY . 5.6 tt -97.84 120.43 38.22 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.873 0.368 . . . . 1.0 110.104 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.624 ' N ' HD23 ' A' ' 3' ' ' LEU . . . 164.0 -43.12 0.32 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -70.88 139.81 50.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.332 . . . . 1.0 110.632 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.64 -40.4 95.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.352 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -105.13 103.75 43.52 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.431 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -82.33 160.05 17.42 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.165 1.91 . . . . 1.0 112.255 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.521 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 29.8 Cg_endo -62.22 -30.2 81.37 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.667 2.245 . . . . 1.0 111.958 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 mt -52.62 162.17 0.99 Allowed Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.826 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.83 152.41 64.04 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.488 1.459 . . . . 1.0 111.443 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -85.97 70.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.692 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.86 -26.93 0.39 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.57 140.67 53.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 111.035 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 15.5 mm100 -102.54 80.95 0.35 Allowed Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.69 88.42 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.681 1.587 . . . . 1.0 112.152 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.695 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.42 137.58 38.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.578 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.28 125.76 26.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.503 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 21' ' ' GLU . 54.6 t -135.93 157.07 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.767 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.523 ' OE1' ' HB2' ' A' ' 34' ' ' ALA . 46.7 tp10 -105.79 122.96 47.16 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.98 -157.76 8.78 Favored Glycine 0 N--CA 1.463 0.491 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -140.51 123.59 16.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.886 0.374 . . . . 1.0 110.36 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -88.94 119.32 29.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 25' ' ' MET . 1.3 mpp? -107.58 136.04 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.509 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -131.68 149.08 52.6 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -65.82 0.41 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.635 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.83 -32.62 85.7 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.814 2.343 . . . . 1.0 113.705 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -174.43 -176.72 1.12 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.434 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -126.72 169.1 13.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 1.0 110.682 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -158.15 141.98 11.28 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.553 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.25 144.34 95.33 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.297 1.331 . . . . 1.0 110.985 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.3 p -152.01 174.21 13.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.321 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -140.09 131.78 27.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.955 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 103' ' ' ILE . 31.1 mt -96.63 121.6 38.64 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.999 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.3 m -129.24 124.67 35.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.197 0.522 . . . . 1.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD23 ' HB1' ' A' ' 115' ' ' ALA . 37.4 tp -90.24 125.86 35.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.432 -0.803 . . . . 1.0 108.851 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.86 155.45 42.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.127 0.489 . . . . 1.0 111.052 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' OE1' ' CZ ' ' A' ' 44' ' ' TYR . 20.6 tt0 -134.19 116.52 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.829 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.464 ' CZ ' ' OE1' ' A' ' 45' ' ' GLU . 34.2 ptt180 -137.25 144.21 42.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.233 0.539 . . . . 1.0 111.248 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 59.11 28.05 17.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.107 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.04 78.37 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -127.31 137.88 52.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CZ ' ' OE1' ' A' ' 39' ' ' GLN . 84.1 m-85 -87.92 135.72 33.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 40' ' ' ARG . 22.6 pt-20 -144.89 144.61 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 1.0 110.482 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.9 tp -103.76 121.16 42.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.292 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.2 mt -105.16 124.77 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.307 -0.406 . . . . 1.0 109.944 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.35 115.89 49.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' C ' HD12 ' A' ' 50' ' ' LEU . 80.4 mt-30 -96.78 131.8 43.13 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.983 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 49' ' ' GLN . 9.1 mp -106.82 130.43 54.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.805 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -104.06 29.17 6.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.126 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE1' ' OE2' ' A' ' 54' ' ' GLU . 96.6 mt-10 -43.69 145.6 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.606 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.14 -36.07 82.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' OE2' ' OE1' ' A' ' 52' ' ' GLU . 3.3 pt-20 -62.03 -46.72 87.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.823 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -177.29 154.96 1.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.567 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -78.01 127.84 32.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.0 109.876 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.42 135.94 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.042 0.449 . . . . 1.0 110.474 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 83.4 mt-30 -108.6 126.37 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.158 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.82 119.02 36.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.716 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.5 mm -92.75 112.64 26.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.93 0.395 . . . . 1.0 110.369 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mm -117.64 89.44 32.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.221 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.67 141.44 95.47 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.228 1.952 . . . . 1.0 112.455 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -83.53 124.81 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.558 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.627 ' ND2' ' CD2' ' A' ' 66' ' ' HIS . 5.2 p30 176.04 -165.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.963 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -59.19 -38.04 78.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.706 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CD2' ' ND2' ' A' ' 64' ' ' ASN . 3.3 p80 -74.54 -2.75 27.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.75 0.31 . . . . 1.0 111.401 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 42.0 t80 -116.25 132.21 56.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.155 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -130.71 148.29 52.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.861 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.1 t -143.2 104.32 4.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.052 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.21 128.14 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.885 0.374 . . . . 1.0 110.886 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' N ' ' A' ' 88' ' ' LYS . 58.2 tp60 -78.9 96.15 5.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.168 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 36.92 57.65 1.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -159.01 164.92 35.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.982 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -68.05 -37.69 81.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.68 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -170.73 81.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.668 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 79' ' ' ILE . 4.6 m -123.15 45.67 2.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.073 0.463 . . . . 1.0 110.523 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.541 ' H ' HD12 ' A' ' 77' ' ' LEU . 5.0 mp -67.62 -36.49 80.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.569 . . . . 1.0 111.439 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.37 -42.91 99.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.453 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 76' ' ' THR . 91.4 mt -110.78 129.46 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.093 0.473 . . . . 1.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 97.8 m-20 -142.11 -30.17 0.57 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.289 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.86 -41.99 94.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.493 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.01 -22.52 5.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.905 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 11.0 t -111.42 122.84 48.9 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.054 0.454 . . . . 1.0 110.414 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 83' ' ' SER . 13.7 m120 -148.74 -166.79 2.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.07 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.402 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 t 56.82 88.92 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.73 72.52 0.7 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.447 -1.461 . . . . 1.0 109.447 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.482 ' CB ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.32 134.94 36.28 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.799 0.333 . . . . 1.0 111.686 -178.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.623 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 63.8 mttp -111.87 131.63 55.23 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 35' ' ' LEU . 34.2 pt -125.15 157.96 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.74 ' NH2' HH22 ' A' ' 100' ' ' ARG . 96.9 mtt180 -131.19 137.94 49.18 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.2 132.25 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -146.91 154.71 41.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.358 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -165.04 172.54 40.73 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -67.64 -44.5 77.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.866 0.365 . . . . 1.0 111.219 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CE2' HG23 ' A' ' 96' ' ' ILE . 1.0 OUTLIER -85.08 -11.76 54.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.121 -0.49 . . . . 1.0 112.073 -178.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.562 HG23 ' CE2' ' A' ' 95' ' ' TRP . 42.4 pt -126.24 153.78 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.639 0.257 . . . . 1.0 110.655 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -92.03 162.6 14.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.667 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -63.42 136.08 57.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.409 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -136.13 159.14 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.131 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.74 HH22 ' NH2' ' A' ' 90' ' ' ARG . 66.6 mtp85 -122.23 145.11 48.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.061 0.458 . . . . 1.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -140.21 155.67 46.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.175 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -139.41 141.51 37.51 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.891 0.376 . . . . 1.0 111.06 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.506 HD11 HD12 ' A' ' 35' ' ' LEU . 5.1 mm -124.03 89.45 51.69 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.62 -15.62 37.72 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.85 1.7 . . . . 1.0 112.762 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -88.65 105.12 17.46 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.4 tt0 -60.43 -53.84 52.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.23 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -53.06 -42.45 65.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.571 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -70.27 -37.68 74.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.492 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.61 -34.44 74.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.423 . . . . 1.0 111.001 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.72 -44.74 95.44 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.309 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.87 -43.25 84.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.164 -0.615 . . . . 1.0 110.579 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.476 ' CE2' HD13 ' A' ' 89' ' ' ILE . 59.1 t80 -60.27 -49.2 78.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.293 -0.867 . . . . 1.0 111.211 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.9 -41.86 86.43 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.336 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 57.8 m -63.53 -44.17 95.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.822 0.344 . . . . 1.0 111.451 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -70.34 -48.8 54.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.609 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' CE1' ' A' ' 112' ' ' PHE . 62.3 t -65.45 -43.57 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.904 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.92 -45.11 93.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 110.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.92 -38.85 89.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.6 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.3 -49.34 76.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.765 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.48 -36.78 74.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.335 . . . . 1.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.76 -44.93 94.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.158 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.9 95.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.285 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -67.86 -41.23 83.22 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.63 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.15 145.24 96.4 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.951 2.434 . . . . 1.0 112.229 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.88 -41.4 97.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.48 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.43 6.1 18.07 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.3 t -66.83 133.46 50.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 1.0 110.881 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.29 -39.77 92.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.322 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -139.56 98.58 7.98 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.178 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.47 160.41 14.78 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.273 1.982 . . . . 1.0 112.32 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 58' ' ' GLN . 33.1 Cg_endo -63.41 -31.07 72.75 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.647 2.231 . . . . 1.0 111.77 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.1 155.6 16.15 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.158 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.55 143.86 99.48 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.336 1.358 . . . . 1.0 111.628 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.6 -44.96 93.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.14 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.62 78.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 140.41 58.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 1.0 110.961 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -104.07 80.7 0.44 Allowed Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.242 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.75 99.95 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.98 1.787 . . . . 1.0 112.102 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -64.65 -43.85 92.3 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.392 0.615 . . . . 1.0 110.154 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.87 141.36 24.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.19 -0.914 . . . . 1.0 109.932 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -131.64 128.87 40.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.212 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.9 162.25 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.147 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -99.75 122.62 43.0 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -123.06 179.2 16.2 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.854 -0.899 . . . . 1.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 93.3 mmm -126.15 99.61 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' A' ' 99' ' ' ARG . 81.3 tt0 -62.29 132.54 52.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.098 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 73.9 mtm -120.8 140.25 51.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.782 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -141.56 148.68 39.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.32 -65.59 0.34 Allowed Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.779 -0.646 . . . . 1.0 112.504 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.63 -31.85 92.62 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.65 2.233 . . . . 1.0 114.108 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 179.35 176.28 0.63 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.399 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -118.01 169.2 9.85 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.981 0.419 . . . . 1.0 110.177 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.39 141.9 13.25 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.448 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 144.91 96.39 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.026 1.15 . . . . 1.0 111.359 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 22' ' ' GLY . 17.1 p -153.58 -179.84 8.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.438 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' C ' HD22 ' A' ' 35' ' ' LEU . . . -138.93 128.64 24.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.081 0.467 . . . . 1.0 110.239 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 35' ' ' LEU . 3.9 mm? -100.52 119.66 38.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.966 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.6 m -130.66 122.01 26.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.0 111.853 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.661 HD23 ' HB1' ' A' ' 115' ' ' ALA . 57.5 tp -90.42 129.99 36.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.006 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.29 148.63 41.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.44 . . . . 1.0 111.457 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -109.02 121.24 44.72 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.037 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.66 136.65 46.6 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.057 0.456 . . . . 1.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 m120 59.73 33.66 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.521 -0.763 . . . . 1.0 111.908 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.37 77.82 Favored Glycine 0 N--CA 1.463 0.476 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -130.36 154.39 47.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.483 -0.359 . . . . 1.0 110.055 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -92.58 135.1 34.36 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -143.94 143.81 31.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 1.0 110.317 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -103.89 124.78 49.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.423 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.53 118.07 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.7 mt -103.44 120.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.643 -0.502 . . . . 1.0 109.643 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' HD12 ' A' ' 50' ' ' LEU . 79.1 mt-30 -115.08 129.58 56.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.762 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.4 mp -101.22 127.37 47.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.562 -0.532 . . . . 1.0 109.562 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -76.73 62.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.298 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.3 154.34 40.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.252 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -62.46 -40.83 97.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.193 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.33 -82.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.882 0.372 . . . . 1.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -142.29 152.14 42.7 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -70.71 123.07 21.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.22 133.89 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.12 0.486 . . . . 1.0 110.481 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 9' ' ' PRO . 81.9 mt-30 -95.23 123.92 38.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.86 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -120.45 117.08 26.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.444 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.22 110.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.911 0.386 . . . . 1.0 110.626 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.438 HG23 ' HE1' ' A' ' 95' ' ' TRP . 34.7 mm -115.16 119.07 39.31 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.165 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.01 150.83 43.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.797 1.665 . . . . 1.0 112.669 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.442 HG23 HE21 ' A' ' 120' ' ' GLN . 97.8 mt -104.46 118.35 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.319 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.9 p30 -172.22 -153.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.234 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.0 p -64.16 -40.24 95.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.191 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -66.6 -41.15 88.92 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.139 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 8.0 t80 -96.23 130.1 43.39 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.788 0.328 . . . . 1.0 110.18 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -139.42 142.54 37.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.541 . . . . 1.0 110.826 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -119.91 115.5 23.92 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.12 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.77 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.91 0.386 . . . . 1.0 110.644 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.658 ' C ' ' H ' ' A' ' 73' ' ' ALA . 49.5 tt0 -81.05 107.18 13.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.416 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 73' ' ' ALA . 94.1 mt-10 60.59 -16.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.458 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . 37.96 -158.09 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.527 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 56.34 3.31 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.143 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 73' ' ' ALA . 5.3 pt-20 179.25 -19.98 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.872 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.37 71.9 1.4 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.126 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.505 ' H ' HD12 ' A' ' 77' ' ' LEU . 4.5 mp -78.5 -74.67 0.26 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.955 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 78' ' ' LEU . 11.1 mp -71.98 -39.01 69.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.698 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 89.4 mt -78.99 137.57 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.181 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 83' ' ' SER . 89.0 m-20 -136.57 -29.29 0.96 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.014 0.435 . . . . 1.0 110.139 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.41 -42.74 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.757 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.86 -9.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.233 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.2 t -139.98 136.43 33.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 1.0 110.239 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 83' ' ' SER . 18.0 m120 -148.54 -173.07 4.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.827 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 85' ' ' SER . 3.0 p 75.7 99.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.44 77.7 0.13 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.499 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.41 139.78 30.67 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.246 0.461 . . . . 1.0 112.246 -177.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -113.1 125.2 54.11 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.334 -0.987 . . . . 1.0 108.334 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pt -119.02 130.46 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.444 ' CZ ' HH11 ' A' ' 100' ' ' ARG . 20.2 mmt180 -96.26 142.59 28.22 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.9 t -124.93 135.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 1.0 110.197 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -131.47 139.36 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.739 -0.664 . . . . 1.0 110.012 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -165.92 170.3 40.6 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.808 -0.917 . . . . 1.0 110.808 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -69.6 -42.7 74.08 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 122.534 -0.392 . . . . 1.0 111.505 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.438 ' HE1' HG23 ' A' ' 61' ' ' ILE . 1.8 p90 -65.55 -32.07 73.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 1.0 111.795 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.486 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.3 pt -128.58 139.35 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 110.338 -0.245 . . . . 1.0 110.338 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.41 -57.58 7.98 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.771 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -175.51 108.22 0.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.426 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' A' ' 24' ' ' GLU . 85.6 mtp180 -107.05 123.84 48.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.662 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.444 HH11 ' CZ ' ' A' ' 90' ' ' ARG . 94.9 mtt-85 -83.97 146.28 28.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.183 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.17 147.48 36.68 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.241 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.05 152.33 39.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.705 0.288 . . . . 1.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -126.84 102.49 25.07 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.89 -13.06 29.08 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.648 1.565 . . . . 1.0 112.953 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -91.81 105.4 17.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.14 -54.82 42.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.167 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.687 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.1 pm0 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.439 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.55 -38.93 81.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 1.0 110.348 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.494 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -57.09 -36.43 70.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.798 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.0 mt -61.88 -46.28 90.11 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.152 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.85 -44.53 80.77 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.905 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.32 -48.87 76.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD13 ' NE2' ' A' ' 71' ' ' GLN . 95.9 mt -65.91 -41.66 91.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.552 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.7 m -62.16 -43.46 98.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.831 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -68.29 -47.32 67.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HA ' HD22 ' A' ' 37' ' ' LEU . 76.6 t -66.59 -42.49 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.953 0.406 . . . . 1.0 111.158 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.32 -42.68 91.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.167 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.76 90.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.248 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.05 87.9 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.623 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 63' ' ' ILE . 60.2 mm-40 -69.9 -38.31 76.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.97 -46.04 92.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.055 0.455 . . . . 1.0 109.832 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.15 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 1.0 111.48 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.39 -39.07 88.83 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.605 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.451 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.479 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.675 -1.37 . . . . 1.0 109.675 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 34.1 Cg_endo -63.9 -22.42 68.71 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.759 2.306 . . . . 1.0 111.988 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.92 -42.11 99.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.247 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.77 -124.73 36.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.7 m -71.62 159.72 33.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 1.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.2 mtm -63.18 -40.09 96.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.149 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -87.05 151.68 52.11 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.173 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.94 159.76 37.66 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.168 1.912 . . . . 1.0 112.109 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.8 -32.51 77.7 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.749 2.299 . . . . 1.0 112.071 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.6 mt -71.08 150.03 94.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.859 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.76 142.03 61.92 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.914 1.742 . . . . 1.0 111.466 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.32 -32.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.734 -0.667 . . . . 1.0 111.349 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.05 -36.36 90.18 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB1' ' HB1' ' A' ' 38' ' ' ALA . . . -80.7 165.87 21.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 1.0 110.978 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.53 80.67 22.9 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.602 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.23 96.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.676 2.251 . . . . 1.0 112.773 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.3 mt -65.37 -41.43 93.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.83 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.06 146.59 27.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.251 -0.886 . . . . 1.0 110.36 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 t -134.31 131.06 37.92 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.807 0.337 . . . . 1.0 110.542 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 35' ' ' LEU . 28.3 m -137.97 160.79 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.367 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -100.08 154.79 18.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.623 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -169.92 -169.61 33.35 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 23' ' ' MET . 2.5 mpt? -132.2 129.19 39.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.963 0.411 . . . . 1.0 110.388 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -91.97 117.36 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.44 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.8 mtm -101.49 135.66 42.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.789 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.79 151.47 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.714 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.35 -67.03 0.33 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 115.799 -0.637 . . . . 1.0 112.667 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.35 -33.77 88.48 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.882 2.388 . . . . 1.0 113.603 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.36 -176.61 0.78 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.603 179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -122.07 168.45 11.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.11 0.481 . . . . 1.0 110.695 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -155.28 142.41 13.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.784 -0.644 . . . . 1.0 109.737 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.03 143.39 94.97 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.355 1.37 . . . . 1.0 111.257 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 22' ' ' GLY . 12.4 p -153.57 -179.2 7.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.385 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.23 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.936 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.52 HD13 HD11 ' A' ' 89' ' ' ILE . 26.6 mt -101.58 123.77 46.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.5 m -127.43 124.29 38.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.227 0.537 . . . . 1.0 111.357 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.618 HD23 ' HB1' ' A' ' 115' ' ' ALA . 54.7 tp -91.59 128.93 37.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.016 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.45 148.68 43.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.159 0.504 . . . . 1.0 111.388 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -109.23 123.06 48.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.723 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -135.09 135.81 41.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.967 0.413 . . . . 1.0 111.194 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.13 34.59 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.658 -0.701 . . . . 1.0 111.523 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.4 21.75 76.11 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -129.89 156.76 43.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -98.54 132.46 43.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -140.79 147.08 38.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.025 0.44 . . . . 1.0 110.065 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -103.99 122.21 44.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.438 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.52 117.76 51.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.0 mt -99.75 118.41 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' HD12 ' A' ' 50' ' ' LEU . 77.0 mt-30 -100.03 131.64 45.87 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.909 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.442 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.6 mp -105.99 123.34 47.84 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -80.11 36.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.154 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' LEU . 35.0 tp10 -46.47 135.0 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.985 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.4 -35.88 81.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -66.79 -80.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.402 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -132.57 129.28 38.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.933 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -61.94 102.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.922 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.91 131.44 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -107.79 136.57 47.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.956 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 40.6 t0 -101.03 123.5 45.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.5 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.31 119.26 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 1.0 110.3 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.459 HD11 ' NH1' ' A' ' 99' ' ' ARG . 6.8 mt -133.11 119.23 15.52 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.896 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.49 157.21 40.82 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.678 1.586 . . . . 1.0 112.598 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.46 119.67 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.537 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' PHE . 53.8 p30 -171.89 -160.06 0.15 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.43 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 t -61.12 -41.79 97.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.041 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -64.81 -36.15 83.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.875 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 64' ' ' ASN . 28.2 t80 -95.0 136.87 34.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.968 0.413 . . . . 1.0 110.439 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' A' ' 92' ' ' GLN . 37.5 ptt180 -143.38 145.99 33.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.904 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 69' ' ' CYS . 27.5 p -117.0 99.66 7.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.384 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 70' ' ' VAL . 31.8 m -102.82 124.26 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.032 0.444 . . . . 1.0 110.985 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.648 ' H ' ' CG2' ' A' ' 76' ' ' THR . 9.2 tp-100 -83.14 100.84 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.381 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 63.94 -26.29 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.792 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 71' ' ' GLN . . . -92.43 -158.79 0.61 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.88 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -133.65 7.18 3.8 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.532 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -170.92 36.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.648 ' CG2' ' H ' ' A' ' 71' ' ' GLN . 7.6 t -94.46 40.46 1.09 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.464 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.4 mt -63.54 -39.56 94.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.514 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 78' ' ' LEU . 3.8 mm? -63.39 -41.28 98.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.659 -0.246 . . . . 1.0 110.565 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' THR . 86.4 mt -116.73 127.55 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.24 0.543 . . . . 1.0 111.228 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 98.5 m-20 -142.52 -39.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.376 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.94 -42.47 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.675 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.33 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.029 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -106.9 78.26 1.23 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.099 0.476 . . . . 1.0 110.577 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -104.67 -170.4 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.404 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.4 m 64.59 88.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.69 82.92 0.06 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.56 135.24 41.27 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.834 0.309 . . . . 1.0 111.834 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 65.7 mttp -111.53 128.71 56.1 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.52 HD11 HD13 ' A' ' 35' ' ' LEU . 33.6 pt -125.01 157.35 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.31 134.63 45.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.99 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.46 132.94 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.366 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.516 ' NE2' ' OE1' ' A' ' 98' ' ' GLU . 86.2 mt-30 -135.4 152.79 51.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.024 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -168.08 167.61 40.26 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 95' ' ' TRP . 36.9 p-10 -68.03 -39.54 83.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.791 0.329 . . . . 1.0 111.266 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.528 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 3.2 p-90 -88.42 -9.89 51.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.759 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.497 HG23 ' CE2' ' A' ' 95' ' ' TRP . 14.3 pt -125.13 151.42 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.787 0.327 . . . . 1.0 110.657 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 -95.34 -171.89 2.51 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 1.0 110.765 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.516 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 48.5 tp10 -61.01 128.45 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 1.0 110.526 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.459 ' NH1' HD11 ' A' ' 61' ' ' ILE . 99.9 mtt180 -135.35 143.39 46.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.033 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -127.16 145.99 50.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.752 0.31 . . . . 1.0 111.181 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -144.25 153.72 42.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.357 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -143.51 147.35 34.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.972 0.415 . . . . 1.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.452 HD11 HD12 ' A' ' 35' ' ' LEU . 5.1 mp -128.03 98.73 26.5 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 -11.29 28.6 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.706 1.604 . . . . 1.0 112.67 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 105.3 17.6 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.2 tt0 -59.09 -53.98 52.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -50.75 -43.52 58.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.576 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -69.97 -40.21 75.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.879 0.371 . . . . 1.0 110.531 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -57.1 -34.87 68.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.083 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.519 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.48 -44.84 81.56 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.185 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CE2' HD13 ' A' ' 89' ' ' ILE . 57.0 t80 -59.88 -48.67 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.158 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.11 -41.36 86.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.389 -0.525 . . . . 1.0 111.281 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -65.59 -46.08 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.607 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.618 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.13 -50.05 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.318 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.4 HG21 ' CE1' ' A' ' 112' ' ' PHE . 61.5 t -64.15 -44.21 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.66 -45.21 95.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.421 . . . . 1.0 110.196 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.42 82.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.452 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.44 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.678 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.462 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 87.3 mt-30 -69.77 -38.6 76.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.956 0.407 . . . . 1.0 110.84 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -63.95 -44.46 92.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.039 0.447 . . . . 1.0 110.919 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.95 75.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.866 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.85 -40.51 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 1.0 110.571 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.595 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.23 150.64 87.24 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.743 2.295 . . . . 1.0 112.029 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.51 141.37 48.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.184 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' SER . . . -85.26 177.42 50.5 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.958 -0.857 . . . . 1.0 110.958 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 4' ' ' GLY . 66.6 m 51.54 102.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.776 0.322 . . . . 1.0 110.467 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.5 mtt -63.59 -39.96 95.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.367 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.37 96.99 41.8 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.307 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.35 159.49 17.34 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.232 1.955 . . . . 1.0 112.256 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.7 -32.23 68.61 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.652 2.235 . . . . 1.0 112.025 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.76 144.44 85.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.956 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.64 148.51 53.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.797 1.665 . . . . 1.0 111.841 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.18 -43.15 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.563 . . . . 1.0 111.109 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.5 -36.64 47.79 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.76 151.12 47.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 1.0 110.825 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -118.15 83.57 20.12 Favored Pre-proline 0 N--CA 1.469 0.483 0 CA-C-N 115.585 -0.734 . . . . 1.0 109.326 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.56 125.04 16.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.262 1.975 . . . . 1.0 112.431 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.7 mt -101.1 -32.66 10.47 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.428 -0.805 . . . . 1.0 109.632 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.48 151.19 29.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.326 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 t -146.33 129.17 16.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.859 0.361 . . . . 1.0 110.556 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -141.43 163.15 20.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.259 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -101.37 122.43 43.72 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -131.54 152.11 19.96 Favored Glycine 0 N--CA 1.464 0.555 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 mmm -99.19 100.66 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.999 0.428 . . . . 1.0 110.187 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.84 126.8 28.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.589 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.441 ' SD ' ' C ' ' A' ' 101' ' ' PHE . 1.6 mpp? -109.85 137.16 48.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.03 149.79 50.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.635 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.28 -66.23 0.3 Allowed Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.915 -0.584 . . . . 1.0 112.633 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.49 -33.28 88.15 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.796 2.331 . . . . 1.0 113.484 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -177.79 -172.51 0.35 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.672 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -122.67 168.87 11.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.047 0.451 . . . . 1.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -154.12 140.87 13.12 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.723 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.22 142.0 84.71 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.267 1.312 . . . . 1.0 111.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' GLY . 13.6 p -150.95 169.23 22.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.551 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.18 118.94 19.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 109.852 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 101' ' ' PHE . 13.2 mt -91.92 126.3 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.012 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.6 m -130.81 120.69 24.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.095 0.474 . . . . 1.0 111.344 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.523 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.6 tp -90.38 130.99 36.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.07 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.81 148.17 32.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.173 0.511 . . . . 1.0 111.362 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.72 127.01 48.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -138.0 138.15 38.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.887 0.375 . . . . 1.0 111.007 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.44 35.22 24.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.662 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.56 27.56 73.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.7 158.95 43.28 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -99.27 130.34 45.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.908 -0.405 . . . . 1.0 109.908 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.27 143.77 34.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.931 0.396 . . . . 1.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.4 125.21 50.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.275 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -103.31 124.6 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mt -99.25 128.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.141 -0.689 . . . . 1.0 109.141 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' C ' HD12 ' A' ' 50' ' ' LEU . 14.2 mm100 -118.4 119.62 35.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.691 0.282 . . . . 1.0 110.807 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -100.58 131.18 46.63 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.572 ' HD1' ' CD2' ' A' ' 56' ' ' HIS . 95.4 m-70 -94.29 60.53 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 1.0 110.413 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.24 157.6 10.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.183 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.15 -38.74 87.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.754 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 54' ' ' GLU . 56.6 mp0 -78.96 -104.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.226 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -106.52 152.49 23.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.572 ' CD2' ' HD1' ' A' ' 51' ' ' HIS . 60.7 m80 -73.3 145.77 45.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.233 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.76 130.7 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.983 0.42 . . . . 1.0 110.303 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -106.53 108.08 19.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.788 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -116.74 113.05 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.633 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.41 115.64 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.387 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.05 120.18 39.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.99 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.38 147.89 33.15 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.791 1.661 . . . . 1.0 112.498 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.513 ' CG2' HE22 ' A' ' 123' ' ' GLN . 96.4 mt -92.8 122.49 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.228 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' PHE . 54.6 p30 -174.16 -159.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.353 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -41.25 90.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.2 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -66.06 -36.28 82.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.353 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . 15.1 t80 -101.54 123.63 45.88 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -133.81 141.08 47.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.326 0.584 . . . . 1.0 111.026 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.0 t -103.31 105.87 16.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.245 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.54 HG12 HD23 ' A' ' 77' ' ' LEU . 5.9 m -111.07 126.4 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.229 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.408 ' OE1' ' O ' ' A' ' 83' ' ' SER . 48.1 tt0 -97.49 131.1 44.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.492 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 59.49 -100.99 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.374 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.58 170.66 16.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.005 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' O ' HD21 ' A' ' 77' ' ' LEU . 80.8 mm-40 -83.4 -10.74 58.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.737 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -82.3 -12.75 57.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.842 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.441 ' O ' ' OG1' ' A' ' 76' ' ' THR . 1.1 p -87.81 42.88 1.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.125 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 70' ' ' VAL . 54.6 mt -61.79 -43.02 99.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.109 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -108.34 -9.36 15.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.595 0.236 . . . . 1.0 111.223 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.437 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 76.5 mt -102.4 130.42 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.911 0.386 . . . . 1.0 110.543 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.659 ' HB3' HD12 ' A' ' 113' ' ' LEU . 94.8 m-20 -144.9 -32.75 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.85 -0.613 . . . . 1.0 110.396 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 41.0 mm -64.58 -42.26 94.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.68 -27.02 15.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.815 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 9.5 t -123.81 119.1 28.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.043 0.449 . . . . 1.0 110.314 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 83' ' ' SER . 23.4 m120 -146.73 -167.0 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 1.0 109.827 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m 64.24 92.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.05 67.18 2.18 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 108.892 -1.683 . . . . 1.0 108.892 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 148.95 25.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.221 0.534 . . . . 1.0 111.596 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HE2' HH21 ' A' ' 90' ' ' ARG . 25.2 pttm -129.85 135.83 48.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.335 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.33 162.89 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.306 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.418 HH21 ' HE2' ' A' ' 88' ' ' LYS . 3.4 mpt_? -123.99 137.52 54.59 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.8 t -116.92 133.84 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.922 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -140.77 152.77 45.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.115 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.42 162.85 35.73 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.552 -1.019 . . . . 1.0 110.552 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -70.97 -47.88 56.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.719 0.295 . . . . 1.0 111.464 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.514 ' CD1' HG23 ' A' ' 96' ' ' ILE . 1.0 OUTLIER -82.65 -9.68 59.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.898 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.514 HG23 ' CD1' ' A' ' 95' ' ' TRP . 33.7 pt -126.74 151.18 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.701 0.286 . . . . 1.0 110.793 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -83.44 164.61 19.8 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.833 0.349 . . . . 1.0 110.946 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -63.46 140.3 58.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -141.03 154.19 45.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.153 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -125.52 154.18 42.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.979 0.419 . . . . 1.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.441 ' C ' ' SD ' ' A' ' 25' ' ' MET . 98.5 m-85 -138.33 158.7 43.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.769 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -144.72 123.45 12.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mm -110.45 96.62 28.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.15 -14.55 28.8 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.536 1.491 . . . . 1.0 112.674 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -94.32 113.66 25.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.974 0.416 . . . . 1.0 110.002 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.03 -55.09 39.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.231 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -52.06 -43.34 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.654 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -68.2 -38.55 82.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.914 0.388 . . . . 1.0 110.131 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.232 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.4 -45.39 91.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.644 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -66.3 -45.41 80.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.974 -0.69 . . . . 1.0 110.703 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.46 -49.61 76.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.284 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 80' ' ' ASP . 3.4 mm? -65.44 -42.56 92.26 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.382 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -63.83 -45.14 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.735 0.303 . . . . 1.0 111.478 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.523 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -64.93 -50.83 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.441 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.68 -46.37 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.03 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.01 -48.02 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 1.0 110.64 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.99 78.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.548 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.424 ' C ' HE21 ' A' ' 123' ' ' GLN . . . -60.98 -40.24 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.553 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.51 -44.8 85.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -66.21 -43.43 86.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.504 0.668 . . . . 1.0 110.488 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -48.32 78.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.904 -1.044 . . . . 1.0 111.998 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.513 HE22 ' CG2' ' A' ' 63' ' ' ILE . 6.3 pt20 -72.2 -38.32 69.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.48 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.062 -0.971 . . . . 1.0 110.567 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.357 -1.497 . . . . 1.0 109.357 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.2 144.18 98.83 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.672 2.248 . . . . 1.0 112.102 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.93 145.76 44.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.265 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 6' ' ' MET . . . -73.56 158.99 52.89 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 t 54.27 3.63 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.608 0.242 . . . . 1.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.533 ' H ' ' C ' ' A' ' 4' ' ' GLY . 10.2 tpp -100.43 -34.97 9.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.893 0.378 . . . . 1.0 110.245 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -44.69 151.93 0.57 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.508 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -38.65 156.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.147 1.898 . . . . 1.0 112.328 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.07 -23.38 73.6 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.532 2.155 . . . . 1.0 111.969 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 10' ' ' LEU . 3.9 mp -66.79 149.15 98.53 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.99 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.05 143.9 91.63 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.67 1.58 . . . . 1.0 111.429 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.88 -43.02 86.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.178 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.4 51.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.39 137.78 44.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.059 0.457 . . . . 1.0 111.025 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -98.95 108.6 50.11 Favored Pre-proline 0 N--CA 1.465 0.309 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.57 103.87 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.532 1.488 . . . . 1.0 112.789 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.88 -43.6 83.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.191 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.21 148.95 28.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.216 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -138.34 131.36 29.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.765 0.317 . . . . 1.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.21 160.14 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.158 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 34' ' ' ALA . 41.8 tp10 -100.1 122.67 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 33' ' ' CYS . . . -132.26 158.16 22.82 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 84.1 mmm -99.37 120.88 40.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.887 0.375 . . . . 1.0 110.203 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.85 118.24 24.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.693 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -102.65 137.21 41.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.07 152.86 52.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.266 -0.425 . . . . 1.0 109.982 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.38 -66.48 0.36 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.894 -0.593 . . . . 1.0 112.506 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.22 -32.92 73.34 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.747 2.298 . . . . 1.0 113.877 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -176.29 -170.3 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 121.105 -0.238 . . . . 1.0 110.385 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -124.71 169.28 12.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.962 0.41 . . . . 1.0 110.25 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 52' ' ' GLU . 9.3 pt-20 -153.57 133.19 7.33 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.797 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.29 142.56 78.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 CA-C-N 120.245 1.123 . . . . 1.0 111.34 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 22' ' ' GLY . 8.9 p -152.1 -170.18 3.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.526 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.472 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -156.8 131.3 8.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.293 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -100.84 123.16 44.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.088 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.4 m -126.34 112.33 15.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.298 0.57 . . . . 1.0 111.723 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.679 HD23 ' HB1' ' A' ' 115' ' ' ALA . 55.4 tp -80.47 127.75 32.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.378 -0.828 . . . . 1.0 109.086 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.06 148.28 36.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.441 . . . . 1.0 111.445 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -102.42 128.99 48.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.901 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -139.9 136.97 34.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.931 0.396 . . . . 1.0 110.872 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 m120 59.18 33.78 22.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.513 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.93 22.56 78.38 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.677 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 48.4 tp60 -132.58 157.13 45.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.677 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 81.0 m-85 -96.3 131.84 42.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -144.06 143.88 31.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 1.0 110.404 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.1 tp -104.2 124.96 50.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.257 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 ' NE2' ' A' ' 58' ' ' GLN . 80.8 mt -100.12 124.81 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.118 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.9 mt -96.53 117.54 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' C ' HD12 ' A' ' 50' ' ' LEU . 78.3 mt-30 -109.15 130.58 55.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.7 mp -104.94 127.76 52.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 76.2 t60 -93.8 25.39 3.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' OE2' ' A' ' 31' ' ' GLU . 95.9 mt-10 -55.02 137.55 46.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.45 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -62.72 -39.7 94.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.26 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -53.47 -51.18 63.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.913 0.387 . . . . 1.0 110.18 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -166.72 148.21 6.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.767 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.03 86.8 6.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.869 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 t -80.81 133.84 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.539 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.432 ' NE2' HG21 ' A' ' 47' ' ' ILE . 50.6 tt0 -128.29 119.28 24.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.744 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.37 129.64 55.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.2 mt -96.41 114.66 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.775 0.321 . . . . 1.0 110.273 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.03 121.37 35.32 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.18 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 155.48 42.57 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.987 1.792 . . . . 1.0 112.628 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' CG ' ' A' ' 64' ' ' ASN . 98.0 mt -98.13 112.79 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.373 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 78.6 m-20 -161.68 -160.67 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.6 t -60.35 -41.94 94.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -66.17 -36.75 83.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.021 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 19.2 t80 -93.03 124.09 36.76 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.823 0.344 . . . . 1.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.49 141.75 45.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.289 0.566 . . . . 1.0 110.769 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 69' ' ' CYS . 26.6 p -113.46 99.7 7.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.222 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.2 m -109.45 128.46 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.448 . . . . 1.0 111.049 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.661 HE21 ' N ' ' A' ' 88' ' ' LYS . 34.1 tp60 -80.77 116.86 20.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' GLN . 17.7 pt-20 32.77 38.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.645 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 71' ' ' GLN . . . -159.2 -156.67 0.54 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.732 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -129.31 17.15 6.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.375 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 77' ' ' LEU . 5.8 pt-20 -161.17 -111.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.624 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.73 HG22 ' O ' ' A' ' 79' ' ' ILE . 89.5 m 38.86 28.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.629 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 75' ' ' GLU . 85.8 mt -65.63 -39.01 91.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 1.0 111.334 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.57 -40.59 97.36 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.648 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 76' ' ' THR . 35.1 mm -109.33 129.24 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.065 0.46 . . . . 1.0 111.025 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -137.69 -27.81 0.92 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.181 0.515 . . . . 1.0 110.077 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.65 -42.61 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.693 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.82 -26.01 44.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.126 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.53 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 5.7 t -104.28 102.61 12.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 83' ' ' SER . 9.8 m120 -136.27 -168.94 2.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.994 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.403 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 2.3 m 62.13 82.58 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.17 77.35 0.26 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 132.64 37.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.798 0.332 . . . . 1.0 111.751 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.661 ' N ' HE21 ' A' ' 71' ' ' GLN . 98.8 mttt -110.22 129.49 55.71 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.404 HD13 ' HE2' ' A' ' 112' ' ' PHE . 48.5 pt -126.83 160.15 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -130.52 133.96 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.482 . . . . 1.0 109.849 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.2 t -114.54 134.55 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.418 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.43 154.96 41.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.327 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.11 167.0 37.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.54 -43.17 94.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.607 0.241 . . . . 1.0 111.608 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.513 ' CE2' HG23 ' A' ' 96' ' ' ILE . 1.5 p-90 -90.48 -6.54 54.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.181 0.437 . . . . 1.0 112.181 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.513 HG23 ' CE2' ' A' ' 95' ' ' TRP . 19.3 pt -126.97 152.76 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.4 162.11 15.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.828 0.347 . . . . 1.0 110.879 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -59.66 137.63 57.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.468 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.43 154.53 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.082 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -124.74 150.97 45.66 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.185 0.517 . . . . 1.0 111.394 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -143.83 156.86 44.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.43 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -148.56 118.67 7.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.365 -0.38 . . . . 1.0 111.048 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.62 99.8 12.55 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.83 -11.82 28.03 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.542 1.495 . . . . 1.0 112.887 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -91.42 106.19 18.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 85' ' ' SER . 80.3 tt0 -59.98 -52.91 63.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.711 -0.677 . . . . 1.0 112.091 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -52.24 -43.83 64.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.406 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.47 -38.96 77.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.0 110.564 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.21 -35.22 71.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.024 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -45.33 93.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.306 -0.558 . . . . 1.0 111.148 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.77 -43.22 84.6 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.787 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.404 ' HE2' HD13 ' A' ' 89' ' ' ILE . 51.8 t80 -61.1 -49.39 77.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.077 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 113' ' ' LEU . 95.8 mt -66.24 -42.02 89.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.472 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 m -63.12 -45.38 92.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 1.0 111.317 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.679 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -66.55 -49.03 67.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.33 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.46 -45.65 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.544 -0.298 . . . . 1.0 110.977 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.1 tp -60.98 -45.1 96.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.034 0.445 . . . . 1.0 110.148 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.22 -37.76 86.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.459 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.18 -49.99 73.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.679 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.503 ' OE1' ' SG ' ' A' ' 69' ' ' CYS . 92.3 mt-30 -70.69 -38.07 73.68 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.227 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.72 -43.09 94.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.007 0.432 . . . . 1.0 110.517 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.6 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -72.33 -35.82 68.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 1.0 110.752 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.019 -0.991 . . . . 1.0 110.476 -179.905 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 32.3 Cg_endo -63.44 -25.17 70.71 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.682 2.255 . . . . 1.0 112.152 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.7 mt 53.13 -171.87 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.08 24.36 76.61 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.9 m -66.19 143.59 57.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 1.0 110.533 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.9 mmm -82.78 148.08 28.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.116 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -41.01 103.93 0.32 Allowed Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.765 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -83.6 159.66 14.47 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.182 1.921 . . . . 1.0 112.241 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.99 -32.8 43.74 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.657 2.238 . . . . 1.0 111.986 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.74 150.38 84.01 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.774 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.603 ' CD ' HE22 ' A' ' 58' ' ' GLN . 24.4 Cg_endo -59.51 140.48 94.22 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.857 1.705 . . . . 1.0 111.542 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.89 -43.79 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.215 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -37.34 -38.88 0.44 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.38 -0.688 . . . . 1.0 111.38 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.28 147.95 41.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.722 0.296 . . . . 1.0 110.538 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -98.2 102.43 14.01 Favored Pre-proline 0 C--O 1.223 -0.338 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -75.28 103.14 1.68 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.5 1.467 . . . . 1.0 113.522 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.1 mt -67.12 -41.84 85.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.178 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 155.31 40.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.259 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -143.49 130.64 20.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.42 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 21' ' ' GLU . 47.9 t -141.31 159.08 22.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.698 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 20' ' ' VAL . 83.0 tt0 -104.55 121.13 42.86 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -123.56 -169.51 13.22 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.837 -0.905 . . . . 1.0 110.837 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 89.3 mmm -136.94 101.47 4.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.87 0.367 . . . . 1.0 110.037 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.578 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 83.0 tt0 -61.05 128.8 38.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.609 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.6 mtm -106.01 136.38 45.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.312 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -135.64 151.91 50.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.72 -68.15 0.29 Allowed Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.74 -0.664 . . . . 1.0 112.605 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.93 -32.47 92.54 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.864 2.376 . . . . 1.0 113.553 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -179.85 -167.01 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.344 -0.243 . . . . 1.0 110.344 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -122.46 168.5 12.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.888 0.375 . . . . 1.0 110.201 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -146.21 138.73 13.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.653 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.34 139.63 73.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 CA-C-N 120.171 1.097 . . . . 1.0 111.418 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.578 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 17.2 p -153.65 177.68 10.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -147.56 138.72 23.63 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.905 0.383 . . . . 1.0 110.122 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 35' ' ' LEU . 5.5 mp -102.62 120.57 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 1.0 109.999 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -127.31 113.17 15.92 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.28 0.562 . . . . 1.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.647 HD23 ' HB1' ' A' ' 115' ' ' ALA . 45.5 tp -86.48 127.51 34.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.434 -0.803 . . . . 1.0 108.975 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.94 156.56 46.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.16 0.505 . . . . 1.0 111.484 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -113.87 122.65 47.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.318 -0.855 . . . . 1.0 109.608 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -133.32 137.89 46.15 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.886 0.374 . . . . 1.0 110.919 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 59.13 34.17 23.18 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.606 -0.725 . . . . 1.0 111.513 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.77 25.34 75.22 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.771 -0.931 . . . . 1.0 110.771 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -134.09 153.33 51.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -93.53 134.9 35.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.126 -0.324 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.02 143.79 31.35 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.963 0.411 . . . . 1.0 110.264 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.0 tp -103.46 116.56 32.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.356 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.8 mt -109.69 115.78 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 101' ' ' PHE . 60.2 mt -106.57 116.9 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' C ' HD12 ' A' ' 50' ' ' LEU . 11.7 mm100 -81.27 128.43 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.705 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD12 ' C ' ' A' ' 49' ' ' GLN . 8.4 mp -110.4 130.26 55.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.935 -0.575 . . . . 1.0 109.615 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.623 ' ND1' ' N ' ' A' ' 51' ' ' HIS . 0.9 OUTLIER -94.53 54.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.218 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -46.61 150.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.308 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.55 -39.97 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.33 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -62.95 -46.13 89.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.133 0.492 . . . . 1.0 110.488 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -168.9 -158.98 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.796 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -111.01 115.11 28.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.893 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.76 138.13 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.169 0.509 . . . . 1.0 110.499 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.681 HE21 HD11 ' A' ' 60' ' ' ILE . 17.3 pt20 -97.56 141.42 30.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -102.06 115.18 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.738 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.681 HD11 HE21 ' A' ' 58' ' ' GLN . 51.8 mm -92.82 101.42 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.923 0.392 . . . . 1.0 110.092 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.8 mm -117.63 90.21 34.96 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.143 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.14 146.48 88.04 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 1.0 112.407 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 96.6 mt -93.28 115.43 32.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.46 ' H ' ' HB3' ' A' ' 67' ' ' PHE . 80.7 m-20 -163.58 -166.75 1.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.177 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -33.24 74.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.223 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.461 ' ND1' ' OD1' ' A' ' 94' ' ' ASP . 6.2 p80 -76.2 -12.48 60.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.743 0.306 . . . . 1.0 111.17 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.46 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 32.9 t80 -114.06 130.05 56.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.052 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.68 145.08 44.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.888 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.4 t -121.55 106.04 11.01 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.399 -0.818 . . . . 1.0 109.2 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 70' ' ' VAL . 5.8 m -107.36 125.37 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.729 0.3 . . . . 1.0 110.762 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.468 HE22 ' N ' ' A' ' 88' ' ' LYS . 9.3 tp-100 -99.1 115.88 30.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.339 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 37.74 57.04 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.7 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' ' OG1' ' A' ' 76' ' ' THR . . . -176.14 162.99 2.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.082 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -68.74 -37.41 79.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.595 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -170.23 80.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.605 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 79' ' ' ILE . 14.6 m -118.02 59.65 0.79 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.172 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.9 -35.45 80.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.301 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.09 -42.05 99.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.335 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 76' ' ' THR . 89.6 mt -119.12 129.32 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.24 0.543 . . . . 1.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 99.9 m-20 -142.63 -33.95 0.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.531 -0.758 . . . . 1.0 109.955 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.503 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 95.8 mt -64.04 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.67 -24.92 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.945 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 m -102.6 59.54 0.8 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.844 0.354 . . . . 1.0 110.429 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 81' ' ' ILE . 12.7 m120 -82.65 -171.63 3.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.145 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 m 66.69 87.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.04 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.12 79.04 0.11 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 139.8 30.84 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.921 0.391 . . . . 1.0 111.754 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' N ' HE22 ' A' ' 71' ' ' GLN . 22.3 pttp -126.83 134.14 50.6 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.3 pt -126.18 161.24 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.231 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.95 138.14 53.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.697 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -117.46 133.96 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.448 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -136.91 134.65 37.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.046 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 123.07 -158.23 17.67 Favored Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 96' ' ' ILE . 94.8 m-20 43.9 -165.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.633 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -70.04 20.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 1.0 112.101 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 94' ' ' ASP . 21.0 pt -130.53 133.61 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.898 0.38 . . . . 1.0 110.628 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -73.38 -44.58 58.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.468 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -174.75 126.22 0.29 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.438 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -137.76 123.66 20.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -89.98 151.15 21.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.925 0.393 . . . . 1.0 111.24 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 48' ' ' ILE . 67.6 m-85 -136.53 148.62 47.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.26 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.95 144.32 45.36 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 1.0 110.753 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 35' ' ' LEU . 6.2 mm -129.41 90.37 44.6 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.27 -17.82 44.76 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 1.0 112.762 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -88.88 108.67 19.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.69 -0.485 . . . . 1.0 109.69 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 85' ' ' SER . 83.8 tt0 -64.91 -53.18 50.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.862 -0.608 . . . . 1.0 112.068 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -53.18 -40.9 64.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.664 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -73.0 -35.88 66.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 1.0 110.396 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 18.9 t -60.73 -34.24 74.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.901 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.8 -44.79 95.24 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.425 -0.51 . . . . 1.0 111.352 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.84 -43.67 83.07 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.969 -0.692 . . . . 1.0 110.189 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.428 ' CZ ' HD23 ' A' ' 35' ' ' LEU . 42.3 t80 -60.22 -49.03 79.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.353 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -65.89 -41.62 91.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.269 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.3 t -63.31 -44.74 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.235 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.87 -50.32 64.94 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.359 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.4 t -64.21 -44.15 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.26 -45.75 92.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 1.0 110.225 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.14 86.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.549 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.7 79.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.809 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.29 -37.62 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 1.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -60.37 -44.51 95.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.029 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.59 94.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.49 -40.2 92.79 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.792 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.222 -0.386 0 CA-C-O 117.943 -1.027 . . . . 1.0 110.386 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.97 -35.67 81.41 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.768 2.312 . . . . 1.0 112.144 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 77.5 mt -62.52 -41.71 99.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.28 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.97 173.76 53.48 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.741 -0.944 . . . . 1.0 110.741 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 t -152.54 151.34 30.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.901 0.382 . . . . 1.0 110.695 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.2 ttm 49.83 -129.9 2.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.501 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -138.73 95.57 9.81 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.059 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.45 159.08 19.66 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.04 1.827 . . . . 1.0 112.216 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.42 -32.61 60.06 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.56 2.174 . . . . 1.0 111.989 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.439 ' HA ' HE22 ' A' ' 58' ' ' GLN . 15.7 mt -70.2 135.41 86.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.064 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.431 ' HD3' HE22 ' A' ' 58' ' ' GLN . 50.7 Cg_endo -68.91 147.58 68.61 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.686 1.59 . . . . 1.0 111.68 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -70.02 -32.39 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.156 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.23 94.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.56 141.83 44.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 1.0 110.778 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.555 HE21 ' NE2' ' A' ' 39' ' ' GLN . 10.3 mt-30 -101.67 100.34 14.03 Favored Pre-proline 0 C--O 1.224 -0.283 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.38 103.15 1.69 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.523 1.482 . . . . 1.0 112.83 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.76 -43.34 89.18 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.131 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.87 151.65 37.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.296 -0.866 . . . . 1.0 110.237 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 t -141.42 128.08 20.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.452 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 21' ' ' GLU . 53.3 t -141.59 160.7 21.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.926 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 55.7 mp0 -103.55 121.96 43.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -124.99 -173.37 13.69 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 25' ' ' MET . 90.7 mmm -131.26 107.31 8.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 1.0 110.125 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE2' ' NE ' ' A' ' 99' ' ' ARG . 84.8 tt0 -76.19 126.48 31.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.644 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 25' ' ' MET . 0.9 OUTLIER -116.04 139.82 49.89 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.634 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.68 150.4 50.62 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 1.0 109.865 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.9 -65.6 0.47 Allowed Glycine 0 CA--C 1.533 1.188 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.665 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.52 -32.36 88.05 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 122.732 2.288 . . . . 1.0 113.786 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.482 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -176.78 -179.56 0.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 121.032 -0.267 . . . . 1.0 110.465 179.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -125.14 169.21 12.42 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.053 0.454 . . . . 1.0 110.787 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -157.92 143.43 12.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.426 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.64 144.23 93.82 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.264 1.309 . . . . 1.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.5 p -149.14 173.67 13.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.403 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' C ' HD22 ' A' ' 35' ' ' LEU . . . -134.7 129.1 34.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.01 0.433 . . . . 1.0 110.182 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' N ' HD22 ' A' ' 35' ' ' LEU . 3.8 mm? -97.4 118.21 33.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.801 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -129.84 113.82 15.15 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.166 0.507 . . . . 1.0 111.56 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD23 ' HB1' ' A' ' 115' ' ' ALA . 47.4 tp -85.98 129.8 34.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.464 -0.789 . . . . 1.0 109.047 178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.12 156.96 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.999 0.428 . . . . 1.0 111.283 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.555 ' NE2' HE21 ' A' ' 15' ' ' GLN . 1.2 tm0? -119.47 119.62 34.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -127.31 137.19 52.76 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.977 0.418 . . . . 1.0 110.913 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 58.86 32.38 22.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.498 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.21 18.45 78.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.655 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 41.3 tp60 -125.51 140.44 52.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.113 -0.328 . . . . 1.0 110.113 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.655 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 69.9 m-85 -80.27 135.72 36.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.51 140.28 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.355 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.5 tp -104.34 126.13 51.18 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.311 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.8 mt -104.37 121.18 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.983 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.7 115.45 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' C ' HD12 ' A' ' 50' ' ' LEU . 80.1 mt-30 -105.65 130.94 53.57 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.879 0.371 . . . . 1.0 110.931 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.605 HD21 ' NH2' ' A' ' 99' ' ' ARG . 10.9 mp -106.16 128.41 53.89 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.407 ' HD1' ' CE1' ' A' ' 56' ' ' HIS . 99.6 m-70 -90.13 62.5 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.331 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 55' ' ' GLN . 97.9 mt-10 -60.85 146.22 47.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.36 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.52 -39.55 93.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.086 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -63.23 -41.07 99.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.72 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' GLU . 15.8 pt20 -172.39 -156.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.407 ' CE1' ' HD1' ' A' ' 51' ' ' HIS . 97.9 m-70 -127.34 127.97 45.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.975 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.79 130.69 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.171 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.439 HE22 ' HA ' ' A' ' 10' ' ' LEU . 50.7 tt0 -102.58 116.26 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.987 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -102.05 113.26 26.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.521 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -94.61 111.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 1.0 110.524 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mm -113.68 120.29 39.67 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.089 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.6 148.1 36.75 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.792 1.661 . . . . 1.0 112.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.0 mt -92.58 122.97 44.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.444 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -172.22 -160.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.266 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.507 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 78.0 p -61.53 -40.01 93.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -68.51 -32.51 72.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.682 0.277 . . . . 1.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 9.8 t80 -95.4 126.14 40.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.044 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 65' ' ' SER . 84.4 mtt85 -137.75 145.91 43.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.2 0.524 . . . . 1.0 110.874 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.2 t -122.33 117.89 27.17 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.064 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 70' ' ' VAL . 4.8 m -118.36 125.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.756 0.312 . . . . 1.0 110.462 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.1 tp-100 -83.68 123.78 30.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.441 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 49.32 -101.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.96 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.89 150.61 48.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.679 . . . . 1.0 110.982 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' O ' HD21 ' A' ' 77' ' ' LEU . 80.5 mm-40 -74.55 -6.4 48.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.739 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -80.65 -9.17 59.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.971 0.415 . . . . 1.0 110.968 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 76' ' ' THR . 1.3 p -100.03 46.69 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.219 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.516 HD21 ' O ' ' A' ' 74' ' ' GLU . 49.1 mt -62.16 -44.4 96.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.11 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.17 -10.5 17.89 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.732 -0.213 . . . . 1.0 110.774 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.41 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 81.8 mt -102.32 132.44 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.997 0.427 . . . . 1.0 110.8 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 98.5 m-20 -141.57 -38.7 0.4 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.039 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 83' ' ' SER . 93.8 mt -64.23 -43.18 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.691 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.0 -11.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.156 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.533 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 30.7 t -133.18 135.15 44.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.009 0.433 . . . . 1.0 110.157 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 83' ' ' SER . 12.7 m120 -146.25 -176.76 5.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.911 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t 72.04 89.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.24 80.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -93.74 133.61 36.93 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -177.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 99.1 mttt -109.95 113.21 25.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.463 ' CG2' ' NE2' ' A' ' 71' ' ' GLN . 2.1 pp -117.51 128.81 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -103.39 146.16 28.9 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.46 133.7 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.897 0.379 . . . . 1.0 110.639 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -136.19 137.95 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.182 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . 179.27 -175.28 47.03 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 65.1 t0 -64.7 -40.99 96.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.858 0.361 . . . . 1.0 111.384 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -60.83 -37.07 80.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.733 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' GLY . 38.1 pt -138.51 140.69 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.679 0.276 . . . . 1.0 110.607 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.432 ' CG ' ' N ' ' A' ' 98' ' ' GLU . 35.8 ptt-85 -71.7 -46.91 57.22 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.511 -0.476 . . . . 1.0 110.753 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' ARG . 48.5 tp10 -175.04 121.45 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.874 0.368 . . . . 1.0 110.228 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.605 ' NH2' HD21 ' A' ' 50' ' ' LEU . 81.0 mtp180 -138.08 124.35 20.48 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.903 -0.777 . . . . 1.0 108.903 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -87.76 149.2 24.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.933 0.396 . . . . 1.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -141.08 148.28 39.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.286 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -144.31 134.44 24.19 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.874 0.369 . . . . 1.0 111.074 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.68 99.72 48.52 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 -13.05 31.08 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.504 1.469 . . . . 1.0 112.768 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -90.72 103.04 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -53.51 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 1.0 112.207 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -53.04 -43.77 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.549 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -69.56 -36.68 76.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.908 0.385 . . . . 1.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 113' ' ' LEU . 1.4 t -60.13 -36.2 76.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.855 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.0 mt -62.53 -44.31 96.66 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.103 -0.639 . . . . 1.0 111.28 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.11 -45.98 75.57 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.749 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.99 -49.01 76.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.818 . . . . 1.0 111.567 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 87' ' ' CYS . 96.7 mt -65.77 -41.36 92.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.221 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.3 -45.89 75.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.306 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.09 -46.84 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.768 0.318 . . . . 1.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -43.46 98.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.474 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.63 88.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.413 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.94 -49.22 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.622 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -69.68 -38.41 77.01 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.189 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.997 0.427 . . . . 1.0 110.624 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.73 -50.21 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.624 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -72.88 -40.24 65.76 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.844 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.665 179.897 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.611 -1.396 . . . . 1.0 109.611 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.59 147.22 95.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.803 2.335 . . . . 1.0 112.125 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.65 -41.26 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.258 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.28 170.91 43.29 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.6 m -81.27 -6.44 58.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 1.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 50.0 ttp -82.94 130.81 35.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.815 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -51.96 151.45 6.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.414 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.99 160.12 43.55 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.15 1.9 . . . . 1.0 112.056 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.26 -31.7 73.8 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.745 2.297 . . . . 1.0 112.134 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.424 ' HA ' HE22 ' A' ' 58' ' ' GLN . 16.5 mt -66.51 144.38 98.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.834 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HD3' HE22 ' A' ' 58' ' ' GLN . 41.7 Cg_endo -66.69 142.43 63.92 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.711 1.608 . . . . 1.0 111.464 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 p -72.16 -32.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.275 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.31 93.75 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.01 144.58 38.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 1.0 111.101 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.37 107.15 33.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.58 102.81 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.457 1.438 . . . . 1.0 112.757 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.03 -43.82 86.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.102 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.97 154.13 35.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.273 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 t -142.81 132.5 23.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 1.0 110.529 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.4 p -142.0 152.3 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.043 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -107.84 121.9 45.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.747 -0.66 . . . . 1.0 109.317 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -129.21 -158.76 9.67 Favored Glycine 0 N--CA 1.462 0.4 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -131.14 131.2 43.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.066 0.46 . . . . 1.0 110.658 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.566 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 25.9 tp10 -91.68 126.53 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.4 mtm -113.67 135.63 53.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.633 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -141.48 149.27 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.237 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -36.39 -64.91 0.56 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 115.745 -0.662 . . . . 1.0 112.762 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.18 -32.79 94.98 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.885 2.39 . . . . 1.0 113.973 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.531 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 178.97 177.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 121.163 -0.215 . . . . 1.0 110.645 179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -122.05 169.23 11.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.05 0.452 . . . . 1.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.32 144.24 9.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.38 146.77 81.33 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 CA-C-N 120.091 1.068 . . . . 1.0 111.412 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 24' ' ' GLU . 31.8 p -153.16 -178.22 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.526 -0.307 . . . . 1.0 110.4 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.04 145.18 24.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.643 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.546 ' CD1' HD11 ' A' ' 89' ' ' ILE . 44.6 mt -115.2 116.45 28.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.277 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -121.56 114.58 21.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.32 0.581 . . . . 1.0 111.559 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.733 HD23 ' HB1' ' A' ' 115' ' ' ALA . 52.5 tp -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.308 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.18 149.64 41.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.066 0.46 . . . . 1.0 111.393 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -104.07 128.38 51.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.665 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -140.62 137.06 33.35 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.749 -0.381 . . . . 1.0 110.895 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 58.79 33.02 22.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.695 -0.684 . . . . 1.0 111.591 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.95 77.09 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.666 ' NE2' ' H ' ' A' ' 44' ' ' TYR . 46.5 tp60 -132.34 157.57 44.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.666 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 86.8 m-85 -99.16 134.43 42.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.043 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -146.22 141.9 27.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.845 0.355 . . . . 1.0 110.336 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.7 tp -104.86 125.05 50.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.631 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.3 mt -98.95 121.71 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.9 mt -107.21 124.76 63.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' C ' HD12 ' A' ' 50' ' ' LEU . 74.0 mt-30 -114.88 122.76 47.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.963 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 49' ' ' GLN . 9.9 mp -105.15 128.37 53.35 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.23 45.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.21 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 50' ' ' LEU . 39.6 tp10 -41.77 146.52 0.25 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.403 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -61.6 -39.28 90.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.292 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -59.0 -47.6 84.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.965 0.412 . . . . 1.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -174.4 -162.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.422 ' NE2' ' NE2' ' A' ' 49' ' ' GLN . 54.5 t60 -97.19 81.47 3.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.061 0.458 . . . . 1.0 109.834 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.77 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.528 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.424 HE22 ' HA ' ' A' ' 10' ' ' LEU . 52.4 tt0 -108.64 116.97 32.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -100.45 132.58 45.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.95 110.85 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.814 0.34 . . . . 1.0 110.139 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -115.09 108.73 47.75 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.238 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 151.23 38.21 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.639 1.559 . . . . 1.0 112.571 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.428 HG23 HE21 ' A' ' 120' ' ' GLN . 98.1 mt -95.08 124.33 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.731 HD21 ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -172.04 -150.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 1.0 109.847 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -72.37 -39.93 67.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 1.0 112.083 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.731 ' CG ' HD21 ' A' ' 64' ' ' ASN . 2.4 p80 -74.61 -16.85 60.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.788 0.328 . . . . 1.0 111.318 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.429 ' HB3' ' H ' ' A' ' 64' ' ' ASN . 61.1 t80 -102.46 123.72 46.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.87 142.51 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.323 0.583 . . . . 1.0 110.853 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 89' ' ' ILE . 4.8 t -125.33 106.67 10.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.212 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.59 129.63 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.053 0.454 . . . . 1.0 111.381 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' LYS . 9.0 tp-100 -80.38 100.58 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.471 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 39.16 56.42 2.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.476 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.75 -170.32 2.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.874 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -101.96 -28.7 12.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.439 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -166.08 92.34 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.666 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 79' ' ' ILE . 6.5 t -138.47 42.18 2.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.125 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.6 -40.73 97.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.338 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 78' ' ' LEU . 3.7 mm? -65.05 -39.58 93.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.626 -0.261 . . . . 1.0 110.484 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.423 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 17.2 mm -102.76 121.64 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.047 0.451 . . . . 1.0 110.91 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 79' ' ' ILE . 97.5 m-20 -143.86 -39.88 0.29 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.271 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.88 -42.62 96.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.678 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.79 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.085 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 11.7 t -109.58 119.8 40.52 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 83' ' ' SER . 13.0 m120 -148.02 -175.19 4.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.078 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.75 88.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.64 71.78 0.79 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.4 -1.48 . . . . 1.0 109.4 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.47 139.29 30.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.952 0.406 . . . . 1.0 111.675 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 52.1 mtpt -116.73 129.33 56.05 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.591 HD12 ' SG ' ' A' ' 69' ' ' CYS . 39.7 pt -125.31 160.14 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -130.23 143.03 50.54 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.913 0.387 . . . . 1.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.11 133.25 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.908 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.74 152.47 42.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -166.23 166.42 38.78 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.68 -41.71 95.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.627 0.251 . . . . 1.0 111.198 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.547 ' CE2' HG23 ' A' ' 96' ' ' ILE . 2.0 p-90 -90.55 -8.57 49.91 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.178 0.436 . . . . 1.0 112.178 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.547 HG23 ' CE2' ' A' ' 95' ' ' TRP . 18.1 pt -126.72 152.06 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 110.141 -0.318 . . . . 1.0 110.141 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -94.58 166.95 11.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.745 0.307 . . . . 1.0 110.652 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -57.25 135.22 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 1.0 110.778 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.71 136.52 40.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.488 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 77.4 mtp180 -106.71 139.5 41.04 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.225 0.536 . . . . 1.0 110.944 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CE2' ' OE1' ' A' ' 24' ' ' GLU . 85.1 m-85 -133.92 152.1 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.198 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.99 127.03 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.907 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.79 89.47 7.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.21 -15.65 35.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.787 1.658 . . . . 1.0 112.777 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.32 106.64 18.63 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -60.81 -53.43 57.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.028 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -52.94 -43.74 66.54 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.628 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.425 ' HB3' HG23 ' A' ' 20' ' ' VAL . 59.1 m170 -68.57 -36.74 79.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.484 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.8 t -63.3 -34.59 78.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.787 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.37 -46.25 89.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.387 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.63 -42.98 81.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.66 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' HD13 ' A' ' 89' ' ' ILE . 46.2 t80 -61.82 -49.05 77.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.104 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.7 -41.57 95.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.474 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -44.5 93.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.903 0.382 . . . . 1.0 111.164 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.733 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -65.9 -48.04 72.8 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.251 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 112' ' ' PHE . 73.0 t -65.67 -42.22 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.828 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.49 -44.66 89.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.997 0.427 . . . . 1.0 110.077 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.69 91.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.435 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.76 76.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.814 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.428 HE21 HG23 ' A' ' 63' ' ' ILE . 59.2 mm-40 -67.88 -39.83 83.62 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.021 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.76 -45.32 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.029 0.442 . . . . 1.0 110.1 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.21 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -67.99 -39.67 83.22 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.722 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.454 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.564 -1.415 . . . . 1.0 109.564 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.88 -23.25 68.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.644 2.229 . . . . 1.0 112.029 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.07 -40.88 98.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.421 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.64 9.92 82.37 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.896 -0.881 . . . . 1.0 110.896 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 m -72.7 150.76 42.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 1.0 110.549 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.6 ttp -80.85 139.73 35.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.494 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -42.58 151.35 0.38 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.543 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 159.28 48.61 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.104 1.869 . . . . 1.0 112.011 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.39 -31.64 72.5 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.75 2.3 . . . . 1.0 111.925 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.404 ' HA ' HE22 ' A' ' 58' ' ' GLN . 8.4 mp -64.39 166.37 11.34 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.94 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.56 148.39 92.45 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.642 1.561 . . . . 1.0 111.561 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.12 -45.05 95.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.15 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.4 -29.97 76.55 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.231 -0.747 . . . . 1.0 111.231 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.76 58.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 1.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -109.4 108.36 59.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 128.13 11.08 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.643 1.562 . . . . 1.0 112.765 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -100.86 -38.85 8.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.713 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.82 154.62 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.105 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -143.34 137.73 28.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.794 0.331 . . . . 1.0 110.512 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 108' ' ' HIS . 2.7 p -140.6 146.92 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.981 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -108.76 122.16 46.57 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . -140.32 -158.06 7.44 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 22' ' ' GLY . 16.7 mmm -127.97 129.06 46.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.909 0.385 . . . . 1.0 110.432 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.63 118.77 25.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.24 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 77.1 mtm -97.8 136.22 38.45 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.508 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.24 151.84 51.5 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -35.19 -64.93 0.45 Allowed Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.954 -0.567 . . . . 1.0 112.704 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.35 -34.05 56.44 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.725 2.283 . . . . 1.0 113.746 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -175.75 -173.41 0.6 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.321 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -121.29 168.36 11.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.9 0.381 . . . . 1.0 110.465 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.13 141.35 13.47 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.742 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.97 145.44 74.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 CA-C-N 120.221 1.115 . . . . 1.0 111.52 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 22' ' ' GLY . 11.5 p -158.97 -176.24 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.608 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.76 134.48 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.182 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 20' ' ' VAL . 51.8 mt -104.18 128.08 51.84 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.003 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -125.02 123.26 39.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.246 0.546 . . . . 1.0 111.522 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.567 HD23 ' HB1' ' A' ' 115' ' ' ALA . 53.1 tp -89.42 127.18 35.8 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.236 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.79 150.11 39.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.133 0.492 . . . . 1.0 111.434 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -106.0 123.88 48.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -134.47 131.27 37.88 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 1.0 110.742 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 m120 61.09 34.6 19.04 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.684 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.35 75.81 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -134.77 149.6 50.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -94.67 134.09 37.63 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -143.59 147.67 34.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.874 0.369 . . . . 1.0 110.432 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 47' ' ' ILE . 4.4 tt -108.4 120.54 42.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.068 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.654 ' N ' HD23 ' A' ' 46' ' ' LEU . 85.8 mt -99.07 128.04 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -95.05 119.78 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' C ' HD12 ' A' ' 50' ' ' LEU . 75.9 mt-30 -107.54 129.95 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.033 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD12 ' C ' ' A' ' 49' ' ' GLN . 10.4 mp -109.5 136.34 49.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -95.45 20.18 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.113 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -48.28 138.32 9.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.271 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -63.19 -38.62 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.414 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.87 -52.17 65.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 1.0 110.31 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -172.32 155.14 3.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -82.92 102.64 11.82 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 1.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -80.57 134.2 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.404 HE22 ' HA ' ' A' ' 10' ' ' LEU . 57.3 tt0 -122.16 108.22 13.06 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.658 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -101.51 125.67 48.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.647 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mm -92.39 105.96 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.09 108.29 48.47 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.044 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.27 145.11 34.06 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.658 1.572 . . . . 1.0 112.449 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.5 123.63 38.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -174.9 -162.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 -40.48 86.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.143 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.424 ' HB3' ' HE1' ' A' ' 95' ' ' TRP . 96.5 m-70 -65.52 -39.81 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.925 -0.31 . . . . 1.0 111.02 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.77 122.56 35.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.206 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -140.31 111.42 7.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.235 0.541 . . . . 1.0 110.927 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.8 p -102.54 111.61 23.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.033 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -116.0 129.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.98 0.419 . . . . 1.0 110.76 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.684 HE22 ' ND2' ' A' ' 84' ' ' ASN . 50.9 tt0 -75.28 120.45 20.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 48.5 -86.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 71' ' ' GLN . . . -71.48 152.81 42.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.551 -0.75 . . . . 1.0 110.804 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.42 -33.96 76.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.566 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 77' ' ' LEU . 80.5 mm-40 -54.9 -70.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.069 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 79' ' ' ILE . 7.1 m 73.54 -26.6 0.19 Allowed 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.98 0.8 . . . . 1.0 110.546 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 75' ' ' GLU . 51.4 mt -65.44 -41.5 93.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.85 -0.613 . . . . 1.0 111.316 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.83 -41.19 87.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.532 -0.303 . . . . 1.0 110.818 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' THR . 49.7 mm -120.12 130.73 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.011 0.434 . . . . 1.0 110.848 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -173.11 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.081 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.8 mm -113.94 -37.08 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.449 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -47.35 82.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.889 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 t -140.12 139.77 35.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.874 0.369 . . . . 1.0 110.519 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.684 ' ND2' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -158.15 36.99 0.25 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.525 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -83.95 112.8 20.49 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 48.32 82.5 0.03 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.212 -1.555 . . . . 1.0 109.212 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.51 ' CB ' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -115.2 150.25 36.4 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.221 0.534 . . . . 1.0 111.573 -177.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 151.47 33.56 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.51 169.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -139.21 126.1 20.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.027 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 130.69 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -152.63 153.33 33.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.11 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.22 163.65 36.16 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -64.19 -42.45 96.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.772 0.32 . . . . 1.0 111.457 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CD2' HG23 ' A' ' 96' ' ' ILE . 18.0 p-90 -84.94 -7.71 59.05 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.869 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.556 HG23 ' CD2' ' A' ' 95' ' ' TRP . 8.8 pt -125.24 161.6 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.766 0.317 . . . . 1.0 110.419 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -98.37 -179.82 4.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.815 0.341 . . . . 1.0 110.807 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 90' ' ' ARG . 80.6 tt0 -60.46 131.44 50.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.0 110.649 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -137.64 135.41 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.572 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -129.61 149.94 51.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.031 0.444 . . . . 1.0 111.601 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -144.71 161.03 40.22 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.333 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -145.26 139.64 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.919 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 20' ' ' VAL . 4.3 mp -125.28 101.08 31.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.04 -12.04 21.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.605 1.537 . . . . 1.0 112.618 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.61 111.53 23.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.34 -51.25 70.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.611 0.597 . . . . 1.0 112.611 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -55.13 -38.95 68.89 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.424 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.564 ' HB3' HG23 ' A' ' 20' ' ' VAL . 66.7 m170 -77.45 -33.8 54.67 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.74 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -53.98 52.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.373 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 pp -63.55 -39.47 94.48 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.908 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.14 -44.81 91.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.661 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.59 -52.84 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.868 -0.605 . . . . 1.0 111.318 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.586 ' CD1' ' NE2' ' A' ' 71' ' ' GLN . 30.4 mt -66.54 -40.75 89.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.2 t -62.5 -44.34 96.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.678 0.275 . . . . 1.0 111.42 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -67.81 -49.66 61.09 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.531 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.25 -43.63 91.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.117 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.33 -46.75 88.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.889 0.376 . . . . 1.0 110.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.2 -29.85 70.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.49 92.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -63.09 -43.16 99.27 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.819 0.342 . . . . 1.0 111.626 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.77 -43.56 98.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.521 0.677 . . . . 1.0 109.916 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.8 87.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.859 -1.064 . . . . 1.0 111.21 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -65.63 -43.55 89.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.676 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.043 -0.979 . . . . 1.0 110.608 179.915 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.461 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.65 -1.38 . . . . 1.0 109.65 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 50.0 Cg_exo -54.39 -36.62 87.98 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.751 2.3 . . . . 1.0 112.032 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.1 mt -95.43 129.67 42.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.397 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.42 -177.35 42.6 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.3 t -61.32 -41.85 97.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.073 0.463 . . . . 1.0 110.689 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.9 mtp -77.67 144.61 37.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.654 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -52.44 152.28 6.52 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.434 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.58 160.38 44.29 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.235 1.957 . . . . 1.0 111.967 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.11 -32.52 91.48 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.668 2.245 . . . . 1.0 111.986 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HA ' HE22 ' A' ' 58' ' ' GLN . 16.0 mt -60.78 140.75 93.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.001 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD3' HE22 ' A' ' 58' ' ' GLN . 39.7 Cg_endo -65.93 144.66 77.51 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.765 1.643 . . . . 1.0 111.587 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -66.06 -43.01 92.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.071 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.99 -37.67 45.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.161 -0.775 . . . . 1.0 111.161 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 143.98 56.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 1.0 110.962 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -104.38 79.9 0.42 Allowed Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 108.882 -0.784 . . . . 1.0 108.882 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.7 96.45 0.14 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.819 1.679 . . . . 1.0 113.157 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.69 -41.92 91.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.269 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.82 151.15 40.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.107 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 t -140.08 131.94 27.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.557 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 35' ' ' LEU . 20.4 m -139.37 159.17 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.255 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -113.56 121.86 45.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 33' ' ' CYS . . . -132.0 178.6 17.83 Favored Glycine 0 N--CA 1.463 0.47 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.8 mtp -118.18 102.89 9.35 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.798 0.332 . . . . 1.0 110.477 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.39 122.45 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.476 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 76.8 mtm -105.47 137.58 43.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.487 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.74 151.24 50.82 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -34.39 -67.2 0.26 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.846 -0.616 . . . . 1.0 112.709 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.12 -32.98 83.37 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.781 2.321 . . . . 1.0 113.401 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -176.8 -172.3 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.626 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -125.18 169.13 12.53 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.184 0.516 . . . . 1.0 110.521 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -152.85 144.38 16.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.05 142.19 91.58 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.365 1.376 . . . . 1.0 111.146 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 22' ' ' GLY . 14.7 p -154.18 -174.64 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.525 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.68 15.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.338 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 20' ' ' VAL . 5.0 mp -110.69 122.09 46.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.009 -0.541 . . . . 1.0 109.949 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.2 m -123.53 115.42 21.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.254 0.549 . . . . 1.0 111.576 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.525 HD23 ' HB1' ' A' ' 115' ' ' ALA . 46.4 tp -81.29 129.41 34.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.266 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.48 152.04 40.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 1.0 111.477 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -109.6 122.94 48.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.71 ' NH1' HD21 ' A' ' 41' ' ' ASN . 66.4 ttp85 -134.63 137.16 43.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.097 0.475 . . . . 1.0 110.688 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.71 HD21 ' NH1' ' A' ' 40' ' ' ARG . 67.7 m-20 60.27 34.2 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.442 -0.799 . . . . 1.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.13 24.01 76.02 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -132.73 150.07 52.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.446 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 59.7 m-85 -92.06 130.27 37.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -143.07 143.14 31.74 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.014 0.435 . . . . 1.0 110.353 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 tp -104.58 129.17 52.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.38 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.0 126.72 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.493 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' HD12 ' A' ' 50' ' ' LEU . 77.7 mt-30 -108.05 128.16 54.42 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.87 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 52' ' ' GLU . 10.0 mp -106.76 129.72 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.322 -0.622 . . . . 1.0 109.322 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' LYS . 64.2 t-80 -43.07 95.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.59 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' LEU . 6.1 pt-20 -37.04 96.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.11 0.481 . . . . 1.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' HIS . 69.1 mttm -61.53 -37.93 85.56 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.916 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.39 -17.77 0.28 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.199 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -143.48 164.47 30.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.744 0.307 . . . . 1.0 110.844 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 55.6 p-80 -69.69 116.99 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.98 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 30.7 m -119.85 130.84 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.895 0.378 . . . . 1.0 110.43 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.446 HE22 ' HD3' ' A' ' 11' ' ' PRO . 50.5 tt0 -151.19 108.26 3.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.809 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.07 117.93 32.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.753 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.17 114.19 29.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.926 0.393 . . . . 1.0 110.313 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mm -110.6 116.86 51.92 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.122 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.6 151.71 41.99 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.784 1.656 . . . . 1.0 112.552 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.53 ' CG2' HE22 ' A' ' 123' ' ' GLN . 96.9 mt -93.71 122.09 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.475 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' PHE . 46.2 p30 -170.73 -163.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.383 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -59.0 -40.93 86.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -66.2 -36.15 82.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.995 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 64' ' ' ASN . 36.5 t80 -95.09 129.59 42.12 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.961 0.41 . . . . 1.0 110.327 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -136.35 146.83 46.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.242 0.544 . . . . 1.0 111.234 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 69' ' ' CYS . 28.2 p -115.47 110.23 18.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.369 -0.832 . . . . 1.0 109.423 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.93 135.42 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.862 0.363 . . . . 1.0 110.797 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.604 HE21 ' CB ' ' A' ' 87' ' ' CYS . 57.6 tt0 -103.41 122.07 44.12 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.87 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 42.78 18.23 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.105 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 71' ' ' GLN . . . -133.62 148.34 51.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.954 -0.567 . . . . 1.0 111.056 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.03 -39.22 79.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.478 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -160.5 78.68 0.64 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.51 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.1 m -140.75 70.07 1.35 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.452 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' H ' HD12 ' A' ' 77' ' ' LEU . 4.8 mp -71.28 -27.78 63.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.408 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 78' ' ' LEU . 11.0 mp -62.28 -40.49 96.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.563 -0.29 . . . . 1.0 110.303 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.3 mt -110.36 126.76 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.277 0.561 . . . . 1.0 110.856 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 34.8 p-10 -157.1 -41.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.579 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 97.4 mt -67.69 -24.21 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.965 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 36.9 t -115.86 127.32 54.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.095 0.474 . . . . 1.0 110.333 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 85' ' ' SER . 10.4 m120 -148.7 -176.94 5.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.236 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 79.49 91.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.19 79.91 0.07 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.224 -1.55 . . . . 1.0 109.224 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.604 ' CB ' HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -115.98 148.18 40.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.777 0.322 . . . . 1.0 111.404 -177.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -106.84 139.65 40.92 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.551 ' C ' HH11 ' A' ' 90' ' ' ARG . 1.8 pp -128.02 161.33 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.551 HH11 ' C ' ' A' ' 89' ' ' ILE . 1.7 mpt_? -126.27 145.84 50.25 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.343 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.5 t -124.57 135.37 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.192 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.445 ' NE2' ' CD ' ' A' ' 98' ' ' GLU . 48.7 mm-40 -128.34 148.92 50.7 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.846 -0.616 . . . . 1.0 110.247 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 96' ' ' ILE . . . -164.5 150.45 18.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -71.02 -46.61 61.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.714 0.292 . . . . 1.0 111.764 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.518 ' CD1' HG23 ' A' ' 96' ' ' ILE . 1.2 p-90 -82.48 -8.23 59.62 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.9 0.333 . . . . 1.0 111.9 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.518 HG23 ' CD1' ' A' ' 95' ' ' TRP . 35.0 pt -127.94 153.88 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.682 0.277 . . . . 1.0 110.731 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' NH2' ' A' ' 99' ' ' ARG . 35.2 ptt-85 -84.5 164.47 18.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.839 0.352 . . . . 1.0 110.664 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' CD ' ' NE2' ' A' ' 92' ' ' GLN . 83.3 tt0 -65.94 127.25 31.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.508 ' NH2' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -130.02 137.51 50.29 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.408 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.411 ' NH1' ' CZ ' ' A' ' 90' ' ' ARG . 95.2 mtt-85 -99.91 152.62 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.829 0.347 . . . . 1.0 111.115 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.08 155.23 42.02 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.966 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -146.62 135.23 22.11 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.894 0.378 . . . . 1.0 111.166 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mm -107.2 103.06 46.64 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.93 -11.84 29.87 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.475 1.45 . . . . 1.0 112.827 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -97.96 121.71 40.2 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.75 -48.79 79.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.64 -0.709 . . . . 1.0 112.41 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -59.65 -40.17 86.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.453 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -71.17 -39.88 71.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.0 110.677 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -56.39 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.358 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.78 -37.81 88.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.314 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -62.54 -45.55 92.43 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.772 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -61.21 -51.33 69.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.072 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 89' ' ' ILE . 94.9 mt -65.6 -42.29 91.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.26 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.5 p -64.71 -46.7 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 1.0 111.6 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB1' HD23 ' A' ' 37' ' ' LEU . . . -64.92 -50.43 66.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.301 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.0 t -65.02 -44.88 95.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.8 tp -61.54 -46.76 88.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.097 0.475 . . . . 1.0 110.518 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.82 80.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.352 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 44' ' ' TYR . . . -62.2 -38.16 88.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.579 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -65.55 -44.97 85.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.863 0.363 . . . . 1.0 111.201 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -66.39 -43.13 86.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.402 0.62 . . . . 1.0 110.484 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.47 77.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.95 -1.023 . . . . 1.0 111.888 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.53 HE22 ' CG2' ' A' ' 63' ' ' ILE . 6.5 pt20 -72.05 -40.31 68.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.625 -179.815 . . . . . . . . 0 0 . 1 stop_ save_